FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Maron, DF
AF Maron, Dina Fine
TI Zika's Global Connections
SO SCIENTIFIC AMERICAN
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0036-8733
J9 SCI AM
JI Sci.Am.
PD JUL
PY 2016
VL 315
IS 1
BP 16
EP 16
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO8GW
UT WOS:000378022200019
PM 27348367
DA 2020-07-08
ER

PT J
AU Lyra, PPR
   Campos, GS
   Bandeira, ID
   Sardi, SI
   Costa, LFD
   Santos, FR
   Ribeiro, CAS
   Jardim, AMB
   Santiago, ACT
   de Oliveira, PMR
   Moreira, LMO
AF Ribeiro Lyra, Priscila Pinheiro
   Campos, Gubio Soares
   Bandeira, Igor Dorea
   Sardi, Silvia Ines
   de Moura Costa, Lilian Ferreira
   Santos, Flavia Rocha
   Santos Ribeiro, Carlos Alexandre
   Barreto Jardim, Alena Maria
   Travassos Santiago, Ana Cecilia
   Ribeiro de Oliveira, Patricia Maria
   Oliveira Moreira, Licia Maria
TI Congenital Chikungunya Virus Infection after an Outbreak in Salvador,
   Bahia, Brazil
SO AJP REPORTS
LA English
DT Article
DE newborn; chikungunya; congenital; infection
ID TRANSMISSION
AB There is little information about the congenital chikungunya virus (CHIKV) transmission. We describe two cases of well-documented congenital CHIKV infection in Salvador-Brazil, where CHIKV has been identified since 2014. The outbreak in the city led to the clinical CHIKV diagnoses of both pregnant women 2 days before delivery. Urine and blood samples from the mothers and newborns were collected and tested for reverse transcription-polymerase chain reaction (PCR) analysis for Zika, dengue, and CHIKV. Both neonates and mothers had positive urine and serum PCR results for CHIKV. The newborns had significant perinatal complications and were admitted to the neonatal intensive care unit. The purpose of our case report is to show how severe congenital CHIKV infection can be and the importance to include CHIKV infection in the differential diagnosis of neonatal sepsis when mothers have clinical signs of the disease and live in an affected area.
C1 [Ribeiro Lyra, Priscila Pinheiro; Bandeira, Igor Dorea; Santos Ribeiro, Carlos Alexandre; Barreto Jardim, Alena Maria; Travassos Santiago, Ana Cecilia; Ribeiro de Oliveira, Patricia Maria; Oliveira Moreira, Licia Maria] Univ Fed Bahia, Sch Med, Climerio Oliveira Matern, Dept Pediat, Salvador, BA, Brazil.
   [Campos, Gubio Soares; Sardi, Silvia Ines; de Moura Costa, Lilian Ferreira; Santos, Flavia Rocha] Univ Fed Bahia, Hlth Sci Inst, Virol Lab, Salvador, BA, Brazil.
RP Lyra, PPR (corresponding author), Univ Fed Bahia, Dept Pediat, Ave Reitor Miguel Calmon S-N, BR-40110060 Salvador, Bahia, Brazil.
EM priscilalyra@yahoo.com
RI amsalu, ribka/G-8780-2019; Bandeira, Igor Dorea/J-8835-2015
OI Bandeira, Igor Dorea/0000-0002-6714-2658
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramful D, 2014, J INFECT DIS, V209, P1726, DOI 10.1093/infdis/jit814
   Ritz N, 2015, PEDIATR INFECT DIS J, V34, P789, DOI 10.1097/INF.0000000000000716
   Vasani R, 2016, PEDIATR DERMATOL, V33, P209, DOI 10.1111/pde.12650
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
NR 11
TC 8
Z9 8
U1 0
U2 3
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 2157-6998
EI 2157-7005
J9 AJP REP
JI AJP Rep.
PD JUL
PY 2016
VL 6
IS 3
BP E299
EP E300
DI 10.1055/s-0036-1587323
PG 2
WC Pediatrics
SC Pediatrics
GA DU9IV
UT WOS:000382531200008
PM 27555980
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Christofferson, RC
AF Christofferson, Rebecca C.
TI Zika Virus Emergence and Expansion: Lessons Learned from Dengue and
   Chikungunya May Not Provide All the Answers
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Review
ID AEGYPTI LINNAEUS; AEDES-AEGYPTI; INFECTION; AMERICAN; SUSCEPTIBILITY;
   TRANSMISSION; ARBOVIRUSES; ANTIBODIES; OUTBREAK; NIGERIA
AB Following the emergence of Zika in the past decade, there are lessons to be learned from similar emergence events of dengue (DENV) and chikungunya (CHIKV). Specifically, as Zika emerges in the Americas there is a natural tendency to apply the knowledge base of DENV and CHIKV to mitigation and control of a virus with such a similar transmission system. However, there are marked differences that may preclude such broad stroke application of this knowledge base without making potentially faulty assumptions. Herein, Zika virus (ZIKV) transmission is reviewed, and the commonalities among these three arboviruses are discussed. Importantly, the divergence of this particular arbovirus is discussed, as is the need to develop ZIKV-specific knowledge base for mitigation of this disease. Specifically reviewed are 1) emergence and persistence patterns, 2) genetic and phenotypic diversity, 3) vector host range, and finally, 4) alternate transmission routes and added complexity of ZIKV transmission and presentation.
C1 [Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
RP Christofferson, RC (corresponding author), Sch Vet Med, Dept Pathobiol Sci, Skip Bertman Dr, Baton Rouge, LA 70803 USA.
EM rcarri1@lsu.edu
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Besnard M, 2014, EURO SURVEILL, V19
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MONATH TP, 1980, AM J TROP MED HYG, V29, P624, DOI 10.4269/ajtmh.1980.29.624
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   ProMED-mail, 2015, ZIK VIR AM
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P443
   Sato Rumi, 2015, Trop Med Health, V43, P85, DOI 10.2149/tmh.2014-34
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2013, EURO SURVEILL, V19
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 33
TC 20
Z9 21
U1 2
U2 7
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUL
PY 2016
VL 95
IS 1
BP 15
EP 18
DI 10.4269/ajtmh.15-0866
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3UX
UT WOS:000400206100005
PM 26903610
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ladhani, SN
   O'Connor, C
   Kirkbride, H
   Brooks, T
   Morgan, D
AF Ladhani, Shamez N.
   O'Connor, Catherine
   Kirkbride, Hilary
   Brooks, Tim
   Morgan, Dilys
TI Outbreak of Zika virus disease in the Americas and the association with
   microcephaly, congenital malformations and Guillain-Barre syndrome
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Article
ID TRANSMISSION
C1 [Ladhani, Shamez N.; O'Connor, Catherine; Kirkbride, Hilary; Morgan, Dilys] Publ Hlth England, Natl Infect Serv, 61 Colindale Ave, London NW9 5EQ, England.
   [Ladhani, Shamez N.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England.
   [Brooks, Tim] Publ Hlth England, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.
RP Ladhani, SN (corresponding author), Publ Hlth England, Immunisat Dept, 61 Colindale Ave, London NW9 5EQ, England.
EM shamez.ladhani@phe.gov.uk
CR Arzusa-Ortega L, 2016, EMERGING INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 5
TC 19
Z9 20
U1 1
U2 98
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD JUL
PY 2016
VL 101
IS 7
BP 600
EP 602
DI 10.1136/archdischild-2016-310590
PG 3
WC Pediatrics
SC Pediatrics
GA DO8WF
UT WOS:000378065400004
PM 26998633
OA Green Published, Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Emerging Zika virus infection: What should we know?
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
AB Zika virus infection is a new emerging viral disease that becomes the present public health threat. At present, this infection can be seen in several countries. The clinical presentation of this infection is a dengue-like illness. Nevertheless, the new information shows that the disease can be sexually transmitted and transplacentally transmitted. In addition, the recent evidence from the recent epidemic in South America shows that the infection in pregnancy can cause neonatal neurological defect. In this short review, the author summarizes and presents interesting data on clinical features of this new emerging infection.
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Dowd A., 2016, BMJ-BRIT MED J, V352, pi692
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Valeyrie-Allanore L, 2015, ANN DERMATOL VENER, V142, pS1, DOI 10.1016/S0151-9638(16)30001-1
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 31
TC 1
Z9 1
U1 0
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD JUL
PY 2016
VL 6
IS 7
BP 551
EP 553
DI 10.1016/j.apjtb.2016.03.014
PG 3
WC Tropical Medicine
SC Tropical Medicine
GA DP6OR
UT WOS:000378617000001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Jamil, Z
   Waheed, Y
   Durrani, TZ
AF Jamil, Zubia
   Waheed, Yasir
   Durrani, Taimoor Zeb
TI Zika virus, a pathway to new challenges
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Public health emergency; Microcephaly; Guillian-Barre
   syndrome; Mosquito bites
ID INFECTION; OUTBREAK; BRAZIL; AMERICA
AB The current Zika outbreak is largest of its kind with 1.4 million cases in Brazil alone. World Health Organization declared the current outbreak as the public health emergency of international concerns. The major route of Zika virus transmission is mosquito bites. Sexual transmission and monkey bites are also observed in few cases. There is dire need to evaluate the other routes of transmission like blood transfusion, lactation and contact with body fluids. Zika virus is infecting infants, not only causing microcephaly but also creating number of complications resulting in bad outcomes of pregnancy. In Brazil alone, 4 000 cases of microcephaly have observed during the current outbreak. The incidence of Guillian-Barre (GB) syndrome is also observed during the current Zika virus outbreak. GB syndrome is acute medical condition leading the patients to death due to weakness of respiratory muscles or can cause the life time disability. There is no anti-viral drug or vaccine available for Zika virus. Zika infection can be prevented by using mosquito repellents, mosquito nets, cooling rooms by air conditions and wearing full sleeves or permethrin treated clothes. The current outbreak of Zika has not only affected the health care but also caused great economic loss. Estimated loss in Latin America and Caribbean is US$3.5 billion. United Nation's sustainable development goal 3.d stresses the strengthening of early warning, risk reduction and management of national and global health risks. The world will keep on facing new challenges in the form of Ebola or Zika; there is strong need to prepare ourselves for any disease outbreak.
C1 [Jamil, Zubia] Fauji Fdn Hosp, Rawalpindi 46000, Pakistan.
   [Waheed, Yasir] Fdn Univ Islamabad, Fdn Univ Med Coll, DHA Phase 1, Islamabad 44000, Pakistan.
   [Durrani, Taimoor Zeb] Illikhar Eye Hosp, Liver Clin, Mayo Rd, Islamabad 44000, Pakistan.
RP Waheed, Y (corresponding author), Fdn Univ Islamabad, Fdn Univ Med Coll, DHA Phase 1, Islamabad 44000, Pakistan.
EM yasir_waheed_199@hotmail.com
RI Waheed, Yasir/AAC-3896-2019; Waheed, Yasir/F-6390-2015
OI Waheed, Yasir/0000-0002-5789-4215; Waheed, Yasir/0000-0002-5789-4215
FU University Medical College; Foundation University Islamabad, DHA-I
   Islamabad, Pakistan
FX University Medical College. Foundation University Islamabad, DHA-I
   Islamabad (44000), Pakistan.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duhaime-Ross A, 2016, THE VERGE
   Elgot J., 2016, GUARDIAN
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korte G., 2016, US TODAY
   LAWDER D., 2016, REUTERS
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Maurice J, 2016, LANCET INFECT DIS
   Musso D, 2015, EMERG INFECT DIS, V21, P552
   Palmer KM, 2016, CDC SEES BIRTH DEFEC
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   REUTERS, 2016, REUTERS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stewart A, 2016, VACCINE ZIKA VIRUS M
   Tozzi J, 2016, 9 PREGNANT AM TOURIS
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 23
TC 20
Z9 21
U1 0
U2 80
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 606
EP 609
DI 10.1016/j.apjtm.2016.05.020
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500002
PM 27393088
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lissauer, D
   Smit, E
   Kilby, MD
AF Lissauer, D.
   Smit, E.
   Kilby, M. D.
TI Zika virus and pregnancy
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
ID GUILLAIN-BARRE-SYNDROME; FRENCH-POLYNESIA; INFECTION
C1 [Lissauer, D.; Kilby, M. D.] Univ Birmingham, Inst Metab & Syst Res, Coll Med & Dent Sci, Ctr Womens & Newborn Hlth, Birmingham, W Midlands, England.
   [Lissauer, D.; Kilby, M. D.] Birmingham Womens Fdn Trust Birmingham Hlth Partn, Fetal Med Ctr, Birmingham, W Midlands, England.
   [Smit, E.] Heart England NHS Fdn Trust, Publ Hlth England, West Midlands Publ Hlth Lab, Birmingham, W Midlands, England.
RP Kilby, MD (corresponding author), Birmingham Womens Fdn Trust, Acad Unit, Third Floor, Birmingham B15 2TG, W Midlands, England.
EM m.d.kilby@bham.ac.uk
OI Kilby, Mark/0000-0001-9987-4223; Lissauer, David/0000-0002-7878-2327
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MR/K007408/1]; Academy of Medical Sciences (AMS)Academy of Medical
   Sciences (AMS) [AMS-SGCL11-Lissauer]
CR [Anonymous], INT RCOG RCM PHE HPS
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, CDC HLTH ADV REC MAN
   CDC, 2016, ZIK VIR
   European Centre for Disease Prevention and Control, 2016, ZIK INF EP SIT
   Freire CCM, 2015, BIORXIV
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pan American Health Organisation, NEUR SYNDR CONG MALF
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vouga M, 2016, LANCET
   WICKS E, 2004, MED LAW REV, V12, P285, DOI DOI 10.1093/MED-LAW/12.3.285
NR 19
TC 8
Z9 8
U1 0
U2 71
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1258
EP 1263
DI 10.1111/1471-0528.14071
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500003
PM 27150456
OA Bronze
DA 2020-07-08
ER

PT J
AU Musso, D
   Gubler, DJ
AF Musso, Didier
   Gubler, Duane J.
TI Zika Virus
SO CLINICAL MICROBIOLOGY REVIEWS
LA English
DT Review
ID WEST-NILE-VIRUS; GUILLAIN-BARRE-SYNDROME; DENGUE HEMORRHAGIC-FEVER;
   RIFT-VALLEY FEVER; ALBOPICTUS DIPTERA-CULICIDAE;
   REVERSE-TRANSCRIPTASE-PCR; ARTHROPOD-BORNE VIRUSES; ROSS RIVER VIRUS;
   YELLOW-FEVER; CHIKUNGUNYA VIRUS
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the genus Flavivirus and the family Flaviviridae. ZIKV was first isolated from a nonhuman primate in 1947 and from mosquitoes in 1948 in Africa, and ZIKV infections in humans were sporadic for half a century before emerging in the Pacific and the Americas. ZIKV is usually transmitted by the bite of infected mosquitoes. The clinical presentation of Zika fever is nonspecific and can be misdiagnosed as other infectious diseases, especially those due to arboviruses such as dengue and chikungunya. ZIKV infection was associated with only mild illness prior to the large French Polynesian outbreak in 2013 and 2014, when severe neurological complications were reported, and the emergence in Brazil of a dramatic increase in severe congenital malformations (microcephaly) suspected to be associated with ZIKV. Laboratory diagnosis of Zika fever relies on virus isolation or detection of ZIKV-specific RNA. Serological diagnosis is complicated by cross-reactivity among members of the Flavivirus genus. The adaptation of ZIKV to an urban cycle involving humans and domestic mosquito vectors in tropical areas where dengue is endemic suggests that the incidence of ZIKV infections may be underestimated. There is a high potential for ZIKV emergence in urban centers in the tropics that are infested with competent mosquito vectors such as Aedes aegypti and Aedes albopictus.
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, France.
   [Gubler, Duane J.] Duke NUS Med Sch, Program Emerging Infect Dis, Signature Res, Singapore, Singapore.
   [Gubler, Duane J.] Partnership Dengue Control, Lyon, France.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, France.; Gubler, DJ (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, Signature Res, Singapore, Singapore.; Gubler, DJ (corresponding author), Partnership Dengue Control, Lyon, France.
EM dmusso@ilm.pf; duane.gubler@duke-nus.edu.sg
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0
   Abraham Alon, 2011, J Clin Neuromuscul Dis, V12, P113, DOI 10.1097/CND.0b013e318209ef9a
   ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005
   Ameline M, 2014, ANN DERMATOL VENER, V141, pS447
   ANDRAL L, 1968, B WORLD HEALTH ORGAN, V38, P855
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Arzuza-Ortega L, 2016, EMERG INFECT DIS LET
   Atkinson B, 2016, EMERG INFECT DIS
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Aubry A, 2015, 64 ANN M AM SOC TROP
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Aubry M, 2012, J CLIN VIROL, V55, P23, DOI 10.1016/j.jcv.2012.05.010
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barber B, 2009, AUST FAM PHYSICIAN, V38, P586
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2009, EUROSURVEILLANCE, V14, P22
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BEARCROFT WGC, 1957, J PATHOL BACTERIOL, V74, P295, DOI 10.1002/path.1700740207
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Berge T, 1975, INT CATALOG ARBOVIRU
   Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bierlaire D, 2014, TRANSFUS CLIN BIOL, V21, P234, DOI DOI 10.1016/J.TRACLI.2014.08.005
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Brust KB, 2014, IDCases, V1, P95, DOI 10.1016/j.idcr.2014.10.009
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CALISHER CH, 1980, INTERVIROLOGY, V14, P229, DOI 10.1159/000149190
   Calisher CH, 2001, EMERG INFECT DIS, V7, P756
   Calvet G., 2016, LANCET INFECT DIS
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Camacho E, 2016, EMERG INFECT DIS LET
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Canals M, 2012, REV CHIL INFECTOL, V29, P388, DOI 10.4067/S0716-10182012000400004
   Cao-Lormeau V-M, 2016, EMERG INFECT DIS
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Cao-Lormeau VM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-35
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   CAREY DE, 1972, B WORLD HEALTH ORGAN, V46, P645
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CASALS J, 1963, AM J TROP MED HYG, V12, P587, DOI 10.4269/ajtmh.1963.12.587
   Casals J., 1966, 9 P S INT C MICR MOS, P441
   Casals J., 1971, COMP VIROLOGY, P307
   CASALS JORDI, 1957, TRANS NEW YORK ACAD SCI, V19, P219
   Centers for Disease Control and Prevention, 2009, BIOS MICR BIOM LAB
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Chambers T., 2008, ENCY VIROLOGY, P241
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   CHANG GJJ, 1994, J CLIN MICROBIOL, V32, P477, DOI 10.1128/JCM.32.2.477-483.1994
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   CHIPPAUX.C, 1966, B WORLD HEALTH ORGAN, V34, P105
   Chippaux-Hyppolite C, 1965, Bull Soc Pathol Exot Filiales, V58, P812
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Clark BM, 2012, J CLIN VIROL, V54, P376, DOI 10.1016/j.jcv.2012.04.012
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Coelho GE, 2012, REV INST MED TROP SP, V54, pS13, DOI 10.1590/S0036-46652012000700006
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Delaunay P, 2009, ARCH PEDIATRIE, V16, pS66, DOI 10.1016/S0929-693X(09)75304-7
   Delbue S, 2014, J NEUROVIROL, V20, P437, DOI 10.1007/s13365-014-0276-0
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Di Sabatino D, 2014, BIOMED RES INT, DOI 10.1155/2014/907852
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dickinson D B, 1965, S Afr J Med Sci, V30, P11
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR FR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, MON CURR THREATS ECD
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Fang MY, 1997, MICROBIOL IMMUNOL, V41, P209, DOI 10.1111/j.1348-0421.1997.tb01192.x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   FILIPE AR, 1975, AM J TROP MED HYG, V24, P516, DOI 10.4269/ajtmh.1975.24.516
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2015, BLOOD TRANSFUS
   Franco L, 2010, EUROSURVEILLANCE, V15, P5
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   GONZALEZ JP, 1979, B SOC PATHOL EXOT, V72, P416
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   Gubler DJ, 2012, HUNTERS TROPICAL MED, P1012
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW A. J., 1961, BULL ENTOMOL RES, V52, P317, DOI 10.1017/S0007485300055449
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P271, DOI 10.1080/00034983.1948.11685376
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1956, P SOC EXP BIOL MED, V91, P521
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hanley KA, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P351, DOI 10.1016/B978-0-12-374153-0.00016-3
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P787
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Himeidan YE, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00169
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Holder P, 2010, J MED ENTOMOL, V47, P600, DOI 10.1603/ME09111
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   KERR JA, 1952, J IMMUNOL, V68, P461
   Kiedrzynski T., 1998, Pacific Health Dialog, V5, P129
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kimura R, 1944, NIPPON IGAKU, V3379, P629
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Kojima G, 2015, EMERG INFECT DIS, V21, P182, DOI 10.3201/eid2101.141581
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuno G, 2001, ACTA VIROL, V45, P139
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Laigret J, 1964, B SOC PATHOL EXOT, V60, P339
   Laird Marshall, 1994, New Zealand Entomologist, V17, P14
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti Robert S, 2003, Adv Virus Res, V61, P67, DOI 10.1016/S0065-3527(03)61002-X
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lanciotti RS, 2016, EMERG INFECT DIS
   Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Lucey DR, 2016, JAMA
   Macesis N, 2015, CLIN INFECT DIS, V61, P1485
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Mallet HP., 2014, 15 JOURN NAT INF BOR, P28
   Marano G, 2015, BLOOD TRANSFUS
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   METTLER NE, 1971, APPL MICROBIOL, V22, P377, DOI 10.1128/AEM.22.3.377-379.1971
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, C BRAS HEM HEM TER C
   Musso D, 2016, LANCET INFECT DIS
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Musso D, 2014, INT J INFECT DIS, V20, P74, DOI 10.1016/j.ijid.2013.12.002
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nemes Z, 2004, EMERG INFECT DIS, V10, P1880, DOI 10.3201/eid1010.040464
   Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
   Nhan T-X, 2014, REV FRANCOPH LAB, V467, P45
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   Nicholson J, 2014, J MED ENTOMOL, V51, P661, DOI 10.1603/ME13204
   Noel Martine, 2005, Pac Health Dialog, V12, P39
   Novella IS, 2011, J MOL MICROB BIOTECH, V21, P71, DOI 10.1159/000332752
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oki M, 2013, EPIDEMIOL INFECT, V141, P2612, DOI 10.1017/S0950268813000447
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV LA
   Pan American Health Organization, 2015, EPIDEMIOLOGICAL ALER
   Pan American Health Organization, 2015, EP UPD ZIK VIR INF
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Paquet C, 2006, EUROSURVEILLANCE, V11
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Perret C, 2003, EMERG INFECT DIS, V9, P1465, DOI 10.3201/eid0911.020788
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2001, EMERG INFECT DIS, V7, P611
   Petersen LR, 2004, NEW ENGL J MED, V351, P2257, DOI 10.1056/NEJMp048261
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   PINTO MR, 1967, B WORLD HEALTH ORGAN, V37, P101
   Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60
   PORTERFIELD JS, 1978, INTERVIROLOGY, V9, P129, DOI 10.1159/000148930
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Powers AM, 2009, FUTURE VIROL, V4, P391, DOI 10.2217/FVL.09.19
   Prado I, 2005, J VIROL METHODS, V125, P75, DOI 10.1016/j.jviromet.2005.01.001
   ProMED-mail, 2015, ZIK VIR PAC VAN
   ProMED-mail, 2014, ZIK VIR PAC 03 NEW C
   ProMED-mail, 2015, UND ILLN BRAZ 02 ZIK
   ProMED-mail, 2015, ZIK VIR SUR
   ProMED-mail, 2014, ZIK VIR PAC 07 CHIL
   ProMED-mail, 2015, UND ILLN BRAZ NE RIO
   Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Richard V, 2015, 64 ANN M AM SOC TROP
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   ROBIN Y, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P833
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Robin Y, 1967, 7 C TECHN ORG COORD
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   SALAUN JJ, 1967, B WORLD HEALTH ORGAN, V37, P343
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sambiri V, 2008, NEW MICROBIOL, V31, P303
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P843
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Simmonds P., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN K. C, 1959, S AFRICAN MED JOUR, V33, P555
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74, DOI 10.1080/00034983.1949.11685396
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130, DOI 10.3181/00379727-77-18700
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Smithburn KC, 1941, AM J TROP MED HYG, V21, P75
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   TAYLOR RM, 1952, J IMMUNOL, V68, P473
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   THEILER M, 1958, AM J TROP MED HYG, V7, P585, DOI 10.4269/ajtmh.1958.7.585
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tukei P., 1974, YELLOW FEVER INFECT
   van den Hurk AF, 2010, VECTOR-BORNE ZOONOT, V10, P489, DOI 10.1089/vbz.2009.0106
   Vandenbogaert M, 2014, 63 AM SOC TROP MED H
   Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis V, 2016, ARBOVIRUSES MOL BIOL
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Ville Y, 2014, CURR OPIN INFECT DIS, V27, P251, DOI 10.1097/QCO.0000000000000066
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2005, ARCH VIROL, P33
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   WHO, 2007, GUID PLAQ RED NEUTR
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1961, WHO TECH REP SER, V219, P1
   World Health Organization, 2014, AS PAC STRAT EM DIS
   World Health Organization, 2014, GUID REG TRANSP INF
   World Health Organization, 2014, PAC SYNDR SURV REP W
   World Health Organization, 2014, DENG PAC SIT UPD 26
   World Health Organization, 1967, WHO TECH REP SER, V369, P1
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
NR 436
TC 601
Z9 608
U1 24
U2 486
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0893-8512
EI 1098-6618
J9 CLIN MICROBIOL REV
JI Clin. Microbiol. Rev.
PD JUL
PY 2016
VL 29
IS 3
BP 487
EP 524
DI 10.1128/CMR.00072-15
PG 38
WC Microbiology
SC Microbiology
GA DK6TI
UT WOS:000375057900003
PM 27029595
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Panchaud, A
   Stojanov, M
   Ammerdorffer, A
   Vouga, M
   Baud, D
AF Panchaud, Alice
   Stojanov, Milos
   Ammerdorffer, Anne
   Vouga, Manon
   Baud, David
TI Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
SO CLINICAL MICROBIOLOGY REVIEWS
LA English
DT Review
ID WEST-NILE-VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CONGENITAL
   CYTOMEGALOVIRUS-INFECTION; YELLOW-FEVER VACCINE; UPDATE INTERIM
   GUIDANCE; CHAIN-REACTION ANALYSIS; N-LINKED GLYCOSYLATION;
   SPRAGUE-DAWLEY RAT; LOW-BIRTH-WEIGHT; UNITED-STATES
AB The rapid spread of the Zika virus (ZIKV) in the Americas and its potential association with thousands of suspected cases of microcephaly in Brazil and higher rates of Guillain-Barre syndrome meet the conditions for a Public Health Emergency of International Concern, as stated by the World Health Organization in February 2016. Two months later, the Centers for Disease Control and Prevention (CDC) announced that the current available evidence supports the existence of a causal relationship between prenatal Zika virus infection and microcephaly and other serious brain anomalies. Microcephaly can be caused by several factors, and its clinical course and prognosis are difficult to predict. Other pathogens with proven teratogenicity have been identified long before the current ZIKV epidemic. Despite the growing number of cases with maternal signs of infection and/or presence of ZIKV in tissues of affected newborns or fetuses, it is currently difficult to assess the magnitude of increase of microcephaly prevalence in Brazil, as well as the role of other factors in the development of congenital neurological conditions. Meanwhile, health agencies and medical organizations have issued cautious guidelines advising health care practitioners and expectant couples traveling to, returning from, or living in affected areas. Analogous to dengue virus (DENV) epidemics, ZIKV has the potential to become endemic in all countries infested by Aedes mosquitoes, while new mutations could impact viral replication in humans, leading to increased virulence and consequently heightened chances of viral transmission to additional naive mosquito vectors. Studies are urgently needed to answer the questions surrounding ZIKV and its role in congenital neurological conditions.
C1 [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Geneva, Switzerland.
   [Panchaud, Alice] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Panchaud, Alice] Univ Lausanne, Swiss Teratogen Informat Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Div Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice; Stojanov, Milos; Ammerdorffer, Anne; Vouga, Manon; Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
   [Stojanov, Milos; Ammerdorffer, Anne; Vouga, Manon; Baud, David] Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
   [Stojanov, Milos; Ammerdorffer, Anne; Vouga, Manon; Baud, David] Univ Lausanne, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
RP Baud, D (corresponding author), Univ Lausanne Hosp, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Panchaud, Alice/S-6535-2019; Ammerdorffer, Anne/G-8508-2016
OI Panchaud, Alice/0000-0001-6086-2401; Ammerdorffer,
   Anne/0000-0002-1059-061X; Baud, David/0000-0001-9914-6496
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [P3SMP3-158808/1]; SNSFSwiss National Science
   Foundation (SNSF) [323530_158123, 310030_156169/1]; Department
   Femme-Mere-Enfant; Fondation Leenaards through the Bourse pour la releve
   academique
FX The contribution of Alice Panchaud was supported by a grant of the Swiss
   National Science Foundation (SNSF P3SMP3-158808/1). Manon Vouga is
   funded through an M.D.-Ph.D. grant from the SNSF (323530_158123). David
   Baud is supported by the Department Femme-Mere-Enfant, by the Fondation
   Leenaards through the Bourse pour la releve academique, and by the SNSF
   (310030_156169/1).
CR Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   American Congress of Obstetricians and Gynecologists, 2016, PRACT ADV UPD INT GU
   American Congress of Obstetricians and Gynecologists, 2016, INT GUID CAR OBST PA
   Anderson JL, 2014, J CHILD NEUROL, V29, P837, DOI 10.1177/0883073813486295
   Andrews WW, 2000, AM J OBSTET GYNECOL, V183, P662, DOI 10.1067/mob.2000.106556
   [Anonymous], 2016, NATURE, V530, P5, DOI 10.1038/530005a
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Astroff AB, 1999, REPROD TOXICOL, V13, P223, DOI 10.1016/S0890-6238(99)00008-8
   Astroff AB, 2000, TERATOLOGY, V61, P222, DOI 10.1002/(SICI)1096-9926(200003)61:3<222::AID-TERA10>3.0.CO;2-M
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Banu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16105
   Barr DB, 2010, SCI TOTAL ENVIRON, V408, P790, DOI 10.1016/j.scitotenv.2009.10.007
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barton LL, 2001, CLIN INFECT DIS, V33, P370, DOI 10.1086/321897
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Baud D., 2015, New Microbes and New Infections, V3, P41, DOI 10.1016/j.nmni.2014.11.004
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Bayer A, 2016, CELL HOST MICROBE
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Benoist G, 2013, FETAL DIAGN THER, V33, P203, DOI 10.1159/000342752
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biesbroeck L, 2013, DERMATOL THER, V26, P433, DOI 10.1111/dth.12107
   Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009
   Bocanegra C, 2016, CLIN MICROBIOL INFEC
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Bonthius DJ, 2007, PLOS PATHOG, V3, P1541, DOI 10.1371/journal.ppat.0030149
   Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227
   Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530
   Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467
   Bowen V, 2015, MMWR-MORBID MORTAL W, V64, P1241, DOI 10.15585/mmwr.mm6444a3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brazil Ministry of Health, 2015, MIN HLTH REL EP B
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   BURNS KF, 1950, P SOC EXP BIOL MED, V75, P621, DOI 10.3181/00379727-75-18285
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996
   Calonge N, 2009, ANN INTERN MED, V150, P705
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Canada Society of Obstetricians and Gynecologists, 2016, SOGC REC ZIKA VIR EX
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcanti DP, 2007, TROP MED INT HEALTH, V12, P833, DOI 10.1111/j.1365-3156.2007.01851.x
   Centers for Disease Control and Prevention, 2016, TRANSCR CDC TEL ZIK
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centers for Disease Control Prevention, 2016, AV BUG BIT
   Centers for Disease Control Prevention, 2016, LYMPH CHOR LCM
   Centers for Disease Control Prevention, 2015, INS REP US SAF
   Centers for Disease Control Prevention, 2015, CONTR EFF AR BIRTH C
   Centre de Reference sur les Agents Teratogenes, 2016, REP GROSS ALL
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Chretien J-P, 2015, PLOS CURR
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Cire Antilles Guyane, 2016, EM VIR ZIK ANT GUYAN
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   College National des Gynecologues et Obstetriciens Francais, 2016, VIR ZIK FEMM ENC AG
   Conseil National Professionnel de Gynecologie et Obstetrique, 2016, VIR ZIKA FEMM ENC AG
   Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Crans WJ, 2004, J VECTOR ECOL, V29, P1
   D'Ortenzio E, 2016, N ENGL J MED
   Carneiro SCD, 2007, CLIN DERMATOL, V25, P212, DOI 10.1016/j.clindermatol.2006.05.009
   de Oliveira RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141852
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deloison B, 2012, PRENATAL DIAG, V32, P869, DOI 10.1002/pd.3923
   Department of Health of Australia, 2016, ZIK VIR INF CLIN PUB
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Direction de la Sante Centre d'hygiene et de salubrite publique, 2015, NOT INV AUT MALF CER
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dugas J, 2010, OCCUP ENVIRON MED, V67, P196, DOI 10.1136/oem.2009.047373
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i630
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Ergaz Z, 2006, REPROD TOXICOL, V21, P421, DOI 10.1016/j.reprotox.2005.01.006
   EUROCAT, 2016, CAS PREV PER 10000 B
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2016, UPD RAP RISK ASS ZIK
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FDA Center for Biologics Evaluation and Research, 2016, REC DON SCREEN DEF P
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Ferreira MC, 2014, GEOSPATIAL HEALTH, V9, P141, DOI 10.4081/gh.2014.12
   Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416
   FIUMARA N J, 1975, Clinical Obstetrics and Gynecology, V18, P183, DOI 10.1097/00003081-197503000-00016
   FIUMARA NJ, 1970, ARCH DERMATOL, V102, P78, DOI 10.1001/archderm.102.1.78
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18
   Freeman K, 2005, BJOG-INT J OBSTET GY, V112, P31, DOI 10.1111/j.1471-0528.2004.00299.x
   FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031
   Gambotto M, 2011, FETOLOGY DIAGNOSIS M
   Garcez P. P., 2016, SCIENCE
   Gay-Andrieu F, 2003, PRENATAL DIAG, V23, P558, DOI 10.1002/pd.632
   Gaytant MA, 2003, EUR J PEDIATR, V162, P248, DOI 10.1007/s00431-002-1115-3
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gilbert R, 2003, BJOG-INT J OBSTET GY, V110, P112
   Gilbert RE, 2002, J MED SCREEN, V9, P135, DOI 10.1136/jms.9.3.135
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gostin LO, 2016, JAMA-J AM MED ASSOC, V315, P1451, DOI 10.1001/jama.2016.1964
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Government of Canada, 2016, CAN REC PREC TREATM
   Government of the Commonwealth of Dominica, 2016, ZIK VIR THREAT DOM
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Guerra B, 2007, AM J OBSTET GYNECOL, V196, P221, DOI 10.1016/j.ajog.2006.08.039
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1322
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Haute Autorite de Sante, 2009, SURV SER PREV TOX RU
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heffernan C, 2015, LANCET INFECT DIS, V15, P143, DOI 10.1016/S1473-3099(14)71077-1
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hindiyeh M, 2001, EMERG INFECT DIS, V7, P748
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hodge JG, 2016, DISASTER MED PUBLIC, V34, P1
   HOHLFELD P, 1991, ULTRASOUND OBST GYN, V1, P241, DOI 10.1046/j.1469-0705.1991.01040241.x
   Hohlfeld P, 2012, LIVRE INTERNE OBSTET
   Hollier LM, 2001, OBSTET GYNECOL, V97, P947, DOI 10.1016/S0029-7844(01)01367-9
   Horton MK, 2011, PEDIATRICS, V127, pE699, DOI 10.1542/peds.2010-0133
   Huang XH, 2014, SCI WORLD J, DOI 10.1155/2014/954849
   Hutton J, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.046
   Instituto Fernandes Figueira da Fiocruz and Centro de Referencia da Rede de Banco de Leite Humano, 2015, COM INF
   Instituto Nacional de Salud Colombia, 2016, B EPIDEMIOLOGICO SEM
   International Committee on Taxonomy of Viruses, 2015, VIR TAX 2014 REL
   Jacquemard F, 2007, BJOG-INT J OBSTET GY, V114, P1113, DOI 10.1111/j.1471-0528.2007.01308.x
   Jampol LM, 2016, JAMA OPHTHALMOL
   Jin J, 2016, JAMA
   Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   KOMROWER GM, 1955, LANCET, V1, P697
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Latin American Colaborative Study of Congenital Malformations, 2015, ECLAMC FIN DOC
   Laurence B, 2008, OPHTHALMOLOGY, V115, P1100, DOI 10.1016/j.ophtha.2008.02.017
   Lazear HM, 2016, CELL HOST MICROBE
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Lim WK, 2004, OPHTHALMOLOGY, V111, P2057, DOI 10.1016/j.ophtha.2004.03.038
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   MacNeil A, 2012, EMERG INFECT DIS, V18, P1256, DOI 10.3201/eid1808.120212
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Mandelbrot L, 2012, PRENATAL DIAG, V32, P511, DOI 10.1002/pd.3843
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981
   Mayor S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1362
   Mbizvo MT, 2014, BEST PRACT RES CL OB, V28, P931, DOI 10.1016/j.bpobgyn.2014.04.014
   MCCARTHY M, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I1813
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i786
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McGee CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023247
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   McGready R, 2001, T ROY SOC TROP MED H, V95, P137, DOI 10.1016/S0035-9203(01)90137-3
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mehta Vandana, 2008, Dermatol Online J, V14, P8
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meritet JF, 2009, PRENATAL DIAG, V29, P626, DOI 10.1002/pd.2240
   Meroni V, 2009, CLIN VACCINE IMMUNOL, V16, P1517, DOI 10.1128/CVI.00253-09
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Ministere de la Sante Publique et de la Population de Haiti, 2016, FICH INF VIR ZIK
   Ministere Francais des affaires sociales de la sante et des droit des femmes, 2016, VIR ZIK DEB EP MART
   Ministry of Health of Jamaica, 2016, NOT MIN HLTH H DALL
   Ministry of Health of Mexico, 2016, ZIK VIR RIS GLOB HEA
   Ministry of health of New Zealand, 2016, ZIK VIR
   Ministry of Health of Samoa, 2016, SIT REP ZIK VIR
   Ministry of Health of Singapore, 2016, ZIK VIR
   Ministry of Health State of Israel, 2015, REC PERS TRAV ABR VI
   Miranda-Filho DDB, 2016, INITIAL DESCRIPTION
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   Monaghan AJ, 2016, PLOS CURR
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Mosti M, 2013, EPIDEMIOL INFECT, V141, P2192, DOI 10.1017/S0950268812002841
   MotherToBaby: a service of the Organization of Teratology Information Specialists, 2016, ZIK VIR PREGN ANSW
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET INFECT DIS
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mytton OT, 2007, BJOG-INT J OBSTET GY, V114, P582, DOI 10.1111/j.1471-0528.2007.01290.x
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0377
   Patz JA, 2001, TRENDS IMMUNOL, V22, P171, DOI 10.1016/S1471-4906(01)01867-1
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Peterman T., 2008, Morbidity and Mortality Weekly Report, V57, P872
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Platt KB, 2004, 02118 NAT PORK BOARD
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Porat S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0204-7
   Public Health Agency of Canada, 2016, ZIK VIR INF AM
   Public Health England, 2016, GUID VIR RASH PREGN
   Public Health England, 2016, NHS INF DIS PREGN SC
   Pulla P, WIRE
   Rac MWF, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.049
   Ramful D, 2014, J INFECT DIS, V209, P1726, DOI 10.1093/infdis/jit814
   Rashid U, 2015, JCPSP-J COLL PHYSICI, V25, pS137, DOI 10.2015/JCPSP.S137S139
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002
   Rios A, 1996, Pediatr Rev, V17, P386
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Robert E, 1999, VACCINE, V17, P283, DOI 10.1016/S0264-410X(98)00051-6
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   Ross SA, 2014, J INFECT DIS, V210, P1415, DOI 10.1093/infdis/jiu263
   Rossi SL, 2016, AM J TROP MED HYG
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roth-Harer A, 2001, ENVIRON TOXICOL PHAR, V9, P103, DOI 10.1016/S1382-6689(00)00069-7
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Royal College of Obstetricians and Gynaecologists, 2016, INT CLIN GUID ZIK VI
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Rudin C, 2008, SWISS MED WKLY, V138, P1
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sauerbrei A, 2007, MED MICROBIOL IMMUN, V196, P89, DOI 10.1007/s00430-006-0031-0
   Sauerbrei A, 2000, J Perinatol, V20, P548, DOI 10.1038/sj.jp.7200457
   SCHEFFER IE, 1991, DEV MED CHILD NEUROL, V33, P916
   SCHOENIG GP, 1994, FUND APPL TOXICOL, V23, P63, DOI 10.1006/faat.1994.1079
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEVER JL, 1988, PEDIATRICS, V82, P181
   SHIMIZU TAKEHIKO, 1954, JAPANESE JOUR EXPTL MED, V24, P363
   Simon-Loriere E, 2011, RNA BIOL, V8, P280, DOI 10.4161/rna.8.2.15193
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sint Maarten Ministry of Public Health Social Development and Labour, 2016, MULT GROUP MEETS PRE
   SKINNER HH, 1976, J HYG-CAMBRIDGE, V76, P299, DOI 10.1017/S0022172400055194
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   TABOR A, 1986, LANCET, V1, P1287
   Tan MP, 2006, REPROD TOXICOL, V21, P410, DOI 10.1016/j.reprotox.2005.04.011
   Tappe D, 2013, EURO SURVEILL, V19
   Teratology Information Service UK, 2014, CHEM INS REP
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   THAITHUMYANON P, 1994, CLIN INFECT DIS, V18, P248, DOI 10.1093/clinids/18.2.248
   Thalib L, 2005, BJOG-INT J OBSTET GY, V112, P567, DOI 10.1111/j.1471-0528.2005.00486.x
   Thiebaut R, 2007, LANCET, V369, P115
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.10.30163
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Ville Y, 2014, CURR OPIN INFECT DIS, V27, P251, DOI 10.1097/QCO.0000000000000066
   Villena I, 2003, PRENATAL DIAG, V23, P1098, DOI 10.1002/pd.754
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2013, J VIROL, V87, P9365, DOI 10.1128/JVI.00567-13
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Walker DG, 2002, LANCET INFECT DIS, V2, P432, DOI 10.1016/S1473-3099(02)00319-5
   Watemberg N, 2002, J CHILD NEUROL, V17, P117, DOI 10.1177/088307380201700205
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WELLER TH, 1957, P SOC EXP BIOL MED, V94, P4, DOI 10.3181/00379727-94-22841
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Wickerham EL, 2012, ENVIRON INT, V47, P80, DOI 10.1016/j.envint.2012.06.007
   Wilcken B, 2015, J PAEDIATR CHILD H, V51, P103, DOI 10.1111/jpc.12817
   Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446
   Wolff T, 2009, ANN INTERN MED, V150, P710, DOI 10.7326/0003-4819-150-10-200905190-00009
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2015, NEUR SYNDR CONG MALF
   World Health Organization, 2016, IHR PROC PUBL HLTH E
   World Health Organization, 2016, ZIK VIR
   World Health Organization, 2015, ZIK VIR OUTBR AM
   World Health Organization, 2016, ZIK VIR INF
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organization-Pan American Health Organisation, 2016, PREL GUID SURV MICR
   World Health Organization-Pan American Health Organisation, 2016, DOC HLTH CAR PROF
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yamada M, 2004, VET PATHOL, V41, P62, DOI 10.1354/vp.41-1-62
   Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018
   Yinon Y, 2010, OBSTET GYNECOL SURV, V65, P736, DOI 10.1097/OGX.0b013e31821102b4
   Yoon Jong Kwang, 2015, J Parasitol Res, V2015, P361021, DOI 10.1155/2015/361021
   Youn S, 2010, J VIROL, V84, P9516, DOI 10.1128/JVI.00775-10
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimmerman JJ, 2012, DIS SWINE
NR 348
TC 77
Z9 80
U1 1
U2 45
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0893-8512
EI 1098-6618
J9 CLIN MICROBIOL REV
JI Clin. Microbiol. Rev.
PD JUL
PY 2016
VL 29
IS 3
BP 659
EP 694
DI 10.1128/CMR.00014-16
PG 36
WC Microbiology
SC Microbiology
GA DU7MH
UT WOS:000382397800004
PM 27281741
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Schuler-Faccini, L
   Sanseverino, MTV
   Vianna, FSL
   da Silva, AA
   Larrandaburu, M
   Marcolongo-Pereira, C
   Abeche, AM
AF Schuler-Faccini, L.
   Sanseverino, M. T. V.
   Vianna, F. S. L.
   da Silva, A. A.
   Larrandaburu, M.
   Marcolongo-Pereira, C.
   Abeche, A. M.
TI Zika Virus: A New Human Teratogen? Implications for Women of
   Reproductive Age
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Editorial Material
AB In 2015 an unprecedented increase of reports of newborns with microcephaly in Brazil made news headlines around the world. A possible etiological association with prenatal maternal infection by Zika virus (ZIKV) was suggested based on temporal and geographic distribution of ZIKV infection and the subsequent increase in the reports of microcephaly cases. Here we discuss ZIKV as a new human teratogen, with comments on potential treatment options.
C1 [Schuler-Faccini, L.; Sanseverino, M. T. V.; Vianna, F. S. L.; da Silva, A. A.; Larrandaburu, M.; Abeche, A. M.] Hosp Clin Porto Alegre, Med Genet Serv, Brazilian Teratogen Informat Serv, SIAT, Porto Alegre, RS, Brazil.
   [Schuler-Faccini, L.; Sanseverino, M. T. V.; Vianna, F. S. L.; Larrandaburu, M.] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, BR-90046900 Porto Alegre, RS, Brazil.
   [da Silva, A. A.] UNIVATES Univ, Lajeado, RS, Brazil.
   [Marcolongo-Pereira, C.] UniRitter Laureate Int Univ, Vet Sci Fac, Porto Alegre, RS, Brazil.
   [Abeche, A. M.] Univ Fed Rio Grande do Sul, Obstet & Gynecol Dept, BR-90046900 Porto Alegre, RS, Brazil.
RP Schuler-Faccini, L (corresponding author), Hosp Clin Porto Alegre, Med Genet Serv, Brazilian Teratogen Informat Serv, SIAT, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, BR-90046900 Porto Alegre, RS, Brazil.
EM lavinia.faccini@ufrgs.br
RI Vianna, Fernanda Sales Luiz/O-4337-2019; Marcolongo-Pereira,
   Clairton/O-6931-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; SANSEVERINO,
   MARIA TERESA V/G-3884-2017; SCHULER-FACCINI, LAVINIA/K-2927-2016
OI Marcolongo-Pereira, Clairton/0000-0002-5593-3110; SCHULER-FACCINI,
   LAVINIA/0000-0002-2428-0460; SANSEVERINO, MARIA TERESA
   V/0000-0002-7404-2911; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
CR Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen E. E., 2016, MMWR MORB MORTAL WKL, P65
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Tang H, 2016, CELL STEM CELL
NR 10
TC 13
Z9 13
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9236
EI 1532-6535
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD JUL
PY 2016
VL 100
IS 1
BP 28
EP 30
DI 10.1002/cpt.386
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DO3UK
UT WOS:000377707200020
PM 27090438
DA 2020-07-08
ER

PT J
AU Rocklov, J
   Quam, MB
   Sudre, B
   German, M
   Kraemer, MUG
   Brady, O
   Bogoch, II
   Liu-Helmersson, J
   Wilder-Smith, A
   Semenza, JC
   Ong, M
   Aaslav, KK
   Khan, K
AF Rocklov, Joacim
   Quam, Mikkel Brandon
   Sudre, Bertrand
   German, Matthew
   Kraemer, Moritz U. G.
   Brady, Oliver
   Bogoch, Isaac I.
   Liu-Helmersson, Jing
   Wilder-Smith, Annelies
   Semenza, Jan C.
   Ong, Mark
   Aaslav, Kaja Kaasik
   Khan, Kamran
TI Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread
   of Zika Virus in Europe
SO EBIOMEDICINE
LA English
DT Article
DE ZIKV; Zika; Air travel; Globalization, mosquito; Climate; Aedes
ID UPDATE INTERIM GUIDANCE; AEDES-ALBOPICTUS; UNITED-STATES; DENGUE;
   TRANSMISSION; SUSCEPTIBILITY; AEGYPTI; TEXAS
AB The explosive Zika virus epidemic in the Americas is amplifying spread of this emerging pathogen into previously unaffected regions of the world, including Europe (Gulland, 2016), where local populations are immunologically naive. As summertime approaches in the northern hemisphere, Aedes mosquitoes in Europe may find suitable climatic conditions to acquire and subsequently transmit Zika virus from viremic travellers to local populations. While Aedes albopictus has proven to be a vector for the transmission of dengue and chikungunya viruses in Europe (Delisle et al., 2015; ECDC, n.d.) there is growing experimental and ecological evidence to suggest that it may also be competent for Zika virus(Chouin-Carneiro et al., 2016; Grard et al., 2014; Li et al., 2012; Wong et al., 2013). Here we analyze and overlay the monthly flows of airline travellers arriving into European cities from Zika affected areas across the Americas, the predicted monthly estimates of the basic reproduction number of Zika virus in areas where Aedes mosquito populations reside in Europe (Aedes aegypti in Madeira, Portugal and Ae. albopictus in continental Europe), and human populations living within areas where mosquito-borne transmission of Zika virus may be possible. We highlight specific geographic areas and timing of risk for Zika virus introduction and possible spread within Europe to inform the efficient use of human disease surveillance, vector surveillance and control, and public education resources. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Rocklov, Joacim; Quam, Mikkel Brandon; Liu-Helmersson, Jing; Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, S-90187 Umea, Sweden.
   [Sudre, Bertrand; Semenza, Jan C.; Aaslav, Kaja Kaasik] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
   [German, Matthew; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England.
   [Brady, Oliver] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Bogoch, Isaac I.] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Ong, Mark] Univ Waterloo, Geomat Program, Waterloo, ON, Canada.
RP Rocklov, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, S-90187 Umea, Sweden.
EM joacim.rocklov@umu.se
RI Wilder-Smith, Annelies/F-8751-2015
OI Rocklov, Joacim/0000-0003-4030-0449; Helmersson,
   Jing/0000-0001-9647-1015
FU European UnionEuropean Union (EU) [282589]; epidemic intelligence
   department at the European Centre for Disease Prevention and Control
   (ECDC)
FX This study is part of the DengueTools project funded by the European
   Union Seventh Framework Program FP7/2007-2013 under grant agreement no.
   282589. We acknowledge the support from the epidemic intelligence
   department at the European Centre for Disease Prevention and Control
   (ECDC).
CR ANDERSON R M, 1991
   Angelini R., 2007, EURO SURVEILL, V12
   [Anonymous], 2016, MOSQ MAPS
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau V. M., 2016, LANCET
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Clark GG, 2008, AM J TROP MED HYG, V78, P361, DOI 10.4269/ajtmh.2008.78.361
   Delisle E, 2015, EURO SURVEILL, V20
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dobson J. E., 2000, PHOTOGRAMM ENG REMOT, V66, P9
   ECDC, AED ALB
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP PREP
   Faria NR, 2016, SCIENCE
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S., 2016, BIORXIV
   Gil JF, 2016, ACTA TROP, V158, P24, DOI 10.1016/j.actatropica.2016.02.003
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i753
   Guzzetta G, 2016, EURO SURVEILL, V21
   Jupille H, 2016, BIORXIV
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski A. J, 2016, PLOS NEGL TROP DIS, V10
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lessler J, 2016, B WHO
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Majumder M. S., 2016, B WHO UNPUB
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maria AT, 2016, EURO SURVEILL, V21
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen L.R., 2016, N ENGL J MED
   Promed, 2015, ZIKA VIR BRAZIL CONF
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Stephenson TS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009127
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Wallinga J. L. M., 2007, P R SOC B, V274
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, ZIK VIR TECHN REP IN
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 52
TC 48
Z9 49
U1 0
U2 31
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUL
PY 2016
VL 9
BP 250
EP 256
DI 10.1016/j.ebiom.2016.06.009
PG 7
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA DT6VL
UT WOS:000381622500036
PM 27344225
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Plourde, AR
   Bloch, EM
AF Plourde, Anna R.
   Bloch, Evan M.
TI A Literature Review of Zika Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Review
ID AEDES-AEGYPTI; TRANSMISSION; INFECTION; OUTBREAK; SPREADS; AMERICA;
   VECTOR; ISLAND
AB Zika virus is a mosquitoborne flavivirus that is the focus of an ongoing pandemic and public health emergency. Previously limited to sporadic cases in Africa and Asia, the emergence of Zika virus in Brazil in 2015 heralded rapid spread throughout the Americas. Although most Zika virus infections are characterized by subclinical or mild influenza-like illness, severe manifestations have been described, including Guillain-Barre syndrome in adults and microcephaly in babies born to infected mothers. Neither an effective treatment nor a vaccine is available for Zika virus; therefore, the public health response primarily focuses on preventing infection, particularly in pregnant women. Despite growing knowledge about this virus, questions remain regarding the virus's vectors and reservoirs, pathogenesis, genetic diversity, and potential synergistic effects of co-infection with other circulating viruses. These questions highlight the need for research to optimize surveillance, patient management, and public health intervention in the current Zika virus epidemic.
C1 [Plourde, Anna R.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Bloch, Evan M.] Johns Hopkins Univ, Baltimore, MD USA.
   [Bloch, Evan M.] Blood Syst Res Inst, San Francisco, CA USA.
RP Plourde, AR (corresponding author), Univ Calif San Francisco, Dept Pathol & Lab Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.
EM anna.plourde@ucsf.edu
RI Bloch, Evan/G-7676-2018
OI Bloch, Evan/0000-0001-8181-9517
CR Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Centers for Disease Control and Prevention, 2016, ZIKA VIRUS DISEASE I
   Dallas County Health and Human Services, 2016, DCHHS REPORTS FIRST
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2016, ZIKA VIRUS DISEASE E
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaffigan TVWR, 2016, SYSTEMATIC CATALOG O
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   US Food and Drug Administration, 2016, RECOMMENDATIONS FOR
NR 40
TC 144
Z9 150
U1 3
U2 137
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1185
EP 1192
DI 10.3201/eid2207.151990
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900006
PM 27070380
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Waggoner, JJ
   Gresh, L
   Mohamed-Hadley, A
   Ballesteros, G
   Davila, MJV
   Tellez, Y
   Sahoo, MK
   Balmaseda, A
   Harris, E
   Pinsky, BA
AF Waggoner, Jesse J.
   Gresh, Lionel
   Mohamed-Hadley, Alisha
   Ballesteros, Gabriela
   Vargas Davila, Maria Jose
   Tellez, Yolanda
   Sahoo, Malaya K.
   Balmaseda, Angel
   Harris, Eva
   Pinsky, Benjamin A.
TI Single-Reaction Multiplex Reverse Transcription PCR for Detection of
   Zika, Chikungunya, and Dengue Viruses
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID TIME RT-PCR; PAN-DENGUE; MICRONESIA; ASSAYS
AB Clinical manifestations of Zika virus, chikungunya virus, and dengue virus infections can be similar. To improve virus detection, streamline molecular workflow, and decrease test costs, we developed and evaluated a multiplex real-time reverse transcription PCR for these viruses.
C1 [Waggoner, Jesse J.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Mohamed-Hadley, Alisha; Sahoo, Malaya K.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   [Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua.
   [Ballesteros, Gabriela; Vargas Davila, Maria Jose; Tellez, Yolanda; Balmaseda, Angel] Minist Hlth, Lab Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
RP Pinsky, BA (corresponding author), 3375 Hillview Ave,Room 2913, Palo Alto, CA 94304 USA.
EM bpinsky@stanford.edu
OI Gresh, Lionel/0000-0002-2333-1748; Pinsky, Benjamin/0000-0001-8751-4810;
   Sahoo, Malaya/0000-0001-9837-4032
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [K08AI110528]; American Society
   of Tropical Medicine and Hygiene; NIHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01AI099631,
   U54AI65359, HHSN2722001000026C]; Pediatric Dengue Vaccine Initiative
   [VE-1]
FX This research was supported by National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health (NIH) grant
   K08AI110528 (to J.J.W.) and the Robert E. Shope International Fellowship
   in Infectious Diseases from the American Society of Tropical Medicine
   and Hygiene. Studies in Nicaragua were supported by NIH grants
   R01AI099631 (to A.B.) and U54AI65359 (to A.B.), NIH contract
   HHSN2722001000026C (to E.H. and A.B.), and VE-1 (to E.H.) from the
   Pediatric Dengue Vaccine Initiative. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Diario El Nuevo, CONF CAS POS ZIK NIC
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 83
Z9 85
U1 1
U2 49
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1295
EP 1297
DI 10.3201/eid2207.160326
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900030
PM 27184629
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cerbino-Neto, J
   Mesquita, EC
   Souza, TML
   Parreira, V
   Wittlin, BB
   Durovni, B
   Lemos, MCF
   Vizzoni, A
   de Filippis, AMB
   Sampaio, SA
   Goncalves, BD
   Bozza, FA
AF Cerbino-Neto, Jose
   Mesquita, Emersom Cicilini
   Souza, Thiago Moreno L.
   Parreira, Viviane
   Wittlin, Bernardo Bastos
   Durovni, Betina
   Ferreira Lemos, Maria Cristina
   Vizzoni, Alexandre
   Bispo de Filippis, Ana Maria
   Sampaio, Simone Alves
   Goncalves, Bianca de Santis
   Bozza, Fernando A.
TI Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil,
   2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION; MICRONESIA; OUTBREAK
C1 [Cerbino-Neto, Jose; Mesquita, Emersom Cicilini; Souza, Thiago Moreno L.; Parreira, Viviane; Vizzoni, Alexandre; Bispo de Filippis, Ana Maria; Sampaio, Simone Alves; Goncalves, Bianca de Santis; Bozza, Fernando A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Wittlin, Bernardo Bastos; Durovni, Betina; Ferreira Lemos, Maria Cristina] Secretaria Municipal Saude Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RP Cerbino-Neto, J (corresponding author), Inst Nacl Infectol Evandro Chagas INI Fiocruz, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM cerbino@fiocruz.br
RI Bozza, Fernando A/A-2618-2013; Vizzoni, Alexandre/W-8718-2019; Souza,
   Thiago Moreno L./G-2900-2012; Neto, Jose Cerbino/P-3713-2018
OI Bozza, Fernando A/0000-0003-4878-0256; Vizzoni,
   Alexandre/0000-0003-0004-5084; Souza, Thiago Moreno
   L./0000-0003-2212-3899; Neto, Jose Cerbino/0000-0001-9254-917X;
   Mesquita, Emersom/0000-0002-5132-3315
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martinez de Salazar P, 2016, ENFERM INFE IN PRESS
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2015, ZIK VIR DIS
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 41
Z9 44
U1 0
U2 15
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1318
EP 1320
DI 10.3201/eid2207.160375
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900041
PM 27070847
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Southwell, BG
   Dolina, S
   Jimenez-Magdaleno, K
   Squiers, LB
   Kelly, BJ
AF Southwell, Brian G.
   Dolina, Suzanne
   Jimenez-Magdaleno, Karla
   Squiers, Linda B.
   Kelly, Bridget J.
TI Zika Virus-Related News Coverage and Online Behavior, United States,
   Guatemala, and Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID AVIAN INFLUENZA
C1 [Southwell, Brian G.; Dolina, Suzanne; Jimenez-Magdaleno, Karla; Squiers, Linda B.; Kelly, Bridget J.] RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
RP Southwell, BG (corresponding author), RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
EM bsouthwell@rti.org
OI Southwell, Brian/0000-0001-5091-8782
CR Dudo AD, 2007, SCI COMMUN, V28, P429, DOI 10.1177/1075547007302211
   Kelly B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2441-7
   Prue C., 2015, NAT C HLTH COMM MARK
   Rowan KE, 2015, SPECTRA, V51, P13
   Southwell Brian, 2003, Minn Med, V86, P14
   Southwell BG, 2006, EMERG INFECT DIS, V12, P1797, DOI 10.3201/eid1211.060672
   Southwell BG, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P607
   Tavernise S, 2016, NY TIMES
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Weeks BE, 2012, HEALTH COMMUN, V27, P158, DOI 10.1080/10410236.2011.571757
NR 10
TC 43
Z9 43
U1 0
U2 19
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1320
EP 1321
DI 10.3201/eid2207.160415
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900042
PM 27100826
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Claeys, C
   Robles, C
   Bertaudiere-Montes, V
   Deschamps-Cottin, M
   Megnifo, HT
   Pelagie-Moutenda, R
   Jeannin, C
   Sonor, F
   Dollin, C
   Sense, M
   Bravet, P
   Weill, L
   Demerrisse, C
   Mazurek, H
   Arrhegini, L
   Etienne, M
   Yebakima, A
   Gustave, J
   Fouque, F
AF Claeys, Cecilia
   Robles, Christine
   Bertaudiere-Montes, Valerie
   Deschamps-Cottin, Magali
   Megnifo, Herve Tepongning
   Pelagie-Moutenda, Renelise
   Jeannin, Charles
   Sonor, Fabrice
   Dollin, Christelle
   Sense, Manon
   Bravet, Pauline
   Weill, Laura
   Demerrisse, Claire
   Mazurek, Hubert
   Arrhegini, Louis
   Etienne, Manuel
   Yebakima, Andre
   Gustave, Joel
   Fouque, Florence
TI Socio-ecological factors contributing to the exposure of human
   populations to mosquito bites that transmit dengue fever, chikungunya
   and zika viruses: a comparison between mainland France and the French
   Antilles
SO ENVIRONNEMENT RISQUES & SANTE
LA English
DT Article
DE dengue; chikungunya; Aedes aegypti; Aedes albopictus;
   interdisciplinarity; socio-ecological factors; France; Antilles; Aedes;
   interdisciplinary research
ID DISEASE
AB This article presents the findings of a research programme involving both researchers and operators involved in Vector Control in France and the French Antilles. We used an interdisciplinary approach to analyse how socio-ecological factors interact to contribute to the exposure of urban and suburban populations to Aedes aegypti and Aedes albopictus, mosquitoes that vector the chikungunya, zika and dengue fever viruses. Our analysis indicates that, beyond the territorial specificities of the sites studied, similar processes work to encourage the presence of mosquitoes at homes in both zones: the presence of water, the structure of gardens, inhabitants' representations of the risk related to mosquitoes, and/or their personal experience. In the French Antilles, the presence of larval breeding sites is also tied to a lack of urban infrastructure. We identify two main categories of larval breeding sites in individual homes: "Behavioural Habitats" (BHs) and "Structural Habitats" (SHs). While the presence of BHs is related to inhabitants' behaviour, SHs are mainly the product of building and garden design. Prevention aimed at curbing larval breeding sites as such needs to begin at the building and garden design stage. This article makes recommendations regarding the layout and management of buildings and gardens.
C1 [Claeys, Cecilia; Robles, Christine; Bertaudiere-Montes, Valerie; Deschamps-Cottin, Magali; Megnifo, Herve Tepongning; Sense, Manon; Bravet, Pauline; Weill, Laura; Demerrisse, Claire; Mazurek, Hubert; Arrhegini, Louis] Aix Marseille Univ IRD LPED, Ctr St Charles, Case 10 3,Pl Victor Hugo, F-13331 Marseille 3, France.
   [Pelagie-Moutenda, Renelise; Sonor, Fabrice; Etienne, Manuel; Yebakima, Andre] Ctr Demousticat & Rech Entomol LAV CTM ARS, Fort De France, Martinique, France.
   [Jeannin, Charles] EID Mediterranee, 130,Rue Cante Gril, F-34000 Montpellier, France.
   [Dollin, Christelle] Pasteur Inst, Rue Victor Hugo, Pointe a Pitre, Guadeloupe, France.
   [Gustave, Joel] ARS, F-97100 Pointe a Pitre, Guadeloupe, France.
   [Fouque, Florence] TDR WHO, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
RP Claeys, C (corresponding author), Aix Marseille Univ IRD LPED, Ctr St Charles, Case 10 3,Pl Victor Hugo, F-13331 Marseille 3, France.
EM cecilia.claeys@univ-amu.fr; christine.robles@univ-amu.fr;
   valerie.montes@univ-amu.fr; magali.deschamps-cottin@univ-amu.fr;
   tepongningherve@yahoo.com; renelise.moutenda@ctm.mq;
   cjeannin@eid-med.org; fabrice.sonor@ctm.mq;
   cdollin@pasteur-guade-loupe.fr; smanon0611@gmail.com;
   pauline.bravet@laposte.net; laura.weil@laposte.net;
   claire.demerrisse@hot-mail.fr; hubert.mazurek@ird.fr;
   Louis.Arreghini@univ-amu.fr; manuel.etienne@ctm.mq;
   andre.yebakima@ctm.mq; Joel.GUSTAVE@ars.sante.fr; fouquef@who.int
FU Fondation de FranceFondation de France; TDR/WHOWorld Health
   Organization; IRD
FX Fondation de France, TDR/WHO and IRD
CR ACSES, 2006, RAPP ET DSDS GUAD
   Claeys C, LIFE08ENVF000488
   Claeys S., 2013, INT REV SOC RES, V3, P151
   Duret P, 2013, SOCIOLOGIE, V4
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gustave J, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/249524
   Hounkpe J., 2012, MEMOIRE DE LEHESP
   Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918
   Mieulet E., 2015, THESIS
   Mieulet E, 2014, HEALTH RISK SOC, V16, P581, DOI 10.1080/13698575.2014.949224
   Ostfeld RS, 2009, CLIN MICROBIOL INFEC, V15, P40, DOI 10.1111/j.1469-0691.2008.02691.x
   Raude J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002094
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Setbon M, 2008, B DALERTE SURVEILLAN, V7, P1
   (WHO) World Health Organization, 2012, WHOHTMNTDVEM20125
   WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342
NR 18
TC 2
Z9 2
U1 0
U2 3
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1635-0421
EI 1952-3998
J9 ENVIRON RISQUE SANTE
JI Environ. Risque Sante
PD JUL-AUG
PY 2016
VL 15
IS 4
BP 318
EP 325
DI 10.1684/ers.2016.0870
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FF2PN
UT WOS:000408739400005
DA 2020-07-08
ER

PT J
AU Giovanetti, M
   Faria, NR
   Nunes, MRT
   de Vasconcelos, JM
   Lourenco, J
   Rodrigues, SG
   Vianez, JL
   da Silva, SP
   Lemos, PS
   Tavares, FN
   Martin, DP
   do Rosario, MS
   Siqueira, IC
   Ciccozzi, M
   Pybus, OG
   de Oliveira, T
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Teixeira Nunes, Marcio Roberto
   de Vasconcelos, Janaina Mota
   Lourenco, Jose
   Rodrigues, Sueli Guerreiro
   Vianez, Joao Lidio, Jr.
   da Silva, Sandro Patroca
   Lemos, Poliana Silva
   Tavares, Fernando Neto
   Martin, Darren Patrick
   do Rosario, Mateus Santana
   Siqueira, Isadora Cristina
   Ciccozzi, Massimo
   Pybus, Oliver G.
   de Oliveira, Tulio
   Alcantara Junior, Luiz Carlos
TI Zika virus complete genome from Salvador, Bahia, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Full-length sequence; Phylogeny
AB In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Giovanetti, Marta; do Rosario, Mateus Santana; Siqueira, Isadora Cristina; Alcantara Junior, Luiz Carlos] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [Teixeira Nunes, Marcio Roberto; de Vasconcelos, Janaina Mota; Rodrigues, Sueli Guerreiro; Vianez, Joao Lidio, Jr.; Lemos, Poliana Silva; Tavares, Fernando Neto] Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Martin, Darren Patrick] Univ Cape Town, Fac Hlth Sci, Div Computat Biol, ZA-7925 Cape Town, South Africa.
   [do Rosario, Mateus Santana] Hosp Santa Isabel, Salvador, BA, Brazil.
   [Ciccozzi, Massimo] Natl Inst Hlth, Rome, Italy.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr, Durban, South Africa.
RP Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, BR-42296710 Salvador, BA, Brazil.
EM giovanetti.marta@gmail.com
RI de Siqueira, Isadora Cristina/R-9953-2016; Faria, Nuno/I-2975-2012;
   Giovanetti, Marta/AAK-7408-2020; CICCOZZI, MASSIMO/C-6484-2016; Pybus,
   Oliver g/B-2640-2012; Vianez Junior, Joao Lidio/I-9547-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Faria,
   Nuno/0000-0001-8839-2798; CICCOZZI, MASSIMO/0000-0003-3866-9239; Pybus,
   Oliver g/0000-0002-8797-2667; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; do Rosario, Mateus/0000-0001-7404-6392;
   Giovanetti, Marta/0000-0002-5849-7326; Lourenco,
   Jose/0000-0002-9318-2581; Alcantara, Luiz/0000-0002-6769-9931
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O., 2014, PLOS NEGLECT TROP D, V9, P8
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grard G, 2014, PLOS NEGLECT TROP D, P8
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, N ENGL J MED
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rodrigues Faria N., 2016, PLOS CURR OUTBREAKS
   Ventura C. V., 2016, LANCET, V16
   Zamree I, 2005, Trop Biomed, V22, P217
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 16
Z9 16
U1 0
U2 112
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2016
VL 41
BP 142
EP 145
DI 10.1016/j.meegid.2016.03.030
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DL5BU
UT WOS:000375652800020
PM 27071531
OA Green Published
DA 2020-07-08
ER

PT J
AU Miller, A
   Yeskey, K
   Garantziotis, S
   Arnesen, S
   Bennett, A
   O'Fallon, L
   Thompson, C
   Reinlib, L
   Masten, S
   Remington, J
   Love, C
   Ramsey, S
   Rosselli, R
   Galluzzo, B
   Lee, J
   Kwok, R
   Hughes, J
AF Miller, Aubrey
   Yeskey, Kevin
   Garantziotis, Stavros
   Arnesen, Stacey
   Bennett, April
   O'Fallon, Liam
   Thompson, Claudia
   Reinlib, Les
   Masten, Scott
   Remington, James
   Love, Cindy
   Ramsey, Steve
   Rosselli, Richard
   Galluzzo, Betsy
   Lee, Joy
   Kwok, Richard
   Hughes, Joseph
TI Integrating Health Research into Disaster Response: The New NIH Disaster
   Research Response Program
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Editorial Material
DE disasters; disaster research; disaster epidemiology; environmental
   health; science preparedness; disaster risk reduction; strategic science
ID COMMUNITY; EPIDEMIOLOGY; SCIENCE; TOOL
AB The need for high quality and timely disaster research has been a topic of great discussion over the past several years. Recent high profile incidents have exposed gaps in knowledge about the health impacts of disasters or the benefits of specific interventions-such was the case with the 2010 Gulf Oil Spill and recent events associated with lead-contaminated drinking water in Flint, Michigan, and the evolving health crisis related to Zika virus disease. Our inability to perform timely research to inform the community about health and safety risks or address specific concerns further heightens anxiety and distrust. Since nearly all disasters, whether natural or man-made, have an environmental health component, it is critical that specialized research tools and trained researchers be readily available to evaluate complex exposures and health effects, especially for vulnerable sub-populations such as the elderly, children, pregnant women, and those with socioeconomic and environmental disparities. In response, the National Institute of Environmental Health Science has initiated a Disaster Research Response Program to create new tools, protocols, networks of researchers, training exercises, and outreach involving diverse groups of stakeholders to help overcome the challenges of disaster research and to improve our ability to collect vital information to reduce the adverse health impacts and improve future preparedness.
C1 [Miller, Aubrey; Bennett, April] NIEHS, Bethesda, MD 20892 USA.
   [Yeskey, Kevin; Galluzzo, Betsy; Lee, Joy] MDB Inc, Washington, DC 20036 USA.
   [Garantziotis, Stavros; O'Fallon, Liam; Thompson, Claudia; Reinlib, Les; Masten, Scott; Remington, James; Kwok, Richard; Hughes, Joseph] NIEHS, Res Triangle Pk, NC 27709 USA.
   [Arnesen, Stacey; Love, Cindy] Natl Lib Med, Bethesda, MD 20892 USA.
   [Ramsey, Steve; Rosselli, Richard] Social & Sci Syst Inc, Durham, NC 27703 USA.
RP Miller, A (corresponding author), NIEHS, Bethesda, MD 20892 USA.
EM miller.aubrey@nih.gov; kyeskey@michaeldbaker.com;
   garantziotis@niehs.nih.gov; arneses@mail.nlm.nih.gov;
   april.bennett@nih.gov; ofallon@niehs.nih.gov; thompso1@niehs.nih.gov;
   reinlib@niehs.nih.gov; masten@niehs.nih.gov; remingtonj@niehs.nih.gov;
   lovec@mail.nlm.nih.gov; SRamsey@s-3.com; RRosselli@s-3.com;
   beagin@michaeldbaker.com; jlee@michaeldbaker.com; Richard.Kwok@nih.gov;
   hughes3@niehs.nih.gov
RI masten, scott/R-1403-2016; Garantziotis, Stavros/A-6903-2009; Kwok,
   Richard/B-6907-2017
OI masten, scott/0000-0002-7847-181X; Garantziotis,
   Stavros/0000-0003-4007-375X; Kwok, Richard/0000-0002-6794-8360
CR Abara W, 2014, INT J ENV RES PUB HE, V11, P5684, DOI 10.3390/ijerph110605684
   Decker John A, 2013, Am J Disaster Med, V8, P25, DOI 10.5055/ajdm.2013.0108
   Institute of Medicine, 2014, EN RAP SUST PUBL HLT
   LECHAT MF, 1976, P ROY SOC MED, V69, P421, DOI 10.1177/003591577606900612
   Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510
   Malilay J, 2014, AM J PUBLIC HEALTH, V104, P2092, DOI 10.2105/AJPH.2014.302010
   McNutt M, 2015, SCIENCE, V348, P11, DOI 10.1126/science.aab2091
   National Biodefense Science Board, 2011, CALL ACT INCL SCI IN
   National Institute of Environmental Health Sciences (NIEHS), MECH TIM SENS RES OP
   O'Fallon LR, 2002, ENVIRON HEALTH PERSP, V110, P155, DOI 10.1289/ehp.02110s2155
   Schoch-Spana M, 2007, BIOSECUR BIOTERROR, V5, P8, DOI 10.1089/bsp.2006.0036
   U. S. Department of Homeland Security, 2011, NAT DIS REC FRAM
   US Department of Homeland Security, 2016, NAT RESP FRAM
   Yeskey K, 2015, DISASTER MED PUBLIC, V9, P444, DOI 10.1017/dmp.2015.53
NR 14
TC 18
Z9 19
U1 0
U2 79
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2016
VL 13
IS 7
AR 676
DI 10.3390/ijerph13070676
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA DS4OG
UT WOS:000380759800052
PM 27384574
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Patino-Cadavid, LJ
   Lozada-Riascos, CO
   Villamil-Gomez, WE
AF Rodriguez-Morales, Alfonso J.
   Jhoana Patino-Cadavid, Leidy
   Lozada-Riascos, Carlos O.
   Villamil-Gomez, Wilmer E.
TI Mapping Zika in municipalities of one coastal department of Colombia
   (Sucre) using geographic information systems during the 2015-2016
   outbreak: implications for public health and travel advice
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
DE Zika; Epidemiology; Public health; Travelers; Colombia; Latin America
ID CHIKUNGUNYA FEVER; GIS
C1 [Rodriguez-Morales, Alfonso J.; Jhoana Patino-Cadavid, Leidy] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Rodriguez-Morales, Alfonso J.; Lozada-Riascos, Carlos O.; Villamil-Gomez, Wilmer E.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Lozada-Riascos, Carlos O.] Univ Tecnol Pereira, Reg Informat Syst, Pereira, Risaralda, Colombia.
   [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, SUE Caribe Programa Doctorado Med Trop, Barranquilla, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), OLFIS, Bucaramanga, Santander, Colombia.; Rodriguez-Morales, AJ (corresponding author), Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Instituto Nacional de Salud de Bogota, 2016, ZIK SEM EP 16 2016
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Secretaria de Salud Departamental Sucre, 2016, B EPIDEMIOLOGICO, V6
NR 9
TC 14
Z9 14
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2016
VL 48
BP 70
EP 72
DI 10.1016/j.ijid.2016.05.012
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DO8PW
UT WOS:000378046700017
PM 27208632
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vorou, R
AF Vorou, Rengina
TI Zika virus, vectors, reservoirs, amplifying hosts, and their potential
   to spread worldwide: what we know and what we should investigate
   urgently
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus infection; Vector; Animal; Aedes; Anopheles; Migrants
ID STEGOMYIA ALBOPICTUS SKUSE; AEDES-ALBOPICTUS; YELLOW-FEVER;
   DIPTERA-CULICIDAE; TRANSMISSION; INFECTION; MOSQUITOS; BRAZIL;
   ARBOVIRUSES; CHIKUNGUNYA
AB Objectives: The widespread epidemic of Zika virus infection in South and Central America and the Caribbean in 2015, along with the increased incidence of microcephaly in fetuses born to mothers infected with Zika virus and the potential for worldwide spread, indicate the need to review the current literature regarding vectors, reservoirs, and amplification hosts.
   Vectors: The virus has been isolated in Africa in mosquitoes of the genera Aedes, Anopheles, and Mansonia, and in Southeast Asia and the Pacific area in mosquitoes of the genus Aedes. Aedes albopictus has invaded several countries in Central Africa and all Mediterranean countries, and continues to spread throughout Central and Northern Europe. The wide distribution of the virus in animal hosts and vectors favors the emergence of recombinants.
   Animal hosts: The virus has been isolated in monkeys, and antibodies have been detected in domestic sheep, goats, horses, cows, ducks, rodents, bats, orangutans, and carabaos.
   Conclusions: It is a public health imperative to define the domestic and wild animal reservoirs, amplification hosts, and vector capacity of the genera Aedes, Anopheles, and Mansonia. These variables will define the geographic distribution of Zika virus along with the indicated timing and scale of the environmental public health interventions worldwide. (C) 2016 The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Vorou, Rengina] Hellen Ctr Dis Control & Prevent, 3-5 Agrafon Str, Athens 15123, Greece.
RP Vorou, R (corresponding author), Hellen Ctr Dis Control & Prevent, 3-5 Agrafon Str, Athens 15123, Greece.
EM vorou@keelpno.gr
OI Vorou, Rengina/0000-0003-4176-8086
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Boukraa S, 2015, J VECTOR ECOL, V40, P398, DOI 10.1111/jvec.12180
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Prata A, 2000, MEM I OSWALDO CRUZ, V95, P183, DOI 10.1590/S0074-02762000000700031
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2016, EURO SURVEILL, P21
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Valerio L, 2015, TRAVEL MED INFECT DI, V13, P415, DOI 10.1016/j.tmaid.2015.06.008
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vorou R, 2016, EURO SURVEILL, V21
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Werner D, 2015, PARASITOL RES, V114, P831, DOI 10.1007/s00436-014-4244-7
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 73
Z9 75
U1 2
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2016
VL 48
BP 85
EP 90
DI 10.1016/j.ijid.2016.05.014
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DO8PW
UT WOS:000378046700022
PM 27208633
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Beckham, JD
   Pastula, DM
   Massey, A
   Tyler, KL
AF Beckham, J. David
   Pastula, Daniel M.
   Massey, Aaron
   Tyler, Kenneth L.
TI Zika Virus as an Emerging Global Pathogen Neurological Complications of
   Zika Virus
SO JAMA NEUROLOGY
LA English
DT Review
ID WEST-NILE-VIRUS; FRENCH-POLYNESIA; TRANSMISSION; BRAZIL; INFECTION;
   ARBOVIRUSES; OUTBREAK; MICRONESIA; STATES; FEVER
AB IMPORTANCE Zika virus (ZIKV) is an emerging arthropod-borne virus (arbovirus) in the genus Flavivirus that has caused a widespread outbreak of febrile illness, is associated with neurological disease, and has spread across the Pacific to the Americas in a short period.
   OBSERVATIONS In this review, we discuss what is currently known about ZIKV, neuroimmunologic complications, and the impact on global human health. Zika virus spread across Africa and Asia in part owing to unique genomic evolutionary conditions and pressures resulting in specific human disease manifestations, complications, and pathogenesis. Recent data suggest that acute ZIKV infection in pregnant women may result in acute infection of fetal tissue and brain tissue, causing microcephaly and potentially severe debilitation of the infant or even death of the fetus. Cases of acute ZIKV are also associated with Guillain-Barre syndrome. With the increased number of cases, new complications such as ocular involvement and sexual transmission have been reported.
   CONCLUSIONS AND RELEVANCE Zika virus is an emerging viral pathogen with significant consequences on human health throughout the world. Ongoing research into this pathogen is urgently needed to produce viable vaccine and therapeutic options.
C1 [Beckham, J. David; Pastula, Daniel M.; Tyler, Kenneth L.] Univ Colorado, Sch Med, Dept Neurol, Neuroinfect Dis Grp, Aurora, CO USA.
   [Beckham, J. David; Massey, Aaron] Univ Colorado, Sch Med, Dept Med, Div Infect Dis, 12700 E 19th Ave,B168, Aurora, CO 80045 USA.
RP Beckham, JD (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Infect Dis, 12700 E 19th Ave,B168, Aurora, CO 80045 USA.
EM david.beckham@ucdenver.edu
RI Pastula, Daniel M./M-1325-2019; Beckham, John/AAE-6694-2020; Tyler,
   Kenneth L./J-2420-2019
OI Pastula, Daniel M./0000-0001-9342-4459; Beckham,
   John/0000-0001-9305-2683; Tyler, Kenneth L./0000-0003-3294-5888; Massey,
   Aaron/0000-0002-8747-0114
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32 AI052066]; BLRD VA [I01 BX003863]
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   *CDCP, AR WITH ZIK
   Centers for Disease Control and Prevention, ZIK VIR PREGN WOM
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization; World Health Organization, ZIK VIR INF
   Petersen LR, 2001, EMERG INFECT DIS, V7, P611
   REAGAN RL, 1953, TEX REP BIOL MED, V11, P347
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 46
TC 33
Z9 34
U1 0
U2 35
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD JUL
PY 2016
VL 73
IS 7
BP 875
EP 879
DI 10.1001/jamaneurol.2016.0800
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA DQ7XC
UT WOS:000379420500021
PM 27183312
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU de Carvalho, BR
   Taitson, PF
   Brandao, KSAG
   Ferriani, RA
   Nakagawa, HM
   Silva, AA
   Lopes, JRC
AF de Carvalho, Bruno R.
   Taitson, Paulo F.
   Brandao, Karina S. A. G.
   Ferriani, Rui Alberto
   Nakagawa, Hitomi M.
   Silva, Adelino A.
   Lopes, Joaquim R. C.
CA SBRA-Brazilian Soc Assisted Reprod
TI Reproductive planning in times of Zika: getting pregnant or delaying
   plans? The opinion of the Brazilian Society of Assisted Reproduction
   Committee - a basis for a bioethical discussion
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Article
DE Zika; microcephaly; human reproduction; bioethics; central nervous
   system disorders
ID VIRUS-INFECTION; TRANSMISSION
AB Although the causality between Zika virus, microcephaly, and other central nervous system disorders has been taken for granted by the scientific community, many uncertainties remain. The gap of knowledge at the moment is large enough to remove part of the confidence physicians have on the advice given to patients - and infertile women in particular - on their reproductive plans. Pretreatment serologic screening is a possible strategy to offer more confidence for individuals choosing to bear children regardless of the Zika virus, but the tests currently available do not seem to be sufficiently adequate. Until now, there is no formal recommendation to avoid pregnancy solely because of the Zika virus outbreak, and the choice of becoming pregnant has been regarded as a personal decision to be made by each woman and her family.
C1 [de Carvalho, Bruno R.; Nakagawa, Hitomi M.; Silva, Adelino A.] GENESIS Ctr Assistance Human Reprod, Brasilia, DF, Brazil.
   [Taitson, Paulo F.] Pontificia Univ Catolica Minas Gerais, Belo Horizonte, MG, Brazil.
   [Brandao, Karina S. A. G.; Lopes, Joaquim R. C.] CENAFERT, Salvador, BA, Brazil.
   [Ferriani, Rui Alberto] Univ Sao Paulo, Sch Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Nakagawa, Hitomi M.] SBRA Brazilian Soc Assisted Reprod, Salvador, BA, Brazil.
RP de Carvalho, BR (corresponding author), GENESIS Ctr Assistance Human Reprod, Brasilia, DF, Brazil.
EM brunoramalho@hotmail.com
RI de Carvalho, Bruno Ramalho/N-1786-2019
OI de Carvalho, Bruno Ramalho/0000-0002-1554-9499; Mohammed,
   Budoor/0000-0003-4352-3867
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Branswell H., 2016, STAT
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Instituto Nacional de Salud, 2016, B EP SEM
   Johansson MA, 2016, N ENGL J ME IN PRESS
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   LaFrance A, 2016, ATLANTIC
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pan American Health Organization/ World Health Organization, 2016, REPR OPAS OMS BRAS D
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Secretaria Estadual de Saude de Pernambuco. Secretaria Executiva de Vigilancia em Saude, 2015, PROT CLIN EP INV CAS
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Simmins Jr CH, 2016, B WHO
   Soares de Araujo JS, B WORLD HLTH
   Sociedade Brasileira de Patologia Clinica/ Medicina Lab-oratorial, POS OF SOC BRAS PAT
   Taitson PF, 2016, ENFERMAGEM REV, V19
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 29
TC 9
Z9 9
U1 0
U2 0
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD JUL-SEP
PY 2016
VL 20
IS 3
BP 159
EP 164
DI 10.5935/1518-0557.20160034
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FA2CX
UT WOS:000405249400014
PM 27584610
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU De Smet, B
   Van den Bossche, D
   van de Werve, C
   Mairesse, J
   Schmidt-Chanasitd, J
   Michiels, J
   Arien, KK
   Van Esbroeck, M
   Cnops, L
AF De Smet, Birgit
   Van den Bossche, Dorien
   van de Werve, Charlotte
   Mairesse, Jacques
   Schmidt-Chanasitd, Jonas
   Michiels, Jo
   Arien, Kevin K.
   Van Esbroeck, Marjan
   Cnops, Lieselotte
TI Confirmed Zika virus infection in a Belgian traveler returning from
   Guatemala, and the diagnostic challenges of imported cases into Europe
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Import; Europe; Real-time RT-PCR
ID STATES
AB We report the first laboratory-confirmed Zika virus (ZIKV) infection in a Belgian traveler after a three week holiday in Guatemala, December 2015. This case along with other imported cases into Europe emphases once again the need for accurate diagnostic tools for this rapidly emerging virus. The challenge is to diagnose patients in the acute phase, which appears short, as serological testing is complicated by cross-reactivity, vaccination status and scarce availability of specific ZIKV tests. (C) 2016 Elsevier B.V. All rights reserved.
C1 [De Smet, Birgit; Van den Bossche, Dorien; Van Esbroeck, Marjan; Cnops, Lieselotte] Inst Trop Med, Dept Clin Sci, Natl Reference Ctr Arboviruses, B-2000 Antwerp, Belgium.
   [van de Werve, Charlotte] Clin St Pierre, Travel Clin, Ottignies, Belgium.
   [Mairesse, Jacques] Clin St Pierre, Biol Clin, Ottignies, Belgium.
   [Schmidt-Chanasitd, Jonas] Inst Trop Med, Natl Reference Ctr Trop Infect Dis, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht, Hamburg, Germany.
   [Schmidt-Chanasitd, Jonas] Partner Site Hamburg Lubeck Borstel, German Ctr Infect Res DZIF, Hamburg, Germany.
   [Michiels, Jo; Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.
RP Cnops, L (corresponding author), Inst Trop Med, Kronenburgstr 43-3, B-2000 Antwerp, Belgium.
EM lcnops@itg.be
RI De Smet, Birgit/F-4638-2014
OI De Smet, Birgit/0000-0002-1790-1900; Cnops,
   Lieselotte/0000-0003-0658-1291; Van Esbroeck, Marjan/0000-0002-7294-6319
FU Belgian Ministry of Social Affairs through Health Insurance System
FX The National Reference Center of arboviruses (ITM) is partially
   supported by the Belgian Ministry of Social Affairs through a fund
   within the Health Insurance System. LC holds an innovation mandate from
   the Flanders Innovation & Entrepreneurship.
CR Barzon L, 2012, Euro Surveill, V17, P20260
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845
   Charrel R. N., 2016, B WHO, V10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci A.S., 2016, N ENGL J MED, V13
   Ginier M., 2016, TRAVEL MED INFECT DI, V1
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Korhonen E.M., 2015, EUROSURVEILL, V21
   Lecuit M., 2015, NEW ENGL J MED, V372, P13
   Maria AT, 2016, EURO SURVEILL, V21
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 20
TC 18
Z9 19
U1 0
U2 68
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUL
PY 2016
VL 80
BP 8
EP 11
DI 10.1016/j.jcv.2016.04.009
PG 4
WC Virology
SC Virology
GA DN9HW
UT WOS:000377391100002
PM 27128355
DA 2020-07-08
ER

PT J
AU Jang, HC
   Park, WB
   Kim, UJ
   Chun, JY
   Choi, SJ
   Choe, PG
   Jung, SI
   Jee, Y
   Kim, NJ
   Choi, EH
   Oh, MD
AF Jang, Hee-Chang
   Park, Wan Beom
   Kim, Uh Jin
   Chun, June Young
   Choi, Su-Jin
   Choe, Pyoeng Gyun
   Jung, Sook-In
   Jee, Youngmee
   Kim, Nam-Joong
   Choi, Eun Hwa
   Oh, Myoung-don
TI First Imported Case of Zika Virus Infection into Korea
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE Zika Virus; Travel; Virus Shedding; Brazil; Korea
ID MICRONESIA; OUTBREAK; BRAZIL; CELLS
AB Since Zika virus has been spreading rapidly in the Americas from 2015, the outbreak of Zika virus infection becomes a global health emergency because it can cause neurological complications and adverse fetal outcome including microcephaly. Here, we report clinical manifestations and virus isolation findings from a case of Zika virus infection imported from Brazil. The patient, 43-year-old Korean man, developed fever, myalgia, eyeball pain, and maculopapular rash, but not neurological manifestations. Zika virus was isolated from his semen, and reverse-transcriptase PCR was positive for the virus in the blood, urine, and saliva on the 7th day of the illness but was negative on the 21st day. He recovered spontaneously without any neurological complications. He is the first case of Zika virus infection in Korea imported from Brazil.
C1 [Jang, Hee-Chang; Kim, Uh Jin; Jung, Sook-In] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Gwangju, South Korea.
   [Park, Wan Beom; Chun, June Young; Choi, Su-Jin; Choe, Pyoeng Gyun; Kim, Nam-Joong; Oh, Myoung-don] Seoul Natl Univ, Coll Med, Dept Internal Med, 103 Daehak Ro, Seoul 03080, South Korea.
   [Jee, Youngmee] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Ctr Pathol & Immunol, Osong, South Korea.
   [Choi, Eun Hwa] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 03080, South Korea.
RP Oh, MD (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 103 Daehak Ro, Seoul 03080, South Korea.
EM mdohmd@snu.ac.kr
RI Chun, June/AAS-2464-2020
OI Kim, Uh Jin/0000-0002-8463-6297; JUNG, SOOK IN/0000-0002-1577-678X;
   Jang, Hee-Chang/0000-0002-3407-8493; Chun, June
   Young/0000-0001-9345-6645; Choe, Pyoeng Gyun/0000-0001-6794-7918
FU Korea Centers for Disease Control and Prevention [2016P2400100]
FX Eun Hwa Choi and Nam-Joong Kim are participating investigators of the
   research program funded by the Korea Centers for Disease Control and
   Prevention (2016P2400100).
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P., 2016, N ENGL J ME IN PRESS
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, ZIK VIR INF OUTBR FR
   Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization (WHO), ZIK SIT REP
NR 20
TC 23
Z9 25
U1 0
U2 76
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD JUL
PY 2016
VL 31
IS 7
BP 1173
EP 1177
DI 10.3346/jkms.2016.31.7.1173
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN6GA
UT WOS:000377169700027
PM 27366020
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, HL
   Tang, RB
AF Chen, Hui-Lan
   Tang, Ren-Bin
TI Zika virus infection: Control and prevention Reply
SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Chen, Hui-Lan] Minist Hlth & Welf, Keelung Hosp, Dept Pediat, Keelung, Taiwan.
   [Tang, Ren-Bin] Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
RP Tang, RB (corresponding author), Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
EM ch9406@chgh.org.com.tw
CR Centers for Disease Control R.O.C (Taiwan), 2016, US TAIW COORG INT TR
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Wiwanitkit V, 2016, J CHIN MED ASSOC, V79, P409, DOI 10.1016/j.jcma.2016.04.002
NR 6
TC 0
Z9 0
U1 0
U2 111
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1726-4901
EI 1728-7731
J9 J CHIN MED ASSOC
JI J. Chin. Med. Assoc.
PD JUL
PY 2016
VL 79
IS 7
BP 410
EP 410
DI 10.1016/j.jcma.2016.04.004
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP6BY
UT WOS:000378583100012
PM 27238558
OA Other Gold
DA 2020-07-08
ER

PT J
AU Routy, JP
   Psomas, C
   Soriano, V
   Philibert, P
   Tissot-Dupont, H
   Lafeuillade, A
AF Routy, Jean-Pierre
   Psomas, Christina
   Soriano, Vicente
   Philibert, Patrick
   Tissot-Dupont, Herve
   Lafeuillade, Alain
TI Highlights from the 2016 International Symposium on HIV & Emerging
   Infectious Diseases (ISHEID) 25-27 May, Marseille, France
SO JOURNAL OF VIRUS ERADICATION
LA English
DT Article
DE HIV; HIV cure; HIV vaccine; hepatitis C; hepatitis B; hepatitis E;
   Ebola; Zika; flu; tuberculosis; human papilloma viruses; sexually
   transmitted infections
ID HEPATITIS-E VIRUS; TRANSMISSION; PREVENTION; EMERGENCE; HISTORY
AB For three days in May 2016, the International Symposium on HIV & Emerging Infectious Diseases gathered participants from all over the world around the theme 'Fighting deadly viruses'. HIV infection remained the main topic of the meeting but hepatitis, Ebola and Zika viruses as well as other emergent pathogens were also extensively covered. In this article we have tried to summarise what was presented during the plenary lectures, the two keynote lectures, and some of the work accepted for oral presentation. However, all abstracts can be found on the Journal of Virus Eradication website (viruseradication.com/abstract.php)
C1 [Routy, Jean-Pierre] McGill Hlth Ctr, Montreal, PQ, Canada.
   [Psomas, Christina] Univ Hosp, Montpellier, France.
   [Soriano, Vicente] La Paz Univ Hosp, Infect Dis Unit, Madrid, Spain.
   [Philibert, Patrick] European Hosp, Marseille, France.
   [Tissot-Dupont, Herve] Inst Hospitalouniv Mediterranee Infect, Marseille, France.
   [Lafeuillade, Alain] Gen Hosp, Toulon, France.
RP Lafeuillade, A (corresponding author), Gen Hosp St Musse, 54 Rue Henri St Claire Deville, F-83056 Toulon, France.
EM alain.lafeuillade@ch-toulon.fr
RI Soriano, Vicente/O-5730-2018; TISSOT-DUPONT, Herve/P-5808-2016
OI Soriano, Vicente/0000-0002-4624-5199; 
CR Barouch D., 2016, J VIRUS ERAD S1, V2, P5
   Barreiro P, 2016, ANTIVIR THER
   Barreiro P., 2016, J VIRUS ERAD S1, V2, P5
   Beavogui AH, 2016, CLIN TRIALS, V13, P73, DOI 10.1177/1740774515619877
   Benhaddou N., 2016, J VIRUS ERAD S1, V2, P6
   Benitez-Gutierrez L, 2016, EXPERT OPIN PHARMACO, V17, P1215, DOI 10.1080/14656566.2016.1182156
   Bonnet M, 2016, INT J TUBERC LUNG D, V20, P177, DOI 10.5588/ijtld.15.0962
   Bonnet M., 2016, J VIRUS ERAD S1, V2, P7
   Bourliere M, 2014, DIGEST LIVER DIS, V46, pS212, DOI 10.1016/j.dld.2014.09.024
   Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Ceyhan M, 2010, EPIDEMIOL INFECT, V138, P1274, DOI 10.1017/S095026880999166X
   Cornberg M., 2016, J VIRUS ERAD S1, V2, P7
   Cotte L., 2016, J VIRUS ERAD, V2, P3
   Dalton H., 2016, J VIRUS ERAD S1, V2, P1
   Dalton HR, 2016, NAT REV NEUROL, V12, P77, DOI 10.1038/nrneurol.2015.234
   Darcis G, 2016, J VIRUS ERAD S1, V2, P10
   de Barbeyrac B, 2013, PRESSE MED, V42, P440, DOI 10.1016/j.lpm.2012.09.025
   Dorell L., 2016, J VIRUS ERAD S1, V2, P3
   Drosten C, 2014, Drug Res (Stuttg), V64 Suppl 1, pS27, DOI 10.1055/s-0033-1358040
   Durantel D, 2016, J HEPATOL, V64, pS117, DOI 10.1016/j.jhep.2016.02.016
   El Khoury L, 2016, J VIRUS ERAD S1, V2, P14
   Fernandez-Montero JV, 2016, J VIRAL HEPATITIS, V23, P47, DOI 10.1111/jvh.12447
   Gautheret-Dejean A., 2016, J VIRUS ERAD S1, V2, P6
   Ginossar T., 2016, J VIRUS ERAD S1, V2, P2
   Guan Y, 2016, CURR OPIN VIROL, V16, pV, DOI 10.1016/j.coviro.2016.03.005
   Gulick R., 2016, J VIRUS ERAD S1, V2, P4
   Jaquet A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1601-4
   Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992
   Kuritzkes D., 2016, J VIRUS ERAD S1, V2, P5
   La Ruche G, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.32.21205
   Lentz P, 2016, J VIRUS ERAD S1, V2, P15
   Lina B, 2014, M S-MED SCI, V30, P851, DOI 10.1051/medsci/20143010011
   Mehraj V, 2016, J VIRUS ERAD S1, V2, P9
   Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195
   Page EE, 2016, CLIN MED, V16, P189, DOI 10.7861/clinmedicine.16-2-189
   Penaranda G, 2016, J VIRUS ERAD S1, V2, P8
   Philibert P, 2016, J VIRUS ERAD S1, V2, P14
   Pol S., 2016, J VIRUS ERAD S1, V2, P1
   Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008
   Radetskyy R, 2016, J VIRUS ERAD S1, V2, P9
   Reig M, 2016, J HEPATOL
   Soriano V., 2016, J VIRUS ERAD S1, V2, P6
   Soriano V, 2016, ANTIVIR THER, V21, P1, DOI 10.3851/IMP2975
   Sprecher A., 2016, J VIRUS ERAD S1, V2, P2
   Troussier T., 2016, J VIRUS ERAD S1, V2, P5
   Van Laethem K., 2016, J VIRUS ERAD S1, V2, P2
   Vasilakis N., 2016, J VIRUS ERAD S1, V2, P2
   Verla-Tebit E, 2015, J GASTROINTEST ONCOL, V6, pE52, DOI 10.3978/j.issn.2078-6891.2014.115
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Bosch FX, 2016, NAT REV CLIN ONCOL, V13, P119, DOI 10.1038/nrclinonc.2015.146
NR 51
TC 0
Z9 0
U1 0
U2 1
PU MEDISCRIPT LTD
PI LONDON
PA 1 MOUNTVIEW CT, 310 FRIERN BARNET LN, LONDON, N20 0LD, ENGLAND
SN 2055-6640
EI 2055-6659
J9 J VIRUS ERAD
JI J. Virus Erad.
PD JUL
PY 2016
VL 2
IS 3
BP 187
EP 192
PG 6
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA FF6EB
UT WOS:000409096400012
PM 27482461
DA 2020-07-08
ER

PT J
AU Nicastri, E
   Castilletti, C
   Di Caro, A
   Capobianchi, MR
   Ippolito, G
AF Nicastri, Emanuele
   Castilletti, Concetta
   Di Caro, Antonino
   Capobianchi, Maria R.
   Ippolito, Giuseppe
TI Diagnosis of Zika virus infection in pregnant women travelling to or
   residing in endemic areas
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Nicastri, Emanuele; Castilletti, Concetta; Di Caro, Antonino; Capobianchi, Maria R.; Ippolito, Giuseppe] Natl Inst Infect Dis INMI Lazzaro Spallanzani IRC, I-00149 Rome, Italy.
RP Nicastri, E (corresponding author), Natl Inst Infect Dis INMI Lazzaro Spallanzani IRC, I-00149 Rome, Italy.
EM emanuele.nicastri@inmi.it
RI Ippolito, Giuseppe/J-7207-2017; nicastri, emanuele/K-7780-2016; Di Caro,
   Antonino/K-6854-2016; Castilletti, Concetta/B-6545-2016; Castilletti,
   Concetta/AAA-8408-2019
OI nicastri, emanuele/0000-0002-5606-8712; Di Caro,
   Antonino/0000-0001-6027-3009; Castilletti, Concetta/0000-0001-9819-236X;
   Castilletti, Concetta/0000-0001-9819-236X; Capobianchi, Maria
   Rosaria/0000-0003-3465-0071; Ippolito, Giuseppe/0000-0002-1076-2979
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CDC, DIV VECT BORN DIS SU
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
NR 4
TC 3
Z9 3
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 771
EP 772
DI 10.1016/S1473-3099(16)30074-3
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600020
PM 27352748
DA 2020-07-08
ER

PT J
AU Fernandes, RCDC
   de Souza, TL
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   de Souza, Thais Louvain
   Medina-Acosta, Enrique
TI Congenital Zika syndrome in Brazil
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, BR-28035581 Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Municipal Program Surveillance Sexually Transmitt, BR-28010140 Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, BR-28035200 Rio De Janeiro, Brazil.
RP Fernandes, RCDC (corresponding author), Fac Med Campos, BR-28035581 Rio De Janeiro, Brazil.; Fernandes, RCDC (corresponding author), Municipal Program Surveillance Sexually Transmitt, BR-28010140 Rio De Janeiro, Brazil.; Fernandes, RCDC (corresponding author), Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, BR-28035200 Rio De Janeiro, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010; Louvain de Souza, Thais/G-2646-2014
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Louvain de Souza,
   Thais/0000-0002-0179-272X
CR [Anonymous], 2016, LANCET INFECT DIS, V16, P265
   [Anonymous], 2016, PROT VIG RESP OC MIC
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brazilian Ministry of Health, 2016, MICR 4 268 CAS SUSPE
   Brazilian Ministry of Health, 2016, SINASC SIST INF NASC
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281
NR 9
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 772
EP 772
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600021
PM 27352749
DA 2020-07-08
ER

PT J
AU Wikan, N
   Smith, DR
AF Wikan, Nitwara
   Smith, Duncan R.
TI Zika virus: history of a newly emerging arbovirus
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID FRENCH-POLYNESIA; YELLOW-FEVER; SEXUAL TRANSMISSION; SEROLOGICAL SURVEY;
   FEDERATED STATES; HUMAN-POPULATION; DENGUE VIRUSES; AEDES-HENSILLI;
   SOUTH-PACIFIC; YAP STATE
AB Zika virus was originally identified in a sentinel rhesus monkey in the Zika Forest of Uganda in 1947. The virus is a member of the family Flaviviridae, genus Flavivirus, and is transmitted to humans by Aedes species mosquitoes. The first report of Zika virus outside Africa and Asia was in 2007 when the virus was associated with a small outbreak in Yap State, part of the Federated States of Micronesia. Since then, Zika virus infections have been reported around the world, including in southeast Asia; French Polynesia and other islands in the Pacific Ocean; and parts of South, Central, and North America. Symptomatic infection in human beings normally results in a mild and self-limiting febrile disease, although recent reports have suggested a possible association with more serious sequelae such as Guillain-Barre syndrome, and microcephaly in newborn infants of mothers infected with Zika virus during pregnancy. In this Review, we summarise the history of Zika virus from its first detection to its current worldwide distribution.
C1 [Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Pathom, Thailand.
   [Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya 73170, Nakhon Pathom, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Mol Pathol Lab, Inst Mol Biosci, Salaya 73170, Nakhon Pathom, Thailand.
EM duncan.smi@mahidol.ac.th
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
FU Mahidol University; Thailand Research FundThailand Research Fund (TRF)
   [IRG5780009, RTA5780009]; Office of the Higher Education Commission;
   Mahidol University under the National Research Universities Initiative;
   Cluster and Program Management Office, National Science and Technology
   Development Agency
FX We are supported by Mahidol University, The Thailand Research Fund
   (IRG5780009 and RTA5780009), the Office of the Higher Education
   Commission and Mahidol University under the National Research
   Universities Initiative and by the Cluster and Program Management
   Office, National Science and Technology Development Agency.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR DIS EP POT A
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, 1 M INT HLTH REG IHR
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 97
TC 169
Z9 172
U1 1
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP E119
EP E126
DI 10.1016/S1473-3099(16)30010-X
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600002
PM 27282424
OA Bronze
DA 2020-07-08
ER

PT J
AU Swanstrom, JA
   Plante, JA
   Plante, KS
   Young, EF
   McGowan, E
   Gallichotte, EN
   Widman, DG
   Heise, MT
   de Silva, AM
   Baric, RS
AF Swanstrom, J. A.
   Plante, J. A.
   Plante, K. S.
   Young, E. F.
   McGowan, E.
   Gallichotte, E. N.
   Widman, D. G.
   Heise, M. T.
   de Silva, A. M.
   Baric, R. S.
TI Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from
   Dengue Patients Are Protective against Zika Virus
SO MBIO
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS; NEUTRALIZING ANTIBODIES; HIGHLY POTENT;
   SEROTYPE 3; INFECTION; VACCINE; DETERMINANTS; PREGNANCY; CHILDREN;
   BRAZIL
AB Zika virus (ZIKV) is a mosquito-borne flavivirus responsible for thousands of cases of severe fetal malformations and neurological disease since its introduction to Brazil in 2013. Antibodies to flaviviruses can be protective, resulting in lifelong immunity to reinfection by homologous virus. However, cross-reactive antibodies can complicate flavivirus diagnostics and promote more severe disease, as noted after serial dengue virus (DENV) infections. The endemic circulation of DENV in South America and elsewhere raises concerns that preexisting flavivirus immunity may modulate ZIKV disease and transmission potential. Here, we report on the ability of human monoclonal antibodies and immune sera derived from dengue patients to neutralize contemporary epidemic ZIKV strains. We demonstrate that a class of human monoclonal antibodies isolated from DENV patients neutralizes ZIKV in cell culture and is protective in a lethal murine model. We also tested a large panel of convalescent-phase immune sera from humans exposed to primary and repeat DENV infection. Although ZIKV is most closely related to DENV compared to other human-pathogenic flaviviruses, most DENV immune sera (73%) failed to neutralize ZIKV, while others had low (50% effective concentration [EC50],<1:100 serum dilution; 18%) or moderate to high (EC50,>1:100 serum dilution; 9%) levels of cross-neutralizing antibodies. Our results establish that ZIKV and DENV share epitopes that are targeted by neutralizing, protective human antibodies. The availability of potently neutralizing human monoclonal antibodies provides an immunotherapeutic approach to control life-threatening ZIKV infection and also points to the possibility of repurposing DENV vaccines to induce cross-protective immunity to ZIKV.
   IMPORTANCE ZIKV is an emerging arbovirus that has been associated with severe neurological birth defects and fetal loss in pregnant women and Guillain-Barre syndrome in adults. Currently, there is no vaccine or therapeutic for ZIKV. The identification of a class of antibodies (envelope dimer epitope 1 [EDE1]) that potently neutralizes ZIKV in addition to all four DENV serotypes points to a potential immunotherapeutic to combat ZIKV. This is especially salient given the precedent of antibody therapy to treat pregnant women infected with other viruses associated with microcephaly, such as cytomegalovirus and rubella virus. Furthermore, the identification of a functionally conserved epitope between ZIKV and DENV raises the possibility that a vaccine may be able to elicit neutralizing antibodies against both viruses.
C1 [Swanstrom, J. A.; Plante, J. A.; Young, E. F.; Gallichotte, E. N.; Widman, D. G.; Baric, R. S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Plante, K. S.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA.
   [Young, E. F.; McGowan, E.; Gallichotte, E. N.; Heise, M. T.; de Silva, A. M.; Baric, R. S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
RP Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.; Baric, RS (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
EM rbaric@email.unc.edu
RI amsalu, ribka/G-8780-2019
OI Widman, Douglas/0000-0002-3585-6373; Plante, Jessica/0000-0002-4768-7458
FU HHS \ National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AI
   107731, U19 AI 100625, T32 AI 007151-36A1]; Bill and Melinda Gates
   Foundation (Bill & Melinda Gates Foundation)
FX This work, including the efforts of Eileen McGowan, Jesica A. Swanstrom,
   Ellen F. Young, Emily N. Gallichotte, Aravinda de Silva, and Ralph S.
   Baric, was funded by HHS vertical bar National Institutes of Health
   (NIH) (R01 AI 107731). This work, including the efforts of Mark T.
   Heise, Ralph S. Baric, and Kenneth S. Plante, was funded by HHS vertical
   bar National Institutes of Health (NIH) (U19 AI 100625). This work,
   including the efforts of Kenneth S. Plante, was funded by HHS vertical
   bar National Institutes of Health (NIH) (T32 AI 007151-36A1). This work,
   including the efforts of Jessica Plante, Eileen McGowan, Aravinda de
   Silva, Ralph S. Baric, Jesica A. Swanstrom, Ellen F. Young, Emily N.
   Gallichotte, and Doug G. Widman, was funded by Bill and Melinda Gates
   Foundation (Bill & Melinda Gates Foundation) (Idea Grant).
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Beckham J. D., 2016, JAMA NEUROL
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031
   Lindesmith LC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001807
   Lindesmith LC, 2014, J VIROL, V88, P8826, DOI 10.1128/JVI.01192-14
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   National Research Council, 2011, GUIDE CARE USE LAB A
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Nigro G, 2012, J INFECT DIS, V205, P215, DOI 10.1093/infdis/jir718
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Young MK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010586.pub2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 44
TC 134
Z9 135
U1 1
U2 32
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2016
VL 7
IS 4
AR e01123
DI 10.1128/mBio.01123-16
PG 8
WC Microbiology
SC Microbiology
GA DW1YQ
UT WOS:000383440500061
PM 27435464
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Resiere, D
AF Resiere, D.
TI Inter-regional medical cooperation in the Caribbean : a major asset for
   the influence of the French medicine
SO MEDECINE ET SANTE TROPICALES
LA English
DT Article
DE Martinique; medical cooperation; inter-regional cooperation; Caribbean
AB Martinique was accepted as an associate member by the Council of Ministers of the Organization of Eastern Caribbean State since February 2015. This membership constitutes a major asset in bringing Martiniquais closer to the other Caribbean populations and should play a key role as it relates to regional cooperation especially in the domain of healthcare. Martinique and several Caribbean countries share common health issues such as; dengue, chikungunya virus, Zika Virus leptospirosis, snakebite, severe cardiovascular diseases (CVD), HTLV-1, sickle cell diseases and so on. This medical cooperation is mainly based in three important areas: training, teaching and transport (medical evacuations). The Inter-regional cooperation between the French Departments of the Americas and all other Caribbean countries is essential for the implementation and improvement of health care. It is urgent for the Caribbean professionals to discuss the possibilities of developing common solid relationships in training, collective scientific research, and continuous medical education.
C1 [Resiere, D.] CHU Martinique, Serv Reanimat, Fort De France, Martinique, France.
RP Resiere, D (corresponding author), CHU Martinique, Serv Reanimat, Fort De France, Martinique, France.
EM dabor.resiere@chu-fortdefrance.fr
CR Mehdaoui H, 2012, EVASAN RAPPORT MISSI
   Pichard E, 2013, MED SANTE TROP, V23, P5, DOI 10.1684/mst.2013.0147
   Quenel P, 2011, NOUVEAUX CONTEXTES N
   Resiere D, 2014, WIMJ, V1, P26
NR 4
TC 1
Z9 1
U1 1
U2 2
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 2261-3684
EI 2261-2211
J9 MED SANTE TROP
JI Med. Sante Trop.
PD JUL-SEP
PY 2016
VL 26
IS 3
BP 234
EP 237
DI 10.1684/mst.2016.0590
PG 4
WC Tropical Medicine
SC Tropical Medicine
GA VD6SI
UT WOS:000437449800003
PM 27694072
DA 2020-07-08
ER

PT J
AU Hamel, R
   Liegeois, F
   Wichit, S
   Pompon, J
   Diop, F
   Talignani, L
   Thomas, F
   Despres, P
   Yssel, H
   Misse, D
AF Hamel, Rodolphe
   Liegeois, Florian
   Wichit, Sineewanlaya
   Pompon, Julien
   Diop, Fode
   Talignani, Loic
   Thomas, Frederic
   Despres, Philippe
   Yssel, Hans
   Misse, Dorothee
TI Zika virus: epidemiology, clinical features and host-virus interactions
SO MICROBES AND INFECTION
LA English
DT Review
DE ZIKA; Arbovirus; Innate immunity; Epidemiology; Host-pathogen
   interactions; Vector
ID HUMAN DENDRITIC CELLS; DENGUE-VIRUS; HUMAN SKIN; RIG-I; TRANSMISSION;
   INFECTION; RECEPTORS; OUTBREAK; SUSCEPTIBILITY; ARBOVIRUSES
AB Very recently, Zika virus (ZIKV) has gained a medical importance following the large-scale epidemics in South Pacific and Latin America. This paper reviews information on the epidemiology and clinical features of Zika disease with a particular emphasis on the host-virus interactions that contribute to the pathogenicity of ZIKV in humans. (C) 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Hamel, Rodolphe; Liegeois, Florian; Wichit, Sineewanlaya; Pompon, Julien; Diop, Fode; Talignani, Loic; Thomas, Frederic; Misse, Dorothee] CNRS, UM1, Lab MIVEGEC, UMR IRD 224, Montpellier, France.
   [Pompon, Julien] Duke NUS Med Sch, Programme Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
   [Despres, Philippe] Univ La Reunion, GIP CYROI, CNRS 9192, UM PIMIT 134,Inserm U1187,IRD 249, St Clothilde 97491, Reunion, France.
   [Yssel, Hans] UPMC, Univ Paris 04, Hop Pitie Salpetriere, AP HP,Ctr Immunol & Malad Infect,Inserm,U1135, Paris, France.
RP Misse, D (corresponding author), CNRS, UM1, Lab MIVEGEC, UMR IRD 224, Montpellier, France.
EM dorothee.misse@ird.fr
RI Florian, Liegeois/D-3798-2013; Yssel, Hans/C-6406-2009; Hamel,
   Rodolphe/AAG-1714-2020; Misse, Dorothee/A-7590-2012
OI Florian, Liegeois/0000-0003-1048-0661; Yssel, Hans/0000-0001-7454-1836;
   Hamel, Rodolphe/0000-0001-8603-7039; Misse,
   Dorothee/0000-0002-6485-3841; THOMAS, Frederic/0000-0003-2238-1978
FU French Research Agency "Agence Nationale de la Recherche"French National
   Research Agency (ANR) [ANR-12-BSV3-0004-01, ANR-14-CE14-0029]; French
   Research Agency "Agence Nationale de la Recherche"French National
   Research Agency (ANR) [ANR-12-BSV3-0004-01, ANR-14-CE14-0029]
FX This work was supported by grants from the French Research Agency
   "Agence Nationale de la Recherche" (ANR-12-BSV3-0004-01;
   ANR-14-CE14-0029).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V2015, P381
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2010, EMERG INFECT DIS, V2012, P349
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Salazar MI, 2013, SCI WORLD J, DOI 10.1155/2013/904067
   Ivory MO, 2015, J INVEST DERMATOL, V135, P1711, DOI 10.1038/jid.2014.544
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, P19
   LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, BISES B INFORM SANIT, P1
   Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roth A, 2014, EUROSURVEILLANCE, P19
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Shipley JG, 2012, VIROLOGY, V432, P232, DOI 10.1016/j.virol.2012.06.009
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 70
TC 42
Z9 46
U1 0
U2 126
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD JUL-AUG
PY 2016
VL 18
IS 7-8
DI 10.1016/j.micinf.2016.03.009
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP9WK
UT WOS:000378848400001
PM 27012221
DA 2020-07-08
ER

PT J
AU Diaz-Quinonez, JA
   Pena-Alonso, R
   Mendieta-Condado, E
   Garces-Ayala, F
   Gonzalez-Duran, E
   Escobar-Escamilla, N
   Vazquez-Pichardo, M
   Torres-Rodriguez, MD
   Nunez-Leon, A
   Torres-Longoria, B
   Lopez-Martinez, I
   Ruiz-Matus, C
   Kuri-Morales, P
   Ramirez-Gonzalez, JE
AF Alberto Diaz-Quinonez, Jose
   Pena-Alonso, Rocio
   Mendieta-Condado, Edgar
   Garces-Ayala, Fabiola
   Gonzalez-Duran, Elizabeth
   Escobar-Escamilla, Noe
   Vazquez-Pichardo, Mauricio
   de la Luz Torres-Rodriguez, Maria
   Nunez-Leon, Alma
   Torres-Longoria, Belem
   Lopez-Martinez, Irma
   Ruiz-Matus, Cuitlahuac
   Kuri-Morales, Pablo
   Ernesto Ramirez-Gonzalez, Jose
TI Complete Genome Sequence of Zika Virus Isolated in Mexico, 2016
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Zika virus belongs to the genus Flavivirus, and its spread remains an international public health emergency. In this report, we describe the obtainment and molecular characterization of a complete viral genome through the direct metagenomic analysis from saliva from an autochthonous transmission case in Mexico.
C1 [Alberto Diaz-Quinonez, Jose; Pena-Alonso, Rocio; Mendieta-Condado, Edgar; Garces-Ayala, Fabiola; Gonzalez-Duran, Elizabeth; Escobar-Escamilla, Noe; Vazquez-Pichardo, Mauricio; de la Luz Torres-Rodriguez, Maria; Nunez-Leon, Alma; Torres-Longoria, Belem; Lopez-Martinez, Irma; Ernesto Ramirez-Gonzalez, Jose] Inst Diagnost & Referencia Epidemiol InDRE Dr Man, Mexico City, DF, Mexico.
   [Alberto Diaz-Quinonez, Jose] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico.
   [Ruiz-Matus, Cuitlahuac] Direcc Gen Epidemiol, Mexico City, DF, Mexico.
   [Kuri-Morales, Pablo] Subsecretaria Prevent & Promoc Salud, Mexico City, DF, Mexico.
   [Escobar-Escamilla, Noe] IPN, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico.
RP Diaz-Quinonez, JA; Ramirez-Gonzalez, JE (corresponding author), Inst Diagnost & Referencia Epidemiol InDRE Dr Man, Mexico City, DF, Mexico.; Diaz-Quinonez, JA (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico.
EM alberto.diaz@salud.gob.mx; ernesto.ramirez@salud.gob.mx
OI Escobar-Escamilla, Noe/0000-0001-8929-476X; Diaz-Quinonez, Jose
   Alberto/0000-0002-3503-7079
CR Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
NR 3
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD JUL-AUG
PY 2016
VL 4
IS 4
AR e00750-16
DI 10.1128/genomeA.00750-16
PG 1
WC Microbiology
SC Microbiology
GA VI1DR
UT WOS:000460662700120
PM 27491989
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Yun, SI
   Song, BH
   Frank, JC
   Julander, JG
   Polejaeva, IA
   Davies, CJ
   White, KL
   Lee, YM
AF Yun, Sang-Im
   Song, Byung-Hak
   Frank, Jordan C.
   Julander, Justin G.
   Polejaeva, Irina A.
   Davies, Christopher J.
   White, Kenneth L.
   Lee, Young-Min
TI Complete Genome Sequences of Three Historically Important,
   Spatiotemporally Distinct, and Genetically Divergent Strains of Zika
   Virus: MR-766, P6-740, and PRVABC-59
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID YELLOW-FEVER; INFECTION; TRANSMISSION; OUTBREAK; EMERGENCE; MOSQUITOS;
   AMERICA; ISLAND; BAHIA
AB Here, we report the 10,807-nucleotide-long consensus RNA genome sequences of three spatiotemporally distinct and genetically divergent Zika virus strains, with the functionality of their genomic sequences substantiated by reverse genetics: MR-766 (African lineage, Uganda, 1947), P6-740 (Asian lineage, Malaysia, 1966), and PRVABC-59 (Asian lineage-derived American strain, Puerto Rico, 2015).
C1 [Yun, Sang-Im; Song, Byung-Hak; Frank, Jordan C.; Julander, Justin G.; Polejaeva, Irina A.; Davies, Christopher J.; White, Kenneth L.; Lee, Young-Min] Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr & Appl Sci, Logan, UT 84322 USA.
RP Lee, YM (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr & Appl Sci, Logan, UT 84322 USA.
EM youngmin.lee@usu.edu
OI Polejaeva, Irina/0000-0002-0858-5889; Davies,
   Christopher/0000-0001-5673-3164
FU Utah Science Technology and Research initiative [A34637, A36815]
FX This work was supported by grants from the Utah Science Technology and
   Research initiative (A34637 and A36815). Also, this research was
   approved as journal paper number UAES #8903. The funders had no role in
   study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, HLTH ADV REC MAN REP
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCrae AW, 1970, SUMMARY APPARENT EPI, P20
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Song BH, 2012, J MICROBIOL, V50, P698, DOI 10.1007/s12275-012-2336-6
   THIEL HJ, 2005, VIRUS TAXONOMY, P981
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 66
TC 16
Z9 16
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD JUL-AUG
PY 2016
VL 4
IS 4
AR e00800-16
DI 10.1128/genomeA.00800-16
PG 4
WC Microbiology
SC Microbiology
GA VI1DR
UT WOS:000460662700156
PM 27540058
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Pastula, DM
   Smith, DE
   Beckham, JD
   Tyler, KL
AF Pastula, Daniel M.
   Smith, Daniel E.
   Beckham, J. David
   Tyler, Kenneth L.
TI An Overview of Zika Virus Disease
SO NEUROHOSPITALIST
LA English
DT Letter
DE Zika virus; arbovirus; arboviral disease; flavivirus; North America
C1 [Pastula, Daniel M.; Smith, Daniel E.; Beckham, J. David; Tyler, Kenneth L.] Univ Colorado Denver, Dept Neurol, Div Infect Dis, Neuroinfect Dis Grp, Aurora, CO USA.
RP Pastula, DM (corresponding author), Univ Colorado Denver, Dept Neurol, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
EM daniel.pastula@ucdenver.edu
RI Beckham, John/AAE-6694-2020
OI Beckham, John/0000-0001-9305-2683
FU NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [T32 NS099042]
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Pan American Health Organization, EP UPD NEUR SYNDR CO
   U.S. Centers for Disease Control and Prevention, TRANSCR CDC TEL ZIK
   U.S. Centers for Disease Control and Prevention, ARB CAT
   US Centers for Disease Control and Prevention, ZIK VIR
NR 5
TC 2
Z9 2
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1941-8744
EI 1941-8752
J9 NEUROHOSPITALIST
JI Neurohospitalist
PD JUL
PY 2016
VL 6
IS 3
BP 93
EP 94
DI 10.1177/1941874416637409
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA VH9DH
UT WOS:000457809900002
PM 27366289
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Anderson, MR
   Kashanchi, F
   Jacobson, S
AF Anderson, Monique R.
   Kashanchi, Fatah
   Jacobson, Steven
TI Exosomes in Viral Disease
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Exosomes; microvesicles; multivesicular bodies; "back fusion"; ESCRT
ID CELL-DERIVED EXOSOMES; MATURE DENDRITIC CELLS; STRUCTURES L-PARTICLES;
   HEPATITIS-C VIRUS; EXTRACELLULAR VESICLES; T-CELLS; SECRETE EXOSOMES;
   EBOLA-VIRUS; DC-SIGN; REPLICATION-COMPETENT
AB Viruses have evolved many mechanisms by which to evade and subvert the immune system to ensure survival and persistence. However, for each method undertaken by the immune system for pathogen removal, there is a counteracting mechanism utilized by pathogens. The new and emerging role of microvesicles in immune intercellular communication and function is no different. Viruses across many different families have evolved to insert viral components in exosomes, a subtype of microvesicle, with many varying downstream effects. When assessed cumulatively, viral antigens in exosomes increase persistence through cloaking viral genomes, decoying the immune system, and even by increasing viral infection in uninfected cells. Exosomes therefore represent a source of viral antigen that can be used as a biomarker for disease and targeted for therapy in the control and eradication of these disorders. With the rise in the persistence of new and reemerging viruses like Ebola and Zika, exploring the role of exosomes become more important than ever.
C1 [Anderson, Monique R.; Jacobson, Steven] NINDS, NIH, Neuroimmunol Branch, Viral Immunol Sect, Bethesda, MD 20892 USA.
   [Anderson, Monique R.] Univ Virginia, Sch Med, Dept Pathol, Mol & Cellular Basis Dis Grad Program, Charlottesville, VA 22903 USA.
   [Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Mol Virol Lab, Manassas, VA 20110 USA.
RP Anderson, MR (corresponding author), NINDS, NIH, Neuroimmunol Branch, Viral Immunol Sect, Bethesda, MD 20892 USA.; Anderson, MR (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Mol & Cellular Basis Dis Grad Program, Charlottesville, VA 22903 USA.
EM andersonmr2@mail.nih.gov
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32 GM007267]; NINDS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01 NS099029]
CR Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615
   Ahsan NA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00139
   Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x
   Alefantis T, 2005, J BIOL CHEM, V280, P17353, DOI 10.1074/jbc.M409851200
   Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862
   Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068
   [Anonymous], J IMMUNOL
   Ansari MA, 2013, J VIROL, V87, P8606, DOI 10.1128/JVI.00805-13
   Arenaccio C, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0216-y
   Arenaccio C, 2014, J VIROL, V88, P11529, DOI 10.1128/JVI.01712-14
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baglio SR, 2016, P NATL ACAD SCI USA, V113, pE587, DOI 10.1073/pnas.1518130113
   Basso M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00127
   Bello-Morales R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-265
   Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009
   Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235
   Boukouris S, 2015, PROTEOM CLIN APPL, V9, P358, DOI 10.1002/prca.201400114
   Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10
   Campbell PE, 2012, J MOL MODEL, V18, P4603, DOI 10.1007/s00894-012-1452-x
   Campbell Tamika D, 2008, Ethn Dis, V18, pS2
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   Chai N, 2008, J VIROL, V82, P7812, DOI 10.1128/JVI.00561-08
   Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484
   Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326
   Comelli L, 2014, MOL BIOSYST, V10, P1146, DOI 10.1039/c3mb70544g
   Cowan EP, 1997, J VIROL, V71, P6982, DOI 10.1128/JVI.71.9.6982-6989.1997
   Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406
   de Carvalho JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113691
   DHIBJALBUT S, 1994, ANN NEUROL, V36, P787, DOI 10.1002/ana.410360516
   Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663
   EL Andaloussi S, 2013, ADV DRUG DELIVER REV, V65, P391, DOI 10.1016/j.addr.2012.08.008
   Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121
   Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003
   Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x
   Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0
   Fraile-Ramos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015318
   Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100
   Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han ZY, 2015, J INFECT DIS, V212, pS138, DOI 10.1093/infdis/jiu838
   Heilingloh CS, 2015, J VIROL, V89, P11046, DOI 10.1128/JVI.01517-15
   Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712
   Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI 10.3844/ajidsp.2009.231.258
   Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740
   Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659
   Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778
   JOHNSTONE RM, 1989, BLOOD, V74, P1844
   Kalamvoki M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0518-2
   Kalamvoki M, 2014, P NATL ACAD SCI USA, V111, pE4991, DOI 10.1073/pnas.1419338111
   Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450
   Kim DK, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20384
   Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596
   Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522
   Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10
   Kubota R, 2000, AIDS RES HUM RETROV, V16, P1705, DOI 10.1089/08892220050193182
   Kuo HT, 2010, TRANSPLANTATION, V90, P1091, DOI 10.1097/TP.0b013e3181f7c053
   Lagana Alessandro, 2013, Frontiers in Genetics, V4, P120, DOI 10.3389/fgene.2013.00120
   Lai FW, 2015, J LEUKOCYTE BIOL, V97, P237, DOI 10.1189/jlb.3RU0513-292RR
   Lee CC, 2012, CLIN CHEM LAB MED, V1, P1, DOI DOI 10.1371/J0URNAL.PPAT.1002904
   Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x
   Lepoutre V, 2009, FRONT BIOSCI-LANDMRK, V14, P1152, DOI 10.2741/3300
   Levin MC, 2002, J INFECT DIS, V186, P1514, DOI 10.1086/344734
   Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x
   Longatti A, 2015, VIRUSES-BASEL, V7, P6707, DOI 10.3390/v7122967
   Longatti A, 2015, J VIROL, V89, P2956, DOI 10.1128/JVI.02721-14
   Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007
   Luo XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124436
   Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011
   Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425
   McDevitt LM, 2006, AM J HEALTH-SYST PH, V63, pS3, DOI 10.2146/ajhp060377
   MCLAUCHLAN J, 1992, VIROLOGY, V190, P682, DOI 10.1016/0042-6822(92)90906-6
   MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269
   Meckes DG, 2015, J VIROL, V89, P5200, DOI 10.1128/JVI.02470-14
   Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110
   Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11
   Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107
   Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005
   Meng B, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0197-x
   Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824
   Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x
   Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641
   Murk JL, 2002, SEMIN CELL DEV BIOL, V13, P303, DOI 10.1016/S1084952102000605
   Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13
   Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767
   Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895
   Nour AM, 2014, TRENDS CELL BIOL, V24, P449, DOI 10.1016/j.tcb.2014.03.006
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Okoye IS, 2014, IMMUNITY, V41, P89, DOI 10.1016/j.immuni.2014.05.019
   Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000
   Ota M, 2014, MICROBIOL IMMUNOL, V58, P119, DOI 10.1111/1348-0421.12121
   Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002
   Gerber PP, 2015, J CELL BIOL, V209, P435, DOI 10.1083/jcb.201409082
   Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304
   Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010
   Plazolles N, 2011, J LEUKOCYTE BIOL, V89, P329, DOI 10.1189/jlb.0710386
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   Rhein BA, 2016, J VIROL
   RIXON FJ, 1992, J GEN VIROL, V73, P277, DOI 10.1099/0022-1317-73-2-277
   Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622
   Romanelli MG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00271
   Roux A, 2013, CLIN IMMUNOL, V148, P16, DOI 10.1016/j.clim.2013.03.012
   Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021
   Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171
   Sampey GC, 2014, J NEUROVIROL, V20, P199, DOI 10.1007/s13365-014-0238-6
   Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x
   Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363
   Schwab A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01132
   Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909
   Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220
   Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489
   Shembade Noula, 2010, World J Biol Chem, V1, P13, DOI 10.4331/wjbc.v1.i1.13
   Silvas JA, 2016, J VIROL, V90, P873, DOI 10.1128/JVI.02490-15
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x
   Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083
   Temme S, 2010, J IMMUNOL, V184, P236, DOI 10.4049/jimmunol.0902192
   Thebaud B, 2012, CIRCULATION, V126, P2553, DOI 10.1161/CIRCULATIONAHA.112.146738
   Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854
   Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5
   Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983
   van Dongen HM, 2016, MICROBIOL MOL BIOL R, V80, P369, DOI 10.1128/MMBR.00063-15
   van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Vincent-Schneider H, 2002, INT IMMUNOL, V14, P713, DOI 10.1093/intimm/dxf048
   Walker JD, 2009, J IMMUNOL, V182, P1548, DOI 10.4049/jimmunol.182.3.1548
   Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513
   Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111
   Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103
   Williamson PR, 2016, LANCET NEUROL, V15, P17, DOI 10.1016/S1474-4422(15)00359-2
   Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438
   Woodward CL, 2015, J VIROL, V89, P1267, DOI 10.1128/JVI.02997-14
   Wurdinger T, 2012, ADV VIROL, V2012, DOI 10.1155/2012/767694
   Yandrapalli N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00220
   Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y
   Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013
   BIOPHYS J
NR 149
TC 58
Z9 58
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD JUL
PY 2016
VL 13
IS 3
BP 535
EP 546
DI 10.1007/s13311-016-0450-6
PG 12
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA DS3JP
UT WOS:000380679400010
PM 27324390
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Leibovitch, EC
   Jacobson, S
AF Leibovitch, Emily C.
   Jacobson, Steven
TI Vaccinations for Neuroinfectious Disease: A Global Health Priority
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Vaccines; Neuroinfectious; Neuroinvasive; Meningitis; Encephalitis; CNS
   infections
ID TICK-BORNE ENCEPHALITIS; VENEZUELAN EQUINE ENCEPHALITIS; VACCINE STRAIN;
   VIRUS; COMPLICATIONS; MALARIA; EPIDEMIOLOGY; INFECTIONS; CHALLENGES;
   IMMUNITY
AB Vaccines for neuroinfectious diseases are becoming an ever-increasing global health priority, as neurologic manifestations and sequelae from existing and emerging central nervous system infections account for significant worldwide morbidity and mortality. The prevention of neurotropic infections can be achieved through globally coordinated vaccination campaigns, which have successfully eradicated nonzoonotic agents such as the variola viruses and, hopefully soon, poliovirus. This review discusses vaccines that are currently available or under development for zoonotic flaviviruses and alphaviruses, including Japanese and tick-borne encephalitis, yellow fever, West Nile, dengue, Zika, encephalitic equine viruses, and chikungunya. Also discussed are nonzoonotic agents, including measles and human herpesviruses, as well as select bacterial, fungal, and protozoal pathogens. While therapeutic vaccines will be required to treat a multitude of ongoing infections of the nervous system, the ideal vaccination strategy is pre-exposure vaccination, with the ultimate goals of minimizing disease associated with zoonotic viruses and the total eradication of nonzoonotic agents.
C1 [Leibovitch, Emily C.; Jacobson, Steven] NINDS, Viral Immunol Sect, NIH, Bethesda, MD 20892 USA.
   [Leibovitch, Emily C.] George Washington Univ, Sch Med, Inst Biomed Sci, Washington, DC 20037 USA.
RP Jacobson, S (corresponding author), NINDS, Viral Immunol Sect, NIH, Bethesda, MD 20892 USA.
EM jacobsons@ninds.nih.gov
CR Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P33
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P201
   [Anonymous], 2015, VACCINE PREVENTABLE
   [Anonymous], 2006, WKLY EPIDEMIOL REC
   Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Broutet N., 2016, EXPERT REV VACCINES
   Broutet N., 2016, N ENGL J MED
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, N ENGL J MED
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Cohen JI, 2013, VACCINE, V31, pB194, DOI 10.1016/j.vaccine.2012.09.041
   CONNELLY KP, 1994, PEDIATR NEUROL, V10, P181, DOI 10.1016/0887-8994(94)90021-3
   De Benedictis P., 2016, EMBO MOL MED
   Dieye Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1965
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608
   GAGLIARDI AM, 2016, COCHRANE DB SYST REV, V3
   George B.P., 2014, PLOS ONE, V9
   Gianchecchi E, 2015, EXPERT REV ANTI-INFE, V13, P1249, DOI 10.1586/14787210.2015.1070096
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gosling R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001994
   Guerbois M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002197
   Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709
   Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458
   Hora R, 2016, METAB BRAIN DIS, V31, P225, DOI 10.1007/s11011-015-9787-5
   Hotez P. J., 2016, PLOS NEGLECT TROP D, V10
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Johnston C, 2016, VACCINE
   Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148
   Kalita J, 2014, NEUROL INDIA, V62, P662, DOI 10.4103/0028-3886.149394
   Kardani K, 2016, VACCINE, V34, P413, DOI 10.1016/j.vaccine.2015.11.062
   Karunamoorthi K., 2013, YELLOW FEVER ENCEPHA, P41
   Kunze U, 2015, CENT EUR J PUBL HEAL, V23, P223
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Liang HB, 2016, CELL MOL IMMUNOL, V13, P36, DOI 10.1038/cmi.2015.76
   Lobigs M, 2012, EXPERT REV VACCINES, V11, P177, DOI [10.1586/erv.11.180, 10.1586/ERV.11.180]
   Long CA, 2016, CURR OPIN MICROBIOL, V32, P96, DOI 10.1016/j.mib.2016.04.006
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mecharles S, 2016, LANCET
   Molina OM, 1999, REV NEUROLOGIA, V29, P296, DOI 10.33588/rn.2904.99224
   Morrison C, 2015, NAT BIOTECHNOL, V33, P1015, DOI 10.1038/nbt1015-1015
   Nanjappa SG, 2014, CURR OPIN IMMUNOL, V28, P27, DOI 10.1016/j.coi.2014.01.014
   Nath A, 2013, ANN NEUROL, V74, P412, DOI 10.1002/ana.23988
   Ogata M, 2015, BONE MARROW TRANSPL, V50, P1030, DOI 10.1038/bmt.2015.76
   Paessler S, 2003, J VIROL, V77, P9278, DOI 10.1128/JVI.77.17.9278-9286.2003
   Palacios R., 2016, VACCINE
   Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac
   Pastula DM, 2016, J NEUROVIROL
   Petersen L.R., 2016, N ENGL J MED
   Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13
   Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353
   Phillips AT, 2014, J VIROL, V88, P1771, DOI 10.1128/JVI.02297-13
   Rella A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00836
   Sanders BP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005483
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Science M, 2014, J PEDIATR-US, V165, P779, DOI 10.1016/j.jpeds.2014.06.014
   Smalley C., 2016, VACCINE
   Smith C, 2015, CURR TOP MICROBIOL, V391, P455, DOI 10.1007/978-3-319-22834-1_16
   Gualberto FAS, 2013, J CLIN VIROL, V58, P737, DOI 10.1016/j.jcv.2013.10.016
   Tesini BL, 2014, CURR OPIN VIROL, V9, P91, DOI 10.1016/j.coviro.2014.09.013
   Tracey J., 2015, SYNDROMIC APPROACH N, P28
   Veje M, 2016, ACTA NEUROL SCAND
   Weinberg A, 2002, ANN NEUROL, V52, P543, DOI 10.1002/ana.10321
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Wilder-Smith A, 2016, EXPERT REV VACCINES, V15, P433, DOI 10.1586/14760584.2016.1154459
   Wilson J.W., 2015, FUNGAL INFECTIONS CE
   Wozniak KL, 2011, CLIN VACCINE IMMUNOL, V18, P717, DOI 10.1128/CVI.00036-11
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
   Zajkowska J, 2011, NEUROL NEUROCHIR POL, V45, P402
NR 74
TC 8
Z9 8
U1 1
U2 65
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD JUL
PY 2016
VL 13
IS 3
BP 562
EP 570
DI 10.1007/s13311-016-0453-3
PG 9
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA DS3JP
UT WOS:000380679400013
PM 27365085
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ibrahim, NK
AF Ibrahim, Nahla Khamis
TI Zika Virus: Epidemiology, current phobia and preparedness for upcoming
   mass gatherings, with examples from World Olympics and Pilgrimage
SO PAKISTAN JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE Emerging diseases; Zika; Epidemiology; Phobia; Mass gathering; Vaccine
   trials; Preparedness; Surveillance
ID PUBLIC-HEALTH PREPAREDNESS; INTERIM GUIDELINES; UNITED-STATES; BRAZIL;
   HAJJ; OUTBREAK; AMERICA
AB Objective: To describe Zika Virus (ZIKV) epidemiology, current phobia, and the required preparedness for its prevention during the upcoming Mass Gathering (MG) events.
   Methods: Electronic databases of PubMed, WHO, CDC, Pan American Health Organization (PAHO), Google, and Cochrane library were extensively searched for ZIKV. Articles were reviewed, scrutinized and critically appraised and the most relevant articles were utilized.
   Results: ZIKV is an emerging Flavivirus which was first isolated from Uganda in 1947. It is transmitted mainly through bite of Aedes mosquitoes. Sexual, perinatal and blood-borne transmissions are implicated. ZIKV is incriminated to cause microcephaly and Guillain-Barre syndrome. The spiky spread of ZIKV and its epidemic potential are especially problematic in countries which host big MGs with endogenous ZIKV circulation. This put millions of international travelers and local inhabitants at risk of acquiring ZIKV, especially in absence of vaccine until now. Brazil Olympic and Paralympics Games, and Muslims Hajj in Saudi Arabia are important upcoming MGs. Regarding Brazil, swiftly epidemic of ZIKV causes phobia and provokes claims and counter-claims about possible postponing or cancellation of such events.
   Recommendations: Intensifying ZIKV epidemiological surveillance (sentinel, syndromic, environmental, laboratory and electronic), and conduction of educational programs are required. Controlling Aedes vector (chemically Et biologically) is essential. Multidisciplinary cooperation is required to win the war against ZIKV.
C1 [Ibrahim, Nahla Khamis] King Abdulaziz Univ, Family & Community Med Dept, Epidemiol, Jeddah, Saudi Arabia.
   [Ibrahim, Nahla Khamis] Univ Alexandria, High Inst Publ Hlth, Dept Epidemiol, Alexandria, Egypt.
RP Ibrahim, NK (corresponding author), King Abdulaziz Univ, Family & Community Med Dept, Epidemiol, Jeddah, Saudi Arabia.
EM nahlakhamis@yahoo.com
RI Ibrahim, Nahla/K-6967-2012
CR Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bueno-Mari R, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00157
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, TRAV HLTH ZIK TRAV I
   CDC, 2016, SURV CONTR AED AEG A
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Colt S., 2016, B WORLD HEALTH ORGAN, V2, DOI [10.2471/BLT.16.176677, DOI 10.2471/BLT.16.176677]
   Dhimal M, 2015, J Nepal Health Res Counc, V13, P248
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Gatrad AR, 2005, BRIT MED J, V330, P133, DOI 10.1136/bmj.330.7483.133
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hutton A, 2013, PREHOSP DISASTER MED, V28, P292, DOI 10.1017/S1049023X13000228
   Ibrahim NKR, 2008, J EGYPT PUBLIC HEAL, V83, P15
   Ibrahim NK, 2014, AUSTIN J PUBLIC HLTH, V1, P1
   Ibrahim NK, 2009, J INFECT PUBLIC HEAL, V40, P30
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Memish ZA, 2013, E MEDITERR HEALTH J, V19, pS5
   Mladinic M, 2014, ARCH IND HYGIENE TOX, V65
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Mweya CN, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.25929
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PAHO/WHO, 2016, ZIK VIR INF STEP STE
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tam JS, 2012, LANCET INFECT DIS, V12, P231, DOI 10.1016/S1473-3099(11)70353-X
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Turris SA, 2016, PREHOSP DISASTER MED, V31, P1, DOI DOI 10.1017/S1049023X1600011X.
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2008, COMM DIS AL RESP MAS
NR 35
TC 8
Z9 8
U1 0
U2 18
PU PROFESSIONAL MEDICAL PUBLICATIONS
PI SADDAR
PA PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO
   BOX 8766, SADDAR, KARACHI 00000, PAKISTAN
SN 1682-024X
J9 PAK J MED SCI
JI Pak. J. Med. Sci.
PD JUL-AUG
PY 2016
VL 32
IS 4
BP 1038
EP 1043
DI 10.12669/pjms.324.10038
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV7JK
UT WOS:000383112000048
PM 27648063
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dhanraj, N
   Mazal, J
AF Dhanraj, Nicole
   Mazal, Jonathan
TI Zika Virus: Implications for Medical Imaging Professionals
SO RADIOLOGIC TECHNOLOGY
LA English
DT Article
ID TRANSMISSION; INFECTION; OUTBREAK; STATES
C1 [Dhanraj, Nicole] Guam Mem Hosp, Radiol, Tamuning, GU USA.
   [Mazal, Jonathan] Amer Reg Int Soc Radiographers & Radiol Technolog, Tamuning, GU USA.
   [Mazal, Jonathan] ASRT Fdn Community Outreach Review Comm, Mangilao, GU USA.
RP Dhanraj, N (corresponding author), Guam Mem Hosp, Radiol, Tamuning, GU USA.
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US
   Centers for Disease Control and Prevention (CDC), ZIK GUILL BARR SYNDR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jones P, 2016, RADIOL TECHNOL, V87, P393
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mitchell C., PAHO STATEMENT ZIKA
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reddy UM, 2014, AM J OBSTET GYNECOL, V210, P387, DOI 10.1016/j.ajog.2014.02.028
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC RADIOLOGIC TECHNOLOGISTS
PI ALBUQUERQUE
PA 15000 CENTRAL AVE, SE, ALBUQUERQUE, NM 87123 USA
SN 0033-8397
EI 1943-5657
J9 RADIOL TECHNOL
JI Radiol. Technol.
PD JUL-AUG
PY 2016
VL 87
IS 6
BP 698
EP 704
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA VI1QJ
UT WOS:000461498600017
PM 27390239
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Peinado, SA
   Velez, ID
   Osorio, JE
AF Aliota, Matthew T.
   Peinado, Stephen A.
   Dario Velez, Ivan
   Osorio, Jorge E.
TI The wMel strain of Wolbachia Reduces Transmission of Zika virus by Aedes
   aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUSES; YELLOW-FEVER; GEOGRAPHIC STRAINS; CHIKUNGUNYA VIRUS;
   MOSQUITO VECTOR; INFECTION; SUSCEPTIBILITY; ALBOPICTUS; OUTBREAK;
   ESTABLISHMENT
AB Zika virus (ZIKV) is causing an explosive outbreak of febrile disease in the Americas. There are no effective antiviral therapies or licensed vaccines for this virus, and mosquito control strategies have not been adequate to contain the virus. A promising candidate for arbovirus control and prevention relies on the introduction of the intracellular bacterium Wolbachia into Aedes aegypti mosquitoes. This primarily has been proposed as a tool to control dengue virus (DENV) transmission; however, evidence suggests Wolbachia infections confer protection for Ae. aegypti against other arboviruses. At present, it is unknown whether or not ZIKV can infect, disseminate, and be transmitted by Wolbachia-infected Ae. aegypti. Using Ae. aegypti infected with the wMel strain of Wolbachia that are being released in Medellin, Colombia, we report that these mosquitoes have reduced vector competence for ZIKV. These results support the use of Wolbachia biocontrol as a multivalent strategy against Ae. aegypti-transmitted viruses.
C1 [Aliota, Matthew T.; Peinado, Stephen A.; Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Dario Velez, Ivan] Univ Antioquia, PECET, Medellin 1226, Colombia.
RP Aliota, MT (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM mtaliota@wisc.edu
OI Aliota, Matthew/0000-0002-6902-9149
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21 AI117413-01]
FX The authors thank Emma Walker and Katrina Larkin for time spent rearing
   mosquitoes. We also thank the Eliminate Dengue Program for sharing
   Wolbachia-infected mosquitoes. This work was partially funded by
   National Institutes of Health Grant # R21 AI117413-01.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Aliota MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039387
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478
   Cornet M., CAH ORSTOM EMP, V27, P47
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, N ENGL J MED
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Mlakar J, 2016, N ENGL J MED
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Rasgon JL, 2004, INSECT BIOCHEM MOLEC, V34, P707, DOI 10.1016/j.ibmb.2004.03.023
   Rasmussen SA, 2016, N ENGL J MED
   Reiczigel J, 2008, COMPUT STAT DATA AN, V52, P5046, DOI 10.1016/j.csda.2008.04.032
   RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weger-Lucarelli J, 2016, J VIROL, V90, P2418, DOI 10.1128/JVI.02792-15
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 47
TC 118
Z9 119
U1 3
U2 96
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 1
PY 2016
VL 6
AR 28792
DI 10.1038/srep28792
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0JB
UT WOS:000378884100001
PM 27364935
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lanteri, MC
   Kleinman, SH
   Glynn, SA
   Musso, D
   Hoots, WK
   Custer, BS
   Sabino, EC
   Busch, MP
AF Lanteri, Marion C.
   Kleinman, Steven H.
   Glynn, Simone A.
   Musso, Didier
   Hoots, W. Keith
   Custer, Brian S.
   Sabino, Ester C.
   Busch, Michael P.
TI Zika virus: a new threat to the safety of the blood supply with
   worldwide impact and implications
SO TRANSFUSION
LA English
DT Editorial Material
ID FRENCH-POLYNESIA; EMERGING PATHOGENS; TRANSMISSION; OUTBREAK; DENGUE;
   INFECTION; DONORS; ARBOVIRUSES; VECTOR; STATES
C1 [Lanteri, Marion C.; Custer, Brian S.; Busch, Michael P.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.
   [Lanteri, Marion C.; Custer, Brian S.; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Kleinman, Steven H.] Univ British Columbia, Vancouver, BC, Canada.
   [Glynn, Simone A.; Hoots, W. Keith] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.
RP Busch, MP (corresponding author), Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
EM mbusch@bloodsystems.org
RI Sabino, Ester Cerdeira/F-7750-2010; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020
OI Sabino, Ester Cerdeira/0000-0003-2623-5126; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR AFP, 2016, WHO SOUNDS ZIKA BLOO
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   [Anonymous], 2016, ASS B, V#16-04
   [Anonymous], 2016, ZIKA VIRUS DISEASE E
   [Anonymous], 2016, REC DON SCREEN DEF P
   [Anonymous], 2016, ASS B, V#16-03
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Atreya Chintamani, 2011, Transfusion, V51, P1855, DOI 10.1111/j.1537-2995.2011.03084.x
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, N ENGL J MED
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Busch MP, 2014, ISBT SCI SER, V9, P276, DOI 10.1111/voxs.12082
   Calvet GA, 2015, BRAZIL J CLIN VIROL, V74, P1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodd RY, 2014, TRANSFUSION, V54, P1693, DOI 10.1111/trf.12705
   Dodd RY, 2003, NEW ENGL J MED, V349, P1205, DOI 10.1056/NEJMp038138
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 2006, FLAVIVIRUSES FIELDS
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kindhauser MK, 2016, B WHO
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet H. P., 2015, B INFORM SANITAIRES
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marks PW, 2016, J INFECT DIS, V213, P1676, DOI 10.1093/infdis/jiw089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreno-Sanchez R, 2006, HEALTH PLACE, V12, P715, DOI 10.1016/j.healthplace.2005.10.001
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nett RJ, 2012, TRANSPL INFECT DIS, V14, P268, DOI 10.1111/j.1399-3062.2012.00743.x
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stein J, 2011, VOX SANG, V101, P277, DOI 10.1111/j.1423-0410.2011.01526.x
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, 2016, MAINT SAF AD BLOOD S
   World Health Organization, 2016, ZIK VIR SIT REP
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 85
TC 29
Z9 30
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2016
VL 56
IS 7
BP 1907
EP 1914
DI 10.1111/trf.13677
PG 8
WC Hematology
SC Hematology
GA DS1NG
UT WOS:000380362100034
PM 27282638
DA 2020-07-08
ER

PT J
AU Grischott, F
   Puhan, M
   Hatz, C
   Schlagenhauf, P
AF Grischott, Franca
   Puhan, Milo
   Hatz, Christoph
   Schlagenhauf, Patricia
TI Non-vector-borne transmission of Zika virus: A systematic review
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Review
DE Zika virus; Non-vector-borne transmission; Sexual transmission;
   Transfusion; Microcephaly
ID PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; SEXUAL TRANSMISSION;
   FRENCH-POLYNESIA; UNITED-STATES; INFECTION; BRAZIL; DENGUE; PREGNANCY;
   DIAGNOSIS
AB Background: Increasing numbers of confirmed cases of Zika virus (ZIKV) infection resulting from non-mosquito-borne transmission have been reported.
   Methods: We performed a systematic literature review (PRISMA guidelines) on intrauterine, intrapartum, sexual and animal bite ZIKV transmission. The presence of the virus in breast milk, urine, saliva and blood transfusions was also reviewed.
   Results: The search resulted in 285 papers of possible relevance, of which we included 53 in the systematic review. Mother-to-child transmission was most frequently described with adverse infant outcomes including microcephaly, intracranial calcification and fetal death. Zika virus RNA has been detected in amniotic fluid, breast milk, seminal fluid, saliva, urine and blood. Semen and blood products have proved to be infectious. Male-to-female and male-to-male ZIKV transmission is documented. There are contradictory results concerning the infectiousness of breast milk and urine and data on saliva, animal bites, transplantation, needlestick injury and laboratory work are inconclusive.
   Conclusions: Our systematic analysis shows that non-vector-borne ZIKV transmission plays a role in the spread of ZIKV and has great societal impact. It has important public health implications for the prevention and control of ZIKV globally and will be a basis for policy and further research. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Grischott, Franca; Puhan, Milo; Hatz, Christoph; Schlagenhauf, Patricia] Univ Zurich, Inst Epidemiol Biostat & Prevent, WHO Collaborating Ctr Travellers Hlth, Ctr Travel Med, Hirschengraben 84, CH-8001 Zurich, Switzerland.
   [Hatz, Christoph] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Med & Diagnost, Socinstr 57, CH-4051 Basel, Switzerland.
RP Schlagenhauf, P (corresponding author), Univ Zurich, Inst Epidemiol Biostat & Prevent, WHO Collaborating Ctr Travellers Hlth, Ctr Travel Med, Hirschengraben 84, CH-8001 Zurich, Switzerland.
EM patricia.schlagenhauf@uzh.ch
OI Schlagenhauf, Patricia/0000-0002-1075-7010; Puhan,
   Milo/0000-0003-4721-1879
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   [Anonymous], 2006, EMERGING INFECT DIS, V16
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Baron S, 1999, ARCH INTERN MED, V159, P303, DOI 10.1001/archinte.159.3.303
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILL B EUR S, V21
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boadle A, BRAZIL REPORTS ZIKA
   Brasil P, 2016, N ENGL J MED
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet G., 2016, LANCET INFECT DIS
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cauchemez S, 2016, LANCET
   Centers for Disease Control and Prevention, VECT SURV CONTR
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio E, 2016, N ENGL J MED
   de Paula Freitas B, 2016, BRAZ JAMA OPHTHALMOL
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, N ENGL J MED
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faria NR, 2016, SCIENCE
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Habu A, 1977, Uirusu, V27, P21
   Hearn P, 2014, AM J TROP MED HYG S1, V91, P62
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Korhonen EM, 2016, EUROSURVEILL B EUR S, V21
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maria AT, 2016, EUROSURVEILL B EUR S, V21
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerioda Saude Secretaria de Vigilancia em Saude, 2016, PROT VIG RESP OC MIC, P16
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, N ENGL J MED
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rasmussen SA, 2016, N ENGL J MED
   Roze B, 2016, EUROSURVEILL B EUR S, V21
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tang H, 2016, CELL STEM CELL
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILL B EUR S, V21
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Werner H, 2016, ULTRASOUND OBSTET GY
NR 83
TC 71
Z9 71
U1 4
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2016
VL 14
IS 4
BP 313
EP 330
DI 10.1016/j.tmaid.2016.07.002
PG 18
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DU5EM
UT WOS:000382235000004
PM 27425793
DA 2020-07-08
ER

PT J
AU dos Santos, CND
   Goldenberg, S
AF Duarte dos Santos, Claudia Nunes
   Goldenberg, Samuel
TI Zika Virus and Vicrocephaly: Challenges for a Long-Term Agenda
SO TRENDS IN PARASITOLOGY
LA English
DT Editorial Material
ID TRANSMISSION; INFECTION; BRAZIL
AB Since its introduction in Brazil in 2015, Zika virus (ZIKV) has begun to spread worldwide. One of the major infection outcomes is related to congenital malformations, but little is known about the pathogenicity of ZIKV. Here we discuss concerns about the ongoing ZIKV epidemic in the context of academic research, politics, and society.
C1 [Duarte dos Santos, Claudia Nunes] Flocruz PR, Inst Carlos Chagas, Lab Virol Mol, Curitiba, PR, Brazil.
   [Goldenberg, Samuel] Flocruz PR, Inst Carlos Chagas, Lab Regulacao Expressao Genica, Curitiba, PR, Brazil.
RP dos Santos, CND (corresponding author), Flocruz PR, Inst Carlos Chagas, Lab Virol Mol, Curitiba, PR, Brazil.
EM clsantos@fiocruz.br
RI Santos, Claudia Duarte dos/P-4868-2019; Duarte dos Santos,
   Claudia/E-1857-2018; GOLDENBERG, SAMUEL/B-4116-2009
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; Duarte dos Santos,
   Claudia/0000-0001-8707-6638; GOLDENBERG, SAMUEL/0000-0002-4892-163X
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Noronha L., 2016, MEM I O CRUZ, V85, P5
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Zanluca C, 2016, MICROBES INFECT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD JUL
PY 2016
VL 32
IS 7
BP 508
EP 511
DI 10.1016/j.pt.2016.03.008
PG 4
WC Parasitology
SC Parasitology
GA DQ3IE
UT WOS:000379095200002
PM 27105931
OA Bronze
DA 2020-07-08
ER

PT J
AU O'Connor, DH
   Osorio, JE
   Tanuri, A
   Kallas, EG
AF O'Connor, David H.
   Osorio, Jorge E.
   Tanuri, Amilcar
   Kallas, Esper G.
TI Forging Collaborative Relationships in Brazil: From AIDS to ZIKV
SO CELL
LA English
DT Editorial Material
AB The Zika virus (ZIKV) outbreak has stimulated collaborations between Brazilians, researchers from other South American countries, and scientists from around the world. The Brazilian response to the HIV/AIDS epidemic demonstrates capabilities that can be applied to the study of ZIKV and provides lessons for developing effective international infectious disease research collaborations.
C1 [O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, BR-2194190 Rio De Janeiro, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil.
RP O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.; Kallas, EG (corresponding author), Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil.; Kallas, EG (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil.
EM dhoconno@wisc.edu; esper.kallas@usp.br
OI Kallas, Esper/0000-0003-2026-6925
CR Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Central Intelligence Agency, 2016, WORLD FACTBOOK
   Gao GF, 2014, SCIENCE, V346, P666, DOI 10.1126/science.346.6209.666
   Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
   Merson MH, 2014, NEW ENGL J MED, V370, P1676, DOI 10.1056/NEJMp1401124
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Office of the United Nations Special Envoy on Ebola, 2016, RES RES 5
   Scimago Journal & Country Rank, 2016, COUNTR RANK
   Sistema Unico de Saude, 2016, PORT DA SAUD
   The World Bank, 2016, WORLD DEV IND REPR H
   World Bank, 2016, COUNTR LEND GROUPS
   World Bank, 2016, RES DEV EXP GDP
   World Health Organization, 2016, SIT REP ZIK VIR DIS
   World Health Organization, 2016, WORLD HLTH ORG COUNT
NR 14
TC 0
Z9 0
U1 0
U2 51
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JUN 30
PY 2016
VL 166
IS 1
BP 2
EP 4
DI 10.1016/j.cell.2016.06.023
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DR9ZH
UT WOS:000380254400002
PM 27368092
OA Bronze
DA 2020-07-08
ER

PT J
AU Lustig, Y
   Mendelson, E
   Paran, N
   Melamed, S
   Schwartz, E
AF Lustig, Y.
   Mendelson, E.
   Paran, N.
   Melamed, S.
   Schwartz, E.
TI Detection of Zika virus RNA in whole blood of imported Zika virus
   disease cases up to 2 months after symptom onset, Israel, December 2015
   to April 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION
AB Zika virus RNA presence in serum, whole-blood and urine samples from six Israeli travellers symptomatic for Zika virus disease was examined. Whole-blood samples were positive for as late as 2 months (58 days) post-symptom onset, longer than for urine (26 days) and serum (3 days). These findings suggest the utility of whole blood in Zika infection diagnosis.
C1 [Lustig, Y.; Mendelson, E.] Minist Hlth, Cent Virol Lab, Tel Hashomer, Israel.
   [Mendelson, E.] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.
   [Paran, N.; Melamed, S.] Israel Inst Biol Res, Ness Ziona, Israel.
   [Schwartz, E.] Sheba Med Ctr, Inst Trop Med, Tel Hashomer, Israel.
RP Lustig, Y (corresponding author), Minist Hlth, Cent Virol Lab, Tel Hashomer, Israel.
EM yaniv.lustig@sheba.health.gov.il
RI Paran, Nir/AAC-1036-2020
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lai L, 2012, TRANSFUSION, V52, P447, DOI 10.1111/j.1537-2995.2011.03289.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Meltzer E, 2016, AM J MED
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Shulman LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039455
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 18
TC 46
Z9 46
U1 2
U2 27
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 30
PY 2016
VL 21
IS 26
BP 7
EP 10
AR 30269
DI 10.2807/1560-7917.ES.2016.21.26.30269
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DQ5KP
UT WOS:000379244400002
PM 27386894
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Trials of Zika vaccine are set to begin in North America
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
NR 3
TC 13
Z9 14
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 28
PY 2016
VL 353
AR i3588
DI 10.1136/bmj.i3588
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DQ2FP
UT WOS:000379018000018
PM 27353042
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Craig, AT
   Paterson, BJ
   Durrheim, DN
AF Craig, Adam T.
   Paterson, Beverley J.
   Durrheim, David N.
TI Commentary: Zika Virus: the Latest Newcomer
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Editorial Material
DE epidemiology; surveillance; disease surveillance; Zika virus (ZIKV);
   outbreaks; communicable diseases; emerging; communicable disease
   epidemiology
C1 [Craig, Adam T.; Paterson, Beverley J.; Durrheim, David N.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.
RP Craig, AT (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.
EM adam.craig@uon.edu.au
RI Paterson, Beverley/G-8248-2013
OI Paterson, Beverley/0000-0001-5108-103X
CR Craig AT, 2016, B WHO
   Global Polio Eradication Initiative, 2016, AC FLACC PAR AFP SUR
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olive JA, 1997, J INFECT DIS, V175, pS160, DOI 10.1093/infdis/175.Supplement_1.S160
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   WHO, 2012, WEEKLY EPIDEMIOL REC, V17, P165
   World Health Organization, 2016, ZIK SIT REP 19 MAY 2
   World Health Organization (WHO), 2016, WEEKLY EPIDEMIOL REC, V15, P193
NR 8
TC 1
Z9 1
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 28
PY 2016
VL 7
AR 1028
DI 10.3389/fmicb.2016.01028
PG 2
WC Microbiology
SC Microbiology
GA DP7NS
UT WOS:000378686700001
PM 27443350
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Savidis, G
   McDougall, WM
   Meraner, P
   Perreira, JM
   Portmann, JM
   Trincucci, G
   John, SP
   Aker, AM
   Renzette, N
   Robbins, DR
   Guo, ZR
   Green, S
   Kowalik, TF
   Brass, AL
AF Savidis, George
   McDougall, William M.
   Meraner, Paul
   Perreira, Jill M.
   Portmann, Jocelyn M.
   Trincucci, Gaia
   John, Sinu P.
   Aker, Aaron M.
   Renzette, Nicholas
   Robbins, Douglas R.
   Guo, Zhiru
   Green, Sharone
   Kowalik, Timothy F.
   Brass, Abraham L.
TI Identification of Zika Virus and Dengue Virus Dependency Factors using
   Functional Genomics
SO CELL REPORTS
LA English
DT Article
ID PHOSPHATIDYLSERINE RECEPTORS; GENES; REPLICATION; INFECTION; SCREEN;
   RNAI; TRANSMISSION; CRISPR-CAS9; DISCOVERY; INSECT
AB The flaviviruses dengue virus (DENV) and Zika virus (ZIKV) are severe health threats with rapidly expanding ranges. To identify the host cell dependencies of DENV and ZIKV, we completed orthologous functional genomic screens using RNAi and CRISPR/Cas9 approaches. The screens recovered the ZIKV entry factor AXL as well as multiple host factors involved in endocytosis (RAB5C and RABGEF), heparin sulfation (NDST1 and EXT1), and transmembrane protein processing and maturation, including the endoplasmic reticulum membrane complex (EMC). We find that both flaviviruses require the EMC for their early stages of infection. Together, these studies generate a high-confidence, systems-wide view of human-flavivirus interactions and provide insights into the role of the EMC in flavivirus replication.
C1 [Savidis, George; McDougall, William M.; Meraner, Paul; Perreira, Jill M.; Portmann, Jocelyn M.; Trincucci, Gaia; Aker, Aaron M.; Renzette, Nicholas; Robbins, Douglas R.; Kowalik, Timothy F.; Brass, Abraham L.] Univ Massachusetts Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.
   [John, Sinu P.] NIAID, Signaling Syst Unit, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Guo, Zhiru; Green, Sharone] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA.
   [Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Med, Div Gastroenterol, Worcester, MA 01655 USA.
RP Brass, AL (corresponding author), Univ Massachusetts Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.; Brass, AL (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Gastroenterol, Worcester, MA 01655 USA.
EM abraham.brass@umassmed.edu
RI John, Sinu/AAS-2054-2020
FU Burroughs Wellcome FoundationBurroughs Wellcome Fund; NIAID, NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272200900041C]; UMMS Center for Clinical and
   Translational Science; Bill and Melinda Gates FoundationGates Foundation
FX We thank R.H. Scheuermann and B. Pickett (J. Craig Venter Institute),
   the University of Maryland Medical System (UMMS; R. Fish, L. Benson, and
   J. Barrett), ICCB-L (C. Shamu, J. Smith, S. Rudnicki, S. Johnston, K.
   Rudnicki, and D. Wrobel), and T. Soellner of Heidelberg University for
   help and inspiration. This work was supported by an Investigators in the
   Pathogenesis of Infectious Disease award from the Burroughs Wellcome
   Foundation to A. L. B. and a subcontract to A. L. B. from contract
   HHSN272200900041C to Northrup Grumman Corporation from NIAID, NIH.
   A.L.B. is grateful to the UMMS Center for Clinical and Translational
   Science and to the Bill and Melinda Gates Foundation for their support.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588
   Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kwon YJ, 2014, ANTIVIR RES, V110, P20, DOI 10.1016/j.antiviral.2014.07.006
   Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Li C., 2016, CELL STEM CELL, V19
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Perreira JM, 2016, ADV VIRUS RES, V94, P1, DOI 10.1016/bs.aivir.2015.11.001
   Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076
   Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031
NR 48
TC 168
Z9 170
U1 1
U2 53
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 28
PY 2016
VL 16
IS 1
BP 232
EP 246
DI 10.1016/j.celrep.2016.06.028
PG 15
WC Cell Biology
SC Cell Biology
GA DQ1GY
UT WOS:000378950700021
PM 27342126
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Widener, A
AF Widener, Andrea
TI Governments launch Zika study of pregnant women, infants
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUN 27
PY 2016
VL 94
IS 26
BP 15
EP 15
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DP6DA
UT WOS:000378585900035
DA 2020-07-08
ER

PT J
AU Liu, HM
   Liu, T
   Xie, LH
   Wang, XM
   Deng, YH
   Chen, CH
   James, AA
   Chen, XG
AF Liu, Hongmei
   Liu, Tong
   Xie, Lihua
   Wang, Xiaoming
   Deng, Yuhua
   Chen, Chun-Hong
   James, Anthony A.
   Chen, Xiao-Guang
TI Functional analysis of Orco and odorant receptors in odor recognition in
   Aedes albopictus
SO PARASITES & VECTORS
LA English
DT Article
DE Mosquito; Olfactory; Heterologous expression; HEK293 cells
ID MOSQUITO ANOPHELES-GAMBIAE; ANTENNAL TRANSCRIPTOME PROFILES; SOUTHERN
   HOUSE MOSQUITO; DROSOPHILA-MELANOGASTER; OLFACTORY SYSTEM; ION CHANNELS;
   HUMAN-SWEAT; DEET; INSIGHTS; VECTOR
AB Background: Aedes albopictus is a globally invasive mosquito and a major vector of arboviruses, including dengue, Zika and Chikungunya. Olfactory-related behaviors, particularly host-seeking, offer opportunities to disrupt the disease-transmission process. A better understanding of odorant receptors (ORs) may assist in explaining host selection and location, and contribute to novel strategy of vector control.
   Methods: Based on previous prediction of 158 putative odorant receptors by Ae. albopictus genome analysis, 29 AalORs were selected for tissue-specific expression profiles in the present study. AalOrco (AalOR7), AalOR10 and AalOR88, highly expressed in female olfactory tissues, were chosen for further structure predictions as well as functional validation including calcium imaging assay in human embryonic kidney (HEK293) cells and RNA interference assay in Ae. albopictus. We also conducted electrophysiological and behavioral assays in mosquitoes after RNA interference of the three genes to determine their roles in host-seeking.
   Results: The results support previous conclusions that individual conventional (ORXs) and Orco can form heteromeric complexes to recognize odorants and respond to components of human volatiles in HEK293 cells. The reduction of AalOrco transcript levels led to a significant decrease in host-seeking and confusion in host preference. In contrast, AalOR10 and AalOR88 knockdown mosquitoes showed no significant behavioral differences compared with controls. The functions of conventional ORs at least AalOR10 and AalOR88 are abolished with inhibited expression of the Orco gene orthologs, along with the concomitant relevant olfactory behavior.
   Conclusions: Combining structural and functional data, we conclude that the product of the Orco gene in this mosquito is crucial for transmitting olfactory signaling and conventional ORs contribute directly to odorant recognition. Our results provide insight into the linkage between odorant receptors and host-seeking in this important vector species.
C1 [Liu, Hongmei; Liu, Tong; Xie, Lihua; Wang, Xiaoming; Deng, Yuhua; Chen, Xiao-Guang] Southern Med Univ, Key Lab Prevent & Control Emerging Infect Dis, Dept Pathogen Biol, Guangdong Higher Educ Inst,Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Chen, Chun-Hong] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan.
   [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, 3205 McGaugh Hall, Irvine, CA 92697 USA.
   [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.
RP Chen, XG (corresponding author), Southern Med Univ, Key Lab Prevent & Control Emerging Infect Dis, Dept Pathogen Biol, Guangdong Higher Educ Inst,Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
EM xgchen2001@hotmail.com
RI Wang, Xiaoming/E-3583-2018
OI Wang, Xiaoming/0000-0003-1232-3125; CHEN, CHUN-HONG/0000-0002-3028-5508;
   James, Anthony/0000-0001-5577-3308
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81371845, 81420108024]; Natural Scientific
   Foundation of Guangdong Province [2013B051000052, 2014A030312016];
   Scientific and Technological Programme of Guangzhou [201508020263];
   National Institute of Allergy and Infectious Diseases (USA)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI083202, R37AI029746]
FX This work was supported by grants from the National Natural Science
   Foundation of China (81371845, 81420108024), Natural Scientific
   Foundation of Guangdong Province (2013B051000052, 2014A030312016),
   Scientific and Technological Programme of Guangzhou (201508020263), and
   the National Institute of Allergy and Infectious Diseases (USA)
   (AI083202) to XGC. AAJ was supported in part by an award from the
   National Institute of Allergy and Infectious Diseases (USA)
   (R37AI029746).
CR Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748
   Cai CQ, 2013, BIOCHEM BIOPH RES CO, V430, P816, DOI 10.1016/j.bbrc.2012.11.063
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   Carraher C, 2015, INSECT BIOCHEM MOLEC, V66, P31, DOI 10.1016/j.ibmb.2015.09.010
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Corcoran JA, 2014, INSECT BIOCHEM MOLEC, V54, P22, DOI 10.1016/j.ibmb.2014.08.005
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Deng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068836
   Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   German PF, 2013, INSECT BIOCHEM MOLEC, V43, P138, DOI 10.1016/j.ibmb.2012.11.002
   Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a
   Hughes DT, 2014, CHEM SENSES, V39, P761, DOI 10.1093/chemse/bju048
   Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9
   Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108
   Jung JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13444
   Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594
   Kumar BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070218
   Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019
   Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Lin W, 2015, INT J BIOL SCI, V11, P772, DOI 10.7150/ijbs.11898
   Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Mukunda L, 2014, CELL CALCIUM, V55, P191, DOI 10.1016/j.ceca.2014.02.013
   Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Qin CF, 2014, SCI CHINA LIFE SCI, V57, P1230, DOI 10.1007/s11427-014-4783-2
   Qiu YT, 2013, J INSECT PHYSIOL, V59, P1111, DOI 10.1016/j.jinsphys.2013.09.001
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749
   Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110
   Sang SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003808
   Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850
   Scialo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036538
   Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Turner RM, 2014, J BIOL CHEM, V289, P31837, DOI 10.1074/jbc.M114.603993
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107
   Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9
   Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861
   Wicher D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00001
   Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111
   Xu PX, 2013, BIOCHEM BIOPH RES CO, V435, P477, DOI 10.1016/j.bbrc.2013.05.015
   Zhou HX, 2010, TRENDS BIOCHEM SCI, V35, P179, DOI 10.1016/j.tibs.2009.10.007
NR 53
TC 10
Z9 11
U1 1
U2 33
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 27
PY 2016
VL 9
AR 363
DI 10.1186/s13071-016-1644-9
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DP9RH
UT WOS:000378834000001
PM 27350348
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Turtle, L
   Bali, T
   Buxton, G
   Chib, S
   Chan, S
   Soni, M
   Hussain, M
   Isenman, H
   Fadnis, P
   Venkataswamy, MM
   Satishkumar, V
   Lewthwaite, P
   Kurioka, A
   Krishna, S
   Shankar, MV
   Ahmed, R
   Begum, A
   Ravi, V
   Desai, A
   Yoksan, S
   Fernandez, S
   Willberg, CB
   Kloverpris, HN
   Conlon, C
   Klenerman, P
   Satchidanandam, V
   Solomon, T
AF Turtle, Lance
   Bali, Tanushka
   Buxton, Gemma
   Chib, Savita
   Chan, Sajesh
   Soni, Mohammed
   Hussain, Mohammed
   Isenman, Heather
   Fadnis, Prachi
   Venkataswamy, Manjunatha M.
   Satishkumar, Vishali
   Lewthwaite, Penny
   Kurioka, Ayako
   Krishna, Srinivasa
   Shankar, M. Veera
   Ahmed, Riyaz
   Begum, Ashia
   Ravi, Vasanthapuram
   Desai, Anita
   Yoksan, Sutee
   Fernandez, Stefan
   Willberg, Christian B.
   Kloverpris, Henrik N.
   Conlon, Christopher
   Klenerman, Paul
   Satchidanandam, Vijaya
   Solomon, Tom
TI Human T cell responses to Japanese encephalitis virus in health and
   disease
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; CROSS-REACTIVITY; NEUTRALIZING ANTIBODIES;
   INFECTION; PROTECTION; LYMPHOCYTES; CD4(+); CHALLENGE; SEQUENCE;
   IMMUNITY
AB Japanese encephalitis (JE) virus (JEV) is an important cause of encephalitis in children of South and Southeast Asia. However, the majority of individuals exposed to JEV only develop mild symptoms associated with long-lasting adaptive immunity. The related flavivirus dengue virus (DENV) cocirculates in many JEV-endemic areas, and clinical data suggest cross-protection between DENV and JEV. To address the role of T cell responses in protection against JEV, we conducted the first full-breadth analysis of the human memory T cell response using a synthetic peptide library. Ex vivo interferon-gamma (IFN-gamma) responses to JEV in healthy JEV-exposed donors were mostly CD8(+) and targeted nonstructural (NS) proteins, whereas IFN-gamma responses in recovered JE patients were mostly CD4(+) and targeted structural proteins and the secreted protein NS1. Among patients, a high quality, polyfunctional CD4(+) T cell response was associated with complete recovery from JE. T cell responses from healthy donors showed a high degree of cross-reactivity to DENV that was less apparent in recovered JE patients despite equal exposure. These data reveal divergent functional CD4(+) and CD8(+) T cell responses linked to different clinical outcomes of JEV infection, associated with distinct targeting and broad flavivirus cross-reactivity including epitopes from DENV, West Nile, and Zika virus.
C1 [Turtle, Lance; Buxton, Gemma; Isenman, Heather; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
   [Turtle, Lance; Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.
   [Turtle, Lance] Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool L7 8XP, Merseyside, England.
   [Bali, Tanushka; Chib, Savita; Chan, Sajesh; Soni, Mohammed; Satchidanandam, Vijaya] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.
   [Hussain, Mohammed; Satishkumar, Vishali; Krishna, Srinivasa; Begum, Ashia] Vijayanagar Inst Med Sci, Coll Med, Dept Microbiol, Bellary 583104, India.
   [Satishkumar, Vishali; Shankar, M. Veera; Ahmed, Riyaz; Begum, Ashia] Vijayanagar Inst Med Sci, Coll Med, Dept Paediat, Bellary 583104, India.
   [Fadnis, Prachi; Venkataswamy, Manjunatha M.; Ravi, Vasanthapuram; Desai, Anita] Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bangalore 560029, Karnataka, India.
   [Lewthwaite, Penny] Natl Hlth Serv Trust, St James Univ Hosp, Leeds Teaching Hosp, Dept Infect & Travel Med, Leeds LS9 7TF, W Yorkshire, England.
   [Kurioka, Ayako; Willberg, Christian B.; Kloverpris, Henrik N.; Conlon, Christopher; Klenerman, Paul] Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Oxford OX1 3SY, England.
   [Yoksan, Sutee] Mahidol Univ Salaya, Inst Mol Biosci, Ctr Vaccine Dev, Bangkok 73170, Thailand.
   [Fernandez, Stefan] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand.
   [Solomon, Tom] Walton Ctr Natl Hlth Serv Fdn Trust, Liverpool L9 7LJ, Merseyside, England.
   [Chib, Savita] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Kloverpris, Henrik N.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa.
   [Kloverpris, Henrik N.] Univ Copenhagen, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark.
RP Turtle, L (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.; Turtle, L (corresponding author), Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.; Turtle, L (corresponding author), Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool L7 8XP, Merseyside, England.; Satchidanandam, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.; Klenerman, P (corresponding author), Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Oxford OX1 3SY, England.
EM lturtle@liverpool.ac.uk; paul.klenerman@medawar.ox.ac.uk;
   vijaya@mcbl.iisc.ernet.in
RI Vasanthapuram, Ravi/AAD-5555-2019
OI Turtle, Lance/0000-0002-0778-1693; Solomon, Tom/0000-0001-7266-6547;
   Willberg, Christian/0000-0001-5299-9344; Kloverpris,
   Henrik/0000-0002-2165-3313
FU National Institutes of Health Tetramer Core Facility
   [HHSN272201300006C]; National Institute of Allergy and Infectious
   Diseases, National Institutes of Health, and Department of Health and
   Human Services [HHSN272201400028C]; Wellcome TrustWellcome Trust
   [087757/Z/08/Z]; National Institute for Health Research, UKNational
   Institute for Health Research (NIHR); Wellcome Trust the National
   Institute for Health Research biomedical research center, Oxford
   [WT091663MA]; Oxford Martin School; Health Protection Research Unit in
   Emerging Infections and Zoonoses of the National Institute for Health
   Research [HPRU-2012-10117]; National Institute for Health
   ResearchNational Institute for Health Research (NIHR) [NF-SI-0514-10177,
   NF-SI-0515-10005, RP-PG-0108-10048]
FX We acknowledge the National Institutes of Health Tetramer Core Facility
   (contract HHSN272201300006C) for provision of MHC class I tetramers and
   the Biodefense and Emerging Infections Research Resources Repository and
   the National Institute of Allergy and Infectious Diseases for provision
   of DENV and WNV peptide libraries. The Virus Pathogen Database and
   Analysis Resource has been wholly funded with federal funds from the
   National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, and Department of Health and Human Services under
   contract HHSN272201400028C. We thank Prof. Phillip Goulder for the gift
   of B cell lines. We thank the director, patients, relatives, and staff
   at VIMS Medical College Hospital and all the volunteers who took part.;
   This work was funded by a Wellcome Trust fellowship (087757/Z/08/Z) to
   L. Turtle (currently funded by the National Institute for Health
   Research, UK). P. Klenerman is a Wellcome Trust Senior Clinical Fellow
   (WT091663MA) funded through the National Institute for Health Research
   biomedical research center, Oxford, and the Oxford Martin School. T.
   Solomon is supported by the Health Protection Research Unit in Emerging
   Infections and Zoonoses of the National Institute for Health Research
   (HPRU-2012-10117).
CR Aihara H, 1998, J VIROL, V72, P8032, DOI 10.1128/JVI.72.10.8032-8036.1998
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07
   Ashok MS, 1999, VACCINE, V18, P68, DOI 10.1016/S0264-410X(99)00180-2
   Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155
   Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818
   Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   CHATURVEDI UC, 1979, CLIN EXP IMMUNOL, V38, P492
   Draenert R, 2004, AIDS, V18, P871, DOI 10.1097/00002030-200404090-00004
   Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   EDELMAN R, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P308
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61
   Gao N, 2010, IMMUNOL LETT, V129, P23, DOI 10.1016/j.imlet.2009.12.023
   Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   HALSTEAD SB, 1962, AM J HYG, V75, P190, DOI 10.1093/oxfordjournals.aje.a120243
   Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   KONISHI E, 1995, AM J TROP MED HYG, V53, P278, DOI 10.4269/ajtmh.1995.53.278
   Konishi E, 1998, VACCINE, V16, P842, DOI 10.1016/S0264-410X(97)00265-X
   Konishi E, 1999, J VIROL, V73, P5527, DOI 10.1128/JVI.73.7.5527-5534.1999
   Kumar P, 2004, J GEN VIROL, V85, P1131, DOI 10.1099/vir.0.19698-0
   Kumar P, 2004, J INFECT DIS, V189, P880, DOI 10.1086/381768
   Kumar P, 2004, J GEN VIROL, V85, P471, DOI 10.1099/vir.0.19531-0
   KURANE I, 1991, J VIROL, V65, P1823, DOI 10.1128/JVI.65.4.1823-1828.1991
   Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81
   Larena M, 2013, EUR J IMMUNOL, V43, P1789, DOI 10.1002/eji.201243152
   Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5
   Lewthwaite P, 2010, EMERG INFECT DIS, V16, P1780, DOI 10.3201/eid1611.100672
   Lewthwaite P, 2010, B WORLD HEALTH ORGAN, V88, P584, DOI 10.2471/BLT.09.071357
   Lewthwaite P, 2010, TROP MED INT HEALTH, V15, P811, DOI 10.1111/j.1365-3156.2010.02537.x
   Libraty DH, 2002, T ROY SOC TROP MED H, V96, P173, DOI 10.1016/S0035-9203(02)90294-4
   LUBINIECKI AS, 1973, AM J TROP MED HYG, V22, P535, DOI 10.4269/ajtmh.1973.22.535
   MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   MuraliKrishna K, 1996, J GEN VIROL, V77, P705, DOI 10.1099/0022-1317-77-4-705
   MURALIKRISHNA K, 1994, J GEN VIROL, V75, P799, DOI 10.1099/0022-1317-75-4-799
   Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115
   PARKER KC, 1994, J IMMUNOL, V152, P163
   Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563
   Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116
   SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Watt G, 2003, AM J TROP MED HYG, V68, P704, DOI 10.4269/ajtmh.2003.68.704
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
NR 64
TC 38
Z9 38
U1 0
U2 53
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD JUN 27
PY 2016
VL 213
IS 7
BP 1331
EP 1352
DI 10.1084/jem.20151517
PG 22
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DS5VA
UT WOS:000380849800018
PM 27242166
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Avelino-Silva, VI
   Martin, JRN
AF Avelino-Silva, Vivian I.
   Martin, Jeff Rey N.
TI Association between Guillain-Barre syndrome and Zika virus infection
SO LANCET
LA English
DT Letter
C1 [Avelino-Silva, Vivian I.] Univ Sao Paulo, Sch Med, Hosp Sirio Libanes, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.
   [Martin, Jeff Rey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
RP Avelino-Silva, VI (corresponding author), Univ Sao Paulo, Sch Med, Hosp Sirio Libanes, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.; Avelino-Silva, VI (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.
EM viviansilva87@gmail.com
RI Avelino-Silva, Vivian I/L-2640-2013
OI Avelino-Silva, Vivian I/0000-0002-6660-3088
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396
NR 2
TC 8
Z9 8
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 25
PY 2016
VL 387
IS 10038
BP 2599
EP 2599
DI 10.1016/S0140-6736(16)30843-1
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP3JX
UT WOS:000378390500019
PM 27353814
OA Bronze
DA 2020-07-08
ER

PT J
AU Bautista, LE
   Sethi, AK
AF Bautista, Leonelo E.
   Sethi, Ajay K.
TI Association between Guillain-Barre syndrome and Zika virus infection
SO LANCET
LA English
DT Letter
C1 [Bautista, Leonelo E.; Sethi, Ajay K.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA.
RP Bautista, LE (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA.
EM lebautista@wisc.edu
CR Aubry M, 2015, 64 ANN M AM SOC TROP
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Nickerson, 1998, REV GEN PSYCHOL, V2, P175, DOI DOI 10.1037/1089-2680.2.2.175
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
NR 6
TC 15
Z9 16
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 25
PY 2016
VL 387
IS 10038
BP 2599
EP 2600
DI 10.1016/S0140-6736(16)30844-3
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP3JX
UT WOS:000378390500020
PM 27353815
OA Bronze
DA 2020-07-08
ER

PT J
AU Fontanet, A
   Cao-Lormeau, VM
   Dub, T
   Mallet, HP
   Ghawche, F
AF Fontanet, Arnaud
   Cao-Lormeau, Van-Mai
   Dub, Timothee
   Mallet, Henri-Pierre
   Ghawche, Frederic
TI Association between Guillain-Barre syndrome and Zika virus infection
   Reply
SO LANCET
LA English
DT Letter
C1 [Fontanet, Arnaud; Dub, Timothee] Inst Pasteur, Emerging Dis Epidemiol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, France.
   [Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, Papeete, France.
   [Ghawche, Frederic] Ctr Hosp Polynesie Francaise, Serv Neurol, Tahiti, France.
RP Fontanet, A (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France.
EM fontanet@pasteur.fr
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
NR 1
TC 5
Z9 6
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 25
PY 2016
VL 387
IS 10038
BP 2600
EP 2600
DI 10.1016/S0140-6736(16)30773-5
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP3JX
UT WOS:000378390500021
PM 27353817
OA Bronze
DA 2020-07-08
ER

PT J
AU Kuehnert, MJ
   Basavaraju, SV
   Moseley, RR
   Pate, LL
   Galel, SA
   Williamson, PC
   Busch, MP
   Alsina, JO
   Climent-Peris, C
   Marks, PW
   Epstein, JS
   Nakhasi, HL
   Hobson, JP
   Leiby, DA
   Akolkar, PN
   Petersen, LR
   Rivera-Garcia, B
AF Kuehnert, Matthew J.
   Basavaraju, Sridhar V.
   Moseley, Robin R.
   Pate, Lisa L.
   Galel, Susan A.
   Williamson, Phillip C.
   Busch, Michael P.
   Alsina, Jose O.
   Climent-Peris, Consuelo
   Marks, Peter W.
   Epstein, Jay S.
   Nakhasi, Hira L.
   Hobson, J. Peyton
   Leiby, David A.
   Akolkar, Pradip N.
   Petersen, Lyle R.
   Rivera-Garcia, Brenda
TI Screening of Blood Donations for Zika Virus Infection - Puerto Rico,
   April 3-June 11, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Kuehnert, Matthew J.; Basavaraju, Sridhar V.; Moseley, Robin R.; Petersen, Lyle R.] CDC, Zika Virus Response Blood Safety Team, Atlanta, GA 30333 USA.
   [Pate, Lisa L.; Galel, Susan A.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Williamson, Phillip C.] Creat Testing Solut, Tempe, AZ USA.
   [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA.
   [Alsina, Jose O.] Banco Sangre Serv Mutuos, San Juan, PR USA.
   [Climent-Peris, Consuelo] Banco Sangre Puerto Rico, San Juan, PR USA.
   [Marks, Peter W.; Epstein, Jay S.; Nakhasi, Hira L.; Hobson, J. Peyton; Leiby, David A.; Akolkar, Pradip N.] US FDA, Silver Spring, MD USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
RP Kuehnert, MJ (corresponding author), CDC, Zika Virus Response Blood Safety Team, Atlanta, GA 30333 USA.
EM eocevent281@cdc.gov
OI Epstein, Jay/0000-0003-2293-9062
CR Barjas-Castro ML, 2016, TRANSFUSION IN PRESS
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Lanteri MC, 2016, TRANSFUSION, V9
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
NR 6
TC 48
Z9 48
U1 0
U2 40
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 24
PY 2016
VL 65
IS 24
BP 627
EP 628
DI 10.15585/mmwr.mm6524e2
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP2UX
UT WOS:000378349900005
PM 27337368
OA Bronze
DA 2020-07-08
ER

PT J
AU Lee, CT
   Vora, NM
   Bajwa, W
   Boyd, L
   Harper, S
   Kass, D
   Langston, A
   McGibbon, E
   Merlino, M
   Rakeman, JL
   Raphael, M
   Slavinski, S
   Tran, A
   Wong, R
   Varma, JK
AF Lee, Christopher T.
   Vora, Neil M.
   Bajwa, Waheed
   Boyd, Lorraine
   Harper, Scott
   Kass, Daniel
   Langston, Aileen
   McGibbon, Emily
   Merlino, Mario
   Rakeman, Jennifer L.
   Raphael, Marisa
   Slavinski, Sally
   Tran, Anthony
   Wong, Ricky
   Varma, Jay K.
CA NYC Zika Response Team
TI Zika Virus Surveillance and Preparedness - New York City, 2015-2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES
C1 [Lee, Christopher T.] New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY 10013 USA.
   [Lee, Christopher T.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Vora, Neil M.; Harper, Scott; McGibbon, Emily; Slavinski, Sally; Varma, Jay K.] New York City Dept Hlth & Mental Hyg, Div Dis Control, New York, NY USA.
   [Vora, Neil M.; Harper, Scott] CDC, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Bajwa, Waheed; Kass, Daniel; Merlino, Mario] New York City Dept Hlth & Mental Hyg, Div Environm Hlth, New York, NY USA.
   [Boyd, Lorraine; Langston, Aileen] New York City Dept Hlth & Mental Hyg, Div Family & Child Hlth, New York, NY USA.
   [Rakeman, Jennifer L.; Tran, Anthony] New York City Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA.
   [Raphael, Marisa] New York City Dept Hlth & Mental Hyg, Off Emergency Preparedness & Response, New York, NY USA.
   [Wong, Ricky] New York City Dept Hlth & Mental Hyg, Off External Affairs, New York, NY USA.
   [Varma, Jay K.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Lee, CT (corresponding author), New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY 10013 USA.; Lee, CT (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
EM klq5@cdc.gov
RI Bajwa, Waheed/AAH-9668-2019
OI Greene, Sharon/0000-0002-3509-2377; Lee, Christopher/0000-0001-7957-1524
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Millman AJ, 2016, MMWR-MORBID MORTAL W, V65, P51, DOI 10.15585/mmwr.mm6503a3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 7
TC 11
Z9 11
U1 0
U2 29
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 24
PY 2016
VL 65
IS 24
BP 629
EP 635
DI 10.15585/mmwr.mm6524e3
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP2UX
UT WOS:000378349900006
PM 27337505
OA Bronze
DA 2020-07-08
ER

PT J
AU Dredze, M
   Broniatowski, DA
   Hilyard, KM
AF Dredze, Mark
   Broniatowski, David A.
   Hilyard, Karen M.
TI Zika vaccine misconceptions: A social media analysis
SO VACCINE
LA English
DT Editorial Material
C1 [Dredze, Mark] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA.
   [Broniatowski, David A.] George Washington Univ, Dept Engn Management & Syst Engn, Washington, DC 20052 USA.
   [Hilyard, Karen M.] Univ Georgia, Coll Publ Hlth, Dept Hlth Promot & Behav, Athens, GA 30602 USA.
RP Broniatowski, DA (corresponding author), George Washington Univ, Dept Engn Management & Syst Engn, Washington, DC 20052 USA.
EM broniatowski@gwu.edu
RI Broniatowski, David/G-5586-2012
OI Broniatowski, David/0000-0002-3302-9497; Dredze,
   Mark/0000-0002-0422-2474
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM114771]
CR Bennett D., 2014, BLOOMBERG BUSINE JUL
   Broniatowski DA, 2016, VACCINE
   Dredze M, 2016, AM J PREV MED, V50, P550, DOI 10.1016/j.amepre.2015.10.002
   Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112
   Miller GR, 1984, JSTOR
   Poland CM, 2011, VACCINE, V29, P6145, DOI 10.1016/j.vaccine.2011.07.131
   Quinn SC, 2009, BIOSECUR BIOTERROR, V7, P275, DOI 10.1089/bsp.2009.0041
NR 7
TC 37
Z9 37
U1 7
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 24
PY 2016
VL 34
IS 30
BP 3441
EP 3442
DI 10.1016/j.vaccine.2016.05.008
PG 2
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DQ1IT
UT WOS:000378955400002
PM 27216759
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Meepagala, KM
   Estep, AS
   Becnel, JJ
AF Meepagala, Kumudini M.
   Estep, Alden S.
   Becnel, James J.
TI Larvicidal and Adulticidal Activity of Chroman and Chromene Analogues
   against Susceptible and Permethrin-Resistant Mosquito Strains
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE mosquitoes; larvicide; repellents; chromenes; chromans; insecticide
   resistance
ID BTI RESISTANCE; FEVER MOSQUITO; PESTICIDES; TOXICITY
AB Mosquitoes play a major role as vectors that transmit parasitic and viral diseases worldwide, especially in tropical and subtropical countries. Mosquito borne diseases not only affect humans but they also affect livestock in many parts of the world. They carry diseases that are lethal to dogs and horses. Dog heartworm disease (Dirofilaria immitis) is a parasitic disease spread through mosquitoes. This disease is not limited to dogs, but it can affect other animals and humans as well. Eastern equine encephalitis (EEE) and West Nile virus (WNV) are also mosquito borne diseases that affect the central nervous system of horses and cause severe complications and death. Emergence of resistance among mosquitoes to current pesticides has increased the importance of the search for alternate compounds that are effective and environmentally benign with diverse modes of actions than those that are commercially available. Aedes aegypti mosquitoes are the primary vector for transmission of Zika viral fever, yellow fever, dengue fever, and chikungunya. Mosquito control is currently the best strategy to prevent mosquito borne diseases. There are numerous approaches for control of potentially dangerous mosquito populations. These approaches include the use of adulticides (insecticides), larvicides, and, to a limited extent, the use of repellents. Our previous studies have shown the mosquito repellent activity of chromenes. In the present study, we demonstrate larvicidal and adulticidal activity of chroman and chromene analogues against a permethrin susceptible laboratory strain as well as activity against a permethrin-resistant strain of Aedes aegypti.
C1 [Meepagala, Kumudini M.] ARS, NPURU, USDA, POB 8048, University, MS 38677 USA.
   [Estep, Alden S.; Becnel, James J.] ARS, CMAVE, USDA, MFRU1600-1700 SW 23rd Dr, Gainesville, FL 32608 USA.
   [Estep, Alden S.] NASJAX, Navy Entomol Ctr Excellence NECE, 937 Child St, Jacksonville, FL 32212 USA.
RP Meepagala, KM (corresponding author), ARS, NPURU, USDA, POB 8048, University, MS 38677 USA.
EM kmeepaga@olemiss.edu
OI Becnel, James/0000-0003-2464-0005; Estep, Alden/0000-0002-8281-3229
FU Deployed War Fighter Protection (DWFP) Research Program of the U.S.
   Department of Defense through the Armed Forces Pest Management Board
FX This study was partly supported by the Deployed War Fighter Protection
   (DWFP) Research Program of the U.S. Department of Defense through the
   Armed Forces Pest Management Board.
CR Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9
   Chuaycharoensuk T, 2012, PARASITE, V19, P427, DOI 10.1051/parasite/2012194427
   Cupp EW, 2003, AM J TROP MED HYG, V68, P495, DOI 10.4269/ajtmh.2003.68.495
   FAGOONEE I, 1981, INSECT SCI APPL, V1, P373, DOI 10.1017/S1742758400000692
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   ISMAN MB, 1986, NATURWISSENSCHAFTEN, V73, P500, DOI 10.1007/BF00367198
   ISMAN MB, 1986, PLANTA MED, P558
   Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]
   Manguin S, 2011, IMPORTANCE OF BIOLOGICAL INTERACTIONS IN THE STUDY OF BIODIVERSITY, P27
   Meepagala KM, 2013, J AGR FOOD CHEM, V61, P9293, DOI 10.1021/jf402635z
   Meepagala KM, 2011, PEST MANAG SCI, V67, P1446, DOI 10.1002/ps.2196
   Meepagala KM, 2010, J AGR FOOD CHEM, V58, P9476, DOI 10.1021/jf101626g
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   PROKSCH P, 1983, J NAT PROD, V46, P331, DOI 10.1021/np50027a006
   Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2
   Tetreau G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-248
   Tetreau G, 2013, ARCH INSECT BIOCHEM, V82, P71, DOI 10.1002/arch.21076
   WISDOM CS, 1983, J ECON ENTOMOL, V76, P993, DOI 10.1093/jee/76.5.993
   Yang YY, 2010, J INSECT PHYSIOL, V56, P1219, DOI 10.1016/j.jinsphys.2010.03.028
NR 20
TC 4
Z9 4
U1 0
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN 22
PY 2016
VL 64
IS 24
BP 4914
EP 4920
DI 10.1021/acs.jafc.6b01299
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA DP6CK
UT WOS:000378584300012
PM 27249182
DA 2020-07-08
ER

PT J
AU Mayor, S
AF Mayor, Susan
TI Abortion requests increase in Latin America after Zika warning, figures
   show
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Aiken ARA, 2016, N ENGL MED, DOI [10.1056/NEJMc1605389, DOI 10.1056/NEJMC1605389]
NR 1
TC 4
Z9 4
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 22
PY 2016
VL 353
AR i3492
DI 10.1136/bmj.i3492
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP8BS
UT WOS:000378723500020
PM 27334910
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Thousands of pregnant women in Puerto Rico are at risk of Zika virus
   infection, CDC warns
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Kuehnert MJ, 2016, MORB MORTAL WKLY REP, V2016
NR 1
TC 1
Z9 1
U1 0
U2 10
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 21
PY 2016
VL 353
AR i3462
DI 10.1136/bmj.i3462
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP8BP
UT WOS:000378723200006
PM 27328974
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Pingen, M
   Bryden, SR
   Pondeville, E
   Schnettler, E
   Kohl, A
   Merits, A
   Fazakerley, JK
   Graham, GJ
   McKimmie, CS
AF Pingen, Marieke
   Bryden, Steven R.
   Pondeville, Emilie
   Schnettler, Esther
   Kohl, Alain
   Merits, Andres
   Fazakerley, John K.
   Graham, Gerard J.
   McKimmie, Clive S.
TI Host Inflammatory Response to Mosquito Bites Enhances the Severity of
   Arbovirus Infection
SO IMMUNITY
LA English
DT Article
ID DENGUE VIRUS-INFECTION; SEMLIKI-FOREST-VIRUS; BONE-MARROW; IN-VIVO;
   MICE; SALIVA; ENCEPHALITIS; POTENTIATION; PATHOGENESIS; MACROPHAGES
AB Aedes aegypti mosquitoes are responsible for transmitting many medically important viruses such as those that cause Zika and dengue. The inoculation of viruses into mosquito bite sites is an important and common stage of all mosquito-borne virus infections. We show, using Semliki Forest virus and Bunyamwera virus, that these viruses use this inflammatory niche to aid their replication and dissemination in vivo. Mosquito bites were characterized by an edema that retained virus at the inoculation site and an inflammatory influx of neutrophils that coordinated a localized innate immune program that inadvertently facilitated virus infection by encouraging the entry and infection of virus-permissive myeloid cells. Neutrophil depletion and therapeutic blockade of inflammasome activity suppressed inflammation and abrogated the ability of the bite to promote infection. This study identifies facets of mosquito bite inflammation that are important determinants of the subsequent systemic course and clinical outcome of virus infection.
C1 [Pingen, Marieke; Bryden, Steven R.; McKimmie, Clive S.] Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
   [Bryden, Steven R.; Graham, Gerard J.] Univ Glasgow, Inst Infect Immunol & Inflammat, Glasgow G12 8TA, Lanark, Scotland.
   [Pondeville, Emilie; Schnettler, Esther; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Merits, Andres] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia.
   [Fazakerley, John K.] Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England.
RP McKimmie, CS (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
EM c.s.mckimmie@leeds.ac.uk
RI McKimmie, Clive/AAD-9509-2019; Pingen, Marieke/F-9990-2012; Merits,
   Andres/H-3125-2015
OI McKimmie, Clive/0000-0002-7694-9509; Pingen,
   Marieke/0000-0001-5689-9076; Merits, Andres/0000-0001-8193-0071;
   Pondeville, Emilie/0000-0001-8545-8472; Bryden,
   Steven/0000-0001-5408-6047; Fazakerley, John/0000-0001-7071-105X
FU MRCMedical Research Council UK (MRC) [G1001724]; BBSRC PhD
   studentshipBiotechnology and Biological Sciences Research Council
   (BBSRC); Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [1511961]; Medical Research CouncilMedical Research Council UK (MRC)
   [G1001724, MC_UU_12014/8]
FX We acknowledge the kind assistance of Melanie McFarlane and Stephanie
   Rainey for the provision of virus stocks and insect cell culture; Ryan
   Ritchie for help with IVIS; Margaret McFadyen and Joy Kean for culture
   of mosquitoes; Prof. Eileen Devaney for her detailed editing of the
   manuscript; and the Institute of Infection, Immunity and Inflammation
   Flow Cytometry Facility, all based at the University of Glasgow. This
   work was funded by the MRC (G1001724) and a BBSRC PhD studentship to
   S.R.B.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689
   Dessens JT, 1998, J VIROL, V72, P8362, DOI 10.1128/JVI.72.10.8362-8364.1998
   Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010
   King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552
   Le Coupanec A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002237
   Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Michlmayr D, 2014, J VIROL, V88, P9553, DOI 10.1128/JVI.03421-13
   Moser LA, 2016, J VIROL, V90, P292, DOI 10.1128/JVI.02280-15
   Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179
   Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x
   Schaeffer E, 2015, J INVEST DERMATOL, V135, P1743, DOI 10.1038/jid.2014.525
   Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704
   Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004
   Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 43
TC 69
Z9 69
U1 2
U2 29
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD JUN 21
PY 2016
VL 44
IS 6
BP 1455
EP 1469
DI 10.1016/j.immuni.2016.06.002
PG 15
WC Immunology
SC Immunology
GA DP2SE
UT WOS:000378341200022
PM 27332734
OA Green Published, Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI From Zubik to Zika (vol 302, pg 10, 2016)
SO NATION
LA English
DT Correction
CR WILLIAMS PJ, 2016, NATION, V302, P10
NR 1
TC 0
Z9 0
U1 0
U2 1
PU NATION CO INC
PI NEW YORK
PA 33 IRVING PLACE, 8TH FLOOR, NEW YORK, NY 10003 USA
SN 0027-8378
J9 NATION
JI Nation
PD JUN 20
PY 2016
VL 302
IS 25-26
BP 34
EP 34
PG 1
WC Political Science
SC Government & Law
GA DO2UI
UT WOS:000377635200027
DA 2020-07-08
ER

PT J
AU Camara, DCP
   Codeo, CT
   Juliano, SA
   Lounibos, LP
   Riback, TIS
   Pereira, GR
   Honorio, NA
AF Portela Camara, Daniel Cardoso
   Codeo, Claudia Torres
   Juliano, Steven A.
   Lounibos, L. Philip
   Souza Riback, Thais Irene
   Pereira, Glaucio Rocha
   Honorio, Nildimar Alves
TI Seasonal Differences in Density But Similar Competitive Impact of Aedes
   albopictus (Skuse) on Aedes aegypti (L.) in Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID LARVAL COMPETITION; CONTAINER MOSQUITOS; INTERSPECIFIC COMPETITION;
   DENGUE VECTORS; SOUTH FLORIDA; URBAN FOREST; DIPTERA; CULICIDAE;
   COEXISTENCE; POPULATIONS
AB Previous studies have shown that the negative effects of density of Ae. albopictus on Ae. aegypti exceed those of Ae. aegypti on Ae. albopictus for population growth, adult size, survivorship, and developmental rate. This competitive superiority has been invoked to explain the displacement of Ae. aegypti by Ae. albopictus in the southeastern USA. In Brazil, these species coexist in many vegetated suburban and rural areas. We investigated a related, but less-well-studied question: do effects of Ae. albopictus on Ae. aegypti larval development and survival occur under field conditions at realistic densities across multiple seasons in Brazil? We conducted additive competition experiments in a vegetated area of Rio de Janeiro where these species coexist. We tested the hypothesis that Ae. aegypti (the focal species, at a fixed density) suffers negative effects on development and survivorship across a gradient of increasing densities of Ae. albopictus (the associate species) in three seasons. The results showed statistically significant effects of both season and larval density on Ae. aegypti survivorship, and significant effects of season on development rate, with no significant season-density interactions. Densities of Aedes larvae in these habitats differed among seasons by a factor of up to 7x. Overall, Spring was the most favorable season for Ae. aegypti survivorship and development. Results showed that under natural conditions the negative competitive effects of Ae. albopictus on Ae. aegypti were expressed primarily as lower survivorship. Coexistence between Ae. aegypti and Ae. albopictus in vegetated areas is likely affected by seasonal environmental differences, such as detrital resource levels or egg desiccation, which can influence competition between these species. Interactions between these Aedes are important in Brazil, where both species are well established and widely distributed and vector dengue, Zika and chikungunya viruses.
C1 [Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios LATHEMA, Rio De Janeiro, Brazil.
   [Portela Camara, Daniel Cardoso; Pereira, Glaucio Rocha; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, DIRAC IOC VPAAPS, Nucleo Operac Sentinela Mosquitos Vetores NOSMOVE, Rio De Janeiro, Brazil.
   [Codeo, Claudia Torres; Souza Riback, Thais Irene] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Behav Ecol Evolut & Systemat Sect, Normal, IL 61761 USA.
   [Lounibos, L. Philip] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL USA.
RP Camara, DCP (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios LATHEMA, Rio De Janeiro, Brazil.; Camara, DCP (corresponding author), Fundacao Oswaldo Cruz, DIRAC IOC VPAAPS, Nucleo Operac Sentinela Mosquitos Vetores NOSMOVE, Rio De Janeiro, Brazil.
EM dcpcamara.ioc@gmail.com
RI Camara, Daniel C. P./S-3504-2018
OI Camara, Daniel C. P./0000-0002-5439-4477; Juliano,
   Steven/0000-0002-6178-4553
FU US National Institutes of Health Fogarty International Center FIRCA
   grant [R03TW007446-01A1]; INCT-EM/CNPq - PAPES V grant, Rede Dengue
   FIOCRUZ [407744/2012-6]; Instituto Oswaldo Cruz, Brazil
FX This research was funded by US National Institutes of Health Fogarty
   International Center FIRCA grant R03TW007446-01A1 - received by LPL and
   SAJ, by INCT-EM/CNPq - PAPES V grant 407744/2012-6, Rede Dengue FIOCRUZ
   and funds from Instituto Oswaldo Cruz, Brazil, received by NAH. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aguiar Ducineia Barros, 2008, Acta Amaz., V38, P357, DOI 10.1590/S0044-59672008000200021
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209
   Bargielowski IE, 2015, INFECT GENET EVOL, V36, P456, DOI 10.1016/j.meegid.2015.08.016
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Bloch EM, 2016, EMERG INFEC IN PRESS
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583
   Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   Fernald E. A., 1985, WATER RESOURCES ATLA
   Fox J., 2011, R COMPANION APPL REG
   GILOTRA SK, 1967, B WORLD HEALTH ORGAN, V37, P437
   GOLDBERG DE, 2001, DESIGN ANAL ECOLOGIC, P77
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Honorio NA, 2006, MEM I OSWALDO CRUZ, V101, P225, DOI 10.1590/S0074-02762006000200017
   Honorio NA, 2001, REV SAUDE PUBL, V35, P385, DOI 10.1590/S0034-89102001000400009
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   HORNBY JA, 1994, J AM MOSQUITO CONTR, V10, P397
   Juliano S. A, 2014, MEM I O CRUZ, V109, P96
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325
   Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611
   Lima-Camara TN, 2013, MEM I OSWALDO CRUZ, V108, P18, DOI 10.1590/0074-0276130381
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221
   Moraes R. M., 1999, REV BRAS BOT, V22, P9
   Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1646/0006-3606(2000)032[0786:ITBAF]2.0.CO;2
   MORELLATO LPC, 1992, J TROP ECOL, V8, P205, DOI 10.1017/S0266467400006362
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   Murrell EG, 2011, ANN ENTOMOL SOC AM, V104, P688, DOI 10.1603/AN10158
   Nazni WA, 2009, SE ASIAN J TROP MED, V40, P40
   O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   R Core Team, 2014, R LANG ENV STAT COMP
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   RStudio Team, 2012, RSTUDIO INT DEV R
   SOTA T, 1992, ENTOMOL EXP APPL, V63, P155, DOI 10.1007/BF00343575
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Williamson M., 1996, BIOL INVASIONS
NR 62
TC 17
Z9 17
U1 1
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 20
PY 2016
VL 11
IS 6
AR e0157120
DI 10.1371/journal.pone.0157120
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WR
UT WOS:000378212000009
PM 27322537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Gene-editing technique could stop Zika
SO NEW SCIENTIST
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU REED BUSINESS INFORMATION LTD
PI SUTTON
PA QUADRANT HOUSE THE QUADRANT, SUTTON SM2 5AS, SURREY, ENGLAND
SN 0262-4079
J9 NEW SCI
JI New Sci.
PD JUN 18
PY 2016
VL 230
IS 3078
BP 10
EP 10
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO8GV
UT WOS:000378022100006
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Maia, M
   Dias, N
   Ventura, LO
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Dias, Natalia
   Ventura, Liana O.
   Belfort, Rubens, Jr.
TI Zika: neurological and ocular findings in infant without microcephaly
SO LANCET
LA English
DT Letter
ID VIRUS
C1 [Ventura, Camila V.; Dias, Natalia; Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Maia, Mauricio; Belfort, Rubens, Jr.] HOPE Eye Hosp, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Vis Inst, Sao Paulo, Brazil.
RP Belfort, R (corresponding author), HOPE Eye Hosp, Recife, PE, Brazil.
EM clinbelf@uol.com.br
RI Ventura, Liana Vieira O/N-6151-2018; Maia, Mauricio/I-5892-2015;
   Ventura, Camila V/N-2654-2018
OI Ventura, Liana Vieira O/0000-0001-6529-6883; Maia,
   Mauricio/0000-0002-7034-8091; Ventura, Camila V/0000-0002-2927-4684
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 5
TC 73
Z9 73
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 18
PY 2016
VL 387
IS 10037
BP 2502
EP 2502
DI 10.1016/S0140-6736(16)30776-0
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO7FG
UT WOS:000377947200018
PM 27287830
OA Bronze
DA 2020-07-08
ER

PT J
AU Turmel, JM
   Abgueguen, P
   Hubert, B
   Vandamme, YM
   Maquart, M
   Le Guillou-Guillemette, H
   Leparc-Goffart, I
AF Turmel, Jean Marie
   Abgueguen, Pierre
   Hubert, Bruno
   Vandamme, Yves Marie
   Maquart, Marianne
   Le Guillou-Guillemette, Helene
   Leparc-Goffart, Isabelle
TI Late sexual transmission of Zika virus related to persistence in the
   semen
SO LANCET
LA English
DT Letter
C1 [Turmel, Jean Marie; Abgueguen, Pierre; Vandamme, Yves Marie] CHU Angers, Dept Infect Dis, F-49933 Angers, France.
   [Le Guillou-Guillemette, Helene] CHU Angers, Virol Lab, F-49933 Angers, France.
   [Hubert, Bruno] French Publ Hlth Agcy, Reg Off, Nantes, France.
   [Maquart, Marianne; Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Marseille, France.
RP Turmel, JM (corresponding author), CHU Angers, Dept Infect Dis, F-49933 Angers, France.
EM jeanmarie.turmel@chu-angers.fr
OI Hubert, Bruno/0000-0003-3640-718X
CR [Anonymous], RAP RISK ASS ZIK VIR
   DOrtenzio E, 2016, NEW ENGL J MED, DOI [10.1056/nejmc1604449, DOI 10.1056/NEJMC1604449]
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   WHO, 2016, TRAV HLTH ADV ZIK VI
NR 5
TC 124
Z9 127
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 18
PY 2016
VL 387
IS 10037
BP 2501
EP 2501
DI 10.1016/S0140-6736(16)30775-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO7FG
UT WOS:000377947200017
PM 27287833
OA Bronze
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Zika congenital syndrome is seen in infants whose mothers had
   asymptomatic infection
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
NR 1
TC 1
Z9 1
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 17
PY 2016
VL 353
AR i3416
DI 10.1136/bmj.i3416
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP1KD
UT WOS:000378248000007
PM 27317419
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Vogel, G
AF Vogel, Gretchen
TI Experts fear Zika's effects may be even worse than thought Doctors and
   researchers are scrambling to define "Zika congenital syndrome"
SO SCIENCE
LA English
DT News Item
NR 0
TC 10
Z9 10
U1 0
U2 8
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 17
PY 2016
VL 352
IS 6292
BP 1375
EP 1376
DI 10.1126/science.352.6292.1375
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO7PV
UT WOS:000377975400010
PM 27313013
DA 2020-07-08
ER

PT J
AU Gao, DZ
   Lou, YJ
   He, DH
   Porco, TC
   Kuang, Y
   Chowell, G
   Ruan, SG
AF Gao, Daozhou
   Lou, Yijun
   He, Daihai
   Porco, Travis C.
   Kuang, Yang
   Chowell, Gerardo
   Ruan, Shigui
TI Prevention and Control of Zika as a Mosquito-Borne and Sexually
   Transmitted Disease: A Mathematical Modeling Analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS; TRANSMISSION; INFERENCE; STATES
AB The ongoing Zika virus (ZIKV) epidemic in the Americas poses a major global public health emergency. While ZIKV is transmitted from human to human by bites of Aedes mosquitoes, recent evidence indicates that ZIKV can also be transmitted via sexual contact with cases of sexually transmitted ZIKV reported in Argentina, Canada, Chile, France, Italy, New Zealand, Peru, Portugal, and the USA. Yet, the role of sexual transmission on the spread and control of ZIKV infection is not well-understood. We introduce a mathematical model to investigate the impact of mosquito-borne and sexual transmission on the spread and control of ZIKV and calibrate the model to ZIKV epidemic data from Brazil, Colombia, and El Salvador. Parameter estimates yielded a basic reproduction number R-0 = 2.055 (95% CI: 0.523-6.300), in which the percentage contribution of sexual transmission is 3.044% (95% CI: 0.123-45.73). Our sensitivity analyses indicate that R-0 is most sensitive to the biting rate and mortality rate of mosquitoes while sexual transmission increases the risk of infection and epidemic size and prolongs the outbreak. Prevention and control efforts against ZIKV should target both the mosquito-borne and sexual transmission routes.
C1 [Gao, Daozhou] Shanghai Normal Univ, Math & Sci Coll, Shanghai 200234, Peoples R China.
   [Lou, Yijun; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Kowloon, Hong Kong, Peoples R China.
   [Porco, Travis C.] Univ Calif San Francisco, Francis I Proctor Fdn, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Porco, Travis C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.
   [Kuang, Yang] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85287 USA.
   [Chowell, Gerardo] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30302 USA.
   [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33146 USA.
RP Ruan, SG (corresponding author), Univ Miami, Dept Math, Coral Gables, FL 33146 USA.
EM ruan@math.miami.edu
RI Ruan, Shigui/AAF-9165-2020; Lou, Yijun/V-1624-2017; He,
   Daihai/A-9347-2008; Gao, Daozhou/J-3157-2014
OI Ruan, Shigui/0000-0002-6348-8205; He, Daihai/0000-0003-3253-654X; Lou,
   Yijun/0000-0003-3864-2001; Gao, Daozhou/0000-0003-3991-569X
FU Models of Infectious Disease Agent Study (MIDAS) [NIGMS U01GM087728];
   Early Career Scheme from Hong Kong Research Grants Council [PolyU
   251001/14M, PolyU 253004/14P]; National Science FoundationNational
   Science Foundation (NSF) [DMS-1518529, DMS-1412454]; NSF part of
   NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program
   [1414374]; UK Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/M008894/1]; Program for Professor of Special Appointment (Eastern
   Scholar) at Shanghai Institutions of Higher Learning [TP2015050];
   Shanghai Gaofeng Project for University Academic Development Program;
   University of Miami Clinical and Translational Science Institute (CTSI)
   Project for Emerging Diseases
FX Research was partially supported by the Models of Infectious Disease
   Agent Study (MIDAS) (NIGMS U01GM087728), Early Career Scheme from Hong
   Kong Research Grants Council (PolyU 251001/14M and PolyU 253004/14P),
   National Science Foundation (DMS-1518529, DMS-1412454), NSF grant
   1414374 as part of the joint NSF-NIH-USDA Ecology and Evolution of
   Infectious Diseases program, UK Biotechnology and Biological Sciences
   Research Council grant BB/M008894/1, Program for Professor of Special
   Appointment (Eastern Scholar) at Shanghai Institutions of Higher
   Learning (TP2015050), Shanghai Gaofeng Project for University Academic
   Development Program, and the University of Miami Clinical and
   Translational Science Institute (CTSI) Project for Emerging Diseases.
CR ANDERSON R M, 1991
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2016, TORONTO STAR
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2016, UPD INT GUID PREV SE
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   COLGATE SA, 1989, P NATL ACAD SCI USA, V86, P4793, DOI 10.1073/pnas.86.12.4793
   Craig AP, 2015, VACCINE, V33, P4520, DOI 10.1016/j.vaccine.2015.07.015
   Dallas County Health Human Services (DCHHS), 2016, DCHHS REP 1 ZIK VIR
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3
   He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   IMAN RL, 1981, J QUAL TECHNOL, V13, P174
   Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103
   Ionides EL, 2011, ANN STAT, V39, P1776, DOI 10.1214/11-AOS886
   Keeling M.J., 2007, MODELING INFECT DIS
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Laumann E. O., 1994, SOCIAL ORG SEXUALITY
   Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization (PAHO), ZIK VIR INF
   Saltelli A., 2000, SENSITIVITY ANAL
   Shapshak P., 2015, Global virology I - identifying and investigating viral diseases, P477
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 42
TC 133
Z9 137
U1 3
U2 48
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 17
PY 2016
VL 6
AR 28070
DI 10.1038/srep28070
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH9DW
UT WOS:000392072900001
PM 27312324
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Perez, S
   Tato, R
   Cabrera, JJ
   Lopez, A
   Robles, O
   Paz, E
   Coira, A
   Sanchez-Seco, MP
   Vazquez, A
   Carballo, R
   Quintas, C
   Pousa, A
AF Perez, S.
   Tato, R.
   Cabrera, J. J.
   Lopez, A.
   Robles, O.
   Paz, E.
   Coira, A.
   Sanchez-Seco, M. P.
   Vazquez, A.
   Carballo, R.
   Quintas, C.
   Pousa, A.
TI Confirmed case of Zika virus congenital infection, Spain, March 2016
SO EUROSURVEILLANCE
LA English
DT Article
AB We describe Zika virus (ZIKV) vertical transmission in an imported case in Spain, in a 17-week pregnant woman. ZIKV IgG, IgM and RNA were detected in serum in week 17. At 19 weeks, ultrasound scan revealed fetal malformations and ZIKV was detected in the amniotic fluid. Pregnancy was terminated at week 21; autopsy of the fetus revealed bilateral hydrocephalus, brain microcalcifications and arthrogryposis multiplex congenita. ZIKV was detected in the umbilical cord and brain tissue.
C1 [Perez, S.; Cabrera, J. J.; Carballo, R.] Univ Hosp Vigo, Dept Microbiol, Vigo, Spain.
   [Tato, R.] Univ Hosp Pontevedra, Dept Microbiol, Pontevedra, Spain.
   [Lopez, A.; Paz, E.] Lucus Augusti Hosp, Dept Gynecol, Lugo, Spain.
   [Robles, O.] Lucus Augusti Hosp, Dept Pathol, Lugo, Spain.
   [Coira, A.] Lucus Augusti Hosp, Dept Microbiol, Lugo, Spain.
   [Sanchez-Seco, M. P.; Vazquez, A.] Carlos III Hlth Inst ISCIII, Natl Ctr Microbiol CNM, Virol Area, Arbovirus & Imported Viral Dis, Madrid, Spain.
   [Quintas, C.] Lucus Augusti Hosp, Dept Prevent Med, Lugo, Spain.
   [Pousa, A.] Conselleria Sanidade, Gen Direct Publ Hlth, Gen Subdirect Epidemiol & Informat Syst, Santiago De Compostela, Spain.
RP Perez, S (corresponding author), Univ Hosp Vigo, Dept Microbiol, Vigo, Spain.
EM sonia.perez.castro@sergas.es
RI ; Vazquez, Ana/H-4911-2013
OI Coira, Amparo/0000-0003-1412-4242; Lopez, Alberto/0000-0003-1879-354X;
   Cabrera Alvargonzalez, Jorge J./0000-0002-0397-0868; PEREZ CASTRO,
   SONIA/0000-0003-1734-1904; SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704;
   Tato Rodriguez, Ruben/0000-0003-3724-6787; Vazquez,
   Ana/0000-0002-9872-3316
CR Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V22, P648, DOI 10.1016/j.cmi.2016.03.025
   Brasil P, 2016, N ENGL J MED
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pan American Health Organization (PAHO) / World Health Organization (WHO), 2016, EP AL ZIK VIR INF
   Pan American Health Organization (PAHO) / World Health Organization (WHO), TIM EM ZIK VIR AM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, GUILL BARR SYNDR COL
NR 21
TC 17
Z9 17
U1 0
U2 29
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 16
PY 2016
VL 21
IS 24
BP 1
EP 4
AR 30261
DI 10.2807/1560-7917.ES.2016.21.24.30261
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DP5KP
UT WOS:000378535500001
PM 27336620
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Musso, D
   Teissier, A
   Rouault, E
   Teururai, S
   de Pina, JJ
   Nhan, TX
AF Musso, Didier
   Teissier, Anita
   Rouault, Eline
   Teururai, Sylviane
   de Pina, Jean-Jacques
   Tu-Xuan Nhan
TI Detection of chikungunya virus in saliva and urine
SO VIROLOGY JOURNAL
LA English
DT Article
DE Chikungunya; CHIKV; PCR; Saliva; French Polynesia; Arbovirus; Urine
ID WEST-NILE-VIRUS; ZIKA VIRUS; FRENCH-POLYNESIA; DENGUE; TRANSMISSION;
   INFECTION; GENOME; PCR
AB Background: Saliva and urine have been used for arthropod-borne viruses molecular detection but not yet for chikungunya virus (CHIKV). We investigated the use of saliva and urine for molecular detection of CHIKV during the French Polynesian outbreak.
   Methods: During the French Polynesian chikungunya outbreak (2014-2015), we collected the same day blood and saliva samples from 60 patients with probable chikungunya (47 during the 1st week post symptoms onset and 13 after), urine was available for 39 of them. All samples were tested using a CHIKV reverse-transcription PCR.
   Results: Forty eight patients had confirmed chikungunya. For confirmed chikungunya presenting during the 1st week post symptoms onset, CHIKV RNA was detected from 86.1 % (31/36) of blood, 58.3 % (21/36) of saliva and 8. 3 % (2/24) of urine. Detection rate of CHIKV RNA was significantly higher in blood compared to saliva. For confirmed chikungunya presenting after the 1st week post symptoms onset, CHIKV RNA was detected from 8.3 % (1/12) of blood, 8.3 % (1/12) of saliva and 0 % (0/8) of urine.
   Conclusions: In contrast to Zika virus (ZIKV), saliva did not increased the detection rate of CHIKV RNA during the 1st week post symptoms onset. In contrast to ZIKV, dengue virus and West Nile virus, urine did not enlarged the window of detection of CHIKV RNA after the 1st week post symptoms onset. Saliva can be used for molecular detection of CHIKV during the 1st week post symptoms onset only if blood is impossible to collect but with a lower sensitivity compared to blood.
C1 [Musso, Didier; Rouault, Eline; Teururai, Sylviane; de Pina, Jean-Jacques; Tu-Xuan Nhan] Inst Louis Malarde, Med Biol Lab, POB 3098713, Papeete, Tahiti, France.
   [Musso, Didier; Teissier, Anita] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, France.
RP Musso, D (corresponding author), Inst Louis Malarde, Med Biol Lab, POB 3098713, Papeete, Tahiti, France.; Musso, D (corresponding author), Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, France.
EM dmusso@ilm.pf
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; DE
   PINA, Jean Jacques/0000-0002-2081-3936
CR Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   European Centre for Disease Prevention and Control, 2007, INF HLTH PRACT
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haute Autorite de la Sante, 2013, DIAGN BIOL DIR PREC, V95
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Jones PH, 2015, J INFECT DIS THER, V3, DOI [10.4172/2332-0877.1000226, DOI 10.4172/2332-0877.1000226]
   Kondo M, 2016, J DERMATOL, V43, P697, DOI 10.1111/1346-8138.13253
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Laigret J, 1967, Bull Soc Pathol Exot Filiales, V60, P339
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   MATHUR A, 1995, INT J EXP PATHOL, V76, P103
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   World Health Organisation, 2008, GUID CLIN MAN CHIK F
NR 29
TC 17
Z9 18
U1 0
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD JUN 16
PY 2016
VL 13
AR 102
DI 10.1186/s12985-016-0556-9
PG 4
WC Virology
SC Virology
GA DO7DN
UT WOS:000377942500001
PM 27306056
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Igreja, RP
AF Igreja, Ricardo P.
TI Olympics fans must take Zika precautions before travelling
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Letter
C1 [Igreja, Ricardo P.] Univ Fed Rio de Janeiro, Fac Med, Rua Martius 325, Rio De Janeiro, RJ, Brazil.
RP Igreja, RP (corresponding author), Univ Fed Rio de Janeiro, Fac Med, Rua Martius 325, Rio De Janeiro, RJ, Brazil.
EM rpigreja@cives.ufrj.br
CR Centers for Disease Control and Prevention, 2016, CTR DIS CONTROL PREV
   Commitee to Advise on Tropical Medicine and Travel (CATMAT), 2005, Can Commun Dis Rep, V31, P1
   Coombes R, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2899
   Igreja RP, 2010, CLIN INFECT DIS, V50, P616, DOI 10.1086/650177
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
NR 5
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 14
PY 2016
VL 353
AR i3255
DI 10.1136/bmj.i3255
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP1GZ
UT WOS:000378239800008
PM 27301356
DA 2020-07-08
ER

PT J
AU Hanners, NW
   Eitson, JL
   Usui, N
   Richardson, RB
   Wexler, EM
   Konopka, G
   Schoggins, JW
AF Hanners, Natasha W.
   Eitson, Jennifer L.
   Usui, Noriyoshi
   Richardson, R. Blake
   Wexler, Eric M.
   Konopka, Genevieve
   Schoggins, John W.
TI Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term
   with Partial Cytopathic and Limited Immunogenic Effects
SO CELL REPORTS
LA English
DT Article
ID 3-DIMENSIONAL ARCHITECTURE; INFECTION; CELLS; REPLICATION; ORGANOIDS;
   BRAZIL; SITES
AB The recent Zika virus (ZIKV) outbreak in the Western hemisphere is associated with severe pathology in newborns, including microcephaly and braindamage. The mechanisms underlying these outcomes are under intense investigation. Here, we show that a 2015 ZIKV isolate replicates in multiple cell types, including primary human fetal neural progenitors (hNPs). In immortalized cells, ZIKV is cytopathic and grossly rearranges endoplasmic reticulum membranes similar to other flaviviruses. In hNPs, ZIKV infection has a partial cytopathic phase characterized by cell rounding, pyknosis, and activation of caspase 3. Despite notable cell death, ZIKV did not activate a cytokine response in hNPs. This lack of cell intrinsic immunity to ZIKV is consistent with our observation that virus replication persists in hNPs for at least 28 days. These findings, supported by published fetal neuropathology, establish a proof-of-concept that neural progenitors in the developing human fetus can be direct targets of detrimental ZIKV-induced pathology.
C1 [Hanners, Natasha W.; Eitson, Jennifer L.; Richardson, R. Blake; Schoggins, John W.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
   [Hanners, Natasha W.] Univ Texas SW Med Ctr Dallas, Div Infect Dis, Dept Pediat, Dallas, TX 75390 USA.
   [Usui, Noriyoshi; Konopka, Genevieve] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.
   [Wexler, Eric M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA.
RP Schoggins, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
EM john.schoggins@utsouthwestern.edu
OI Hanners, Natasha W./0000-0002-3391-4197; Usui,
   Noriyoshi/0000-0001-8079-8013; Konopka, Genevieve/0000-0002-3363-7302
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DK095031, AI117922, MH102603]; Rita
   Allen Foundation
FX We thank Katrina Mar for technical advice and the UT Southwestern
   Electron Microscopy Core Facility for technical support. This work was
   supported in part by NIH grants DK095031 (J.W.S.), AI117922 (J.W.S.),
   MH102603 (G.K.), and a grant from the Rita Allen Foundation (J.W.S.).
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH or the other
   funders.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010
   Cugola F. R., 2016, NATURE
   Dang J., 2016, CELL STEM CELL
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Driggers RW, 2016, N ENGL J MED
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kindhauser MK, 2016, B WHO
   Konopka G, 2012, MOL PSYCHIATR, V17, P202, DOI 10.1038/mp.2011.60
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL
   Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, P16
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu K. Y., 2016, CELL RES
NR 30
TC 65
Z9 66
U1 0
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 14
PY 2016
VL 15
IS 11
BP 2315
EP 2322
DI 10.1016/j.celrep.2016.05.075
PG 8
WC Cell Biology
SC Cell Biology
GA DO4TG
UT WOS:000377776400001
PM 27268504
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Gostin, LO
   Hodge, JG
AF Gostin, Lawrence O.
   Hodge, James G., Jr.
TI Is the United States Prepared for a Major Zika Virus Outbreak?
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
C1 [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20001 USA.
   [Hodge, James G., Jr.] Arizona State Univ, Publ Hlth Law & Policy Program, Sandra Day OConnor Coll Law, Tempe, AZ USA.
RP Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.
EM gostin@law.georgetown.edu
OI Gostin, Lawrence/0000-0001-5286-4044
CR [Anonymous], 2016, FED REG, V81, P10878
   Boodman E, CHRISTIE CALLS QUARA
   Kim M, MOSQUITOES SELF DEST
   McNeil Jr DG, PUERTO RICO BRACES I
   Pollack A, NEW WEAPON FIGHT ZIK
   Sullivan P, GOP SKEPTICAL NEW FU
   Tavernise S, CDC OFFERS GUIDELINE
   The White House, FACT SHEET PREP RESP
   World Health Organization, WHO DIR GEN BRIEFS M
NR 9
TC 2
Z9 2
U1 0
U2 25
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JUN 14
PY 2016
VL 315
IS 22
BP 2395
EP 2396
DI 10.1001/jama.2016.4919
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO3CE
UT WOS:000377656900012
PM 27074330
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Savidis, G
   Perreira, JM
   Portmann, JM
   Meraner, P
   Guo, ZR
   Green, S
   Brass, AL
AF Savidis, George
   Perreira, Jill M.
   Portmann, Jocelyn M.
   Meraner, Paul
   Guo, Zhiru
   Green, Sharone
   Brass, Abraham L.
TI The IFITMs Inhibit Zika Virus Replication
SO CELL REPORTS
LA English
DT Article
ID INFLUENZA-A VIRUS; DENGUE VIRUS; PROTEINS; INFECTION; LINE
AB Zika virus has emerged as a severe health threat with a rapidly expanding range. The IFITM family of restriction factors inhibits the replication of a broad range of viruses, including the closely related flaviruses West Nile virus and dengue virus. Here, we show that IFITM1 and IFITM3 inhibit Zika virus infection early in the viral life cycle. Moreover, IFITM3 can prevent Zika-virus-induced cell death. These results suggest that strategies to boost the actions and/or levels of the IFITMs might be useful for inhibiting a broad range of emerging viruses.
C1 [Savidis, George; Perreira, Jill M.; Portmann, Jocelyn M.; Meraner, Paul; Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.
   [Guo, Zhiru; Green, Sharone] Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Sch Med, Worcester, MA 01655 USA.
   [Brass, Abraham L.] Univ Massachusetts, Div Gastroenterol, Dept Med, Sch Med, Worcester, MA 01655 USA.
RP Brass, AL (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.; Brass, AL (corresponding author), Univ Massachusetts, Div Gastroenterol, Dept Med, Sch Med, Worcester, MA 01655 USA.
EM abraham.brass@umassmed.edu
FU NIH National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [1R01AI091786]; Burroughs Wellcome FoundationBurroughs Wellcome Fund;
   UMMS Center for Clinical and Translational Science; Bill and Melinda
   Gates FoundationGates Foundation
FX We thank University of Massachusetts Medical School (UMMS) colleagues R.
   Fish, L. Benson, and J. Barrett. We thank Thomas Soellner of Heidelberg
   University for inspiration. This work was supported by grant
   1R01AI091786 from the NIH National Institute of Allergy and Infectious
   Diseases and by the Investigators in the Pathogenesis of Infectious
   Disease Award from the Burroughs Wellcome Foundation, both to A.L.B.
   A.L.B. is grateful to the UMMS Center for Clinical and Translational
   Science and to the Bill and Melinda Gates Foundation for their support.
CR Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694
   D'Ortenzio E, 2016, N ENGL J MED
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, N ENGL J MED
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Yang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124985
   Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433
NR 31
TC 95
Z9 98
U1 1
U2 33
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 14
PY 2016
VL 15
IS 11
BP 2323
EP 2330
DI 10.1016/j.celrep.2016.05.074
PG 8
WC Cell Biology
SC Cell Biology
GA DO4TG
UT WOS:000377776400002
PM 27268505
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU MacKenzie, D
AF MacKenzie, Debora
TI We need to Zika-proof the Rio Olympics
SO NEW SCIENTIST
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU REED BUSINESS INFORMATION LTD
PI SUTTON
PA QUADRANT HOUSE THE QUADRANT, SUTTON SM2 5AS, SURREY, ENGLAND
SN 0262-4079
J9 NEW SCI
JI New Sci.
PD JUN 11
PY 2016
VL 230
IS 3077
BP 19
EP 19
DI 10.1016/S0262-4079(16)31043-0
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO5UH
UT WOS:000377847800011
DA 2020-07-08
ER

PT J
AU Ahmad, N
   White, J
AF Ahmad, Nina
   White, Jennifer
CA Zika Pregnancy Working Grp
TI Possible Zika Virus Infection Among Pregnant Women - United States and
   Territories, May 2016 (vol 65, pg 514, 2016)
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Correction
C1 [Ahmad, Nina; White, Jennifer; Zika Pregnancy Working Grp] New York State Dept Hlth, New York, NY USA.
RP Ahmad, N (corresponding author), New York State Dept Hlth, New York, NY USA.
CR Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
NR 1
TC 0
Z9 0
U1 0
U2 44
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 10
PY 2016
VL 65
IS 22
BP 587
EP 587
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP2EH
UT WOS:000378300400006
DA 2020-07-08
ER

PT J
AU Rolfe, AJ
   Bosco, DB
   Wang, JY
   Nowakowski, RS
   Fan, JQ
   Ren, Y
AF Rolfe, Alyssa J.
   Bosco, Dale B.
   Wang, Jingying
   Nowakowski, Richard S.
   Fan, Jianqing
   Ren, Yi
TI Bioinformatic analysis reveals the expression of unique transcriptomic
   signatures in Zika virus infected human neural stem cells
SO CELL AND BIOSCIENCE
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; DENGUE VIRUS; MECHANISMS;
   CYTOSCAPE; NETWORKS; DISEASE; PROTEIN; FEVER
AB Background: The single-stranded RNA Flavivirus, Zika virus (ZIKV), has recently re-emerged and spread rapidly across the western hemisphere's equatorial countries, primarily through Aedes mosquito transmission. While symptoms in adult infections appear to be self-limiting and mild, severe birth defects, such as microcephaly, have been linked to infection during early pregnancy. Recently, Tang et al. (Cell Stem Cell 2016, doi: 10.1016/j.stem.2016.02.016) demonstrated that ZIKV efficiently infects induced pluripotent stem cell (iPSC) derived human neural progenitor cells (hNPCs), resulting in cell cycle abnormalities and apoptosis. Consequently, hNPCs are a suggested ZIKV target.
   Methods: We analyzed the transcriptomic sequencing (RNA-seq) data (GEO: GSE78711) of ZIKV (Strain: MR766) infected hNPCs. For comparison to the ZIKV-infected hNPCs, the expression data from hNPCs infected with human cytomegalovirus (CMV) (Strain: AD169) was used (GEO: GSE35295). Utilizing a combination of Gene Ontology, database of human diseases, and pathway analysis, we generated a putative systemic model of infection supported by known molecular pathways of other highly related viruses.
   Results: We analyzed RNA-sequencing data for transcript expression alterations in ZIKV-infected hNPCs, and then compared them to expression patterns of iPSC-derived hNPCs infected with CMV, a virus that can also induce severe congenital neurological defects in developing fetuses. We demonstrate for the first time that many of cellular pathways correlate with clinical pathologies following ZIKV infection such as microcephaly, congenital nervous system disorders and epilepsy. Furthermore, ZIKV activates several inflammatory signals within infected hNPCs that are implicated in innate and acquired immune responses, while CMV-infected hNPCs showed limited representation of these pathways. Moreover, several genes related to pathogen responses are significantly upregulated upon ZIKV infection, but not perturbed in CMV-infected hNPCs.
   Conclusion: The presented study is the first to report enrichment of numerous pro-inflammatory pathways in ZIKV-infected hNPCs, indicating that hNPCs are capable of signaling through canonical pro-inflammatory pathways following viral infection. By defining gene expression profiles, new factors in the pathogenesis of ZIKV were identified which could help develop new therapeutic strategies.
C1 [Rolfe, Alyssa J.; Bosco, Dale B.; Wang, Jingying; Nowakowski, Richard S.; Ren, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West St, Tallahassee, FL 32306 USA.
   [Fan, Jianqing] Princeton Univ, Stat Lab, Princeton, NJ 08540 USA.
RP Ren, Y (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West St, Tallahassee, FL 32306 USA.
EM yi.ren@med.fsu.edu
RI Fan, Jianqing/B-2115-2008
OI Rolfe, Alyssa/0000-0002-1427-549X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01GM100474,
   R01GM072611]
FX Thanks to Stephanie Hurwitz for review of the manuscript. This work was
   supported by the National Institutes of Health (R01GM100474 and
   R01GM072611).
CR Aggarwal A, 2013, J NEUROSCI RURAL PRA, V4, P288, DOI 10.4103/0976-3147.118781
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16
   Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39
   MARTIN EM, 1961, BIOCHEM J, V80, P585, DOI 10.1042/bj0800585
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NAKAO S, 1989, BLOOD, V74, P1235
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515
   R Core Team, 2015, R LANG ENV STAT COMP
   Rappaport N, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat018
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zuguang G, 2015, COMPLEXHEATMAP MAKIN
NR 36
TC 23
Z9 23
U1 1
U2 80
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD JUN 10
PY 2016
VL 6
AR 42
DI 10.1186/s13578-016-0110-x
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DO4VI
UT WOS:000377782600004
PM 27293547
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zambon, M
AF Zambon, M.
TI Zika virus, the new kid on the block
SO EUROSURVEILLANCE
LA English
DT Editorial Material
C1 [Zambon, M.] Publ Hlth England, London, England.
RP Zambon, M (corresponding author), Publ Hlth England, London, England.
EM Maria.Zambon@phe.gov.uk
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Coelho FC, 2016, BIORXIV, DOI 10.1101/055459
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deen GF, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1511410, DOI 10.1056/NEJM0A1511410]
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Niedrig M, 2005, J CLIN VIROL, V34, P22, DOI 10.1016/j.jcv.2005.01.004
   Public Health England (PHE), ZIK VIR INT ALG ASS
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rezza G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.21.30238
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   United Nations Development Group (UNDG)-Western and Central Africa, 2015, SOC IMP EB VIR DIS W
   World Health Organization, 2016, ZIK SIT REP
NR 15
TC 0
Z9 0
U1 0
U2 16
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 2
EP 5
AR 30255
DI 10.2807/1560-7917.ES.2016.21.23.30255
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200001
PM 27311776
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Reusken, C
   Pas, S
   GeurtsvanKessel, C
   Mogling, R
   van Kampen, J
   Langerak, T
   Koopmans, M
   van der Eijk, A
   van Gorp, E
AF Reusken, C.
   Pas, S.
   GeurtsvanKessel, C.
   Mogling, R.
   van Kampen, J.
   Langerak, T.
   Koopmans, M.
   van der Eijk, A.
   van Gorp, E.
TI Longitudinal follow-up of Zika virus RNA in semen of a traveller
   returning from Barbados to the Netherlands with Zika virus disease,
   March 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION; UNITED-STATES
AB We report the longitudinal follow-up of Zika virus (ZIKV) RNA in semen of a traveller who developed ZIKV disease after return to the Netherlands from Barbados, March 2016. Persistence of ZIKV RNA in blood, urine, saliva and semen was followed until the loads reached undetectable levels. RNA levels were higher in semen than in other sample types and declined to undetectable level at day 62 post onset of symptoms.
C1 [Reusken, C.; Pas, S.; GeurtsvanKessel, C.; Mogling, R.; van Kampen, J.; Langerak, T.; Koopmans, M.; van der Eijk, A.; van Gorp, E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Reusken, C.; Pas, S.; GeurtsvanKessel, C.; Mogling, R.; van Kampen, J.; Langerak, T.; Koopmans, M.; van der Eijk, A.; van Gorp, E.] Erasmus MC, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Rotterdam, Netherlands.
RP Reusken, C (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.; Reusken, C (corresponding author), Erasmus MC, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019; Pas, Suzan D/M-9863-2013
OI Koopmans, Marion/0000-0002-5204-2312; Pas, Suzan D/0000-0003-1943-1217;
   Langerak, Thomas/0000-0003-4340-1560
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   ECDC, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR OUTBR AM PAC
   Federal public service, WAARSCHUWING IN VERB
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   National Coordination Centre for Communicable Disease Control (LCI), LCI RICHTL ZIK
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization/ World Health Organization, 2016, CUM ZIK SUSP CONF CA
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, 2016, DIS OUTBREAK NE 0120
NR 18
TC 27
Z9 27
U1 0
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 6
EP 9
AR 30251
DI 10.2807/1560-7917.ES.2016.21.23.30251
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200002
PM 27313200
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kmietowicz, Z
AF Kmietowicz, Zosia
TI Olympic Games are likely to be free of Zika cases, say officials
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Coombes R, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2899
NR 1
TC 1
Z9 1
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 9
PY 2016
VL 353
AR i3233
DI 10.1136/bmj.i3233
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO5YQ
UT WOS:000377859500006
PM 27284020
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Freour, T
   Mirallie, S
   Hubert, B
   Splingart, C
   Barriere, P
   Maquart, M
   Leparc-Goffart, I
AF Freour, T.
   Mirallie, S.
   Hubert, B.
   Splingart, C.
   Barriere, P.
   Maquart, M.
   Leparc-Goffart, I.
TI Sexual transmission of Zika virus in an entirely asymptomatic couple
   returning from a Zika epidemic area, France, April 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID STATES
AB The current Zika virus outbreak and its potential severe health consequences, especially congenital fetal syndrome, have led to increased concern about sexual transmission, especially in pregnant women and women of reproductive age. Here we report a case of Zika virus sexual transmission, likely male-to-female, in a totally asymptomatic couple.
C1 [Freour, T.; Mirallie, S.; Splingart, C.; Barriere, P.] CHU Nantes, Serv Med Reprod, Nantes, France.
   [Hubert, B.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Pays de la Loire, St Maurice, France.
   [Maquart, M.; Leparc-Goffart, I.] French Armed Forces Biomed Res Inst, Marseille, France.
RP Leparc-Goffart, I (corresponding author), French Armed Forces Biomed Res Inst, Marseille, France.
EM isabelle.leparcgoffart@gmail.com
OI Hubert, Bruno/0000-0003-3640-718X
CR Agence de la Biomedecine, REC PROF CADR EP VIR
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Coelho FC, SEXUAL TRANSMISSION
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), CURR ZIK TRANSM
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haneche F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.18.30222
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Sow MS, 2016, J INFECT DIS, V214, P1475, DOI 10.1093/infdis/jiw078
   Turmel J. M., 2016, LANCET
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 15
TC 74
Z9 76
U1 0
U2 19
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 10
EP 12
AR 30254
DI 10.2807/1560-7917.ES.2016.21.23.30254
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200003
PM 27311680
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Frank, C
   Cadar, D
   Schlaphof, A
   Neddersen, N
   Gunther, S
   Schmidt-Chanasit, J
   Tappe, D
AF Frank, C.
   Cadar, D.
   Schlaphof, A.
   Neddersen, N.
   Guenther, S.
   Schmidt-Chanasit, J.
   Tappe, D.
TI Sexual transmission of Zika virus in Germany, April 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID INFECTION; TRAVELERS
AB Zika virus (ZIKV), an emerging mosquito-borne flavivirus, causes a mild dengue fever-like illness but has recently been associated with neurological disease and severe birth defects. The virus is currently causing a large epidemic in the Americas. Here, we report a male-to-female sexual transmission of ZIKV in Germany in April 2016, following travel to Puerto Rico of the male patient, demonstrated by subsequent seroconversions and molecular identification of identical virus sequences from both patients.
C1 [Frank, C.] Robert Koch Inst, Dept Infect Dis Epidemiol, Div Gastrointestinal Infect Zoonoses & Trop Infec, Berlin, Germany.
   [Cadar, D.; Schlaphof, A.; Neddersen, N.; Guenther, S.; Schmidt-Chanasit, J.; Tappe, D.] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, J.; Tappe, D.] German Ctr Infect Res DZIF, Site Hamburg Luebeck Borstel, Hamburg, Germany.
RP Schmidt-Chanasit, J (corresponding author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Schmidt-Chanasit, J (corresponding author), German Ctr Infect Res DZIF, Site Hamburg Luebeck Borstel, Hamburg, Germany.
EM jonassi@gmx.de
OI Frank, Christina/0000-0001-6776-8450; Gunther,
   Stephan/0000-0002-6562-0230; Cadar, Daniel/0000-0002-8063-2766
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   European Centre for Disease Prevention and Control (ECDC), RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   WHO, 2016, PREV SEX TRANSM ZIK
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 20
TC 47
Z9 47
U1 0
U2 17
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 13
EP 16
AR 30252
DI 10.2807/1560-7917.ES.2016.21.23.30252
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200004
PM 27311329
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cugola, FR
   Fernandes, IR
   Russo, FB
   Freitas, BC
   Dias, JLM
   Guimaraes, KP
   Benazzato, C
   Almeida, N
   Pignatari, GC
   Romero, S
   Polonio, CM
   Cunha, I
   Freitas, CL
   Brandao, WN
   Rossato, C
   Andrade, DG
   Faria, DD
   Garcez, AT
   Buchpigel, CA
   Braconi, CT
   Mendes, E
   Sall, AA
   Zanotto, PMD
   Peron, JPS
   Muotri, AR
   Beltrao-Braga, PCB
AF Cugola, Fernanda R.
   Fernandes, Isabella R.
   Russo, Fabiele B.
   Freitas, Beatriz C.
   Dias, Joao L. M.
   Guimaraes, Katia P.
   Benazzato, Cecilia
   Almeida, Nathalia
   Pignatari, Graciela C.
   Romero, Sarah
   Polonio, Carolina M.
   Cunha, Isabela
   Freitas, Carla L.
   Brandao, Wesley N.
   Rossato, Cristiano
   Andrade, David G.
   Faria, Daniele de P.
   Garcez, Alexandre T.
   Buchpigel, Carlos A.
   Braconi, Carla T.
   Mendes, Erica
   Sall, Amadou A.
   Zanotto, Paolo M. de A.
   Peron, Jean Pierre S.
   Muotri, Alysson R.
   Beltrao-Braga, Patricia C. B.
TI The Brazilian Zika virus strain causes birth defects in experimental
   models
SO NATURE
LA English
DT Article
ID INFECTION; BRAIN; GROWTH
AB Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinel rhesus monkeys(1). Until the twentieth century, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored by Aedes aegypti mosquitoes, ZIKV caused the first noteworthy epidemic on Yap Island in Micronesia(2). Patients experienced fever, skin rash, arthralgia and conjunctivitis(2). From 2013 to 2015, the Asian lineage of the virus caused further massive outbreaks in New Caledonia and French Polynesia. In 2013, ZIKV reached Brazil, later spreading to other countries in South and Central America3. In Brazil, the virus has been linked to congenital malformations, including microcephaly and other severe neurological diseases, such as Guillain-Barre syndrome(4,5). Despite clinical evidence, direct experimental evidence showing that the Brazilian ZIKV (ZIKVBR) strain causes birth defects remains absent(6). Here we demonstrate that ZIKVBR infects fetuses, causing intrauterine growth restriction, including signs of microcephaly, in mice. Moreover, the virus infects human cortical progenitor cells in vitro, leading to an increase in cell death. We also report that the infection of human brain organoids results in a reduction of proliferative zones and disrupted cortical layers. These results indicate that ZIKVBR crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment. Our data reinforce the growing body of evidence linking the ZIKVBR outbreak to the alarming number of cases of congenital brain malformations. Our model can be used to determine the efficiency of therapeutic approaches to counteracting the harmful impact of ZIKVBR in human neurodevelopment.
C1 [Cugola, Fernanda R.; Fernandes, Isabella R.; Russo, Fabiele B.; Dias, Joao L. M.; Guimaraes, Katia P.; Benazzato, Cecilia; Almeida, Nathalia; Pignatari, Graciela C.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.
   [Fernandes, Isabella R.; Freitas, Beatriz C.; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA.
   [Russo, Fabiele B.; Pignatari, Graciela C.] Tismoo, BR-01401000 Sao Paulo, Brazil.
   [Polonio, Carolina M.; Cunha, Isabela; Freitas, Carla L.; Brandao, Wesley N.; Rossato, Cristiano; Andrade, David G.; Peron, Jean Pierre S.] Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil.
   [Faria, Daniele de P.; Garcez, Alexandre T.; Buchpigel, Carlos A.] Univ Sao Paulo, USP Sch Med, Dept Radiol & Oncol, BR-05403010 Sao Paulo, Brazil.
   [Braconi, Carla T.; Mendes, Erica; Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Microbiol Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508000 Sao Paulo, Brazil.
   [Sall, Amadou A.] Inst Pasteur, Dakar 220, Senegal.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.; Muotri, AR (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA.; Peron, JPS (corresponding author), Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.
EM jeanpierre@usp.br; muotri@ucsd.edu; patriciacbbbraga@usp.br
RI de A. Zanotto, Paolo M./B-9286-2019; Russo, Fabiele/N-4340-2017; de
   Paula Faria, Daniele/D-7858-2015; Benazzato, Cecilia/AAB-8869-2019;
   Buchpiguel, Carlos/AAC-6237-2020; Buchpiguel, Carlos A/C-3774-2012;
   Beltrao-Braga, Patricia C B/D-6450-2013; Mendes, Erica/L-7333-2018;
   Benazzato, Cecilia/U-5873-2017; Brandao, Wesley N/K-5919-2017; Peron,
   Jean Pierre S/F-9248-2012; Braconi, Carla T./B-3320-2014; de Paula
   Faria, Daniele/U-1731-2019; Cugola, Fernanda/I-9556-2016
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Russo,
   Fabiele/0000-0002-4076-1846; de Paula Faria,
   Daniele/0000-0002-1766-2786; Buchpiguel, Carlos/0000-0003-0956-2790;
   Buchpiguel, Carlos A/0000-0003-0956-2790; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Mendes, Erica/0000-0001-9007-1053; Benazzato,
   Cecilia/0000-0002-8656-0871; Brandao, Wesley N/0000-0001-9306-3251;
   Braconi, Carla T./0000-0002-5370-8980; Peron, Jean
   Pierre/0000-0003-1638-8866; Almeida dos Santos,
   Nathalia/0000-0003-3145-186X; Rossato, Cristiano/0000-0003-1124-0520;
   Cugola, Fernanda/0000-0002-6677-2404
FU Zika Network FAPESP [2011/18703-2, 2014/17766-9]; NGO 'The Tooth Fairy
   Project'; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [U19MH107367, R01MH094753]; NARSAD Independent Investigator GrantNARSAD
FX This work was supported by grants from the Zika Network FAPESP projects
   2011/18703-2 and 2014/17766-9, the NGO 'The Tooth Fairy Project', the
   National Institutes of Health through the U19MH107367, R01MH094753 and
   an NARSAD Independent Investigator Grant to A.R.M. We would like to
   thank M. Goncalves and M. A. Miglino for scientific discussions, G.
   Amarante-Mendes for the FITC-Annexin V reagent, M. Zatz for the SJL
   mice, E. Durigon and his group for the ZIKV<SUP>BR</SUP> aliquots, P.
   Vasconcelos for providing a lyophilized ZIKV<SUP>BR</SUP> seed, N. Olsen
   for reagent and equipment support, D. Candido for analysis support, F.
   Mastrantonio for drawings and R. E. Grassi for electron and confocal
   microscopy support.
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freire C. C. d. M., 2015, PREPRINT
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jang EA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00176
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian X., 2016, CELL, V165, P1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Stock NK, 2013, J VIROL, V87, P2895, DOI 10.1128/JVI.01116-12
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 36
TC 584
Z9 602
U1 10
U2 278
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 9
PY 2016
VL 534
IS 7606
BP 267
EP +
DI 10.1038/nature18296
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO0NH
UT WOS:000377475100045
PM 27279226
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU van Hemert, F
   Berkhout, B
AF van Hemert, Formijn
   Berkhout, Ben
TI Nucleotide composition of the Zika virus RNA genome and its codon usage
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; ZIKV; Viral RNA genome; Nucleotide composition; Nucleotide
   bias; Purine-rich; Codon usage; RNA structure; Flavivirus
ID MOLECULAR CHARACTERIZATION; FEVER-VIRUS; WEB SERVER; SELECTION; BIAS;
   TRANSMISSION; EVOLUTION; RECOMBINATION; RECOGNITION; SEQUENCES
AB Background: RNA viruses have genomes with a distinct nucleotide composition and codon usage. We present the global characteristics of the RNA genome of Zika virus (ZIKV), an emerging pathogen within the Flavivirus genus. ZIKV was first isolated in 1947 in Uganda, caused a widespread epidemic in South and Central America and the Caribbean in 2015 and has recently been associated with microcephaly in newborns.
   Methods: The nearly 11 kb positive-stranded RNA genome of ZIKV was analyzed for its nucleotide composition, also in the context of the folded RNA molecule. Nucleotide trends were investigated along the genome length by skew analyses and we analyzed the codons used for translation of the ZIKV proteins.
   Results: ZIKV RNA has a biased nucleotide composition in being purine-rich and pyrimidine-poor. This preference for purines is a general characteristic of the mosquito-borne and tick-borne flaviviruses. The virus-specific nucleotide bias is further enriched in the unpaired, single-stranded regions of the structured ZIKV RNA genome, thus further imposing this ZIKV-specific signature. The codons used for translation of the ZIKV proteins is also unusual, but we show that it is the underlying bias in nucleotide composition of the viral RNA that largely dictates these codon preferences.
   Conclusions: The ZIKV RNA genome has a biased nucleotide composition that dictates the codon usage of this flavivirus. We discuss the evolutionary scenarios and molecular mechanisms that may be responsible for these distinctive ZIKV RNA genome features.
C1 [van Hemert, Formijn; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,Ctr Infect & Immun Amsterdam C, NL-1105 AZ Amsterdam, Netherlands.
RP Berkhout, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,Ctr Infect & Immun Amsterdam C, NL-1105 AZ Amsterdam, Netherlands.
EM b.berkhout@amc.uva.nl
FU NWO-Chemical Sciences (TOP grant)
FX We thank Alexander Pasternak and Tonja van der Kuyl for critical reading
   of the manuscript. RNA research in the BB laboratory is sponsored by
   NWO-Chemical Sciences (TOP grant).
CR Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498
   Behura SK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-37
   BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026
   BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705
   Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674
   Berkhout B, 2015, VIRUS RES, V202, P41, DOI 10.1016/j.virusres.2014.11.031
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE
   Francino HP, 1999, NATURE, V400, P30, DOI 10.1038/21804
   Freire CCM, 2015, BIORXIV
   Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X
   Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286
   Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168
   KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057
   Lara-Ramirez EE, 2014, BIOMED RES INT, DOI 10.1155/2014/851425
   Leifer I, 2013, VIROLOGY, V438, P51, DOI 10.1016/j.virol.2013.01.013
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Mlakar J, 2016, N ENGL J MED
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   ROTHBERG PG, 1981, NUCLEIC ACIDS RES, V9, P6221, DOI 10.1093/nar/9.23.6221
   Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835
   Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tang H, 2016, CELL STEM CELL
   Vabret N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033502
   van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92
   van Hemert F, 2014, VIRUS RES, V193, P16, DOI 10.1016/j.virusres.2014.03.019
   van Hemert FJ, 2013, RNA BIOL, V10, P211, DOI 10.4161/rna.22896
   VANHEMERT FJ, 1995, J MOL EVOL, V41, P132, DOI 10.1007/BF00170664
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   WATTERSON GA, 1992, MOL BIOL EVOL, V9, P666
   Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237
   WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Zheng H, 2013, J VET SCI, V14, P27, DOI 10.4142/jvs.2013.14.1.27
   Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 56
TC 29
Z9 31
U1 2
U2 29
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUN 8
PY 2016
VL 13
AR 95
DI 10.1186/s12985-016-0551-1
PG 9
WC Virology
SC Virology
GA DO0ZK
UT WOS:000377507600001
PM 27278486
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hall, RA
   Macdonald, J
AF Hall, Roy A.
   Macdonald, Joanne
TI Synthetic Biology Provides a Toehold in the Fight against Zika
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID VIRUS; AMPLIFICATION
AB The World Health Organization has identified the development of a rapid point-of-care diagnostic test for Zika virus as a top research priority. In a recent Cell paper, Pardee et al. (2016) have exploited recent advances in synthetic biology and molecular engineering to deliver a sensitive, affordable, and field-ready Zika test.
C1 [Hall, Roy A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.
   [Macdonald, Joanne] Univ Sunshine Coast, Sch Sci & Engn, Genecol Res Ctr, Inflammat & Healing Res Cluster, Maroochydore, Qld 4558, Australia.
   [Macdonald, Joanne] Columbia Univ, Div Expt Therapeut, New York, NY 10027 USA.
RP Hall, RA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.
EM roy.hall@uq.edu.au
RI Macdonald, Joanne/A-2320-2013
OI Macdonald, Joanne/0000-0003-4624-3545
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   James A, 2015, EXPERT REV MOL DIAGN, V15, P1475, DOI 10.1586/14737159.2015.1090877
   Li J, 2015, BIOSENS BIOELECTRON, V64, P196, DOI 10.1016/j.bios.2014.08.069
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Poje JE, 2014, ANGEW CHEM INT EDIT, V53, P9222, DOI 10.1002/anie.201402698
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   2014, TOEHOLD SWITCH RNA S
NR 11
TC 4
Z9 4
U1 0
U2 77
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 752
EP 754
DI 10.1016/j.chom.2016.05.020
PG 3
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000005
PM 27281566
OA Bronze
DA 2020-07-08
ER

PT J
AU Dutra, HLC
   Rocha, MN
   Dias, FBS
   Mansur, SB
   Caragata, EP
   Moreira, LA
AF Carneiro Dutra, Heverton Leandro
   Neves Rocha, Marcele
   Stehling Dias, Fernando Braga
   Mansur, Simone Brutman
   Caragata, Eric Pearce
   Moreira, Luciano Andrade
TI Wolbachia Blocks Currently Circulating Zika Virus Isolates in Brazilian
   Aedes aegypti Mosquitoes
SO CELL HOST & MICROBE
LA English
DT Article
ID DENGUE; POPULATIONS; INFECTION; CHIKUNGUNYA; PLASMODIUM
AB The recent association of Zika virus with cases of microcephaly has sparked a global health crisis and highlighted the need for mechanisms to combat the Zika vector, Aedes aegypti mosquitoes. Wolbachia pipientis, a bacterial endosymbiont of insect, has recently garnered attention as a mechanism for arbovirus control. Here we report that Aedes aegypti harboring Wolbachia are highly resistant to infection with two currently circulating Zika virus isolates from the recent Brazilian epidemic. Wolbachia-harboring mosquitoes displayed lower viral prevalence and intensity and decreased disseminated infection and, critically, did not carry infectious virus in the saliva, suggesting that viral transmission was blocked. Our data indicate that the use of Wolbachia-harboring mosquitoes could represent an effective mechanism to reduce Zika virus transmission and should be included as part of Zika control strategies.
C1 [Carneiro Dutra, Heverton Leandro; Neves Rocha, Marcele; Stehling Dias, Fernando Braga; Mansur, Simone Brutman; Caragata, Eric Pearce; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, BR-30190002 Belo Horizonte, MG, Brazil.
   [Stehling Dias, Fernando Braga] Plataforma Vetores Doencas Fiocruz, BR-60190800 Fortaleza, Ceara, Brazil.
RP Moreira, LA (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, BR-30190002 Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
RI Dutra, Heverton Leandro Carneiro/V-7517-2019
OI Dutra, Heverton Leandro Carneiro/0000-0002-0917-4512; Dias,
   Fernando/0000-0001-7747-6136
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CNPqNational
   Council for Scientific and Technological Development (CNPq); CAPESCAPES;
   Brazilian Ministry of Health (DECIT/SVS); Foundation for National
   Institutes of Health through Vector-Based Transmission of Control:
   Discovery Research (VCTR) program of Grand Challenges in Global Health
   Initiatives of Bill and Melinda Gates Foundation
FX We are grateful to all members of the Mosquitos Vetores Group
   (MV-CPqRR/FIOCRUZ), particularly Jessica Silva, who helped to develop
   the salivation assay. We thank Dr. Luis Villegas for helpful discussion
   on statistics and Dr. Alexandre Machado for assistance with viral
   cultures. The Zika virus isolates were kindly provided by the Department
   of Virology and Experimental Therapy (Aggeu Magalhaes Research
   Center/FIOCRUZ) and by the Laboratory of Viral Isolation (Evandro Chagas
   Institute). We thank INCT-EM for the Real-Time PCR machine, and the
   Brazilian and Australian teams of the Eliminate Dengue program,
   particularly Prof. Scott L. O'Neill for donating the original wMel line
   and the Entomology team for providing field mosquito eggs. This work was
   supported by FAPEMIG, CNPq, CAPES, the Brazilian Ministry of Health
   (DECIT/SVS), and a grant to Monash University from the Foundation for
   the National Institutes of Health through the Vector-Based Transmission
   of Control: Discovery Research (VCTR) program of the Grand Challenges in
   Global Health Initiatives of the Bill and Melinda Gates Foundation.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 28
TC 202
Z9 207
U1 7
U2 104
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 771
EP 774
DI 10.1016/j.chom.2016.04.021
PG 4
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000008
PM 27156023
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Grant, A
   Ponia, SS
   Tripathi, S
   Balasubramaniam, V
   Miorin, L
   Sourisseau, M
   Schwarz, MC
   Sanchez-Seco, MP
   Evans, MJ
   Best, SM
   Garcia-Sastre, A
AF Grant, Alesha
   Ponia, Sanket S.
   Tripathi, Shashank
   Balasubramaniam, Vinod
   Miorin, Lisa
   Sourisseau, Marion
   Schwarz, Megan C.
   Paz Sanchez-Seco, Mari
   Evans, Matthew J.
   Best, Sonja M.
   Garcia-Sastre, Adolfo
TI Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
SO CELL HOST & MICROBE
LA English
DT Article
ID WEST-NILE-VIRUS; NS5 PROTEIN; FLAVIVIRUS; IDENTIFICATION; ANTAGONIST;
   ACTIVATION; MECHANISMS; EMERGENCE; EVOLUTION; INFECTION
AB The ongoing epidemic of Zika virus (ZIKV) illustrates the importance of flaviviruses as emerging human pathogens. All vector-borne flaviviruses studied thus far have to overcome type I interferon (IFN) to replicate and cause disease in vertebrates. The mechanism(s) by which ZIKV antagonizes IFN signaling is unknown. Here, we report that the nonstructural protein NS5 of ZIKV and other flaviviruses examined could suppress IFN signaling, but through different mechanisms. ZIKV NS5 expression resulted in proteasomal degradation of the IFN-regulated transcriptional activator STAT2 from humans, but not mice, which may explain the requirement for IFN deficiency to observe ZIKV-induced disease in mice. The mechanism of ZIKV NS5 resembles dengue virus (DENV) NS5 and not its closer relative, Spondweni virus (SPOV). However, unlike DENV, ZIKV did not require the E3 ubiquitin ligase UBR4 to induce STAT2 degradation. Hence, flavivirus NS5 proteins exhibit a remarkable functional convergence in IFN antagonism, albeit by virus-specific mechanisms.
C1 [Grant, Alesha; Tripathi, Shashank; Balasubramaniam, Vinod; Miorin, Lisa; Sourisseau, Marion; Schwarz, Megan C.; Evans, Matthew J.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Grant, Alesha; Tripathi, Shashank; Balasubramaniam, Vinod; Miorin, Lisa; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Ponia, Sanket S.; Best, Sonja M.] NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
   [Paz Sanchez-Seco, Mari] Inst Hlth Carlos III, Natl Ctr Microbiol, Lab Arbovirus & Imported Viral Dis, Madrid 28029, Spain.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
RP Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
EM adolfo.garcia-sastre@mssm.edu
RI Best, Sonja M/G-7301-2017; RMT Balasubramaniam, Vinod/B-6957-2017
OI Best, Sonja M/0000-0003-0206-297X; RMT Balasubramaniam,
   Vinod/0000-0001-9583-307X; Garcia-Sastre, Adolfo/0000-0002-6551-1827;
   Evans, Matthew/0000-0002-4991-3877; SANCHEZ-SECO, MARIA
   PAZ/0000-0001-9033-7704
FU Intramural Research Program of the NIH, National Institute of Allergy
   and Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID);  [U19AI118610]
FX We thank Barbara W. Johnson, Ana Fernandez-Sesma, and Steve Whitehead
   for kindly providing the 2015 PR ZIKV, 16881 DENV2, and 2015 Fortaleza
   ZIKV strains, respectively. We thank Genhong Cheng for
   IFNAR1<SUP>-/-</SUP> MEFs. We thank the microscopy and FACS SRF at Icahn
   School of Medicine for their support and Richard Cadagan for excellent
   technical assistance. This work was supported in part by the Intramural
   Research Program of the NIH, National Institute of Allergy and
   Infectious Diseases. These studies were also partly supported by a
   supplement to NIAID grant U19AI118610.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bayer A, 2016, CELL HOST MICROBE
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   COIMBRA TLM, 1993, INTERVIROLOGY, V36, P144, DOI 10.1159/000150333
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, CELL HOST MICROBE
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Ouyang J, 2014, CELL HOST MICROBE, V16, P616, DOI 10.1016/j.chom.2014.10.001
   Rajsbaum R, 2014, IMMUNITY, V40, P880, DOI 10.1016/j.immuni.2014.04.018
   Rasmussen SA, 2016, N ENGL J MED
   Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004
   Rossi SL, 2016, AM J TROP MED HYG
   Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   WOLFE MS, 1982, LANCET, V2, P1306
NR 44
TC 338
Z9 344
U1 7
U2 75
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 882
EP 890
DI 10.1016/j.chom.2016.05.009
PG 9
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000018
PM 27212660
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Shan, C
   Xie, XP
   Muruato, AE
   Rossi, SL
   Roundy, CM
   Azar, SR
   Yang, YJ
   Tesh, RB
   Boume, N
   Barrett, AD
   Vasilakis, N
   Weaver, SC
   Shi, PY
AF Shan, Chao
   Xie, Xuping
   Muruato, Antonio E.
   Rossi, Shannan L.
   Roundy, Christopher M.
   Azar, Sasha R.
   Yang, Yujiao
   Tesh, Robert B.
   Boume, Nigel
   Barrett, Alan D.
   Vasilakis, Nikos
   Weaver, Scott C.
   Shi, Pei-Yong
TI An Infectious cDNA Clone of Zika Virus to Study Viral Virulence,
   Mosquito Transmission, and Antiviral Inhibitors
SO CELL HOST & MICROBE
LA English
DT Article
ID FULL-LENGTH CDNA; WEST NILE VIRUS; DENGUE VIRUS; RNA; FLAVIVIRUS;
   VACCINE; THROUGHPUT; EPIDEMIC; RECOVERY; AMERICA
AB The Asian lineage of Zika virus (ZIKV) has recently caused epidemics and severe disease. Unraveling the mechanisms causing increased viral transmissibility and disease severity requires experimental systems. We report an infectious cDNA clone of ZIKV that was generated using a clinical isolate of the Asian lineage. The cDNA clone-derived RNA is infectious in cells, generating recombinant ZIKV. The recombinant virus is virulent in established ZIKV mouse models, leading to neurological signs relevant to human disease. Additionally, recombinant ZIKV is infectious for Aedes aegypti and thus provides a means to examine virus transmission. The infectious cDNA clone was further used to generate a luciferase ZIKV that exhibited sensitivity to a panflavivirus inhibitor, highlighting its potential utility for antiviral screening. This ZIKV reverse genetic system, together with mouse and mosquito infection models, may help identify viral determinants of human virulence and mosquito transmission as well as inform vaccine and therapeutic strategies.
C1 [Shan, Chao; Xie, Xuping; Yang, Yujiao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Rossi, Shannan L.; Roundy, Christopher M.; Azar, Sasha R.; Tesh, Robert B.; Barrett, Alan D.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Roundy, Christopher M.; Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Tesh, Robert B.; Barrett, Alan D.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Tesh, Robert B.; Barrett, Alan D.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Boume, Nigel; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Boume, Nigel; Barrett, Alan D.; Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Boume, Nigel] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019; Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556; Shan, Chao/0000-0002-3953-3782
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI120942, AI087856]
FX We are grateful to Mariano A. Garcia-Blanco, Shelton S. Brarick, and
   their lab members for providing lab space, equipment, and helpful
   discussions during the course of this work. We thank James C. Lee,
   Shirley J. Broz, Lisa M. Pipper, and Julia K. Melchor for their support
   during the establishment of P.-Y.S.'s lab at UTMB. This research was
   supported by NIH grants AI120942 and AI087856.
CR Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Calvet G., 2016, LANCET INFECT DIS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, BIORXIV
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fitzpatrick KA, 2010, VIROLOGY, V404, P89, DOI 10.1016/j.virol.2010.04.029
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   KHROMYKH AA, 1994, J VIROL, V68, P4580, DOI 10.1128/JVI.68.7.4580-4588.1994
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   LINDENBACH B, 2013, FIELDS VIROLOGY, V1, P712
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Mandl CW, 1997, J GEN VIROL, V78, P1049, DOI 10.1099/0022-1317-78-5-1049
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   RICE C M, 1989, New Biologist, V1, P285
   Rossi SL, 2016, AM J TROP MED HYG
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Shustov AV, 2007, J VIROL, V81, P11737, DOI 10.1128/JVI.01112-07
   Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13
   SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zmurko J., 2016, BIORXIV
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 39
TC 136
Z9 138
U1 2
U2 57
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 891
EP 900
DI 10.1016/j.chom.2016.05.004
PG 10
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000019
PM 27198478
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Spong, CY
AF Spong, Catherine Y.
TI Understanding Zika virus pathogenesis: an interview with Catherine Spong
SO BMC MEDICINE
LA English
DT Editorial Material
DE Zika; Infants; Pregnancy; Neurology; Microcephaly; Miscarriage;
   Stillbirth; Infectious disease; Cohort; Fetal anomaly
AB A recent outbreak of Zika virus has been linked to fetal abnormalities in pregnant women who have been infected. The scientific community is working toward understanding Zika virus pathogenesis to better manage affected women and children. In an interview with Dr. Catherine Spong, we discuss the aims and challenges of a forthcoming longitudinal study of a cohort of pregnant women in areas of current active Zika virus transmission.
C1 [Spong, Catherine Y.] NICHHD, Eunice Kennedy Shriver, NIH, Bethesda, MD 20892 USA.
RP Spong, CY (corresponding author), NICHHD, Eunice Kennedy Shriver, NIH, Bethesda, MD 20892 USA.
EM spongc@mail.nih.gov
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 9
TC 1
Z9 1
U1 0
U2 43
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD JUN 6
PY 2016
VL 14
AR 84
DI 10.1186/s12916-016-0628-0
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO2DA
UT WOS:000377588700001
PM 27268016
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Clinical features and neuroimaging (CT and MRI) findings in presumed
   Zika virus related congenital infection and microcephaly: retrospective
   case series study (vol 353, pg i1901, 2016)
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Correction
CR Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 1
TC 0
Z9 0
U1 0
U2 15
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 6
PY 2016
VL 353
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO5YA
UT WOS:000377857800014
DA 2020-07-08
ER

PT J
AU Williams, PJ
AF Williams, Patricia J.
TI From Zubik to Zika The religious right's quest to opt out of certain
   laws is a public-health threat
SO NATION
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 2
PU NATION CO INC
PI NEW YORK
PA 33 IRVING PLACE, 8TH FLOOR, NEW YORK, NY 10003 USA
SN 0027-8378
J9 NATION
JI Nation
PD JUN 6
PY 2016
VL 302
IS 23-24
BP 10
EP 11
PG 2
WC Political Science
SC Government & Law
GA DN0YV
UT WOS:000376793900008
DA 2020-07-08
ER

PT J
AU Widener, A
AF Widener, Andrea
TI Zika funding bill fails in Senate
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUN 4
PY 2016
VL 94
IS 27
BP 17
EP 17
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DQ3MU
UT WOS:000379107200036
DA 2020-07-08
ER

PT J
AU Vogel, G
AF Vogel, Gretchen
TI Mosquito hunters search for Zika vectors
SO SCIENCE
LA English
DT News Item
NR 0
TC 5
Z9 5
U1 0
U2 18
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 3
PY 2016
VL 352
IS 6290
BP 1152
EP 1153
DI 10.1126/science.352.6290.1152
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN4NY
UT WOS:000377045700011
PM 27257232
OA Bronze
DA 2020-07-08
ER

PT J
AU Rabe, IB
   Staples, JE
   Villanueva, J
   Hummel, KB
   Johnson, JA
   Rose, L
   Hills, S
   Wasley, A
   Fischer, M
   Powers, AM
AF Rabe, Ingrid B.
   Staples, J. Erin
   Villanueva, Julie
   Hummel, Kimberly B.
   Johnson, Jeffrey A.
   Rose, Laura
   Hills, Susan
   Wasley, Annemarie
   Fischer, Marc
   Powers, Ann M.
TI Interim Guidance for Interpretation of Zika Virus Antibody Test Results
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES; PERSISTENCE; INFECTION; OUTBREAK; YELLOW; WOMEN; SERUM
C1 [Rabe, Ingrid B.; Staples, J. Erin; Villanueva, Julie; Hummel, Kimberly B.; Johnson, Jeffrey A.; Rose, Laura; Hills, Susan; Wasley, Annemarie; Fischer, Marc; Powers, Ann M.] CDC, Zika Virus Response Epidemiol & Lab Teams, Atlanta, GA 30333 USA.
RP Rabe, IB (corresponding author), CDC, Zika Virus Response Epidemiol & Lab Teams, Atlanta, GA 30333 USA.
EM irabe@cdc.gov
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CDC, REV DIAGN TEST ZIK C
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH S
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 23
TC 160
Z9 161
U1 3
U2 27
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 3
PY 2016
VL 65
IS 21
BP 543
EP 546
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DN4IL
UT WOS:000377028200004
PM 27254248
OA Bronze
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI WHO recommends eight week abstinence or safer sex after return from Zika
   areas
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR WHO, 2018, ZIK VIR COMPL QUEST
NR 1
TC 1
Z9 2
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 2
PY 2016
VL 353
AR i3097
DI 10.1136/bmj.i3097
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO0OU
UT WOS:000377479000007
PM 27255107
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Driggers, RW
   Ho, CY
   Korhonen, EM
   Kuivanen, S
   Jaaskelainen, AJ
   Smura, T
   Rosenberg, A
   Hill, DA
   DeBiasi, RL
   Vezina, G
   Timofeev, J
   Rodriguez, FJ
   Levanov, L
   Razak, J
   Iyengar, P
   Hennenfent, A
   Kennedy, R
   Lanciotti, R
   du Plessis, A
   Vapalahti, O
AF Driggers, R. W.
   Ho, C. -Y.
   Korhonen, E. M.
   Kuivanen, S.
   Jaaskelainen, A. J.
   Smura, T.
   Rosenberg, A.
   Hill, D. A.
   DeBiasi, R. L.
   Vezina, G.
   Timofeev, J.
   Rodriguez, F. J.
   Levanov, L.
   Razak, J.
   Iyengar, P.
   Hennenfent, A.
   Kennedy, R.
   Lanciotti, R.
   du Plessis, A.
   Vapalahti, O.
TI Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain
   Abnormalities
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID TRANSMISSION
AB The current outbreak of Zika virus (ZIKV) infection has been associated with an apparent increased risk of congenital microcephaly. We describe a case of a pregnant woman and her fetus infected with ZIKV during the 11th gestational week. The fetal head circumference decreased from the 47th percentile to the 24th percentile between 16 and 20 weeks of gestation. ZIKV RNA was identified in maternal serum at 16 and 21 weeks of gestation. At 19 and 20 weeks of gestation, substantial brain abnormalities were detected on ultrasonography and magnetic resonance imaging (MRI) without the presence of microcephaly or intracranial calcifications. On postmortem analysis of the fetal brain, diffuse cerebral cortical thinning, high ZIKV RNA loads, and viral particles were detected, and ZIKV was subsequently isolated.
C1 [Driggers, R. W.; Timofeev, J.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA.
   [Rodriguez, F. J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Driggers, R. W.; Timofeev, J.; Razak, J.] Childrens Natl Hlth Syst, Sibley Mem Hosp, Div Maternal Fetal Med, Washington, DC 20010 USA.
   [Ho, C. -Y.; Rosenberg, A.; Hill, D. A.] Childrens Natl Hlth Syst, Div Pathol, Washington, DC USA.
   [Ho, C. -Y.; Rosenberg, A.; Hill, D. A.] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA.
   [DeBiasi, R. L.] Childrens Natl Hlth Syst, Div Pediat Infect Dis, Washington, DC USA.
   [Vezina, G.] Childrens Natl Hlth Syst, Dept Diagnost Radiol & Imaging, Washington, DC USA.
   [du Plessis, A.] Childrens Natl Hlth Syst, Div Fetal & Transit Med, Fetal Med Inst, Washington, DC 20010 USA.
   [Ho, C. -Y.; Hill, D. A.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA.
   [DeBiasi, R. L.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat & Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
   [Vezina, G.] George Washington Univ, Sch Med & Hlth Sci, Dept Radiol & Pediat, Washington, DC 20052 USA.
   [Iyengar, P.] Ctr Dis Control & Prevent CDC, Ctr Policy Planning & Evaluat, Washington, DC USA.
   [Hennenfent, A.] Dist Columbia Dept Hlth, Council State & Territorial Epidemiologists CST A, Washington, DC USA.
   [Kennedy, R.] One Med Grp, Washington, DC USA.
   [Korhonen, E. M.; Kuivanen, S.; Smura, T.; Levanov, L.; Vapalahti, O.] Univ Helsinki, Dept Virol, Helsinki, Finland.
   [Korhonen, E. M.; Vapalahti, O.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.
   [Jaaskelainen, A. J.; Vapalahti, O.] Univ Helsinki, Dept Virol & Immunol, Helsinki, Finland.
   [Jaaskelainen, A. J.; Vapalahti, O.] Helsinki Univ Hosp, Helsinki, Finland.
   [Lanciotti, R.] CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Driggers, RW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA.; Driggers, RW (corresponding author), Childrens Natl Hlth Syst, Sibley Mem Hosp, Div Maternal Fetal Med, Washington, DC 20010 USA.; du Plessis, A (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, Fetal Med Inst, Washington, DC 20010 USA.; Vapalahti, O (corresponding author), Univ Helsinki, Dept Virol, Helsinki, Finland.; Vapalahti, O (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.; Vapalahti, O (corresponding author), Univ Helsinki, Dept Virol & Immunol, Helsinki, Finland.; Vapalahti, O (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.
EM rdrigge1@jhmi.edu; adupless@childrensnational.org;
   olli.vapalahti@helsinki.fi
RI Pinto, Marcelo/G-7503-2012; Hennenfent, Andrew/K-6548-2019; Ho,
   Cheng-Ying/AAA-5098-2019; Smura, Teemu P/C-4063-2016
OI Pinto, Marcelo/0000-0003-3462-7277; Vapalahti, Olli/0000-0003-2270-6824;
   Korhonen, Essi/0000-0003-4730-7715; Rosenberg, Avi/0000-0003-2356-950X
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2016, MMWR MORB MORTAL WKL
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, ZIK TRAV INF
   Centers for Disease Control and Prevention, ZIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, 2016, CDC HLTH ADV REC MAN
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gilbert-Barness E, 2005, HDB PEDIAT AUTOPSY, P54
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Harreld JH, 2011, AM J NEURORADIOL, V32, P490, DOI 10.3174/ajnr.A2310
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kline-Fath B, 2015, FUNDAMENTAL ADV FETA, P860
   Korhonen E., 2016, EURO SURVEILL, V21
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2015, EMERG INFEC IN PRESS
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Tang H, 2016, CELL STEM CELL
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 30
TC 451
Z9 461
U1 2
U2 4
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUN 2
PY 2016
VL 374
IS 22
BP 2142
EP 2151
DI 10.1056/NEJMoa1601824
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB2RP
UT WOS:000387209900007
PM 27028667
OA Bronze
DA 2020-07-08
ER

PT J
AU Hazin, AN
   Poretti, A
   Martelli, CMT
   Huisman, TA
AF Hazin, Adriano N.
   Poretti, Andrea
   Turchi Martelli, Celina M.
   Huisman, Thierry A.
CA Microcephaly Epidemic Res Grp
TI Computed Tomographic Findings in Microcephaly Associated with Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Hazin, Adriano N.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Poretti, Andrea; Huisman, Thierry A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.
   [Turchi Martelli, Celina M.] Res Ctr Aggeu Magalhaes, Recife, PE, Brazil.
RP Poretti, A (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.
EM aporett1@jhmi.edu
RI Marques, Ernesto T. A/L-4967-2013; Poretti, Andrea/H-6269-2019
OI Marques, Ernesto T. A/0000-0003-3826-9358; Poretti,
   Andrea/0000-0002-9594-3858; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
CR Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang H, 2016, CELL STEM CELL
NR 5
TC 121
Z9 127
U1 0
U2 4
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUN 2
PY 2016
VL 374
IS 22
BP 2193
EP 2195
DI 10.1056/NEJMc1603617
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB2RP
UT WOS:000387209900036
PM 27050112
OA Bronze
DA 2020-07-08
ER

PT J
AU D'Ortenzio, E
   Matheron, S
   Yazdanpanah, Y
AF D'Ortenzio, Eric
   Matheron, Sophie
   Yazdanpanah, Yazdan
TI Evidence of Sexual Transmission of Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID CONTACT
C1 [D'Ortenzio, Eric; Yazdanpanah, Yazdan] Inst Natl Sante & Rech Med, Paris, France.
   [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Paris, France.
RP Yazdanpanah, Y (corresponding author), Inst Natl Sante & Rech Med, Paris, France.
EM yazdan.yazdanpanah@aphp.fr
RI Matheron, Sophie/D-7420-2017
OI Matheron, Sophie/0000-0001-7879-6553; D'Ortenzio,
   Eric/0000-0002-4527-6209; Hubert, Bruno/0000-0003-3640-718X
CR Arkinson B, 2016, EMERG INFEC IN PRESS
   Barzon L., 2016, EURO SURVEILL, V21
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
NR 5
TC 400
Z9 407
U1 2
U2 30
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUN 2
PY 2016
VL 374
IS 22
BP 2195
EP 2198
DI 10.1056/NEJMc1604449
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB2RP
UT WOS:000387209900037
PM 27074370
OA Bronze
DA 2020-07-08
ER

PT J
AU Brault, AC
   Bowen, RA
AF Brault, Aaron C.
   Bowen, Richard A.
TI The Development of Small Animal Models for Zika Virus Vaccine Efficacy
   Testing and Pathological Assessment
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Editorial Material
C1 [Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.
RP Brault, AC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM abrault@cdc.gov
CR de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
NR 6
TC 7
Z9 7
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 2016
VL 94
IS 6
BP 1187
EP 1188
DI 10.4269/ajtmh.16-0277
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3UV
UT WOS:000400205900002
PM 27139439
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pocock, L
   Rezaeian, M
AF Pocock, Lesley
   Rezaeian, Mohsen
TI Zika and Virus Evolution
SO WORLD FAMILY MEDICINE
LA English
DT Article
AB This is our second update this year on the Zika virus. While the update is to provide family doctors with the current snapshot of its epidemiology and particularly current precautions for patients, it is a timely reminder that the 'shelf life' (obsolescence) of medical education and information can range from several weeks to years. Shelf life of medical education and information is a particular problem when dealing with emerging viruses. Not only can new strains mutate and develop within short periods of time, the clinical sequelae can often only be revealed over time. Until pregnant women infected with the Zika virus gave birth, the major deforming aspects on the foetus were not apparent, and until a large number of infected pregnant women gave birth, the rate of mutation was not apparent. Until new cases of Zika have been confirmed in new regions, the spread of the virus has not been apparent.
C1 [Pocock, Lesley] Medi WORLD Int, Sherbrooke, Vic, Australia.
   [Rezaeian, Mohsen] Rafsanjan Univ Med Sci, Rafsanjan Med Sch, Occupat Environm Res Ctr, Dept Epidemiol & Biostat, Rafsanjan, Iran.
RP Pocock, L (corresponding author), Medi WORLD Int, Sherbrooke, Vic, Australia.
EM lesleypocock@mediworld.com.au
RI Rezaeaian, Mohsen/C-6513-2008
OI Rezaeaian, Mohsen/0000-0003-3070-0166
CR [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   [Anonymous], 2016, UNDERSTANDING EVOLUT
   [Anonymous], 2008, UNDERSTANDING EVOLUT
   Calisher Charles H., TONY SCHOUNTZ BATS I
   Jamieson Denise J., 2016, NEW ENGL J MED, V374, P1981, DOI [10.1056/NEJMsr1604338, DOI 10.1056/NEJMSR1604338]
   Li Wenhui, ANIMAL ORIGINS SEVER
   Pocock L, 2016, MEJFM, V14
   Pocock L., 2015, MEJFM, V13
   Pocock L, 2014, WORLD FAM MED, V12, P22
   Sarmiento-Ospina Andrea, LANCET INFECT DIS
   Schnirring L, 2016, CIDRAP NEWS     0413
NR 11
TC 1
Z9 1
U1 0
U2 12
PU MEDI+WORLD INT
PI RADCLIFFE NORTH
PA 3 DAVIS ST, RADCLIFFE NORTH, 4020, AUSTRALIA
SN 1839-0188
EI 1839-0196
J9 WORLD FAM MED
JI World Fam. Med.
PD JUN
PY 2016
VL 14
IS 5
BP 19
EP 26
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA EE8QL
UT WOS:000389890700005
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Cardiac problem because of Zika virus infection: a possibility
SO ANATOLIAN JOURNAL OF CARDIOLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2010, INT J CARDIOL, V144, P120, DOI 10.1016/j.ijcard.2008.12.114
NR 5
TC 6
Z9 6
U1 0
U2 5
PU TURKISH SOC CARDIOLOGY
PI BAHCELIEVLER
PA COBANCESME SANAYI CAD NO 11, NISH ISTANBUL A BLOK KAT 8 NO 47-48,
   YENIBOSNA, BAHCELIEVLER, ISTANBUL 34196, TURKEY
SN 2149-2263
EI 2149-2271
J9 ANATOL J CARDIOL
JI Anat. J. Cardiol.
PD JUN
PY 2016
VL 16
IS 6
BP 455
EP 456
DI 10.14744/AnatolJCardiol.2016.7140
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX5MN
UT WOS:000384425200019
PM 27282681
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Nurses are essential to education and community resilience to Zika virus
SO INTERNATIONAL NURSING REVIEW
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-8132
EI 1466-7657
J9 INT NURS REV
JI Int. Nurs. Rev.
PD JUN
PY 2016
VL 63
IS 2
BP 155
EP 155
PG 1
WC Nursing
SC Nursing
GA DY0US
UT WOS:000384812300006
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Benelli, G
AF Govindarajan, Marimuthu
   Benelli, Giovanni
TI One-pot fabrication of silver nanocrystals using Ormocarpum
   cochinchinense: Biophysical characterization of a potent mosquitocidal
   and toxicity on non-target mosquito predators
SO JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
LA English
DT Article
DE Biological control agent; Biosafety; Culicidae; Fabaceae; Plant-borne
   larvicide; Nanobiotechnology
ID AEGYPTI DIPTERA-CULICIDAE; GREEN SYNTHESIS; ANOPHELES-STEPHENSI;
   AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; VETERINARY IMPORTANCE; LEAF
   EXTRACT; ANTIBACTERIAL ACTIVITY; VECTOR CONTROL; NANOPARTICLES
AB Mosquito vectors (Diptera: Culicidae) are vectors of pathogens and parasites of public health importance, including malaria, dengue, chikungunya, Japanese encephalitis, lymphatic filariasis and Zika virus. Novel eco-friendly control tools against Culicidae are a priority. In this research, silver nanoparticles (Ag NPs) were rapidly synthesized using the aqueous leaf extract of Ormocarpum cochinchinense as a cheap, non-toxic material. The bio-reduced Ag NPs were characterized by UV-visible spectrophotometry, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy-dispersive spectroscopy (EDX) and X-ray diffraction analysis (XRD). The acute toxicity of O. cochinchinense leaf extract and synthesized Ag NP was evaluated against larvae of the malaria vector Anopheles stephensi, the dengue vector Aedes aegypti and the filariasis vector Culex quinquefasciatus. Compared to the leaf aqueous extract, synthesized Ag NPs showed high toxicity against A. stephensi, A. aegypti and C. quinquefasciatus, with LC50 values of 10.43, 11.26 and 1235 mu g/mL, respectively. Synthesized Ag NPs were found safer to non-target mosquito predators Diplonychus indicus and Gambusia affinis, with LC50 values ranging from 522.13 to 637.70 mu g/mL. Overall, this study firstly shed light to O. cochinchinense's potential as a bioresource for rapid, cheap and effective nanosynthesis of mosquitocides. (C) 2016 Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society. Published by Elsevier B.V. All rights reserved.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; g.benelli@sssup.it
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931
CR Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Bean A. R., 2006, AUST SYST BOT SOC NE, V127, P5
   Benelli G., 2016, PARASITOL RES
   Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Chopra R. N., 2002, GLOSSARY INDIAN MED, P182
   DEO P G, 1988, International Pest Control, V30, P118
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gamble J. S., 1935, FLORA PRESIDENCY MAD, P331
   Govindarajan M, 2005, Trop Biomed, V22, P1
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Ivanov VK, 2007, SUPERLATTICE MICROST, V42, P421, DOI 10.1016/j.spmi.2007.04.046
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Jeong SH, 2005, J MATER SCI, V40, P5407, DOI 10.1007/s10853-005-4339-8
   Kumar M. D., 2013, Journal of Herbs, Spices & Medicinal Plants, V19, P1, DOI 10.1080/10496475.2012.726954
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Murugan K, 2016, PARASITOL RES, V115, P107, DOI 10.1007/s00436-015-4726-2
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Sap-lam N, 2010, Journal of Applied Sciences, V10, P3132
   Savithramma N., 2011, International Journal of ChemTech Research, V3, P1394
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Shanmugam N, 2014, APPL NANOSCI, V4, P881, DOI 10.1007/s13204-013-0271-4
   Shanthi P., 2008, Indian Journal of Plant Physiology, V13, P29
   Singh BP, 2010, J ENVIRON QUAL, V39, P1
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Vadivalagan C, 2016, PARASITOL RES, V115, P1149, DOI 10.1007/s00436-015-4847-7
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   Wealth of India, 2001, DICT IND RAW MAT IND, VVII, P106
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Yang W, 2009, TALANTA, V78, P557, DOI 10.1016/j.talanta.2008.12.009
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
   Zhang MJ, 2008, NANO LETT, V8, P1277, DOI 10.1021/nl0725704
NR 52
TC 15
Z9 15
U1 0
U2 33
PU KOREAN SOC APPLIED ENTOMOLOGY
PI SUWON
PA NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA,
   249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA
SN 1226-8615
EI 1876-7990
J9 J ASIA-PAC ENTOMOL
JI J. Asia-Pac. Entomol.
PD JUN
PY 2016
VL 19
IS 2
BP 377
EP 385
DI 10.1016/j.aspen.2016.04.003
PG 9
WC Entomology
SC Entomology
GA DX6TB
UT WOS:000384514900019
DA 2020-07-08
ER

PT J
AU Duran, N
   Islan, GA
   Duran, M
   Castro, GR
AF Duran, Nelson
   Islan, German A.
   Duran, Marcela
   Castro, Guillermo R.
TI Nanobiotechnology Solutions against Aedes aegypti
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Review
DE Aedes aegypti; mosquitoes; nanostructures; nanobiotechnology; antiviral;
   nanobiosensors; nanoinsecticides
ID STEPHENSI LISTON DIPTERA; SILVER NANOPARTICLES; ANOPHELES-STEPHENSI;
   GREEN SYNTHESIS; LEAF EXTRACT; LARVICIDAL ACTIVITY; POLYMERIC
   NANOPARTICLES; INTRACELLULAR DELIVERY; CULEX-QUINQUEFASCIATUS; GOLD
   NANOPARTICLES
AB United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/ World Health Organization (WHO) implemented the Training in Tropical Diseases (TDR) program with excellent results; however, due to current challenges, this active program requires new and innovative solutions. Nowadays, Aedes aegyptis-borne diseases can be added among neglected diseases. Surveillance and control must be considered owing to a great risk of infection with dengue, chikungunya and zika viruses. Although investigations on several vaccines are in progress, new insights in term of development of drugs that evade from resistance are of paramount importance. Nanobiotechnology appears as one of the most innovative strategy in the search of new uses for old pharmaceuticals or in the development of innovative and intelligent nanomedicines for neglected diseases. Liposomes, solid lipid nanoparticles, nanoemulsions, polymeric nanoparticles, metallic nanoparticles, quantum dots, carbon dots and carbon nanotubes were the focus of the current advances. In this direction, we have focused this overview on new advances in diagnostic assays as nanobiosensors, antivirus and nanoinsecticides on Aedes aegyptis control.
C1 [Duran, Nelson] Univ Estadual Campinas Unicamp, Inst Quim, Lab Quim Biol, BR-13083970 Campinas, SP, Brazil.
   [Duran, Nelson] Univ Estadual Campinas Unicamp, Inst Quim, Lab NanoBioss, BR-13083970 Campinas, SP, Brazil.
   [Duran, Nelson; Duran, Marcela] LNNano CNPEM, BR-13083100 Campinas, SP, Brazil.
   [Islan, German A.; Castro, Guillermo R.] Univ Nacl La Plata, Sch Sci, UNLP CONICET CCT La Plata, Appl Biotechnol Inst CINDEFI,Nanobiomat Lab, La Plata, Buenos Aires, Argentina.
   [Duran, Marcela] Univ Estadual Campinas Unicamp, Inst Biol, Lab Carcinogenese Urogenital & Imunoterapia, BR-13083970 Campinas, SP, Brazil.
RP Duran, N (corresponding author), Univ Estadual Campinas Unicamp, Inst Quim, Lab Quim Biol, BR-13083970 Campinas, SP, Brazil.; Duran, N (corresponding author), Univ Estadual Campinas Unicamp, Inst Quim, Lab NanoBioss, BR-13083970 Campinas, SP, Brazil.; Duran, N; Duran, M (corresponding author), LNNano CNPEM, BR-13083100 Campinas, SP, Brazil.; Duran, M (corresponding author), Univ Estadual Campinas Unicamp, Inst Biol, Lab Carcinogenese Urogenital & Imunoterapia, BR-13083970 Campinas, SP, Brazil.
EM duran@iqm.unicamp.br; marceladuranduran@gmail.com
RI Castro, Guillermo R./D-1199-2013
OI Castro, Guillermo R./0000-0002-6187-7805; Duran,
   Nelson/0000-0001-8372-5143; Islan, German Abel/0000-0002-3275-1349
FU INOMAT (CNPq)National Council for Scientific and Technological
   Development (CNPq); Brazilian Network on Nanotechnology (MCTI/CNPq);
   NanoBioss (MCTI); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX Support from INOMAT (CNPq), Brazilian Network on Nanotechnology
   (MCTI/CNPq), NanoBioss (MCTI) and FAPESP are acknowledged. The authors
   also thank Mauricio Ramalho Custodio for the design art photography of
   the cover image.
CR Alex MRA, 2011, EUR J PHARM SCI, V42, P11, DOI 10.1016/j.ejps.2010.10.002
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Arjunan NK, 2012, VECTOR-BORNE ZOONOT, V12, P262, DOI 10.1089/vbz.2011.0661
   Baeumner AJ, 2002, ANAL CHEM, V74, P1442, DOI 10.1021/ac015675e
   Banu AN, 2014, PARASITOL RES, V113, P311, DOI 10.1007/s00436-013-3656-0
   Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890
   Bender AR, 1996, ANTIMICROB AGENTS CH, V40, P1467, DOI 10.1128/AAC.40.6.1467
   Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013
   Borase P. H., 2013, NANOMED BIOTHER DISC, V3, P111
   Bowman MC, 2008, J AM CHEM SOC, V130, P6896, DOI 10.1021/ja710321g
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   CDC, SURV CONTR AED AEG A
   Clayton R, 2009, ANTIVIR RES, V84, P142, DOI 10.1016/j.antiviral.2009.08.003
   Das S, 2015, ACS APPL MATER INTER, V7, P19530, DOI 10.1021/acsami.5b05232
   De Jaeghere F, 2000, J CONTROL RELEASE, V68, P291, DOI 10.1016/S0168-3659(00)00272-8
   de Mareuil J, 2002, ANTIVIR RES, V54, P175, DOI 10.1016/S0166-3542(02)00002-5
   Deda DK, 2015, J BRAZIL CHEM SOC, V26, P2448, DOI 10.5935/0103-5053.20150316
   Dembri A, 2001, PHARM RES-DORDR, V18, P467, DOI 10.1023/A:1011050209986
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Duarte JL, 2015, REV BRAS FARMACOGN, V25, P189, DOI [10.1016/j.bjp.2015.02.2010, 10.1016/j.bjp.2015.02.010]
   Duran N, 2016, NANOMED-NANOTECHNOL, V12, P789, DOI 10.1016/j.nano.2015.11.016
   Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002
   Duran N, 2010, QUIM NOVA, V33, P151, DOI 10.1590/S0100-40422010000100028
   Duran N, 2009, CURR NANOSCI, V5, P396, DOI 10.2174/157341309789378069
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6
   Gaikwad SC, 2013, J BRAZIL CHEM SOC, V24, P1974, DOI 10.5935/0103-5053.20130247
   Ghosh V, 2013, ASIAN J CHEM, V25, pS321
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Gong TT, 2014, AIDS RES HUM RETROV, V30, pA143, DOI 10.1089/aid.2014.5288.abstract
   Gunaseelan S, 2010, ADV DRUG DELIVER REV, V62, P518, DOI 10.1016/j.addr.2009.11.021
   Ham AS, 2009, PHARM RES-DORDR, V26, P502, DOI 10.1007/s11095-008-9765-2
   Hunsawong T, 2015, VACCINE, V33, P1702, DOI 10.1016/j.vaccine.2015.02.016
   Hussain A, 2014, J ANIM PLANT SCI, V24, P1110
   Idrees Sobia, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P232, DOI 10.1016/S2221-1691(13)60057-X
   Jahanshahi P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03851
   Jhaveri A, 2016, EXPERT OPIN DRUG DEL, V13, P49, DOI 10.1517/17425247.2015.1086745
   Kalimuthu K., 2013, Journal of Entomological and Acarological Research, V45, P57, DOI 10.4081/jear.2013.e11
   Kuo YC, 2006, INT J PHARMACEUT, V327, P160, DOI 10.1016/j.ijpharm.2006.07.044
   Lembo David, 2010, Antiviral Chemistry & Chemotherapy, V21, P53, DOI 10.3851/IMP1684
   LEROUX JC, 1995, J PHARM SCI, V84, P1387, DOI 10.1002/jps.2600841202
   Lobenberg R, 1998, J CONTROL RELEASE, V50, P21, DOI 10.1016/S0168-3659(97)00105-3
   Mashwani ZUR, 2015, APPL MICROBIOL BIOT, V99, P9923, DOI 10.1007/s00253-015-6987-1
   Miller JL, 2012, ANTIMICROB AGENTS CH, V56, P6379, DOI 10.1128/AAC.01554-12
   Mondal NK, 2015, IJSR PUB, V3, P47
   Mungrue K., 2014, ADV LAB MED INT, V4, P1
   Olliaro PL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003379
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Peh A. E., 2010, FRONT BIOSCI SCHOLAR, V3, P806
   Pollock S, 2010, P NATL ACAD SCI USA, V107, P17176, DOI 10.1073/pnas.1009445107
   Poopathi S, 2015, ENVIRON SCI POLLUT R, V22, P2956, DOI 10.1007/s11356-014-3560-x
   Prabhu RH, 2015, INT J NANOMED, V10, P1001, DOI 10.2147/IJN.S56932
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Rai M., 2015, NANOTECHNOLOGY DIAGN
   Rai M, 2012, J BRAZIL CHEM SOC, V23, P14, DOI 10.1590/S0103-50532012000100004
   Rossi-Bergmann B, 2012, J NANO RES-SW, V20, P89, DOI 10.4028/www.scientific.net/JNanoR.20.89
   Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1
   Sareen Sarah J, 2012, RES J RECENT SCI, V1, P52
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Saxena M, 2013, RSC ADV, V3, P22504, DOI 10.1039/c3ra44100h
   Sayce AC, 2010, TRENDS MICROBIOL, V18, P323, DOI 10.1016/j.tim.2010.04.003
   Serizawa T, 2013, BIOMACROMOLECULES, V14, P613, DOI 10.1021/bm4000822
   Shah LK, 2006, PHARM RES, V23, P2638, DOI 10.1007/s11095-006-9101-7
   Shegokar R, 2010, INT J PHARMACEUT, V399, P129, DOI 10.1016/j.ijpharm.2010.07.044
   Silva EF, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-13
   Silva MMS, 2015, J CHEM TECHNOL BIOT, V90, P194, DOI 10.1002/jctb.4305
   Silveira CP, 2015, RSC ADV, V5, P81348, DOI 10.1039/c5ra15006j
   Smith AJ, 2011, MOL PHARMACEUT, V8, P1867, DOI 10.1021/mp200209j
   Soni N, 2012, ASIAN PAC J TROP DIS, V2, pS356, DOI DOI 10.1016/S2222-1808(12)60181-9
   SONI N, 2012, REP PARASITOL, V2, P1, DOI DOI 10.2147/RIP.S29033
   Soni N, 2013, ADV NANOPART, V2, P125, DOI DOI 10.4236/ANP.2013.22021
   Soni N, 2012, PARASITOL RES, V111, P2091, DOI 10.1007/s00436-012-3056-x
   Soni N, 2012, PARASITOL RES, V110, P175, DOI 10.1007/s00436-011-2467-4
   Suganya A, 2013, PARASITOL RES, V112, P1385, DOI 10.1007/s00436-012-3269-z
   Sundaravadivelan C, 2013, PARASITOL RES, V112, P303, DOI [10.1007/s00436-012-3138-9, 10.100]
   Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461
   Tsai MJ, 2012, INT J PHARMACEUT, V423, P461, DOI 10.1016/j.ijpharm.2011.12.009
   Veerakumar K, 2014, PARASITOL RES, V113, P4567, DOI 10.1007/s00436-014-4147-7
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Yumei L., 2009, PRACT PHARM CLIN REM, V12, P104
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zhang GJ, 2010, SENSOR ACTUAT B-CHEM, V146, P138, DOI 10.1016/j.snb.2010.02.021
   Zhang Y, 2015, LAB CHIP, V15, P1465, DOI 10.1039/c4lc01127a
   Zoppe JO, 2014, BIOMACROMOLECULES, V15, P1534, DOI 10.1021/bm500229d
NR 87
TC 6
Z9 6
U1 1
U2 35
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD JUN
PY 2016
VL 27
IS 7
BP 1139
EP 1149
DI 10.5935/0103-5053.20160122
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA DV7FF
UT WOS:000383101000002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nebbia, G
   Douthwaite, ST
AF Nebbia, Gaia
   Douthwaite, Samuel Thomas
TI Zika infection: From obscurity to public health emergency
SO OBSTETRIC MEDICINE
LA English
DT Editorial Material
ID BRAZIL; VIRUS
C1 [Nebbia, Gaia; Douthwaite, Samuel Thomas] St Thomas Hosp, London, England.
RP Douthwaite, ST (corresponding author), St Thomas Hosp, London, England.
EM sam.douthwaite@gstt.nhs.uk
CR Brasil P, 2016, N ENGL J MED
   Calvet G, LANCET INFECT DIS
   Cauchemez S., LANCET
   Driggers RW, N ENGL J MED
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Tang H, CELL STEM CELL
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 9
TC 1
Z9 1
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1753-495X
EI 1753-4968
J9 OBSTET MED
JI Obstet. Med.
PD JUN
PY 2016
VL 9
IS 2
BP 53
EP +
DI 10.1177/1753495X16648078
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DV7MI
UT WOS:000383119800001
PM 27512493
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Slenczka, W
AF Slenczka, Werner
TI Zika Virus Disease
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID INTERIM GUIDELINES; DENGUE VIRUSES; UNITED-STATES; YELLOW-FEVER;
   INFECTION; TRANSMISSION; OUTBREAK; ARBOVIRUSES; MOSQUITOS; NIGERIA
AB The history of Zika virus disease serves as a paradigm of a typical emerging viral infection. Zika virus disease, a mosquito-borne flavivirus, was first isolated in 1947 in the Zika forest of Uganda. The same virus was also isolated from jungle-dwelling mosquitoes (Aedes [Stegomyia] africanus). In many areas of Africa and South Asia human infections with Zika virus were detected by both serology and virus isolation. About 80% of infections are asymptomatic, and in 20% a mostly mild disease with fever, rash, arthralgia, and conjunctivitis may occur. Fetal infections with malformations were not recorded in Africa or Asia. Zika virus was imported to northern Brazil possibly during the world soccer championship that was hosted by Brazil in June through July 2014. A cluster of severe fetal malformations with microcephaly and ocular defects was noted in 2015 in the northeast of Brazil, and intrauterine infections with Zika virus were confirmed. The dramatic change in Zika virus pathogenicity upon its introduction to Brazil has remained an enigma.
C1 [Slenczka, Werner] Univ Marburg, Inst Virol, D-35037 Marburg, Germany.
RP Slenczka, W (corresponding author), Univ Marburg, Inst Virol, D-35037 Marburg, Germany.
EM slenczka-marburg@t-online.de
OI Khan, Yawar/0000-0003-1964-591X
CR [Anonymous], 2015, CDC HLTH INFORM INT
   Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110
   Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013
   Bielefeldt-Ohmann H, 2012, INT J EXP PATHOL, V93, P24, DOI 10.1111/j.1365-2613.2011.00795.x
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention (CDC), 2016, UPD INT GUID PREV SE
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Da Paula Freitas B, 2016, JAMA OPHTHALMOL, V2016, DOI [10.1001 / jamaophthalmol., DOI 10.1001/JAMAOPHTHALM0L]
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Slenczka W, 1968, Ger Med Mon, V13, P524
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization/ PAN American Health Organization, 2016, ZIK VIR MICR GUILL B
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 51
TC 5
Z9 5
U1 0
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JUN
PY 2016
VL 4
IS 3
AR UNSP EI10-0019-2016
DI 10.1128/microbiolspec.EI10-0019-2016
PG 8
WC Microbiology
SC Microbiology
GA DT9GD
UT WOS:000381803300023
PM 27337468
DA 2020-07-08
ER

PT J
AU Stamm, LV
AF Stamm, Lola V.
TI Zika Virus in the Americas An Obscure Arbovirus Comes Calling
SO JAMA DERMATOLOGY
LA English
DT Editorial Material
C1 [Stamm, Lola V.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Program Infect Dis, Chapel Hill, NC USA.
RP Stamm, LV (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Program Infect Dis,Hooker Res Ctr 3302, S Columbia St, Chapel Hill, NC 27599 USA.
EM lstamm@email.unc.edu
CR [Anonymous], 2016, GENETIC ENG BIOTECHN
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 9
TC 5
Z9 5
U1 0
U2 50
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6068
EI 2168-6084
J9 JAMA DERMATOL
JI JAMA Dermatol.
PD JUN
PY 2016
VL 152
IS 6
BP 621
EP 622
DI 10.1001/jamadermatol.2016.1499
PG 2
WC Dermatology
SC Dermatology
GA DR0HM
UT WOS:000379588600001
PM 27167249
OA Bronze
DA 2020-07-08
ER

PT J
AU Robinson, JK
AF Robinson, June K.
TI Zika Virus
SO JAMA DERMATOLOGY
LA English
DT Editorial Material
CR Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Jin Jill, 2016, JAMA, V315, P2482, DOI 10.1001/jama.2016.4741
NR 2
TC 0
Z9 0
U1 0
U2 61
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6068
EI 2168-6084
J9 JAMA DERMATOL
JI JAMA Dermatol.
PD JUN
PY 2016
VL 152
IS 6
BP 693
EP 693
DI 10.1001/jamadermatol.2016.1635
PG 1
WC Dermatology
SC Dermatology
GA DR0HM
UT WOS:000379588600018
PM 27166755
OA Bronze
DA 2020-07-08
ER

PT J
AU Franca, RFO
   Neves, MHL
   Ayres, CFJ
   Melo-Neto, OP
   Brandao, SP
AF Franca, Rafael F. O.
   Neves, Maria Helena L.
   Junqueira Ayres, Constancia F.
   Melo-Neto, Osvaldo P.
   Brandao Filho, Sinval P.
TI First International Workshop on Zika Virus Held by Oswaldo Cruz
   Foundation FIOCRUZ in Northeast Brazil March 2016-A Meeting Report
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEXUAL CONTACT; TRANSMISSION
C1 [Franca, Rafael F. O.; Neves, Maria Helena L.; Junqueira Ayres, Constancia F.; Melo-Neto, Osvaldo P.; Brandao Filho, Sinval P.] Fundacao Oswaldo Cruz Fiocruz, IAM, Recife, PE, Brazil.
RP Franca, RFO; Brandao, SP (corresponding author), Fundacao Oswaldo Cruz Fiocruz, IAM, Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br; sinval@cpqam.fiocruz.br
RI Ayres, Constancia/AAQ-3448-2020; de Melo Neto, Osvaldo P/B-1366-2015;
   Brandao-Filho, Sinval Pinto/AAP-4792-2020
OI de Melo Neto, Osvaldo P/0000-0001-5402-7346; Brandao-Filho, Sinval
   Pinto/0000-0003-3768-2810; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
CR Barreto ML, 2016, LANCET
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Christofferson RC, 2016, AM J TROP MED HYG
   Cohen J, 2016, Q A SCOTT HALSTEAD Z, DOI [10.1126/science.aaf4154, DOI 10.1126/SCIENCE.AAF4154]
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
NR 14
TC 22
Z9 27
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004760
DI 10.1371/journal.pntd.0004760
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200026
PM 27258065
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guzzetta, G
   Montarsi, F
   Baldacchino, FA
   Metz, M
   Capelli, G
   Rizzoli, A
   Pugliese, A
   Rosa, R
   Poletti, P
   Merler, S
AF Guzzetta, Giorgio
   Montarsi, Fabrizio
   Baldacchino, Frederic Alexandre
   Metz, Markus
   Capelli, Gioia
   Rizzoli, Annapaola
   Pugliese, Andrea
   Rosa, Roberto
   Poletti, Piero
   Merler, Stefano
TI Potential Risk of Dengue and Chikungunya Outbreaks in Northern Italy
   Based on a Population Model of Aedes albopictus (Diptera: Culicidae)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID KOREICUS HULECOETEOMYIA-KOREICA; INVASIVE MOSQUITO; ZIKA VIRUS;
   COLD-ACCLIMATION; VECTOR; AEGYPTI; TEMPERATURE; OVIPOSITION; EUROPE;
   EPIDEMIOLOGY
AB The rapid invasion and spread of Aedes albopictus (Skuse, 1894) within new continents and climatic ranges has created favorable conditions for the emergence of tropical arboviral diseases in the invaded areas. We used mosquito abundance data from 2014 collected across ten sites in northern Italy to calibrate a population model for Aedes albopictus and estimate the potential of imported human cases of chikungunya or dengue to generate the condition for their autochthonous transmission in the absence of control interventions. The model captured intra-year seasonality and heterogeneity across sites in mosquito abundance, based on local temperature patterns and the estimated site-specific mosquito habitat suitability. A robust negative correlation was found between the latter and local late spring precipitations, indicating a possible washout effect on larval breeding sites. The model predicts a significant risk of chikungunya outbreaks in most sites if a case is imported between the beginning of summer and up to mid-November, with an average outbreak probability between 4.9% and 25%, depending on the site. A lower risk is predicted for dengue, with an average probability between 4.2% and 10.8% for cases imported between mid-July and mid-September. This study shows the importance of an integrated entomological and medical surveillance for the evaluation of arboviral disease risk, which is a precondition for designing cost-effective vector control programs.
C1 [Guzzetta, Giorgio; Poletti, Piero; Merler, Stefano] Fdn Bruno Kessler, Trento, Italy.
   [Montarsi, Fabrizio; Capelli, Gioia] Ist Zooprofilatt Sperimentale Venezie, Parasitol Lab, Padua, Italy.
   [Baldacchino, Frederic Alexandre; Metz, Markus; Rizzoli, Annapaola; Rosa, Roberto] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy.
   [Pugliese, Andrea] Univ Trento, Dept Math, Trento, Italy.
   [Poletti, Piero] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy.
RP Guzzetta, G (corresponding author), Fdn Bruno Kessler, Trento, Italy.
EM guzzetta@fbk.eu
RI Rosa, Roberto/B-8562-2011; Pugliese, Andrea/E-1905-2011; Rizzoli,
   Annapaola/J-2439-2012; merler, stefano/I-3557-2017
OI Rosa, Roberto/0000-0002-8655-2230; Pugliese, Andrea/0000-0002-3512-8560;
   Rizzoli, Annapaola/0000-0003-3997-6783; merler,
   stefano/0000-0002-5117-0611; Poletti, Piero/0000-0001-5453-5199;
   Guzzetta, Giorgio/0000-0002-9296-9470
FU Autonomous Province of Trento, Research fund "Grandi Progetti", project
   LExEM (Laboratory of excellence for epidemiology and modelling)
FX This study was funded by the Autonomous Province of Trento, Research
   fund "Grandi Progetti 2012", project LExEM (Laboratory of excellence for
   epidemiology and modelling) awarded to AP. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Angelini P, 2010, EURO SURVEILL, V15
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dieng H, 2012, INT J BIOMETEOROL, V56, P113, DOI 10.1007/s00484-011-0402-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Fortuna C, 2015, MED VET ENTOMOL, V29, P430, DOI 10.1111/mve.12133
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Metz M, 2014, REMOTE SENS-BASEL, V6, P3822, DOI 10.3390/rs6053822
   Ministero della Salute, 2015, SORV CAS UM CHIK DEN
   Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292
   Montarsi F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1208-4
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Reiskind MH, 2012, J MED ENTOMOL, V49, P71, DOI 10.1603/ME10270
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098
   Aznar VR, 2013, ECOL MODEL, V253, P44, DOI 10.1016/j.ecolmodel.2012.12.004
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Toma L, 2003, J AM MOSQUITO CONTR, V19, P19
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   Tsunoda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095606
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yee DA, 2012, J MED ENTOMOL, V49, P825, DOI 10.1603/ME11132
NR 60
TC 17
Z9 17
U1 4
U2 86
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004762
DI 10.1371/journal.pntd.0004762
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200028
PM 27304211
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pylro, VS
   Oliveira, FS
   Morais, DK
   Cuadros-Orellana, S
   Pais, FSM
   Medeiros, JD
   Geraldo, JA
   Gilbert, J
   Volpini, AC
   Fernandes, GR
AF Pylro, Victor Satler
   Oliveira, Francislon Silva
   Morais, Daniel Kumazawa
   Cuadros-Orellana, Sara
   Pais, Fabiano Sviatopolk-Mirsky
   Medeiros, Julliane Dutra
   Geraldo, Juliana Assis
   Gilbert, Jack
   Volpini, Angela Cristina
   Fernandes, Gabriel Rocha
TI ZIKV - CDB: A Collaborative Database to Guide Research Linking SncRNAs
   and ZIKA Virus Disease Symptoms
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MICRORNAS; PREDICTION; FAMILY; RNAS
AB Background
   In early 2015, a ZIKA Virus (ZIKV) infection outbreak was recognized in northeast Brazil, where concerns over its possible links with infant microcephaly have been discussed. Providing a causal link between ZIKV infection and birth defects is still a challenge. MicroRNAs (miRNAs) are small noncoding RNAs (sncRNAs) that regulate post-transcriptional gene expression by translational repression, and play important roles in viral pathogenesis and brain development. The potential for flavivirus-mediated miRNA signalling dysfunction in brain-tissue development provides a compelling hypothesis to test the perceived link between ZIKV and microcephaly.
   Methodology/Principal Findings
   Here, we applied in silico analyses to provide novel insights to understand how Congenital ZIKA Syndrome symptoms may be related to an imbalance in miRNAs function. Moreover, following World Health Organization (WHO) recommendations, we have assembled a database to help target investigations of the possible relationship between ZIKV symptoms and miRNA-mediated human gene expression.
   Conclusions/Significance
   We have computationally predicted both miRNAs encoded by ZIKV able to target genes in the human genome and cellular (human) miRNAs capable of interacting with ZIKV genomes. Our results represent a step forward in the ZIKV studies, providing new insights to support research in this field and identify potential targets for therapy.
C1 [Pylro, Victor Satler; Oliveira, Francislon Silva; Morais, Daniel Kumazawa; Cuadros-Orellana, Sara; Pais, Fabiano Sviatopolk-Mirsky; Medeiros, Julliane Dutra; Geraldo, Juliana Assis; Volpini, Angela Cristina; Fernandes, Gabriel Rocha] Fiocruz MS, Biosyst Informat & Genom Grp, Rene Rachou Res Ctr, CPqRR, Belo Horizonte, MG, Brazil.
   [Gilbert, Jack] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.
   [Gilbert, Jack] Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA.
   [Gilbert, Jack] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.
RP Pylro, VS; Fernandes, GR (corresponding author), Fiocruz MS, Biosyst Informat & Genom Grp, Rene Rachou Res Ctr, CPqRR, Belo Horizonte, MG, Brazil.
EM victor.pylro@cpqrr.fiocruz.br; gabriel.fernandes@cpqrr.fiocruz.br
RI Gilbert, Jack/AAF-3270-2019; Cuadros-Orellana, Sara/I-7331-2012; Morais,
   Daniel Kumazawa/I-3551-2019; da Rocha Fernandes, Gabriel/A-5383-2010;
   Pais, Fabiano S/G-5178-2015; Pylro, Victor Satler/G-6045-2010
OI Cuadros-Orellana, Sara/0000-0002-0602-7867; Morais, Daniel
   Kumazawa/0000-0003-3328-7848; da Rocha Fernandes,
   Gabriel/0000-0002-4897-8521; Pais, Fabiano S/0000-0001-5958-2867; Pylro,
   Victor Satler/0000-0003-2154-9150; Assis Geraldo,
   Juliana/0000-0001-5995-8684
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [168223/2014-7]; CAPESCAPES
FX FAPEMIG, CNPq and CAPES funded this work. FSMP received research
   fellowship from the CNPq (process number 168223/2014-7). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ahmed F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S9
   Berger J., 2015, BIOCHIM BIOPHYS ACTA, V4889, P426
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enright AJ, 2004, GENOME BIOL, V5
   Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Garcez P. P., 2016, SCIENCE
   Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011
   Gupta M, 2013, J BIOL CHEM, V288, P14522, DOI 10.1074/jbc.M112.430371
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Kadri S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S35
   Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018
   Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109
   Klase ZA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-15
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010
   Tang H, 2016, CELL STEM CELL
   Teng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09912
   Whitty CJM, 2015, LANCET, V386, P1797, DOI 10.1016/S0140-6736(15)00758-8
   Witkos TM, 2011, CURR MOL MED, V11, P93
NR 29
TC 12
Z9 12
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004817
DI 10.1371/journal.pntd.0004817
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200056
PM 27332714
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reiter, P
AF Reiter, Paul
TI Control of Urban Zika Vectors: Should We Return to the Successful
   PAHO/WHO Strategy?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI
C1 [Reiter, Paul] Inst Pasteur, Paris, France.
RP Reiter, P (corresponding author), Inst Pasteur, Paris, France.
EM paul.reiter@pasteur.fr
CR Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2015, VACCINE, V33, P1233, DOI 10.1016/j.vaccine.2015.01.002
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   United Nations, 2014, WORLD URB PROSP 2014
NR 9
TC 6
Z9 7
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004769
DI 10.1371/journal.pntd.0004769
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200032
PM 27249063
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mawson, AR
AF Mawson, Anthony R.
TI Pathogenesis of Zika Virus-Associated Embryopathy
SO BIORESEARCH OPEN ACCESS
LA English
DT Article
DE embryopathy; Guillain-Barre syndrome; hypervitaminosis A; liver;
   microcephaly; pregnancy; retinoids; virus; Zika
ID GUILLAIN-BARRE-SYNDROME; RETINOIC ACID; VITAMIN-A; ISOTRETINOIN; LIVER;
   CELLS; CALCIFICATION; REPLICATION; TERATOLOGY; METABOLISM
AB A strong causal association has become evident between Zika virus (ZIKV) infection during pregnancy and the occurrence of fetal growth restriction, microcephaly and eye defects. Circumstantial evidence is presented in this paper in support of the hypothesis that these effects, as well as the Guillain-Barre syndrome, are due to an endogenous form of hypervitaminosis A resulting from ZIKV infection-induced damage to the liver and the spillage of stored vitamin A compounds ("retinoids") into the maternal and fetal circulation in toxic concentrations. Retinoids are mainly stored in the liver (about 80%) and are essential for numerous biological functions. In higher concentration, retinoids are potentially cytotoxic, pro-oxidant, mutagenic and teratogenic, especially if sudden shifts occur in their bodily distribution. Although liver involvement has not been mentioned specifically in recent reports, conventional liver enzyme tests underestimate the true extent of liver dysfunction. The proposed model could be tested by comparing retinoid concentration and expression profiles in microcephalic newborns of ZIKV-infected mothers and nonmicrocephalic newborn controls, and by correlating these profiles with measures of clinical severity.
C1 [Mawson, Anthony R.] Jackson State Univ, Sch Publ Hlth Initiat, Dept Epidemiol & Biostat, 350 West Woodrow Wilson Ave,Room 229, Jackson, MS 39213 USA.
RP Mawson, AR (corresponding author), Jackson State Univ, Sch Publ Hlth Initiat, Dept Epidemiol & Biostat, 350 West Woodrow Wilson Ave,Room 229, Jackson, MS 39213 USA.
EM anthony.r.mawson@jsums.edu
CR ADAMS J, 1993, REPROD TOXICOL, V7, P175, DOI 10.1016/0890-6238(93)90273-A
   Allen LH, 2002, J NUTR, V132, p2907S, DOI 10.1093/jn/132.9.2907S
   ANGULO A, 1995, J VIROL, V69, P3831, DOI 10.1128/JVI.69.6.3831-3837.1995
   Barbero P, 2004, BIRTH DEFECTS RES A, V70, P831, DOI 10.1002/bdra.20078
   Bell TM, 1971, ARCH GES VIRUSFORSCH, V35
   BENKE PJ, 1984, JAMA-J AM MED ASSOC, V251, P3267, DOI 10.1001/jama.251.24.3267
   Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399
   Dan Z, 2005, FASEB J, V19, P845, DOI 10.1096/fj.04-2809fje
   DE LUCA LM, 1986, PROG LIVER DIS, V8, P81
   de Oliveira MR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/140267
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   Dick GW, 1952, T R SOC TROP MED HYG, V46
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ganguly J., 1989, BIOCH VITAMIN A
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HUAN BF, 1992, P NATL ACAD SCI USA, V89, P9059, DOI 10.1073/pnas.89.19.9059
   Huk DJ, 2013, ARTERIOSCL THROM VAS, V33, P285, DOI 10.1161/ATVBAHA.112.300388
   Ihara H, 1998, J NUTR SCI VITAMINOL, V44, P329
   KURTZ PJ, 1984, TOXICOLOGY, V30, P115, DOI 10.1016/0300-483X(84)90122-7
   LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401
   Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002
   Laroche ML, 2007, ANN PHARMACOTHER, V41, P1073, DOI 10.1345/aph.1K028
   LEE MO, 1994, P NATL ACAD SCI USA, V91, P5632, DOI 10.1073/pnas.91.12.5632
   Lee SA, 2007, J BIOL CHEM, V282, P35621, DOI 10.1074/jbc.M706372200
   LEO MA, 1985, J BIOL CHEM, V260, P5228
   LITWAK G, 2007, VITAMIN A VITAMINS H, V75
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963
   Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200
   Fernandez-Real JM, 2008, DIABETES, V57, P1918, DOI 10.2337/db08-0041
   Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002
   Masuda E, 2015, BIOTECHNIQUES, V58, P318, DOI 10.2144/000114300
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nau H, 2012, BIOCH MOL BAS VIT A, P465
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   PAHO WHO, 2016, CAS DEF ZIK RES
   Patatanian E, 2008, J CLIN PHARM THER, V33, P331, DOI 10.1111/j.1365-2710.2008.00935.x
   Penniston KL, 2006, AM J CLIN NUTR, V83, P191
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Popper H, 1985, GASTROENTEROLOGY, V5, P2697
   Pritchard J, 2004, BRIT MED J, V328, P1537, DOI 10.1136/bmj.328.7455.1537
   Rodahl K, 1943, BIOCHEM J, V37, P166, DOI 10.1042/bj0370166
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIM W, 1989, CELLS HEPATIC SINUSO, P91
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, p1e3
   World Health Organization, 2016, ZIK SIT REP NEUR SY
NR 58
TC 11
Z9 11
U1 0
U2 33
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2164-7860
J9 BIORESEARCH OPEN ACC
JI BioResearch Open Access
PD JUN
PY 2016
VL 5
IS 1
BP 171
EP 176
DI 10.1089/biores.2016.0004
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DQ4FE
UT WOS:000379158500001
PM 27403405
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goulet, V
   Septfons, A
   Leparc-Goffart, I
   Benachi, A
   Couturier, E
   Mailles, A
   Noel, H
   De Valk, H
   Paty, MC
AF Goulet, V.
   Septfons, A.
   Leparc-Goffart, I.
   Benachi, A.
   Couturier, E.
   Mailles, A.
   Noel, H.
   De Valk, H.
   Paty, M. C.
TI Epidemiological surveillance of fetal diseases related to Zika virus,
   mainland France, 2016
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 51
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD JUN
PY 2016
VL 106
IS 6
SI SI
BP 504
EP 504
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HM
UT WOS:000379023400015
DA 2020-07-08
ER

PT J
AU Tian, HL
   Ji, XY
   Yang, XY
   Xie, W
   Yang, KL
   Chen, C
   Wu, C
   Chi, H
   Mu, ZY
   Wang, ZF
   Yang, HT
AF Tian, Hongliang
   Ji, Xiaoyun
   Yang, Xiaoyun
   Xie, Wei
   Yang, Kailin
   Chen, Cheng
   Wu, Chen
   Chi, Heng
   Mu, Zhongyu
   Wang, Zefang
   Yang, Haitao
TI The crystal structure of Zika virus helicase: basis for antiviral drug
   design
SO PROTEIN & CELL
LA English
DT Letter
ID RESOLUTION
C1 [Tian, Hongliang; Yang, Xiaoyun; Xie, Wei; Chen, Cheng; Wu, Chen; Chi, Heng; Mu, Zhongyu; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Tian, Hongliang; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
   [Yang, Kailin] Case Western Reserve Univ, Lerner Coll, Cleveland Clin, Cleveland, OH 44195 USA.
RP Yang, HT (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
EM yanght@tju.edu.cn
RI ; Yang, Kailin/L-2205-2013
OI Ji, Xiaoyun/0000-0002-0801-8825; Xie, Wei/0000-0002-4550-6211; Yang,
   Kailin/0000-0001-5968-6738
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1
   Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LINDENBACH BD, 2001, FUNDAMENTAL VIROLOGY
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pierson T.C., 2013, FLAVIVIRUSES, V2
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
NR 14
TC 50
Z9 53
U1 0
U2 23
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD JUN
PY 2016
VL 7
IS 6
BP 450
EP 454
DI 10.1007/s13238-016-0275-4
PG 5
WC Cell Biology
SC Cell Biology
GA DQ4NN
UT WOS:000379180700007
PM 27172988
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI CDC Director Calls Zika in Puerto Rico a "Challenge and Crisis"
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 1
PY 2016
VL 62
IS 11
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP3YX
UT WOS:000378433400001
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Revision to CDC's Zika Travel Notices: Minimal Likelihood for
   Mosquito-Borne Zika Virus Transmission at Elevations Above 2000 Meters
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 1
PY 2016
VL 62
IS 11
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP3YX
UT WOS:000378433400003
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI FDA Issues Recommendations to Reduce the Risk of Zika Virus Transmission
   by Human Cell and Tissue Products
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 1
PY 2016
VL 62
IS 11
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP3YX
UT WOS:000378433400002
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Research Indicates Other Mosquitoes May Be Able to Carry Zika
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 1
PY 2016
VL 62
IS 11
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP3YX
UT WOS:000378433400005
DA 2020-07-08
ER

PT J
AU Khurshid, Z
   Zohaib, S
   Najeeb, S
   Zafar, MS
   Slowey, PD
   Almas, K
AF Khurshid, Zohaib
   Zohaib, Sana
   Najeeb, Shariq
   Zafar, Muhammad Sohail
   Slowey, Paul D.
   Almas, Khalid
TI Human Saliva Collection Devices for Proteomics: An Update
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE omics; salivaomics; proteomics; salivary biomarkers; saliva collection
   devices
ID HUMAN WHOLE; ZIKA VIRUS; HEALTH; BIOMARKERS; TECHNOLOGIES; PHYSIOLOGY;
   SECRETION; GENOMICS; STEROIDS; STORAGE
AB There has been a rapid growth in the interest and adaptation of saliva as a diagnostic specimen over the last decade, and in the last few years in particular, there have been major developments involving the application of saliva as a clinically relevant specimen. Saliva provides a "window" into the oral and systemic health of an individual, and like other bodily fluids, saliva can be analyzed and studied to diagnose diseases. With the advent of new, more sensitive technologies to detect smaller concentrations of analytes in saliva relative to blood levels, there have been a number of critical developments in the field that we will describe. In particular, recent advances in standardized saliva collection devices that were not available three to four years ago, have made it easy for safe, simple, and non-invasive collection of samples to be carried out from patients. With the availability of these new technologies, we believe that in the next decade salivary proteomics will make it possible to predict and diagnose oral as well as systemic diseases, cancer, and infectious diseases, among others. The aim of this article is to review recent developments and advances in the area of saliva specimen collection devices and applications that will advance the field of proteomics.
C1 [Khurshid, Zohaib] King Faisal Univ, Coll Dent, Al Hufuf 31982, Al Ahsa, Saudi Arabia.
   [Zohaib, Sana] King Faisal Univ, Sch Engn, Dept Biomed Engn, Al Hufuf 31982, Al Ahsa, Saudi Arabia.
   [Najeeb, Shariq] Al Farabi Coll, Restorat Dent Sci, Riyadh 361724, Saudi Arabia.
   [Zafar, Muhammad Sohail] Taibah Univ, Dept Restorat Dent, Coll Dent, Al Madinah 41311, Al Munawwarah, Saudi Arabia.
   [Slowey, Paul D.] Oasis Diagnost Corp, 15720 NE 31st Ave, Vancouver, WA 98686 USA.
   [Almas, Khalid] Univ Dammam, Div Periodontol, Coll Dent, Dammam 31441, Saudi Arabia.
RP Zafar, MS (corresponding author), Taibah Univ, Dept Restorat Dent, Coll Dent, Al Madinah 41311, Al Munawwarah, Saudi Arabia.
EM drzohaibkhurshid@gmail.com; szohaib@kfu.edu.sa; shariqnajeeb@gmail.com;
   MZAFAR@taibahu.edu.sa; pds@4saliva.com; Kalmas@uod.edu.sa
RI Khurshid, Zohaib/K-9314-2015; Almas, Khalid/A-5267-2015; Zafar, Muhammad
   S/N-2800-2014; Zohaib, Sana/AAF-2157-2019
OI Khurshid, Zohaib/0000-0001-7998-7335; Almas, Khalid/0000-0002-2552-587X;
   Zafar, Muhammad S/0000-0002-5157-7067; Zohaib, Sana/0000-0003-1907-749X;
   Slowey, Paul/0000-0002-9151-1011; Najeeb, Shariq/0000-0002-3803-6055
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Ai JY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-302
   Amado FML, 2013, CLIN BIOCHEM, V46, P506, DOI 10.1016/j.clinbiochem.2012.10.024
   Aps JKM, 2005, FORENSIC SCI INT, V150, P119, DOI 10.1016/j.forsciint.2004.10.026
   Bassim CW, 2012, J CLIN IMMUNOL, V32, P1390, DOI 10.1007/s10875-012-9738-4
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Broadhurst M. J., 2015, LANCET, V386
   Carlson A, 1909, EXP BIOL MED, V7, P52
   Caswell S. V., 2015, ADV SALIVARY DIAGNOS, P121, DOI [DOI 10.1007/978-3-662-45399-5, 10.1007/978-3-662-45399-5]
   Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011
   Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009
   EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Farnaud SJC, 2010, THESCIENTIFICWORLDJO, V10, P434, DOI 10.1100/tsw.2010.38
   Garg K, 2015, IRAN J BASIC MED SCI, V18, P529
   Groschl M, 2008, J PHARMACEUT BIOMED, V47, P478, DOI 10.1016/j.jpba.2008.01.033
   Groschl M, 2006, STEROIDS, V71, P1097, DOI 10.1016/j.steroids.2006.09.007
   Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633
   Henson BS, 2010, METHODS MOL BIOL, V666, P21, DOI 10.1007/978-1-60761-820-1_2
   Horgan RP, 2011, OBSTET GYNAECOL, V13, P189, DOI 10.1576/toag.13.3.189.27672
   Huang CM, 2004, ARCH ORAL BIOL, V49, P951, DOI 10.1016/j.archoralbio.2004.06.003
   Huynh AHS, 2015, J PERIODONTAL RES, V50, P637, DOI 10.1111/jre.12244
   Khurshid S. Z. Zohaib, 2015, DENT SCI, V2, P260, DOI [10.1016/j.jobcr.2015.08.006.in, DOI 10.1016/J.JOBCR.2015.08.006.IN]
   Khurshid Z., 2015, SAUDI PHARM J
   Khurshid Z., 2016, SAUDI PHARM J
   Khurshid Z., 2016, INT J MOL SCI, V17
   Khurshid Z, 2016, OPEN DENT J, V10, P166, DOI 10.2174/1874210601610010166
   KUTSCHER AH, 1967, J ORAL THER PHARMACO, V3, P391
   Latterich M, 2008, EUR J CANCER, V44, P2737, DOI 10.1016/j.ejca.2008.09.007
   Lee YH, 2012, J MOL MED, V90, P427, DOI 10.1007/s00109-011-0829-0
   Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Michishige F, 2006, J MED INVESTIG, V53, P140, DOI 10.2152/jmi.53.140
   Mohamed R, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Neyraud E, 2006, J PROTEOME RES, V5, P2474, DOI 10.1021/pr060189z
   Punyadeera C, 2013, NANOBIOMATERIALS IN CLINICAL DENTISTRY, P453
   Range H, 2012, J CLIN PERIODONTOL, V39, P799, DOI 10.1111/j.1600-051X.2012.01913.x
   Sheikh Z., 2014, HDB ORAL BIOMATERIAL, V6, P605
   Shirtcliff EA, 2015, CLIN THER, V37, P505, DOI 10.1016/j.clinthera.2015.02.014
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Slowey P., 2015, P 2 N AM SAL S SEATT
   Sorsa T, 2016, PERIODONTOL 2000, V70, P142, DOI 10.1111/prd.12101
   Speicher DJ, 2015, DIAGN MICR INFEC DIS, V82, P120, DOI 10.1016/j.diagmicrobio.2015.02.013
   Sreebny LM, 2000, INT DENT J, V50, P140, DOI 10.1111/j.1875-595X.2000.tb00554.x
   Streckfus C., 2015, ADV SALIVARY DIAGNOS
   Streckfus CF, 2002, ORAL DIS, V8, P69, DOI 10.1034/j.1601-0825.2002.1o834.x
   Su S.-B., 2013, BIOMED RES INT, V2013, P2
   Thongboonkerd V., 2008, PROTEOMICS HUMAN BOD, V2
   Topkas E, 2012, CLIN CHIM ACTA, V413, P1066, DOI 10.1016/j.cca.2012.02.020
   TRUELOVE EL, 1967, J DENT RES, V46, P1400, DOI 10.1177/00220345670460064301
   Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507
   Wainwright WW, 1934, J DENT RES, V14, P425
   Wang QH, 2015, CLIN CHIM ACTA, V438, P214, DOI 10.1016/j.cca.2014.08.037
   Wang QH, 2014, TALANTA, V119, P299, DOI 10.1016/j.talanta.2013.11.008
   Wang QH, 2014, CLIN CHIM ACTA, V427, P79, DOI 10.1016/j.cca.2013.10.004
   Yakob Maha, 2014, Curr Oral Health Rep, V1, P133
   Zafar MS, 2015, TISSUE ENG REGEN MED, V12, P387, DOI 10.1007/s13770-015-0030-6
   Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0
   Zhang Y, 2016, PERIODONTOL 2000, V70, P38, DOI 10.1111/prd.12099
NR 60
TC 30
Z9 31
U1 2
U2 68
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2016
VL 17
IS 6
AR 846
DI 10.3390/ijms17060846
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DP9EK
UT WOS:000378799300060
PM 27275816
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Codeco, C
   Villela, D
   Gomes, MF
   Bastos, L
   Cruz, O
   Struchiner, C
   Carvalho, LM
   Coelho, F
AF Codeco, Claudia
   Villela, Daniel
   Gomes, Marcelo F.
   Bastos, Leonardo
   Cruz, Oswaldo
   Struchiner, Claudio
   Carvalho, Luis Max
   Coelho, Flavio
TI Zika is not a reason for missing the Olympic Games in Rio de Janeiro:
   response to the open letter of Dr Attaran and colleagues to Dr Margaret
   Chan, Director - General, WHO, on the Zika threat to the Olympic and
   Paralympic Games
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Editorial Material
DE Zika; Olympic Games
ID FOREIGN VISITORS; DENGUE; RISK
AB Attaran and colleagues in an open letter to WHO expressed their concern about the upcoming Olympic and Paralympic Games in Rio de Janeiro and the threat posed by the Zika epidemic (Attaran 2016). We agree that Zika virus is of great public health concern and much remains to be known about this disease. Care should be taken to reduce the risk of infection, especially to pregnant women. However, we argue that this is not sufficient reason for changing the original plans for the Games, in particular because of the time of the year when they will take place. The present article outlines several scientific results related to Zika and mosquito-borne infectious diseases dynamics that we believe ratify the current position of WHO in not endorsing the postponing or relocation of the 2016 Olympic and Paralympic Games (WHO 2016).
C1 [Codeco, Claudia; Villela, Daniel; Gomes, Marcelo F.; Bastos, Leonardo; Cruz, Oswaldo; Struchiner, Claudio; Carvalho, Luis Max] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
   [Coelho, Flavio] Fundacao Getulio Vargas, Rio De Janeiro, RJ, Brazil.
RP Codeco, C (corresponding author), Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
EM codeco@fiocruz.br
RI Carvalho, Luiz Max/J-6446-2014; Bastos, Leonardo Soares/AAD-5335-2019;
   Struchiner, Claudio J/M-9360-2013; Villela, Daniel/AAG-6445-2019;
   amsalu, ribka/G-8780-2019; Carvalho, Luiz Max/AAC-8266-2020; Ferreira da
   Costa Gomes, Marcelo/K-4469-2013; Coelho, Flavio/L-1089-2018
OI Carvalho, Luiz Max/0000-0001-5736-5578; Bastos, Leonardo
   Soares/0000-0002-1406-0122; Struchiner, Claudio J/0000-0003-2114-847X;
   Villela, Daniel/0000-0001-8371-2959; Carvalho, Luiz
   Max/0000-0001-5736-5578; Ferreira da Costa Gomes,
   Marcelo/0000-0003-4693-5402; Coelho, Flavio/0000-0003-3868-4391
CR Attaran A., 2016, HARVARD PUBLIC HLTH
   Bastos L, 2016, BIORXIV
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Codeco C, 2016, BIORXIV
   Coelho FC, 2016, BIORXIV
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   WHO, 2016, ZIK VIR OL PAR GAM R
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 12
TC 14
Z9 14
U1 0
U2 8
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2016
VL 111
IS 6
BP 414
EP 415
DI 10.1590/0074-02760160003
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ0LC
UT WOS:000378889800011
PM 27304097
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brasil, P
   Pereira, JP
   Gabaglia, CR
   Damasceno, L
   Wakimoto, M
   Nogueira, RMR
   de Sequeira, PC
   Siqueira, AM
   de Carvalho, LMA
   da Cunha, DC
   Calvet, GA
   Neves, ES
   Moreira, ME
   Baiao, AER
   de Carvalho, PRN
   Janzen, C
   Valderramos, SG
   Cherry, JD
   de Filippis, AMB
   Nielsen-Saines, K
AF Brasil, Patricia
   Pereira, Jose P., Jr.
   Gabaglia, Claudia Raja
   Damasceno, Luana
   Wakimoto, Mayumi
   Ribeiro Nogueira, Rita M.
   de Sequeira, Patricia Carvalho
   Siqueira, Andre Machado
   Abreu de Carvalho, Liege M.
   da Cunha, Denise Cotrim
   Calvet, Guilherme A.
   Neves, Elizabeth S.
   Moreira, Maria E.
   Rodrigues Baiao, Ana E.
   Nassar de Carvalho, Paulo R.
   Janzen, Carla
   Valderramos, Stephanie G.
   Cherry, James D.
   Bispo de Filippis, Ana M.
   Nielsen-Saines, Karin
TI Zika Virus Infection in Pregnant Women in Rio de JaneiroPreliminary
   Report
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Meeting Abstract
C1 [Brasil, Patricia; Pereira, Jose P., Jr.; Damasceno, Luana; Wakimoto, Mayumi; Ribeiro Nogueira, Rita M.; de Sequeira, Patricia Carvalho; Siqueira, Andre Machado; Abreu de Carvalho, Liege M.; da Cunha, Denise Cotrim; Calvet, Guilherme A.; Neves, Elizabeth S.; Moreira, Maria E.; Rodrigues Baiao, Ana E.; Nassar de Carvalho, Paulo R.; Bispo de Filippis, Ana M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Janzen, Carla; Valderramos, Stephanie G.; Cherry, James D.; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Calvet,
   Guilherme/G-6959-2013
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Calvet,
   Guilherme/0000-0002-3545-5238; Siqueira, Andre/0000-0003-2208-0294
NR 0
TC 3
Z9 3
U1 0
U2 56
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD JUN
PY 2016
VL 71
IS 6
BP 331
EP 333
DI 10.1097/01.ogx.0000483239.08585.8d
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP3XL
UT WOS:000378429200006
OA Green Published
DA 2020-07-08
ER

PT J
AU Langer, A
   Caglia, JM
   Menendez, C
AF Langer, Ana
   Caglia, Jacquelyn M.
   Menendez, Clara
TI Sexual and Reproductive Health and Rights in the Time of Zika in Latin
   America and the Caribbean
SO STUDIES IN FAMILY PLANNING
LA English
DT Editorial Material
C1 [Langer, Ana; Caglia, Jacquelyn M.] Harvard TH Chan Sch Publ Hlth, Women & Hlth Initiat, 651Huntington Ave,FXB Bldg,7th Floor, Boston, MA 02115 USA.
   [Menendez, Clara] Univ Barcelona, Maternal Child & Reprod Hlth Initiat, Barcelona Inst Global Hlth, Hosp Clin, E-08007 Barcelona, Spain.
RP Langer, A (corresponding author), Harvard TH Chan Sch Publ Hlth, Women & Hlth Initiat, 651Huntington Ave,FXB Bldg,7th Floor, Boston, MA 02115 USA.
EM alanger@hsph.harvard.edu
RI Menendez, Clara/Q-3446-2016
OI Menendez, Clara/0000-0002-2641-6907
NR 0
TC 3
Z9 3
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0039-3665
EI 1728-4465
J9 STUD FAMILY PLANN
JI Stud. Fam. Plan.
PD JUN
PY 2016
VL 47
IS 2
BP 179
EP 181
DI 10.1111/j.1728-4465.2016.00058.x
PG 3
WC Demography; Public, Environmental & Occupational Health
SC Demography; Public, Environmental & Occupational Health
GA DP8CM
UT WOS:000378725500005
PM 27285427
DA 2020-07-08
ER

PT J
AU Davidson, R
AF Davidson, Robert
TI Secret Weapon Against Zika
SO US PHARMACIST
LA English
DT Editorial Material
EM rdavidson@uspharmacist.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOBSON PUBLISHING LLC
PI NEW YORK
PA 100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA
SN 0148-4818
EI 2331-3501
J9 US PHARM
JI US Pharm.
PD JUN
PY 2016
VL 41
IS 6
BP 5
EP 5
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DP9FX
UT WOS:000378803200001
DA 2020-07-08
ER

PT J
AU Arora, N
   Banerjee, AK
   Narasu, ML
AF Arora, Neelima
   Banerjee, Amit K.
   Narasu, Mangamoori Lakshmi
TI Zika virus: an emerging arboviral disease
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE Aedes aegypti; Aedes albopictus; Flavivirus; mosquito-borne viral
   disease; transmission; Zika virus outbreak
ID DENGUE; TRANSMISSION; WOLBACHIA; OUTBREAK
C1 [Arora, Neelima; Narasu, Mangamoori Lakshmi] JawaharLal Nehru Technol Univ, Inst Sci & Technol Autonomous, Ctr Biotechnol, Hyderabad, Telangana, India.
   [Banerjee, Amit K.] Indian Inst Chem Technol, Uppal Rd, Hyderabad, Telangana, India.
RP Arora, N (corresponding author), JawaharLal Nehru Technol Univ, Inst Sci & Technol Autonomous, Ctr Biotechnol, Hyderabad, Telangana, India.
EM neelimaiict@gmail.com
RI Banerjee, Amit Kumar/A-1009-2009
OI Banerjee, Amit Kumar/0000-0002-2502-0521
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   [Anonymous], 2016, ZIKA VIRUS MICROCEPH
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Craig AT, 2017, B WORLD HEALTH ORGAN, V95, P69, DOI 10.2471/BLT.16.171892
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Kurosu Takeshi, 2011, Trop Med Health, V39, P29, DOI 10.2149/tmh.2011-S02
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 30
TC 4
Z9 4
U1 0
U2 55
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUN
PY 2016
VL 11
IS 6
BP 395
EP 399
DI 10.2217/fvl-2016-0048
PG 5
WC Virology
SC Virology
GA DO9FW
UT WOS:000378091400001
OA Bronze
DA 2020-07-08
ER

PT J
AU Hillebrandt, D
   Richards, P
   Clark, A
   Jean, D
AF Hillebrandt, David
   Richards, Paul
   Clark, Andy
   Jean, Dominique
TI Zika Virus Advice for Mountaineers: A UIAA Medcom Consensus Advice Sheet
SO HIGH ALTITUDE MEDICINE & BIOLOGY
LA English
DT Article
DE mountain travel; travel advice; Zika virus
AB With the current media coverage of the spread of Zika virus from Africa and Asia to Central and South America and its possible relationship with fetal abnormalities, UIAA Medcom has produced an advice sheet for mountaineers visiting risk areas.
C1 [Hillebrandt, David] UIAA, UIAA Med Commiss, Bern, Switzerland.
   [Richards, Paul] South Essex Travel Clin, Billericay, Essex, England.
   [Jean, Dominique] CHU Grenoble, Ctr Pluridisciplinaire Diagnost Prenatal, F-38043 Grenoble, France.
RP Hillebrandt, D (corresponding author), Derriton House, Holsworthy EX22 6JX, Devon, England.
EM dh@hillebrandt.org.uk
NR 0
TC 0
Z9 0
U1 0
U2 32
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1527-0297
EI 1557-8682
J9 HIGH ALT MED BIOL
JI High Alt. Med. Biol.
PD JUN
PY 2016
VL 17
IS 2
BP 70
EP 71
DI 10.1089/ham.2016.0013
PG 2
WC Biophysics; Public, Environmental & Occupational Health; Sport Sciences
SC Biophysics; Public, Environmental & Occupational Health; Sport Sciences
GA DO8PG
UT WOS:000378044900003
PM 27081746
DA 2020-07-08
ER

PT J
AU Ali, T
   Aziz, S
   Khan, M
AF Ali, Tayyaba
   Aziz, Sina
   Khan, Mahjabeen
TI Zika Virus - An International Public Health Emergency
SO ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE
LA English
DT Article
DE Aedes; Flavivirus; Guillain Barre Syndrome; microcephaly; Zika Virus
AB Zika Virus is a member of the virus family flaviviridae and the genus flavivirus. It is spread by day time active Aedes mosquitoes, such as A. aegypti and A. albopictus. This is the same mosquito that spread and causes dengue, chikungunya and yellow fever. The first known case of Zika fever was reported in a sentinel rhesus monkey stationed on a tree platform in the Zika Forest in Uganda in 1947. Sexual transmission of Zika virus from men to women has been witnessed in at least 4 cases. Zika virus has also been isolated from semen samples. Cases of vertical perinatal transmission, from mother to the baby during pregnancy have been reported. WHO declared the couple of microcephaly and Guillain-Barre syndrome (GBS) cases reported in Brazil are strongly suspected to be associated with the Zika virus outburst. Thus, World Health Organisation (WHO) declared that a coordinated and an organized international response is required to improve surveillance, identification of infections, congenital malformations, and neurological complications, to heighten the control of mosquito populations at risk, and to execute the development of diagnostic tests and vaccines to secure people from this international public health emergency.
C1 [Ali, Tayyaba] Abbasi Shaheed Hosp, Karachi Med & Dent Coll, Karachi, Pakistan.
   [Aziz, Sina] Abbasi Shaheed Hosp, Karachi Med & Dent Coll, Dept Paediat, Karachi, Pakistan.
   [Khan, Mahjabeen] Karachi Dow Univ Hlth Sci, Civil Hosp, Dept Gynaecol, Karachi, Pakistan.
RP Ali, T (corresponding author), Karachi Med & Dent Coll, Karachi, Pakistan.
EM tayyabaali_388@hotmail.com
CR [Anonymous], 2016, TRANSCR CDC TEL ZIK
   [Anonymous], 2015, ZIK VIR
   [Anonymous], 2016, OUTBR ZIK VIR COMPL
   Centers for Disease Control and Prevention, 2015, HELP CONTR MOSQ SPRE
   Centers for Disease Control and Prevention, 2016, ZIKA VIRUS
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Fauci AS, N ENGL J MED, V374, P601
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McNeil Jr Donald, NY TIMES
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, UPDATE INTERIM GUIDE
   Romero S., 2015, NY TIMES
   Romero S, 2016, NY TIMES
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLL
PI KARACHI
PA BLOCK M, N NAZIMABAD, KARACHI, 74700, PAKISTAN
SN 1563-3241
J9 ANN ABBASI SHAHEED H
JI Ann. Abbasi Shaheed Hosp. Karachi Med. Dent. Coll.
PD JUN
PY 2016
VL 21
IS 2
BP 124
EP 127
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO2AC
UT WOS:000377580600010
DA 2020-07-08
ER

PT J
AU Nishiura, H
   Mizumoto, K
   Rock, KS
   Yasuda, Y
   Kinoshita, R
   Miyamatsu, Y
AF Nishiura, Hiroshi
   Mizumoto, Kenji
   Rock, Kat S.
   Yasuda, Yohei
   Kinoshita, Ryo
   Miyamatsu, Yuichiro
TI A theoretical estimate of the risk of microcephaly during pregnancy with
   Zika virus infection
SO EPIDEMICS
LA English
DT Article
DE Microcephaly; Zika infection; Gestation; Statistical estimation; Brazil
ID CONGENITAL-RUBELLA SYNDROME; BRAZIL
AB Objectives: There has been a growing concern over Zika virus (ZIKV) infection, particularly since a probable link between ZIKV infection during pregnancy and microcephaly in the baby was identified. The present study aimed to estimate a theoretical risk of microcephaly during pregnancy with ZIKV infection in Northeastern Brazil in 2015.
   Methods: Temporal distributions of microcephaly, reported dengue-like illness and dengue seropositive in Brazil were extracted from secondary data sources. Using an integral equation model and a back calculation technique, we estimated the risk of microcephaly during pregnancy with Zika virus infection.
   Results: If the fraction of Zika virus infections among a total of seronegative dengue-like illness cases is 30%, the risk of microcephaly following infection during the first trimester was estimated at 46.7% (95% CI: 9.1, 84.2), comparable to the risk of congenital rubella syndrome. However, the risk of microcephaly was shown to vary widely from 14.0% to 100%. The mean gestational age at delivery with microcephaly was estimated at 37.5 weeks (95% CI: 36.9, 39.3).
   Conclusions: The time interval between peaks of reported dengue-like illness and microcephaly was consistent with cause-outcome relationship. Our modeling framework predicts that the incidence of microcephaly is expected to steadily decline in early 2016, Brazil. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Nishiura, Hiroshi; Mizumoto, Kenji; Rock, Kat S.; Yasuda, Yohei; Kinoshita, Ryo; Miyamatsu, Yuichiro] Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
   [Nishiura, Hiroshi; Yasuda, Yohei; Kinoshita, Ryo; Miyamatsu, Yuichiro] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
   [Mizumoto, Kenji] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.
   [Nishiura, Hiroshi; Mizumoto, Kenji; Kinoshita, Ryo; Miyamatsu, Yuichiro] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
RP Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
EM nishiurah@gmail.com
OI Mizumoto, Kenji/0000-0002-2748-6560; Kinoshita, Ryo/0000-0002-0116-4598
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26670308,
   26700028]; Japan Agency for Medical Research and DevelopmentJapan Agency
   for Medical Research and Development (AMED); Japan Science and
   Technology Agency Agency (JST) CREST program; RISTEX program for Science
   of Science, Technology and Innovation Policy; JSPS Postdoctoral
   FellowshipMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of Science;
   Japanese Society for the Promotion of Science (JSPS) KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [15K20936]
FX HN received funding support from the JSPS KAKENHI Grant Numbers 26670308
   and 26700028, Japan Agency for Medical Research and Development, the
   Japan Science and Technology Agency (JST) CREST program and RISTEX
   program for Science of Science, Technology and Innovation Policy. KSR
   was supported by the JSPS Postdoctoral Fellowship for Foreign
   Researchers. KM received funding support from the Japanese Society for
   the Promotion of Science (JSPS) KAKENHI Grant Number 15K20936.
CR Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176
   de Paula Freitas B, 2016, JAMA OPHTHA IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gao ZH, 2013, VACCINE, V31, P691, DOI 10.1016/j.vaccine.2012.11.043
   Ministerio da Saude, 2009, GUIA VIGILANCIA EPID
   Ministerio da Saude, 2016, SIT EP DAD
   Ministerio da Saude, 2016, PERG RESP MICR
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishiura H., 2016, INT J INFEC IN PRESS
   Nishiura H., 2016, EPIDEMIOLOGICA UNPUB
   Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60
   Pybus O., 2016, PLOS CURR OUTBREAKS
   Regis C.T., 2016, B WHO IN PRESS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2016, MON CAS DENG FIBR CH
   United Nations Population Division, 2016, VIT STAT BRAZ
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 18
TC 27
Z9 27
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD JUN
PY 2016
VL 15
BP 66
EP 70
DI 10.1016/j.epidem.2016.03.001
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DO6CK
UT WOS:000377870200007
PM 27288540
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Long, D
   Long, B
   Koyfman, A
AF Long, Drew
   Long, Brit
   Koyfman, Alex
TI ZIKA VIRUS: WHAT DO EMERGENCY PHYSICIANS NEED TO KNOW?
SO JOURNAL OF EMERGENCY MEDICINE
LA English
DT Review
DE Zika virus; flavivirus; mosquito; Aedes; blood; microcephaly
ID SPREADS; AMERICA; OUTBREAK; STATES; CHILD
AB Background: Zika virus currently dominates headlines, creating public fear due to its complications. With the ease of worldwide travel, this disease has spread rapidly to the U.S. Objectives: To provide physicians with an updated clinical review of the epidemiology, pathogenesis, diagnosis, management, and mimics of zika virus. Discussion: This flavivirus is spread by the bite of the Aedes mosquito during daylight. The ease of worldwide travel has allowed the virus to spread to Mexico and the U.S. Main transmission route is via blood contact or sexual activity involving mucous membranes. Incubation ranges from 2 to 12 days, but only 20% of patients experience symptoms. Fever is low grade with conjunctivitis, arthralgias, myalgias, and a maculopapular rash. Chikungunya and Dengue Fever differ in that patients experience higher fever and no conjunctivitits. The dreaded complication of Zika virus is microcephaly in infants born to infected mothers. Guillain-Barre Syndrome is also linked to the virus. Historical factors including travel history are paramount, and diagnosis includes PCR or serology. No current treatment regimen exists beyond symptom control. The emergency physician must seek to rule out other similar diseases such as malaria, chikungunya, and dengue fever. Conclusion: Zika virus has created public fear due to complications, and this flavivirus spread by the Aedes mosquito presents similarly to Chikungunya and Dengue Fever. The dreaded complication of Zika virus is microcephaly in infants born to infected mothers. This review provides key information concerning the disease and management. (c) 2016 Elsevier Inc. All rights reserved.
C1 [Long, Drew] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.
   [Long, Brit] San Antonio Mil Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.
   [Koyfman, Alex] Univ Texas SW Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA.
RP Long, B (corresponding author), San Antonio Mil Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.
CR [Anonymous], ZIK VIR
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atkinson B, DETECTION ZIKA VIRUS
   Baombe J, 2016, BREAKING NEWS ZIKA V
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Dehning M, 2016, BRIEF CLIN PRACTICE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health-Manuatu Hauora, ZIK VIR
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   O'Dowd A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i875
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pan American Health Organization, ZIK VIR INF ZIK FEV
   Pan American Health Organization, ZIK VIR INF
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization World Health Organization., QUEST ANSW ZIK PREGN
   Pan American Health Organization World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pike L, 2016, ZIKA VIRUS WHAT EMER
   U.S. Centers for Disease Control and Prevention, EM PREP RESP REC MAN
   US Centers for Disease Control and Prevention, ZIK VIR
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, ZIK VIR INF
NR 38
TC 5
Z9 5
U1 0
U2 76
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0736-4679
EI 1090-1280
J9 J EMERG MED
JI J. Emerg. Med.
PD JUN
PY 2016
VL 50
IS 6
BP 832
EP 838
DI 10.1016/j.jemermed.2016.03.033
PG 7
WC Emergency Medicine
SC Emergency Medicine
GA DO7VF
UT WOS:000377990400004
PM 27157106
DA 2020-07-08
ER

PT J
AU Ames, H
   Rodriguez, F
   Hill, D
   Ho, CY
AF Ames, Heather
   Rodriguez, Fausto
   Hill, D.
   Ho, Cheng-Ying
TI Early neuropathological findings in congenital Zika virus infection
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 92nd Annual Meeting of the American-Association-of-Neuropathologist-Inc
CY JUN 16-19, 2016
CL Baltimore, MD
SP Amer Assoc Neuropathologist Inc
C1 [Ames, Heather; Rodriguez, Fausto] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.
   [Hill, D.; Ho, Cheng-Ying] Childrens Natl Hlth Syst, Div Pathol, Washington, DC USA.
RI Ho, Cheng-Ying/AAA-5098-2019
NR 0
TC 0
Z9 0
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2016
VL 75
IS 6
MA 1
BP 567
EP 567
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO3FC
UT WOS:000377665000010
DA 2020-07-08
ER

PT J
AU Chimelli, L
   Melo, ASO
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Camacho, AHS
   Gomes, GC
   Melo, FO
   Batista, AGM
   Machado, HN
   Awad, E
   Ferreira, TA
   Andrade, RD
   Mello, RJV
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Camacho, Aline H. S.
   Gomes, Giovanna C.
   Melo, Fabiana O.
   Batista, Alba G. M.
   Machado, Heloisa N.
   Awad, Elizabeth
   Ferreira, Thales A.
   Andrade, Rodrigo D.
   Mello, Roberto J. V.
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Tanuri, Amilcar
TI Neuropathological aspects of congenital Zika virus infection in Brazil
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 92nd Annual Meeting of the American-Association-of-Neuropathologist-Inc
CY JUN 16-19, 2016
CL Baltimore, MD
SP Amer Assoc Neuropathologist Inc
C1 [Chimelli, Leila; Camacho, Aline H. S.; Gomes, Giovanna C.] State Inst Brain, Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Melo, Fabiana O.] Res Inst Prof Amorim Neto, Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.] Hlth Secretary Campina Grande, Campina Grande, PB, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Sao Paulo, SP, Brazil.
   [Machado, Heloisa N.; Awad, Elizabeth] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil.
   [Ferreira, Thales A.] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Andrade, Rodrigo D.] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Mello, Roberto J. V.] Hlth Inst Elpidio de Almeida, Campina Grande, PB, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, RJ, Brazil.
RI Ferreira, Thales Araujo/AAA-6252-2019; Melo, Adriana S O/H-5650-2016
NR 0
TC 0
Z9 0
U1 0
U2 55
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2016
VL 75
IS 6
MA 2
BP 567
EP 567
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO3FC
UT WOS:000377665000011
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI ZIka virus infection in Asia: Reappraisal on phylogenetic data of Asian
   lineage
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cabrera-Gaytan David Alejandro, 2016, Rev Med Inst Mex Seguro Soc, V54, P225
   Chan JF, 2016, J INFECT
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
NR 6
TC 3
Z9 3
U1 0
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUN
PY 2016
VL 9
IS 6
BP 614
EP 615
DI 10.1016/j.apjtm.2016.04.017
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DN9UK
UT WOS:000377426000018
PM 27262078
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Marks, PW
   Epstein, JS
   Borio, LL
AF Marks, Peter W.
   Epstein, Jay S.
   Borio, Luciana L.
TI Maintaining a Safe Blood Supply in an Era of Emerging Pathogens
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE blood safety; donor screening tests; emerging pathogens;
   pathogen-reduction; Zika virus
ID ZIKA VIRUS; TRANSMISSION; TRANSFUSION; STATES; BRAZIL
AB Coming shortly after outbreaks of dengue and chikungunya virus in related locations, the recent outbreak of Zika virus in the southern part of the western hemisphere is yet another reminder that infectious pathogens continue to emerge rapidly and can adversely affect public health, including the safety of the blood supply. In response to Zika virus, public health measures that rely largely on donor deferral and sourcing of blood from non-outbreak areas until a blood donor screening test becomes available have been implemented to address the safety of the blood supply in the United States. However, a more universal approach to ensuring blood safety in the setting of rapidly emerging infectious diseases is needed.
C1 [Marks, Peter W.; Epstein, Jay S.; Borio, Luciana L.] US FDA, 10903 New Hampshire Ave WO1-3317, Silver Spring, MD 20993 USA.
RP Borio, LL (corresponding author), US FDA, 10903 New Hampshire Ave WO1-3317, Silver Spring, MD 20993 USA.
EM luciana.borio@fda.hhs.gov
OI Epstein, Jay/0000-0003-2293-9062
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Centers for Disease Control and Prevention, AR ZIK COUNTR TERR A
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, REC DON SCREEN DEF P
   Freedman J, 2014, TRANSFUS APHER SCI, V50, P5, DOI 10.1016/j.transci.2013.12.003
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hogshire L, 2013, CURR OPIN HEMATOL, V20, P546, DOI 10.1097/MOH.0b013e32836508bd
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Salunkhe V, 2015, TRANSFUS APHER SCI, V52, P19, DOI 10.1016/j.transci.2014.12.016
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 9
Z9 10
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2016
VL 213
IS 11
BP 1676
EP 1677
DI 10.1093/infdis/jiw089
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DO0BC
UT WOS:000377443400002
PM 26962237
OA Bronze
DA 2020-07-08
ER

PT J
CA Soc Maternal-Fetal Med SMFM Public
TI Ultrasound screening for fetal microcephaly following Zika virus
   exposure
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Editorial Material
AB The practice of medicine continues to evolve, and individual circumstances will vary. This publication reflects information available at the time of its submission for publication and is neither designed nor intended to establish an exclusive standard of perinatal care. This publication is not expected to reflect the opinions of all members of the Society for Maternal-Fetal Medicine.
CR ACOG and SMFM, PRACT ADV UPD INT GU
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Persutte WH, 1998, ULTRASOUND OBST GYN, V11, P317, DOI 10.1046/j.1469-0705.1998.11050317.x
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   Zika situation report neurological syndrome and congenital anomalies, ZIK SIT REP NEUR SYN
NR 10
TC 30
Z9 32
U1 0
U2 61
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JUN
PY 2016
VL 214
IS 6
BP B2
EP B4
DI 10.1016/j.ajog.2016.02.043
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DN6YP
UT WOS:000377222800001
PM 26901275
OA Bronze
DA 2020-07-08
ER

PT J
AU Yusuf, M
   Hussain, HF
AF Yusuf, Muhammad
   Hussain, Hareem Fatima
TI Zika virus: Another alarming threat
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Yusuf, Muhammad; Hussain, Hareem Fatima] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
RP Yusuf, M (corresponding author), Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
EM m.yusufhafiz17@gmail.com
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 3
TC 2
Z9 2
U1 0
U2 50
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD JUN
PY 2016
VL 66
IS 6
BP 789
EP 789
PG 1
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA DM9LF
UT WOS:000376687000036
PM 27339593
DA 2020-07-08
ER

PT J
AU Guillemette-Artur, P
   Besnard, M
   Eyrolle-Guignot, D
   Jouannic, JM
   Garel, C
AF Guillemette-Artur, Prisca
   Besnard, Marianne
   Eyrolle-Guignot, Dominique
   Jouannic, Jean-Marie
   Garel, Catherine
TI Prenatal brain MRI of fetuses with Zika virus infection
SO PEDIATRIC RADIOLOGY
LA English
DT Article
DE Brain; Fetus; Intrauterine infection; Magnetic resonance imaging;
   Prenatal diagnosis; Ultrasound; Zika virus
AB An outbreak of Zika virus was observed in French Polynesia in 2013-2014. Maternal Zika virus infection has been associated with fetal microcephaly and severe cerebral damage.
   To analyze the MRI cerebral findings in fetuses with intrauterine Zika virus infection.
   We retrospectively analyzed prospectively collected data. Inclusion criteria comprised cases with (1) estimated conception date between June 2013 and May 2014, (2) available US and MRI scans revealing severe fetal brain lesions and (3) positive polymerase chain reaction for Zika virus in the amniotic fluid. We recorded pregnancy history of Zika virus infection and analyzed US and MRI scans.
   Three out of 12 cases of severe cerebral lesions fulfilled all inclusion criteria. History of maternal Zika virus infection had been documented in two cases. Calcifications and ventriculomegaly were present at US in all cases. MRI showed micrencephaly (n = 3), low cerebellar biometry (n = 2), occipital subependymal pseudocysts (n = 2), polymicrogyria with laminar necrosis and opercular dysplasia (n = 3), absent (n = 1) or hypoplastic (n = 1) corpus callosum and hypoplastic brainstem (n = 1).
   Severe cerebral damage was observed in our series, with indirect findings suggesting that the germinal matrix is the principal target for Zika virus. The lesions are very similar to severe forms of congenital cytomegalovirus and lymphocytic choriomeningitis virus infections.
C1 [Guillemette-Artur, Prisca] Ctr Hosp Polynesie Francaise, Serv Radiol, Pirae, Tahiti, France.
   [Besnard, Marianne] Ctr Hosp Polynesie Francaise, Serv Reanimat Neonatale, Pirae, Tahiti, France.
   [Eyrolle-Guignot, Dominique] Ctr Hosp Polynesie Francaise, Serv Obstet, Pirae, Tahiti, France.
   [Jouannic, Jean-Marie] Univ Paris 06, Hop Enfants Armand Trousseau, Serv Med Foetale, Paris, France.
   [Garel, Catherine] Hop Enfants Armand Trousseau, Dept Radiol, 26 Ave Dr Arnold Netter, Paris, France.
RP Garel, C (corresponding author), Hop Enfants Armand Trousseau, Dept Radiol, 26 Ave Dr Arnold Netter, Paris, France.
EM catherine.garel@aphp.fr
CR Besnard M, 2014, EURO SURVEILL, V19
   Blondiaux E, 2013, ACTA RADIOL, V54, P1046, DOI 10.1258/ar.2012.120428
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duin LK, 2007, PRENATAL DIAG, V27, P81, DOI 10.1002/pd.1631
   Esteban H, 2015, ULTRASOUND OBST GYN, V46, P678, DOI 10.1002/uog.14820
   Garel C, 2004, AM J NEURORADIOL, V25, P1563
   Glenn OA, 2007, J MATERN-FETAL NEO M, V20, P769, DOI 10.1080/14767050701580960
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kucharski AJ, 2016, BIORXIV, P7, DOI [10. 1101/ 038588, DOI 10.1101/038588]
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Mandelbrot L, 2012, PRENATAL DIAG, V32, P511, DOI 10.1002/pd.3843
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mutnal MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016211
   Paladini D, 2009, ULTRASOUND OBST GYN, V33, P720, DOI 10.1002/uog.6393
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tilea B, 2009, ULTRASOUND OBST GYN, V33, P173, DOI 10.1002/uog.6276
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
NR 23
TC 44
Z9 44
U1 0
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0301-0449
EI 1432-1998
J9 PEDIATR RADIOL
JI Pediatr. Radiol.
PD JUN
PY 2016
VL 46
IS 7
BP 1032
EP 1039
DI 10.1007/s00247-016-3619-6
PG 8
WC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
SC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
GA DN4FX
UT WOS:000377020100010
PM 27090801
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI EVIDENCE INDICATES ZIKA CAUSES NEURAL STEM CELLS TO SELF-DESTRUCT
SO STEM CELLS TRANSLATIONAL MEDICINE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2157-6564
EI 2157-6580
J9 STEM CELL TRANSL MED
JI Stem Cells Transl. Med.
PD JUN
PY 2016
VL 5
IS 6
BP XII
EP XII
DI 10.1016/j.stem.2016.04.014
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA DN1OO
UT WOS:000376835500001
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU McNeill, C
   Shreve, MD
   Jarrett, A
   Perry, C
AF McNeill, Charleen
   Shreve, Marilou D.
   Jarrett, Anna
   Perry, Cheryl
TI Zika: What Providers Need to Know
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Article
DE arboviruses; flaviviridae; infectious disease; treatment guidelines;
   Zika virus
ID HEALTH; VIRUS; TRANSMISSION; DEET
AB Emerging or reemerging infectious diseases (EIDs) are rapidly increasing. EIDs will remain a major cause of disease and death worldwide. One such EID is the Zika virus (ZIKV). ZIKV proves to be a global public health crisis. In January 2016, it became a notifiable condition in the United States. Providers must be knowledgeable regarding preventive measures as well as the proper diagnosis and treatment for it. The most current, evidence-based guidelines for managing ZIKV in the general population as well as specific recommendations for pregnant women are presented. (C) 2016 Elsevier Inc. All rights reserved.
C1 [McNeill, Charleen; Shreve, Marilou D.; Jarrett, Anna; Perry, Cheryl] Univ Arkansas, Eleanor Mann Sch Nursing, Fayetteville, AR 72701 USA.
RP McNeill, C (corresponding author), Univ Arkansas, Eleanor Mann Sch Nursing, Fayetteville, AR 72701 USA.
EM cmcneill@uark.edu
RI Shreve, Marilou/M-1366-2019; McNeill, Charleen/AAE-9324-2019
OI Shreve, Marilou/0000-0003-0896-5125; McNeill,
   Charleen/0000-0002-6787-4787
CR [Anonymous], 2016, TOOLS HLTH CAR PROV
   [Anonymous], 2016, SYMPT DIAGN TREATM
   [Anonymous], 2016, SCI NEWSSH ZIK VIR I
   [Anonymous], 2016, MOSQ BIT PREV US
   [Anonymous], 2016, ZIK VIR
   [Anonymous], 2015, EP UPD ZIK VIR INF
   [Anonymous], 2016, ZIK VIR
   [Anonymous], 2016, CLIN EV DIS
   [Anonymous], 2015, INF CONS ANT EM INF
   Brown DM, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P519, DOI 10.1079/9781845939649.0519
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, 2016, TRANSM RISKS
   Centers for Disease Control and Prevention (CDC), 2016, DIAGN TEST
   Centers for Disease Control and Protection, 2016, EST RANG AED AEG AED
   Cetron M., 2016, MMWR MORB MORTAL WKL
   Chen-Hussey V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-173
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Kabasenche WP, 2013, ENV HLTH, V13, P1
   Kallen B., 2014, EPIDEMIOLOGY HUMAN C, P27
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kronen MR, 2007, FIELDS VIROLOGY, V2, P1102
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   MORSE SS, 1990, J INFECT DIS, V162, P1, DOI 10.1093/infdis/162.1.1
   Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088
   Mosquera A, 2015, PUBLIC HEALTH NURS, V32, P550, DOI 10.1111/phn.12217
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nhan T, 2015, CLIN MICROBIOL, V4, P222
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Pullella P., 2016, POPE SIGNALS POSSIBL
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Tian JN, 2014, J ENVIRON HEALTH, V76, P162
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Zaccagnini M. E., 2014, DOCTOR NURSING PRACT
NR 39
TC 1
Z9 1
U1 1
U2 56
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD JUN
PY 2016
VL 12
IS 6
BP 359
EP 370
DI 10.1016/j.nurpra.2016.04.009
PG 11
WC Nursing
SC Nursing
GA DM9FB
UT WOS:000376669300014
OA Bronze
DA 2020-07-08
ER

PT J
AU Yakob, L
   Walker, T
AF Yakob, Laith
   Walker, Thomas
TI Alternative vector control methods to manage the Zika virus outbreak:
   more haste, less speed Reply
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID COMPETITION; SPACE
C1 [Yakob, Laith; Walker, Thomas] Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
RP Yakob, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
EM laith.yakob@lshtm.ac.uk
RI Yakob, Laith/AAD-4521-2019; Walker, Thomas/B-9198-2014
OI Yakob, Laith/0000-0001-8639-4511; Walker, Thomas/0000-0002-3545-012X
FU Wellcome TrustWellcome Trust [101285]
CR Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   PAHO WHO, DENG PAHO WHO DAT MA
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   World Health Organization, MOSQ CONTR CAN IT ST
   Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yakob L, 2009, J ECON ENTOMOL, V102, P50, DOI 10.1603/029.102.0108
NR 10
TC 1
Z9 2
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUN
PY 2016
VL 4
IS 6
BP E365
EP E366
DI 10.1016/S2214-109X(16)00086-3
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM6LH
UT WOS:000376463200014
PM 27198838
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus at the games: is it safe?
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
NR 0
TC 3
Z9 3
U1 0
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 619
EP 619
DI 10.1016/S1473-3099(16)30069-X
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500001
PM 27177718
OA Bronze
DA 2020-07-08
ER

PT J
AU Musso, D
   Baud, D
AF Musso, Didier
   Baud, David
TI Zika virus: time to move from case reports to case control
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; INFECTION
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, POB 30, F-98713 Papeete, Tahiti, France.
   [Baud, David] Univ Lausanne Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, Matern, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, POB 30, F-98713 Papeete, Tahiti, France.
EM dmusso@ilm.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496
CR Calvet G., 2016, LANCET INFECT DIS
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Pan American Health Organization (PAHO), 2016, EP UPD NEUR SYNDR CO
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ville Y, 2014, CURR OPIN INFECT DIS, V27, P251, DOI 10.1097/QCO.0000000000000066
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 11
TC 12
Z9 12
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 620
EP 621
DI 10.1016/S1473-3099(16)00096-7
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500002
PM 26897106
OA Bronze
DA 2020-07-08
ER

PT J
AU Blonz, ER
AF Blonz, Edward R.
TI Zika virus and GLUT1
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Blonz, Edward R.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.
RP Blonz, ER (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.
EM er@blonz.com
CR Cauchemez S, 2016, LANCET
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernando WMADB, 2015, BRIT J NUTR, V114, P1, DOI 10.1017/S0007114515001452
   Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6
   PAHWA S, 1986, JAMA-J AM MED ASSOC, V255, P2299, DOI 10.1001/jama.255.17.2299
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Wang DZ, 2002, HEBEI FORESTORY TECH, V30, P30
   Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10
NR 8
TC 2
Z9 3
U1 0
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 642
EP 642
DI 10.1016/S1473-3099(16)30062-7
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500021
PM 27184421
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika and self-destructing neural stem cells
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 650
EP 650
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500042
DA 2020-07-08
ER

PT J
AU Benelli, G
   Lo Iacono, A
   Canale, A
   Mehlhorn, H
AF Benelli, Giovanni
   Lo Iacono, Annalisa
   Canale, Angelo
   Mehlhorn, Heinz
TI Mosquito vectors and the spread of cancer: an overlooked connection?
SO PARASITOLOGY RESEARCH
LA English
DT Review
DE Aedes; Anopheles; Arbovirus; Artesunate; Dengue; Epstein-Barr virus;
   Malaria; Nanosynthesis; Tumor biology; Zika virus
ID NECROSIS-FACTOR-ALPHA; DENGUE VIRUS; ZIKA VIRUS;
   HEPATOCELLULAR-CARCINOMA; VETERINARY IMPORTANCE; MEDIATED SYNTHESIS;
   DECLINING MALARIA; NANOPARTICLES; TRANSMISSION; ALLERGY
AB Mosquitoes (Diptera: Culicidae) represent a key threat for millions of humans and animals worldwide, vectoring important pathogens and parasites, including malaria, dengue, filariasis, and Zika virus. Besides mosquito-borne diseases, cancers figure among the leading causes of mortality worldwide. It is expected that annual cancer cases will rise from 14 million in 2012 to 22 million within the next two decades. Notably, there are few contrasting evidences of the relationship between cancer and mosquito-borne diseases, with special reference to malaria. However, analogies at the cellular level for the two diseases were reported. Recently, a significant association of malaria incidence with all cancer mortality in 50 USA states was highlighted and may be explained by the ability of Plasmodium to induce suppression of the immune system. However, it was hypothesized that Anopheles vectors may transmit obscure viruses linked with cancer development. The possible activation of cancer pathways by mosquito feeding events is not rare. For instance, the hamster reticulum cell sarcoma can be transmitted through the bites of Aedes aegypti by a transfer of tumor cells. Furthermore, mosquito bites may influence human metabolic pathways following different mechanisms, leading to other viral infections and/or oncogenesis. Hypersensitivity to mosquito bites is routed by a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy, and oncogenesis. During dengue virus infection, high viral titers, macrophage infiltration, and tumor necrosis factor alpha production in the local tissues are the three key important events that lead to hemorrhage. Overall, basic epidemiological knowledge on the relationships occurring between mosquito vector activity and the spread of cancer is urgently needed, as well as detailed information about the ability of Culicidae to transfer viruses or tumor cells among hosts over time. Current evidences on nanodrugs with multipotency against mosquito-borne diseases and cancers are reviewed, with peculiar attention to their mechanisms of action.
C1 [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Lo Iacono, Annalisa] St Anna Sch Adv Studies, Piazza Martiri Liberta 33, I-56127 Pisa, Italy.
   [Mehlhorn, Heinz] Univ Dusseldorf, Dept Parasitol, Dusseldorf, Germany.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX We are grateful to M. Nicoletti and K. Murugan for helpful discussions
   on the topic. G. Benelli is supported by PROAPI (PRAF 2015) and
   University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Asada H, 2007, J DERMATOL SCI, V45, P153, DOI 10.1016/j.jdermsci.2006.11.002
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   BANFIELD WG, 1965, SCIENCE, V148, P1239, DOI 10.1126/science.148.3674.1239
   BANFIELD WG, 1966, CANCER-AM CANCER SOC, V19, P1333, DOI 10.1002/1097-0142(196610)19:10<1333::AID-CNCR2820191002>3.0.CO;2-I
   Barik TK, 2008, PARASITOL RES, V103, P253, DOI 10.1007/s00436-008-0975-7
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   CBTRUS, 2008, STAT REP PRIM BRAIN, P1
   Chaturvedi D, 2010, CHEM SOC REV, V39, P435, DOI 10.1039/b816679j
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Dobler Gerhard, 2010, Denisia, P501
   Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412
   Efferth T, 2001, INT J ONCOL, V18, P767
   Espina LM, 2003, AM J TROP MED HYG, V68, P48, DOI 10.4269/ajtmh.2003.68.48
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gopinath P, 2010, COLLOID SURFACE B, V77, P240, DOI 10.1016/j.colsurfb.2010.01.033
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   Kawa K, 2001, BLOOD, V98, P3173, DOI 10.1182/blood.V98.10.3173
   Kilham L, 1955, AM J EPIDEMIOL, P6155
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   Lehrer S, 2010, ANTICANCER RES, V30, P1371
   Lehrer S, 2010, MED HYPOTHESES, V74, P167, DOI 10.1016/j.mehy.2009.07.005
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Majumder DD, 2006, IETE J RES, V52, P339
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Rajasekharreddy P, 2014, MAT SCI ENG C-MATER, V39, P203, DOI 10.1016/j.msec.2014.03.003
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Sanpui P, 2011, ACS APPL MATER INTER, V3, P218, DOI 10.1021/am100840c
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Shanthi K, 2015, RSC ADV, V5, P44998, DOI 10.1039/c5ra05803a
   Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23
   Suffness M, 1990, METHODS PLANT BIOCH, P71
   Sun RB, 2012, BIOMED ENVIRON SCI, V25, P495, DOI 10.3967/0895-3988.2012.05.001
   Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001
   Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751
   Tsuge I, 1999, CLIN EXP IMMUNOL, V115, P385
   Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996
   WELSH JD, 1976, GASTROENTEROLOGY, V70, P392
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   World Health Organization, 2015, FACT SHEET WORLD MAL
   Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08
NR 49
TC 15
Z9 15
U1 0
U2 67
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD JUN
PY 2016
VL 115
IS 6
BP 2131
EP 2137
DI 10.1007/s00436-016-5037-y
PG 7
WC Parasitology
SC Parasitology
GA DM1JH
UT WOS:000376101000001
PM 27053131
OA Bronze
DA 2020-07-08
ER

PT J
AU Marrs, C
   Olson, G
   Saade, G
   Hankins, G
   Wen, T
   Patel, J
   Weaver, S
AF Marrs, Caroline
   Olson, Gayle
   Saade, George
   Hankins, Gary
   Wen, Tony
   Patel, Janak
   Weaver, Scott
TI Zika Virus and Pregnancy: A Review of the Literature and Clinical
   Considerations
SO AMERICAN JOURNAL OF PERINATOLOGY
LA English
DT Review
DE Zika virus; pregnancy; fetus; transmission; microcephaly
ID UNITED-STATES; INTERIM GUIDELINES; VERTICAL TRANSMISSION; SEXUAL
   TRANSMISSION; FRENCH-POLYNESIA; DENGUE INFECTION; OUTBREAK; BRAZIL;
   WOMEN; CHILD
AB The latest Zika virus (ZIKV) outbreak has reached epidemic proportions as it spreads throughout South and Central America. In November 2015, the Brazilian Ministry of Health reported a 20-fold increase in the number of cases of neonatal microcephaly, which corresponds geographically and temporally to the ZIKV outbreak. Case reports have provided some evidence of a causal link between maternal ZIKV infection, fetal microcephaly, and intracranial calcifications. The sparse data regarding ZIKV in pregnancy come solely from case reports and personal communications, and recommendations for management of ZIKV exposure during pregnancy are rapidly evolving. Our objective is to review and synthesize the current literature regarding ZIKV as it pertains to pregnancy and provide some assistance to clinicians who may have to manage a pregnant patient with potential exposure to ZIKV. We will also explore certain aspects of related viruses in pregnancy in hopes to shed light on this little-known topic.
C1 [Marrs, Caroline; Olson, Gayle; Saade, George; Hankins, Gary; Wen, Tony] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, 301 Univ Blvd,JSA 3-400, Galveston, TX 77555 USA.
   [Patel, Janak] Univ Texas Med Branch, Dept Pediat, Div Pediat Infect Dis, Galveston, TX 77555 USA.
   [Weaver, Scott] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Weaver, Scott] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA.
   [Weaver, Scott] Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA.
RP Marrs, C (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, 301 Univ Blvd,JSA 3-400, Galveston, TX 77555 USA.
EM carolinemarrs@gmail.com
RI amsalu, ribka/G-8780-2019; Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R24 AI120942]
CR AABB, AABB ASS B
   Agencia Saude, 2015, MICR MIN SAUD DIV B
   [Anonymous], 2015, CDC HLTH INFORM INT
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bianchi DW, 2010, FETOLOGY DIAGNOSIS M, P166
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, SURV CONTR AED AEG A
   CDC, 2016, CDC EM OP CTR MOV HI
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centers for Disease Control and Prevention Division of Vector-Borne Diseases Arboviral Diseases and Dengue Branches, 2016, UPD DIAGN TEST ZIK C
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   CHERVENAK FA, 1984, AM J OBSTET GYNECOL, V149, P512, DOI 10.1016/0002-9378(84)90027-9
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dontigny L, 2008, J OBSTET GYNAECOL CA, V30, P152, DOI 10.1016/S1701-2163(16)32740-2
   Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   European Centre for Disease Prevention and Control, 2016, RAPID RISK ASS ZIK V
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Kuhn JH, 2015, HARRISONS PRINCIPLES
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kurmanavicius J, 1999, BRIT J OBSTET GYNAEC, V106, P126, DOI 10.1111/j.1471-0528.1999.tb08212.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Leite JM, 2008, ULTRASOUND OBST GYN, P133
   Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377
   Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MORB MORTAL WKLY REP
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, PREL GUID SURV MICR
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization World Health Organization., QUEST ANSW ZIK PREGN
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pilu G, 2008, ULTRASOUND OBST GYN, P382
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   SMFM, 2016, AM J OBSTET GYNECOL, DOI 10.1016/j.ajog.2016.02.043
   Society of Maternal Fetal Medicine, 2016, PRACT ADV UPD INT GU
   Spenser BR, 2015, AABB ANN M OCT 24 27
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 71
TC 34
Z9 43
U1 1
U2 34
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0735-1631
EI 1098-8785
J9 AM J PERINAT
JI Am. J. Perinatol.
PD JUN
PY 2016
VL 33
IS 7
BP 625
EP 639
DI 10.1055/s-0036-1580089
PG 15
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA DM7FE
UT WOS:000376521500001
PM 26939047
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Rossi, SL
   Tesh, RB
   Azar, SR
   Muruato, AE
   Hanley, KA
   Auguste, AJ
   Langsjoen, RM
   Paessler, S
   Vasilakis, N
   Weaver, SC
AF Rossi, Shannan L.
   Tesh, Robert B.
   Azar, Sasha R.
   Muruato, Antonio E.
   Hanley, Kathryn A.
   Auguste, Albert J.
   Langsjoen, Rose M.
   Paessler, Slobodan
   Vasilakis, Nikos
   Weaver, Scott C.
TI Characterization of a Novel Murine Model to Study Zika Virus
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RECEPTOR-DEFICIENT MICE; WEST-NILE-VIRUS; DENGUE VIRUS; INFECTION;
   TRANSMISSION; ENCEPHALITIS; URINE; OUTBREAK; IMMUNITY; BRAZIL
AB The mosquito-borne Zika virus (ZIKV) is responsible for an explosive ongoing outbreak of febrile illness across the Americas. ZIKV was previously thought to cause only a mild, flu-like illness, but during the current outbreak, an association with Guillain Barre syndrome and microcephaly in neonates has been detected. A previous study showed that ZIKV requires murine adaptation to generate reproducible murine disease. In our study, a low-passage Cambodian isolate caused disease and mortality in mice lacking the interferon (IFN) alpha receptor (A129 mice) in an age-dependent manner, but not in similarly aged immunocompetent mice. In A129 mice, viremia peaked at 107 plaque-forming units/mL by day 2 postinfection (PI) and reached high titers in the spleen by day 1. ZIKV was detected in the brain on day 3 PI and caused signs of neurologic disease, including tremors, by day 6. Robust replication was also noted in the testis. In this model, all mice infected at the youngest age (3 weeks) succumbed to illness by day 7 PI. Older mice (11 weeks) showed signs of illness, viremia, and weight loss but recovered starting on day 8. In addition, AG129 mice, which lack both type I and II IFN responses, supported similar infection kinetics to A129 mice, but with exaggerated disease signs. This characterization of an Asian lineage ZIKV strain in a murine model, and one of the few studies reporting a model of Zika disease and demonstrating age-dependent morbidity and mortality, could provide a platform for testing the efficacy of antivirals and vaccines.
C1 [Rossi, Shannan L.; Tesh, Robert B.; Auguste, Albert J.; Paessler, Slobodan; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Tesh, Robert B.; Auguste, Albert J.; Paessler, Slobodan; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Langsjoen, Rose M.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Muruato, Antonio E.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
RP Rossi, SL (corresponding author), Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
EM slrossi@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556; Auguste, Albert/0000-0001-9048-0041
FU NIH grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R24AI120942]; Department of Homeland
   SecurityUnited States Department of Homeland Security (DHS)
   [HSHQDC-10-A-BOA33]; NCATS CTSA [UL1 TR001439]; McLaughlin fellowship;
   National Center for Research ResourcesUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [5P20RR016480-12]; National
   Institute of General Medical Sciences of the NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [8 P20
   GM103451-12]
FX This work was supported by NIH grant 1R24AI120942 (Robert B. Tesh, Nikos
   Vasilakis, and Scott C. Weaver), and Shannan L. Rossi was funded through
   a contract through the Department of Homeland Security
   HSHQDC-10-A-BOA33. Rose M. Langsjoen and Sasha R. Azar are funded
   through NCATS CTSA UL1 TR001439. Albert J. Auguste is funded by the
   McLaughlin fellowship, and Kathryn A. Hanley was supported by grants
   from the National Center for Research Resources (5P20RR016480-12) and
   the National Institute of General Medical Sciences (8 P20 GM103451-12)
   of the NIH.
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, AR WITH ZIK
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kondo M, 2016, J DERMATOL, V43, P697, DOI 10.1111/1346-8138.13253
   Lever MS, 2012, J MED MICROBIOL, V61, P8, DOI 10.1099/jmm.0.036210-0
   Lobigs M, 2003, J GEN VIROL, V84, P567, DOI 10.1099/vir.0.18654-0
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   McNeil Jr Donald G., 2016, NY TIMES
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Paessler S, 2007, VIROLOGY, V367, P307, DOI 10.1016/j.virol.2007.05.041
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Rossi SL, 2013, VIROLOGY, V437, P81, DOI 10.1016/j.virol.2012.11.013
   Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seymour RL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003800
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tavernise S, 2016, NY TIMES
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   VESTERGAARD BF, 1971, AM J PATHOL, V64, P541
   World Health Organization, 2016, ZIK VIR SIT REP
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 267
Z9 276
U1 0
U2 13
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 2016
VL 94
IS 6
BP 1362
EP 1369
DI 10.4269/ajtmh.16-0111
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3UV
UT WOS:000400205900029
PM 27022155
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Al-Tawfiq, JA
   Gautret, P
   Benkouiten, S
   Memish, ZA
AF Al-Tawfiq, Jaffar A.
   Gautret, Philippe
   Benkouiten, Samir
   Memish, Ziad A.
TI Mass Gatherings and the Spread of Respiratory Infections Lessons from
   the Hajj
SO ANNALS OF THE AMERICAN THORACIC SOCIETY
LA English
DT Article
DE mass gathering; respiratory infections; Hajj; pilgrimage
ID INFLUENZA-A H1N1; SYNDROME CORONAVIRUS; SAUDI-ARABIA; MERS-COV; TRACT
   INFECTIONS; FRENCH PILGRIMS; TUBERCULOSIS INFECTION; HEALTH-HAZARDS;
   NASAL CARRIAGE; RISK
AB The mass gathering of people is a potential source for developing, propagating, and disseminating infectious diseases on a global scale. Of the illnesses associated with mass gatherings, respiratory tract infections are the most common, the most easily transmitted, and the most likely to be spread widely beyond the site of the meeting by attendees returning home. Many factors contribute to the spread of these infections during mass gatherings, including crowding, the health of the attendees, and the type and location of meetings. The annual Hajj in the Kingdom of Saudi Arabia is the largest recurring single mass gathering in the world. Every year more than 10 million pilgrims attend the annual Hajj and Umrah. Attendees assemble in confined areas for several days. People with a wide range of age, health, susceptibility to illness, and hygiene sophistication come in close contact, creating an enormous public health challenge. Controlling respiratory infections at the Hajj requires surveillance, rapid diagnostic testing, and containment strategies. Although the Hajj is without equal, other mass gatherings can generate similar hazards. The geographic colocalization of the Zika virus epidemic and the 2016 SummerOlympic Games in Brazil is a current example of great concern. The potential of international mass gatherings for local and global calamity calls for greater global attention and research.
C1 [Al-Tawfiq, Jaffar A.] Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
   [Al-Tawfiq, Jaffar A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Gautret, Philippe; Benkouiten, Samir] Aix Marseille Univ, CNRS 7278, Unite Rech Malad Infect & Trop Emergentes, Inserm 1095,IRD 198,UM63, Marseille, France.
   [Gautret, Philippe; Benkouiten, Samir] Inst Hosp Univ Mediterranee Infect, F-13005 Marseille, France.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, POB 54146, Riyadh 11514, Saudi Arabia.
   [Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia.
RP Memish, ZA (corresponding author), Alfaisal Univ, Coll Med, POB 54146, Riyadh 11514, Saudi Arabia.; Memish, ZA (corresponding author), Alfaisal Univ, Minist Hlth, POB 54146, Riyadh 11514, Saudi Arabia.
EM zmemish@yahoo.com
CR Ahmed QA, 2006, LANCET, V367, P1025, DOI 10.1016/S0140-6736(06)68431-6
   Al-Ghamdi SM, 2003, SAUDI MED J, V24, P1073
   Al-Jasser FS, 2012, SAUDI MED J, V33, P879
   Al-Orainey IO, 2013, SAUDI MED J, V34, P676
   Al-Tawfiq JA, 2015, CLIN MICROBIOL INFEC, V21, P109, DOI [10.1016/j.cmi.2015.02.008, 10.1016/j.cmi.2014.11.013, 10.1016/j.cmi.2014.07.005]
   Al-Tawfiq JA, 2013, E MEDITERR HEALTH J, V19, pS48
   Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6
   Al-Tawfiq JA, 2016, HUM VACC IMMUNOTHER, V12, P326, DOI 10.1080/21645515.2015.1058456
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001
   Al-Tawfiq JA, 2013, CURR OPIN PULM MED, V19, P192, DOI 10.1097/MCP.0b013e32835f1ae8
   Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, V26, P725, DOI 10.1016/j.idc.2012.05.005
   Alfelali M, 2016, HUM VACC IMMUNOTHER, V12, P709, DOI 10.1080/21645515.2015.1085144
   Alfelali M, 2015, VACCINE, V33, P2562, DOI 10.1016/j.vaccine.2015.04.006
   Alherabi AZ, 2011, SAUDI MED J, V32, P933
   Allegranzi B, 2009, AM J INFECT CONTROL, V37, P28, DOI 10.1016/j.ajic.2008.01.014
   Alqahtani AS, 2015, CLIN MICROBIOL INFEC, V21, P115, DOI 10.1016/j.cmi.2014.11.026
   Alzahrani Abdullah G, 2012, J Infect Public Health, V5, P22, DOI 10.1016/j.jiph.2011.10.003
   Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8
   Annan A, 2015, TROP MED INT HEALTH, V20, P807, DOI 10.1111/tmi.12482
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P381
   Ashshi A, 2014, J INFECT DEV COUNTR, V8, P1169, DOI 10.3855/jidc.4204
   Baharoon S, 2009, TRAVEL MED INFECT DI, V7, P247, DOI 10.1016/j.tmaid.2008.09.002
   Balaban V, 2012, J TRAVEL MED, V19, P163, DOI 10.1111/j.1708-8305.2012.00602.x
   Balkhy HH, 2004, J TRAVEL MED, V11, P82, DOI 10.2310/7060.2004.17027
   Barasheed Osamah, 2014, Virologica Sinica, V29, P364, DOI 10.1007/s12250-014-3507-x
   Benkouiten S, 2014, TRAVEL MED INFECT DI, V12, P429, DOI 10.1016/j.tmaid.2014.06.005
   Benkouiten S, 2014, EMERG INFECT DIS, V20, P1821, DOI 10.3201/eid2011.140600
   Benkouiten S, 2014, CLIN INFECT DIS, V58, pE106, DOI 10.1093/cid/cit749
   Blyth CC, 2010, EMERG INFECT DIS, V16, P809, DOI 10.3201/eid1605.091136
   Botelho-Nevers E, 2010, J TRAVEL MED, V17, P197, DOI 10.1111/j.1708-8305.2010.00410.x
   Dunning J, 2014, LANCET INFECT DIS, V14, P1259, DOI 10.1016/S1473-3099(14)70821-7
   El-Sheikh SM, 1998, TROP MED INT HEALTH, V3, P205
   Elachola H, 2014, INT J INFECT DIS, V20, P77, DOI 10.1016/j.ijid.2013.12.001
   Fanoy EB, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-16
   Gardner LM, 2014, RISK ANAL, V34, P1391, DOI 10.1111/risa.12253
   Gautret P, 2013, CLIN MICROBIOL INFEC, V19, pE315, DOI 10.1111/1469-0691.12174
   Gautret P, 2015, TRAVEL MED INFECT DI, V13, P485, DOI 10.1016/j.tmaid.2015.09.008
   Gautret P, 2015, TRAVEL MED INFECT DI, V13, P159, DOI 10.1016/j.tmaid.2015.02.005
   Gautret P, 2013, TRAVEL MED INFECT DI, V11, P95, DOI 10.1016/j.tmaid.2013.03.003
   Gautret P, 2011, J TRAVEL MED, V18, P53, DOI 10.1111/j.1708-8305.2010.00480.x
   Gautret P, 2009, J TRAVEL MED, V16, P377, DOI 10.1111/j.1708-8305.2009.00358.x
   Gundlapalli AV, 2006, EMERG INFECT DIS, V12, P144, DOI 10.3201/eid1201.050645
   Haworth E, 2013, J ROY SOC MED, V106, P215, DOI 10.1258/jrsm.2012.120170
   Hayden FG, 2013, INFLUENZA OTHER RESP, V7, P36, DOI 10.1111/irv.12173
   [International Society for Infectious Diseases ProMed mail], 2014, MERS COV E MED 73 SA, V73
   International Society for Infectious Diseases, 2013, NOV COR E MED 03 SAU
   Ishola DA, 2011, J EPIDEMIOL GLOB HEA, V1, P33, DOI 10.1016/j.jegh.2011.06.004
   Jefferson T, 2011, COCHRANE DB SYST REV, V6
   Kandeel A, 2011, EMERG INFECT DIS, V17, P1266, DOI 10.3201/eid1707.101484
   Khan K, 2010, J TRAVEL MED, V17, P75, DOI 10.1111/j.1708-8305.2010.00397.x
   Kraaij-Dirkzwager M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.21.20817
   Lessler J, 2014, PLOS CURR, V6, P1, DOI DOI 10.1371/CURRENTS.0UTBREAKS.C5C9C9ABD636164A9B6FD4DBDA974369
   Lim HC, 2010, BRIT J SPORT MED, V44, P528, DOI 10.1136/bjsm.2009.069831
   Madani TA, 2007, ANN SAUDI MED, V27, P101, DOI 10.4103/0256-4947.51528
   Madani TA, 2006, ANN SAUDI MED, V26, P346, DOI 10.5144/0256-4947.2006.346
   Mandourah Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-117
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   Memish ZA, 2006, SAUDI MED J, V27, P1367
   Memish ZA, 2014, J INFECT DIS, V210, P1067, DOI 10.1093/infdis/jiu150
   Memish ZA, 2014, INT J INFECT DIS, V25, P186, DOI 10.1016/j.ijid.2014.06.003
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Memish ZA, 2013, EXPERT REV ANTI-INFE, V11, P979, DOI 10.1586/14787210.2013.836965
   Memish ZA, 2012, J TRAVEL MED, V19, P15, DOI 10.1111/j.1708-8305.2011.00575.x
   Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1
   Meysamie A, 2006, SAUDI MED J, V27, P1049
   Michael J A, 1997, Prehosp Disaster Med, V12, P305
   Moattari A, 2012, INFLUENZA OTHER RESP, V6, pe77, DOI 10.1111/j.1750-2659.2012.00380.x
   Rashid H, 2008, Emerg Health Threats J, V1, pe2, DOI 10.3134/ehtj.08.002
   Rashid H, 2008, CLIN MICROBIOL INFEC, V14, P569, DOI 10.1111/j.1469-0691.2008.01987.x
   Razavi SM, 2013, J ROY SOC MED, V106, P386, DOI 10.1177/0141076813504327
   Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778
   Soliman T, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0025-8
   van Hal SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006620
   Verhoeven PO, 2015, CLIN MICROBIOL INFEC, V21
   Wilder-Smith A, 2005, TROP MED INT HEALTH, V10, P336, DOI 10.1111/j.1365-3156.2005.01395.x
   Wilder-Smith A, 2003, CLIN INFECT DIS, V37, P1270, DOI 10.1086/378748
   World Health Organization, 2008, COMM DIS AL RESP MAS
   Ziyaeyan M, 2012, INFLUENZA OTHER RESP, V6, pe80, DOI 10.1111/j.1750-2659.2012.00381.x
NR 78
TC 22
Z9 22
U1 1
U2 8
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1546-3222
EI 2325-6621
J9 ANN AM THORAC SOC
JI Ann. Am. Thoracic Society
PD JUN
PY 2016
VL 13
IS 6
BP 759
EP 765
DI 10.1513/AnnalsATS.201511-772FR
PG 7
WC Respiratory System
SC Respiratory System
GA FR4KO
UT WOS:000419034300001
PM 27088298
DA 2020-07-08
ER

PT J
AU Weaver, SC
   Costa, F
   Garcia-Blanco, MA
   Ko, AI
   Ribeiro, GS
   Saade, G
   Shi, PY
   Vasilakis, N
AF Weaver, Scott C.
   Costa, Federico
   Garcia-Blanco, Mariano A.
   Ko, Albert I.
   Ribeiro, Guilherme S.
   Saade, George
   Shi, Pei-Yong
   Vasilakis, Nikos
TI Zika virus: History, emergence, biology, and prospects for control
SO ANTIVIRAL RESEARCH
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; AEDES-AEGYPTI; POTENTIAL VECTOR; DENGUE VIRUS;
   YELLOW-FEVER; HOST FACTORS; PUERTO-RICO; INFECTION; MOSQUITOS; BRAZIL
AB Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. After its putative evolution in sub-Saharan Africa, ZIKV spread in the distant past to Asia and has probably emerged on multiple occasions into urban transmission cycles involving Aedes (Stegomyia) spp. mosquitoes and human amplification hosts, accompanied by a relatively mild dengue-like illness. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice relatively rare congenital microcephaly and Guillain-Barre syndromes. Another hypothesis is that phenotypic changes in Asian lineage ZIKV strains led to these disease outcomes. Here, we review potential strategies to control the ongoing outbreak through vector-centric approaches as well as the prospects for the development of vaccines and therapeutics. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Costa, Federico; Ko, Albert I.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Garcia-Blanco, Mariano A.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Saade, George] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Costa, Federico/G-1838-2015; Weaver, Scott C/D-6490-2011; Ribeiro,
   Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Weaver, Scott
   C/0000-0001-8016-8556; Ribeiro, Guilherme/0000-0002-6798-2059; Ko,
   Albert Icksang/0000-0001-9023-2339; Garcia-Blanco,
   Mariano/0000-0001-8538-1997
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI120942, AI093491, AI121207]
FX The authors' research on Zika virus is supported by NIH grants AI120942
   and AI093491 to SCW, and AI121207 to AIK.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Atkinson B, 2016, EMERG INFEC IN PRESS
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrows NJ, 2014, METHODS MOL BIOL, V1138, P285, DOI 10.1007/978-1-4939-0348-1_18
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Committee S. P., 2016, AM J OBSTET GYNECOL
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Cornet M., 1979, ORSTOM ENTOMOL MED P, V17, P149
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   de Paula Freitas B., 2016, JAMA OPHTHALMOL BRAZ
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria N. R., 2016, SCI ONLINE
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Garcia-Blanco MA, 2015, RNA, V21, P525, DOI 10.1261/rna.050138.115
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler D J, 1987, P R Health Sci J, V6, P107
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanley KA, 2013, INFECT GENET EVOL
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.003, 10.5365/WPSAR.2013.4.2.003]
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marrs C, 2016, AM J PERINATOL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McGee CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023247
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen E., 2016, INT J INFECT DIS IJI
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Tang H, 2016, CELL STEM CELL
   Taucher C, 2010, J VIROL, V84, P599, DOI 10.1128/JVI.01063-09
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 78
TC 315
Z9 322
U1 17
U2 288
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2016
VL 130
BP 69
EP 80
DI 10.1016/j.antiviral.2016.03.010
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA DM2ZW
UT WOS:000376217600009
PM 26996139
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Benelli, G
AF Benelli, Giovanni
TI Spread of Zika virus: The key role of mosquito vector control
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
AB Mosquitoes (Diptera: Culicidae) represent a key threat for millions of humans and animals worldwide, since they act as vectors for important parasites and pathogens, including malaria, filariasis and a wide number of arboviruses. The recent outbreaks of Zika virus infections occurring in South America, Central America, and the Caribbean, represent the most recent four arrivals of important arboviruses in the western hemisphere, over the last 20 years, namely dengue, West Nile virus, and chikungunya. Since there are no specific treatments for Zika virus and the other arboviruses mentioned above, it should be highlighted that the eco-friendly and effective control of mosquito vectors is of pivotal importance. Besides radiation, transgenic and symbiont-based mosquito control approaches, an effective option may be the employ of biological control agents of mosquito young instars, in presence of ultra-low quantities of green-synthesized nanoparticles, which magnify their predation efficiency. Furthermore, behaviour-based control tools relying on the employ of swarming behaviour manipulation (i.e. the "lure and kill" approach), pheromone traps, sound traps need further research attention. In particular, detailed basic information on the physical and chemical cues routing mosquito swarming and mating dynamics is urgently required.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
CR Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Becker Norbert, 2012, P31
   Benelli G., 2016, PARASITOL RES
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Melaun C, 2015, PARASITOL RES, V114, P1051, DOI 10.1007/s00436-014-4274-1
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   WHO, 2014, MALARIA
   World Health Organization, 2016, ZIK VIR
NR 40
TC 29
Z9 29
U1 0
U2 7
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD JUN
PY 2016
VL 6
IS 6
BP 468
EP 471
DI 10.1016/j.apjtb.2016.03.012
PG 4
WC Tropical Medicine
SC Tropical Medicine
GA DN3EU
UT WOS:000376946000002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Troncoso, A
AF Troncoso, Alcides
TI Zika threatens to become a huge worldwide pandemic
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
AB The Aedes aegypti mosquito which transmits Zika virus (as well as dengue, chikungunya and yellow fever) represents a high risk for global transmission. This virus comes from Africa, the Zika forest in Uganda, where it was discovered in 1947 in a rhesus monkey. In May 2015, the first local cases were recorded in Brazil, surpassing 1.5 million cases in December of the same year. By March 2016, local transmission of Zika was recognized in 34 countries. Its clinical condition is similar to dengue febrile illness, although milder. The final geographical distribution area is constantly expanding. Recently, it has been associated with cases of Guillain-Barre syndrome in Brazil, Colombia, El Salvador, Venezuela and Suriname. Microcephaly was documented in Brazil. This article discusses some factors that contributed to the spread of Zika virus in South America. Climate change associated with the events of the phenomenon of "El Nino" is also analyzed. The biggest concern is how quickly Zika is spreading around the world and that it could be far more dangerous than previously thought. Zika virus infection, by its explosive potential, has every chance of becoming a global pandemic.
C1 [Troncoso, Alcides] Univ Buenos Aires, Dept Infect Dis, Sch Med, Buenos Aires, DF, Argentina.
RP Troncoso, A (corresponding author), Univ Buenos Aires, Dept Infect Dis, Sch Med, Buenos Aires, DF, Argentina.
EM microbiologiayparasitologia@yahoo.com.ar
CR Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x
   Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636
   Llinas GA, 2012, VECTOR-BORNE ZOONOT, V12, P254, DOI 10.1089/vbz.2011.0696
   Ayorinde A. F., 2014, Research Journal of Environmental Toxicology, V8, P46, DOI 10.3923/rjet.2014.46.52
   Barbazan P, 2010, MED VET ENTOMOL, V24, P66, DOI 10.1111/j.1365-2915.2009.00848.x
   Basso C, 2012, AM J TROP MED HYG, V87, P1083, DOI 10.4269/ajtmh.2012.12-0328
   Zambrini DAB, 2011, REV SAUDE PUBL, V45, P428, DOI 10.1590/S0034-89102011000200023
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Diaz-Nieto LM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001963
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Erica RW, 2009, PRENSA MED ARGENT, V96, P185
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Koou SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0471-0
   Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee J, 2016, J KOREAN MED SCI, V31, P331, DOI 10.3346/jkms.2016.31.3.331
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635
   Martinez Fernanda N., 2009, Prensa Medica Argentina, V96, P671
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   MONATH TP, 1988, ARBOVIRUSES EPIDEMIO, V5, P139
   Monath TP, 2001, ENCY ARTHROPOD TRANS, P571
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nafziger EW, 2000, WAR HUNGER DISPLACEM, P91
   Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Rey JR, 2015, BIOMEDICA, V35, P177, DOI [10.1590/S0120-41572015000200005, 10.7705/biomedica.v35i2.2514]
   Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Rubio A, 2011, MEM I OSWALDO CRUZ, V106, P678, DOI 10.1590/S0074-02762011000600006
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P608, DOI 10.2987/5738.1
   Seley Celeste, 2009, Prensa Medica Argentina, V96, P215
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Soliani C, 2010, MED VET ENTOMOL, V24, P316, DOI 10.1111/j.1365-2915.2010.00890.x
   Troncoso AR, 2010, DENGUE DENGUE HEMORR, P167
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Visintin AM, 2009, J AM MOSQUITO CONTR, V25, P208, DOI 10.2987/08-5702.1
   Weaver Scott C., 1997, P329
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 81
TC 7
Z9 8
U1 0
U2 7
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD JUN
PY 2016
VL 6
IS 6
BP 520
EP 527
DI 10.1016/j.apjtb.2016.04.004
PG 8
WC Tropical Medicine
SC Tropical Medicine
GA DN3EU
UT WOS:000376946000011
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Costello, A
   Dua, T
   Duran, P
   Gulmezoglu, M
   Oladapo, OT
   Perea, W
   Pires, J
   Ramon-Pardo, P
   Rollins, N
   Saxena, S
AF Costello, Anthony
   Dua, Tarun
   Duran, Pablo
   Gulmezoglu, Metin
   Oladapo, Olufemi T.
   Perea, William
   Pires, Joao
   Ramon-Pardo, Pilar
   Rollins, Nigel
   Saxena, Shekhar
TI Defining the syndrome associated with congenital Zika virus infection
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Editorial Material
C1 [Costello, Anthony; Rollins, Nigel] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland.
   [Dua, Tarun; Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [Duran, Pablo] WHO, Pan Amer Hlth Org, Ctr Perinatol Women & Reprod Hlth, Montevideo, Uruguay.
   [Gulmezoglu, Metin; Oladapo, Olufemi T.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.
   [Perea, William] WHO, Dept Pandem & Epidem Dis, CH-1211 Geneva, Switzerland.
   [Pires, Joao] WHO, Reg Off Europe, Div Communicable Dis & Hlth Secur, DK-2100 Copenhagen, Denmark.
   [Ramon-Pardo, Pilar] WHO, Dept Communicable Dis & Hlth Anal, Pan Amer Hlth Org, Washington, DC USA.
RP Dua, T (corresponding author), WHO, Dept Mental Hlth & Subst Abuse, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM duat@who.int
FU World Health OrganizationWorld Health Organization [001]
NR 0
TC 80
Z9 81
U1 1
U2 6
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JUN
PY 2016
VL 94
IS 6
BP 406
EP 406
DI 10.2471/BLT.16.176990
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DO9HT
UT WOS:000378096800001
PM 27274588
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wu, KY
   Zuo, GL
   Li, XF
   Ye, Q
   Deng, YQ
   Huang, XY
   Cao, WC
   Qin, CF
   Luo, ZG
AF Wu, Kong-Yan
   Zuo, Guo-Long
   Li, Xiao-Feng
   Ye, Qing
   Deng, Yong-Qiang
   Huang, Xing-Yao
   Cao, Wu-Chun
   Qin, Cheng-Feng
   Luo, Zhen-Ge
TI Vertical transmission of Zika virus targeting the radial glial cells
   affects cortex development of offspring mice
SO CELL RESEARCH
LA English
DT Article
DE Zika virus; vertical transmission; radial glial cells; cortical
   development
ID INFECTION; BRAIN; AMERICA; BRAZIL
AB The recent Zika virus (ZIKV) epidemic in Latin America coincided with a marked increase in microcephaly in newborns. However, the causal link between maternal ZIKV infection and malformation of the fetal brain has not been firmly established. Here we show a vertical transmission of ZIKV in mice and a marked effect on fetal brain development. We found that intraperitoneal (i.p.) injection of a contemporary ZIKV strain in pregnant mice led to the infection of radial glia cells (RGs) of dorsal ventricular zone of the fetuses, the primary neural progenitors responsible for cortex development, and caused a marked reduction of these cortex founder cells in the fetuses. Interestingly, the infected fetal mice exhibited a reduced cavity of lateral ventricles and a discernable decrease in surface areas of the cortex. This study thus supports the conclusion that vertically transmitted ZIKV affects fetal brain development and provides a valuable animal model for the evaluation of potential therapeutic or preventative strategies.
C1 [Wu, Kong-Yan; Zuo, Guo-Long; Luo, Zhen-Ge] Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.
   [Li, Xiao-Feng; Ye, Qing; Deng, Yong-Qiang; Huang, Xing-Yao; Cao, Wu-Chun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zuo, Guo-Long; Luo, Zhen-Ge] Chinese Acad Sci Univ, Beijing, Peoples R China.
   [Luo, Zhen-Ge] ShanghaiTech Univ, Shanghai, Peoples R China.
RP Luo, ZG (corresponding author), Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Luo, ZG (corresponding author), Chinese Acad Sci Univ, Beijing, Peoples R China.; Luo, ZG (corresponding author), ShanghaiTech Univ, Shanghai, Peoples R China.
EM qincf@bmi.ac.cn; zgluo@ion.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Luo, Zhen-Ge/0000-0001-5037-0542
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31330032, 31490591, 31321091, 61327902, 31371063,
   81522025, 8151101191]; National Key Basic Research Program of
   ChinaNational Basic Research Program of China [2014CB910203]; Chinese
   Academy of SciencesChinese Academy of Sciences [XDB02040003]; Youth
   Innovation Promotion Association CAS [2016247]; UK Academy of Medical
   Sciences
FX We thank Dr Fu-Chun Zhang at Guangzhou No. 8 People's hospital for
   providing the convalescent serum from the recovered patient. This study
   was partially supported by grants from, the National Natural Science
   Foundation of China (31330032, 31490591, 31321091, and 61327902 to ZGL,
   31371063 to KYW, 81522025 and 8151101191 to CFQ), the National Key Basic
   Research Program of China (2014CB910203), the Strategic Priority
   Research Program of the Chinese Academy of Sciences (XDB02040003), the
   Youth Innovation Promotion Association CAS (2016247 to KYW), and the
   Newton Advanced Fellowship from the UK Academy of Medical Sciences (to
   CFQ).
CR Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 38
TC 163
Z9 165
U1 0
U2 69
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD JUN
PY 2016
VL 26
IS 6
BP 645
EP 654
DI 10.1038/cr.2016.58
PG 10
WC Cell Biology
SC Cell Biology
GA DO0DL
UT WOS:000377449500005
PM 27174054
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Cavalheiro, S
   Lopez, A
   Serra, S
   Da Cunha, A
   da Costa, MDS
   Moron, A
   Lederman, HM
AF Cavalheiro, Sergio
   Lopez, Amanda
   Serra, Suzana
   Da Cunha, Arthur
   da Costa, Marcos Devanir S.
   Moron, Antonio
   Lederman, Henrique M.
TI Microcephaly and Zika virus: neonatal neuroradiological aspects
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Zika virus; Microcephaly; Ventriculomegaly; Lissencephaly; Intracranial
   calcifications; Aedes aegypti
ID INFECTION
AB The aim of this study is to describe some radiological features in the newborns with microcephaly caused by Zika virus infection during pregnancy.
   We radiologically analyzed 13 cases of newborns with microcephaly born to mothers who were infected by the Zika virus in the early stage of pregnancy.
   The most frequently observed radiological findings were microcephaly and decreased brain parenchymal volume associated with lissencephaly, ventriculomegaly secondary to the lack of brain tissue (not hypertensive), and coarse and anarchic calcifications mainly involving the subcortical cortical transition, and the basal ganglia.
   Although it cannot be concluded that there is a definitive pathognomonic radiographic pattern of microcephaly caused by Zika virus, gross calcifications and anarchic distribution involving the subcortical cortical transition and the basal ganglia, in association with lissencephaly and in the absence of hypertensive ventriculomegaly, are characteristic of this type of infection.
C1 [Cavalheiro, Sergio; da Costa, Marcos Devanir S.] Univ Fed Sao Paulo, Dept Neurosurg, Rua Botucatu 591,Conj 41, BR-04023062 Sao Paulo, SP, Brazil.
   [Lopez, Amanda; Serra, Suzana; Da Cunha, Arthur] Hosp Restauracao, Neurosurg Serv, Recife, PE, Brazil.
   [Moron, Antonio] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, SP, Brazil.
   [Lederman, Henrique M.] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, SP, Brazil.
RP Cavalheiro, S (corresponding author), Univ Fed Sao Paulo, Dept Neurosurg, Rua Botucatu 591,Conj 41, BR-04023062 Sao Paulo, SP, Brazil.
EM sergiocavalheironeuro@gmail.com
RI da Costa, Marcos Devanir Silva/K-7128-2019; MORON, ANTONIO
   F./H-4987-2013
OI da Costa, Marcos Devanir Silva/0000-0003-3552-6347; MORON, ANTONIO
   F./0000-0002-7963-1758
CR Adibi J. J., 2016, LANCET
   Almeida G, 1964, ARQ NEURO-PSIQUIAT, V22, P1
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   CDC, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, N ENGL J MED
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morquio L, 1903, HIDROCEFALIA REV MED, V6, P4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Swan C, 1943, MED J AUSTRALIA, V2, P1
   Swan C, 1946, J PATHOL, V56, P6
NR 11
TC 48
Z9 50
U1 0
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JUN
PY 2016
VL 32
IS 6
BP 1057
EP 1060
DI 10.1007/s00381-016-3074-6
PG 4
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA DN3VD
UT WOS:000376991200010
PM 27080092
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Musso, D
   Baud, D
   Gubler, DJ
AF Musso, D.
   Baud, D.
   Gubler, D. J.
TI Zika virus: what do we know?
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Editorial Material
ID UNITED-STATES; TRANSMISSION; HEALTH
C1 [Musso, D.] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete 98713, Tahiti, France.
   [Baud, D.] Univ Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, Matern, Lausanne, Switzerland.
   [Gubler, D. J.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
RP Musso, D (corresponding author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, France.
EM dmusso@ilm.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496
CR Baud D, 2016, LANCET INFECT DIS
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau V. M., 2016, LANCET
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Faria NR, 2016, SCIENCE
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   International Federation of Red Cross and Red Crescent Societies World Health Organization UNICEF, 2016, RISK COMM COMM ENG Z
   Korhonen E., 2016, EURO SURVEILL, V21
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET INFECT DIS, V3099
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shakir R, 2016, LANCET NEUROL, V15, P353, DOI 10.1016/S1474-4422(16)00072-7
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   World Health Organization, 2016, ZIK SIT REP WHO
NR 23
TC 11
Z9 11
U1 0
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2016
VL 22
IS 6
BP 494
EP 496
DI 10.1016/j.cmi.2016.03.032
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DQ5NM
UT WOS:000379252100005
PM 27067096
OA Bronze
DA 2020-07-08
ER

PT J
AU Ribeiro, LS
   Marques, RE
   de Jesus, AMR
   de Almeida, RP
   Teixeira, MM
AF Ribeiro, Lucas Secchim
   Marques, Rafael Elias
   Ribeiro de Jesus, Amelia Maria
   de Almeida, Roque Pacheco
   Teixeira, Mauro Martins
TI Zika crisis in Brazil: challenges in research and development
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID VIRUS-INFECTION; DENGUE VIRUS; TRANSMISSION; REPLICATION; MICRONESIA;
   INHIBITORS; PREGNANCY; EPIDEMIC; MODEL; MICE
AB Infection with the Zika virus (ZIKV) usually causes a mild acute illness, but two major severe syndromes have been described during the epidemic in Brazil: microcephaly and the Guillain-Barre Syndrome. There is now much evidence to show that ZIKV can infect and damage neuronal cells in vitro. In experimental animals, ZIKV has significant neurotropism and can cause brain damage. At present, diagnosis is still a challenge in the field and there is no treatment available. Another major challenge is that one must devise therapies for pregnant women, at all stages of pregnancy. Devising adequate treatment for ZIKV infections represents a challenge that will only be met by the joint effort of the research community.
C1 [Ribeiro, Lucas Secchim] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Ribeiro, Lucas Secchim; Marques, Rafael Elias; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Immunopharmacol, Belo Horizonte, MG, Brazil.
   [Ribeiro de Jesus, Amelia Maria; de Almeida, Roque Pacheco] Univ Fed Sergipe, Lab Biol Mol, Univ Hosp, Aracaju, Brazil.
   [Ribeiro de Jesus, Amelia Maria; de Almeida, Roque Pacheco] Univ Fed Sergipe, Programa Pos Grad Ciencias Saude, Univ Hosp, Aracaju, Brazil.
RP Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Immunopharmacol, Belo Horizonte, MG, Brazil.
EM mmtex@icb.ufmg.br
RI amsalu, ribka/G-8780-2019; Marques, Rafael Elias/R-4890-2016; Teixeira,
   Mauro M/A-4587-2008
OI Marques, Rafael Elias/0000-0002-6949-0947; Teixeira, Mauro
   M/0000-0002-6944-3008; Secchim Ribeiro, Lucas/0000-0001-8876-3827
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
FX We would like to thank CNPq and FAPEMIG for their financial support.
CR [Anonymous], 2016, LANCET INFECT DIS, V16, P265
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Brazilian Health Ministry BR, 2015, MIN SAUD DIV B EP
   Brazilian Health Ministry BR, 2016, EPIDEMIOL WEEK, V2016, P5
   Brazilian Health Ministry BR, 2016, MON MICR CAS BRAZ
   Calvet G., 2016, LANCET INFECT DIS
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Faria NR, 2016, SCIENCE
   Garcez PPLE, 2016, PEERJ PREPRINTS, V4
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear H M, 2016, JAMA
   Lazear H. M., 2016, J VIROL
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison Juliet, 2014, JAKSTAT, V3, pe27715, DOI 10.4161/jkst.27715
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Roberts SS, 2010, BIRTH DEFECTS RES A, V88, P551, DOI 10.1002/bdra.20682
   Rossi SL, 2016, AM J TROP MED HYG
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang H, 2016, CELL STEM CELL
   Thorne C, 2007, DRUG SAFETY, V30, P203, DOI 10.2165/00002018-200730030-00004
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Vogel G, 2016, SCIENCE, V351, P1377, DOI 10.1126/science.351.6280.1377
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 52
TC 22
Z9 22
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD JUN
PY 2016
VL 18
BP 76
EP 81
DI 10.1016/j.coviro.2016.04.002
PG 6
WC Virology
SC Virology
GA DU5TC
UT WOS:000382273200014
PM 27179929
DA 2020-07-08
ER

PT J
AU Li, JD
   Xiong, Y
   Wu, W
   Liu, XQ
   Qu, J
   Zhao, X
   Zhang, S
   Li, JH
   Li, WH
   Liao, Y
   Gong, T
   Wang, LJ
   Shi, Y
   Xiong, YF
   Ni, DX
   Li, Q
   Liang, MF
   Hu, GL
   Li, DX
AF Li, Jiandong
   Xiong, Ying
   Wu, Wei
   Liu, Xiaoqing
   Qu, Jing
   Zhao, Xiang
   Zhang, Shuo
   Li, Jianhua
   Li, Weihong
   Liao, Yong
   Gong, Tian
   Wang, Lijing
   Shi, Yong
   Xiong, Yanfeng
   Ni, Daxin
   Li, Qun
   Liang, Mifang
   Hu, Guoliang
   Li, Dexin
TI Zika Virus in a Traveler Returning to China from Caracas, Venezuela,
   February 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
C1 [Li, Jiandong; Wu, Wei; Qu, Jing; Zhao, Xiang; Zhang, Shuo; Wang, Lijing; Liang, Mifang; Li, Dexin] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Changbai Rd 155, Beijing 102206, Peoples R China.
   [Xiong, Ying; Liu, Xiaoqing; Gong, Tian; Shi, Yong; Hu, Guoliang] Jiangxi Prov Ctr Dis Control & Prevent, Beijingdong Rd 555, Nanchang 330029, Peoples R China.
   [Li, Jiandong; Liao, Yong; Xiong, Yanfeng] Ganzhou Municipal Ctr Dis Control & Prevent, Ganzhou, Peoples R China.
   [Ni, Daxin; Li, Qun] Chinese Ctr Dis Control & Prevent, Off Emergence Response, Beijing, Peoples R China.
   [Li, Weihong] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China.
RP Li, DX (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Changbai Rd 155, Beijing 102206, Peoples R China.; Hu, GL (corresponding author), Jiangxi Prov Ctr Dis Control & Prevent, Beijingdong Rd 555, Nanchang 330029, Peoples R China.
EM jxcdchgl@163.com; lidx@chinacdc.cn
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Xu RM, 1990, VECTOR DENGUE FEVER, P51
NR 10
TC 26
Z9 30
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2016
VL 22
IS 6
BP 1133
EP 1136
DI 10.3201/eid2206.160273
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DN0YY
UT WOS:000376794200038
PM 27070735
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khan, AW
   Ali, S
AF Khan, Abdul Waheed
   Ali, Shahid
TI Zika virus infection: Some issues of urgent attention
SO INFECTION DISEASE & HEALTH
LA English
DT Letter
DE Zika virus; Infection; Diagnosis; Transmission; Prevention
C1 [Khan, Abdul Waheed; Ali, Shahid] Univ Swat, Ctr Biotechnol & Microbiol, Mingora, Pakistan.
RP Khan, AW (corresponding author), Univ Swat, Ctr Biotechnol & Microbiol, Mingora, Pakistan.
EM khan_ibge@yahoo.com
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasir S, 2016, J ARTHOROPOD BORNE D
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2468-0451
J9 INFECT DIS HEALTH
JI Infect. Dis. Health
PD JUN
PY 2016
VL 21
IS 2
BP 84
EP 85
DI 10.1016/j.idh.2016.06.001
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA VG2ET
UT WOS:000445698500005
OA Bronze
DA 2020-07-08
ER

PT J
AU Zumla, A
   McCloskey, B
   Bin Saeed, AA
   Dar, O
   Al Otabi, B
   Perlmann, S
   Gautret, P
   Roy, N
   Blumberg, L
   Azhar, EI
   Barbeschi, M
   Memish, Z
   Petersen, E
AF Zumla, A.
   McCloskey, B.
   Bin Saeed, A. A.
   Dar, O.
   Al Otabi, B.
   Perlmann, S.
   Gautret, P.
   Roy, N.
   Blumberg, L.
   Azhar, E. I.
   Barbeschi, M.
   Memish, Z.
   Petersen, E.
TI What is the experience from previous mass gathering events? Lessons for
   Zika virus and the Olympics 2016
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Mass gatherings; Hajj; Mela Kumba; Zika virus; Olympic games
ID RESPIRATORY SYNDROME; SOUTH-KOREA; OUTBREAK; DISEASE
AB All previous experiences from different mass gathering show that vaccine preventable diseases is the most important infections like influenza, hepatitis A, polio and meningitis. Three mass gathering held in Africa during the Ebola outbreak accepted participants from West Africa and was able to handle the theoretical risk without any incident. Therefore we believe that the Olympic games in Rio de Janeiro should not be cancelled. The number of visitors to the games is a tiny fraction (1%) of other visitors to Zika endemic countries and it will have no measurable effect on the risk of spreading Zika virus, if the games was cancelled. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Zumla, A.] UCL, Div Infect & Immun, London, England.
   [Zumla, A.] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   [McCloskey, B.] Publ Hlth England, Global Hlth Dept, London, England.
   [Bin Saeed, A. A.] King Saud Univ, Coll Med, Dept Family & Community Med, Riyadh, Saudi Arabia.
   [Dar, O.] Publ Hlth England, London, England.
   [Al Otabi, B.] WHO, Collaborating Ctr Mass Gatherings Med, Off Deputy Minister Prevent Med, Minist Hlth, Riyadh, Saudi Arabia.
   [Perlmann, S.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Gautret, P.] North Hosp, Infect Dis & Trop Med Unit, Marseille, France.
   [Roy, N.] Tata Inst Social Sci, Sch Habitat Studies, Environm Hlth Resource Hub, Mumbai, Maharashtra, India.
   [Blumberg, L.] Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa.
   [Azhar, E. I.] King Abdulaziz Univ, Fac Appl Med Sci, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah, Saudi Arabia.
   [Azhar, E. I.] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah, Saudi Arabia.
   [Barbeschi, M.] WHO, Geneva, Switzerland.
   [Memish, Z.] Alfaisal Univ, Coll Med, Minist Hlth, Riyadh, Saudi Arabia.
   [Petersen, E.] Univ Aarhus, Inst Clin Med, Aarhus, Denmark.
   [Petersen, E.] Royal Hosp, Dept Infect Dis, Muscat, Oman.
RP Petersen, E (corresponding author), Univ Aarhus, Inst Clin Med, Aarhus, Denmark.; Petersen, E (corresponding author), Royal Hosp, Dept Infect Dis, Muscat, Oman.
EM eskild.petersen@gmail.com
OI Azhar, Esam/0000-0002-1736-181X; Roy MD, PhD,
   Nobhojit/0000-0003-2022-7416; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735
CR Aitsi-Selmi A, 2016, INT J INFECT DIS, V47, P101, DOI 10.1016/j.ijid.2016.04.006
   Alqahtani AS, 2016, INT J INFECT DIS, V47, P53, DOI 10.1016/j.ijid.2016.02.005
   Atabani SF, 2016, INT J INFECT DIS, V47, P10, DOI 10.1016/j.ijid.2016.04.016
   Barasheed O, 2016, INT J INFECT DIS, V47, P105, DOI 10.1016/j.ijid.2016.03.023
   Bauch CT, 2013, LANCET, V382, P662, DOI 10.1016/S0140-6736(13)61504-4
   Blumberg L, 2016, INT J INFECT DIS, V47, P38, DOI 10.1016/j.ijid.2016.06.011
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   David S, 2016, INT J INFECT DIS, V47, P42, DOI 10.1016/j.ijid.2016.01.010
   El-Ghany M. A., 2016, International Journal of Infectious Diseases, V47, P29, DOI 10.1016/j.ijid.2016.05.024
   Gautret P, 2016, INT J INFECT DIS, V47, P46, DOI 10.1016/j.ijid.2016.03.007
   Gautret P, 2016, INT J INFECT DIS, V47, P83, DOI 10.1016/j.ijid.2016.01.013
   Griffiths K, 2016, TRAVEL MED INFECT DI, V14, P414, DOI 10.1016/j.tmaid.2016.05.002
   Hadi MA, 2016, INT J INFECT DIS, V47, P95, DOI 10.1016/j.ijid.2016.06.003
   Haseeb A, 2016, INT J INFECT DIS, V47, P92, DOI 10.1016/j.ijid.2016.06.006
   Hopkins N, 2016, INT J INFECT DIS, V47, P112, DOI 10.1016/j.ijid.2015.12.017
   Ismail SA, 2016, INT J INFECT DIS, V47, P15, DOI 10.1016/j.ijid.2016.05.011
   Kupferschmidt K, 2012, SCIENCE, V336, P1224, DOI 10.1126/science.336.6086.1224
   Laaveri T, 2016, CLIN MICROBIOL INFEC, V22, P535, DOI 10.1016/j.cmi.2016.02.011
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Lee SS, 2015, INT J INFECT DIS, V38, P65, DOI 10.1016/j.ijid.2015.07.014
   Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403
   Perlman S, 2016, INT J INFECT DIS, V47, P23, DOI 10.1016/j.ijid.2016.04.008
   Petersen E, 2015, INT J INFECT DIS, V36, P54, DOI 10.1016/j.ijid.2015.06.004
   US Centers for Disease Control and Prevention, 2016, 2016 SUMM OL
   Wilder-Smith A, 2003, CLIN INFECT DIS, V36, P679, DOI 10.1086/367858
   Yezli S, 2016, INT J INFECT DIS, V47, P71, DOI 10.1016/j.ijid.2015.12.010
   Yezli S, 2016, INT J INFECT DIS, V47, P65, DOI 10.1016/j.ijid.2015.11.014
   Yezli S, 2016, INT J INFECT DIS, V47, P60, DOI 10.1016/j.ijid.2016.04.007
   Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012
   Zumla A, 2016, INT J INFECT DIS, V47, P86, DOI 10.1016/j.ijid.2016.02.003
NR 30
TC 8
Z9 8
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2016
VL 47
BP 1
EP 4
DI 10.1016/j.ijid.2016.06.010
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EC7NC
UT WOS:000388325500001
PM 27321962
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zumla, A
   Dar, O
   Kock, R
   Muturi, M
   Ntoumi, F
   Kaleebu, P
   Eusebio, M
   Mfinanga, S
   Bates, M
   Mwaba, P
   Ansumana, R
   Khan, M
   Alagaili, AN
   Cotteno, M
   Azhar, EI
   Maeurer, M
   Ippolito, G
   Petersen, E
AF Zumla, Alimuddin
   Dar, Osman
   Kock, Richard
   Muturi, Matthew
   Ntoumi, Francine
   Kaleebu, Pontiano
   Eusebio, Macete
   Mfinanga, Sayoki
   Bates, Matthew
   Mwaba, Peter
   Ansumana, Rashid
   Khan, Mishal
   Alagaili, Abdulaziz N.
   Cotteno, Matthew
   Azhar, Esam I.
   Maeurer, Markus
   Ippolito, Giuseppe
   Petersen, Eskild
TI Taking forward a 'One Health' approach for turning the tide against the
   Middle East respiratory syndrome coronavirus and other zoonotic
   pathogens with epidemic potential
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
DE One Health; MERS-CoV; Zoonoses; Camels; Epidemic
ID MERS-COV; DROMEDARY CAMELS; PUBLIC-HEALTH; SURVEILLANCE; PREPAREDNESS;
   LESSONS; RISK
AB The appearance of novel pathogens of humans with epidemic potential and high mortality rates have threatened global health security for centuries. Over the past few decades new zoonotic infectious diseases of humans caused by pathogens arising from animal reservoirs have included West Nile virus, Yellow fever virus, Ebola virus, Nipah virus, Lassa Fever virus, Hanta virus, Dengue fever virus, Rift Valley fever virus, Crimean-Congo haemorrhagic fever virus, severe acute respiratory syndrome coronavirus, highly pathogenic avian influenza viruses, Middle East Respiratory Syndrome Coronavirus, and Zika virus. The recent Ebola Virus Disease epidemic in West Africa and the ongoing Zika Virus outbreak in South America highlight the urgent need for local, regional and international public health systems to be be more coordinated and better prepared. The One Health concept focuses on the relationship and interconnectedness between Humans, Animals and the Environment, and recognizes that the health and wellbeing of humans is intimately connected to the health of animals and their environment (and vice versa). Critical to the establishment of a One Health platform is the creation of a multidisciplinary team with a range of expertise including public health officers, physicians, veterinarians, animal husbandry specialists, agriculturalists, ecologists, vector biologists, viral phylogeneticists, and researchers to cooperate, collaborate to learn more about zoonotic spread between animals, humans and the environment and to monitor, respond to and prevent major outbreaks. We discuss the unique opportunities for Middle Eastern and African stakeholders to take leadership in building equitable and effective partnerships with all stakeholders involved in human and health systems to take forward a 'One Health' approach to control such zoonotic pathogens with epidemic potential. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   [Dar, Osman] Publ Hlth England London, Chatham House Ctr Global Hlth Secur, Royal Inst Int Affairs, London, England.
   [Kock, Richard] Univ London Royal Vet Coll, Dept Pathol & Pathogen Biol, London NW1 0TU, Herts, England.
   [Muturi, Matthew] Kenya Zoonot Dis Unit, Nairobi, Kenya.
   [Ntoumi, Francine] Fdn Congolaise Rech Med, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Kaleebu, Pontiano] MRC, Uganda Virus Res Inst Res Unit AIDS, Entebbe, Uganda.
   [Eusebio, Macete] Minist Hlth, Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Eusebio, Macete] Minist Hlth, Natl Directorate Publ Hlth, Maputo, Mozambique.
   [Mfinanga, Sayoki] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania.
   [Bates, Matthew; Mwaba, Peter] Univ Teaching Hosp, UNZA UCLMS Project, Lusaka, Zambia.
   [Ansumana, Rashid] Mercy Hosp, Res Lab, Kulanda Town, Bo, Sierra Leone.
   [Khan, Mishal] London Sch Hyg & Trop Med, London, England.
   [Khan, Mishal] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Alagaili, Abdulaziz N.] King Saud Univ, Coll Sci, Dept Zool, Mammals Res Chair, Riyadh 11451, Saudi Arabia.
   [Cotteno, Matthew] Wellcome Trust Sanger Inst, Cambridge, England.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah, Saudi Arabia.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah, Saudi Arabia.
   [Maeurer, Markus] Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden.
   [Ippolito, Giuseppe] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Rome, Italy.
   [Petersen, Eskild] Univ Aarhus, Aarhus, Denmark.
   [Petersen, Eskild] Royal Hosp, Muscat, Oman.
RP Petersen, E (corresponding author), Univ Aarhus, Aarhus, Denmark.; Petersen, E (corresponding author), Royal Hosp, Muscat, Oman.
EM eskildp@dadlnet.dk
RI Ippolito, Giuseppe/J-7207-2017; Mwaba, Peter/V-6017-2019; Alagaili,
   Abdulaziz/C-4278-2018
OI Azhar, Esam/0000-0002-1736-181X; Kock, Richard/0000-0002-6561-3209;
   Cotten, Matthew/0000-0002-3361-3351; Ippolito,
   Giuseppe/0000-0002-1076-2979; Alagaili, Abdulaziz/0000-0002-9733-4220;
   Bates, Matthew/0000-0003-0464-1529; Maeurer, Markus/0000-0002-8436-8077;
   Zumla, Professor Sir Alimuddin/0000-0002-5111-5735
CR Alagaili AN, 2014, MBIO, V5, DOI 10.1128/mBio.00884-14
   American Veterinary Medical Association, 2008, ON HLTH NEW PROF IMP
   [Anonymous], 2014, OIE WORLD ORG AN HLT
   [Anonymous], 2016, EB VIR DIS OUTBR
   Arabi YM, 2016, J INFECT PUBLIC HEAL, V9, P205, DOI 10.1016/j.jiph.2016.03.005
   Arabi YM, 2016, LANCET RESP MED, V4, P93, DOI 10.1016/S2213-2600(16)00007-2
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Briese T, 2014, MBIO, V5
   Du L, 2016, TRENDS MICROBIOL, V24, P87, DOI 10.1016/j.tim.2015.12.013
   Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171
   Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X
   Hui DS, 2015, CURR OPIN PULM MED, V21, P284, DOI 10.1097/MCP.0000000000000153
   Hui DS, 2014, J INFECT DIS, V209, P173, DOI 10.1093/infdis/jit591
   International Organization for Standardization, 2014, WHO DEV ISO STAND
   International Severe Acute Respiratory and Emerging Infection Consortium, WEBS INT SEV AC RESP
   Ippolito G, 2015, LANCET INFECT DIS, V15, P1254, DOI 10.1016/S1473-3099(15)00236-4
   Jacobsen KH, 2016, ECOHEALTH, V13, P200, DOI 10.1007/s10393-016-1100-5
   Mathis Margaux, 2015, Wkly Epidemiol Rec, V90, P238
   McCloskey B, 2014, LANCET INFECT DIS, V14, P1001, DOI 10.1016/S1473-3099(14)70846-1
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0
   One Health, 2014, WHAT IS ON HLTH
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen E, 2015, INT J INFECT DIS, V36, P54, DOI 10.1016/j.ijid.2015.06.004
   Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590
   Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608
   Saudi Ministry of Health, 2016, WEEKL MERS COV MON
   Smith MJ, 2015, MONASH BIOETH REV, V33, P130, DOI 10.1007/s40592-015-0038-7
   The FAO-OIE-WHO Collaboration, 2010, SHAR RESP COORD GLOB
   Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.379.6070, 10.11694/pamj.supp.2015.22.1.6626]
   Uyeki TM, 2016, EMERG INFECT DIS, V22
   Wang Y, 2015, BIOMED RES INT, V2015, P6, DOI DOI 10.1128/MBI0.01280-15
   WHO, 2016, ZOONOSES
   WHO, 2016, MIDDL E RESP SYNDR C
   WHO, 2015, DIS OUTBREAK NE 0208
   Who Mers-Cov Research Group, 2013, PLOS CURR, V5, DOI [10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8, DOI 10.1371/CURRENTS.OUTBREAKS.0BF719E352E7478F8AD85FA30127DDB8]
   World Bank, 2010, PEOPL PATH OUR PLAN, V1
   World Health Organization, 2016, WHO PUBL LIST TOP EM
   World Health Organization, 2016, IHR EM COMM MIDDL E
   World Health Organization, 2016, GOARN
   World Health Organization, 2016, ROADM RES PROD DEV M
   World Health Organization, 2016, ZIK VIR
   World Health Organization, 2016, RES DEV BLUEPR ACT P
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A, 2015, INT J INFECT DIS, V37, P77, DOI 10.1016/j.ijid.2015.06.020
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
   Zumla A, 2015, NATURE, V523, P35, DOI 10.1038/523035b
NR 48
TC 31
Z9 31
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2016
VL 47
BP 5
EP 9
DI 10.1016/j.ijid.2016.06.012
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA EC7NC
UT WOS:000388325500002
PM 27321961
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Derrington, SM
   Cellura, P
   McDermott, LE
   Gubitosi, T
   Sonstegard, AM
   Chen, S
   Garg, A
AF Derrington, Sarah M.
   Cellura, Paul
   McDermott, Laura E.
   Gubitosi, Taylor
   Sonstegard, Anna Marie
   Chen, Sheng
   Garg, Amit
TI Mucocutaneous Findings and Course in an Adult With Zika Virus Infection
SO JAMA DERMATOLOGY
LA English
DT Article
AB IMPORTANCE The Zika virus epidemic has been declared a public health emergency of international concern by the World Health Organization. We describe the mucocutaneous features and histologic correlation in a patient with the acute Zika virus infection.
   OBSERVATIONS We observed the presence of a diffuse papular descending eruption, petechiae on the palate, and hyperemic sclerae in a 44-year-old man returning from Puerto Rico with confirmatory testing for the Zika virus.
   CONCLUSIONS AND RELEVANCE A detailed awareness of mucocutaneous findings associated with Zika virus infection will support its early recognition and will facilitate elimination of Zika infection from consideration for concerned patients who present with other, more common erythematous eruptions.
C1 [Derrington, Sarah M.; Cellura, Paul; McDermott, Laura E.; Gubitosi, Taylor; Sonstegard, Anna Marie; Chen, Sheng; Garg, Amit] Hofstra Northwell Sch Med, Dept Dermatol, 1991 Marcus Ave,Ste 300,New Hyde Pk, Hempstead, NY 11042 USA.
RP Garg, A (corresponding author), Hofstra Northwell Sch Med, Dept Dermatol, 1991 Marcus Ave,Ste 300,New Hyde Pk, Hempstead, NY 11042 USA.
EM amgarg@northwell.edu
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
NR 6
TC 17
Z9 17
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6068
EI 2168-6084
J9 JAMA DERMATOL
JI JAMA Dermatol.
PD JUN
PY 2016
VL 152
IS 6
BP 691
EP 693
DI 10.1001/jamadermatol.2016.1433
PG 3
WC Dermatology
SC Dermatology
GA DR0HM
UT WOS:000379588600017
PM 27168495
OA Bronze
DA 2020-07-08
ER

PT J
AU Imperato, PJ
AF Imperato, Pascal James
TI The Convergence of a Virus, Mosquitoes, and Human Travel in Globalizing
   the Zika Epidemic
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Review
DE Zika virus; Zika virus infection; Zika virus and travel; Microcephaly;
   Guillain-Barre syndrome; Zika Forest and Pascal James Imperato; Kisubi
   Catholic Mission; Aedes aegypti
ID SEXUAL TRANSMISSION; INFECTIONS; NIGERIA
AB The Zika virus was first identified in 1947 in the Zika Forest of Uganda. It was discovered in a rhesus monkey that had been placed in a cage on a sentinel platform in the forest by the Virus Research Institute. When this writer visited the institute and the Zika Forest in 1961, work was underway to identify mosquito species at various levels of the tree canopy. This was done through the placement of traps at various levels of a 120-foot-high steel tower which this writer climbed. At that time, researchers isolated 12 strains of Zika virus from traps on the tower. Over the next six decades, the virus spread slowly to other parts of Africa, and eventually appeared in Southeast Asia, transmitted by Aedes aegypti and other Aedes mosquito species. By 1981, only 14 cases of illness had been reported as due to the Zika virus. Since most infections with this virus are either mild or asymptomatic, its true geographic spread was not fully appreciated. The current globalization of the Zika epidemic began on the Pacific island of Yap in the Federated States of Polynesia in 2007. This was the first known presence of the Zika virus outside of Africa and Southeast Asia. It was estimated that 73 % of the island's population had been infected. In 2013, the virus spread to French Polynesia where an estimated 28,000 cases occurred in a population of 270,000. During that year and afterwards, microcephaly and other congenital abnormalities were observed in the infants of women who were pregnant when they contracted the virus. It is currently not known if cases of microcephaly have resulted from infection of pregnant women or from infection plus some other co-factor. The epidemic rapidly spread to the Cook Islands and Easter Island. In 2015, Zika virus infection was diagnosed in Brazil where it was associated with microcephaly in the infants of some women who were pregnant when they contracted the disease. Cases of the Guillain-Barr, syndrome were also found to be associated with Zika virus infection. How the disease entered Brazil is a matter of conjecture. However, the strain responsible for the epidemic in Brazil and elsewhere in South and Central America is phylogenetically identical to that which caused the epidemic in French Polynesia. The wide distribution of Aedes aegypti, a principal vector of the virus, and other Aedes species has greatly facilitated the spread of the disease. Aedes aegypti is an invasive species of mosquito in the Western Hemisphere that has adapted well to densely-populated urban environments. In addition, male-to-female human sexual transmission has increasingly been demonstrated in the US and elsewhere. In February 2016, the World Health Organization (WHO) declared the current Zika outbreak a Public Health Emergency of international concern. On the recommendation of its Emergency Committee on Zika Virus and Observed Increase in Neurological Disorders and Neonatal Malformations, WHO issued a group of recommendations to contain the epidemic. The globalization of the Zika virus was made possible by the widespread presence in various parts of the world of Aedes vectors and increased human travel that facilitated geographic spread. This globalization of Zika follows upon that of West Nile, Ebola, Dengue, and Chikungunya. Its ultimate spread is difficult to predict, but will hopefully be restricted through vigorous preventive measures.
C1 [Imperato, Pascal James] Suny Downstate Med Ctr, Sch Publ Hlth, 450 Clarkson Ave,MSC 43, Brooklyn, NY 11203 USA.
RP Imperato, PJ (corresponding author), Suny Downstate Med Ctr, Sch Publ Hlth, 450 Clarkson Ave,MSC 43, Brooklyn, NY 11203 USA.
EM pascal.imperato@downstate.edu
RI amsalu, ribka/G-8780-2019
CR [Anonymous], 2016, WHO 1 M INT HLTH REG
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   McNeil Jr D. G, 2016, NY TIMES, VCLXV, pA5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Saint Louis C., 2016, NY TIMES, VCLXV, pA5
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tavernise S., 2016, NY TIMES, VCLXV, pA14
   Tavernise S, 2016, NY TIMES, pA3
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 40
Z9 43
U1 0
U2 91
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD JUN
PY 2016
VL 41
IS 3
BP 674
EP 679
DI 10.1007/s10900-016-0177-7
PG 6
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DK3TB
UT WOS:000374839200029
PM 26969497
OA Bronze
DA 2020-07-08
ER

PT J
AU Cavalcanti, LPD
   Tauil, PL
   Alencar, CH
   Oliveira, W
   Teixeira, MM
   Heukelbach, J
AF de Goes Cavalcanti, Luciano Pamplona
   Tauil, Pedro Luiz
   Alencar, Carlos Henrique
   Oliveira, Wanderson
   Teixeira, Mauro Martins
   Heukelbach, Jorg
TI Zika virus infection, associated microcephaly, and low yellow fever
   vaccination coverage in Brazil: is there any causal link?
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Zika; Brazil; epidemiology
AB Introduction: Since the end of 2014, Zika virus (ZIKV) infection has been rapidly spreading in Brazil.
   Methodology: To analyze the possible association of yellow fever vaccine with a protective effect against ZIKV-related microcephaly, the following spatial analyses were performed, using Brazilian municipalities as units: i) yellow fever vaccination coverage in Brazilian municipalities in individuals aged 15-49; ii) reported cases of microcephaly by municipality; and iii) confirmed cases of microcephaly related to ZIKV, by municipality. SaTScan software was used to identify clusters of municipalities for high risk of microcephaly.
   Results: There were seven significant high risk clusters of confirmed microcephaly cases, with four of them located in the Northeast where yellow fever vaccination rates were the lowest. The clusters harbored only 2.9% of the total population of Brazil, but 15.2% of confirmed cases of microcephaly.
   Conclusion: We hypothesize that pregnant women in regions with high yellow fever vaccination coverage may pose their offspring to lower risk for development of microcephaly. There is an urgent need for systematic studies to confirm the possible link between low yellow fever vaccination coverage, Zika virus infection and microcephaly.
C1 [de Goes Cavalcanti, Luciano Pamplona; Alencar, Carlos Henrique; Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, Ceara, Brazil.
   [Oliveira, Wanderson] Minist Saude Brasil, Coordenacao Geral Vigilancia & Resposta Emergenci, Brasilia, DF, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Heukelbach, Jorg] James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia.
   [Heukelbach, Jorg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
   [Tauil, Pedro Luiz] Univ Brasilia UnB, Fac Med, Brasilia, DF, Brazil.
RP Cavalcanti, LPD (corresponding author), Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, Ceara, Brazil.
EM pamplona.luciano@gmail.com
RI amsalu, ribka/G-8780-2019; Teixeira, Mauro M/A-4587-2008; Oliveira,
   Wanderson/AAF-5182-2019
OI Teixeira, Mauro M/0000-0002-6944-3008; Oliveira,
   Wanderson/0000-0002-9662-1930; Alencar, Carlos
   Henrique/0000-0003-2967-532X; Heukelbach, Jorg/0000-0002-7845-5510
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Brasil, 2015, PROT VIG RESP OC MIC
   Brasil. Secretaria de Vigilancia em Saude. Departamento de Vigilancia em Saude, 2005, MAN VIG EP PRIM NAO
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan M, 2016, LANCET, DOI [10.1016/S0140-6736(16)30620-1, DOI 10.1016/S0140-6736(16)30620-1.]
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Cavalcante KRLJ, 2016, EPIDEMIOL SERV SAUDE, V25, P11, DOI [10.5123/S1679-49742016000100002, 10.5123/s1679-49742016000100002]
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 17
Z9 17
U1 0
U2 31
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD JUN
PY 2016
VL 10
IS 6
BP 563
EP 566
DI 10.3855/jidc.8575
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DQ5SY
UT WOS:000379266500003
PM 27367003
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Massey, TH
   Robertson, NP
AF Massey, T. H.
   Robertson, N. P.
TI Zika virus and neurology: proving cause and effect
SO JOURNAL OF NEUROLOGY
LA English
DT Editorial Material
C1 [Massey, T. H.; Robertson, N. P.] Cardiff Univ, Div Psychol Med & Clin Neurosci, Dept Neurol, Univ Hosp Wales, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.
RP Robertson, NP (corresponding author), Cardiff Univ, Div Psychol Med & Clin Neurosci, Dept Neurol, Univ Hosp Wales, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.
EM robertsonnp@cardiff.ac.uk
NR 0
TC 2
Z9 3
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD JUN
PY 2016
VL 263
IS 6
BP 1255
EP 1257
DI 10.1007/s00415-016-8165-5
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA VB9EF
UT WOS:000423055300001
PM 27230852
OA Green Published, Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Pastula, DM
   Smith, DE
   Beckham, JD
   Tyler, KL
AF Pastula, Daniel M.
   Smith, Daniel E.
   Beckham, J. David
   Tyler, Kenneth L.
TI Four emerging arboviral diseases in North America: Jamestown Canyon,
   Powassan, chikungunya, and Zika virus diseases
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Review
DE Arbovirus; Arboviral disease; Jamestown Canyon virus; Powassan virus;
   Chikungunya virus; Zika virus; North America
ID GUILLAIN-BARRE-SYNDROME; INFECTION; BUNYAVIRIDAE; CALIFORNIA; SEROGROUP;
   OUTBREAK; STATES; FEVER
AB Arthropod-borne viruses, or arboviruses, are viruses that are transmitted through the bites of mosquitoes, ticks, or sandflies. There are numerous arboviruses throughout the world capable of causing human disease spanning different viral families and genera. Recently, Jamestown Canyon, Powassan, chikungunya, and Zika viruses have emerged as increasingly important arboviruses that can cause human disease in North America. Unfortunately, there are currently no proven disease-modifying therapies for these arboviral diseases, so treatment is largely supportive. Given there are also no commercially available vaccines for these four arboviral infections, prevention is the key. To prevent mosquito or tick bites that might result in one of these arboviral diseases, people should wear long-sleeved shirts and pants while outside if feasible, apply insect repellant when going outdoors, using window screens or air conditioning to keep mosquitoes outside, and perform tick checks after being in wooded or brushy outdoor areas.
C1 [Pastula, Daniel M.] Univ Colorado Denver, Dept Neurol, Neuroinfect Dis Grp, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
   Univ Colorado Denver, Div Infect Dis, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
RP Pastula, DM (corresponding author), Univ Colorado Denver, Dept Neurol, Neuroinfect Dis Grp, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
EM Daniel.Pastula@ucdenver.edu
RI Pastula, Daniel M./M-1325-2019; Tyler, Kenneth L./J-2420-2019
OI Pastula, Daniel M./0000-0001-9342-4459; Tyler, Kenneth
   L./0000-0003-3294-5888
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32 AI052066]
CR AGUIRRE AA, 1992, J WILDLIFE DIS, V28, P435, DOI 10.7589/0090-3558-28.3.435
   Anderson JF, 2015, AM J TROP MED HYG, V92, P377, DOI 10.4269/ajtmh.14-0291
   Andreadis TG, 2008, VECTOR-BORNE ZOONOT, V8, P175, DOI 10.1089/vbz.2007.0169
   Angelini R, 2007, EUROSURVEILLANCE, V12
   [Anonymous], ZIK VIR
   [Anonymous], PREV TICK BIT
   [Anonymous], ARB
   [Anonymous], PREV MOSQ BIT
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Centers for Disease Control, POW VIR
   Centers for Disease Control and Prevention (CDC), CHIK VIR
   Deibel R, 1983, Prog Clin Biol Res, V123, P313
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Gatherer D, 2015, J GEN VIROL
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   GRIMSTAD PR, 1986, AM J TROP MED HYG, V35, P376, DOI 10.4269/ajtmh.1986.35.376
   Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022
   Johnson Diep K Hoang, 2010, WMJ, V109, P91
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2013, EURO SURVEILL, V19
   Pastula DM, 2015, AM J TROP MED HYG, V93, P384, DOI 10.4269/ajtmh.15-0196
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Walters LL, 1999, AM J TROP MED HYG, V60, P806, DOI 10.4269/ajtmh.1999.60.806
NR 30
TC 24
Z9 24
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2016
VL 22
IS 3
BP 257
EP 260
DI 10.1007/s13365-016-0428-5
PG 4
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA DO0JR
UT WOS:000377465700001
PM 26903031
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Farahnik, B
   Beroukhim, K
   Blattner, CM
   Young, J
AF Farahnik, Benjamin
   Beroukhim, Kourosh
   Blattner, Collin M.
   Young, John, III
TI Cutaneous manifestations of the Zika virus
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Editorial Material
DE disease prevention and control; microcephaly; public health concerns;
   viral exanthem; Zika virus
C1 [Farahnik, Benjamin] Univ Vermont, Coll Med, Burlington, VT 05405 USA.
   [Beroukhim, Kourosh] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Blattner, Collin M.] Good Samaritan Reg Med Ctr, Corvallis, OR USA.
   [Young, John, III] Silver Falls Dermatol, 1793 13th St SE, Salem, OR 97302 USA.
RP Young, J (corresponding author), Silver Falls Dermatol, 1793 13th St SE, Salem, OR 97302 USA.
EM jyoung@silverfallsderm.net
CR CDC Division of Vector-Borne Diseases, 2016, REV DIAGN TEST ZIK C
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Mann D, 2016, PRACT DERMATOL, V13, P10
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   WHO, 2016, ZIK VIR FACT SHEET
NR 6
TC 7
Z9 7
U1 0
U2 46
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD JUN
PY 2016
VL 74
IS 6
BP 1286
EP 1287
DI 10.1016/j.jaad.2016.02.1232
PG 2
WC Dermatology
SC Dermatology
GA DM2LV
UT WOS:000376179200056
PM 27016775
DA 2020-07-08
ER

PT J
AU Boete, C
   Reeves, RG
AF Boete, Christophe
   Reeves, R. Guy
TI Alternative vector control methods to manage the Zika virus outbreak:
   more haste, less speed
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID AMERICA
C1 [Boete, Christophe] Aix Marseille Univ, UMR Emergence Pathol Virales, Inserm 1207, EHESP,IRD 190, F-13385 Marseille, France.
   [Reeves, R. Guy] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.
RP Boete, C (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales, Inserm 1207, EHESP,IRD 190, F-13385 Marseille, France.
EM cboete@gmail.com
RI BOETE, Christophe/A-7926-2010
OI BOETE, Christophe/0000-0001-9043-8652
CR Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   James S, 2011, SCIENCE, V334, P771, DOI 10.1126/science.1213798
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 5
TC 2
Z9 2
U1 0
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUN
PY 2016
VL 4
IS 6
BP E363
EP E363
DI 10.1016/S2214-109X(16)00084-X
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM6LH
UT WOS:000376463200012
PM 27198836
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Bouyer, J
   Chandre, F
   Gilles, J
   Baldet, T
AF Bouyer, Jeremy
   Chandre, Fabrice
   Gilles, Jeremie
   Baldet, Thierry
TI Alternative vector control methods to manage the Zika virus outbreak:
   more haste, less speed
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID MOSQUITOS
C1 [Bouyer, Jeremy; Baldet, Thierry] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34398 Montpellier, France.
   [Chandre, Fabrice] Inst Rech Dev, Unite Mixte Rech Malad infect & Vecteurs Ecol Gen, Montpellier, France.
   [Gilles, Jeremie] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.
RP Bouyer, J (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34398 Montpellier, France.
EM bouyer@cirad.fr
RI Chandre, Fabrice/Q-3429-2019; Bouyer, Jeremy/AAK-7370-2020
OI Bouyer, Jeremy/0000-0002-1913-416X; Chandre, Fabrice/0000-0002-1994-9705
FU European Research Council under the European UnionEuropean Research
   Council (ERC) [682387-REVOLINC]
FX We declare no competing interests. This project has been selected for
   funding from the European Research Council under the European Union's
   Horizon 2020 research and innovation programme (grant agreement No
   682387-REVOLINC). This Correspodence reflects only the authors' views
   and the Agency is not responsible for any use that may be made of the
   information it contains.
CR Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X
   Curtis Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003999
   Locatelli MAF, 2011, ARCH ENVIRON CON TOX, V60, P385, DOI 10.1007/s00244-010-9550-1
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 5
TC 11
Z9 11
U1 0
U2 74
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUN
PY 2016
VL 4
IS 6
BP E364
EP E364
DI 10.1016/S2214-109X(16)00082-6
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM6LH
UT WOS:000376463200013
PM 27198837
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, FC
   Li, XF
   Deng, YQ
   Tong, YG
   Qin, CF
AF Zhang, Fu-Chun
   Li, Xiao-Feng
   Deng, Yong-Qiang
   Tong, Yi-Gang
   Qin, Cheng-Feng
TI Excretion of infectious Zika virus in urine
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Zhang, Fu-Chun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Li, Xiao-Feng; Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.
   [Tong, Yi-Gang; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.; Qin, CF (corresponding author), State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
EM qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Tong, Yigang/0000-0002-8503-8045
FU Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS)
   [NAF003\\1003]
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
NR 5
TC 55
Z9 60
U1 0
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 641
EP 642
DI 10.1016/S1473-3099(16)30070-6
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500020
PM 27184420
OA Bronze
DA 2020-07-08
ER

PT J
AU Calvet, G
   Aguiar, RS
   Melo, ASO
   Sampaio, SA
   de Filippis, I
   Fabri, A
   Araujo, ESM
   de Sequeira, PC
   de Mendonca, MCL
   de Oliveira, L
   Tschoeke, DA
   Schrago, CG
   Thompson, FL
   Brasil, P
   dos Santos, FB
   Nogueira, RMR
   Tanurit, A
   Filippis, AMB
AF Calvet, Guilherme
   Aguiar, Renato S.
   Melo, Adriana S. O.
   Sampaio, Simone A.
   de Filippis, Ivano
   Fabri, Allison
   Araujo, Eliane S. M.
   de Sequeira, Patricia C.
   de Mendonca, Marcos C. L.
   de Oliveira, Louisi
   Tschoeke, Diogo A.
   Schrago, Carlos G.
   Thompson, Fabiano L.
   Brasil, Patricia
   dos Santos, Flavia B.
   Nogueira, Rita M. R.
   Tanurit, Amilcar
   de Filippis, Ana M. B.
TI Detection and sequencing of Zika virus from amniotic fluid of fetuses
   with microcephaly in Brazil: a case study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; INFECTION; OUTBREAK; FEVER
AB Background The incidence of microcephaly in Brazil in 2015 was 20 times higher than in previous years. Congenital microcephaly is associated with genetic factors and several causative agents. Epidemiological data suggest that microcephaly cases in Brazil might be associated with the introduction of Zika virus. We aimed to detect and sequence the Zika virus genome in amniotic fluid samples of two pregnant women in Brazil whose fetuses were diagnosed with microcephaly.
   Methods In this case study, amniotic fluid samples from two pregnant women from the state of Paraiba in Brazil whose fetuses had been diagnosed with microcephaly were obtained, on the recommendation of the Brazilian health authorities, by ultrasound-guided transabdominal amniocentesis at 28 weeks' gestation. The women had presented at 18 weeks' and 10 weeks' gestation, respectively, with clinical manifestations that could have been symptoms of Zika virus infection, including fever, myalgia, and rash. After the amniotic fluid samples were centrifuged, DNA and RNA were extracted from the purified virus particles before the viral genome was identified by quantitative reverse transcription PCR and viral metagenomic next-generation sequencing. Phylogenetic reconstruction and investigation of recombination events were done by comparing the Brazilian Zika virus genome with sequences from other Zika strains and from flaviviruses that occur in similar regions in Brazil.
   Findings We detected the Zika virus genome in the amniotic fluid of both pregnant women. The virus was not detected in their urine or serum. Tests for dengue virus, chikungunya virus, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus, HIV, Treponema pallidum, and parvovirus B19 were all negative. After sequencing of the complete genome of the Brazilian Zika virus isolated from patient 1, phylogenetic analyses showed that the virus shares 97-100% of its genomic identity with lineages isolated during an outbreak in French Polynesia in 2013, and that in both envelope and NS 5 genomic regions, it clustered with sequences from North and South America, southeast Asia, and the Pacific. After assessing the possibility of recombination events between the Zika virus and other flaviviruses, we ruled out the hypothesis that the Brazilian Zika virus genome is a recombinant strain with other mosquito-borne flaviviruses.
   Interpretation These findings strengthen the putative association between Zika virus and cases of microcephaly in neonates in Brazil. Moreover, our results suggest that the virus can cross the placental barrier. As a result, Zika virus should be considered as a potential infectious agent for human fetuses. Pathogenesis studies that confirm the tropism of Zika virus for neuronal cells are warranted.
C1 [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, BR-21040900 Rio De Janeiro, Brazil.
   [Sampaio, Simone A.; Fabri, Allison; Araujo, Eliane S. M.; de Sequeira, Patricia C.; de Mendonca, Marcos C. L.; dos Santos, Flavia B.; Nogueira, Rita M. R.; de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Nacl Controle & Qualidade, BR-21040900 Rio De Janeiro, Brazil.
   [Aguiar, Renato S.; de Oliveira, Louisi; Schrago, Carlos G.; Tanurit, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Tschoeke, Diogo A.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Melo, Adriana S. O.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestaotecnol CT2, Rio de Janeiro, Brazil.
RP Filippis, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
EM abispo@ioc.fiocruz.br
RI Aguiar, Renato S/G-3542-2015; de Filippis, Ivano/X-8759-2019; amsalu,
   ribka/G-8780-2019; Melo, Adriana S O/H-5650-2016; Schrago,
   Carlos/E-4612-2012; Tschoeke, Diogo A/F-9913-2019; Calvet,
   Guilherme/G-6959-2013
OI Aguiar, Renato S/0000-0001-5180-3717; de Filippis,
   Ivano/0000-0003-0610-8648; Schrago, Carlos/0000-0001-6257-8906;
   Tschoeke, Diogo A/0000-0001-8134-4259; Calvet,
   Guilherme/0000-0002-3545-5238
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Consellho Nacional de Desenvolvimento e Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazilian Ministry of Health, 2016, MINIST SAFICLE INVES
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437
   Harris SR, 2013, DEV NEUROREHABIL, V16, P129, DOI 10.3109/17518423.2012.737040
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Lanari M, 2012, EARLY HUM DEV, V88, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Sibley SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098569
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 532
Z9 553
U1 12
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 653
EP 660
DI 10.1016/S1473-3099(16)00095-5
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500044
PM 26897108
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Tappe, D
   Perez-Giron, JV
   Zammarchi, L
   Rissland, J
   Ferreira, DF
   Jaenisch, T
   Gomez-Medina, S
   Gunther, S
   Bartoloni, A
   Munoz-Fontela, C
   Schmidt-Chanasit, J
AF Tappe, Dennis
   Perez-Giron, Jose Vicente
   Zammarchi, Lorenzo
   Rissland, Juergen
   Ferreira, Davis F.
   Jaenisch, Thomas
   Gomez-Medina, Sergio
   Guenther, Stephan
   Bartoloni, Alessandro
   Munoz-Fontela, Cesar
   Schmidt-Chanasit, Jonas
TI Cytokine kinetics of Zika virus-infected patients from acute to
   reconvalescent phase
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Zika virus; Arbovirus; Flavivirus; Zika fever; Outbreak; Cytokine
ID SERUM-LEVELS; DENGUE
AB Zika virus is an emerging mosquito-borne flavivirus currently causing large epidemics in the Pacific Ocean region and Brazil. Clinically, Zika fever resembles dengue fever, but is less severe. Whereas the clinical syndrome and laboratory diagnostic procedures have been described, little attention was paid to the immunology of the disease and its possible use for clinical follow-up of patients. Here, we investigate the role of cytokines in the pathogenesis of Zika fever in travelers returning from Asia, the Pacific, and Brazil. Polyfunctional T cell activation (Th1, Th2, Th9, and Th17 response) was seen during the acute phase characterized by respective cytokine level increases, followed by a decrease in the reconvalescent phase.
C1 [Tappe, Dennis; Guenther, Stephan; Munoz-Fontela, Cesar; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Tappe, Dennis; Guenther, Stephan; Munoz-Fontela, Cesar; Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
   [Perez-Giron, Jose Vicente; Gomez-Medina, Sergio; Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.
   [Zammarchi, Lorenzo; Bartoloni, Alessandro] Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
   [Rissland, Juergen] Univ Saarland, Med Ctr, Inst Virol, Homburg, Germany.
   [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
RP Tappe, D (corresponding author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Tappe, D (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
EM tappe@bnitm.de
RI BARTOLONI, ALESSANDRO/K-3403-2018; Jaenisch, Thomas/H-3473-2017
OI BARTOLONI, ALESSANDRO/0000-0001-9758-1523; ZAMMARCHI,
   Lorenzo/0000-0003-0892-8404; Gunther, Stephan/0000-0002-6562-0230
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Guzman-Fulgencio M, 2012, J ANTIMICROB CHEMOTH, V67, P1238, DOI 10.1093/jac/dkr595
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Martina Byron E. E., 2014, Science Progress, V97, P197, DOI 10.3184/003685014X14049173153889
   McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 73
Z9 75
U1 0
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD JUN
PY 2016
VL 205
IS 3
BP 269
EP 273
DI 10.1007/s00430-015-0445-7
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DM3QR
UT WOS:000376261700009
PM 26702627
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Gostin, LO
   Katz, R
AF Gostin, Lawrence O.
   Katz, Rebecca
TI The International Health Regulations: The Governing Framework for Global
   Health Security
SO MILBANK QUARTERLY
LA English
DT Article
DE International Health Regulations; global health security; World Health
   Organization reform; crisis management; emergency response
ID ZIKA VIRUS; OUTBREAK; EBOLA; SARS; EPIDEMIC
AB The International Health Regulations (IHR) are the governing framework for global health security yet require textual and operational reforms to remain effective, particularly as parallel initiatives are developed. The World Health Organization (WHO) is the agency charged with oversight of the IHR, and its leadership and efficient functioning are prerequisites for the effective implementation of the IHR. We reviewed the historical origins of the IHR and their performance over the past 10 years and analyzed all of the ongoing reform panel efforts to provide a series of politically feasible recommendations for fundamental reform. This article offers proposals for fundamental reformwith politically feasible pathwaysof the IHR, their operations and implementation, WHO oversight, and State Party conformance.
   ContextThe International Health Regulations (IHR) have been the governing framework for global health security for the past decade and are a nearly universally recognized World Health Organization (WHO) treaty, with 196 States Parties. In the wake of the Ebola epidemic, major global commissions have cast doubt on the future effectiveness of the IHR and the leadership of the WHO.
   MethodsWe conducted a review of the historical origins of the IHR and their performance over the past 10 years and analyzed all of the ongoing reform panel efforts to provide a series of politically feasible recommendations for fundamental reform.
   FindingsWe propose a series of recommendations with realistic pathways for change. These recommendations focus on the development and strengthening of IHR core capacities; independently assessed metrics; new financing mechanisms; harmonization with the Global Health Security Agenda, Performance of Veterinary Services (PVS) Pathways, the Pandemic Influenza Preparedness Framework, and One Health strategies; public health and clinical workforce development; Emergency Committee transparency and governance; tiered public health emergency of international concern (PHEIC) processes; enhanced compliance mechanisms; and an enhanced role for civil society.
   ConclusionsEmpowering the WHO and realizing the IHR's potential will shore up global health securitya vital investment in human and animal healthwhile reducing the vast economic consequences of the next global health emergency.
C1 [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW,McDonough 574, Washington, DC 20001 USA.
   [Katz, Rebecca] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
RP Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW,McDonough 574, Washington, DC 20001 USA.
EM gostin@law.georgetown.edu
OI Gostin, Lawrence/0000-0001-5286-4044
CR [Anonymous], 2015, LANCET, V386, P103, DOI 10.1016/S0140-6736(15)61225-9
   [Anonymous], 2014, LANCET, V384, P1321, DOI 10.1016/S0140-6736(14)61697-4
   [Anonymous], 2015, NY TIMES
   [Anonymous], 2016, INT HLTH REG
   Boateng L., 2015, PERSPECTIVES GLOBAL
   Buse K, 2014, CURRENT LEGAL ISSUES, V16
   Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960
   Fleck F, 2003, B WORLD HEALTH ORGAN, V81, P625
   general L.O. GOSTIN, 2014, GLOBAL HLTH LAW
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Gostin LO, 2014, LANCET, V384, P1323, DOI 10.1016/S0140-6736(14)61791-8
   Gostin LO, 2015, JAMA
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Heymann DL, 2013, LANCET, V381, P779, DOI 10.1016/S0140-6736(13)60185-3
   Heymann DL, 2004, PHILOS T ROY SOC B, V359, P1127, DOI 10.1098/rstb.2004.1484
   Howard-Jones N, 1975, SCI BACKGR INT SAN C
   Jha A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i409
   Katz R, 2009, EMERG INFECT DIS, V15, P1165, DOI 10.3201/eid1508.090665
   Lescano AG, 2007, SCIENCE, V318, P574, DOI 10.1126/science.1146837
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Lucey DR, 2015, MERS IN KOREA WHY TH
   McNeil Jr D. G., 2013, NY TIMES
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Standley CJ, 2015, SCIENCE, V348, P762, DOI 10.1126/science.aaa5521
   Phu TD, 2014, MMWR-MORBID MORTAL W, V63, P77
   United Nations Development Group (UNDG)-Western and Central Africa, 2015, SOC IMP EB VIR DIS W
   WHA, 1995, WHA487
   WHA, 2002, WHA5516
   WHA, 2001, WHA5414
   White House, 2015, FACT SHEET US COMM G
   White House, 2014, GLOB HLTH SEC AG WOR
   WHO, 2013, EM RESP FRAM, P19
   WHO, 2015, IMPL INT HLTH REG 20
   WHO, 2009, CURR WHO PHAS PAND A
   WHO, 2005, STAT PART INT HLTH R
   WHO, 2015, REP RB INT ASS PAN
   WHO, 2016, DIR GEN EX BOARD ITS
   WHO, 2015, MIDDL E RESP SYNDR S
   WHO, ADV GROUP REF WHOS W
   WHO, 2015, EM COMM 9 M SUMM BRI
   World Health Organization, EB VIR DIS OUTBR
   World Health Organization, 2015, 2014 EB VIR DIS OUTB
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
   World Health Organization (WHO), 2013, IHR COR CAP MON FRAM
NR 48
TC 32
Z9 32
U1 16
U2 50
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-378X
EI 1468-0009
J9 MILBANK Q
JI Milbank Q.
PD JUN
PY 2016
VL 94
IS 2
BP 264
EP 313
DI 10.1111/1468-0009.12186
PG 50
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA DP5OX
UT WOS:000378548000008
PM 27166578
OA Green Published
DA 2020-07-08
ER

PT J
AU Dudley, DM
   Aliota, MT
   Mohr, EL
   Weiler, AM
   Lehrer-Brey, G
   Weisgrau, KL
   Mohns, MS
   Breitbach, ME
   Rasheed, MN
   Newman, CM
   Gellerup, DD
   Moncla, LH
   Post, J
   Schultz-Darken, N
   Schotzko, ML
   Hayes, JM
   Eudailey, JA
   Moody, MA
   Permar, SR
   O'Connor, SL
   Rakasz, EG
   Simmons, HA
   Capuano, S
   Golos, TG
   Osorio, JE
   Friedrich, TC
   O'Connor, DH
AF Dudley, Dawn M.
   Aliota, Matthew T.
   Mohr, Emma L.
   Weiler, Andrea M.
   Lehrer-Brey, Gabrielle
   Weisgrau, Kim L.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Rasheed, Mustafa N.
   Newman, Christina M.
   Gellerup, Dane D.
   Moncla, Louise H.
   Post, Jennifer
   Schultz-Darken, Nancy
   Schotzko, Michele L.
   Hayes, Jennifer M.
   Eudailey, Josh A.
   Moody, M. Anthony
   Permar, Sallie R.
   O'Connor, Shelby L.
   Rakasz, Eva G.
   Simmons, Heather A.
   Capuano, Saverio
   Golos, Thaddeus G.
   Osorio, Jorge E.
   Friedrich, Thomas C.
   O'Connor, David H.
TI A rhesus macaque model of Asian-lineage Zika virus infection
SO NATURE COMMUNICATIONS
LA English
DT Article
AB Infection with Asian-lineage Zika virus (ZIKV) has been associated with Guillain-Barre syndrome and fetal abnormalities, but the underlying mechanisms remain poorly understood. Animal models of infection are thus urgently needed. Here we show that rhesus macaques are susceptible to infection by an Asian-lineage ZIKV closely related to strains currently circulating in the Americas. Following subcutaneous inoculation, ZIKV RNA is detected in plasma 1 day post infection (d.p.i.) in all animals (N = 8, including 2 pregnant animals), and is also present in saliva, urine and cerebrospinal fluid. Non-pregnant and pregnant animals remain viremic for 21 days and for up to at least 57 days, respectively. Neutralizing antibodies are detected by 21 d.p.i. Rechallenge 10 weeks after the initial challenge results in no detectable virus replication, indicating protective immunity against homologous strains. Therefore, Asian-lineage ZIKV infection of rhesus macaques provides a relevant animal model for studying pathogenesis and evaluating potential interventions against human infection, including during pregnancy.
C1 [Dudley, Dawn M.; Mohns, Mariel S.; Breitbach, Meghan E.; Rasheed, Mustafa N.; Newman, Christina M.; Moncla, Louise H.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.
   [Aliota, Matthew T.; Moncla, Louise H.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53705 USA.
   [Weiler, Andrea M.; Lehrer-Brey, Gabrielle; Weisgrau, Kim L.; Gellerup, Dane D.; Post, Jennifer; Schultz-Darken, Nancy; Schotzko, Michele L.; Hayes, Jennifer M.; Rakasz, Eva G.; Simmons, Heather A.; Capuano, Saverio; Golos, Thaddeus G.; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
   [Eudailey, Josh A.; Moody, M. Anthony; Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.
   [Eudailey, Josh A.; Moody, M. Anthony; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Obstet & Gynecol, Madison, WI 53706 USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.; O'Connor, DH (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
EM dhoconno@wisc.edu
RI Rakasz, Eva G/H-9197-2019; Moody, M/AAB-6947-2020
OI Moody, M/0000-0002-3890-5855; Friedrich, Thomas/0000-0001-9831-6895;
   Aliota, Matthew/0000-0002-6902-9149
FU DHHS/PHS/NIH [R01Al116382-01A1, R01Al107157-01A1, DP2HD075699]; Research
   Facilities Improvement ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR15459-01, RR020141-01];  [P51OD011106]
FX We thank the Veterinary, Animal Care, Scientific Protocol Implementation
   and the Pathology staff at the WNPRC for their contribution to this
   study. We thank the DHHS/PHS/NIH (R01Al116382-01A1 to D.H.O'C.),
   (R01Al107157-01A1 to T.G.G.) and (DP2HD075699 to S.R.P.) for funding. We
   also thank the P51OD011106 awarded to the WNPRC, Madison-Wisconsin. This
   research was conducted in part at a facility constructed with support
   from Research Facilities Improvement Program grants RR15459-01 and
   RR020141-01.
CR Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Brasil P, 2016, N ENGL J MED
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauck M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-107
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Lugo-Roman LA, 2010, J MED PRIMATOL, V39, P41, DOI 10.1111/j.1600-0684.2009.00394.x
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pomplun N, 2015, CYTOM PART A, V87A, P890, DOI 10.1002/cyto.a.22727
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   Staprans SI, 1999, J VIROL, V73, P4829, DOI 10.1128/JVI.73.6.4829-4839.1999
   Stockham S.L., 2002, FUNDAMENTALS VET CLI
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 24
TC 214
Z9 216
U1 0
U2 51
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN
PY 2016
VL 7
AR 12204
DI 10.1038/ncomms12204
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ3PV
UT WOS:000379115100001
PM 27352279
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Molnar, Z
   Kennedy, S
AF Molnar, Zoltan
   Kennedy, Stephen
TI Risks of Zika virus during the first trimester of pregnancy
SO NATURE REVIEWS NEUROLOGY
LA English
DT Editorial Material
AB The ongoing Zika virus (ZIKV) epidemic in the Americas raises urgent questions about the risks of microcephaly in the children of ZIKV-infected mothers. New research into the 2013-2014 ZIKV outbreak in French Polynesia supports a link between maternal ZIKV infection during the first trimester of pregnancy and microcephaly.
C1 [Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford OX1 3QX, England.
   [Kennedy, Stephen] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
RP Molnar, Z (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford OX1 3QX, England.
EM zoltan.molnar@dpag.ox.ac.uk
RI Molnar, Zoltan/J-7281-2012
OI Molnar, Zoltan/0000-0002-6852-6004
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102];
   Medical Research CouncilMedical Research Council UK (MRC) [MR/N026039/1]
CR Brasil P, 2016, N ENGL J MED
   Cauchemez S, 2016, LANCET
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez P. P., 2016, SCIENCE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008
   Stolp Helen, 2012, Front Psychiatry, V3, P50, DOI 10.3389/fpsyt.2012.00050
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
NR 10
TC 2
Z9 2
U1 0
U2 61
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4758
EI 1759-4766
J9 NAT REV NEUROL
JI Nat. Rev. Neurol.
PD JUN
PY 2016
VL 12
IS 6
BP 315
EP U13
DI 10.1038/nrneurol.2016.71
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA DN1LR
UT WOS:000376827800001
PM 27150532
OA Bronze
DA 2020-07-08
ER

PT J
AU Whalley, K
AF Whalley, Katherine
TI Spinning organoids shed light on Zika
SO NATURE REVIEWS NEUROSCIENCE
LA English
DT Editorial Material
OI Whalley, Katherine/0000-0001-9598-5671
NR 0
TC 0
Z9 0
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-003X
EI 1471-0048
J9 NAT REV NEUROSCI
JI Nat. Rev. Neurosci.
PD JUN
PY 2016
VL 17
IS 6
DI 10.1038/nrn.2016.66
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA DM2GG
UT WOS:000376164500003
PM 27194600
OA Bronze
DA 2020-07-08
ER

PT J
AU Bharucha, T
   Breuer, J
AF Bharucha, Tehmina
   Breuer, Judith
TI Review: A neglected Flavivirus: an update on Zika virus in 2016 and the
   future direction of research
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Review
DE arbovirus; emerging infection; Flavivirus; public health
ID GUILLAIN-BARRE-SYNDROME; JAPANESE ENCEPHALITIS; YELLOW-FEVER;
   NEUROLOGICAL MANIFESTATIONS; FRENCH-POLYNESIA; ENVELOPE PROTEIN;
   CONTROLLED-TRIAL; INFECTION; TRANSMISSION; DENGUE
AB The 2015-16 global emergence of Zika virus infection (ZIKV) and its link with Guillain-Barre Syndrome and microcephaly, at the tail-end of the Ebola epidemic, has provoked unease throughout the international community. The World Health Organisation declared ZIKV a public health emergency on 1st February 2016, but until the 31st March 2016 maintained that there was insufficient evidence that ZIKV was independently responsible for any serious complications. Our current understanding of this arthropod-borne flavivirus is still at an early stage. The first reported human infections were 60 years ago, and until the first outbreak in Micronesia in 2007, there were only 14 documented cases. Nonetheless, there are parallels that we can draw from our understanding of other related arbo-flaviviruses, such as dengue, Japanese encephalitis and West Nile viruses. This article provides a focussed review of the literature on ZIKV to date, with perspectives on the direction of future research.
C1 [Bharucha, Tehmina; Breuer, Judith] UCL, London WC1E 6BT, England.
   [Bharucha, Tehmina] Royal Free Hosp NHS Fdn Trust, Dept Virol, London, England.
RP Bharucha, T (corresponding author), UCL, Div Infect & Immun, Cruciform Bldg,Gower St, London WC1E 6BT, England.
EM t.bharucha@doctors.org.uk
OI Breuer, Judith/0000-0001-8246-0534
FU National Institute for Health ResearchNational Institute for Health
   Research (NIHR) [3410]
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Carteaux G, 2016, N ENGL J MED
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Donadieu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084473
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   Howard CR, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.37
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kariwa H, 2013, INT J ENV RES PUB HE, V10, P7144, DOI 10.3390/ijerph10127144
   Kindhausera MK, 2016, B WHO
   King AMQ, 2011, VIRUS TAXONOMY
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kumar R, 2009, CLIN INFECT DIS, V48, P400, DOI 10.1086/596309
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Majumder MS, 2016, B WHO, DOI 10.2471/BLT.16.171009
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2015, MEM I O CRUZ, V110, P569
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 2003, CURR OPIN INFECT DIS, V16, P375, DOI 10.1097/00001432-200310000-00002
   Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2
   Solomon TW. R., 2014, INFECT CENTRAL NERVO, P210
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Velandia ML, 2012, FLAVIVIRUS NEUROTROP
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, ZIK SIT REP
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
   Zhang F, 2014, COCHRANE DATABASE SY
   Zuckerman AJ, 2009, PRINCIPLES PRACTICE
NR 66
TC 7
Z9 7
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD JUN
PY 2016
VL 42
IS 4
BP 317
EP 325
DI 10.1111/nan.12326
PG 9
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO1BC
UT WOS:000377512300001
PM 27029817
DA 2020-07-08
ER

PT J
AU Bonaldo, MC
   Ribeiro, IP
   Lima, NS
   dos Santos, AAC
   Menezes, LSR
   da Cruz, SOD
   de Mello, IS
   Furtado, ND
   de Moura, EE
   Damasceno, L
   da Silva, KAB
   de Castro, MG
   Gerber, AL
   de Almeida, LGP
   Lourenco-de-Oliveira, R
   Vasconcelos, ATR
   Brasil, P
AF Bonaldo, Myrna C.
   Ribeiro, Ieda P.
   Lima, Noemia S.
   dos Santos, Alexandre A. C.
   Menezes, Lidiane S. R.
   da Cruz, Stephanie O. D.
   de Mello, Iasmim S.
   Furtado, Nathalia D.
   de Moura, Elaine E.
   Damasceno, Luana
   da Silva, Kely A. B.
   de Castro, Marcia G.
   Gerber, Alexandra L.
   de Almeida, Luiz G. P.
   Lourenco-de-Oliveira, Ricardo
   Vasconcelos, Ana Tereza R.
   Brasil, Patricia
TI Isolation of Infective Zika Virus from Urine and Saliva of Patients in
   Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; WEST-NILE-VIRUS; TRANSMISSION; ENCEPHALITIS;
   DENGUE; FLAVIVIRUS; OUTBREAK; SAMPLES
AB Background
   Zika virus (ZIKV) is an emergent threat provoking a worldwide explosive outbreak. Since January 2015, 41 countries reported autochthonous cases. In Brazil, an increase in Guillain-Barre syndrome and microcephaly cases was linked to ZIKV infections. A recent report describing low experimental transmission efficiency of its main putative vector, Ae. aegypti, in conjunction with apparent sexual transmission notifications, prompted the investigation of other potential sources of viral dissemination. Urine and saliva have been previously established as useful tools in ZIKV diagnosis. Here, we described the presence and isolation of infectious ZIKV particles from saliva and urine of acute phase patients in the Rio de Janeiro state, Brazil.
   Methodology/Principal Findings
   Nine urine and five saliva samples from nine patients from Rio de Janeiro presenting rash and other typical Zika acute phase symptoms were inoculated in Vero cell culture and submitted to specific ZIKV RNA detection and quantification through, respectively, NAT-Zika, RT-PCR and RT-qPCR. Two ZIKV isolates were achieved, one from urine and one from saliva specimens. ZIKV nucleic acid was identified by all methods in four patients. Whenever both urine and saliva samples were available from the same patient, urine viral loads were higher, corroborating the general sense that it is a better source for ZIKV molecular diagnostic. In spite of this, from the two isolated strains, each from one patient, only one derived from urine, suggesting that other factors, like the acidic nature of this fluid, might interfere with virion infectivity. The complete genome of both ZIKV isolates was obtained. Phylogenetic analysis revealed similarity with strains previously isolated during the South America outbreak.
   Conclusions/Significance
   The detection of infectious ZIKV particles in urine and saliva of patients during the acute phase may represent a critical factor in the spread of virus. The epidemiological relevance of this finding, regarding the contribution of alternative non-vectorial ZIKV transmission routes, needs further investigation.
C1 [Bonaldo, Myrna C.; Ribeiro, Ieda P.; Lima, Noemia S.; dos Santos, Alexandre A. C.; Menezes, Lidiane S. R.; da Cruz, Stephanie O. D.; de Mello, Iasmim S.; Furtado, Nathalia D.; de Moura, Elaine E.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Damasceno, Luana; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [da Silva, Kely A. B.; de Castro, Marcia G.; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Gerber, Alexandra L.; de Almeida, Luiz G. P.; Vasconcelos, Ana Tereza R.] Petropolis, Lab Nacl Comp Cient, Rio De Janeiro, Brazil.
RP Bonaldo, MC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br
RI Gerber, Alexandra Lehmkuhl/P-9412-2019; Vasconcelos, Ana Tereza
   R/I-1011-2012; Almeida, Luiz/G-5829-2012
OI Gerber, Alexandra Lehmkuhl/0000-0001-5724-6106; Vasconcelos, Ana Tereza
   R/0000-0002-4632-2086; Bonaldo, Myrna/0000-0001-9899-3386; Ribeiro,
   Ivonizete Pires/0000-0003-0737-5430; Almeida, Luiz/0000-0002-7124-2715
CR Anders KL, 2012, AM J TROP MED HYG, V87, P165, DOI 10.4269/ajtmh.2012.11-0713
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Barzon L., 2016, EURO SURVEILL, V21
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, ZIKA VIRUS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Kumar S., 2016, MOL BIOL EVOL
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lanciotti RS, 2016, EMERG INFECT DIS
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   LUBY JP, 1980, AM J TROP MED HYG, V29, P265, DOI 10.4269/ajtmh.1980.29.265
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MATHUR A, 1995, INT J EXP PATHOL, V76, P103
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nei M.a.K. S, 2000, MOL EVOLUTION PHYLOG, P352
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Roze B, 2016, EURO SURVEILL, P21
   Saude M.d., 2016, INFORME EPIDEMIOLOGI
   Shugars DC, 1999, J INFECT DIS, V179, pS431, DOI 10.1086/314799
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Sufiawati I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088803
   Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 104
Z9 108
U1 2
U2 54
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004816
DI 10.1371/journal.pntd.0004816
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200055
PM 27341420
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pagliari, C
   Vijaykumar, S
AF Pagliari, Claudia
   Vijaykumar, Santosh
TI Digital Participatory Surveillance and the Zika Crisis: Opportunities
   and Caveats
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
C1 [Pagliari, Claudia] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Sch Med, Edinburgh Global Hlth Acad, Edinburgh, Midlothian, Scotland.
   [Vijaykumar, Santosh] Nanyang Technol Univ, Emerging Technol Lab, Sch Comp Sci & Engn, Singapore, Singapore.
RP Pagliari, C (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Sch Med, Edinburgh Global Hlth Acad, Edinburgh, Midlothian, Scotland.
EM claudia.pagliari@ed.ac.uk
RI Pagliari, Claudia/P-6412-2018
OI Pagliari, Claudia/0000-0001-5791-7723
FU Farr Institute for Health Informatics Research (Scotland) MRC
   [MR/K007017/1]; Administrative Data Research Centre for Scotland, ESRC
   [ES/L007487/1]; Science and Practice of Social Machines EPSRC
   [EP/J017728/1]; Economic and Social Research CouncilEconomic & Social
   Research Council (ESRC) [ES/L007487/1]; Engineering and Physical
   Sciences Research CouncilEngineering & Physical Sciences Research
   Council (EPSRC) [EP/J017728/1, EP/J017728/2]; Medical Research
   CouncilMedical Research Council UK (MRC) [MR/K007017/1]
FX CP is a collaborator on three RCUK-funded research programmes relevant
   to this article: The Farr Institute for Health Informatics Research
   (Scotland) MRC, Grant number MR/K007017/1; The Administrative Data
   Research Centre for Scotland, ESRC, Grant number ES/L007487/1; The
   Science and Practice of Social Machines EPSRC, EP/J017728/1. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bajardi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114925
   Bajardi P, 2014, J MED INTERNET RES, V16, P190, DOI 10.2196/jmir.3010
   Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107
   Chunara R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09540
   Edelstein M, 2016, ZIKA IS NOT NEW EBOL
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157
   Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042
   Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413
   Karamouzian M, 2015, INT J HEALTH POLICY, V4, P55, DOI 10.15171/ijhpm.2014.128
   Lwin MO, 2014, ACTA TROP, V130, P100, DOI 10.1016/j.actatropica.2013.09.021
   Ogoina D, 2015, INT HLTH
   Thomas J., 2016, WHATSAPP PROVIDED EA
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Wojcik OP, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-7
   World Health Organization, 2016, DISP RUM ZIK MICR 20
NR 15
TC 9
Z9 9
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004795
DI 10.1371/journal.pntd.0004795
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200047
PM 27294787
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Zhang, YJ
   Chen, WX
   Wong, G
   Bi, YH
   Yan, JY
   Sun, Y
   Chen, EF
   Yan, H
   Lou, XY
   Mao, HY
   Xia, SC
   Gao, GF
   Shi, WF
   Chen, ZP
AF Zhang, Yanjun
   Chen, Wenxian
   Wong, Gary
   Bi, Yuhai
   Yan, Juying
   Sun, Yi
   Chen, Enfu
   Yan, Hao
   Lou, Xiuyu
   Mao, Haiyan
   Xia, Shichang
   Gao, George F.
   Shi, Weifeng
   Chen, Zhiping
TI Highly diversified Zika viruses imported to China, 2016
SO PROTEIN & CELL
LA English
DT Letter
ID OUTBREAK; STATES
C1 [Zhang, Yanjun; Yan, Juying; Sun, Yi; Chen, Enfu; Yan, Hao; Lou, Xiuyu; Mao, Haiyan; Xia, Shichang; Chen, Zhiping] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.
   [Chen, Wenxian] Yiwu Ctr Dis Control & Prevent, Yiwu 322000, Peoples R China.
   [Wong, Gary; Bi, Yuhai; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing 100101, Peoples R China.
   [Shi, Weifeng] Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
   [Bi, Yuhai; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.
   [Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Off Director Gen, Beijing 102206, Peoples R China.
RP Chen, ZP (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.; Shi, WF (corresponding author), Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
EM shiwf@ioz.ac.cn; zhpchen@cdc.zj.cn
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 16
TC 38
Z9 40
U1 0
U2 11
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD JUN
PY 2016
VL 7
IS 6
BP 461
EP 464
DI 10.1007/s13238-016-0274-5
PG 4
WC Cell Biology
SC Cell Biology
GA DQ4NN
UT WOS:000379180700009
PM 27209301
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Duarte, G
AF Duarte, Geraldo
TI Challenges of Zika Virus Infection in Pregnant Women
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Editorial Material
ID INTERIM GUIDANCE; UNITED-STATES; ULTRASOUND; STANDARDS; BRAZIL
C1 [Duarte, Geraldo] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
RP Duarte, G (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM gduarte@fmrp.usp.br
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   CDC, 2016, ZIK VIR DIAGN TEST
   CHERVENAK FA, 1984, AM J OBSTET GYNECOL, V149, P512, DOI 10.1016/0002-9378(84)90027-9
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Duarte G., 2016, FEMINA, V44, P26
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Sao Paulo. Secretaria de Estado da Saude. Coordenadoria de Controle de Doencas. Centro de Vigilancia Epidemiologica. Instituto Adolfo Lutz, 2015, 1 SECR EST SAUD
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Villar J, 2015, LANCET GLOB HEALTH, V3, pE681, DOI 10.1016/S2214-109X(15)00163-1
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   World Health Organization, 2016, WHOZIKVMOC162
   World Health Organization. Centers for Disease Control and Prevention, 2014, INT CLEAR BIRTH DEF
NR 27
TC 2
Z9 2
U1 0
U2 2
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JUN
PY 2016
VL 38
IS 6
BP 263
EP 265
DI 10.1055/s-0036-1584206
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4PQ
UT WOS:000410246900001
PM 27232529
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Duarte, G
AF Duarte, Geraldo
TI Zika Virus Infection in Pregnant Women: Topic for Discussion Reply
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Letter
C1 [Duarte, Geraldo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
RP Duarte, G (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Duarte G., 2016, REV BRAS GINECOL OBS
NR 2
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JUN
PY 2016
VL 38
IS 6
BP 314
EP 314
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4PQ
UT WOS:000410246900010
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Sriwijitalai, W
   Wiwanitkit, V
AF Sriwijitalai, Won
   Wiwanitkit, Viroj
TI Zika Virus Infection in Pregnant Women: Topic for Discussion
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Letter
C1 [Sriwijitalai, Won] 2RVT Med Ctr, Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
RP Sriwijitalai, W (corresponding author), 2RVT Med Ctr, Med Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
NR 0
TC 2
Z9 2
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JUN
PY 2016
VL 38
IS 6
BP 314
EP 314
DI 10.1055/s-0036-1584947
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4PQ
UT WOS:000410246900009
PM 27399927
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Frumence, E
   Roche, M
   Krejbich-Trotot, P
   El-Kalamouni, C
   Nativel, B
   Rondeau, P
   Misse, D
   Gadea, G
   Viranaicken, W
   Despres, P
AF Frumence, Etienne
   Roche, Marjolaine
   Krejbich-Trotot, Pascale
   El-Kalamouni, Chaker
   Nativel, Brice
   Rondeau, Philippe
   Misse, Dorothee
   Gadea, Gilles
   Viranaicken, Wildriss
   Despres, Philippe
TI The South Pacific epidemic strain of Zika virus replicates efficiently
   in human epithelial A549 cells leading to IFN-beta production and
   apoptosis induction
SO VIROLOGY
LA English
DT Article
DE Zika virus; Arbovirus; Emerging virus; Viral pathogenicity; Apoptosis;
   Oxidative stress; Innate immunity; Type-I interferon; Human epithelial
   cells
ID WEST NILE VIRUS; DENGUE VIRUS; PROINFLAMMATORY CYTOKINES; INNATE
   IMMUNITY; INFECTION; INTERFERON; PROTEIN; IRF-7; OUTBREAK; ACTIVATE
AB Zika virus (ZIKV) is an emerging flavivirus since the first epidemics in South Pacific in 2007. The recent finding that ZIKV is now circulating in Western Hemisphere and can be associated to severe human diseases, warrants the need for its study. Here we evaluate the susceptibility of human lung epithelial A549 cells to South Pacific epidemic strain of ZIKV isolated in 2013. We showed that ZIKV growth in A549 cells is greatly efficient. ZIKV infection resulted in the secretion of IFN-beta followed by the expression of pro-inflammatory cytokines such as IL-1 beta, and transcriptional activity of IFIT genes. At the maximum of virus progeny production, ZIKV triggers mitochondrial apoptosis through activation of caspases-3 and -9. Whereas at early infection times, the rapid release of IFN-1 beta which exerts an antiviral effect against ZIKV might delay apoptosis in infected cells. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Frumence, Etienne; Roche, Marjolaine; Krejbich-Trotot, Pascale; El-Kalamouni, Chaker; Gadea, Gilles; Viranaicken, Wildriss; Despres, Philippe] Univ Reunion, UM Proc Infect Milieu Insulaire Trop PIMIT 13, INSERM, U1187,CNRS UMR9192,IRD UMR249,Plateforme Technol, F-97490 St Clotilde, Reunion, France.
   [Nativel, Brice; Rondeau, Philippe] Univ Reunion, UMR Diabet Atherothrombose Therapies Reunion Ocea, INSERM, U1188,Plateforme Technol CYROI, F-97490 St Clotilde, Reunion, France.
   [Misse, Dorothee] Lab MIVEGEC, UMR IRD CNRS UM 224, F-34394 Montpellier, France.
RP Viranaicken, W; Despres, P (corresponding author), Univ Reunion, UM Proc Infect Milieu Insulaire Trop PIMIT 13, INSERM, U1187,CNRS UMR9192,IRD UMR249,Plateforme Technol, F-97490 St Clotilde, Reunion, France.
EM wildriss.viranaicken@univ-reunion.fr; philippe.despres@univ-reunion.fr
RI rondeau, philippe/Q-1967-2019; Gilles, Gadea/M-9966-2015; MISSE,
   DOROTHEE/A-7590-2012
OI rondeau, philippe/0000-0002-4652-1376; Gilles,
   Gadea/0000-0001-6325-4866; MISSE, DOROTHEE/0000-0002-6485-3841; NATIVEL,
   Brice/0000-0003-3719-7903
FU Agence Nationale de la Recherche, FranceFrench National Research Agency
   (ANR) [ANR-12-BSV3-0004-01]; Conseil Regional de l'Ile de La Reunion,
   France [DIRED 20121399, DIRED 20131515]
FX We thank Patrick Mavingui, Pascale Guiraud, Olivier Meilhac and Philippe
   Gasque for helpful discussions. We would like to thank Mai-Lormeau and
   Didier Musso for kindly providing the ZIKV strain PF-25013-18. DM and PD
   were supported by the Grant ANR-12-BSV3-0004-01 (KerARBO) from the
   Agence Nationale de la Recherche, France. EF and BN were supported by
   grants DIRED 20121399 and DIRED 20131515, respectively, from the Conseil
   Regional de l'Ile de La Reunion, France.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Catteau A, 2004, PROG MOL SUBCELL BIO, V36, P171
   Courageot MP, 2003, ADV VIRUS RES, V60, P157, DOI 10.1016/S0065-3527(03)60005-9
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101
   Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martin-Acebes MA, 2015, AUTOPHAGY, V11, P861, DOI 10.1080/15548627.2015.1037062
   Martins SD, 2012, VIRUSES-BASEL, V4, P2736, DOI 10.3390/v4112736
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   Mizushima N, 2007, AUTOPHAGY, V3, P542
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Suthar MS, 2012, J VIROL, V86, P7704, DOI 10.1128/JVI.00401-12
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296
   Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 77
Z9 78
U1 1
U2 38
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JUN
PY 2016
VL 493
BP 217
EP 226
DI 10.1016/j.virol.2016.03.006
PG 10
WC Virology
SC Virology
GA DL7MH
UT WOS:000375824300021
PM 27060565
OA Bronze
DA 2020-07-08
ER

PT J
AU Attaway, DF
   Jacobsen, KH
   Falconer, A
   Manca, G
   Waters, NM
AF Attaway, David F.
   Jacobsen, Kathryn H.
   Falconer, Allan
   Manca, Germana
   Waters, Nigel M.
TI Risk analysis for dengue suitability in Africa using the ArcGIS
   predictive analysis tools (PA tools)
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Geographic information systems; Risk mapping; Developing
   countries; Medical geography; Africa
ID VECTOR AEDES-AEGYPTI; VIRUS TRANSMISSION; TEMPERATURE; FEVER; MALARIA;
   VULNERABILITY; MOSQUITOS; MODELS
AB Background: Risk maps identifying suitable locations for infection transmission are important for public health planning. Data on dengue infection rates are not readily available in most places where the disease is known to occur.
   Methods: A newly available add-in to Esri's ArcGIS software package, the ArcGIS Predictive Analysis Toolset (PA Tools), was used to identify locations within Africa with environmental characteristics likely to be suitable for transmission of dengue virus.
   Results: A more accurate, robust, and localized (1 km x 1 km) dengue risk map for Africa was created based on bioclimatic layers, elevation data, high-resolution population data, and other environmental factors that a search of the peer-reviewed literature showed to be associated with dengue risk. Variables related to temperature, precipitation, elevation, and population density were identified as good predictors of dengue suitability. Areas of high dengue suitability occur primarily within West Africa and parts of Central Africa and East Africa, but even in these regions the suitability is not homogenous.
   Conclusion: This risk mapping technique for an infection transmitted by Aedes mosquitoes draws on entomological, epidemiological, and geographic data. The method could be applied to other infectious diseases (such as Zika) in order to provide new insights for public health officials and others making decisions about where to increase disease surveillance activities and implement infection prevention and control efforts. The ability to map threats to human and animal health is important for tracking vectorborne and other emerging infectious diseases and modeling the likely impacts of climate change. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Attaway, David F.; Falconer, Allan; Waters, Nigel M.] George Mason Univ, Dept Geog & GeoInformat Sci, 4400 Univ Dr,MS 6C3, Fairfax, VA 22030 USA.
   [Attaway, David F.] Esri, 8615 Westwood Ctr Dr, Vienna, VA 22182 USA.
   [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr,MS 5B7, Fairfax, VA 22030 USA.
   [Manca, Germana] Penn State Univ, Dept Geog, Lab Geoinformat & Earth Observat, University Pk, PA 16802 USA.
   [Manca, Germana] Penn State Univ, Inst Cybersci, University Pk, PA 16802 USA.
   [Waters, Nigel M.] Univ Calgary, Inst Publ Hlth, Fac Med, 3280Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.
RP Attaway, DF (corresponding author), Esri, 8615 Westwood Ctr Dr, Vienna, VA 22182 USA.
EM dattaway@esri.com
RI Jacobsen, Kathryn H./B-5857-2008
OI Jacobsen, Kathryn H./0000-0002-4198-6246; manca,
   germana/0000-0002-7490-8068
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arboleda S, 2009, INT J ENV RES PUB HE, V6, P3040, DOI 10.3390/ijerph6123040
   Battersby S. E., 2014, CARTOGRAPHICA INT J, V49, P85, DOI [10.3138/carto.49.2.2313, DOI 10.3138/CARTO.49.2.2313]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bontemps S., 2011, GLOBCOVER 2009 PRODU
   Bontemps S., 2010, GLOBCOVER 2009 PRODU
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Bright E.A., 2011, LANDSCAN 2011
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164
   Collenberg E, 2006, J MED VIROL, V78, P683, DOI 10.1002/jmv.20593
   Conn JE, 2015, AM J TROP MED HYG, V93, P28, DOI 10.4269/ajtmh.15-0009
   Esri, 2014, GETT START ARCGIS PR
   Esri, 2014, ARCGIS PRED AN TOOLS
   Franco L, 2010, EUROSURVEILLANCE, V15, P5
   Gassert F., 2013, WORKING PAPER
   Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92
   Global Administrative Areas, 2012, GADM DAT GLOB ADM AR
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Halstead Scott B., 2008, V5, P75
   Hassan H, 2012, GEOSPATIAL HEALTH, V7, P21, DOI 10.4081/gh.2012.101
   Heng B., 1998, DENGUE SINGAPORE TEC, V2, P139
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hogland J.S., 2014, IMPR AN US FUNCT DAT, P1
   Hoogeveen J., 2000, INLAND WATER BODIES
   Jenness J., 2007, CIFA TECH, V33, P1
   Kienberger S, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-29
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011
   MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040
   MCLEAN DM, 1975, MOSQ NEWS, V35, P322
   Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824
   Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279
   Pollack A., 2015, 1 DENGUE FEVER VACCI
   Raheel U, 2011, J INFECT DEV COUNTR, V5, P239, DOI 10.3855/jidc.1017
   Rezayat M, 2000, COMPUT AIDED DESIGN, V32, P299, DOI 10.1016/S0010-4485(00)00013-0
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stocker T., 2013, CLIMATE CHANGE 2013
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   TURELL MJ, 1990, AM J TROP MED HYG, V43, P543, DOI 10.4269/ajtmh.1990.43.543
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P73
NR 49
TC 10
Z9 10
U1 2
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2016
VL 158
BP 248
EP 257
DI 10.1016/j.actatropica.2016.02.018
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DK8GU
UT WOS:000375166000034
PM 26945482
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Microcephaly risk with Zika infection is 1-13% in first trimester, study
   shows
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
NR 1
TC 1
Z9 1
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 31
PY 2016
VL 353
AR i3048
DI 10.1136/bmj.i3048
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO0OF
UT WOS:000377477500010
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Baraka, V
   Kweka, EJ
AF Baraka, Vito
   Kweka, Eliningaya J.
TI The Threat of Zika Virus in Sub-Saharan Africa - The Need to Remain
   Vigilant
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE arboviral infections; Zika virus; diagnosis surveillance and control;
   sub-Saharan Africa; commentary
C1 [Baraka, Vito] Natl Inst Med Res, Tanga Res Ctr, Tanga, Tanzania.
   [Baraka, Vito] Univ Antwerp, Gouverneur Kinsbergen Centrum, Global Hlth Inst, Antwerp, Belgium.
   [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Arusha, Tanzania.
   [Kweka, Eliningaya J.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Med Parasitol & Entomol, Mwanza, Tanzania.
RP Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Arusha, Tanzania.
EM kwekae@tpri.or.tz
OI Baraka, Vito/0000-0001-9694-9293
CR Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Mnzava AP, 2014, T ROY SOC TROP MED H, V108, P550, DOI 10.1093/trstmh/tru101
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Wang H, 2016, INFECT DIS TRANSL ME, V2, P10
NR 10
TC 3
Z9 3
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD MAY 31
PY 2016
VL 4
AR UNSP 110
DI 10.3389/fpubh.2016.00110
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE6GM
UT WOS:000408308000001
PM 27303663
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Waddell, LA
   Greig, JD
AF Waddell, Lisa A.
   Greig, Judy D.
TI Scoping Review of the Zika Virus Literature
SO PLOS ONE
LA English
DT Review
ID YELLOW-FEVER EPIDEMIC; ARBOVIRUS INFECTIONS; SEXUAL TRANSMISSION; DENGUE
   VIRUSES; ANTIBODIES; NIGERIA; BRAZIL; FLAVIVIRUSES; MOSQUITOS; OUTBREAK
AB The global primary literature on Zika virus (ZIKV) (n = 233 studies and reports, up toMarch 1, 2016) has been compiled using a scoping review methodology to systematically identify and characterise the literature underpinning this broad topic using methods that are documented, updateable and reproducible. Our results indicate that more than half the primary literature on ZIKV has been published since 2011. The articles mainly covered three topic categories: epidemiology of ZIKV (surveillance and outbreak investigations) 56.6%(132/233), pathogenesis of ZIKV (case symptoms/outcomes and diagnosis) 38.2%(89/233) and ZIKV studies (molecular characterisation and in vitro evaluation of the virus) 18.5%(43/233). There has been little reported in the primary literature on ZIKV vectors (12/233), surveillance for ZIKV (13/233), diagnostic tests (12/233) and transmission (10/233). Three papers reported on ZIKV prevention/control strategies, one investigated knowledge and attitudes of health professionals and two vectormapping studies were reported. The majority of studies used observational study designs, 89.7%(209/233), of which 62/233 were case studies or case series, while fewer (24/233) used experimental study designs. Several knowledge gaps were identified by this review with respect to ZIKV epidemiology, the importance of potential non-human primates and other hosts in the transmission cycle, the burden of disease in humans, and complications related to human infection with ZIKV. Historically there has been little research on ZIKV; however, given its current spread through Australasia and the Americas, research resources are now being allocated to close many of the knowledge gaps identified in this scoping review. Future updates of this project will probably demonstrate enhanced evidence and understanding of ZIKV and its impact on public health.
C1 [Waddell, Lisa A.; Greig, Judy D.] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada.
   [Waddell, Lisa A.] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.
RP Waddell, LA (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada.; Waddell, LA (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.
EM Lisa.Waddell@phac-aspc.gc.ca
OI waddell, lisa/0000-0003-4887-5124
FU Public Health Agency of Canada
FX This study was funded through the Public Health Agency of Canada
   (http://www.phac-aspc.gc.ca). The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Agence Regionale de Sante, 2016, SIT EP POINT EP 21 J
   Agence Regionale de Sante, 2014, B VEILL SAN, V2
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   [Anonymous], 2016, CDC INVESTIGATING 14
   Antonjaya, 2012, AM J TROP MED HYG, V87, P122
   Araujo J, B WHO
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Aubry M, 2015, VOX SANG S1, V109, P189
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Baba S. S., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P343, DOI 10.1590/S0036-46651998000600002
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boche R, 1974, Bull Soc Pathol Exot Filiales, V67, P126
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   Brust KB, 2014, IDCases, V1, P95, DOI 10.1016/j.idcr.2014.10.009
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G., 2016, LANCET INFECT DIS
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau Roche, 2014, AM J TROP MED HYG, V91, P588
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Center for Disease Control and Prevention, 2016, ZIK WEBP
   Center for Disease Control and Prevention, 2016, SUBJ REV DIAGN TEST
   Center for Disease Control ROC (Taiwan), 2016, 1 IMP CAS ZIK VIR IN
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Crabtree Crockett, 2011, AM J TROP MED HYG, V85, P374
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, ZIKA VIRUS EMERGENCE, V9, pe10
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Direction de la sante Bureau de veille sanitaire, 2016, SURV VEILL SAN POL F
   Direction de la Sante - Bureau de Veille sanitaire, 2014, SURV DENG ZIK POL FR
   DOWNS W. G., 1965, CARIBBEAN MED J, V27, P39
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire CCM, 2015, BIORXIV
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Goorhuis A, 2015, PROMED MAIL
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hearn P, 2014, AM J TROP MED HYG S1, V91, P62
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Institut de Veille Sanitaire, 2014, VIR ZIK POL 2013 201
   Institut de Veille Sanitaire, 2014, B HEBD INT, V442
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Jouannic JM, 2016, LANCET
   Karimi O, 2016, LANCET
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kucharski AJ, 2016, BIORXIV
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS
   Ledermann Crockett, 2012, AM J TROP MED HYG, V87, P170
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lobo JMD, 2010, AM J TROP MED HYG, V83, P314
   Macesic N, 2015, CLIN INFECT DIS, V61, P1445, DOI 10.1093/cid/civ401
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet H. P., 2015, B INFORM SANITAIRES
   Mallet HP, 2014, C 15ES JNI BORD 11 1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Mattar S, 2015, REV MVZ CORDOBA, V20, P4511, DOI 10.21897/rmvz.53
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR MORB MORTAL WKL, V65
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER BR, 1991, AM J TROP MED HYG, V45, P399, DOI 10.4269/ajtmh.1991.45.399
   Millon P, 2015, MED HUMAINE PATHOLOG
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mossel Kading, 2014, AMERICAN JOURNAL OF, V91, P260
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   New Zealand Public Health, 2015, OUTBR MUMPS LIK ILLN, V13
   New Zealand Public Health, 2015, SUMM KEY TRENDS NOT, V13
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, REP INCR CONG MICR O
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2016, ZIK EP UPD 17 FEBR 2
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization, 2015, EP AL ZIK VIR INF 7
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pham MT, 2014, SCOPING REV SCOPING, DOI [10.1002/jrsm.1123, DOI 10.1002/JRSM.1123]
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   REAGAN R L, 1955, Tex Rep Biol Med, V13, P934
   REAGAN RL, 1953, TEX REP BIOL MED, V11, P347
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   ROBERT V, 1993, B SOC PATHOL EXOT, V86, P90
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rockefeller Foundation, 1951, ROCK FDN ANN REP, P131
   RODHAIN F, 1987, B SOC PATHOL EXOT, V80, P155
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1986, ANN INST PASTEUR VIR, V137E, P155, DOI 10.1016/S0769-2617(86)80201-5
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623
   Tsegaye, 2014, AM J TROP MED HYG, V91, P53
   Tusevljak N, 2012, FOODBORNE PATHOG DIS, V9, P487, DOI 10.1089/fpd.2011.1063
   UK government, 2016, HLTH PROTECTION REPO, V10
   VANPEENEN PFD, 1975, ANN TROP MED PARASIT, V69, P475, DOI 10.1080/00034983.1975.11687035
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Vouga M, 2016, LANCET
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weitzel T, 2016, AM J TROP MED HYG
   WHO (World Health Organization) report, 2016, NEUR SYNDR CONG AN
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organisation, 2015, PAC SYNDR SURV REP W
   World Health Organization, 2015, DIS OUTBREAK NE 1215
   World Health Organization, 2016, DIS OUTBREAK NE 0212
   World Health Organization, 2014, PAC SYNDR SURV WEEK
   World Health Organization, 2016, ZIK POT COMPL
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2015, DIS OUTBREAK NE 1221
   World Health Organization, 2015, DIS OUTBREAK NE 1222
   World Health Organization, 2016, DIS OUTBREAK NE 1212
   World Health Organization, 2016, DIS OUTBREAK NE 0121
   World Health Organization, 2015, DIS OUTBREAK NE 1127
   World Health Organization, 2015, DIS OUTBREAK NE 1113
   World Health Organization, 2016, DIS OUTBREAK NE 0129
   World Health Organization, 2016, WHOZIKVMOC161
   World Health Organization, 2015, PAC SYNDR SURV WEEK
   World Health Organization, 2015, DIS OUTBREAK NE 1205
   World Health Organization, 2016, DIS OUTBREAK NE 0120
   World Health Organization, 2015, DIS OUTBREAK NE 1021
   World Health Organization, 2016, ZIK SIT REP FEBR 16
   World Health Organization, 2016, DIS OUTBREAK NE 0127
   World Health Organization, 2016, PAC SYNDR SURV WEEK
   World Health Organization, 2015, DIS OUTBREAK NE 1203
   World Health Organization, 2015, DIS OUTBREAK NE 1111
   World Health Organization, 2016, DIS OUTBREAK NE 0108
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organization, 2016, ZIK VIR MICR GULL BA
   World Health Organization Regional Office of Western Pacific, 2015, PAC SYNDR SURV REP
   World Health Organization (WHO), 2016, DIS OUTBREAK NE 0208
   Wurapa Ofula, 2012, AM J TROP MED HYG, V87, P126
   Wurapa Ofula, 2013, AM J TROP MED HYG, V89, P278
   Yasri S., 2015, Asian Pacific Journal of Tropical Disease, V5, P1007, DOI 10.1016/S2222-1808(15)60974-4
   Young I, 2014, PREV VET MED, V113, P339, DOI 10.1016/j.prevetmed.2013.11.009
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 232
TC 29
Z9 31
U1 0
U2 115
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2016
VL 11
IS 5
AR e0156376
DI 10.1371/journal.pone.0156376
PG 45
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN5XX
UT WOS:000377146100034
PM 27244249
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Simeone, RM
   Shapiro-Mendoza, CK
   Meaney-Delman, D
   Petersen, EE
   Galang, RR
   Oduyebo, T
   Rivera-Garcia, B
   Valencia-Prado, M
   Newsome, KB
   Perez-Padilla, J
   Williams, TR
   Biggerstaff, M
   Jamieson, DJ
   Honein, MA
AF Simeone, Regina M.
   Shapiro-Mendoza, Carrie K.
   Meaney-Delman, Dana
   Petersen, Emily E.
   Galang, Romeo R.
   Oduyebo, Titilope
   Rivera-Garcia, Brenda
   Valencia-Prado, Miguel
   Newsome, Kimberly B.
   Perez-Padilla, Janice
   Williams, Tonya R.
   Biggerstaff, Matthew
   Jamieson, Denise J.
   Honein, Margaret A.
CA Zika Pregnancy Working Grp
TI Possible Zika Virus Infection Among Pregnant Women - United States and
   Territories, May 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID REPRODUCTIVE AGE; TRAVELERS; EXPOSURE
C1 [Simeone, Regina M.; Newsome, Kimberly B.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Shapiro-Mendoza, Carrie K.; Petersen, Emily E.; Oduyebo, Titilope; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Galang, Romeo R.; Oduyebo, Titilope] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Galang, Romeo R.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
   [Valencia-Prado, Miguel] Puerto Rico Dept Hlth, Puerto Rico Birth Defects Surveillance & Prevent, San Juan, PR USA.
   [Perez-Padilla, Janice] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Williams, Tonya R.] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Biggerstaff, Matthew] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
RP Simeone, RM (corresponding author), CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM eocbirthdef@cdc.gov
RI Hennenfent, Andrew/K-6548-2019; Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Rao,
   Carol/0000-0001-7187-2189; Jamieson, Denise/0000-0003-2597-1201
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   CDC, 2016, ZIK MAC ELISA US EM
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
NR 9
TC 29
Z9 29
U1 0
U2 10
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 27
PY 2016
VL 65
IS 20
BP 514
EP 519
DI 10.15585/mmwr.mm6520e1
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM8LI
UT WOS:000376614200003
PM 27248295
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Brazilian Zika in Cape Verde
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAY 27
PY 2016
VL 352
IS 6289
BP 1037
EP 1037
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM6RT
UT WOS:000376480800005
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI US Zika funding battle
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAY 27
PY 2016
VL 352
IS 6289
BP 1037
EP 1038
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM6RT
UT WOS:000376480800008
DA 2020-07-08
ER

PT J
AU Waltz, E
AF Waltz, Emily
TI INFECTIOUS DISEASE Infected mosquitoes could fight Zika
SO NATURE
LA English
DT News Item
CR Dutra H.L.C., 2016, CELL HOST MICROBE
NR 1
TC 18
Z9 19
U1 0
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 26
PY 2016
VL 533
IS 7604
BP 450
EP 451
DI 10.1038/533450a
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM6EJ
UT WOS:000376443100010
PM 27225098
OA Bronze
DA 2020-07-08
ER

PT J
AU Van Esbroeck, M
   Meersman, K
   Michiels, J
   Arien, KK
   Van den Bossche, D
AF Van Esbroeck, M.
   Meersman, K.
   Michiels, J.
   Arien, K. K.
   Van den Bossche, D.
TI Letter to the editor: Specificity of Zika virus ELISA: interference with
   malaria
SO EUROSURVEILLANCE
LA English
DT Letter
C1 [Van Esbroeck, M.; Meersman, K.; Van den Bossche, D.] Inst Trop Med, Natl Reference Ctr Arboviruses, Dept Clin Sci, B-2000 Antwerp, Belgium.
   [Michiels, J.; Arien, K. K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.
RP Van Esbroeck, M (corresponding author), Inst Trop Med, Natl Reference Ctr Arboviruses, Dept Clin Sci, B-2000 Antwerp, Belgium.
EM mvesbroeck@itg.be
OI Van Esbroeck, Marjan/0000-0002-7294-6319
CR Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002
NR 3
TC 14
Z9 14
U1 0
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAY 26
PY 2016
VL 21
IS 21
BP 32
EP 33
AR 30237
DI 10.2807/1560-7917.ES.2016.21.21.30237
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DN0KD
UT WOS:000376751900005
PM 27254259
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kieny, MP
   Moorthy, V
   Bagozzi, D
AF Kieny, Marie-Paule
   Moorthy, Vasee
   Bagozzi, Daniela
TI Use open data to curb Zika virus
SO NATURE
LA English
DT Letter
C1 [Kieny, Marie-Paule; Moorthy, Vasee; Bagozzi, Daniela] WHO, CH-1211 Geneva, Switzerland.
RP Bagozzi, D (corresponding author), WHO, CH-1211 Geneva, Switzerland.
EM bagozzid@who.int
RI Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019
OI Kieny, Marie-Paule/0000-0002-5943-6488; Moorthy,
   Vasee/0000-0002-6535-2854
FU World Health OrganizationWorld Health Organization [001]
CR Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
NR 1
TC 2
Z9 2
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 26
PY 2016
VL 533
IS 7604
BP 469
EP 469
DI 10.1038/533469b
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM6EJ
UT WOS:000376443100019
PM 27225109
OA Bronze
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Obama calls on Congress to fully fund Zika response
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Gulland A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2887
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1545
NR 2
TC 0
Z9 0
U1 0
U2 35
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 23
PY 2016
VL 353
AR i2921
DI 10.1136/bmj.i2921
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN3BM
UT WOS:000376937200008
PM 27216764
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Erickson, B
AF Erickson, Britt
TI Congress moves on emergency Zika funding
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD MAY 23
PY 2016
VL 94
IS 21
BP 17
EP 17
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DM6NS
UT WOS:000376470300036
DA 2020-07-08
ER

PT J
AU Rodrigues, LC
AF Rodrigues, Laura C.
TI Microcephaly and Zika virus infection
SO LANCET
LA English
DT Editorial Material
ID BRAZIL
C1 [Rodrigues, Laura C.] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Rodrigues, Laura C.] MERG, Recife, PE, Brazil.
RP Rodrigues, LC (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.; Rodrigues, LC (corresponding author), MERG, Recife, PE, Brazil.
EM laura.rodrigues@lshtm.ac.uk
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cauchemez S, 2016, LANCET
   Centre D'Hygiene et de Salubrite Publique, 2015, NOT INV AUT MALF CER
   Centro de Operacoes de Emergencias em Saude Publica Sobre Microcefalias, 2016, INF EP 15 SEM EP SE
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 11
TC 37
Z9 37
U1 0
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 21
PY 2016
VL 387
IS 10033
BP 2070
EP 2072
DI 10.1016/S0140-6736(16)00742-X
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6HC
UT WOS:000376450800008
PM 26993880
OA Bronze
DA 2020-07-08
ER

PT J
AU Cauchemez, S
   Besnard, M
   Bompard, P
   Dub, T
   Guillemette-Artur, P
   Eyrolle-Guignot, D
   Salje, H
   Van Kerkhove, MD
   Abadie, V
   Garel, C
   Fontanet, A
   Mallet, HP
AF Cauchemez, Simon
   Besnard, Marianne
   Bompard, Priscillia
   Dub, Timothee
   Guillemette-Artur, Prisca
   Eyrolle-Guignot, Dominique
   Salje, Henrik
   Van Kerkhove, Maria D.
   Abadie, VRonique
   Garel, Catherine
   Fontanet, Arnaud
   Mallet, Henri-Pierre
TI Association between Zika virus and microcephaly in French Polynesia,
   2013-15: a retrospective study
SO LANCET
LA English
DT Article
ID PREGNANT-WOMEN; UNITED-STATES; INFECTION; OUTBREAK; CHILDREN; MOTHER
AB Background The emergence of Zika virus in the Americas has coincided with increased reports of babies born with microcephaly. On Feb 1, 2016, WHO declared the suspected link between Zika virus and microcephaly to be a Public Health Emergency of International Concern. This association, however, has not been precisely quantified.
   Methods We retrospectively analysed data from a Zika virus outbreak in French Polynesia, which was the largest documented outbreak before that in the Americas. We used serological and surveillance data to estimate the probability of infection with Zika virus for each week of the epidemic and searched medical records to identify all cases of microcephaly from September, 2013, to July, 2015. Simple models were used to assess periods of risk in pregnancy when Zika virus might increase the risk of microcephaly and estimate the associated risk.
   Findings The Zika virus outbreak began in October, 2013, and ended in April, 2014, and 66% (95% CI 62-70) of the general population were infected. Of the eight microcephaly cases identified during the 23-month study period, seven (88%) occurred in the 4-month period March 1 to July 10, 2014. The timing of these cases was best explained by a period of risk in the first trimester of pregnancy. In this model, the baseline prevalence of microcephaly was two cases (95% CI 0-8) per 10 000 neonates, and the risk of microcephaly associated with Zika virus infection was 95 cases (34-191) per 10 000 women infected in the first trimester. We could not rule out an increased risk of microcephaly from infection in other trimesters, but models that excluded the first trimester were not supported by the data.
   Interpretation Our findings provide a quantitative estimate of the risk of microcephaly in fetuses and neonates whose mothers are infected with Zika virus.
C1 [Cauchemez, Simon; Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Dub, Timothee; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.
   [Van Kerkhove, Maria D.; Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth, Paris, France.
   [Besnard, Marianne] French Polynesia Hosp Ctr, Neonatal Care Dept, Pirae, Tahiti, France.
   [Guillemette-Artur, Prisca] French Polynesia Hosp Ctr, Dept Med Imaging, Pirae, Tahiti, France.
   [Eyrolle-Guignot, Dominique] French Polynesia Hosp Ctr, Dept Obstet Gynecol, Pirae, Tahiti, France.
   [Bompard, Priscillia; Mallet, Henri-Pierre] Bur Veille Sanitaire, Direct Sante, Papeete, Tahiti, France.
   [Salje, Henrik] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA.
   [Abadie, VRonique] Hop Necker Enfants Malad, Gen Paediat Dept, Paris, France.
   [Garel, Catherine] Hop Enfants Armand Trousseau, Dept Paediat Radiol, Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France.
RP Cauchemez, S (corresponding author), Inst Pasteur, Math Modelling Infect Dis Unit, 28 Rue Dr Roux, F-75015 Paris, France.
EM simon.cauchemez@pasteur.fr
OI Van Kerkhove, Maria/0000-0002-6135-0018; Salje,
   Henrik/0000-0003-3626-4254
FU Labex-IBEID; NIH-MIDAS; AXA Research fund; EU-PREDEMICS
FX Labex-IBEID, NIH-MIDAS, AXA Research fund, EU-PREDEMICS.
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Burnham K. P., 2002, MODEL SELECTION MULT
   Butler D, 2016, NATURE, V530, P12
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   de Jong EP, 2011, PRENATAL DIAG, V31, P419, DOI 10.1002/pd.2714
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Eurocat, 2003, EUR SURV CONG AN EUR
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Institut de Statistique de Polynesie Francaise, 2014, GRANDS IND POP ISS E
   King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Liu J. S., 2001, MONTE CARLO STRATEGI
   Mallet H. P., 2015, B INFORM SANITAIRES
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Olusanya BO, 2012, INT HEALTH, V4, P128, DOI 10.1016/j.inhe.2011.12.006
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Regis CT, MICROCEPHALY NE BRAZ
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   Vauloup-Fellous C, 2013, ANN BIOL CLIN-PARIS, V71, P5, DOI 10.1684/abc.2013.0897
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Washington Post, 2016, WASHINGTON POST
   Whitehouse AJO, 2012, ARCH DIS CHILD, V97, P49, DOI 10.1136/adc.2009.180331
   WHO, 2016, GUILL BARR SYNDR SAL
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
NR 44
TC 480
Z9 487
U1 3
U2 113
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 21
PY 2016
VL 387
IS 10033
BP 2125
EP 2132
DI 10.1016/S0140-6736(16)00651-6
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6HC
UT WOS:000376450800036
PM 26993883
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Coombes, R
AF Coombes, Rebecca
TI Call to cancel 2016 Olympics because of Zika risk is not backed by WHO
   guidance
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Attaran A, 2016, HARVARD PUBLIC H MAY
   Brooks M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2548
   Ministry of Health, 2016, B EPIDEMIOLOGICO, V47, P18
NR 3
TC 3
Z9 3
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 20
PY 2016
VL 353
AR i2899
DI 10.1136/bmj.i2899
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6GI
UT WOS:000376448200015
PM 27207862
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI WHO warns of risk of Zika virus in Europe
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 7
Z9 8
U1 0
U2 9
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 20
PY 2016
VL 353
AR i2887
DI 10.1136/bmj.i2887
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6GI
UT WOS:000376448200010
PM 27207768
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kvajo, M
   Monteiro, J
AF Kvajo, Mirna
   Monteiro, Joao
TI Publishing Science in the Time of Zika
SO CELL
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 19
PY 2016
VL 165
IS 5
BP 1029
EP 1029
DI 10.1016/j.cell.2016.05.030
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DM6QT
UT WOS:000376478200001
PM 27203101
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika must remain a high priority
SO NATURE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 52
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 19
PY 2016
VL 533
IS 7603
BP 291
EP 291
DI 10.1038/533291a
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM0AH
UT WOS:000376004300009
PM 27193639
OA Bronze
DA 2020-07-08
ER

PT J
AU Miner, JJ
   Cao, B
   Govero, J
   Smith, AM
   Fernandez, E
   Cabrera, OH
   Garber, C
   Noll, M
   Klein, RS
   Noguchi, KK
   Mysorekar, IU
   Diamond, MS
AF Miner, Jonathan J.
   Cao, Bin
   Govero, Jennifer
   Smith, Amber M.
   Fernandez, Estefania
   Cabrera, Omar H.
   Garber, Charise
   Noll, Michelle
   Klein, Robyn S.
   Noguchi, Kevin K.
   Mysorekar, Indira U.
   Diamond, Michael S.
TI Zika Virus Infection during Pregnancy in Mice Causes Placental Damage
   and Fetal Demise
SO CELL
LA English
DT Article
ID ENCEPHALITIS-VIRUS; MOUSE PLACENTA; DETERMINANTS; TROPHOBLAST; BRAZIL;
   BRAIN
AB Zika virus (ZIKV) infection in pregnant women causes intrauterine growth restriction, spontaneous abortion, and microcephaly. Here, wedescribe two mouse models of placental and fetal disease associated with in utero transmission of ZIKV. Female mice lacking type I interferon signaling (Ifnar1(-/-)) crossed to wild-type (WT) males produced heterozygous fetuses resembling the immune status of human fetuses. Maternal inoculation at embryonic day 6.5 (E6.5) or E7.5 resulted in fetal demise that was associated with ZIKV infection of the placenta and fetal brain. We identified ZIKV within trophoblasts of the maternal and fetal placenta, consistent with a transplacental infection route. Antibody blockade of Ifnar1 signaling in WT pregnant mice enhanced ZIKV trans-placental infection although it did not result in fetal death. These models will facilitate the study of ZIKV pathogenesis, in utero transmission, and testing of therapies and vaccines to prevent congenital malformations.
C1 [Miner, Jonathan J.; Govero, Jennifer; Smith, Amber M.; Fernandez, Estefania; Garber, Charise; Noll, Michelle; Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.
   [Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Klein, Robyn S.; Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Cabrera, Omar H.; Noguchi, Kevin K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Mysorekar, IU; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM mysorekari@wudosis.wustl.edu; diamond@borcim.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972, R01
   HD052664, R01 NS052632]; Intellectual and Developmental Disabilities
   Research Center at Washington University (NIH/NICHD) [U54 HD087011];
   Rheumatology Research Foundation Scientist Development Award; NIH
   Pre-doctoral training grant award [T32 AI007163]; NIH Research Education
   Program [R25 HG006687]; Preventing Prematurity Initiative grant from the
   Burroughs Wellcome Fund; Prematurity Research Initiative Investigator
   award from the March of Dimes
FX This work was supported by grants from the NIH (R01 AI073755 and R01
   AI104972 to M.S.D., R01 HD052664 to K.K.N., and R01 NS052632 to R.S.K.)
   and the Intellectual and Developmental Disabilities Research Center at
   Washington University (NIH/NICHD U54 HD087011). J.J.M., E.F., and D.J.P.
   were supported by a Rheumatology Research Foundation Scientist
   Development Award, NIH Pre-doctoral training grant award (T32 AI007163),
   and the NIH Research Education Program (R25 HG006687), respectively. The
   work also was supported by a Preventing Prematurity Initiative grant
   from the Burroughs Wellcome Fund and a Prematurity Research Initiative
   Investigator award from the March of Dimes (to I.U.M). We thank Wandy
   Betty for her TEM assistance, Fredrik Kraus for his expertise in
   placental pathology, and Justin Richner for advice with establishing the
   RNA FISH assays. Finally, we acknowledge Xavier de Lamballerie
   (Emergence des Pathologies Virales, Aix-Marseille Universite, Marseille,
   France) and the European Virus Archive goes Global (EVAg) for consenting
   to the use of H/PF/2013 ZIKV strain for this study under a material
   transfer agreement with the EVAg parter, Aix-Marseille Universite.
   M.S.D. is a consultant for Inbios, Visterra, and Takeda Pharmaceuticals
   and on the Scientific Advisory Boards of Moderna and OraGene.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003
   ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975
   Arechavaleta-Velasco F, 2002, J REPROD IMMUNOL, V55, P113, DOI 10.1016/S0165-0378(01)00143-7
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bayer A., 2016, CELL HOST MICROBE, V16, P30100
   Brasil P, 2016, N ENGL J MED
   Brien J. D., 2013, CURR PROTOC MICROBIO, V31
   Calvet G., 2016, LANCET INFECT DIS
   Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Edwards MS, 2015, PEDIATR DEVEL PATHOL, V18, P155, DOI 10.2350/14-09-1548-CR.1
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, CELL HOST MICROBE
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Rasmussen SA, 2016, N ENGL J MED
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Rossi SL, 2016, AM J TROP MED HYG
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang H, 2016, CELL STEM CELL
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
   Zeldovich VB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002804
NR 43
TC 451
Z9 463
U1 3
U2 171
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 19
PY 2016
VL 165
IS 5
BP 1080
EP 1090
DI 10.1016/j.cell.2016.05.008
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DM6QT
UT WOS:000376478200010
PM 27180225
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Qian, XY
   Nguyen, HN
   Song, MM
   Hadiono, C
   Ogden, SC
   Hammack, C
   Yao, B
   Hamersky, GR
   Jacob, F
   Zhong, C
   Yoon, KJ
   Jeang, W
   Lin, L
   Li, YJ
   Thakor, J
   Berg, DA
   Zhang, C
   Kang, E
   Chickering, M
   Nauen, D
   Ho, CY
   Wen, ZX
   Christian, KM
   Shi, PY
   Maher, BJ
   Wu, H
   Jin, P
   Tang, HL
   Song, HJ
   Ming, GL
AF Qian, Xuyu
   Ha Nam Nguyen
   Song, Mingxi M.
   Hadiono, Christopher
   Ogden, Sarah C.
   Hammack, Christy
   Yao, Bing
   Hamersky, Gregory R.
   Jacob, Fadi
   Zhong, Chun
   Yoon, Ki-Jun
   Jeang, William
   Lin, Li
   Li, Yujing
   Thakor, Jai
   Berg, Daniel A.
   Zhang, Ce
   Kang, Eunchai
   Chickering, Michael
   Nauen, David
   Ho, Cheng-Ying
   Wen, Zhexing
   Christian, Kimberly M.
   Shi, Pei-Yong
   Maher, Brady J.
   Wu, Hao
   Jin, Peng
   Tang, Hengli
   Song, Hongjun
   Ming, Guo-li
TI Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV
   Exposure
SO CELL
LA English
DT Article
ID SELF-ORGANIZATION; DIFFERENTIATION; TISSUE; CELLS; DYSREGULATION;
   NEURONS; RISK; MICE
AB Cerebral organoids, three-dimensional cultures that model organogenesis, provide a new platform to investigatehuman brain development. High cost, variability, and tissue heterogeneity limit their broad applications. Here, we developed a miniaturized spinning bioreactor (Spin Omega) to generate forebrain-specific organoids from human iPSCs. These organoids recapitulate key features of human cortical development, including progenitor zone organization, neurogenesis, gene expression, and, notably, a distinct human-specific outer radial glia cell layer. We also developed protocols for midbrain and hypothalamic organoids. Finally, we employed the forebrain organoid platform to model Zika virus (ZIKV) exposure. Quantitative analyses revealed preferential, productive infection of neural progenitors with either African or Asian ZIKV strains. ZIKV infection leads to increased cell death and reduced proliferation, resulting in decreased neuronal cell-layer volume resembling microcephaly. Together, our brain-region-specific organoids and Spin Omega provide an accessible and versatile platform for modeling human brain development and disease and for compound testing, including potential ZIKV antiviral drugs.
C1 [Qian, Xuyu; Ha Nam Nguyen; Song, Mingxi M.; Hadiono, Christopher; Jacob, Fadi; Zhong, Chun; Yoon, Ki-Jun; Jeang, William; Thakor, Jai; Berg, Daniel A.; Zhang, Ce; Kang, Eunchai; Chickering, Michael; Nauen, David; Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Ha Nam Nguyen; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA.
   [Zhong, Chun; Yoon, Ki-Jun; Zhang, Ce; Kang, Eunchai; Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Hamersky, Gregory R.; Maher, Brady J.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA.
   [Nauen, David] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Maher, Brady J.; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Song, Mingxi M.] Riverhill High Sch, Clarksville, MD 21029 USA.
   [Hadiono, Christopher] Byram Hills High Sch, Armonk, NY 10504 USA.
   [Ogden, Sarah C.; Hammack, Christy; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
   [Yao, Bing; Lin, Li; Li, Yujing; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.
   [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
   [Jeang, William] Clear Lake High Sch, Harris, TX 77058 USA.
   [Ho, Cheng-Ying] Childrens Natl Med Ctr, Div Pathol, Washington, DC 20010 USA.
   [Ho, Cheng-Ying] George Washington Univ, Pathol & Pediat, Washington, DC 20010 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
EM shongju1@jhmi.edu; gming1@jhmi.edu
RI Qian, Xuyu/C-1240-2017; Yoon, Ki-Jun/S-8170-2018; Wu, Hao/H-3899-2017;
   Wen, Zhexing/L-1228-2018; Ho, Cheng-Ying/AAA-5098-2019; Li,
   Yujing/AAJ-1411-2020; Wu, Hao/AAG-8660-2020; Maher, Brady/L-8314-2016
OI Qian, Xuyu/0000-0001-5944-3816; Wu, Hao/0000-0003-1269-7354; Wen,
   Zhexing/0000-0002-1518-3845; Li, Yujing/0000-0002-4363-2484; Wu,
   Hao/0000-0003-1269-7354; Maher, Brady/0000-0001-5930-885X; Berg,
   Daniel/0000-0001-9595-2052; Ming, Guo-li/0000-0002-2517-6075; Jacob,
   Fadi/0000-0002-0094-8454; Jeang, William/0000-0002-5401-8535; Thakor,
   Jai/0000-0001-7583-186X; Yoon, Ki-Jun/0000-0003-2985-2541; Yao,
   Bing/0000-0002-3205-8130; nauen, david/0000-0002-2652-9944
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS048271, MH105128, NS095348,
   NS047344, ES021957, AI119530, AI111250, NS051630, NS079625, MH102690,
   MH104593]; MSCRF; SFARI [308988]
FX We thank Hopkins WSE machine shop and Nathaniel Leon for help of 3D
   printing and members of the Ming and Song laboratories for discussion;
   L. Liu and Y. Cai for technical support; and Robert B. Tesh at UTMB and
   the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
   for the Cambodian strain ZIKV<SUP>C</SUP>. This work was supported by
   grants from NIH (NS048271, MH105128, and NS095348 to G.L.M.; NS047344
   and ES021957 to H.S.; AI119530 and AI111250 to H.T.; NS051630, NS079625,
   and MH102690 to P.J.; and MH104593 to B.J.M.), MSCRF (to H.S.), and
   SFARI (308988 to H.S.).
CR Bayer A, 2016, CELL HOST MICROBE
   Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P361, DOI 10.1016/j.tins.2004.05.007
   Blackshaw S, 2010, J NEUROSCI, V30, P14925, DOI 10.1523/JNEUROSCI.4499-10.2010
   Calvet G., 2016, LANCET INFECT DIS
   Cauchemez S, 2016, LANCET
   Chung S, 2005, MOL CELL NEUROSCI, V28, P241, DOI 10.1016/j.mcn.2004.09.008
   Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011
   Driggers RW, 2016, N ENGL J MED
   Faria NR, 2016, SCIENCE
   Garcez P. P., 2016, SCIENCE
   GOODWIN TJ, 1993, P SOC EXP BIOL MED, V202, P181
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898
   JESSUP JM, 1993, J CELL BIOCHEM, V51, P290, DOI 10.1002/jcb.240510308
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078
   Roost MS, 2015, STEM CELL REP, V4, P1112, DOI 10.1016/j.stemcr.2015.05.002
   Tang H, 2016, CELL STEM CELL
   Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/nmeth.3629, 10.1038/NMETH.3629]
   Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
   Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011
NR 36
TC 590
Z9 601
U1 9
U2 158
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 19
PY 2016
VL 165
IS 5
BP 1238
EP 1254
DI 10.1016/j.cell.2016.04.032
PG 17
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DM6QT
UT WOS:000376478200022
PM 27118425
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Pardee, K
   Green, AA
   Takahashi, MK
   Braff, D
   Lambert, G
   Lee, JW
   Ferrante, T
   Ma, D
   Donghia, N
   Fan, M
   Daringer, NM
   Bosch, I
   Dudley, DM
   O'Connor, DH
   Gehrke, L
   Collins, JJ
AF Pardee, Keith
   Green, Alexander A.
   Takahashi, Melissa K.
   Braff, Dana
   Lambert, Guillaume
   Lee, Jeong Wook
   Ferrante, Tom
   Ma, Duo
   Donghia, Nina
   Fan, Melina
   Daringer, Nichole M.
   Bosch, Irene
   Dudley, Dawn M.
   O'Connor, David H.
   Gehrke, Lee
   Collins, James J.
TI Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular
   Components
SO CELL
LA English
DT Article
ID EPIDEMIC; DENGUE; QUANTIFICATION; DIAGNOSTICS
AB The recent Zika virus outbreak highlights the need for low-cost diagnostics that can be rapidly developed for distribution and use in pandemic regions. Here, we report a pipeline for the rapid design, assembly, and validation of cell-free, paper-based sensors for the detection of the Zika virus RNA genome. By linking isothermal RNA amplification to toehold switch RNA sensors, we detect clinically relevant concentrations of Zika virus sequences and demonstrate specificity against closely related Dengue virus sequences. When coupled with a novel CRISPR/Cas9-based module, our sensors can discriminate between viral strains with single-base resolution. We successfully demonstrate a simple, field-ready sample-processing workflow and detect Zika virus from the plasma of a viremic macaque. Our freeze-dried biomolecular platform resolves important practical limitations to the deployment of molecular diagnostics in the field and demonstrates how synthetic biology can be used to develop diagnostic tools for confronting global health crises.
C1 [Pardee, Keith] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada.
   [Green, Alexander A.; Ma, Duo] Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Tempe, AZ 85287 USA.
   [Green, Alexander A.; Ma, Duo] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.
   [Takahashi, Melissa K.; Braff, Dana; Daringer, Nichole M.; Bosch, Irene; Gehrke, Lee; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Braff, Dana] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Braff, Dana; Lambert, Guillaume; Lee, Jeong Wook; Ferrante, Tom; Donghia, Nina; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Lambert, Guillaume] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.
   [Fan, Melina] Addgene, Cambridge, MA 02139 USA.
   [Dudley, Dawn M.; O'Connor, David H.] UW Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Dudley, Dawn M.; O'Connor, David H.] UW Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Gehrke, Lee] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Gehrke, Lee; Collins, James J.] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Collins, James J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
RP Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (corresponding author), Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
EM jimjc@mit.edu
RI Green, Alexander A./X-7025-2019
OI Green, Alexander A./0000-0003-2058-1204; Fan, Melina/0000-0002-6196-8408
FU Wyss Institute for Biologically Inspired Engineering; MIT's Center for
   Microbiome Informatics and Therapeutics; Defense Threat Reduction
   AgencyUnited States Department of DefenseDefense Threat Reduction Agency
   [HDTRA1-14-1-0006]; Arizona State University; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI100190]
FX We would like to thank Marcelle Tuttle from the Church Lab (Wyss
   Institute) for the vectors used to produce the lentivirus. We would also
   like to thank Xiao Tan and Shimyn Slomovic for helpful comments on the
   manuscript, as well as Ewen Cameron, Andres Cubillos, James Niemi and
   Dionna Williams for assistance with project logistics. The work was
   supported by the Wyss Institute for Biologically Inspired Engineering,
   MIT's Center for Microbiome Informatics and Therapeutics, and the
   Defense Threat Reduction Agency grant HDTRA1-14-1-0006. A.A.G
   acknowledges startup funds provided by Arizona State University. L.G.
   acknowledges support from NIH AI100190.
CR Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Calvet G., 2016, LANCET INFECT DIS
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Casper ET, 2007, HARMFUL ALGAE, V6, P112, DOI 10.1016/j.hal.2006.11.001
   Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685
   Crannell ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112146
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874
   Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lu TK, 2013, TRENDS BIOTECHNOL, V31, P325, DOI 10.1016/j.tibtech.2013.03.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stefan CP, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0509-3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Ulrich RM, 2010, HARMFUL ALGAE, V9, P116, DOI 10.1016/j.hal.2009.08.010
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, 2016, WHO FAST TRACK AV DI
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zika Experimental Science Team, 2016, ZIKV 001 INF 3 RHES
NR 31
TC 291
Z9 301
U1 51
U2 284
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 19
PY 2016
VL 165
IS 5
BP 1255
EP 1266
DI 10.1016/j.cell.2016.04.059
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DM6QT
UT WOS:000376478200023
PM 27160350
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Kostyuchenko, VA
   Lim, EXY
   Zhang, SJ
   Fibriansah, G
   Ng, TS
   Ooi, JSG
   Shi, J
   Lok, SM
AF Kostyuchenko, Victor A.
   Lim, Elisa X. Y.
   Zhang, Shuijun
   Fibriansah, Guntur
   Ng, Thiam-Seng
   Ooi, Justin S. G.
   Shi, Jian
   Lok, Shee-Mei
TI Structure of the thermally stable Zika virus
SO NATURE
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; ENVELOPE GLYCOPROTEIN; CRYO-EM;
   ENCEPHALITIS-VIRUS; CRYSTAL-STRUCTURE; PROTEIN; RESOLUTION; MATURATION;
   INFECTION
AB Zika virus (ZIKV), formerly a neglected pathogen, has recently been associated with microcephaly in fetuses(1), and with Guillian-Barre syndrome in adults(2). Here we present the 3.7 angstrom resolution cryoelectron microscopy structure of ZIKV, and show that the overall architecture of the virus is similar to that of other flaviviruses. Sequence and structural comparisons of the ZIKV envelope (E) protein with other flaviviruses show that parts of the E protein closely resemble the neurovirulent West Nile and Japanese encephalitis viruses, while others are similar to dengue virus (DENV). However, the contribution of the E protein to flavivirus pathobiology is currently not understood. The virus particle was observed to be structurally stable even when incubated at 40 degrees C, in sharp contrast to the less thermally stable DENV3. This is also reflected in the infectivity of ZIKV compared to DENV serotypes 2 and 4 (DENV2 and DENV4) at different temperatures. The cryoelectron microscopy structure shows a virus with a more compact surface. This structural stability of the virus may help it to survive in the harsh conditions of semen(4), saliva(5) and urine(6). Antibodies or drugs that destabilize the structure may help to reduce the disease outcome or limit the spread of the virus.
C1 [Kostyuchenko, Victor A.; Lim, Elisa X. Y.; Zhang, Shuijun; Fibriansah, Guntur; Ng, Thiam-Seng; Ooi, Justin S. G.; Lok, Shee-Mei] Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore.
   [Kostyuchenko, Victor A.; Lim, Elisa X. Y.; Zhang, Shuijun; Fibriansah, Guntur; Ng, Thiam-Seng; Ooi, Justin S. G.; Shi, Jian; Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore 117557, Singapore.
   [Shi, Jian] Natl Univ Singapore, Dept Biol Sci, CryoEM Unit, Singapore 117557, Singapore.
RP Lok, SM (corresponding author), Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore 117557, Singapore.
EM sheemei.lok@duke-nus.edu.sg
RI ; Fibriansah, Guntur/P-1201-2015
OI Lok, Shee-Mei/0000-0003-4631-8041; Fibriansah,
   Guntur/0000-0002-9990-3335; Ooi, Justin/0000-0003-4899-8255
FU Singapore Ministry of Education Tier 3 grantMinistry of Education,
   Singapore [MOE2012-T3-1-008]; National Research Foundation
   [NRF-NRFI2016-01]; Duke-NUS Signature Research Programme - Ministry of
   Health, SingaporeMinistry of Health-SingaporeNational University of
   Singapore
FX We thank the European Virus Archive for providing us with the ZIKV
   H/PF/2013 strain. We thank S. Lambert for helping to edit the paper. The
   work is supported by Singapore Ministry of Education Tier 3 grant
   (MOE2012-T3-1-008), National Research Foundation Investigatorship award
   (NRF-NRFI2016-01) awarded to S.-M.L. and the Duke-NUS Signature Research
   Programme funded by the Ministry of Health, Singapore.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Liu XG, 2007, J STRUCT BIOL, V160, P11, DOI 10.1016/j.jsb.2007.06.009
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 29
TC 245
Z9 256
U1 2
U2 120
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 19
PY 2016
VL 533
IS 7603
BP 425
EP +
DI 10.1038/nature17994
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM0AH
UT WOS:000376004300055
PM 27093288
OA Bronze
DA 2020-07-08
ER

PT J
AU Rasmussen, SA
   Jamieson, DJ
   Honein, MA
   Petersen, LR
AF Rasmussen, Sonja A.
   Jamieson, Denise J.
   Honein, Margaret A.
   Petersen, Lyle R.
TI Zika Virus and Birth Defects - Reviewing the Evidence for Causality
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID TERATOGEN UPDATE; INFECTION; BRAZIL; BRAIN; ASSOCIATION; OUTBREAK;
   STATES
C1 [Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Ctr Surveillance Epidemiol & Lab Serv, Div Publ Hlth Informat Disseminat, Atlanta, GA USA.
   [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA.
   [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA USA.
   [Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
RP Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-33, Atlanta, GA 30329 USA.
EM skr9@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Associated Press-NORC Center for Public Affairs Research, 2016, ZIK VIR AM AW OP US
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753
   Calvet G., 2016, LANCET INFECT DIS
   Carey JC, 2009, BIRTH DEFECTS RES A, V85, P63, DOI 10.1002/bdra.20533
   Cauchemez S, 2016, LANCET
   Chan JF, 2016, J INFECT
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frank C, 2016, EMBO MOL MED
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Instituto Nacional de Salud, 2016, B EP SEM
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JONES KL, 1973, LANCET, V2, P999
   LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mitchell AA, 2010, NEW ENGL J MED, V363, P2161, DOI 10.1056/NEJMe1009631
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   National Birth Defects Prevention Network, 2013, MAJ BIRTH DEF DAT PO
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Palacios R, 2016, VACCINE, DOI [10.1056/NEJMsr1604338, DOI 10.1056/NEJMSR1604338]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reefhuis J, EMERG INFEC IN PRESS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scialli AR, 2005, BIRTH DEFECTS RES A, V73, P421, DOI 10.1002/bdra.21039
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Tang H, 2016, CELL STEM CELL
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Webster WS, 1998, TERATOLOGY, V58, P13
   Williams JV, 2010, J INFECT DIS, V201, P1611, DOI 10.1086/652406
NR 44
TC 938
Z9 963
U1 16
U2 315
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 19
PY 2016
VL 374
IS 20
BP 1981
EP 1987
DI 10.1056/NEJMsr1604338
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM1OX
UT WOS:000376116600014
PM 27074377
OA Bronze
DA 2020-07-08
ER

PT J
AU Orsborne, J
   Banks, SD
   Hendy, A
   Gezan, SA
   Kaur, H
   Wilder-Smith, A
   Lindsay, SW
   Logan, JG
AF Orsborne, James
   Banks, Sarah DeRaedt
   Hendy, Adam
   Gezan, Salvador A.
   Kaur, Harparkash
   Wilder-Smith, Annelies
   Lindsay, Steve W.
   Logan, James G.
TI Personal Protection of Permethrin-Treated Clothing against Aedes
   aegypti, the Vector of Dengue and Zika Virus, in the Laboratory
SO PLOS ONE
LA English
DT Article
ID ANOPHELES-GAMBIAE; CONTROLLED-TRIAL; INSECTICIDE; EFFICACY; MALARIA;
   RESISTANCE; UNIFORMS; NETS; BEDNETS; IMPACT
AB Background
   The dengue and Zika viruses are primarily transmitted by Aedes aegypti mosquitoes, which are most active during day light hours and feed both in and outside of the household. Personal protection technologies such as insecticide-treated clothing could provide individual protection. Here we assessed the efficacy of permethrin-treated clothing on personal protection in the laboratory.
   Methods
   The effect of washing on treated clothing, skin coverage and protection against resistant and susceptible Ae. aegypti was assessed using modified WHO arm-in-cage assays. Coverage was further assessed using free-flight room tests to investigate the protective efficacy of unwashed factory-dipped permethrin-treated clothing. Clothing was worn as full coverage (long sleeves and trousers) and partial coverage (short sleeves and shorts). Residual permethrin on the skin and its effect on mosquitoes was measured using modified WHO cone assays and quantified using high-pressure liquid chromatography (HPLC) analysis.
   Results
   In the arm-in-cage assays, unwashed clothing reduced landing by 58.9% (95% CI 49.2-66.9) and biting by 28.5%(95% CI 22.5-34.0), but reduced to 18.5% (95% CI 14.7-22.3) and 11.1% (95% CI 8.5-13.8) respectively after 10 washes. Landing and biting for resistant and susceptible strains was not significantly different (p<0.05). In free-flight room tests, full coverage treated clothing reduced landing by 24.3% (95% CI 17.4-31.7) and biting by 91% (95% CI 82.2-95.9) with partial coverage reducing landing and biting by 26.4%(95% CI 20.3-31.2) and 49.3%(95% CI 42.1-59.1) respectively with coverage type having no significant difference on landing (p<0.05). Residual permethrin was present on the skin in low amounts (0.0041mg/cm(2)), but still produced a KD of >80% one hour after wearing treated clothing.
   Conclusion
   Whilst partially covering the body with permethrin-treated clothing provided some protection against biting, wearing treated clothing with long sleeves and trousers provided the highest form of protection. Washing treated clothing dramatically reduced protection provided. Permethrin-treated clothing could provide protection to individuals from Ae. aegypti that show permethrin resistance. Additionally, it could continue to provide protection even after the clothing has been worn. Field trials are urgently needed to determine whether clothing can protect against dengue and Zika.
C1 [Orsborne, James; Banks, Sarah DeRaedt; Hendy, Adam; Kaur, Harparkash; Logan, James G.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.
   [Gezan, Salvador A.] Univ Florida, SFRC, Gainesville, FL USA.
   [Wilder-Smith, Annelies] Umea Univ, Dept Global Hlth & Epidemiol, Umea, Sweden.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England.
   [Orsborne, James; Logan, James G.] London Sch Hyg & Trop Med, Arctec, London WC1, England.
RP Logan, JG (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.; Logan, JG (corresponding author), London Sch Hyg & Trop Med, Arctec, London WC1, England.
EM james.logan@lshtm.ac.uk
RI Wilder-Smith, Annelies/F-8751-2015
FU European UnionEuropean Union (EU) [282589]
FX The authors have received funding from the European Union Seventh
   Framework Programme FP7/2007-2013 under grant agreement 282589. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164
   Ahmed S, 2015, EMERG INFECT DIS, V21, P909, DOI 10.3201/eid2105.141813
   [Anonymous], 2009, GUID EFF TEST MOSQ R
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Appel KE, 2008, INT J HYG ENVIR HEAL, V211, P88, DOI 10.1016/j.ijheh.2007.10.005
   Asilian A, 2003, J CLIN PHARM THER, V28, P175, DOI 10.1046/j.1365-2710.2003.00476.x
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, ANTICIPATING INT SPR
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x
   Chua K. B., 2005, SMJ Singapore Medical Journal, V46, P639
   Corbel V, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-22
   Corp. I, 2013, IBM SPSS STAT WIND V
   Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389
   Darriet F, 2000, B SOC PATHOL EXOT, V93, P131
   Darriet F, 1997, MED TROPICAL REV COR, V58, P349
   Ditsuwan T, 2013, TROP MED INT HEALTH, V18, P230, DOI 10.1111/tmi.12030
   Dom NC, 2013, PROCD SOC BEHV, V85, P100, DOI 10.1016/j.sbspro.2013.08.342
   EAMSILA C, 1994, J AM MOSQUITO CONTR, V10, P515
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Etang J, 2007, T ROY SOC TROP MED H, V101, P881, DOI 10.1016/j.trstmh.2007.05.012
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   FINLEY EL, 1974, B ENVIRON CONTAM TOX, V12, P268, DOI 10.1007/BF01709118
   Fulmali PV, 2008, INDIAN J MED RES, V127, P589
   Ghosh A, 2015, INDIAN J MED MICROBI, V33, P3, DOI 10.4103/0255-0857.148369
   Gonzalez JO, 2002, T ROY SOC TROP MED H, V96, P370, DOI 10.1016/S0035-9203(02)90363-9
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Institute S, 2009, SAS SYST WIND REL 9, P486
   Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208
   Kimani EW, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-63
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690
   LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x
   Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Marinkovic S.S, 2006, CHEM IND CHEM ENG Q, V12, P58, DOI DOI 10.2298/CICEQ0601058S
   Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061
   MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x
   Narahashi T, 1998, NEUROTOXICOLOGY, V19, P581
   Hung NT, 2012, PAEDIATR INT CHILD H, V32, P39, DOI 10.1179/2046904712Z.00000000051
   Pan American Health Organization, 1995, DENG DENG HEM FEV AM
   Pennetier C, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-81
   Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119
   Rafinejad J., 2008, Journal of Vector Borne Diseases, V45, P143
   Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613
   Rossbach B, 2010, TOXICOL LETT, V192, P50, DOI 10.1016/j.toxlet.2009.06.863
   SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   SCHRECK CE, 1986, J MED ENTOMOL, V23, P396, DOI 10.1093/jmedent/23.4.396
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, P65, DOI 10.15585/mmwr.mm6503e2er
   SNODGRASS HL, 1992, J TOXICOL ENV HEALTH, V35, P91, DOI 10.1080/15287399209531598
   Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8
   Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   W.H.O, 2015, DENG HAEM FEV, V2, P25
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yao TT, 2015, MED VET ENTOMOL, V29, P37, DOI 10.1111/mve.12088
   Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x
   Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429
NR 71
TC 21
Z9 21
U1 0
U2 79
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2016
VL 11
IS 5
AR e0152805
DI 10.1371/journal.pone.0152805
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM3YJ
UT WOS:000376282300002
PM 27187593
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI More Evidence Linking Zika Virus to Birth Defects
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 60
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 17
PY 2016
VL 315
IS 19
BP 2056
EP 2056
DI 10.1001/jama.2016.5735
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL9PN
UT WOS:000375975300006
DA 2020-07-08
ER

PT J
AU Voelker, R
AF Voelker, Rebecca
TI Miami Obstetrician Uses Evidence to Quell Zika Fears
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 17
PY 2016
VL 315
IS 19
BP 2051
EP 2052
DI 10.1001/jama.2016.4069
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL9PN
UT WOS:000375975300002
PM 27119524
OA Bronze
DA 2020-07-08
ER

PT J
AU Costa, F
   Sarno, M
   Khouri, R
   Freitas, BD
   Siqueira, I
   Ribeiro, GS
   Ribeiro, HC
   Campos, GS
   Alcantara, LC
   Reis, MG
   Weaver, SC
   Vasilakis, N
   Ko, AI
   Almeida, AR
AF Costa, Federico
   Sarno, Manoel
   Khouri, Ricardo
   Freitas, Bruno de Paula
   Siqueira, Isadora
   Ribeiro, Guilherme S.
   Ribeiro, Hugo C.
   Campos, Gubio S.
   Alcantara, Luiz C.
   Reis, Mitermayer G.
   Weaver, Scott C.
   Vasilakis, Nikos
   Ko, Albert I.
   Almeida, Antonio Raimundo
TI Emergence of Congenital Zika Syndrome: Viewpoint From the Front Lines
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID VIRUS; DENGUE
C1 [Khouri, Ricardo; Ribeiro, Guilherme S.; Alcantara, Luiz C.] Minist Saude, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Freitas, Bruno de Paula; Ribeiro, Hugo C.] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Ave Paulo 6,2240,Apt 1004, BR-41810001 Salvador, BA, Brazil.
   Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
   [Costa, Federico] Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
   [Sarno, Manoel] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia & Maternidade Clime, Rua Limoeiro 137, BR-41055150 Salvador, BA, Brazil.
   [Siqueira, Isadora; Reis, Mitermayer G.] Funda, Ctr Pesquisas Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Almeida, Antonio Raimundo] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia, Ave Santa Luzia 149-302,Ed Bosque Italia, BR-40295050 Salvador, BA, Brazil.
RP Costa, F (corresponding author), Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
EM fcosta2001@gmail.com
RI Ko, Albert Icksang/P-2343-2015; de Siqueira, Isadora
   Cristina/R-9953-2016; Reis, Mitermayer/AAO-9742-2020; Costa,
   Federico/G-1838-2015; Weaver, Scott C/D-6490-2011; Ribeiro,
   Guilherme/B-6624-2008; Khouri, Ricardo/M-3184-2018
OI Ko, Albert Icksang/0000-0001-9023-2339; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Reis, Mitermayer/0000-0002-3051-9060;
   Costa, Federico/0000-0001-6951-2336; Weaver, Scott
   C/0000-0001-8016-8556; Ribeiro, Guilherme/0000-0002-6798-2059; Khouri,
   Ricardo/0000-0001-5664-4436; Alcantara, Luiz/0000-0002-6769-9931
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01 TW009504]; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI121207]
CR Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 9
TC 45
Z9 47
U1 0
U2 15
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 17
PY 2016
VL 164
IS 10
BP 689
EP +
DI 10.7326/M16-0332
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8GF
UT WOS:000375878500019
PM 26914810
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Armstrong, C
AF Armstrong, Carrie
TI CDC Updates Interim Guidance on Caring for Women with Possible Exposure
   to Zika Virus
SO AMERICAN FAMILY PHYSICIAN
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ACAD FAMILY PHYSICIANS
PI KANSAS CITY
PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA
SN 0002-838X
EI 1532-0650
J9 AM FAM PHYSICIAN
JI Am. Fam. Physician
PD MAY 15
PY 2016
VL 93
IS 10
BP 874
EP +
PG 3
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA DL8KO
UT WOS:000375891100009
PM 27175724
DA 2020-07-08
ER

PT J
AU Machado-Alba, JE
   Machado-Duque, ME
   Gaviria-Mendoza, A
   Orozco-Giraldo, VA
AF Machado-Alba, Jorge E.
   Machado-Duque, Manuel E.
   Gaviria-Mendoza, Andres
   Orozco-Giraldo, Viviana A.
TI Hormonal contraceptive prescriptions in Colombia and Zika virus
SO LANCET
LA English
DT Letter
C1 [Machado-Alba, Jorge E.] Univ Tecnol Pereira, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Colombia.
   Audifarma SA, Pereira, Colombia.
RP Machado-Alba, JE (corresponding author), Univ Tecnol Pereira, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Colombia.
EM machado@utp.edu.co
OI Gaviria-Mendoza, Andres/0000-0003-2500-7658; Machado-Duque, Manuel
   E/0000-0001-8458-0986
CR Ministry of Health and Social Protection (Colombia), VIR DEL ZIK
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Zwizwai R, 2016, LANCET INFECT DIS, V16, P299, DOI 10.1016/S1473-3099(16)00083-9
NR 4
TC 5
Z9 5
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 14
PY 2016
VL 387
IS 10032
BP 1993
EP 1993
DI 10.1016/S0140-6736(16)30429-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8HJ
UT WOS:000375881500017
PM 27156436
OA Bronze
DA 2020-07-08
ER

PT J
AU Musso, D
   Stramer, SL
   Busch, MP
AF Musso, Didier
   Stramer, Susan L.
   Busch, Michael P.
CA AABB Transfusion-Transmitted Dis
   Int Soc Blood Transfusion Working
TI Zika virus: a new challenge for blood transfusion
SO LANCET
LA English
DT Letter
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
   [Stramer, Susan L.] Amer Red Cross, Gaithersburg, MD USA.
   [Busch, Michael P.] Blood Syst Res Inst, Int Soc Blood Transfus, San Francisco, CA USA.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
EM dmusso@ilm.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   WHO, 2016, MAINT SAF AD BLOOD S
NR 5
TC 48
Z9 48
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 14
PY 2016
VL 387
IS 10032
BP 1993
EP 1994
DI 10.1016/S0140-6736(16)30428-7
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8HJ
UT WOS:000375881500018
PM 27156435
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Interim Guidance for Zika Virus Testing of Urine - United States, 2016
   (vol 65, pg 474, 2016)
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Correction
CR 2016, MMWR, V65, P474
NR 1
TC 0
Z9 0
U1 0
U2 52
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 13
PY 2016
VL 65
IS 18
BP 484
EP 484
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL9FQ
UT WOS:000375947600012
DA 2020-07-08
ER

PT J
AU Cohen, J
AF Cohen, Jon
TI INFECTIOUS DISEASE Animals show how Zika harms fetuses
SO SCIENCE
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 13
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAY 13
PY 2016
VL 352
IS 6287
BP 752
EP 753
DI 10.1126/science.352.6287.752
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL5FP
UT WOS:000375663000010
PM 27174964
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Interim Guidance for Zika Virus Testing of Urine - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
ID EPIDEMIC
OI Khan, Yawar/0000-0003-1964-591X
CR Bingham AM, 2016, MMWR MORB MORTAL WKL, V65
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   CDC, 2016, MEM REV DIAGN TEST Z
   CDC, 2016, COLL SUBM BOD FLUIDS
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH S
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
NR 9
TC 29
Z9 30
U1 0
U2 50
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 13
PY 2016
VL 65
IS 18
BP 474
EP 474
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL9FQ
UT WOS:000375947600005
PM 27171368
OA Bronze
DA 2020-07-08
ER

PT J
AU Bingham, AM
   Cone, M
   Mock, V
   Heberlein-Larson, L
   Stanek, D
   Blackmore, C
   Likos, A
AF Bingham, Andrea M.
   Cone, Marshall
   Mock, Valerie
   Heberlein-Larson, Lea
   Stanek, Danielle
   Blackmore, Carina
   Likos, Anna
TI Comparison of Test Results for Zika Virus RNA in Urine, Serum, and
   Saliva Specimens from Persons with Travel-Associated Zika Virus Disease
   - Florida, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Bingham, Andrea M.; Cone, Marshall; Mock, Valerie; Heberlein-Larson, Lea; Stanek, Danielle; Blackmore, Carina; Likos, Anna] Florida Dept Health, Tampa, FL 33602 USA.
RP Bingham, AM (corresponding author), Florida Dept Health, Tampa, FL 33602 USA.
EM Andrea.Bingham@flhealth.gov
OI Khan, Yawar/0000-0003-1964-591X
CR [Anonymous], 2016, ZIK VIR EM US AUTH E
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
NR 9
TC 139
Z9 143
U1 2
U2 20
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 13
PY 2016
VL 65
IS 18
BP 475
EP 478
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL9FQ
UT WOS:000375947600006
PM 27171533
OA Bronze
DA 2020-07-08
ER

PT J
AU Garcez, PP
   Loiola, EC
   Da Costa, RM
   Higa, LM
   Trindade, P
   Delvecchio, R
   Nascimento, JM
   Brindeiro, R
   Tanuri, A
   Rehen, SK
AF Garcez, Patricia P.
   Loiola, Erick Correia
   da Costa, Rodrigo Madeiro
   Higa, Luiza M.
   Trindade, Pablo
   Delvecchio, Rodrigo
   Nascimento, Juliana Minardi
   Brindeiro, Rodrigo
   Tanuri, Amilcar
   Rehen, Stevens K.
TI Zika virus impairs growth in human neurospheres and brain organoids
SO SCIENCE
LA English
DT Article
ID CEREBRAL ORGANOIDS; TRANSMISSION; INFECTION; GENERATION
AB Since the emergence of Zika virus (ZIKV), reports of microcephaly have increased considerably in Brazil; however, causality between the viral epidemic and malformations in fetal brains needs further confirmation. We examined the effects of ZIKV infection in human neural stem cells growing as neurospheres and brain organoids. Using immunocytochemistry and electron microscopy, we showed that ZIKV targets human brain cells, reducing their viability and growth as neurospheres and brain organoids. These results suggest that ZIKV abrogates neurogenesis during human brain development.
C1 [Garcez, Patricia P.; Loiola, Erick Correia; da Costa, Rodrigo Madeiro; Trindade, Pablo; Nascimento, Juliana Minardi; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Higa, Luiza M.; Delvecchio, Rodrigo; Brindeiro, Rodrigo; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Nascimento, Juliana Minardi] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
RP Garcez, PP; Rehen, SK (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.; Garcez, PP; Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
EM ppgarcez@icb.ufrj.br; srehen@lance-ufrj.org
RI Trindade, Pablo/D-8913-2016; Loiola, Erick/I-4106-2016; Higa,
   Luiza/W-2698-2019; Madeiro, Rodrigo/M-6433-2017; Nascimento,
   Juliana/B-8764-2009; Rehen, Stevens K/J-5874-2012; Garcez,
   Patricia/F-8026-2012
OI Trindade, Pablo/0000-0001-5953-7054; Loiola, Erick/0000-0002-7926-795X;
   Madeiro, Rodrigo/0000-0001-5646-8858; Nascimento,
   Juliana/0000-0003-3126-4984; Rehen, Stevens K/0000-0003-4216-9501;
   Garcez, Patricia/0000-0002-9107-1335
FU Brazilian Development Bank; Funding Authority for Studies and
   ProjectsCiencia Tecnologia e Inovacao (FINEP); National Council of
   Scientific and Technological DevelopmentNational Council for Scientific
   and Technological Development (CNPq); Foundation for Research Support in
   the State of Rio de Janeiro; Sao Paulo Research FoundationFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/21035-0];
   Coordination for the Improvement of Higher Education PersonnelCAPES
FX The authors thank the laboratory crew members M. Costa, I. Gomes, G.
   Vitoria, J. Sochacki, R. Maciel, and M. Alloati for providing technical
   support and cultures of human iPS cells and brain organoids. We
   acknowledge O. M. Barth for comments on the electron micrographs. We
   also thank F. Pamplona for assistance with the Mind the Graph science
   infographic maker and Centro Nacional de Biologia Estrutural e Bioimagem
   for the use of their electron microscopy facility. Funds (not
   specifically for Zika virus studies) were provided by the Brazilian
   Development Bank; the Funding Authority for Studies and Projects; the
   National Council of Scientific and Technological Development; the
   Foundation for Research Support in the State of Rio de Janeiro; and
   fellowships from the Sao Paulo Research Foundation (grant 2014/21035-0)
   and Coordination for the Improvement of Higher Education Personnel. All
   protocols and procedures were approved by the institutional research
   ethics committee of Hospital Copa D'Or under approved protocol no.
   727.269. The authors declare no competing financial interests.
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Grief C, 1997, ARCH VIROL, V142, P2347, DOI 10.1007/s007050050247
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 496
Z9 510
U1 7
U2 143
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAY 13
PY 2016
VL 352
IS 6287
BP 816
EP 818
DI 10.1126/science.aaf6116
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL5FP
UT WOS:000375663000038
PM 27064148
OA Bronze
DA 2020-07-08
ER

PT J
AU Haug, CJ
   Kieny, MP
   Murgue, B
AF Haug, Charlotte J.
   Kieny, Marie Paule
   Murgue, Bernadette
TI The Zika Challenge
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID VIRUS
C1 [Haug, Charlotte J.] WHO, Geneva, Switzerland.
   [Kieny, Marie Paule] WHO, Hlth Syst & Innovat, Geneva, Switzerland.
   [Murgue, Bernadette] WHO, WHO R&D Blueprint, Geneva, Switzerland.
RP Haug, CJ (corresponding author), WHO, Geneva, Switzerland.
RI Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019
OI Kieny, Marie-Paule/0000-0002-5943-6488; Haug,
   Charlotte/0000-0001-8217-7376
FU World Health OrganizationWorld Health Organization [001]
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
NR 5
TC 55
Z9 56
U1 1
U2 22
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 12
PY 2016
VL 374
IS 19
BP 1801
EP 1803
DI 10.1056/NEJMp1603734
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL6JS
UT WOS:000375746100001
PM 27028782
OA Bronze
DA 2020-07-08
ER

PT J
AU Dieng, H
   Yusop, NSBT
   Kamal, NNB
   Ahmad, AH
   Ghani, IA
   Abang, F
   Satho, T
   Ahmad, H
   Zuharah, WF
   Ab Majid, AH
   Morales, RE
   Morales, NP
   Hipolito, CN
   Noweg, GT
AF Dieng, Hamady
   Yusop, Nur Syafiqah Bt. Tan
   Kamal, Nurafidah Natasyah Bt.
   Ahmad, Abu Hassan
   Ghani, Idris Abd
   Abang, Fatimah
   Satho, Tomomitsu
   Ahmad, Hamdan
   Zuharah, Wan Fatma
   Ab Majid, Abdul Hafiz
   Morales, Ronald E.
   Morales, Noppawan P.
   Hipolito, Cirilo N.
   Noweg, Gabriel Tonga
TI Exposure of a Dengue Vector to Tea and Its Waste: Survival,
   Developmental Consequences, and Significance for Pest Management
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE dengue; tea; mosquito; Ae. albopictus
ID AEDES-ALBOPICTUS DIPTERA; INSECTICIDE RESISTANCE; AEGYPTI DIPTERA;
   LETHAL OVITRAP; COFFEE GROUNDS; BODY-SIZE; CAFFEINE; CULICIDAE;
   MOSQUITO; BEHAVIOR
AB Dengue mosquitoes are evolving into a broader global public health menace, with relentless outbreaks and the rise in number of Zika virus disease cases as reminders of the continued hazard associated with Aedes vectors. The use of chemical insecticides-the principal strategy against mosquito vectors-has been greatly impeded due to the development of insecticide resistance and the shrinking spectrum of effective agents. Therefore, there is a pressing need for new chemistries for vector control. Tea contains hundreds of chemicals, and its waste, which has become a growing global environmental problem, is almost as rich in toxicants as green leaves. This paper presents the toxic and sublethal effects of different crude extracts of tea on Aedes albopictus. The survival rates of larvae exposed to tea extracts, especially fresh tea extract (FTE), were markedly lower than those in the control treatment group. In addition to this immediate toxicity against different developmental stages, the extracts tested caused a broad range of sublethal effects. The developmental time was clearly longer in containers with tea, especially in those with young larvae (YL) and FTE. Among the survivors, pupation success was reduced in containers with tea, which also produced low adult emergence rates with increasing tea concentration. The production of eggs tended to be reduced in females derived from the tea treatment groups. These indirect effects of tea extracts on Ae. albopictus exhibited different patterns according to the exposed larval stage. Taken together, these findings indicate that tea and its waste affect most key components of Ae. albopictus vectorial capacity and may be useful for dengue control. Reusing tea waste in vector control could also be a practical solution to the problems associated with its pollution.
C1 [Dieng, Hamady; Noweg, Gabriel Tonga] Univ Malaysia Sarawak, IBEC, Kuching, Kota Samarahan, Malaysia.
   [Yusop, Nur Syafiqah Bt. Tan; Kamal, Nurafidah Natasyah Bt.; Ahmad, Abu Hassan; Ahmad, Hamdan; Zuharah, Wan Fatma; Ab Majid, Abdul Hafiz] Univ Sains Malaysia, Sch Biol Sci, George Town, Penang, Malaysia.
   [Ghani, Idris Abd] Univ Kebangsaan Malaysia, Fac Sci & Technol, Bangi 43600, Malaysia.
   [Abang, Fatimah] Univ Malaysia Sarawak, Fac Resource Sci & Technol, Kota Samarahan, Malaysia.
   [Satho, Tomomitsu] Fukuoka Univ, Fac Pharmaceut Sci, 8-19-1 Nanakuma, Fukuoka 81401, Japan.
   [Morales, Ronald E.] Mahidol Univ, Fac Trop Med, Dept Med Entomol, Bangkok, Thailand.
   [Morales, Noppawan P.] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand.
   [Hipolito, Cirilo N.] Univ Malaysia, Fac Engn, Dept Chem Engn & Energy Sustainabil, Miri, Sarawak, Malaysia.
RP Dieng, H (corresponding author), Univ Malaysia Sarawak, IBEC, Kuching, Kota Samarahan, Malaysia.
EM hamadydieng69@gmail.com
RI Majid, Abdul Hafiz Ab/B-6248-2013; ahmad, hamdan/E-3635-2012; Zuharah,
   Wan Fatma/A-5498-2011; Majid, Abdul Hafiz Ab/N-3058-2019
OI Majid, Abdul Hafiz Ab/0000-0001-5297-8981; Zuharah, Wan
   Fatma/0000-0002-5789-2244; Majid, Abdul Hafiz Ab/0000-0001-5297-8981;
   Morales, Noppawan/0000-0002-5365-2884
FU Ministry of Higher Education, MalaysiaMinistry of Education, Malaysia;
   USM (Universiti Sains Malaysia)Universiti Sains Malaysia
   [304/Pbiology/650575/U112]
FX This work was supported by a Long Term Research Grant (LRGS) for
   Infectious Diseases, 2011-2014, Ministry of Higher Education, Malaysia,
   and USM (Universiti Sains Malaysia) (304/Pbiology/650575/U112).
CR [Anonymous], 2014, GUARDIAN NEWS
   Aoyama N., 2013, ASAHI SHIMBUM GLOBE
   Azmat R, 2010, PAK J BOT, V42, P3065
   Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0
   Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566
   Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410
   Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3
   Daniels S., 2005, TEA WASTE RICH EXTRA
   Derraik J. G. B., 2005, Annals of Medical Entomology, V14, P14
   Dieng H, 2015, ACTA TROP, V145, P68, DOI 10.1016/j.actatropica.2015.01.004
   Dieng H, 2014, ACTA TROP, V130, P123, DOI 10.1016/j.actatropica.2013.11.001
   Dieng H, 2011, J AM MOSQUITO CONTR, V27, P263, DOI 10.2987/11-6124.1
   Elango G., 2012, Journal of King Saud University Science, V24, P73, DOI 10.1016/j.jksus.2010.08.012
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   GUTIERREZ PM, 2014, INT RES J BIOL SCI, V3, P23
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hamady D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-206
   HARE SGF, 1986, J AM MOSQUITO CONTR, V2, P325
   Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301
   Khan Mahfuza, 2007, Pakistan Journal of Biological Sciences, V10, P3656
   Laranja AT, 2003, GENET MOL BIOL, V26, P419, DOI 10.1590/S1415-47572003000400004
   Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131
   Li MJ, 2014, WORLD J CLIN ONCOL, V5, P520, DOI 10.5306/wjco.v5.i3.520
   Lu M, 2013, MOLECULES, V18, P2754, DOI 10.3390/molecules18032754
   Macchioni F., 2004, Annali della Facolta di Medicina Veterinaria di Pisa, V57, P215
   Magellan TM, 2013, HORTTECHNOLOGY, V23, P201, DOI 10.21273/HORTTECH.23.2.201
   Maiga H, 2014, ACTA TROP, V132, pS102, DOI 10.1016/j.actatropica.2013.08.018
   MITCHELL MJ, 1993, INSECT BIOCHEM MOLEC, V23, P65, DOI 10.1016/0965-1748(93)90083-5
   MONTGOMERY BL, 2005, ARBOVIRUS RES AUST, V9, P268
   Nandal M., 2014, INT J CURR ENG TECHN, V4, P244
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592
   Norizan SNM, 2013, SENSORS-BASEL, V13, P5117, DOI 10.3390/s130405117
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395
   Primavesi L., 2014, POLYPHENOLS HUMAN HL, P849
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Ritchie SC, 2005, ARBOVIRUS RES AUST, V9, P324
   Ritchie SA, 2008, J AM MOSQUITO CONTR, V24, P47, DOI 10.2987/5658.1
   Satho T, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0874-6
   *SYST SOFTW INC, 2004, SYST WIND STAT
   Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862
   Thompson AG, 2004, ENVIRON MONIT ASSESS, V91, P87, DOI 10.1023/B:EMAS.0000009231.04123.2d
   Thomson Reuters/Zawya, 2013, LIPT JEB AL FACT ACH
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wasewar K. L., 2010, International Journal of Research and Reviews in Applied Sciences, V3, P303
   Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203
   Wink M, 1992, INSECT PLANT INTERAC, V4
   World Health Organization (WHO), 2013, GLOB STRAT DENG PREV
   Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222
   Yee DA, 2004, J VECTOR ECOL, V29, P315
   2010, EPPO B, V40, P313
NR 53
TC 2
Z9 2
U1 0
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 11
PY 2016
VL 64
IS 18
BP 3485
EP 3491
DI 10.1021/acs.jafc.6b01157
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA DL9ND
UT WOS:000375969100001
PM 27115536
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Xie, XP
   Shan, C
   Shi, PY
AF Xie, Xuping
   Shan, Chao
   Shi, Pei-Yong
TI Restriction of Zika Virus by Host Innate Immunity
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID RESISTANCE; CELLS
AB Recent epidemics of Zika virus (ZIKV) have brought increasing concerns of heightened disease severity and neurotropism. In this issue of Cell Host & Microbe, Lazear et al. (2016) and Bayer et al. (2016) show that innate immunity can restrict ZIKV infection and disease development.
C1 [Xie, Xuping; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Xie, Xuping; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Xie, Xuping; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019
OI Shan, Chao/0000-0002-3953-3782
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rossi SL, 2016, AM J TROP MED HYG, P16
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi PY, 2014, CELL HOST MICROBE, V16, P269, DOI 10.1016/j.chom.2014.08.011
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
NR 10
TC 16
Z9 16
U1 0
U2 39
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 566
EP 567
DI 10.1016/j.chom.2016.04.019
PG 2
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500002
PM 27173920
OA Bronze
DA 2020-07-08
ER

PT J
AU Rasmussen, AL
   Katze, MG
AF Rasmussen, Angela L.
   Katze, Michael G.
TI Genomic Signatures of Emerging Viruses: A New Era of Systems
   Epidemiology
SO CELL HOST & MICROBE
LA English
DT Review
ID POLYMERASE-CHAIN-REACTION; CROSS FOUNDER MICE; EBOLA-VIRUS; RAPID
   DETECTION; REAL-TIME; GENETIC DIVERSITY; RT-PCR; DNA; INFECTION;
   PATHOGENS
AB Compared to classical epidemiologic methods, genomics can be used to precisely monitor virus evolution and transmission in real time across large, diverse populations. Integration of pathogen genomics with data about host genetics and global transcriptional responses to infection allows for comprehensive studies of population-level responses to infection and provides novel methods for predicting clinical outcomes. As genomic technologies become more accessible, these methods will redefine how emerging viruses are studied and outbreaks are contained. Here we review the existing and emerging genomic technologies that are enabling systems epidemiology and systems virology and making it possible to respond rapidly to emerging viruses such as Zika.
C1 [Rasmussen, Angela L.; Katze, Michael G.] Univ Washington, Dept Microbiol, 960 Republican St, Seattle, WA 98109 USA.
RP Katze, MG (corresponding author), Univ Washington, Dept Microbiol, 960 Republican St, Seattle, WA 98109 USA.
EM honey@uw.edu
OI Rasmussen, Angela/0000-0001-9462-3169
CR Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861
   Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800
   Casas I, 1997, J VIROL METHODS, V66, P39, DOI 10.1016/S0166-0934(97)00035-9
   D'Ortenzio E, 2016, N ENGL J MED
   Dong H, 2015, GENOM DATA, V6, P1, DOI 10.1016/j.gdata.2015.07.018
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Edwards KM, 2014, EXPERT REV VACCINES, V13, P1183, DOI 10.1586/14760584.2014.946015
   Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247
   Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799
   Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18
   Garcez P. P., 2016, SCIENCE
   Gardeux V, 2015, J BIOMED INFORM, V55, P94, DOI 10.1016/j.jbi.2015.03.003
   Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15
   Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Haeussler M, 2014, PLOS CURR, V2014, P6
   Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015
   Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001
   Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234
   Jansen L, 2015, LIVER INT, V35, P1824, DOI 10.1111/liv.12768
   Josset L, 2014, RNA BIOL, V11, P875, DOI 10.4161/rna.29442
   Katze M., 2016, VIRAL PATHOGENESIS E
   Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816
   Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551
   Luebke Robert W, 2004, J Immunotoxicol, V1, P15, DOI 10.1080/15476910490438342
   MacNeil A, 2014, VACCINE, V32, P4893, DOI 10.1016/j.vaccine.2014.07.005
   Madoui MA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1519-z
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   Martinez MT, 2009, NANO LETT, V9, P530, DOI 10.1021/nl8025604
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   McElhaney JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00041
   Nicholson TL, 2011, J CLIN MICROBIOL, V49, P1542, DOI 10.1128/JCM.01876-10
   Palacios G, 2006, EMERG INFECT DIS, V12, P692, DOI 10.3201/eid1204.051515
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quinones-Mateu ME, 2014, J CLIN VIROL, V61, P9, DOI 10.1016/j.jcv.2014.06.013
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Rasmussen AL, 2012, HEPATOLOGY, V56, P17, DOI 10.1002/hep.25612
   Rasmussen SA, 2016, N ENGL J MED
   Renois F, 2010, J CLIN MICROBIOL, V48, P3836, DOI 10.1128/JCM.00733-10
   Sanghavi SK, 2012, J MED VIROL, V84, P162, DOI 10.1002/jmv.22186
   Scarpino SV, 2015, CLIN INFECT DIS, V60, P1079, DOI 10.1093/cid/ciu1131
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Sloots TP, 2015, PATHOLOGY, V47, P191, DOI 10.1097/PAT.0000000000000241
   Sorgenfrei S, 2011, NAT NANOTECHNOL, V6, P125, DOI 10.1038/nnano.2010.275
   Stadler T., 2014, PLOS CURR, V6, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS
   Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Tang H, 2016, CELL STEM CELL
   Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Valassina M, 1997, CLIN DIAGN VIROL, V8, P227, DOI 10.1016/S0928-0197(97)10001-0
   Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Xiong H, 2014, G3-GENES GENOM GENET, V4, P1429, DOI 10.1534/g3.114.011759
   Yao FJ, 2014, CHEM COMMUN, V50, P13853, DOI 10.1039/c4cc06135g
   Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280
NR 67
TC 7
Z9 8
U1 0
U2 36
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 611
EP 618
DI 10.1016/j.chom.2016.04.016
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500011
PM 27173929
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wang, L
   Valderramos, SG
   Wu, AP
   Ouyang, SY
   Li, CF
   Brasil, P
   Bonaldo, M
   Coates, T
   Nielsen-Saines, K
   Jiang, TJ
   Aliyari, R
   Cheng, GH
AF Wang, Lulan
   Valderramos, Stephanie G.
   Wu, Aiping
   Ouyang, Songying
   Li, Chunfeng
   Brasil, Patricia
   Bonaldo, Myrna
   Coates, Thomas
   Nielsen-Saines, Karin
   Jiang, Taijiao
   Aliyari, Roghiyh
   Cheng, Genhong
TI From Mosquitos to Humans: Genetic Evolution of Zika Virus
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID STATES
AB Initially isolated in 1947, Zika virus (ZIKV) has recently emerged as a significant public health concern. Sequence analysis of all 41 known ZIKV RNA open reading frames to date indicates that ZIKV has undergone significant changes in both protein and nucleotide sequences during the past half century.
C1 [Wang, Lulan; Valderramos, Stephanie G.; Ouyang, Songying; Li, Chunfeng; Aliyari, Roghiyh; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Valderramos, Stephanie G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.
   [Ouyang, Songying] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.
   [Brasil, Patricia] Inst Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, BR-21040900 Rio De Janeiro, Brazil.
   [Bonaldo, Myrna] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [Coates, Thomas] Univ Calif Los Angeles, UCLA Ctr World Hlth, Los Angeles, CA 90024 USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
RP Aliyari, R; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Jiang, TJ; Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Jiang, TJ; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Jiang, TJ; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
EM jtj@ism.cams.cn; aliyarirs@ucla.edu; gcheng@mednet.ucla.edu
RI Gaw, Stephanie/K-4592-2019
OI Gaw, Stephanie/0000-0003-0891-6964
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI078389, R01 AI069120, R56 AI078389,
   R01 AI056154]; NICHD NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [K12 HD000849]
CR Bonaldo M. C., 2016, BIORXIV
   Brasil P, 2016, N ENGL J MED
   Broutet N., 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lazear HM, 2016, CELL HOST MICROBE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ramachandran S, 2011, J VIROL, V85, P6369, DOI 10.1128/JVI.02204-10
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
NR 17
TC 121
Z9 125
U1 0
U2 72
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 561
EP 565
DI 10.1016/j.chom.2016.04.006
PG 5
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500001
PM 27091703
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Dai, LP
   Song, J
   Lu, XS
   Deng, YQ
   Musyoki, AM
   Cheng, HJ
   Zhang, YF
   Yuan, Y
   Song, H
   Haywood, J
   Xiao, HX
   Yan, JH
   Shi, Y
   Qin, CF
   Qi, JX
   Gao, GF
AF Dai, Lianpan
   Song, Jian
   Lu, Xishan
   Deng, Yong-Qiang
   Musyoki, Abednego Moki
   Cheng, Huijun
   Zhang, Yanfang
   Yuan, Yuan
   Song, Hao
   Haywood, Joel
   Xiao, Haixia
   Yan, Jinghua
   Shi, Yi
   Qin, Cheng-Feng
   Qi, Jianxun
   Gao, George F.
TI Structures of the Zika Virus Envelope Protein and Its Complex with a
   Flavivirus Broadly Protective Antibody
SO CELL HOST & MICROBE
LA English
DT Article
ID WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES;
   DENGUE VIRUS; FUSION-LOOP; NEUTRALIZING ANTIBODIES; EBOLA-VIRUS;
   ENCEPHALITIS-VIRUS; CRYSTAL-STRUCTURE; ASIAN LINEAGE
AB Zika virus (ZIKV), a mosquito-borne flavivirus, is a current global public health concern. The flavivirus envelope (E) glycoprotein is responsible for virus entry and represents a major target of neutralizing antibodies for other flaviviruses. Here, we report the structures of ZIKV E protein at 2.0 angstrom and in complex with a flavivirus broadly neutralizing murine antibody 2A10G6 at 3.0 angstrom. ZIKV-E resembles all the known flavivirus E structures but contains a unique, positively charged patch adjacent to the fusion loop region of the juxtaposed monomer, which may influence host attachment. The ZIKV-E-2A10G6 complex structure reveals antibody recognition of a highly conserved fusion loop. 2A10G6 binds to ZIKV-E with high affinity in vitro and neutralizes currently circulating ZIKV strains in vitro and in mice. The E protein fusion loop epitope represents a potential candidate for therapeutic antibodies against ZIKV.
C1 [Dai, Lianpan; Cheng, Huijun; Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing 100101, Peoples R China.
   [Song, Jian; Musyoki, Abednego Moki; Yuan, Yuan; Song, Hao; Haywood, Joel; Yan, Jinghua; Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100071, Peoples R China.
   [Song, Jian; Musyoki, Abednego Moki; Yuan, Yuan; Song, Hao; Haywood, Joel; Yan, Jinghua; Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
   [Lu, Xishan; Zhang, Yanfang; Xiao, Haixia; Gao, George F.] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.
   [Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.
   [Yan, Jinghua; Shi, Yi; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
   [Yan, Jinghua; Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.
   [Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Engn, Beijing 100101, Peoples R China.
   [Gao, George F.] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
RP Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing 100101, Peoples R China.; Qi, JX; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100071, Peoples R China.; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
EM qincf@bmi.ac.cn; jxqi@im.ac.cn; gaof@im.ac.cn
RI Qin, Cheng-Feng/I-6839-2019; Haywood, Joel/G-8311-2016
OI Qin, Cheng-Feng/0000-0002-0632-2807; Song, Hao/0000-0002-2811-0370;
   Haywood, Joel/0000-0003-1576-9704
FU Task-Force of Zika Virus Research from the Chinese Academy of Sciences
   (CAS); Emergency Task-Force Project of the National Natural Science
   Foundation of China (NSFC) [81641001]; Zika Special Project of the
   National Infectious Disease Control ST Grand Project; Strategic Priority
   Research Program of the Chinese Academy of SciencesChinese Academy of
   Sciences [XDB08020100]; Excellent Young Scientist Program of the Chinese
   Academy of Sciences; Youth Innovation Promotion Association CAS
   [2015078]; Excellent Young Scientist Program from the NSFC [81522025];
   Academy of Medical Sciences, UK; NSFCNational Natural Science Foundation
   of China; NSFC Innovative Research Group [81321063]
FX This work was supported by the Task-Force of Zika Virus Research from
   the Chinese Academy of Sciences (CAS), the Emergency Task-Force Project
   (Grant No. 81641001) of the National Natural Science Foundation of China
   (NSFC), Zika Special Project of the National Infectious Disease Control
   S&T Grand Project, and Strategic Priority Research Program of the
   Chinese Academy of Sciences (XDB08020100). We thank the staff of BL17U
   beamline at Shanghai Synchrotron Radiation Facility for assistance
   during data collection. Y.S. is supported by the Excellent Young
   Scientist Program of the Chinese Academy of Sciences and the Youth
   Innovation Promotion Association CAS (Grant No. 2015078). C.-F.Q. is
   supported by the Excellent Young Scientist Program from the NSFC (No.
   81522025) and the Newton Advanced Fellowship from the Academy of Medical
   Sciences, UK and NSFC. G.F.G. is a leading principal investigator of the
   NSFC Innovative Research Group (Grant No. 81321063). We thank Shihua Li,
   Gary Wong, Kefang Liu, and Helin Zhang for their technical support.
CR Aad G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.161801
   Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kostyuchenko V.A., 2016, NATURE
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lai RPJ, 2014, J BIOL CHEM, V289, P29912, DOI 10.1074/jbc.M114.569566
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu J, 2011, J VIROL, V85, P7372, DOI 10.1128/JVI.00350-11
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575
   Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
   Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 55
TC 236
Z9 251
U1 6
U2 111
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 696
EP 704
DI 10.1016/j.chom.2016.04.013
PG 9
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500019
PM 27158114
OA Bronze
DA 2020-07-08
ER

PT J
AU Bayer, A
   Lennemann, NJ
   Ouyang, YS
   Bramley, JC
   Morosky, S
   Marques, ETD
   Cherry, S
   Sadovsky, Y
   Coyne, CB
AF Bayer, Avraham
   Lennemann, Nicholas J.
   Ouyang, Yingshi
   Bramley, John C.
   Morosky, Stefanie
   De Azeved Marques, Ernesto Torres, Jr.
   Cherry, Sara
   Sadovsky, Yoel
   Coyne, Carolyn B.
TI Type III Interferons Produced by Human Placental Trophoblasts Confer
   Protection against Zika Virus Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID IN-VITRO; LAMBDA; BRAIN; DIFFERENTIATION; BRAZIL; CELLS
AB During mammalian pregnancy, the placenta acts as a barrier between the maternal and fetal compartments. The recently observed association between Zika virus (ZIKV) infection during human pregnancy and fetal microcephaly and other anomalies suggests that ZIKV may bypass the placenta to reach the fetus. This led us to investigate ZIKV infection of primary human trophoblasts (PHTs), which are the barrier cells of the placenta. We discovered that PHT cells from full-term placentas are refractory to ZIKV infection. In addition, medium from uninfected PHT cells protects non-placental cells from ZIKV infection. PHT cells constitutively release the type III interferon (IFN) IFN lambda 1, which functions in both a paracrine and autocrine manner to protect trophoblast and non-trophoblast cells from ZIKV infection. Our data suggest that for ZIKV to access the fetal compartment, it must evade restriction by trophoblast- derived IFNl1 and other trophoblast-specific antiviral factors and/or use alternative strategies to cross the placental barrier.
C1 [Bayer, Avraham; Ouyang, Yingshi; Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.
   [Bayer, Avraham; Ouyang, Yingshi; Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.
   [Lennemann, Nicholas J.; Bramley, John C.; Morosky, Stefanie; Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
   [De Azeved Marques, Ernesto Torres, Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
   [De Azeved Marques, Ernesto Torres, Jr.] Fundacao Osvaldo Cruz FIOCRUZ, BR-50670420 Recife, PE, Brazil.
   [Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Sadovsky, Y; Coyne, CB (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.; Sadovsky, Y; Coyne, CB (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.; Sadovsky, Y; Coyne, CB (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
EM ysadovsky@mwri.magee.edu; coynec2@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01-AI081759, R01-HD075665,
   T32-AI049820]; Burroughs Wellcome Investigators in the Pathogenesis of
   Infectious Disease Awards
FX We thank Saumendra Sarkar and Donald Burke (University of Pittsburgh)
   for reagents and/or advice, Ted Pierson (NIH/NIAID) and Margaret Kielian
   (Albert Einstein College of Medicine) for DENV reagents, and Kwang Sik
   Kim (Johns Hopkins University) for the HBMECs used in the study. This
   project was supported by NIH R01-AI081759 (C.B.C.), NIH R01-HD075665
   (C.B.C. and Y.S.), and T32-AI049820 (N.J.L.). In addition, C.B.C. and
   S.C. are supported by Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Awards.
CR Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Bazer FW, 1996, AM J REPROD IMMUNOL, V35, P297
   Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Cauchemez S, 2016, LANCET
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   LEFEVRE F, 1993, J BIOL CHEM, V268, P19760
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MORRISH DW, 1987, J CLIN ENDOCR METAB, V65, P1282, DOI 10.1210/jcem-65-6-1282
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Shu Q, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005150
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406
   Thirkill TL, 1997, J CELL BIOCHEM, V65, P460, DOI 10.1002/(SICI)1097-4644(19970615)65:4<460::AID-JCB2>3.0.CO;2-M
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7
NR 34
TC 236
Z9 239
U1 2
U2 66
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 705
EP 712
DI 10.1016/j.chom.2016.03.008
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500020
PM 27066743
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Lazear, HM
   Govero, J
   Smith, AM
   Platt, DJ
   Fernandez, E
   Miner, JJ
   Diamond, MS
AF Lazear, Helen M.
   Govero, Jennifer
   Smith, Amber M.
   Platt, Derek J.
   Fernandez, Estefania
   Miner, Jonathan J.
   Diamond, Michael S.
TI A Mouse Model of Zika Virus Pathogenesis
SO CELL HOST & MICROBE
LA English
DT Article
ID UNITED-STATES; ALPHA/BETA; TRANSMISSION; INFECTION; ISOLATIONS;
   OUTBREAK; PROTEIN; BRAZIL; ROLES; BRAIN
AB The ongoing Zika virus (ZIKV) epidemic and unexpected clinical outcomes, including Guillain-Barre syndrome and birth defects, has brought an urgent need for animal models. We evaluated infection and pathogenesis with contemporary and historical ZIKV strains in immunocompetent mice and mice lacking components of the antiviral response. Four-to six-week-old Irf3(-/-) Irf5(-/-) Irf7(-/-) triple knockout mice, which produce little interferon alpha/beta, and mice lacking the interferon receptor (Ifnar1(-/-)) developed neurological disease and succumbed to ZIKV infection, whereas single Irf3(-/-), Irf5(-/-), and Mavs(-/-) knockout mice exhibited no overt illness. Ifnar1(-/-) mice sustained high viral loads in the brain and spinal cord, consistent with evidence that ZIKV causes neurodevelopmental defects in human fetuses. The testes of Ifnar1(-/-) mice had the highest viral loads, which is relevant to sexual transmission of ZIKV. This model of ZIKV pathogenesis will be valuable for evaluating vaccines and therapeutics as well as understanding disease pathogenesis.
C1 [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Govero, Jennifer; Smith, Amber M.; Platt, Derek J.; Fernandez, Estefania; Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Platt, Derek/0000-0003-0766-4590;
   Lazear, Helen/0000-0002-8649-4579
FU University of North Carolina Department of Microbiology and Immunology;
   Lineberger Comprehensive Cancer Center; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI073755, R01 AI104972]; Rheumatology Research Foundation Scientist
   Development Award; NIH Pre-Doctoral Training Grant award [T32 AI007163];
   NIH Research Education Program [R25 HG006687]
FX This work was supported by start-up funds from the University of North
   Carolina Department of Microbiology and Immunology and the Lineberger
   Comprehensive Cancer Center (H.M.L.), as well as grants from the NIH
   (R01 AI073755 and R01 AI104972) (M.S.D.). J.J.M., E.F., and D.J.P. were
   supported by a Rheumatology Research Foundation Scientist Development
   Award, NIH Pre-Doctoral Training Grant award (T32 AI007163), and NIH
   Research Education Program (R25 HG006687), respectively. M.S.D. is a
   consultant for InBios and Visterra and a member of the Scientific
   Advisory Board of Moderna.
CR Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Brien J.D., 2013, CURR PROTOC MICROBIO, V31, P18
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET
   Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08
   Lazear H. M., 2016, J VIROL
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005
   Pagni S, 2012, IMMUNOL RES, V54, P152, DOI 10.1007/s12026-012-8334-2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   Rossi SL, 2016, AM J TROP MED HYG
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308
   Tang H, 2016, CELL STEM CELL
   VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EURO SURVEILL, V21
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Willison HJ, 2016, LANCET
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
NR 67
TC 473
Z9 482
U1 4
U2 148
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 720
EP 730
DI 10.1016/j.chom.2016.03.010
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500022
PM 27066744
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Voelker, R
AF Voelker, Rebecca
TI Protecting Health Workers From Zika During Labor and Delivery
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
ID UNITED-STATES
C1 [Voelker, Rebecca] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
RP Voelker, R (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
CR Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Salinas JL, 2016, MMWR-MORBID MORTAL W, V65, P273, DOI 10.15585/mmwr.mm6511a2
NR 2
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 10
PY 2016
VL 315
IS 18
BP 1939
EP 1939
DI 10.1001/jama.2016.4781
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EL9YZ
UT WOS:000394977300002
DA 2020-07-08
ER

PT J
AU Behura, SK
   Sarro, J
   Li, P
   Mysore, K
   Severson, DW
   Emrich, SJ
   Duman-Scheel, M
AF Behura, Susanta K.
   Sarro, Joseph
   Li, Ping
   Mysore, Keshava
   Severson, David W.
   Emrich, Scott J.
   Duman-Scheel, Molly
TI High-throughput cis-regulatory element discovery in the vector mosquito
   Aedes aegypti
SO BMC GENOMICS
LA English
DT Article
DE Genome; FAIRE-seq; Dengue virus; Zika; Next generation sequencing;
   Drosophila
ID DROSOPHILA-MELANOGASTER; UNTRANSLATED REGIONS; MICRORNA EXPRESSION;
   GENOME SEQUENCE; OPEN CHROMATIN; TRANSCRIPTION; ENHANCERS; DENGUE;
   GENES; FAIRE
AB Background: Despite substantial progress in mosquito genomic and genetic research, few cis-regulatory elements (CREs), DNA sequences that control gene expression, have been identified in mosquitoes or other non-model insects. Formaldehyde-assisted isolation of regulatory elements paired with DNA sequencing, FAIRE-seq, is emerging as a powerful new high-throughput tool for global CRE discovery. FAIRE results in the preferential recovery of open chromatin DNA fragments that are not bound by nucleosomes, an evolutionarily conserved indicator of regulatory activity, which are then sequenced. Despite the power of the approach, FAIRE-seq has not yet been applied to the study of non-model insects. In this investigation, we utilized FAIRE-seq to profile open chromatin and identify likely regulatory elements throughout the genome of the human disease vector mosquito Aedes aegypti. We then assessed genetic variation in the regulatory elements of dengue virus susceptible (Moyo-S) and refractory (Moyo-R) mosquito strains.
   Results: Analysis of sequence data obtained through next generation sequencing of FAIRE DNA isolated from A. aegypti embryos revealed >121,000 FAIRE peaks (FPs), many of which clustered in the 1 kb 5' upstream flanking regions of genes known to be expressed at this stage. As expected, known transcription factor consensus binding sites were enriched in the FPs, and of these FoxA1, Hunchback, Gfi, Klf4, MYB/ph3 and Sox9 are most predominant. All of the elements tested in vivo were confirmed to drive gene expression in transgenic Drosophila reporter assays. Of the >13,000 single nucleotide polymorphisms (SNPs) recently identified in dengue virus-susceptible and refractory mosquito strains, 3365 were found to map to FPs.
   Conclusion: FAIRE-seq analysis of open chromatin in A. aegypti permitted genome-wide discovery of CREs. The results of this investigation indicate that FAIRE-seq is a powerful tool for identification of regulatory DNA in the genomes of non-model organisms, including human disease vector mosquitoes.
C1 [Behura, Susanta K.; Sarro, Joseph; Li, Ping; Mysore, Keshava; Severson, David W.; Emrich, Scott J.; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Behura, Susanta K.; Sarro, Joseph; Severson, David W.; Emrich, Scott J.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Sarro, Joseph; Li, Ping; Mysore, Keshava; Severson, David W.; Duman-Scheel, Molly] Indiana Univ Sch Med, Dept Med & Mol Genet, 1234 Notre Dame Ave, South Bend, IN 46617 USA.
   [Emrich, Scott J.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.
RP Emrich, SJ; Duman-Scheel, M (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; Emrich, SJ; Duman-Scheel, M (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Duman-Scheel, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, 1234 Notre Dame Ave, South Bend, IN 46617 USA.
EM semrich@nd.edu; mscheel@nd.edu
RI Mysore, Keshava/P-6248-2019
OI Mysore, Keshava/0000-0003-2794-7029
FU National Institutes of Health, National Center for Advancing
   Translational Sciences, Clinical and Translational Sciences Award
   [UL1TR001108]; University of Notre Dame Genomics and Bioinformatics Core
   Facility
FX We are grateful to the staff of VectorBase and the University of Notre
   Dame Genomics and Bioinformatics Core Facility for their assistance.
   Thanks to Emily Andrews for assistance with the egg collections.
   Drosophila transgenics were generated by Rainbow Transgenic Flies, Inc.
   (Camarillo, CA). Open chromatin profiling was performed with a pilot
   grant to MDS from the Indiana Clinical and Translational Sciences
   Institute which is funded in part by Grant Number UL1TR001108 from the
   National Institutes of Health, National Center for Advancing
   Translational Sciences, Clinical and Translational Sciences Award. A
   Navari Family Foundation grant to MDS supported analysis of FP
   sequences. An NIH-NIAID R21AI117145-01 to MDS supported reporter
   generation and analysis. The University of Notre Dame Genomics and
   Bioinformatics Core Facility provided further support for this project.
   The funding bodies did not play roles in the experimental design,
   collection, analysis, or interpretation of data, writing of the
   manuscript or decision to submit it for publication.
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Behura SK, 2015, J MOL BIOL, V427, P521, DOI 10.1016/j.jmb.2014.11.008
   Behura SK, 2013, EVOL APPL, V6, P1079, DOI 10.1111/eva.12088
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonizzoni M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-739
   Borel C, 2011, GENOME RES, V21, P68, DOI 10.1101/gr.109371.110
   Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035
   Chavali PL, 2011, NUCLEIC ACIDS RES, V39, P6908, DOI 10.1093/nar/gkr303
   Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299
   Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530
   Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506
   Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003
   Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902
   GUNDERSON SI, 1990, GENE DEV, V4, P2048, DOI 10.1101/gad.4.12a.2048
   Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198
   Haugen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021694
   Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61
   Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854
   Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021
   Kundaje A, ENCODE TF CHIP SEQ P
   Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466
   McKay DJ, 2013, DEV CELL, V27, P306, DOI 10.1016/j.devcel.2013.10.009
   Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089
   Meyer CG, 2014, SEMIN IMMUNOL, V26, P445, DOI 10.1016/j.smim.2014.09.005
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003
   Pesole G, 1999, TRENDS GENET, V15, P378, DOI 10.1016/S0168-9525(99)01795-3
   Sarro J, 2013, DEV DYNAM, V242, P1466, DOI 10.1002/dvdy.24059
   Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x
   SHARP SJ, 1988, MOL CELL BIOL, V8, P1266, DOI 10.1128/MCB.8.3.1266
   Sieglaff DH, 2009, P NATL ACAD SCI USA, V106, P3053, DOI 10.1073/pnas.0813264106
   Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444
   Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111
   THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249
   Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3
   Zhang G, 2011, NUCLEIC ACIDS RES, V39, P3331, DOI 10.1093/nar/gkq1257
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 48
TC 7
Z9 8
U1 0
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD MAY 10
PY 2016
VL 17
AR 341
DI 10.1186/s12864-016-2468-x
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA DM4WP
UT WOS:000376348300001
PM 27161480
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Protecting Health Workers From Zika During Labor and Delivery
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
ID UNITED-STATES
CR Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Salinas JL, 2016, MMWR-MORBID MORTAL W, V65, P273, DOI 10.15585/mmwr.mm6511a2
NR 2
TC 0
Z9 0
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 10
PY 2016
VL 315
IS 18
BP 1939
EP 1939
DI 10.1001/jama.2016.4850
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL2JP
UT WOS:000375461100005
DA 2020-07-08
ER

PT J
AU Lazear, HM
   Stringer, EM
   de Silva, AM
AF Lazear, Helen M.
   Stringer, Elizabeth M.
   de Silva, Aravinda M.
TI The Emerging Zika Virus Epidemic in the Americas Research Priorities
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
C1 [Lazear, Helen M.; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Stringer, Elizabeth M.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC USA.
   [Stringer, Elizabeth M.; de Silva, Aravinda M.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA.
   [Lazear, Helen M.] Univ N Carolina, Sch Med, 160 Dent Circle,9021 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.
RP Lazear, HM (corresponding author), Univ N Carolina, Sch Med, 160 Dent Circle,9021 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.
EM helen.lazear@med.unc.edu
OI Lazear, Helen/0000-0002-8649-4579
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
NR 8
TC 24
Z9 25
U1 0
U2 7
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 10
PY 2016
VL 315
IS 18
BP 1945
EP 1946
DI 10.1001/jama.2016.2899
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL2JP
UT WOS:000375461100008
PM 26963564
OA Bronze
DA 2020-07-08
ER

PT J
AU Hess, G
AF Hess, Glenn
TI FDA approves first commercial test for Zika
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD MAY 9
PY 2016
VL 94
IS 19
BP 14
EP 14
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DL3BD
UT WOS:000375508300036
DA 2020-07-08
ER

PT J
AU Brooks, M
AF Brooks, Michael
TI ZIKA Mosquitoes and Zika: time to harness genetic modification?
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
ID DRIVE
EM mb@michaelbrooks.org
CR Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017
   LaFrance A, 2016, ATLANTIC
   Purdue Extension, 2016, US PUBL OV SUPP US G
   Suresh A., 2016, ARE GENETICALLY ENG
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Worth K., 2016, PBS NEWSHOUR    0307
NR 11
TC 4
Z9 4
U1 0
U2 13
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 9
PY 2016
VL 353
AR i2548
DI 10.1136/bmj.i2548
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6EX
UT WOS:000376444500003
PM 27160110
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Dirlikov, E
   Ryff, KR
   Torres-Aponte, J
   Thomas, DL
   Perez-Padilla, J
   Munoz-Jordan, J
   Caraballo, EV
   Garcia, M
   Segarra, MO
   Malave, G
   Simeone, RM
   Shapiro-Mendoza, CK
   Reyes, LR
   Alvarado-Ramy, F
   Harris, AF
   Rivera, A
   Major, CG
   Mayshack, M
   Alvarado, LI
   Lenhart, A
   Valencia-Prado, M
   Waterman, S
   Sharp, TM
   Rivera-Garcia, B
AF Dirlikov, Emilio
   Ryff, Kyle R.
   Torres-Aponte, Jomil
   Thomas, Dana L.
   Perez-Padilla, Janice
   Munoz-Jordan, Jorge
   Caraballo, Elba V.
   Garcia, Myriam
   Segarra, Marangely Olivero
   Malave, Graciela
   Simeone, Regina M.
   Shapiro-Mendoza, Carrie K.
   Reyes, Lourdes Romero
   Alvarado-Ramy, Francisco
   Harris, Angela F.
   Rivera, Aidsa
   Major, Chelsea G.
   Mayshack, Marrielle
   Alvarado, Luisa I.
   Lenhart, Audrey
   Valencia-Prado, Miguel
   Waterman, Steve
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1,
   2015-April 14, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID INTERIM GUIDANCE; UNITED-STATES; PREVENTION
C1 [Dirlikov, Emilio; Ryff, Kyle R.; Torres-Aponte, Jomil; Thomas, Dana L.; Mayshack, Marrielle; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00936 USA.
   [Dirlikov, Emilio] CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Thomas, Dana L.] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Perez-Padilla, Janice; Munoz-Jordan, Jorge; Caraballo, Elba V.; Rivera, Aidsa; Major, Chelsea G.; Waterman, Steve; Sharp, Tyler M.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Off Publ Hlth Preparedness & Response, Biol & Chem Emergencies Lab, San Juan, PR USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Publ Hlth Lab, San Juan, PR USA.
   [Simeone, Regina M.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Shapiro-Mendoza, Carrie K.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Reyes, Lourdes Romero] Puerto Rico Women Infants & Children Program, San Juan, PR USA.
   [Alvarado-Ramy, Francisco] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Harris, Angela F.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Major, Chelsea G.; Mayshack, Marrielle] CDC, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Alvarado, Luisa I.] Ponce Hlth Sci Univ, St Lukes Episcopal Hosp Consortium, San Juan, PR USA.
   [Lenhart, Audrey] CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Valencia-Prado, Miguel] Puerto Rico Dept Hlth, Puerto Rico Birth Defects Surveillance & Preven S, San Juan, PR USA.
RP Dirlikov, E (corresponding author), Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00936 USA.; Dirlikov, E (corresponding author), CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
EM Zika@salud.gov.pr
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Dirlikov,
   Emilio/0000-0003-4631-2643; Caraballo, Elba/0000-0001-9921-4276
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, N ENGL J MED
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
NR 10
TC 33
Z9 33
U1 0
U2 14
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 6
PY 2016
VL 65
IS 17
BP 451
EP 455
DI 10.15585/mmwr.mm6517e2
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL1GP
UT WOS:000375380900005
PM 27149205
OA Bronze
DA 2020-07-08
ER

PT J
AU Miner, JJ
   Diamond, MS
AF Miner, Jonathan J.
   Diamond, Michael S.
TI Understanding How Zika Virus Enters and Infects Neural Target Cells
SO CELL STEM CELL
LA English
DT Editorial Material
ID RECEPTORS; BRAIN
AB Zika virus is a mosquito-transmitted flavivirus that has become a public health concern because of its ability to cause microcephaly. In this issue of Cell Stem Cell, Tang et al. (2016) and Nowakowski et al. (2016) use human neural stem cell models and single-cell RNA sequencing to investigate Zika virus tropism and potential entry receptors.
C1 [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
CR Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lazear H.M., 2016, CELL HOST M IN PRESS
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rossi S.L., 2016, AM J TROP M IN PRESS
NR 8
TC 33
Z9 33
U1 0
U2 57
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 559
EP 560
DI 10.1016/j.stem.2016.04.009
PG 3
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DL4HE
UT WOS:000375594200002
PM 27152436
OA Bronze
DA 2020-07-08
ER

PT J
AU Tang, HL
   Hammack, C
   Ogden, SC
   Wen, ZX
   Qian, XY
   Li, YJ
   Yao, B
   Shin, J
   Zhang, FR
   Lee, EM
   Christian, KM
   Didier, RA
   Jin, P
   Song, HJ
   Ming, GL
AF Tang, Hengli
   Hammack, Christy
   Ogden, Sarah C.
   Wen, Zhexing
   Qian, Xuyu
   Li, Yujing
   Yao, Bing
   Shin, Jaehoon
   Zhang, Feiran
   Lee, Emily M.
   Christian, Kimberly M.
   Didier, Ruth A.
   Jin, Peng
   Song, Hongjun
   Ming, Guo-li
TI Zika Virus Infects Human Cortical Neural Progenitors and Attenuates
   Their Growth
SO CELL STEM CELL
LA English
DT Article
ID CELLS
AB The suspected link between infection by Zika virus (ZIKV), a re-emerging flavivirus, and microcephaly is an urgent global health concern. The direct target cells of ZIKV in the developing human fetus are not clear. Here we show that a strain of the ZIKV, MR766, serially passaged in monkey and mosquito cells efficiently infects human neural progenitor cells (hNPCs) derived from induced pluripotent stem cells. Infected hNPCs further release infectious ZIKV particles. Importantly, ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth. Global gene expression analysis of infected hNPCs reveals transcriptional dysregulation, notably of cell-cycle-related pathways. Our results identify hNPCs as a direct ZIKV target. In addition, we establish a tractable experimental model system to investigate the impact and mechanism of ZIKV on human brain development and provide a platform to screen therapeutic compounds.
C1 [Tang, Hengli; Hammack, Christy; Ogden, Sarah C.; Lee, Emily M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.
   [Wen, Zhexing; Qian, Xuyu; Shin, Jaehoon; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Shin, Jaehoon; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Li, Yujing; Yao, Bing; Zhang, Feiran; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.
   [Didier, Ruth A.] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.
RP Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
EM tang@bio.fsu.edu; shongju1@jhmi.edu; gming1@jhmi.edu
RI Wen, Zhexing/L-1228-2018; Qian, Xuyu/C-1240-2017; Li,
   Yujing/AAJ-1411-2020
OI Wen, Zhexing/0000-0002-1518-3845; Qian, Xuyu/0000-0001-5944-3816; Li,
   Yujing/0000-0002-4363-2484; Zhang, Feiran/0000-0001-6222-6177; Yao,
   Bing/0000-0002-3205-8130; Ming, Guo-li/0000-0002-2517-6075
FU College of Arts and Sciences at Florida State University; Department of
   Biological Science at Florida State University; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI119530, AI111250, NS047344, NS048271, NS095348, NS051630,
   NS079625, MH102690]; MSCRF
FX We thank Yichen Cheng, Taylor Lee, and Jianshe Lang of the Tang
   laboratory, Lihong Liu and Yuan Cai of the Ming and Song laboratories,
   Luoxiu Huang of the Jin laboratory for technical assistance, Zhiheng Xu
   and additional laboratory members for suggestions, and Timothy Megraw
   for assistance with confocal imaging. H.T. thanks the College of Arts
   and Sciences and the Department of Biological Science at Florida State
   University for seed funding. This work was partially supported by NIH
   (AI119530/AI111250 to H.T., NS047344 to H.S., NS048271/NS095348 to
   G-I.M., and NS051630/NS079625/MH102690 to P.J.), MSCRF (to H.S.), and
   start-up funding (to H.S.).
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Mlakar J, 2016, N ENGL J MED
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
NR 12
TC 597
Z9 615
U1 8
U2 41
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 587
EP 590
DI 10.1016/j.stem.2016.02.016
PG 4
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DL4HE
UT WOS:000375594200009
PM 26952870
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Nowakowski, TJ
   Pollen, AA
   Di Lullo, E
   Sandoval-Espinosa, C
   Bershteyn, M
   Kriegstein, AR
AF Nowakowski, Tomasz J.
   Pollen, Alex A.
   Di Lullo, Elizabeth
   Sandoval-Espinosa, Carmen
   Bershteyn, Marina
   Kriegstein, Arnold R.
TI Expression Analysis Highlights AXL as a Candidate Zika Virus Entry
   Receptor in Neural Stem Cells
SO CELL STEM CELL
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; TAM RECEPTORS; CORTICAL
   DEVELOPMENT; RADIAL GLIA; BRAIN; CHILDREN; MALFORMATIONS; PROGENITORS;
   NEOCORTEX; UPDATE
AB The recent outbreak of Zika virus (ZIKV) in Brazil has been linked to substantial increases in fetal abnormalities and microcephaly. However, information about the underlying molecular and cellular mechanisms connecting viral infection to these defects remains limited. In this study we have examined the expression of receptors implicated in cell entry of several enveloped viruses including ZIKV across diverse cell types in the developing brain. Using single-cell RNA-seq and immunohistochemistry, we found that the candidate viral entry receptor AXL is highly expressed by human radial glial cells, astrocytes, endothelial cells, and microglia in developing human cortex and by progenitor cells in developing retina. We also show that AXL expression in radial glia is conserved in developing mouse and ferret cortex and in human stem cell-derived cerebral organoids, highlighting multiple experimental systems that could be applied to study mechanisms of ZIKV infectivity and effects on brain development.
C1 [Nowakowski, Tomasz J.; Pollen, Alex A.; Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Bershteyn, Marina; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.
   [Nowakowski, Tomasz J.; Pollen, Alex A.; Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Bershteyn, Marina; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.
RP Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Kriegstein, AR (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.
EM kriegsteina@stemcell.ucsf.edu
FU Damon Runyon Cancer Research Foundation [DRG-2166-13]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U01 MH105989, R37 NS35710, R01NS075998]; CIRMCalifornia Institute
   for Regenerative Medicine [GCIR-06673-A]
FX We are grateful to Hanna Retallack, Shaohui Wang, Anne Leyrat, Joe
   Shuga, Aaron Diaz, Mercedes Paredes, Joseph LoTurco, Melanie Bedolli,
   Lillian Adame, Joe DeRisi, and Jeremy Reiter for helpful comments,
   suggestions, and technical help. A.A.P. is supported by a Damon Runyon
   Cancer Research Foundation postdoctoral fellowship (DRG-2166-13). This
   research was supported by NIH awards U01 MH105989, R37 NS35710, and
   R01NS075998 to A.R.K. and CIRM award GCIR-06673-A, and by gifts from
   Helen Ford and Bernard Osher. All work using human tissues and cells was
   conducted in strict observance of the protocols approved by the Human
   Gamete, Embryo, and Stem Cell Research Committee (institutional review
   board), and work involving animal tissues was performed in accordance
   with protocols approved by the University of California San Francisco
   Institutional Animal Care and Use Committee.
CR AHLFORS K, 1986, PEDIATRICS, V78, P1058
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P., 2016, N ENGL J ME IN PRESS
   Calvet G., 2016, LANCET INFE IN PRESS
   Carteaux G., 2016, N ENGL J ME IN PRESS
   CONBOY TJ, 1986, PEDIATRICS, V77, P801
   de Paula Freitas B., 2016, JAMA OPTHAL IN PRESS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229
   Kawasaki H, 2015, AM J PATHOL, V185, P1304, DOI 10.1016/j.ajpath.2015.01.032
   Lanari M, 2012, EARLY HUM DEV, V88, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S., 2016, LANCET IN PRESS
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NAKAO T, 1970, PEDIATRICS, V46, P483
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Ostrem BEL, 2014, CELL REP, V8, P656, DOI 10.1016/j.celrep.2014.06.058
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SINHA SK, 1972, J MENT DEFIC RES, V16, P90
   Tang H, 2016, CELL STEM C IN PRESS
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
NR 44
TC 270
Z9 273
U1 5
U2 107
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 591
EP 596
DI 10.1016/j.stem.2016.03.012
PG 6
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DL4HE
UT WOS:000375594200010
PM 27038591
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Di Luca, M
   Severini, F
   Toma, L
   Boccolini, D
   Romi, R
   Remoli, ME
   Sabbatucci, M
   Rizzo, C
   Venturi, G
   Rezza, G
   Fortuna, C
AF Di Luca, M.
   Severini, F.
   Toma, L.
   Boccolini, D.
   Romi, R.
   Remoli, M. E.
   Sabbatucci, M.
   Rizzo, C.
   Venturi, G.
   Rezza, G.
   Fortuna, C.
TI Experimental studies of susceptibility of Italian Aedes albopictus to
   Zika virus
SO EUROSURVEILLANCE
LA English
DT Article
ID WEST-NILE-VIRUS; VECTOR COMPETENCE; CHIKUNGUNYA VIRUS; INFECTION;
   MOSQUITOS; DIPTERA
AB We report a study on vector competence of an Italian population of Aedes albopictus for Zika virus (ZIKV). Ae. albopictus was susceptible to ZIKV infection (infection rate: 10%), and the virus could disseminate and was secreted in the mosquito's saliva (dissemination rate: 29%; transmission rate: 29%) after an extrinsic incubation period of 11 days. The observed vector competence was lower than that of an Ae. aegypti colony tested in parallel.
C1 [Di Luca, M.; Severini, F.; Toma, L.; Boccolini, D.; Romi, R.] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Unit Vector Borne Dis & Int Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Remoli, M. E.; Venturi, G.; Rezza, G.; Fortuna, C.] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Natl Reference Lab Arboviruses, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Sabbatucci, M.] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, European Programme Publ Hlth Microbiol Training E, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Rizzo, C.] Ist Super Sanita, Natl Ctr Epidemiol & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.
RP Fortuna, C (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Natl Reference Lab Arboviruses, Viale Regina Elena 299, I-00161 Rome, Italy.
EM claudia.fortuna@iss.it
RI Remoli, Maria Elena ME/O-9447-2015; Rizzo, Caterina/H-4092-2012; rezza,
   giovanni/D-4393-2016; FORTUNA, CLAUDIA/O-9446-2015; VENTURI,
   GIULIETTA/O-8123-2015; Sabbatucci, Michela/M-9642-2017; DI LUCA,
   MARCO/C-4966-2016
OI Remoli, Maria Elena ME/0000-0003-3565-383X; Rizzo,
   Caterina/0000-0002-5583-7508; rezza, giovanni/0000-0003-0268-6790;
   FORTUNA, CLAUDIA/0000-0001-8878-4505; VENTURI,
   GIULIETTA/0000-0002-9078-8350; Sabbatucci, Michela/0000-0001-5889-1780;
   DI LUCA, MARCO/0000-0003-1442-3672
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Powers AM, 2009, FUTURE VIROL, V4, P391, DOI 10.2217/FVL.09.19
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101
   Richards SL, 2012, J MED ENTOMOL, V49, P132, DOI 10.1603/ME10280
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 18
TC 63
Z9 64
U1 0
U2 27
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAY 5
PY 2016
VL 21
IS 18
BP 6
EP 9
AR 30223
DI 10.2807/1560-7917.ES.2016.21.18.30223
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DM2EI
UT WOS:000376159000002
PM 27171034
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Chen, LH
   Hamer, DH
AF Chen, Lin H.
   Hamer, Davidson H.
TI Zika Virus: Rapid Spread in the Western Hemisphere
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID MICRONESIA
C1 [Chen, Lin H.] Mt Auburn Hosp, Div Infect Dis, 330 Mt Auburn St,South 2, Cambridge, MA 02138 USA.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, 801 Massachusetts Ave,Crosstown Third Floor, Boston, MA 02118 USA.
RP Chen, LH (corresponding author), Mt Auburn Hosp, 330 Mt Auburn St, Cambridge, MA 02138 USA.
EM lchen@hms.harvard.edu
RI Hamer, Davidson/J-2020-2019
OI Hamer, Davidson/0000-0002-4700-1495; Chen, Lin/0000-0002-5684-8436
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hennessey M, 2015, ZIK VIR SPREADS NEW
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pan American Health Organization, ZIK VIR INF
NR 10
TC 61
Z9 64
U1 0
U2 5
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 3
PY 2016
VL 164
IS 9
BP 613
EP +
DI 10.7326/M16-0150
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL6IX
UT WOS:000375744000021
PM 26832396
DA 2020-07-08
ER

PT J
AU Aragao, MDV
AF Vasco Aragao, Maria de Fatima
TI Zika virus study in The BMJ was different from the one reported in the
   New England Journal of Medicine
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Letter
C1 [Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Leite Recife Pernam, Brazil.
   [Vasco Aragao, Maria de Fatima] Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
RP Aragao, MDV (corresponding author), Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Leite Recife Pernam, Brazil.; Aragao, MDV (corresponding author), Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
EM fatima.vascoaragao@gmail.com
CR Hazin AN, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1603617, DOI 10.1056/NEJMC1603617]
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 2
TC 1
Z9 1
U1 0
U2 20
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 3
PY 2016
VL 353
AR i2444
DI 10.1136/bmj.i2444
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL4AE
UT WOS:000375574000009
PM 27142055
DA 2020-07-08
ER

PT J
AU Wilby, KJ
   Nasr, ZG
AF Wilby, Kyle J.
   Nasr, Ziad G.
TI Zika Virus: Facts, Prevention Strategies, and an Informed Tourist
   Perspective
SO CANADIAN JOURNAL OF HOSPITAL PHARMACY
LA English
DT Letter
C1 [Wilby, Kyle J.; Nasr, Ziad G.] Qatar Univ, Coll Pharm, Doha, Qatar.
RP Wilby, KJ (corresponding author), Qatar Univ, Coll Pharm, Doha, Qatar.
RI Wilby, Kyle/R-3018-2018
OI Wilby, Kyle/0000-0002-1670-2512
CR [Anonymous], 2016, ZIK VIR S AM
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   MacFadden DR, 2016, CAN MED ASSOC J, V188, P367, DOI 10.1503/cmaj.151486
   Musso D, 2015, EMERG INFECT DIS, V21, P552
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oster AM, 2016, MMWR MORB MORTAL WKL
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
NR 9
TC 0
Z9 0
U1 0
U2 1
PU CANADIAN SOC HOSPITAL PHARMACISTS
PI OTTAWA
PA 30 CONCOURSE GATE, UNIT#3, OTTAWA, ON K2E 7V7, CANADA
SN 0008-4123
J9 CAN J HOSP PHARM
JI Can. J. Hosp. Pharm.
PD MAY-JUN
PY 2016
VL 69
IS 3
BP 255
EP U89
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EP1PK
UT WOS:000397156600014
PM 27403008
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Serodiagnosis of acute and past Zika virus infections by ELISA
SO BRITISH JOURNAL OF HOSPITAL MEDICINE
LA English
DT News Item
CR Steinhagen K, 2016, ECCMID 2016
NR 1
TC 0
Z9 0
U1 0
U2 4
PU MA HEALTHCARE LTD
PI LONDON
PA ST JUDES CHURCH, DULWICH ROAD, LONDON SE24 0PB, ENGLAND
SN 1750-8460
EI 1759-7390
J9 BRIT J HOSP MED
JI Br. J. Hosp. Med.
PD MAY
PY 2016
VL 77
IS 5
BP 267
EP 267
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DY2QF
UT WOS:000384936400018
DA 2020-07-08
ER

PT J
AU Byk, LA
   Iglesias, NG
   De Maio, FA
   Gebhard, LG
   Rossi, M
   Gamarnik, AV
AF Byk, Laura A.
   Iglesias, Nestor G.
   De Maio, Federico A.
   Gebhard, Leopoldo G.
   Rossi, Mario
   Gamarnik, Andrea V.
TI Dengue Virus Genome Uncoating Requires Ubiquitination
SO MBIO
LA English
DT Article
ID WEST-NILE-VIRUS; CAPSID PROTEIN; CORE PROTEIN; NUCLEAR-LOCALIZATION;
   MONOCLONAL-ANTIBODY; ENVELOPE PROTEIN; MEMBRANE-FUSION; INFECTION; RNA;
   PROTEASOME
AB The process of genome release or uncoating after viral entry is one of the least-studied steps in the flavivirus life cycle. Flaviviruses are mainly arthropod-borne viruses, including emerging and reemerging pathogens such as dengue, Zika, and West Nile viruses. Currently, dengue virus is one of the most significant human viral pathogens transmitted by mosquitoes and is responsible for about 390 million infections every year around the world. Here, we examined for the first time molecular aspects of dengue virus genome uncoating. We followed the fate of the capsid protein and RNA genome early during infection and found that capsid is degraded after viral internalization by the host ubiquitin-proteasome system. However, proteasome activity and capsid degradation were not necessary to free the genome for initial viral translation. Unexpectedly, genome uncoating was blocked by inhibiting ubiquitination. Using different assays to bypass entry and evaluate the first rounds of viral translation, a narrow window of time during infection that requires ubiquitination but not proteasome activity was identified. In this regard, ubiquitin E1-activating enzyme inhibition was sufficient to stabilize the incoming viral genome in the cytoplasm of infected cells, causing its retention in either endosomes or nucleocapsids. Our data support a model in which dengue virus genome uncoating requires a nondegradative ubiquitination step, providing new insights into this crucial but understudied viral process.
   IMPORTANCE Dengue is the most significant arthropod-borne viral infection in humans. Although the number of cases increases every year, there are no approved therapeutics available for the treatment of dengue infection, and many basic aspects of the viral biology remain elusive. After entry, the viral membrane must fuse with the endosomal membrane to deliver the viral genome into the cytoplasm for translation and replication. A great deal of information has been obtained in the last decade regarding molecular aspects of the fusion step, but little is known about the events that follow this process, which leads to viral RNA release from the nucleocapsid. Here, we investigated the fate of nucleocapsid components (capsid protein and viral genome) during the infection process and found that capsid is degraded by the ubiquitin-proteasome system. However, in contrast to that observed for other RNA and DNA viruses, dengue virus capsid degradation was not responsible for genome uncoating. Interestingly, we found that dengue virus genome release requires a nondegradative ubiquitination step. These results provide the first insights into dengue virus uncoating and present new opportunities for antiviral intervention.
C1 [Byk, Laura A.; Iglesias, Nestor G.; De Maio, Federico A.; Gebhard, Leopoldo G.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.
   [Rossi, Mario] Consejo Nacl Invest Cient & Tecn, Inst Invest Biomed Buenos Aires IBioBA, Partner Inst Max Planck Soc, Polo Cient Tecnol, Buenos Aires, DF, Argentina.
RP Gamarnik, AV (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.
EM agamarnik@leloir.org.ar
RI Rossi, Mario/E-7666-2012
OI Rossi, Mario/0000-0001-6349-8895
FU ANPCyT ArgentinaANPCyT [PICT-2014-2111]; NIAID \ National Institutes of
   Health (NIH) [R01.AI095175]
FX This work, including the efforts of Andrea Gamarnik, was funded by
   ANPCyT Argentina (PICT-2014-2111). This work, including the efforts of
   Andrea Gamarnik, was funded by NIAID vertical bar National Institutes of
   Health (NIH) (R01.AI095175).
CR Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919
   Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10
   Greene W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002703
   Huotari J, 2012, P NATL ACAD SCI USA, V109, P823, DOI 10.1073/pnas.1118744109
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Iglesias NG, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P334, DOI 10.1079/9781845939649.0334
   Kanlaya R, 2010, J PROTEOME RES, V9, P4960, DOI 10.1021/pr100219y
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Klumpp K, 2014, CURR OPIN VIROL, V5, P63, DOI 10.1016/j.coviro.2014.02.002
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   PIPER RC, 2014, COLD SPRING HARB PER, V6, DOI DOI 10.1101/CSHPERSPECT.A016808
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   SINGH I, 1992, J VIROL, V66, P7049, DOI 10.1128/JVI.66.12.7049-7058.1992
   Su WC, 2013, P NATL ACAD SCI USA, V110, P17516, DOI 10.1073/pnas.1312374110
   TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhou HL, 2013, GENE DEV, V27, P1046, DOI 10.1101/gad.215681.113
NR 34
TC 28
Z9 28
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2016
VL 7
IS 3
AR e00804-16
DI 10.1128/mBio.00804-16
PG 10
WC Microbiology
SC Microbiology
GA DW1YP
UT WOS:000383440300064
PM 27353759
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodrigues, ML
   Morel, CM
AF Rodrigues, Marcio L.
   Morel, Carlos M.
TI The Brazilian Dilemma: Increased Scientific Production and High
   Publication Costs during a Global Health Crisis and Major Economic
   Downturn
SO MBIO
LA English
DT Editorial Material
ID ZIKA VIRUS; PAGE CHARGES; OUTBREAK
C1 [Rodrigues, Marcio L.; Morel, Carlos M.] Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, Brazil.
   [Rodrigues, Marcio L.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
RP Rodrigues, ML; Morel, CM (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, Brazil.; Rodrigues, ML (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
EM marciolrodrig@gmail.com; morel@cdts.fiocruz.br
RI Rodrigues, Marcio/J-3727-2013; Morel, Carlos M/B-4079-2009; Morel,
   Carlos/Q-9657-2019
OI Rodrigues, Marcio/0000-0002-6081-3439; Morel, Carlos
   M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
FU Wellcome TrustWellcome Trust [WT104741MA]
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CNPq, 2016, ED UN CHAM MCTI CNPQ
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   GRUNDFEST H, 1969, SCIENCE, V164, P905, DOI 10.1126/science.164.3882.905-c
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kligfield P, 2005, J ELECTROCARDIOL, V38, P296, DOI 10.1016/j.jelectrocard.2005.05.004
   Nature Medicine, 2011, NAT MED, V11, P1169
   Petherick A, 2011, NAT MED, V17, P1173, DOI 10.1038/nm1011-1173
   World Factbook, 2009, COUNTR COMP GROSS DO
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 5
Z9 5
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2016
VL 7
IS 3
AR e00907-16
DI 10.1128/mBio.00907-16
PG 2
WC Microbiology
SC Microbiology
GA DW1YP
UT WOS:000383440300075
PM 27353760
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giovanetti, M
   Milano, T
   Alcantara, LC
   Carcangiu, L
   Cella, E
   Lai, A
   Lo Presti, A
   Pascarella, S
   Zehender, G
   Angeletti, S
   Ciccozzi, M
AF Giovanetti, Marta
   Milano, Teresa
   Alcantara, Luiz Carlos
   Carcangiu, Laura
   Cella, Eleonora
   Lai, Alessia
   Lo Presti, Alessandra
   Pascarella, Stefano
   Zehender, Gianguglielmo
   Angeletti, Silvia
   Ciccozzi, Massimo
TI Zika virus spreading in South America: evolutionary analysis of emerging
   neutralizing resistant Phe279Ser strains
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Phylogeny; Evolution
ID AMINO-ACID SITES; ENVELOPE PROTEIN; AEDES-AEGYPTI; SEQUENCE; PREDICTION;
   INFERENCE; ACCURACY; DYNAMICS; MODELS; POWER
AB Objective: To investigate the genetic diversity of Zika virus (ZIKV) and the relationships existing among these circulating viruses worldwide. To evaluate the genetic polymorphisms harboured from ZIKV that can have an influence on the virus circulation. Methods: Three different ZIKV dataset were built. The first dataset included 63 E gene sequences, the second one 22 NS3 sequences and the third dataset was composed of 108 NS5 gene sequences. Phylogenetic and selective pressure analysis was performed. The edited nucleic acid alignment from the Envelope dataset was used to generate a conceptual translation to the corresponding peptide sequences through UGene software. Results: The phylogeographic reconstruction was able to discriminate unambiguously that the Brazilian strains are belonged to the Asian lineage. The structural analysis reveals instead the presence of the Ser residue in the Brazilian sequences (however already observed in other previously reported ZIKV infections) that could suggest the presence of a neutralization-resistant population of viruses. Conclusions: Phylogenetic, evolutionary and selective pressure analysis contributed to improve the knowledge on the circulation of ZIKV.
C1 [Giovanetti, Marta; Carcangiu, Laura; Cella, Eleonora; Lo Presti, Alessandra; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz Carlos] Oswaldo Cruz Fdn LHGB CPqGM FIOCRUZ, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Lab Infect Dis & Trop Med, I-20122 Milan, Italy.
   [Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.
EM ciccozzi@iss.it
RI CICCOZZI, MASSIMO/C-6484-2016; Lo Presti, Alessandra/K-1451-2016; Cella,
   Eleonora/J-9961-2016; Giovanetti, Marta/AAK-7408-2020
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Lo Presti,
   Alessandra/0000-0001-7611-5021; Cella, Eleonora/0000-0002-7870-9744;
   Giovanetti, Marta/0000-0002-5849-7326; Alcantara,
   Luiz/0000-0002-6769-9931
CR Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Bisset J A, 2001, Rev Cubana Med Trop, V53, P37
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, PLOS NEGL TROP DIS, V201
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nielsen R, 1998, GENETICS, V148, P929
   Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodriguez MM, 2001, J MED ENTOMOL, V38, P623, DOI 10.1603/0022-2585-38.5.623
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schroedinger L., 2015, PYMOL MOL GRAPHICS S
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
NR 47
TC 13
Z9 13
U1 0
U2 41
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAY
PY 2016
VL 9
IS 5
BP 445
EP 452
DI 10.1016/j.apjtm.2016.03.028
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DL0YS
UT WOS:000375359100006
PM 27261852
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Koenig, KL
   Almadhyan, A
   Burns, MJ
AF Koenig, Kristi L.
   Almadhyan, Abdulmajeed
   Burns, Michael J.
TI Identify-Isolate-Inform: A Tool for Initial Detection and Management of
   Zika Virus Patients in the Emergency Department
SO WESTERN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Article
AB First isolated in 1947 from a monkey in the Zika forest in Uganda, and from mosquitoes in the same forest the following year, Zika virus has gained international attention due to concerns for infection in pregnant women potentially causing fetal microcephaly. More than one million people have been infected since the appearance of the virus in Brazil in 2015. Approximately 80% of infected patients are asymptomatic. An association with microcephaly and other birth defects as well as Guillain-Barre Syndrome has led to a World Health Organization declaration of Zika virus as a Public Health Emergency of International Concern in February 2016. Zika virus is a vector-borne disease transmitted primarily by the Aedes aegypti mosquito. Male to female sexual transmission has been reported and there is potential for transmission via blood transfusions. After an incubation period of 2-7 days, symptomatic patients develop rapid onset fever, maculopapular rash, arthralgia, and conjunctivitis, often associated with headache and myalgias. Emergency department (ED) personnel must be prepared to address concerns from patients presenting with symptoms consistent with acute Zika virus infection, especially those who are pregnant or planning travel to Zika-endemic regions, as well as those women planning to become pregnant and their partners. The identify-isolate-inform (3I) tool, originally conceived for initial detection and management of Ebola virus disease patients in the ED, and later adjusted for measles and Middle East Respiratory Syndrome, can be adapted for real-time use for any emerging infectious disease. This paper reports a modification of the 3I tool for initial detection and management of patients under investigation for Zika virus. Following an assessment of epidemiologic risk, including travel to countries with mosquitoes that transmit Zika virus, patients are further investigated if clinically indicated. If after a rapid evaluation, Zika or other arthropod-borne diseases are the only concern, isolation (contact, droplet, airborne) is unnecessary. Zika is a reportable disease and thus appropriate health authorities must be notified. The modified 3I tool will facilitate rapid analysis and triggering of appropriate actions for patients presenting to the ED at risk for Zika.
C1 [Koenig, Kristi L.; Almadhyan, Abdulmajeed] Univ Calif Irvine, Med Ctr, Ctr Disaster Med Sci, Dept Emergency Med, Orange, CA 92668 USA.
   [Burns, Michael J.] Univ Calif Irvine, Med Ctr, Dept Emergency Med, Orange, CA 92668 USA.
   [Burns, Michael J.] Univ Calif Irvine, Med Ctr, Dept Med, Div Infect Dis, Orange, CA 92668 USA.
   [Almadhyan, Abdulmajeed] Qassim Univ, Dept Emergency Med, Buraydah, Saudi Arabia.
RP Koenig, KL (corresponding author), Univ Calif Irvine, Dept Emergency Med, Ctr Disaster Med Sci, 333 City Blvd West,Suite 640,Rt 128-01, Orange, CA 92868 USA.
EM kkoenig@uci.edu
RI amsalu, ribka/G-8780-2019
CR [Anonymous], 2016, POT ZIK VIR RISK EST
   [Anonymous], 2016, WHO ZIKA STRATEGIC R
   [Anonymous], 2016, FDA ISSUES RECOMMEND
   Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Barbisch D, 2015, DISASTER MED PUBLIC
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S., LANCET
   CDC, 2016, DIV VECT BORN DIS ME
   Centers for Disease Control and Prevention, 2016, WEB UPD INT ZIK VIR
   Darlington S., CNN BRAZIL WARNS PRE
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Koenig KL, 2014, ANN EMERG MED
   Koenig KL, 2014, W J EMERG MED
   Koenig KL, 2014, 2014 EBOLA VIRUS OUT
   Koenig KL, DISASTER MED PUBLIC
   Koenig KL, 2015, W J EMERG MED
   Koenig KL, 2016, DISASTER MED PUBLIC
   Korte G., 2016, US TODAY
   Lucey DR, 2016, JAMA
   Maron D. F., 2016, SCI AM
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   WHO Emergency Preparedness and Response, 2015, ZIK VIR DIS INT CAS
   WHO statement on the first meeting of the International Health Regulations, 2005, 1 M INT HLTH REG IHR
NR 24
TC 11
Z9 11
U1 2
U2 11
PU WESTJEM
PI ORANGE
PA C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01,
   ORANGE, CA 92868 USA
SN 1936-900X
EI 1936-9018
J9 WEST J EMERG MED
JI West. J. Emerg. Med.
PD MAY
PY 2016
VL 17
IS 3
BP 238
EP 244
DI 10.5811/westjem.2016.3.30188
PG 7
WC Emergency Medicine
SC Emergency Medicine
GA DV3QH
UT WOS:000382837400001
PM 27330653
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ottersen, T
   Hoffman, SJ
   Groux, G
AF Ottersen, Trygve
   Hoffman, Steven J.
   Groux, Gaelle
TI EBOLA AGAIN SHOWS THE INTERNATIONAL HEALTH REGULATIONS ARE BROKEN: WHAT
   CAN BE DONE DIFFERENTLY TO PREPARE FOR THE NEXT EPIDEMIC?
SO AMERICAN JOURNAL OF LAW & MEDICINE
LA English
DT Article
ID ADDRESSING ANTIBIOTIC-RESISTANCE; GLOBAL HEALTH; PANDEMIC PREPAREDNESS;
   GOVERNANCE CHALLENGES; ECONOMIC-IMPACT; LESSONS; H1N1; INFLUENZA;
   FRAMEWORK; IMPLEMENTATION
AB Epidemics are among the greatest threats to humanity, and the International Health Regulations are the world's key legal instrument for addressing this threat. Since their revision in 2005, the IHR have faced two big tests: the 2009 H1N1 influenza pandemic and the 2014 Ebola epidemic in West Africa. Both exposed major shortcomings of the IHR, and both offered profound lessons for the future. The objective of this Article is twofold. First, we seek to compare the lessons learned from H1N1 and Ebola for reforming the IHR in order to test the hypothesis that they are similar. Second, we seek to examine the barriers to implementing these lessons and to identify strategies for overcoming those barriers. We find that the lessons from H1N1 and Ebola are indeed similar, and that opportunities to act on lessons from H1N1 were woefully missed. We identify many political barriers to global collective action and implementation of lessons for the IHR. On that basis, we describe strategies to overcome these barriers, which will hopefully be deployed now to reform the IHR before the policy window following Ebola closes, and before the inevitable next epidemic comes. The emerging threat of the Zika virus underscores that we have no time to waste.
C1 [Ottersen, Trygve] Univ Oslo, Dept Community Med & Global Hlth, Oslo Grp Global Hlth Policy, Oslo, Norway.
   [Hoffman, Steven J.; Groux, Gaelle] Univ Ottawa, Fac Law, Global Strategy Lab, Ctr Hlth Law Policy & Eth, Ottawa, ON, Canada.
RP Ottersen, T (corresponding author), Univ Oslo, Dept Community Med & Global Hlth, Oslo Grp Global Hlth Policy, Oslo, Norway.
EM trygve.ottersen@medisin.uio.no; steven.hoffman@globalstrategylab.org;
   gaelle.groux@globalstrategylab.org
OI Hoffman, Steven/0000-0002-2064-3711
FU Research Council of Norway's Global Health & Vaccination Programme
   (GLOBVAC)Research Council of Norway [234608]; Canadian Institutes of
   Health ResearchCanadian Institutes of Health Research (CIHR); Trudeau
   Foundation
FX Thank you to Benedikte Alveberg, Steinar Andresen, Frode Forland,
   Elizabeth Peacocke, and Jeremy Shiffman for providing feedback on
   earlier drafts of this manuscript, and to Tanner McInnis and Kelsey
   Vercammen for their research assistance. This work was completed as part
   of the International Collaboration for Capitalizing on Cost-Effective
   and Life-Saving Commodities (i4C) that is funded through the Research
   Council of Norway's Global Health & Vaccination Programme (GLOBVAC
   Project #234608). SJH is additionally funded by the Canadian Institutes
   of Health Research and the Trudeau Foundation.
CR Andresen S, 2015, J LAW MED ETHICS, V43, P46, DOI 10.1111/jlme.12274
   Anema A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-1
   [Anonymous], 2014, LANCET, V384, P1321, DOI 10.1016/S0140-6736(14)61697-4
   [Anonymous], 2009, Wkly Epidemiol Rec, V84, P173
   [Anonymous], 2011, STRENGTH RESP PAND O
   [Anonymous], 2005, INT HLTH REG 2015
   [Anonymous], 2015, PUSH LIM YEAR LARG E, P12
   [Anonymous], REV COMM ROL INT HLT
   [Anonymous], 2016, PROTECTING HUMANITY, P11
   [Anonymous], 2014, TRANSCR UN HLTH COV
   [Anonymous], 2015, LIMN            0710
   [Anonymous], 2015, INT CRISIS GRP  1028
   [Anonymous], BIOGR MEMB ADV IHR E
   [Anonymous], 2009, OR 2009 H1N1 FLU SWI
   [Anonymous], IHR EM COMM REG EB
   [Anonymous], WHO REF MIL
   [Anonymous], 2010, 2009 H1N1 PAND
   [Anonymous], 2016, STAT PART INT HLTH R
   [Anonymous], LIST MEMB ADV INT HL
   [Anonymous], 2009, BBC
   [Anonymous], 2008, JAKARTA POST
   [Anonymous], 2015, DIR GEN SPEC SESS EX
   Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5
   BBC News, 2014, BBC NEWS
   Behdinan A, 2015, J LAW MED ETHICS, V43, P68, DOI 10.1111/jlme.12277
   Bogich Tiffany L., 2012, PLOS MED, V9, P1
   Bogich Tiffany L., 2012, PLOS MED, V9, P2
   Browne Andrew, 2009, WALL ST J
   Chan M, 2009, WORLD NOW START 2009
   Cheng Maria, 2015, BUSINESS INSIDER
   Clift Charles, 2015, IS YET ANOTHER EBOLA
   Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3513
   COMM'N ON A GLOBAL HEALTH RISK FRAMEWORK FOR THE FUTURE & NAT'L ACAD. OF MED, 2016, NEGL DIM GLOB SEC FR, P18
   Dahlberg Rasmus, 2016, DISASTER RES MULTIDI
   Davies S. E., 2015, DIS DIPLOMACY INT NO
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   DECLICH S, 1994, B WORLD HEALTH ORGAN, V72, P285
   Feler Lane, 2015, COLUM J TRANSNATL L, V13, P28
   Feler Lane, 2015, COLUM J TRANSNATL L, V13, P13
   Fidler D. P., 2015, EBOLA REPORT MISSES
   Fidler D.P., 2005, CHIN J INT LAW, Viv, P331
   FIDLER DAVID P., 1999, INT LAW INFECT DIS, P22
   Fidler DP, 2006, J LAW MED ETHICS, V34, P85, DOI 10.1111/j.1748-720X.2006.00011.x
   Fidler DP, 2005, CHIN J INT LAW, V4, P325, DOI DOI 10.1093/CHINESEJIL/JMI029
   Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802
   Fink S, 2014, NY TIMES
   FLYNN Daniel, 2014, REUTERS
   Flynn Paul, 2010, HANDLING H1N1 PANDEM, P17
   Foulkes Imogen, 2010, BBC
   Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339
   Garrett L, 2015, FOREIGN AFF, V94, P80
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gopinathan U, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0128-6
   Gostin LO, 2015, LANCET, V386, P2222, DOI 10.1016/S0140-6736(15)00948-4
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3
   Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P2376, DOI 10.1001/jama.2009.849
   GOSTIN LAWRENCE O., 2014, GLOBAL HLTH LAW, P202
   Hardiman MC, 2012, EMERG INFECT DIS, V18, P1041, DOI 10.3201/eid1807.120395
   Harrell Eben, 2010, TIME
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Hodge J.G., 2010, MINNESOTA J LAW SCI, V1, P599
   Hodge Jr James G., 2010, MINN L J SCI TECH, V11, P607
   Hoffman S. J., 2016, SYSTEMATIC REVS, V5, P1
   Hoffman SJ, 2016, J CLIN EPIDEMIOL, V75, P47, DOI 10.1016/j.jclinepi.2015.12.010
   Hoffman SJ, 2015, ROUTLEDGE HANDBOOK OF GLOBAL HEALTH SECURITY, P239
   Hoffman SJ, 2015, J LAW MED ETHICS, V43, P65, DOI 10.1111/jlme.12276
   Hoffman SJ, 2015, J LAW MED ETHICS, V43, P53, DOI 10.1111/jlme.12275
   Hoffman SJ, 2015, J LAW MED ETHICS, V43, P363, DOI 10.1111/jlme.12253
   Hoffman SJ, 2015, AM J PUBLIC HEALTH, V105, P1523, DOI 10.2105/AJPH.2015.302726
   Hoffman SJ, 2015, AM J PUBLIC HEALTH, V105, P26, DOI 10.2105/AJPH.2014.302085
   Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710
   Hoffman SJ, 2014, PUBLIC HEALTH, V128, P188, DOI 10.1016/j.puhe.2013.08.021
   Hoffman SJ, 2010, HEALTH POLICY PLANN, V25, P510, DOI 10.1093/heapol/czq037
   Hoffman Steven J., 2015, MAPPING GLOBAL HLTH, P5
   Hoffman Steven J., B WHO, V93, P867
   INST. FOR HEALTH METRICS & EVALUATION, 2014, FIN GLOB HLTH 2013 T, P19
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   JOINT UNITED NATIONS PROGRAMME ON HVI/AIDS [UNAIDS] & WHO, 2009, AIDS EP UPD DEC 2009, P7
   Kamradt-Scott A, 2016, THIRD WORLD Q, V37, P401, DOI 10.1080/01436597.2015.1112232
   Kamradt-Scott Adam, 2013, HLTH DIPL MONITOR, V4, P14
   Kamradt-Scott Adam, 2013, HLTH DIPL MONITOR, V4, P15
   Kamradt-Scott Adam, 2010, HLTH DIPL MONITOR, V1, P10
   Kamradt-Scott Adam, 2010, HLTH DIPL MONITOR, V1, P11
   KATES, 2015, US RESPONSE EBOLA ST, P4
   Katz R, 2010, GLOB HLTH GOV, VIII, P2
   Katz R, 2015, LANCET GLOB HEALTH, V3, pE352, DOI 10.1016/S2214-109X(15)00025-X
   Katz Rebecca, 2010, GLOBAL HLTH GOVERNAN, P1
   Keller AC, 2012, RISK HAZARDS CRISIS, V3, DOI 10.1515/1944-4079.1101
   Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003
   Keogh-Brown Marcus Richard, 2008, HLTH POLY, V88, P117
   Keung N., 2014, TORONTO STAR
   Kickbusch I, 2010, J LAW MED ETHICS, V38, P550, DOI 10.1111/j.1748-720X.2010.00511.x
   Kingdon J. W., 1995, AGENDAS ALTERNATIVES
   Knobler Stacey, 2004, LEARNING SARS PREPAR, P4
   Kupferschmidt Kai, 2015, SCIENCE
   Lavis John N., 2012, PLOS MED, V9, P4
   Lavis John N., 2012, PLOS MED, V9, P1
   Liu B, 2015, INT J HEALTH POLICY, V4, P381, DOI 10.15171/ijhpm.2015.84
   Mackey TK, 2012, J PUBLIC HEALTH POL, V33, P119, DOI 10.1057/jphp.2011.51
   McKirdy Euan, 2014, CNN             1028
   Medecins sans Frontieres, 2014, EB W AFR EP REQ MASS
   Molenaar Bente, 2011, HLTH DIPLOMACY MONIT, V2, P20
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Nishtar Sania, 2007, HEARTFILE       0701
   Nuzzo Jennifer B., 2011, GLOBAL HLTH GOV, V4, P1
   Nuzzo Jennifer B., 2011, GLOBAL HLTH GOV, V4, P10
   Ooms Gorik, 2015, SAVE HUMANITY WHAT M, p[257, 258]
   Organization W.H, GLOB HLTH OBS DAT RE
   Osborne James, 2009, FOX NEWS
   Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068
   Phu Tran Dac, 2013, MMWR-MORBID MORTAL W, V63, P77
   Piot Peter, 2010, ENSURING HLTH ALL NE
   PREVENT Project, 2011, PAND WHOL OF SOC APP, P69
   Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862
   Rassy Dunia, 2013, HEALTH ECON, V22, P831
   Rizvi Z, 2015, J LAW MED ETHICS, V43, P74, DOI 10.1111/jlme.12278
   Rodier G, 2007, EMERG INFECT DIS, V13, P1447, DOI 10.3201/eid1310.070732
   RUBIN HARVEY, 2011, FUTURE GLOBAL SHOCKS, P4
   Sack K., 2014, NY TIMES
   Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7
   Siedner Mark J., 2015, PLOS MED, V12, P6
   Siedner Mark J., 2015, PLOS MED, V12, P1
   Stephens David S., 2015, PLOS MED, V12, P1
   THE WORLD BANK, 2010, PEOPL PATH OUR PLAN, P7
   THE WORLD BANK, 2012, PEOPL PATH OUR PLAN, P23
   Thompson Nick, 2014, CNN             1202
   UNITED NATIONS, 2015, MAK DIFF PROG REP 20, P9
   UNITED NATIONS, 1945, CHART UN
   von Tigerstrom Barbara, 2005, Health Law J, V13, P35
   Wamala Joseph F., 2010, BMC PUBLIC HEALTH, V10, P1
   Wamala Joseph F., 2010, BMC PUBLIC HEALTH, V10, P4
   WATSON TOWERS, 2013, EXTREME RISKS INSURA, P3
   WHO, 2015, ON YEAR EB EP DEADL
   WHO, 2015, EB SIT REP 30 DEC 20
   WHO, 2016, EB13820 WHO, P20
   WHO, PROGR BUDG 2014 2015
   *WHO, 2009, SWIN INFL UPD 3
   WHO, PROGR BUDG PERF ASS
   WHO, 2014, REP SECR EB VIR DIS, P2
   WHO, 2016, ADV GROUP REF WHOS W, p[10, 14]
   WHO, 2015, ADV GROUP REF WHOS W, p[4, 10]
   WHO, 2013, CHECKL IND MON PROGR, P15
   WHO, 2016, EB SIT REP 20 JAN
   WHO. International Health Regulations, 2005, SUMM STAT PART 2013
   Wilson K, 2010, HEALTH POLICY PLANN, V25, P505, DOI 10.1093/heapol/czq026
   WORLD BANK GRP. [WBG], 2013, WORLD DEV REP 2014 R, P18
   WORLD HEALTH ASSEMBLY, 2008, WORLD DEV REP 2008 A, P3
   WORLD HEALTH ORG. [ WHO], 2015, REP EB INT ASS PAN, P5
   World Health Organization, 2008, PROGR BUDG 2006 2007, P262
   World Health Organization, 2010, H1N1 POSTP PER
   World Health Organization, 2016, GLOB HLTH OBS DAT RE
   World Health Organization, 2016, GLOB HTLH OBS GHO DA
   World Health Organization, 2015, PHYS ACT STRAT WHO E, P14
   World Health Organization, 2006, PUBL HLTH INN INT PR, P13
   World Health Organization (WHO), 2009, COMMUNICATION
   WRIGHT SIMON, 2015, WAKE CALL LESSONS EB, P1
   Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056732
   Zhang Ying, 2013, PLOS ONE, V8, P5
NR 161
TC 8
Z9 8
U1 2
U2 53
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0098-8588
EI 2375-835X
J9 AM J LAW MED
JI Am. J. Law Med.
PD MAY
PY 2016
VL 42
IS 2-3
BP 356
EP 392
DI 10.1177/0098858816658273
PG 37
WC Law
SC Government & Law
GA DS7KJ
UT WOS:000380962100006
PM 29086649
DA 2020-07-08
ER

PT J
AU Mourya, DT
   Shil, P
   Sapkal, GN
   Yadav, PD
AF Mourya, Devendra T.
   Shil, Pratip
   Sapkal, Gajanan N.
   Yadav, Pragya D.
TI Zika virus: Indian perspectives
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Review
DE Aedes; microcephaly; mosquito; vector; vertical transmission; Zika virus
ID TRANSMISSION; INFECTIONS; ARBOVIRUSES; NIGERIA
AB The emergence of Zika virus (ZiV), a mosquito borne Flavivirus like dengue (DEN) and chikungunya (CHIK), in Brazil in 2014 and its spread to various countries have led to a global health emergency. Aedes aegypti is the major vector for ZiV. Fast dissemination of this virus in different geographical areas posses a major threat especially to regions where the population lacks herd immunity against the ZiV and there is abundance of Aedes mosquitoes. In this review, we focus on current global scenario, epidemiology, biology, diagnostic challenges and remedial measures for ZiV considering the Indian perspective.
C1 [Mourya, Devendra T.; Shil, Pratip; Sapkal, Gajanan N.; Yadav, Pragya D.] ICMR Natl Inst Virol, 20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
RP Mourya, DT (corresponding author), ICMR Natl Inst Virol, 20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
EM dtmourya@gmail.com
RI Shil, Pratip/M-8986-2019
CR BHATT PN, 1967, INDIAN J MED RES, V55, P1295
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, ZIK GUILL BARR SYNDR
   Center for Disease Control Atlanta United States, REV TEST ALG ZIK CHI
   Centers for Disease Control and Prevention, MORBIDITY MORTALITY
   Constancia FJA, 2016, LANCET INFECT DIS
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Enserink M, SCI NEWS
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fields BN, 2007, FIELDS VIROLOGY, P1156
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire CCM, 2015, BIORXIV
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2010, EMERG INFECT DIS, V2012, P349
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lowes L, 2016, J PEDIATR REHAB MED, V9, P65, DOI 10.3233/PRM-160362
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maron DF, SCI AM
   McKenna M., ZIV NEW THREAT NEW K
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mosquitocatalogue.org, 1963 WORLD WID MOSQ
   Mourya DT, 2015, EMERG INFECT DIS, V21, P1837, DOI 10.3201/eid2110.141961
   Mourya Devendra T, 2014, WHO South East Asia J Public Health, V3, P8, DOI 10.4103/2224-3151.206890
   Mourya DT, 2012, J VIROL METHODS, V186, P49, DOI 10.1016/j.jviromet.2012.07.019
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira Melo A S, ULTRASOUND OBSTET GY, V47, P6
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Shil Pratip, 2006, In Silico Biology, V6, P373
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Statnews, WHATS PRED 3 4 MILL
   WHO, WHO DIR GEN SUMM OUT
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organisation, ZIK VIR COMPL
   World Health Organization, DENG CONTR HUM
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 11
Z9 11
U1 2
U2 60
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0971-5916
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD MAY
PY 2016
VL 143
BP 553
EP 564
DI 10.4103/0971-5916.187103
PG 12
WC Immunology; Medicine, General & Internal; Medicine, Research &
   Experimental
SC Immunology; General & Internal Medicine; Research & Experimental
   Medicine
GA DS9PH
UT WOS:000381115100005
PM 27487998
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ong, CW
AF Ong, C. W.
TI Zika virus: an emerging infectious threat
SO INTERNAL MEDICINE JOURNAL
LA English
DT Editorial Material
ID UNITED-STATES; INTERIM GUIDELINES; SEXUAL TRANSMISSION; PREGNANT-WOMEN;
   BRAZIL; INDONESIA; TRAVELERS; OUTBREAK; BRAIN
C1 [Ong, C. W.] Canberra Hosp, Dept Microbiol, Canberra, ACT, Australia.
RP Ong, CW (corresponding author), Canberra Hosp, Dept Microbiol, Canberra, ACT, Australia.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Australian Government Department of Health, 2016, ZIK VIR INF CLIN PUB
   Australian Government Department of Health, 2016, NAT NOT DIS SURV SYS
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, ZIK VIR HLTH CAR PRO
   Communicable Diseases Network Australia, 2016, INT REC RED RISK SEX
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF FACTSH H
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   King A.M.Q., 2012, VIRUS TAXONOMY CLASS
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lopez-Camelo JS, 2015, ECLAMC FINAL DOCUMEN
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   New Zealand Government Ministry of Health, 2016, ZIK VIR INT GUID INF
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Public Health England Royal College of Obstetricians and Gynaecologists Royal College of Midwives Health Protection Scotland NHS Scotland, 2016, ZIK VIR INT ALG ASS
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Queensland Government Department of Health, 2014, ZIK VIR QUEENSL HLTH
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, CAR WOM CONF ZIK VIR
   Russell RC, 2005, COMMUN DIS INTELL, V29, P296
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares de Aracjo J, 2016, B WORLD HLT IN PRESS
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 46
TC 7
Z9 8
U1 0
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-0903
EI 1445-5994
J9 INTERN MED J
JI Intern. Med. J.
PD MAY
PY 2016
VL 46
IS 5
BP 525
EP 530
DI 10.1111/imj.13059
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6WL
UT WOS:000380041900001
PM 27170237
OA Bronze
DA 2020-07-08
ER

PT J
AU Honein, M
   Jamieson, DJ
AF Honein, M.
   Jamieson, D. J.
TI Exploring the Link between Zika Virus and Adverse Pregnancy and Birth
   Outcomes
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Honein, M.; Jamieson, D. J.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA SR2
BP 376
EP 376
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100057
DA 2020-07-08
ER

PT J
AU Schuler-Faccini, L
AF Schuler-Faccini, L.
TI Exploring the Link between Zika Virus and Microcephaly
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Schuler-Faccini, L.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
RI SCHULER-FACCINI, LAVINIA/C-8309-2013
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
NR 0
TC 0
Z9 0
U1 0
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA SR1
BP 376
EP 376
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100056
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Ventura, LO
   Maia, M
   Belfort, JRR
AF Ventura, C. V.
   Ventura, L. O.
   Maia, M.
   Belfort, J. R. R.
TI Ocular Features and Limb Anomalies in Patients with Microcephaly and
   Presumed Zika Virus Congenital Infection in Pernambuco, Brazil
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Ventura, C. V.; Ventura, L. O.; Belfort, J. R. R.] Altino Ventura Fdn FAV, Recife, PE, Brazil.
   [Ventura, L. O.] HOPE Eye Hosp, Recife, PE, Brazil.
   [Ventura, C. V.; Maia, M.; Belfort, J. R. R.] Fed Univ Sao Paulo Unifesp, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA 13
BP 391
EP 391
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100082
DA 2020-07-08
ER

PT J
AU Schuler-Faccini, L
   Ribeiro, E
   Pessoa, A
AF Schuler-Faccini, L.
   Ribeiro, E.
   Pessoa, A.
TI Zika Virus Infection in Brazil and Brain Anomalies Defects
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Schuler-Faccini, L.] Univ Fed Rio Grande do Sul, Teratogen Informat Serv, Porto Alegre, RS, Brazil.
   [Ribeiro, E.; Pessoa, A.] Hosp Albert Sabin, Fortaleza, Ceara, Brazil.
RI SCHULER-FACCINI, LAVINIA/C-8309-2013
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
NR 0
TC 1
Z9 1
U1 0
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA 4
BP 443
EP 443
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100154
DA 2020-07-08
ER

PT J
AU Nandy, A
   Basak, SC
AF Nandy, Ashesh
   Basak, Subhash C.
TI A Brief Review of Computer-Assisted Approaches to Rational Design of
   Peptide Vaccines
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE peptide vaccines; computer assisted vaccine development; epitopes;
   alignment-free analysis; web based approaches; sequence descriptors;
   rational peptide vaccine design; dengue; chikungunya; rotavirus; Zika
   virus
ID CORONAVIRUS PHYLOGENY; IN-VIVO; INFLUENZA; PROTEIN; VACCINOLOGY;
   RESPONSES; CELL
AB The growing incidences of new viral diseases and increasingly frequent viral epidemics have strained therapeutic and preventive measures; the high mutability of viral genes puts additional strains on developmental efforts. Given the high cost and time requirements for new drugs development, vaccines remain as a viable alternative, but there too traditional techniques of live-attenuated or inactivated vaccines have the danger of allergenic reactions and others. Peptide vaccines have, over the last several years, begun to be looked on as more appropriate alternatives, which are economically affordable, require less time for development and hold the promise of multi-valent dosages. The developments in bioinformatics, proteomics, immunogenomics, structural biology and other sciences have spurred the growth of vaccinomics where computer assisted approaches serve to identify suitable peptide targets for eventual development of vaccines. In this mini-review we give a brief overview of some of the recent trends in computer assisted vaccine development with emphasis on the primary selection procedures of probable peptide candidates for vaccine development.
C1 [Nandy, Ashesh] Ctr Interdisciplinary Res & Educ, Jodhpur Pk, Kolkata 700068, India.
   [Basak, Subhash C.] Univ Minnesota, Duluth, MN 55811 USA.
RP Nandy, A (corresponding author), Ctr Interdisciplinary Res & Educ, Jodhpur Pk, Kolkata 700068, India.
EM anandy43@yahoo.com; sbasak@nrri.umn.edu
OI Nandy, Ashesh/0000-0002-1649-7731
CR Almeida JPM, 2015, SMALL, V11, P1453, DOI 10.1002/smll.201402179
   [Anonymous], 2016, EB VIR DIS OUTBR
   [Anonymous], 2008, WKLY EPIDEMIOL REC, V83, P421
   Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065
   Basak SC, 2006, TOP HETEROCYCL CHEM, V3, P39, DOI 10.1007/7081_025
   Basak SC, 2016, CURR COMPUT-AID DRUG, V12, P2, DOI 10.2174/1573409912999160315115502
   Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108
   Chakraborty Sajib, 2010, In Silico Biology, V10, P235, DOI 10.3233/ISB-2010-0435
   Chit A, 2014, VACCINE, V32, P3336, DOI 10.1016/j.vaccine.2013.06.055
   Chroboczek J, 2014, ACTA BIOCHIM POL, V61, P531
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Ghosh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040749
   Ghosh A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-6
   Ghosh A, 2009, J CHEM INF MODEL, V49, P2627, DOI 10.1021/ci9001662
   Gomase Virendra S, 2007, Curr Drug Discov Technol, V4, P117
   GOMASE VS, 2008, GENE THER MOL BIOL, V12, P83
   Gonzalez-Diaz H, 2009, J THEOR BIOL, V261, P136, DOI 10.1016/j.jtbi.2009.07.029
   Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638
   Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004
   Hardy LW, 2003, CURRENT DRUG DISCOVE, V3, P15
   Hawkins DM, 2006, J CHEM INF MODEL, V46, P9, DOI 10.1021/ci050252p
   Huber SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00171
   Islam R, 2012, FUTURE VIROL, V7, P1029, DOI 10.2217/FVL.12.95
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   LANGEVELD JPM, 1994, J VIROL, V68, P4506, DOI 10.1128/JVI.68.7.4506-4513.1994
   Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515
   Liao B, 2006, CHEM PHYS LETT, V421, P313, DOI 10.1016/j.cplett.2006.01.030
   Liao SJ, 2013, J HUAZHONG U SCI-MED, V33, P735, DOI 10.1007/s11596-013-1189-5
   Ludewig B, 2000, VACCINE, V19, P23, DOI 10.1016/S0264-410X(00)00163-8
   Moisa A.A., 2012, INSIGHT CONTROL INFE
   Monso M, 2011, J PEPT SCI, V17, P24, DOI 10.1002/psc.1292
   Nandy A, 2015, CURR COMPUT-AID DRUG, V11, P110, DOI 10.2174/1573409911666150722122034
   Oany AR, 2014, DRUG DES DEV THER, V8, P1139, DOI [10.2147/DDDT.567861, 10.2147/DDDT.S67861]
   Oyarzn P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-52
   Poland GA, 2016, CURR OPIN VIROL, V17, P116, DOI 10.1016/j.coviro.2016.03.003
   Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344
   Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI 10.2217/PGS.09.25
   Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224
   Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5
   Rojas-Caraballo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105323
   Sarkar T, 2015, COMPUT BIOL CHEM, V59, P8, DOI 10.1016/j.compbiolchem.2015.08.003
   Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004
   Sirskyj D, 2011, IMMUNOL CELL BIOL, V89, P81, DOI 10.1038/icb.2010.65
   Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2
   Sobolev BN, 2005, CURR COMPUT-AID DRUG, V1, P207, DOI 10.2174/1573409053585681
   Stanaway J.D., 2016, LANCET INFECT DIS
   Suzuki H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-97
   Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x
   Varghese JN, 1999, DRUG DEVELOP RES, V46, P176, DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6
   VILAR S, 2010, TOPOLOGICAL INDICES, P145
   WANG RB, 1995, J IMMUNOL, V154, P2784
   Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12
   World Health Organization, 2015, MIDDL E RESP SYNDR C
NR 53
TC 19
Z9 21
U1 1
U2 28
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2016
VL 17
IS 5
AR 666
DI 10.3390/ijms17050666
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DP9BJ
UT WOS:000378791400060
PM 27153063
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baum, P
   Fiastro, A
   Kunselman, S
   Vega, C
   Ricardo, C
   Galli, B
   Nascimento, M
AF Baum, Paige
   Fiastro, Anna
   Kunselman, Shane
   Vega, Camila
   Ricardo, Christine
   Galli, Beatriz
   Nascimento, Marcos
TI Ensuring a rights-based health sector response to women affected by Zika
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
ID ABORTION
C1 [Baum, Paige; Fiastro, Anna; Kunselman, Shane; Vega, Camila; Ricardo, Christine] Yale Univ, Sch Publ Hlth, Sch Law, Global Hlth Justice Partnership, 127 Wall St, New Haven, CT 06511 USA.
   [Galli, Beatriz] Ipas Brasil, Rio De Janeiro, Brazil.
   [Nascimento, Marcos] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Ricardo, C (corresponding author), Yale Univ, Sch Publ Hlth, Sch Law, Global Hlth Justice Partnership, 127 Wall St, New Haven, CT 06511 USA.
EM christine.ricardo@yale.edu
CR [Anonymous], REPROD HLTH
   [Anonymous], 1988, PROT SAN SALV
   Diniz D, 2010, CIENC SAUDE COLETIVA, V15, P959, DOI 10.1590/S1413-81232010000700002
   Erdman JN, 2012, INT J GYNECOL OBSTET, V118, P83, DOI 10.1016/j.ijgo.2012.04.002
   FUSCO CLB, 2013, REPROD CLIM, V28, P2
   Goldman Lisa A, 2005, Reprod Health, V2, P10
   Instituto de Pesquisa Economica Aplicada, EST BRAS RAD SEG SAU
   Miller M, 2016, WASHINGTON POST
   Ministerio da Saude, AT HUM AB
   Ministerio da Saude, 2009, PESQ NAC DEM SAUD CR
   Ministerio de Salud y Proteccion Social, LIN ROV AB CLIN GEST
   MONTEIRO MFG, 2015, REPROD CLIM, V30, P11
   New York Times, 2016, NY TIMES
   Rozenberg R, 2013, CIENC SAUDE COLETIVA, V18, P3645, DOI 10.1590/S1413-81232013001200020
   Secretaria de Atencao a Sau'de Ministerio da Saude, PROT AT SAUD RESP OC
   World Health Organization, 2012, SAF AB TECHN POL GUI
   World Health Organization, PREGN MAN CONT ZIK V
NR 17
TC 12
Z9 12
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00064416
DI 10.1590/0102-311X00064416
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900021
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Camargo, TMCR
AF Coeli Rochel de Camargo, Thais Medina
TI The debate on abortion and Zika: lessons from the AIDS epidemic
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Coeli Rochel de Camargo, Thais Medina] Univ Sao Paulo, Fac Filosofia Letras & Ciencias Humanas, Sao Paulo, Brazil.
RP de Camargo, TMCR (corresponding author), Rua Afonso Pena 141,Apto 402, BR-20270244 Rio De Janeiro, RJ, Brazil.
EM thais.camargo@gmail.com
OI Rochel de Camargo, Thais/0000-0002-9006-6526
CR Amato Neto V, 1989, AIDS E ABORTO
   Diniz Debora, 2008, Rev. Estud. Fem., V16, P647, DOI 10.1590/S0104-026X2008000200019
   Ferraz L., 2016, FOLHA DE S PAULO
   Ferree MM, 2003, AM J SOCIOL, V109, P304, DOI 10.1086/378343
   Figueiredo Argelina Cheibub, 2007, BRAZILIAN POLITICAL, V1, P182
   Gomes EC, 2009, VALORES RELIGIOSOS P, P45
   Htun M., 2003, SEX STATE ABORTAION
   PINTO Cell Regina Jardim, 2003, HIST FEMINISMO BRASI
   Rocha Maria Isabel Baltar da, 2006, Rev. bras. estud. popul., V23, P369, DOI 10.1590/S0102-30982006000200011
   Rocha MIB, 1996, ESTUD FEM, V4, P381
   Senra R, 2016, BBC
   Ventura M., 2009, DIREITOS REPRODUTIVO
   Villela WV, 2007, CAD SAUDE PUBLICA, V23, P471, DOI 10.1590/S0102-311X2007000200025
NR 13
TC 2
Z9 2
U1 0
U2 8
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00071516
DI 10.1590/0102-311X00071516
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900023
PM 27192026
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Diniz, D
AF Diniz, Debora
TI Zika virus and women
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Diniz, Debora] Univ Brasilia, Fac Direito, Brasilia, DF, Brazil.
   [Diniz, Debora] Anis Inst Bioet Direitos Humanos & Genero, BR-70673970 Brasilia, DF, Brazil.
RP Diniz, D (corresponding author), Anis Inst Bioet Direitos Humanos & Genero, Setor Sudoeste, CP 8011, BR-70673970 Brasilia, DF, Brazil.
EM d.diniz@anis.org.br
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569
CR Brasil P, 2016, N ENGL J MED
   Cavarero Adriana, 2007, Rev. Estud. Fem., V15, P650
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias Ministerio da Saude, 2016, MON CAS MICR BRAS
   Corte Interamericana de Derechos Humanos, 2015, DEM EST EC REL JUEZ
   LUGONES MARÍA, 2008, Tabula Rasa, P73
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sassaki RK, 2010, REACAO REV NACL REAB, VXIV, P14
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 9
TC 31
Z9 31
U1 0
U2 19
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00046316
DI 10.1590/0102-311X00046316
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900020
PM 27192024
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Luna, F
AF Luna, Florencia
TI Zika and pregnancy: rethinking certain tools
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Luna, Florencia] Consejo Nacl Invest Cient & Tecn, Fac Latinoamer Ciencias Sociales, RA-1033 Buenos Aires, DF, Argentina.
RP Luna, F (corresponding author), Consejo Nacl Invest Cient & Tecn, Fac Latinoamer Ciencias Sociales, RA-1033 Buenos Aires, DF, Argentina.
EM florlunaflacso@gmail.com
CR Brockington I, 2001, INT CLIN PSYCHOPHARM, V16, pS7, DOI 10.1097/00004850-200103002-00003
   FRAUTSCHI S, 1994, INT J GYNECOL OBSTET, V47, P275, DOI 10.1016/0020-7292(94)90574-6
   LUNA F, 1995, BIOETHICS, V9, P283, DOI 10.1111/j.1467-8519.1995.tb00363.x
   Luna F., 1997, DILEMAS ETICOS, P151
   Luna Florencia, 2016, Rev. Bioética y Derecho, V0, P5, DOI 10.1344/rbd2016.36.15373
   Rondón Marta B., 2015, An. Fac. med., V76, P407, DOI 10.15381/anales.v76i4.11411
NR 6
TC 1
Z9 1
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR eCO080516
DI 10.1590/0102-311XCO080516
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900016
PM 27276695
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pitanguy, J
AF Pitanguy, Jacqueline
TI Women's reproductive rights and the Zika virus epidemic
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Pitanguy, Jacqueline] CEPIA, Rua Russel 694,Apto 201, BR-22210010 Rio De Janeiro, RJ, Brazil.
RP Pitanguy, J (corresponding author), CEPIA, Rua Russel 694,Apto 201, BR-22210010 Rio De Janeiro, RJ, Brazil.
EM pitanguy@cepia.org.br
NR 0
TC 6
Z9 6
U1 0
U2 56
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00066016
DI 10.1590/0102-311X00066016
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900022
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Stern, AM
AF Stern, Alexandra Minna
TI Zika and reproductive justice
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Stern, Alexandra Minna] Univ Michigan, 3700 Haven Hall, Ann Arbor, MI 48103 USA.
RP Stern, AM (corresponding author), Univ Michigan, 3700 Haven Hall, Ann Arbor, MI 48103 USA.
EM amstern@med.umich.edu
CR Carless W., 2016, NEW BILL AIMS MAKE B
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Diniz SG, 2012, REPROD HEALTH MATTER, V20, P94, DOI 10.1016/S0968-8080(12)40657-7
   High-Level Task Force for ICPD, 2014, POL REC ICPD 2014 SE
   Ross L., REPROD JUSTICE BRIEF
NR 5
TC 6
Z9 6
U1 0
U2 8
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00081516
DI 10.1590/0102-311X00081516
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900004
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Nunes, ML
   Carlini, CR
   Marinowic, D
   Neto, FK
   Fiori, HH
   Scotta, MC
   Zanella, PLA
   Soder, RB
   da Costa, JC
AF Nunes, Magda Lahorgue
   Carlini, Celia Regina
   Marinowic, Daniel
   Neto, Felipe Kalil
   Fiori, Humberto Holmer
   Scotta, Marcelo Comerlato
   Avila Zanella, Pedro Luis
   Soder, Ricardo Bernardi
   da Costa, Jaderson Costa
TI Microcephaly and Zika virus: a clinical and epidemiological analysis of
   the current outbreak in Brazil
SO JORNAL DE PEDIATRIA
LA English
DT Review
DE Zika virus; Microcephaly; Pregnancy; Cortical development; Neuroimaging
ID INTERIM GUIDELINES; HEAD CIRCUMFERENCE; UNITED-STATES; HUMAN BRAIN;
   CHIKUNGUNYA; INFECTION; DENGUE; ILLNESS; DISORDERS; STANDARDS
AB Objective: This study aimed to critically review the literature available regarding the Zika virus outbreak in Brazil and its possible association with microcephaly cases.
   Sources: Experts from Instituto do Cerebro do Rio Grande do Sul performed a critical (nonsystematic) literature review regarding different aspects of the Zika virus outbreak in Brazil, such as transmission, epidemiology, diagnostic criteria, and its possible association with the increase of microcephaly reports. The PubMed search using the key word "Zika virus'' in February 2016 yielded 151 articles. The manuscripts were reviewed, as well as all publications/guidelines from the Brazilian Ministry of Health, World Health Organization and Centers for Disease Control and Prevention (CDC - United States).
   Summary of findings: Epidemiological data suggest a temporal association between the increased number of microcephaly notifications in Brazil and outbreak of Zika virus, primarily in the Brazil's Northeast. It has been previously documented that many different viruses might cause congenital acquired microcephaly. Still there is no consensus on the best curve to measure cephalic circumference, specifically in preterm neonates. Conflicting opinions regarding the diagnosis of microcephaly (below 2 or 3 standard deviations) that should be used for the notifications were also found in the literature.
   Conclusion: The development of diagnostic techniques that confirm a cause-effect association and studies regarding the physiopathology of the central nervous system impairment should be prioritized. It is also necessary to strictly define the criteria for the diagnosis of microcephaly to identify cases that should undergo an etiological investigation. (C) 2016 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [Nunes, Magda Lahorgue; Fiori, Humberto Holmer; Avila Zanella, Pedro Luis; da Costa, Jaderson Costa] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.
   [Nunes, Magda Lahorgue; Carlini, Celia Regina; Marinowic, Daniel; Neto, Felipe Kalil; Fiori, Humberto Holmer; Scotta, Marcelo Comerlato; Avila Zanella, Pedro Luis; Soder, Ricardo Bernardi; da Costa, Jaderson Costa] Inst Cerebro Rio Grande Sul Inscer, Zika Team, Porto Alegre, RS, Brazil.
   [Carlini, Celia Regina; Marinowic, Daniel] Inst Cerebro Rio Grande Sul Inscer, Porto Alegre, RS, Brazil.
   [Neto, Felipe Kalil] Pontificia Univ Catolica Rio Grande Sul PUCRS, Postgrad Program Pediat & Child Hlth, Porto Alegre, RS, Brazil.
   [Scotta, Marcelo Comerlato] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Dept Pediat, Porto Alegre, RS, Brazil.
   [Soder, Ricardo Bernardi] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Dept Diagnost Methods, Porto Alegre, RS, Brazil.
RP Nunes, ML (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.; Nunes, ML (corresponding author), Inst Cerebro Rio Grande Sul Inscer, Zika Team, Porto Alegre, RS, Brazil.
EM nunes@pucrs.br
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Scotta,
   Marcelo/J-5258-2017
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Scotta,
   Marcelo/0000-0001-5892-4052
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX MLN, CRC, and JCC receive a research productivity grant from CNPq.
CR [Anonymous], 2015, PROT AT MULH ID FERT
   Arai A, 2012, BRAIN RES, V1470, P89, DOI 10.1016/j.brainres.2012.06.009
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Bae BI, 2013, SCIENCE, V342, P200, DOI 10.1126/science.1245812
   BECKER LE, 1992, AM J NEURORADIOL, V13, P537
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V9
   BHUSHAN V, 1991, J CLIN EPIDEMIOL, V44, P1027, DOI 10.1016/0895-4356(91)90004-S
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doenc as Transmissiveis, 2015, PROT VIG RESP OC MIC
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   COES, 2016, MICR AT ENTR COL MIC
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS MICR BR, P1
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Freire CCM, 2015, BIORXIV
   FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Golden JA, 2001, NEUROPATH APPL NEURO, V27, P22, DOI 10.1046/j.0305-1846.2001.00307.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Ichida JK, 2015, EMBO J, V34, P1456, DOI 10.15252/embj.201591267
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Javelle E, 2014, J CLIN VIROL, V59, P270, DOI 10.1016/j.jcv.2014.01.011
   Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2015, PROT AT SAUD RESP OC
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   PAHO, 2015, NEUR SYNDR CONG MALF, P1
   Pan American Health Organization (PAHO), 2016, LIN PREL VIG MICR RE
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   RAKIC P, 1978, POSTGRAD MED J, V54, P25
   RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P
   RORKE LB, 1994, J NEUROPATH EXP NEUR, V53, P105, DOI 10.1097/00005072-199403000-00001
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, P1189
   Tetro JA, 2016, MICROBES INFECT
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Volpe JJ, 2001, NEUROLOGY NEWBORN
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization (WHO), 2016, WHO CHILD GROWTH STA
   Zhang R, 2013, ACTA PHARMACOL SIN, V34, P765, DOI 10.1038/aps.2013.21
NR 78
TC 40
Z9 45
U1 0
U2 29
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAY-JUN
PY 2016
VL 92
IS 3
BP 230
EP 240
DI 10.1016/j.jped.2016.02.009
PG 11
WC Pediatrics
SC Pediatrics
GA DP9VP
UT WOS:000378846100004
PM 27049675
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Eberhardt, KA
   Vinnemeier, CD
   Dehnerdt, J
   Rolling, T
   Steffen, R
   Cramer, JP
AF Eberhardt, Kirsten Alexandra
   Vinnemeier, Christof David
   Dehnerdt, Johanna
   Rolling, Thierry
   Steffen, Robert
   Cramer, Jakob Peter
TI Travelers to the FIFA world cup 2014 in Brazil: Health risks related to
   mass gatherings/sports events and implications for the Summer Olympic
   Games in Rio de Janeiro in 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Mass gathering; Brazil; FIFA world cup 2014; Summer Olympic Games 2016
ID PARALYMPIC GAMES; RESEARCH AGENDA; ZIKA VIRUS; MEDICINE; VISITORS;
   DISEASES; DENGUE; ADVICE
AB Background: Health threats during mass gatherings, such as the FIFA world cup 2014 differ from traditional health risks. The influence of event type, demographics of attendees and environmental conditions are still not fully understood.
   Methods: An observational, prospective case-control survey conducted at the Frankfurt international airport in Germany on 544 travelers to the FIFA world cup 2014 and 432 regular travelers to Brazil departing after the end of the world cup.
   Results: Travelers to the FIFA world cup 2014 were predominantly male whereas the gender distribution in the control group was more balanced. The majority in both groups obtained insect bites and sunburns as environmental risk factors. Every third traveler suffered from diarheal complaints in both groups, whereas the proportion of travelers with flu-like symptoms was higher in the case group. Travelers to the FIFA world cup 2014 indicated alcohol intake and sexual contacts outside of a relationship more frequently than travelers in the control group.
   Conclusions: The additional health risks of travelers to sporting events as the FIFA world cup 2014 should be addressed in addition to traditional health threats in pre-travel counseling for the Summer Olympic Games 2016 in Brazil. (C) 2016 Published by Elsevier Ltd.
C1 [Eberhardt, Kirsten Alexandra; Vinnemeier, Christof David; Dehnerdt, Johanna; Rolling, Thierry; Cramer, Jakob Peter] Bernhard Nocht Inst Trop Med, Clin Res Unit, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Vinnemeier, Christof David; Rolling, Thierry] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Sect Trop Med, Hamburg, Germany.
   [Steffen, Robert] Univ Zurich, Ctr Travel Med, WHO Collaborating Ctr Travelers Hlth, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.
RP Cramer, JP (corresponding author), Bernhard Nocht Inst Trop Med, Clin Res Unit, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM cramer@bni-hamburg.de
OI Rolling, Thierry/0000-0002-0277-5067; Eberhardt,
   Kirsten/0000-0002-1002-0326
FU Frankfurt international airport; airlines Lufthansa; TAP Portugal
FX We are grateful to the travelers participating in this study. We thank
   the Frankfurt international airport and the airlines Lufthansa and TAP
   Portugal for their support. JPC accepted a position at Takeda
   Pharmaceuticals International AG, Vaccine Business Unit, Zurich
   Switzerland.
CR Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8
   Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Aldea M, 2015, INT HEALTH, V7, P272, DOI 10.1093/inthealth/ihu076
   Alqahtani AS, 2015, VACCINE, V33, P6552, DOI 10.1016/j.vaccine.2015.09.076
   Alquthami AH, 2014, PREHOSP DISASTER MED, V29, P167, DOI 10.1017/S1049023X14000144
   Arbon P, 2001, Prehosp Disaster Med, V16, P150
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Botelho-Nevers E, 2013, EUROSURVEILLANCE, V18, P32
   Burton JO, 2012, PREHOSP DISASTER MED, V27, P458, DOI 10.1017/S1049023X12000830
   Ezzedine Khaled, 2007, Travel Med Infect Dis, V5, P176, DOI 10.1016/j.tmaid.2006.08.001
   Gaines J, 2014, JAMA INTERN MED, V174, P1383, DOI 10.1001/jamainternmed.2014.2227
   Gallego V, 2014, TRAVEL MED INFECT DI, V12, P208, DOI 10.1016/j.tmaid.2014.04.004
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Gocotano AE, 2015, B WORLD HEALTH ORGAN, V93, P810, DOI 10.2471/BLT.15.158089
   Hall V, 2015, SEX TRANSM INFECT, V91, P592, DOI 10.1136/sextrans-2014-051826
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heywood AE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-321
   Hopkins N, 2016, INT J INFECT DIS
   Hopkins N, 2016, J EPIDEMIOL GLOB HEA, V6, P49, DOI 10.1016/j.jegh.2015.06.001
   Hutton A, 2015, AUST J PRIM HEALTH, V21, P249, DOI 10.1071/PY13094
   Hutton A, 2011, PREHOSP DISASTER MED, V26, P414, DOI 10.1017/S1049023X12000155
   Iliaki E, 2014, J TRAVEL MED, V21, P214, DOI 10.1111/jtm.12117
   Jentes ES, 2010, AM J TROP MED HYG, V82, P466, DOI 10.4269/ajtmh.2010.09-0660
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Locoh-Donou S, 2016, INTERN EMERG MED
   Locoh-Donou S, 2013, AM J EMERG MED, V31, P843, DOI 10.1016/j.ajem.2013.01.016
   Lund A, 2015, PREHOSP DISASTER MED, V30, P271, DOI 10.1017/S1049023X15004598
   Lund A, 2014, PREHOSP DISASTER MED, V29, P648, DOI 10.1017/S1049023X14001216
   Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1
   Rack J, 2005, J TRAVEL MED, V12, P248, DOI 10.2310/7060.2005.12502
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Shoaf K, 2014, PREHOSP DISASTER MED, V29, P409, DOI 10.1017/S1049023X1400065X
   Sile B, 2015, SEX TRANSM DIS, V42, P710, DOI 10.1097/OLQ.0000000000000370
   Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006
   Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6
   Tam JS, 2012, LANCET INFECT DIS, V12, P231, DOI 10.1016/S1473-3099(11)70353-X
   Turris SA, 2014, DISASTER MED PUBLIC, V16, P1
   van Panhuis WG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003063
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   Wilson ME, 2014, TRAVEL MED INFECT DI, V12, P205, DOI 10.1016/j.tmaid.2014.04.001
   Woo C, 2013, TRAVEL MED INFECT DI, V11, P438, DOI 10.1016/j.tmaid.2013.10.008
   World Health Organization, 2008, COMM DIS AL RESP MAS
NR 42
TC 10
Z9 10
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 212
EP 220
DI 10.1016/j.tmaid.2016.05.014
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000006
PM 27238909
DA 2020-07-08
ER

PT J
AU Nishiura, H
   Mizumoto, K
   Villamil-Gomez, WE
   Rodriguez-Morales, AJ
AF Nishiura, Hiroshi
   Mizumoto, Kenji
   Villamil-Gomez, Wilmer E.
   Rodriguez-Morales, Alfonso J.
TI Preliminary estimation of the basic reproduction number of Zika virus
   infection during Colombia epidemic, 2015-2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Transmission; Epidemiology; Colombia; Latin America
ID AMERICA
C1 [Nishiura, Hiroshi; Mizumoto, Kenji] Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
   [Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
   [Nishiura, Hiroshi; Mizumoto, Kenji] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Cartagena, Programa Doctorado Med Trop, Cartagena, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Barranquilla, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Panamer Assoc Infect Dis, Comm Travel Med, Quito, Ecuador.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Asociac Colombiana Infectol, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] Int Soc Chemotherapy, Working Grp Zoonoses, Aberdeen, Scotland.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Mizumoto,
   Kenji/0000-0002-2748-6560
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Instituto Nacional de Salud de Bogota, 2016, ZIK SEM EP 10 2016
   Majumder MS, 2016, B WHO IN PRESS
   Nishiura H, 2016, EPIDEMICS IN PRESS
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127
   Villamil-Gomez WE, 2016, J INFECT PU IN PRESS
NR 8
TC 28
Z9 29
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 274
EP 276
DI 10.1016/j.tmaid.2016.03.016
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000015
PM 27060613
OA Bronze
DA 2020-07-08
ER

PT J
AU Tridane, A
   El Khajah, A
   Ali, BR
AF Tridane, Abdessamad
   El Khajah, Abdelmajid
   Ali, Bassam R.
TI The possible threat of Zika virus in the Middle East
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika virus; Middle East; Congenital microcephaly; Travel warning
ID TRANSMISSION
C1 [Tridane, Abdessamad] United Arab Emirates Univ, Coll Sci, Dept Math Sci, POB 15551, Al Ain, U Arab Emirates.
   [El Khajah, Abdelmajid] United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates.
   [Ali, Bassam R.] United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.
RP Tridane, A (corresponding author), United Arab Emirates Univ, Coll Sci, Dept Math Sci, POB 15551, Al Ain, U Arab Emirates.
EM a-tridane@uaeu.ac.ae
RI Tridane, Abdessamad/I-3147-2019
OI Tridane, Abdessamad/0000-0001-8471-7807; Ali, Bassam
   R/0000-0003-1306-6618
CR Al-Gazali L, 2010, HUM MUTAT, V31, P505, DOI 10.1002/humu.21232
   Bastaki F, 2015, CONGENIT ANOM
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Korhonen EM, 2015, EUROSURVEILLANCE, V21, P2016
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Zain AA, 2016, KHALEEJ TIMES   0201
NR 9
TC 3
Z9 3
U1 0
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 277
EP 278
DI 10.1016/j.tmaid.2016.03.003
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000016
PM 26972490
DA 2020-07-08
ER

PT J
AU Betancourt-Trejos, ML
   Narvaez-Maldonado, CF
   Ortiz-Erazo, WF
   Arias-Guzman, JS
   Gil-Restrepo, AF
   Sanchez-Rueda, MA
   Munoz-Calle, NJ
   Maya-Betancourth, JG
   Rodriguez-Morales, AJ
AF Liliana Betancourt-Trejos, Mariet
   Fernando Narvaez-Maldonado, Carlos
   Fernando Ortiz-Erazo, Wilder
   Sebastian Arias-Guzman, Juan
   Felipe Gil-Restrepo, Andres
   Angel Sanchez-Rueda, Miguel
   Jaime Munoz-Calle, Nestor
   Gabriel Maya-Betancourth, Juan
   Rodriguez-Morales, Alfonso J.
TI Healthcare students and workers' knowledge about Zika and its
   association with microcephaly in two cities of Colombia
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Healthcare workers; Knowledge; Medical education; Microcephaly
ID LATIN-AMERICA; THREAT
C1 [Liliana Betancourt-Trejos, Mariet; Fernando Narvaez-Maldonado, Carlos; Fernando Ortiz-Erazo, Wilder; Sebastian Arias-Guzman, Juan; Felipe Gil-Restrepo, Andres; Angel Sanchez-Rueda, Miguel; Jaime Munoz-Calle, Nestor; Gabriel Maya-Betancourth, Juan; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Int Soc Chemotherapy, Working Grp Zoonoses, Aberdeen, Scotland.
   [Rodriguez-Morales, Alfonso J.] Panamer Assoc Infect Dis, Comm Travel Med, Quito, Ecuador.
   [Rodriguez-Morales, Alfonso J.] Asociac Colombiana Infectol, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Gil Restrepo, Andres
   Felipe/0000-0002-5265-6015
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Instituto Nacional de Salud de Bogota, 2016, ZIK SEM EP 13 2016
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
NR 6
TC 11
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 283
EP 285
DI 10.1016/j.tmaid.2016.03.017
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000019
PM 27063652
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Garcia-Loaiza, CJ
   Galindo-Marquez, ML
   Sabogal-Roman, JA
   Marin-Loaiza, S
   Lozada-Riascos, CO
   Diaz-Quijano, FA
AF Rodriguez-Morales, Alfonso J.
   Julian Garcia-Loaiza, Carlos
   Leonor Galindo-Marquez, Maria
   Alejandro Sabogal-Roman, Juan
   Marin-Loaiza, Santiago
   Lozada-Riascos, Carlos O.
   Diaz-Quijano, Fredi A.
TI Zika infection GIS-based mapping suggest high transmission activity in
   the border area of La Guajira, Colombia, a northeastern coast Caribbean
   department, 2015-2016: Implications for public health, migration and
   travel
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Epidemiology; Travelers; Colombia; Latin America
ID INFORMATION-SYSTEM GIS; OUTBREAK IMPLICATIONS; CHIKUNGUNYA FEVER;
   MUNICIPALITIES; AMERICA; ADVICE
C1 [Rodriguez-Morales, Alfonso J.; Julian Garcia-Loaiza, Carlos; Leonor Galindo-Marquez, Maria; Alejandro Sabogal-Roman, Juan; Marin-Loaiza, Santiago] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Riohacha, La Guajira, Colombia.
   [Lozada-Riascos, Carlos O.] Univ Tecnol Pereira, Reg Informat Syst, Pereira, Risaralda, Colombia.
   [Diaz-Quijano, Fredi A.] Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
RP Rodriguez-Morales, AJ (corresponding author), OLFIS, Riohacha, La Guajira, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016; Diaz-Quijano, Fredi
   Alexander/I-3740-2012
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Diaz-Quijano, Fredi
   Alexander/0000-0002-1134-1930; Galindo Marquez, Maria
   Leonor/0000-0003-2498-0878
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Instituto Nacional de Salud de Bogota, 2016, ZIK SEM EP 06 2016
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
NR 8
TC 17
Z9 17
U1 5
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 286
EP 288
DI 10.1016/j.tmaid.2016.03.018
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000020
PM 27063653
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI Zika in the United States of America and a Fateful 1969 Decision
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Editorial Material
ID AEDES-AEGYPTI; MOSQUITOS
AB The United States Gulf Coast's current risk to Zika transmitted by Aedes aegypti mosquitoes can be traced back to some important federal health policy decisions made during the 1960s.
C1 [Hotez, Peter J.] Baylor Coll Med, Sabin Vaccine Inst, Houston, TX 77030 USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
RP Hotez, PJ (corresponding author), Baylor Coll Med, Sabin Vaccine Inst, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA.; Hotez, PJ (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.
EM hotez@bcm.edu
OI Hotez, Peter/0000-0001-8770-1042
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   [Anonymous], 1997, REV PANAM SALUD PUBL, V1, P68
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Faria NR, 2016, SCIENCE
   HOBBS JH, 1991, J AM MOSQUITO CONTR, V7, P488
   Hotez P, 2009, HEALTH AFFAIR, V28, P1720, DOI 10.1377/hlthaff.28.6.1720
   McKenna M, 2016, DISORGANIZED MOSQUIT
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   SLOSEK J, 1986, SOC SCI MED, V23, P249, DOI 10.1016/0277-9536(86)90345-X
   Soper FL, 1967, AM J PUBLIC HLTH NAT, V53, P7
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Woodall JP, 2016, INT J INFECT DIS
NR 17
TC 7
Z9 7
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004765
DI 10.1371/journal.pntd.0004765
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300072
PM 27227971
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Silveira, FP
   Campos, SV
AF Silveira, Fernantla P.
   Campos, Silvia V.
TI The Zika epidemics and transplantation
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
DE Zika virus; transplantation; complications; microcephaly; Guillain-Barre
   syndrome; donor-derived infection
ID VIRUS; TRANSMISSION; STATES
AB In the last few months an epidemic of Zika virus (ZIKV) has affected several countries, and it continues to spread rapidly. This virus was initially thought to cause only a mild febrile illness; however, the current epidemic has shown that it is associated with serious complications. Increasing reports are linking ZIKV to devastating conditions such as microcephaly in newborns and important neurologic syndromes. Although ZIKV infection has not yet been reported in transplant recipients, it is likely that it will be reported soon because of the number of transplants performed in affected areas and global travel. We discuss the effect of ZIKV in transplantation and propose recommendations to prevent donor derived infections. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
C1 [Silveira, Fernantla P.] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA USA.
   [Campos, Silvia V.] Univ Sao Paulo, Lung Transplant Grp, Div Pulm, Heart Inst InCor, Sao Paulo, Brazil.
RP Silveira, FP (corresponding author), 3601 Fifth Ave,Ste 3A, Pittsburgh, PA 15237 USA.
EM silveirafd@upmc.edu
CR Associac Brasileira de Transplantes de Orgaos (BR), 2015, REG BRAS TRANSPL
   Brasil P, 2016, N ENGL J MED
   Calvet G, LANCET INFECT DIS
   Cao-Lormeau VM, LANCET
   Centers for Disease Control and Prevention, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, LANCET INFECT DIS
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   United Network for Organ Sharing, GUID ORG DON TRANSPL
   WHO, 2016, MAINT SAF AD BLOOD S
NR 15
TC 13
Z9 13
U1 0
U2 58
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
EI 1557-3117
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD MAY
PY 2016
VL 35
IS 5
BP 560
EP 563
DI 10.1016/j.healun.2016.03.010
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA DN3HB
UT WOS:000376951900003
PM 27197772
OA Bronze
DA 2020-07-08
ER

PT J
AU Kotton, CN
AF Kotton, Camille Nelson
TI Zika Virus and Solid Organ Transplantation: Significant Pathogen or
   Harbinger of Things to Come?
SO TRANSPLANTATION
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Kotton, Camille Nelson] Harvard Univ, Massachusetts Gen Hosp, Transplant & Immunocompromised Host Infect Dis, Infect Dis Div,Med Sch, Boston, MA USA.
RP Kotton, CN (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,Cox 5, Boston, MA 02114 USA.
EM ckotton@partners.org
OI Kotton, Camille/0000-0001-7320-2234
CR [Anonymous], 2016, GUIDANCE ORGAN DONAT
   [Anonymous], 2016, GUILLAIN BARRE SYNDR
   CDC, 2016, ALL COUNTR TERR ACT
   Centres for Disease Control and Prevention, 2016, ZIK VIR DIAGN TEST C
   Costa SD, 2015, AM J TROP MED HYG, V93, P394, DOI 10.4269/ajtmh.15-0038
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Kaul DR, 2015, AM J TRANSPLANT, V15, P5, DOI 10.1111/ajt.13093
   Laffoon B., 2010, Morbidity and Mortality Weekly Report, V59, P1335
   Lieshout-Krikke RW, 2013, VOX SANG, V104, P12, DOI 10.1111/j.1423-0410.2012.01631.x
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Prevention CfDCa, 2016, ZIK VIR CLIN EV DIS
   Regan DM, 2016, ASS BLOOD BANKS AABB, V16-03
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
NR 15
TC 6
Z9 6
U1 0
U2 52
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD MAY
PY 2016
VL 100
IS 5
BP 970
EP 972
DI 10.1097/TP.0000000000001179
PG 3
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA DN5QU
UT WOS:000377126000007
PM 27023395
DA 2020-07-08
ER

PT J
AU dos Santos, AG
   Stucchi, RSB
   Boin, IFSF
   Ataide, E
   Angerami, R
   Cunha, MS
   Souza, RP
   Fonseca, BAL
AF dos Santos, Andrea G.
   Stucchi, Raquel S. B.
   Boin, Ilka F. S. F.
   Ataide, Elaine
   Angerami, Rodrigo
   Cunha, Mariana S.
   Souza, Renato P.
   Fonseca, Benedito A. L.
TI First Reported Case: Zika Virus Infection in a Liver Transplant Patient
SO TRANSPLANTATION
LA English
DT Meeting Abstract
CT 22nd Annual International Congress of the
   International-Liver-Transplantation-Society (ILTS)
CY MAY 04-07, 2016
CL Seoul, SOUTH KOREA
SP Int Liver Transplantat Soc
C1 [dos Santos, Andrea G.; Stucchi, Raquel S. B.; Boin, Ilka F. S. F.; Ataide, Elaine] State Univ Campinas UNICAMP, Fac Med Sci, Unit Liver Transplantat, Campinas, SP, Brazil.
   [Angerami, Rodrigo] State Univ Campinas UNICAMP, Hosp Clin, Sect Hosp Epidemiol, Campinas, SP, Brazil.
   [Cunha, Mariana S.; Souza, Renato P.] Adolfo Lutz Inst, Div Vector Borne Dis, Sao Paulo, Brazil.
   [Fonseca, Benedito A. L.] Univ Sao Paulo, Sch Med Ribeirao Preto, Div Infect Dis, Dept Internal Med, BR-14049 Ribeirao Preto, SP, Brazil.
RI Angerami, Rodrigo Nogueira/A-8926-2013; Boin, Ilka FSF/C-7811-2009;
   Boin, Ilka/M-7184-2019
OI Angerami, Rodrigo Nogueira/0000-0002-4976-9238; 
NR 0
TC 0
Z9 0
U1 0
U2 57
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD MAY
PY 2016
VL 100
SU 5
MA LB-18
BP S166
EP S166
PG 1
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA DN5QY
UT WOS:000377126400278
DA 2020-07-08
ER

PT J
AU Campos, GC
   Sardi, SI
   Sarno, M
   Brites, C
AF Campos, Gubio C.
   Sardi, Silvia I.
   Sarno, Manoel
   Brites, Carlos
TI Zika virus infection, a new public health challenge
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
ID OUTBREAK
C1 [Campos, Gubio C.; Sardi, Silvia I.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Sarno, Manoel; Brites, Carlos] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
RP Brites, C (corresponding author), Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
EM crbrites@gmail.com
RI sardi, silvia ines/P-9349-2016
OI sardi, silvia ines/0000-0002-2002-8436
CR [Anonymous], 2016, B EP, V47, P3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   WHO/CDC/ICBDSR, 2016, ASS INF MICR CONT ZI
NR 7
TC 4
Z9 4
U1 0
U2 16
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD MAY-JUN
PY 2016
VL 20
IS 3
BP 227
EP 228
DI 10.1016/j.bjid.2016.05.001
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DM6ER
UT WOS:000376443900001
PM 27215946
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU De Carvalho, NS
   De Carvalho, BF
   Fugaca, CA
   Doris, B
   Biscaia, ES
AF De Carvalho, Newton Sergio
   De Carvalho, Beatriz Freitas
   Fugaca, Cyllian Arias
   Doris, Bruna
   Biscaia, Evellyn Silverio
TI Zika virus infection during pregnancy and microcephaly occurrence: a
   review of literature and Brazilian data
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; Microcephaly; Aedes mosquitoes; Pregnancy
ID TRANSMISSION; ISLAND; CHILD
AB In November of 2015, the Ministry of Health of Brazil published an announcement confirming the relationship between Zika virus and the microcephaly outbreak in the Northeast, suggesting that infected pregnant women might have transmitted the virus to their fetuses. The objectives of this study were to conduct a literature review about Zika virus infection and microcephaly, evaluate national and international epidemiological data, as well as the current recommendations for the health teams. Zika virus is an arbovirus, whose main vector is the Aedes sp. The main symptoms of the infection are maculopapular rash, fever, non-purulent conjunctivitis, and arthralgia. Transmission of this pathogen occurs mainly by mosquito bite, but there are also reports via the placenta. Microcephaly is defined as a measure of occipto-frontal circumference being more than two standard deviations below the mean for age and gender. The presence of microcephaly demands evaluation of the patient, in order to diagnose the etiology. Health authorities issued protocols, reports and notes concerning the management of microcephaly caused by Zika virus, but there is still controversy about managing the cases. The Ministry of Health advises notifying any suspected or confirmed cases of children with microcephaly related to the pathogen, which is confirmed by a positive specific laboratory test for the virus. The first choice for imaging exam in children with this malformation is transfontanellar ultrasound. The most effective way to control this outbreak of microcephaly probably caused by this virus is to combat the vector. Since there is still uncertainty about the period of vulnerability of transmission via placenta, the use of repellents is crucial throughout pregnancy. More investigations studying the consequences of this viral infection on the body of newborns and in their development are required. (C) 2016 Elsevier Editora Ltda.
C1 [De Carvalho, Newton Sergio] Univ Fed Parana UFPR, Dept Gynecol & Obstet, Infect Dis Gynecol & Obstet Sect, Clin Hosp, Curitiba, Parana, Brazil.
   [De Carvalho, Newton Sergio] Postgrad Educ Program Obstet, Curitiba, Parana, Brazil.
   [De Carvalho, Newton Sergio] Univ Fed Parana UFPR, Curitiba, Parana, Brazil.
   [De Carvalho, Beatriz Freitas; Fugaca, Cyllian Arias; Doris, Bruna; Biscaia, Evellyn Silverio] Pontificia Univ Catolica Parana PUC PR, Curitiba, Parana, Brazil.
RP De Carvalho, NS (corresponding author), Univ Fed Parana UFPR, Dept Gynecol & Obstet, Infect Dis Gynecol & Obstet Sect, Clin Hosp, Curitiba, Parana, Brazil.; De Carvalho, NS (corresponding author), Postgrad Educ Program Obstet, Curitiba, Parana, Brazil.; De Carvalho, NS (corresponding author), Univ Fed Parana UFPR, Curitiba, Parana, Brazil.
EM newtonsdc@gmail.com
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Brasil, 2015, PROT VIG RESP OC MIC
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, HLTH CAR PROV DIAGN
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2015, MON CAS MICR BRAS IN, P52
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2015, MON CAS MICR BRAS IN, P46
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2009, NORM MAN TECN
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EURO SURVEILL, P2014
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization. World Health Organization, 2015, ZIK VIR ZIK SURV AM
   PARSONSON IM, 1977, INFECT IMMUN, V15, P254, DOI 10.1128/IAI.15.1.254-262.1977
   Sadler TW, 1997, EMBRIOLOGIA MED LANG, P250
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude-Ministerio da Saude, 2015, B EP, P48
   Secretaria estadual de saude de Pernambuco (BR). Secretaria executiva de vigilancia em saude, 2015, PROT CLIN EP INV CAS
   Secretaria Estadual de Saude de Sao Paulo. Coordenadoria deControle de Doencas. Centro de Vigilancia Epidemiologica. Instituto Adolfo Lutz, 2015, 01 SECR EST SAUD SAO, V01
   Secretaria Estadual de Saude do Parana, 2015, 012015I SESA
   Secretaria Estadual de Saude do Parana. Superintendencia devigilancia em saude, 2015, PROT VIG RESP OC MIC
   Sweet RL, 2009, INFECT DIS FEMALE GE, P266
   Vasconcelos P. F. C., 2015, REV PANAMAZ SAUDE, V2, P9
   Wasay M, 2015, NEUROLOGY, V84, P421, DOI 10.1212/WNL.0000000000001177
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 35
TC 32
Z9 32
U1 1
U2 30
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD MAY-JUN
PY 2016
VL 20
IS 3
BP 282
EP 289
DI 10.1016/j.bjid.2016.02.006
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DM6ER
UT WOS:000376443900011
PM 27102780
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cardona-Cardona, AF
   Morales, AJR
AF Cardona-Cardona, Andres F.
   Rodriguez Morales, Alfonso J.
TI Severe abdominal pain in a patient with Zika infection: A case in
   Risaralda, Colombia
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
ID AMERICA
C1 [Cardona-Cardona, Andres F.] Hosp Cristo Rey, Balboa, Risaralda, Colombia.
   [Cardona-Cardona, Andres F.; Rodriguez Morales, Alfonso J.] Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Salud Publ & Infecc, Pereira, Risaralda, Colombia.
   [Rodriguez Morales, Alfonso J.] Org Latinoamer Fomento Invest Salud, Bucaramanga, Santander, Colombia.
RP Morales, AJR (corresponding author), Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Salud Publ & Infecc, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Cardona Cardona, Andres
   Felipe/0000-0002-1361-3514
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Arzusa-Ortega L, 2016, EMERG INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Duran A, 2013, INVEST CLIN, V54, P299
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Oehler E, 2014, EURO SURVEILL, V19
   Pinho SC, 2013, REV SOC BRAS MED TRO, V46, P765
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
NR 11
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAY-JUN
PY 2016
VL 9
IS 3
BP 372
EP 373
DI 10.1016/j.jiph.2016.03.001
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DM6LM
UT WOS:000376463900027
PM 27005012
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhang, HM
   Srinivas, S
   Li, DF
   Feng, YJ
AF Zhang, Huimin
   Srinivas, Swaminath
   Li, Defeng
   Feng, Youjun
TI Origin, dissemination and entry of the pandemic Zika viruses
SO SCIENCE BULLETIN
LA English
DT Article
DE Zika virus; Flavivirus; Dissemination; Entry; Origin
ID FRENCH-POLYNESIA; OUTBREAK
AB Zika virus (ZIKV) is a previously-neglected, but newly-emerging zoonotic pathogen that has swept most of the western hemisphere. The unexpected attention aroused worldwide lies in the explosive spread of ZIKV to Brazil and USA in 2015 and its rare correlation to microcephaly in newborns, raising a serious challenge to public health. We show the origin and fast dissemination of these epidemic ZIKA isolates. Phylogenetic analyses revealed that all the newly-emerging ZIKV isolates belong to the Asian-American Lineage. Structural analyses of the ZIKV E surface protein suggested that it might adopt a similar entry mechanism to that of other Flavi-viruses like Dengue Virus and West Nile Virus.
C1 [Zhang, Huimin; Feng, Youjun] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Peoples R China.
   [Zhang, Huimin] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Srinivas, Swaminath] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
   [Li, Defeng] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.
RP Feng, YJ (corresponding author), Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Peoples R China.
EM fengyj@zju.edu.cn
OI Srinivas, Swaminath/0000-0002-7210-5122
FU Zhejiang Provincial Natural Science Foundation for Distinguished Young
   Scholars [LR15H190001]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31570027]; Zhejiang
   University; "Young 1000 Talents'' Award
FX This work was supported by Zhejiang Provincial Natural Science
   Foundation for Distinguished Young Scholars (LR15H190001), the National
   Natural Science Foundation of China (31570027), and the start-up package
   from Zhejiang University (Y.F.). Dr. Feng is a recipient of the "Young
   1000 Talents'' Award.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 13
TC 1
Z9 1
U1 0
U2 76
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2095-9273
EI 2095-9281
J9 SCI BULL
JI Sci. Bull.
PD MAY
PY 2016
VL 61
IS 10
BP 749
EP 751
DI 10.1007/s11434-016-1068-0
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM5SR
UT WOS:000376410900002
OA Bronze
DA 2020-07-08
ER

PT J
AU Shakib, K
AF Shakib, Kaveh
TI Epidemic of Zika virus and maxillofacial surgery
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Editorial Material
DE Zika virus; Microcephaly; Guillain Barre syndrome; Virus induced
   congenital malformation
AB Zika is a RNA virus spread by the ubiquitous Aedes mosquitoes. It was first discovered in Uganda in 1947, and arrived in south-east Asia by the middle of the 20th century. In 2014 the virus started to spread across the Pacific Islands to reach South America. Since then it has spread rapidly northwards, and reached Mexico and the Caribbean in November 2015. Clinically it presents as a self-limiting febrile illness. However, there is increasing evidence of a link between Zika virus and the Guillain-Barre syndrome, and maternal Zika virus infection and microcephaly of the fetus. (C) 2016 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Shakib, Kaveh] Univ London Royal Free Hosp, Dept Oral & Maxillofacial Surg, London, England.
RP Shakib, K (corresponding author), Univ London Royal Free Hosp, Dept Oral & Maxillofacial Surg, London, England.
EM k.shakib@nhs.net
CR [Anonymous], BBC NEWS
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Gatherer D, 2015, J GEN VIROL
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Public Health England, ZIK VIR TRAV ADV PRE
   Ventura CV, 2016, LANCET
   World Health Organization, GUILL BARR SYNDR SAL
   World Health Organization, ZIK VIR FACTSH
NR 10
TC 2
Z9 2
U1 0
U2 58
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
EI 1532-1940
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD MAY
PY 2016
VL 54
IS 4
BP 355
EP 357
DI 10.1016/j.bjoms.2016.02.001
PG 3
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA DL8GE
UT WOS:000375878400001
PM 26907929
DA 2020-07-08
ER

PT J
AU Granato, C
   Lazari, C
   Serafini, PC
AF Granato, Celso
   Lazari, Carolina
   Serafini, Paulo C.
TI New threat on the horizon: The Zika virus
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
ID BRAZIL; TRANSMISSION; OUTBREAK; INFECTION
C1 [Granato, Celso] Univ Fed Sao Paulo, Discipline Infect Dis, Sao Paulo, Brazil.
   [Granato, Celso; Lazari, Carolina] Fleury Med Grp, Sao Paulo, Brazil.
   [Lazari, Carolina] Univ Sao Paulo, Fac Med, Dept Infect Dis, BR-04501000 Sao Paulo, SP, Brazil.
   [Serafini, Paulo C.] Univ Sao Paulo, Discipline Gynecol, Dept Obstet & Gynecol, BR-04501000 Sao Paulo, SP, Brazil.
   [Serafini, Paulo C.] Huntington Reprod Med, Reprod Endocrinol, Sao Paulo, Brazil.
   [Serafini, Paulo C.] Univ Sao Paulo, Human Reprod Serv, BR-04501000 Sao Paulo, SP, Brazil.
RP Serafini, PC (corresponding author), Univ Sao Paulo, Huntington Med Reprod, Disciplina Ginecol, Fac Med, Ave Republ Libano 529, BR-04501000 Sao Paulo, SP, Brazil.
EM pauloivf@aol.com
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Besnard M, 2014, EURO SURVEILL, V19
   Brazilian Ministry of Health, 2016, SE07201614A20022016
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, N ENGL J MED
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EURO SURVEILL, V19
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Waggoner JJ, J CLIN MICROBIOL
   World Health Organization, 2017, PREV POT SEX TRANSM
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 1
Z9 1
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAY
PY 2016
VL 133
IS 2
BP 137
EP 138
DI 10.1016/j.ijgo.2016.03.006
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DL6HE
UT WOS:000375739500002
PM 27058990
DA 2020-07-08
ER

PT J
AU Harris, LH
   Silverman, NS
   Marshall, MF
AF Harris, Lisa H.
   Silverman, Neil S.
   Marshall, Mary Faith
TI The Paradigm of the Paradox: Women, Pregnant Women, and the Unequal
   Burdens of the Zika Virus Pandemic
SO AMERICAN JOURNAL OF BIOETHICS
LA English
DT Editorial Material
C1 [Harris, Lisa H.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.
   [Silverman, Neil S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Marshall, Mary Faith] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Marshall, Mary Faith] Univ Virginia, Sch Nursing, Charlottesville, VA 22908 USA.
RP Marshall, MF (corresponding author), Univ Virginia, Sch Nursing, Charlottesville, VA 22908 USA.; Marshall, MF (corresponding author), Univ Virginia, Sch Med, Ctr Biomed Eth & Humanities, POB 800758, Charlottesville, VA 22908 USA.
EM mfm@virginia.edu
CR Ahmed Azam, 2016, NY TIMES
   Boorstein M., 2016, WASHINGTON POST
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control, 2016, MORBIDITY MORTALITY
   DeBruin D, 2012, AM J PUBLIC HEALTH, V102, P586, DOI 10.2105/AJPH.2011.300483
   Diniz D., 2016, NY TIMES
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Farmer P, 1999, INFECT INEQUALITIES
   Guttmacher Institute, 2015, FACT SHEET CONTR US
   Martines Roosecelis Brasil, 2016, MMWR Morb Mortal Wkly Rep, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melhado L., 2013, INT PERSPECT SEX R H, V39, P163
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   World Health Organization, 2016, ZIK VIR POT COMPL QU
   Zielinksi A., 2016, THINK PROGR
NR 15
TC 20
Z9 21
U1 0
U2 11
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1526-5161
EI 1536-0075
J9 AM J BIOETHICS
JI Am. J. Bioeth.
PD MAY
PY 2016
VL 16
IS 5
BP 1
EP 4
DI 10.1080/15265161.2016.1177367
PG 4
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA DK4TA
UT WOS:000374911100002
PM 27111356
OA Bronze
DA 2020-07-08
ER

PT J
AU Reefhuis, J
   Gilboa, SM
   Johansson, MA
   Valencia, D
   Simeone, RM
   Hills, SL
   Polen, K
   Jamieson, DJ
   Petersen, LR
   Honein, MA
AF Reefhuis, Jennita
   Gilboa, Suzanne M.
   Johansson, Michael A.
   Valencia, Diana
   Simeone, Regina M.
   Hills, Susan L.
   Polen, Kara
   Jamieson, Denise J.
   Petersen, Lyle R.
   Honein, Margaret A.
TI Projecting Month of Birth for At-Risk Infants after Zika Virus Disease
   Outbreaks
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UPDATE INTERIM GUIDELINES; UNITED-STATES; INFECTION; BRAZIL
AB The marked increase in infants born with microcephaly in Brazil after a 2015 outbreak of Zika virus disease suggests an association between maternal Zika virus infection and congenital microcephaly. To project the timing of delivery of infants born to mothers infected during early pregnancy in 1 city in Bahia State, Brazil, we incorporated data on reported Zika cases and microcephaly cases into a graphical schematic of weekly birth cohorts. We projected that these births would occur through February 2016. Applying similar projections to a hypothetical location at which Zika virus transmission started in November, we projected that full term infants at risk for Zika virus infection would be born during April September 2016. We also developed a modifiable spreadsheet tool that public health officials and researchers can use for their countries to plan for deliveries of infants to women who were infected with Zika virus during different pregnancy trimesters.
C1 [Reefhuis, Jennita; Gilboa, Suzanne M.; Johansson, Michael A.; Valencia, Diana; Simeone, Regina M.; Polen, Kara; Jamieson, Denise J.; Honein, Margaret A.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E86, Atlanta, GA 30329 USA.
   [Hills, Susan L.; Petersen, Lyle R.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Reefhuis, J (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E86, Atlanta, GA 30329 USA.
EM nzr5@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201; Johansson,
   Michael/0000-0002-5090-7722
CR [Anonymous], 2015, EPIDEMIOLOGICAL ALER
   Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bodeus M, 2010, J CLIN VIROL, V47, P201, DOI 10.1016/j.jcv.2009.11.009
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cha A., 2016, WASHINGTON POST
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, RAPID RISK ASSESSMEN
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Live Birth Information System Brazil (SINASC), LIVE BIRTH DATA FOR
   Live Birth Information System Brazil (SINASC), MICROCEPHALY IN BRAZ
   Live Birth Information System Brazil (SINASC), PANEL, V3
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER E, 1982, LANCET, V2, P781
   Ministry of Health Brazil, MONITORAMENTO DOS CA
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Pan American Health Organization World Health Organization, COUNTRIES AND TERRIT
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2016, IHR PROCEDURES CONCE
NR 23
TC 28
Z9 29
U1 0
U2 28
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 828
EP 832
DI 10.3201/eid2205.160290
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100008
PM 27088494
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cao-Lormeau, VM
AF Van-Mai Cao-Lormeau
TI Tropical Islands as New Hubs for Emerging Arboviruses
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID CHIKUNGUNYA VIRUS; ZIKA VIRUS; TRANSMISSION
C1 [Van-Mai Cao-Lormeau] Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, France.
RP Cao-Lormeau, VM (corresponding author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, France.
EM mlormeau@ilm.pf
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 10
TC 16
Z9 19
U1 0
U2 12
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 913
EP 915
DI 10.3201/eid2205.150547
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100027
PM 27088243
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Atkinson, B
   Hearn, P
   Afrough, B
   Lumley, S
   Carter, D
   Aarons, EJ
   Simpson, AJ
   Brooks, TJ
   Hewson, R
AF Atkinson, Barry
   Hearn, Pasco
   Afrough, Babak
   Lumley, Sarah
   Carter, Daniel
   Aarons, Emma J.
   Simpson, Andrew J.
   Brooks, Timothy J.
   Hewson, Roger
TI Detection of Zika Virus in Semen
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Atkinson, Barry; Hearn, Pasco; Afrough, Babak; Lumley, Sarah; Carter, Daniel; Aarons, Emma J.; Simpson, Andrew J.; Brooks, Timothy J.; Hewson, Roger] Publ Hlth England, Porton Down, England.
   [Brooks, Timothy J.; Hewson, Roger] Natl Inst Hlth Res, Liverpool, Merseyside, England.
RP Atkinson, B (corresponding author), Publ Hlth England, Porton Manor Farm Rd, Salisbury SP4 0JG, Wilts, England.
EM barry.atkinson@phe.gov.uk
RI Lumley, Sarah/I-1057-2019
OI Lumley, Sarah/0000-0002-8605-3650; Carter, Daniel/0000-0002-8021-9277;
   Afrough, Babak/0000-0002-6651-1239; Atkinson, Barry/0000-0002-1348-7204;
   Hearn, Pasco/0000-0001-8060-3183
CR Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization, 2016, REP INCR CONG MICR O
NR 3
TC 201
Z9 209
U1 0
U2 33
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 940
EP 940
DI 10.3201/eid2205.160107
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100042
PM 27088817
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jampol, LM
   Goldstein, DA
AF Jampol, Lee M.
   Goldstein, Debra A.
TI Zika Virus Infection and the Eye
SO JAMA OPHTHALMOLOGY
LA English
DT Editorial Material
C1 [Jampol, Lee M.; Goldstein, Debra A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, 645 N Michigan Ave,Ste 440, Chicago, IL 60611 USA.
RP Jampol, LM (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, 645 N Michigan Ave,Ste 440, Chicago, IL 60611 USA.
EM l-jampol@northwestern.edu
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Boze B; Vector Disease Control International, ZIKA VIRUS EMERGING
   Centers for Disease Control and Prevention, ZIK VIR
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 8
TC 21
Z9 23
U1 0
U2 74
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAY
PY 2016
VL 134
IS 5
BP 535
EP 536
DI 10.1001/jamaophthalmol.2016.0284
PG 3
WC Ophthalmology
SC Ophthalmology
GA DL7CB
UT WOS:000375796100015
PM 26865476
OA Bronze
DA 2020-07-08
ER

PT J
AU Wooton, AK
AF Wooton, Angela K.
TI Zika Virus: An Emerging Threat to Travelers
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Editorial Material
C1 [Wooton, Angela K.] Univ So Indiana, Nursing, 8600 Univ Blvd, Evansville, IN 47712 USA.
RP Wooton, AK (corresponding author), Univ So Indiana, Nursing, 8600 Univ Blvd, Evansville, IN 47712 USA.
EM awooton57@gmail.com
OI Wooton, Angela/0000-0002-1992-2174
CR AccessScience Editors, 2016, SPREAD ZIK VIR DIS
   US Centers for Disease Control and Prevention, 2016, ZIK VIR
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD MAY
PY 2016
VL 12
IS 5
BP E237
EP E238
DI 10.1016/j.nurpra.2016.02.016
PG 2
WC Nursing
SC Nursing
GA DL4LH
UT WOS:000375607100012
DA 2020-07-08
ER

PT J
AU Zanluca, C
   dos Santos, CND
AF Zanluca, Camila
   Duarte dos Santos, Claudia Nunes
TI Zika virus - an overview
SO MICROBES AND INFECTION
LA English
DT Review
DE Zika virus; Flavivirus; Arthropod-borne virus; Viral emergence
ID SEXUAL TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; MOSQUITOS;
   ARBOVIRUSES; INFECTION; OUTBREAK; VECTOR; BRAZIL; FEVER
AB Zika virus (ZIKV) is currently one of the most important emerging viruses in the world. Recently, it has caused outbreaks and epidemics, and has been associated with severe clinical manifestations and congenital malformations. However to date, little is known about the pathogenicity of the virus and the consequences of ZIKV infection. In this paper, we provide an overview of the current knowledge on ZIKV. (C) 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Mol Virol Lab, Curitiba, Parana, Brazil.
RP dos Santos, CND (corresponding author), Inst Carlos Chagas ICC Fiocruz, CIC, Rua Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
RI Duarte dos Santos, Claudia/E-1857-2018; Santos, Claudia Duarte
   dos/P-4868-2019
OI Duarte dos Santos, Claudia/0000-0001-8707-6638; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; Zanluca, Camila/0000-0001-7350-9105
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2012, EMERG INFECT DIS, V2015, P722
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire CCM, 2015, SPREAD PANDEMIC ZIKA, V2015, P1
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2010, EMERG INFECT DIS, V2012, P349
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   ICTV. International comittee on taxonomy of viruses, 2014, VIRUS TAXONOMY
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kutsuna S, 2014, EURO SURVEILL, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P7
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PAHO: Pan American Health Organization, 2016, CHIK
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pond WL, 1963, T R SOC TROP MED HYG, V57, P364
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2013, EURO SURVEILL, V19
   Tognarelli J, 2015, ARCH VIROL
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 79
TC 46
Z9 50
U1 0
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAY
PY 2016
VL 18
IS 5
BP 295
EP 301
DI 10.1016/j.micinf.2016.03.003
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DL3XY
UT WOS:000375568200001
PM 26993028
OA Bronze
DA 2020-07-08
ER

PT J
AU Ogden, SC
   Hammack, C
   Tang, HL
AF Ogden, Sarah C.
   Hammack, Christy
   Tang, Hengli
TI Zika virus and neural developmental defects: building a case for a cause
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Editorial Material
C1 [Ogden, Sarah C.; Hammack, Christy; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
RP Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
EM tang@bio.fsu.edu
CR Brasil P., 2016, NEW ENGL J MED, DOI [10.1056/NEIMoa1602412, DOI 10.1056/NEIMOA1602412]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617
NR 10
TC 1
Z9 1
U1 0
U2 62
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD MAY
PY 2016
VL 59
IS 5
BP 536
EP 538
DI 10.1007/s11427-016-5053-2
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DL8II
UT WOS:000375885300013
PM 27066795
OA Other Gold
DA 2020-07-08
ER

PT J
AU Waxman, MA
AF Waxman, Matthew A.
TI Update on Emerging Infections: News From the Centers for Disease Control
   and Prevention
SO ANNALS OF EMERGENCY MEDICINE
LA English
DT Editorial Material
ID ZIKA VIRUS OUTBREAK; STATES
C1 [Waxman, Matthew A.] Olive View UCLA Med Ctr, Dept Emergency Med, 14445 Olive View Dr, Sylmar, CA 91342 USA.
RP Waxman, MA (corresponding author), Olive View UCLA Med Ctr, Dept Emergency Med, 14445 Olive View Dr, Sylmar, CA 91342 USA.
CR [Anonymous], 2016, ZIK VIR INF
   Centers for Disease Control and Prevention, 2015, CHIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nasci RS, 2015, CDC HLTH INFORM INT
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 0
Z9 0
U1 0
U2 57
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-0644
EI 1097-6760
J9 ANN EMERG MED
JI Ann. Emerg. Med.
PD MAY
PY 2016
VL 67
IS 5
BP 645
EP 647
DI 10.1016/j.annemergmed.2016.02.022
PG 3
WC Emergency Medicine
SC Emergency Medicine
GA DL1DU
UT WOS:000375373200019
OA Bronze
DA 2020-07-08
ER

PT J
AU Palomo, AM
AF Martinez Palomo, Adolfo
TI Zika virus: An international emergency?
SO JOURNAL OF PUBLIC HEALTH POLICY
LA English
DT Editorial Material
DE Zika virus; public health emergency of international concern; women's
   health; microcephaly; mosquito
AB This Viewpoint discusses the World Health Organization's Declaration on 1 February 2016 that the epidemic infection caused by the Zika virus is a public health emergency of international concern - the basis of the decision and controversy surrounding it.
C1 [Martinez Palomo, Adolfo] Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
RP Palomo, AM (corresponding author), Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
EM amartine@cinvestav.mx
NR 0
TC 1
Z9 1
U1 1
U2 64
PU PALGRAVE MACMILLAN LTD
PI BASINGSTOKE
PA BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND
SN 0197-5897
EI 1745-655X
J9 J PUBLIC HEALTH POL
JI J. Public Health Policy
PD MAY
PY 2016
VL 37
IS 2
BP 133
EP 135
DI 10.1057/jphp.2016.11
PG 3
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DK7XS
UT WOS:000375140800002
PM 26911655
DA 2020-07-08
ER

PT J
AU Vasconcelos, PFC
   Calisher, CH
AF Vasconcelos, Pedro F. C.
   Calisher, Charles H.
TI Emergence of Human Arboviral Diseases in the Americas, 2000-2016
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Review
DE Arbovirus; Bourbon; Cache Valley; Chikungunya; Emerging; Heartland;
   Iquitos; Mayaro; Powassan; The Americas; Zika; Zoonoses
ID CACHE VALLEY VIRUS; BUNYAMWERA SEROGROUP VIRUSES; ZIKA VIRUS;
   UNITED-STATES; CHIKUNGUNYA VIRUS; OROPOUCHE VIRUS; FEBRILE ILLNESS;
   OUTBREAK; TRANSMISSION; ENCEPHALITIS
AB In addition to individual or clusters of cases of human infections with arboviruses, the past 15 years has seen the emergence of newly recognized arboviruses and the re-emergence of others. Mentioned in this brief summary are Bourbon, Cache Valley, chikungunya, Heartland, Itaqui, Mayaro, Oropouche, Powassan, and Zika viruses, the latter being a remarkable occurrence.
C1 [Vasconcelos, Pedro F. C.] Brazilian Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
   [Vasconcelos, Pedro F. C.] Univ Para State, Dept Pathol, Belem, Para, Brazil.
   [Calisher, Charles H.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, 3195 Rampart Rd,Delivery Code 1690, Ft Collins, CO 80523 USA.
RP Calisher, CH (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, 3195 Rampart Rd,Delivery Code 1690, Ft Collins, CO 80523 USA.
EM calisher@cybersafe.net
RI Vasconcelos, Pedro/AAH-3142-2019
CR Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   CALISHER CH, 1986, AM J TROP MED HYG, V35, P429, DOI 10.4269/ajtmh.1986.35.429
   CALISHER CH, 1995, EMERG INFECT DIS, V1, P147, DOI 10.3201/eid0104.950409
   Campbell GL, 2006, EMERG INFECT DIS, V12, P854, DOI 10.3201/eid1205.051625
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CHUMAKOV MP, 1963, ACTA VIROL, V7, P82
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EDWARDS JF, 1989, VET PATHOL, V26, P33, DOI 10.1177/030098588902600106
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022
   HOLDEN P, 1959, SCIENCE, V130, P1187, DOI 10.1126/science.130.3383.1187
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kosoy OI, 2015, EMERG INFECT DIS, V21, P760, DOI 10.3201/eid2105.150150
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McLEAN D M, 1959, Can Med Assoc J, V80, P708
   McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen NL, 2013, J CLIN MICROBIOL, V51, P1966, DOI 10.1128/JCM.00252-13
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P270
   Pinheiro FM, 1962, REV SERV ESP SAUDE P, V12, P15
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Rodriguez-Roche R, 2016, J VIROL, DOI [10.1128/JVI.02647.15, DOI 10.1128/JVI.02647.15]
   Rothman AL, 2016, J INFECT DIS, V214, P825, DOI 10.1093/infdis/jiw068
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209
   Sexton DJ, 1997, NEW ENGL J MED, V336, P547, DOI 10.1056/NEJM199702203360804
   Tavakolipoor P, 2016, TRAVEL MED INFECT DI, V14, P39, DOI 10.1016/j.tmaid.2016.01.007
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Vedovello D, 2015, ARCH VIROL, V160, P1189, DOI 10.1007/s00705-015-2378-2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wang LF, 2014, REV SCI TECH OIE, V33, P569, DOI 10.20506/rst.33.2.2311
   World Health Organization Food and Agriculture Organization of the United Nations and World Organization for Animal Health, 2004, WHO FAO OIE JOINT CO
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
NR 51
TC 44
Z9 47
U1 1
U2 55
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 295
EP 301
DI 10.1089/vbz.2016.1952
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DK3RZ
UT WOS:000374836400001
PM 26991057
DA 2020-07-08
ER

PT J
AU Gardner, LM
   Chen, N
   Sarkar, S
AF Gardner, Lauren M.
   Chen, Nan
   Sarkar, Sahotra
TI Global risk of Zika virus depends critically on vector status of Aedes
   albopictus
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Gardner, Lauren M.; Chen, Nan] Univ New South Wales Australia, Sydney, NSW, Australia.
   [Sarkar, Sahotra] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
RP Gardner, LM (corresponding author), Univ New South Wales Australia, Sydney, NSW, Australia.
EM l.gardner@unsw.edu.au
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Gardner LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/103679
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), 2016, WHO SIT REP ZIK VIR
NR 6
TC 39
Z9 43
U1 0
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 522
EP 523
DI 10.1016/S1473-3099(16)00176-6
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DJ5TL
UT WOS:000374272900014
PM 26997578
OA Bronze
DA 2020-07-08
ER

PT J
AU Baud, D
   Van Mieghem, T
   Musso, D
   Truttmann, AC
   Panchaud, A
   Vouga, M
AF Baud, David
   Van Mieghem, Tim
   Musso, Didier
   Truttmann, Anita C.
   Panchaud, Alice
   Vouga, Manon
TI Clinical management of pregnant women exposed to Zika virus
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Baud, David; Vouga, Manon] Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Baud, David; Vouga, Manon] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Baud, David; Vouga, Manon] Univ Lausanne Hosp, Lausanne, Switzerland.
   [Van Mieghem, Tim] Univ Hosp Leuven, Div Woman & Child, Dept Obstet & Gynecol, Leuven, Belgium.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
   [Truttmann, Anita C.] Univ Lausanne Hosp, Dept Femme Mere Enfant, Clin Neonatol, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Swiss Teratogen Informat Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
RP Baud, D (corresponding author), Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Musso, Didier/AAO-8178-2020; Panchaud, Alice/S-6535-2019; Musso,
   Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Panchaud, Alice/0000-0001-6086-2401;
   Musso, Didier/0000-0002-9226-0971; Baud, David/0000-0001-9914-6496
CR Calvet G., 2016, LANCET INFECT DIS
   Musso D, 2016, LANCET INFECT DIS
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
NR 5
TC 25
Z9 25
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 523
EP 523
DI 10.1016/S1473-3099(16)30008-1
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DJ5TL
UT WOS:000374272900015
PM 27056096
OA Bronze
DA 2020-07-08
ER

PT J
AU Triunfol, M
AF Triunfol, Marcia
TI Microcephaly in Brazil: confidence builds in Zika connection
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 6
Z9 6
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 527
EP +
DI 10.1016/S1473-3099(16)30015-9
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DJ5TL
UT WOS:000374272900019
PM 27599648
DA 2020-07-08
ER

PT J
AU Bourtzis, K
   Lees, RS
   Hendrichs, J
   Vreysen, MJB
AF Bourtzis, Kostas
   Lees, Rosemary Susan
   Hendrichs, Jorge
   Vreysen, Marc J. B.
TI More than one rabbit out of the hat: Radiation, transgenic and
   symbiont-based approaches for sustainable management of mosquito and
   tsetse fly populations
SO ACTA TROPICA
LA English
DT Review
DE Mosquitoes; Tsetse flies; Vectors; Sterile insect technique; Wolbachia;
   Sodalis
ID GLOSSINA-PALPALIS-GAMBIENSIS; ALBOPICTUS DIPTERA-CULICIDAE; STERILE
   INSECT TECHNIQUE; STANDARD OPERATING PROCEDURES; MALARIA VECTOR
   MOSQUITO; YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; ANOPHELES-ARABIENSIS;
   CYTOPLASMIC INCOMPATIBILITY; GENOME SEQUENCE
AB Mosquitoes (Diptera: Culicidae) and tsetse flies (Diptera: Glossinidae) are bloodsucking vectors of human and animal pathogens. Mosquito-borne diseases (malaria, filariasis, dengue, zika, and chikungunya) cause severe mortality and morbidity annually, and tsetse fly-borne diseases (African trypanosomes causing sleeping sickness in humans and nagana in livestock) cost Sub-Saharan Africa an estimated US$ 4750 million annually. Current reliance on insecticides for vector control is unsustainable: due to increasing insecticide resistance and growing concerns about health and environmental impacts of chemical control there is a growing need for novel, effective and safe biologically-based methods that are more sustainable. The integration of the sterile insect technique has proven successful to manage crop pests and disease vectors, particularly tsetse flies, and is likely to prove effective against mosquito vectors, particularly once sex-separation methods are improved. Transgenic and symbiont-based approaches are in development, and more advanced in (particularly Aedes) mosquitoes than in tsetse flies; however, issues around stability, sustainability and biosecurity have to be addressed, especially when considering population replacement approaches. Regulatory issues and those relating to intellectual property and economic cost of application must also be overcome. Standardised methods to assess insect quality are required to compare and predict efficacy of the different approaches. Different combinations of these three approaches could be integrated to maximise their benefits, and all have the potential to be used in tsetse and mosquito area-wide integrated pest management programmes. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Bourtzis, Kostas; Lees, Rosemary Susan; Hendrichs, Jorge; Vreysen, Marc J. B.] Joint FAO IAEA Div Nucl Techn Food & Agr, Insect Pest Control Subprogramme, Vienna, Austria.
RP Bourtzis, K (corresponding author), Joint FAO IAEA Div Nucl Techn Food & Agr, Insect Pest Control Subprogramme, Vienna, Austria.
EM K.Bourtzis@iaea.org; R.S.Lees@iaea.org; J.Hendrichs@iaea.org;
   M.Vreysen@iaea.org
RI Lees, Rosemary Susan/H-3425-2019
OI Lees, Rosemary Susan/0000-0002-4232-9125
CR Abd-Alla AMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061875
   Abd-Alla AMM, 2013, J INVERTEBR PATHOL, V112, pS2, DOI 10.1016/j.jip.2012.07.009
   Abd-Alla AMM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001220
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Ageep TB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-484
   AKRAM M, 1975, Pakistan Journal of Zoology, V7, P177
   Alam U, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002415
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384
   Alsan M, 2015, AM ECON REV, V105, P382, DOI 10.1257/aer.20130604
   Alvarez L., 2015, NY TIMES
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   ARUNACHALAM N, 1985, J MED ENTOMOL, V22, P648, DOI 10.1093/jmedent/22.6.648
   Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288
   Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440
   Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296
   Balestrino F, 2014, J MED ENTOMOL, V51, P155, DOI 10.1603/ME13130
   Balestrino F, 2012, J MED ENTOMOL, V49, P595, DOI 10.1603/ME11188
   Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914
   Balestrino F, 2011, J AM MOSQUITO CONTR, V27, P227, DOI 10.2987/10-6085.1
   Balestrino F, 2010, J AM MOSQUITO CONTR, V26, P365, DOI 10.2987/10-6008.1
   Barclay HJ, 2013, POPUL ECOL, V55, P53, DOI 10.1007/s10144-012-0339-0
   Barclay HJ, 2011, POPUL ECOL, V53, P89, DOI 10.1007/s10144-010-0224-7
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Bernardini F, 2014, P NATL ACAD SCI USA, V111, P7600, DOI 10.1073/pnas.1404996111
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bohannon J, 2015, SCIENCE, V347, P1300, DOI 10.1126/science.347.6228.1300
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Bourtzis K., 2007, P125, DOI 10.1007/978-1-4020-6059-5_11
   BOURTZIS K, 2006, INSECT SYMBIOSIS, V2, P225
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Bouyer F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003112
   Bouyer J, 2013, PREV VET MED, V112, P443, DOI 10.1016/j.prevetmed.2013.05.017
   Bouyer J, 2010, J MED ENTOMOL, V47, P543, DOI 10.1603/ME09149
   Brelsfoard C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002728
   Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38
   Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129
   Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432
   Caceres C., 2002, P 6 INT FRUIT FLY S, P367
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254
   Capone A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-182
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023
   Cecchi G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-39
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Chen B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-314
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748
   Crain PR, 2013, J MED ENTOMOL, V50, P1152, DOI 10.1603/ME12263
   Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289
   DARROW DI, 1968, MOSQ NEWS, V28, P21
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   De Vooght L, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0156-6
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Dicko AH, 2014, P NATL ACAD SCI USA, V111, P10149, DOI 10.1073/pnas.1407773111
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Donnelly B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0822-0
   Doudoumis V, 2013, J INVERTEBR PATHOL, V112, pS94, DOI 10.1016/j.jip.2012.05.010
   Dyck V. A., 2000, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V53, P239
   Eckermann KN, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S17
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001
   Fas Kuzoe, 2005, TDRIDETRY051 WHO
   Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Favia G, 2014, CABI BIOTECH SER, P227, DOI 10.1079/9781780644516.0227
   FAY R. W., 1959, MOSQUITO NEWS, V19, P144
   Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27
   Feldmann U., 2013, BIOTECHNOLOGIES WORK, P125
   FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567
   Food and Agriculture Organization of the United Nations, 2005, INT STAND PHYT MEAS
   Food and Agriculture Organization of the United Nations, 2014, SEN NEARS 1 VICT WAR
   Food and Agriculture Organization of the United Nations, 2014, PAAT THE DIS
   Food and Agriculture Organization of the United Nations International Atomic Energy Agency United States Department of Agriculture, 2015, PROD QUAL CONTR STER
   Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107
   Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7
   Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977
   Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273
   Handler AM, 2009, MED VET ENTOMOL, V23, P98, DOI 10.1111/j.1365-2915.2008.00773.x
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Hughes GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004182
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Insect Pest Control Laboratory Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, 2015, STAND OP PROC DET MA
   Iyaloo DP, 2014, ACTA TROP, V132, pS140, DOI 10.1016/j.actatropica.2013.11.011
   Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743
   Jiang XF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0459-2
   Joint FAO/1AEA Programme Nuclear Techniques in Food and Agriculture, 2013, INS PEST CONTR NEWSL
   Joint FAO/IAEA Programme Nuclear Techniques in Food and Agriculture, 2015, INS PEST CONTR
   Joint FAO/IAEA Programme Nuclear Techniques in Food and Agriculture, 2014, FAO IAEA ASS GOV SEN
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kassam R, 2015, ACTA TROP, V152, P252, DOI 10.1016/j.actatropica.2015.07.028
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2
   Klein TA, 2012, PATHOG GLOB HEALTH, V106, P20, DOI 10.1179/2047773212Y.0000000003
   KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902
   Labbe GMC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001724
   Lampe DJ, 2014, CABI BIOTECH SER, P208, DOI 10.1079/9781780644516.0208
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Lindh JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000474
   Long SA, 2015, J VECTOR ECOL, V40, P139, DOI 10.1111/jvec.12142
   Lowe R. E., 1981, CYTOGENETICS GENETIC, P231
   Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020
   Marinotti O, 2013, NUCLEIC ACIDS RES, V41, P7387, DOI 10.1093/nar/gkt484
   Marinotti O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-142
   Marois E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-302
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Medici A, 2011, J ECON ENTOMOL, V104, P266, DOI 10.1603/EC10108
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Mubarqui RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103077
   Muhanguzi D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003284
   Munhenga G, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-27
   Munhenga G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-208
   Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932
   Mutika GN, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0465-y
   Mutika GN, 2013, ENTOMOL EXP APPL, V146, P177, DOI 10.1111/j.1570-7458.2012.01305.x
   Ndeledje N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067580
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   North American Plant Protection Organization (NAPPO), 2007, NAPPO REG STAND PHYT, P27
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Okamoto KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081860
   Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Pagabeleguem S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0869-3
   Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111
   Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011
   Qualls WA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0819-8
   Reid W, 2016, CURR OPIN INSECT SCI, V13, P43, DOI 10.1016/j.cois.2015.11.001
   Ren XX, 2014, PEERJ, V2, DOI 10.7717/peerj.584
   Ricci I, 2011, ENVIRON MICROBIOL, V13, P911, DOI 10.1111/j.1462-2920.2010.02395.x
   Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3
   Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008
   Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P727, DOI 10.1007/1-4020-4051-2_28
   Roll Back Malaria Partnership/UNDP, 2013, MULT ACT FRAM MAL
   Scott MJ, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S3
   Scott TW, 2006, WAG UR FRON, V11, P171, DOI 10.1007/1-4020-3799-6_16
   Seck MT, 2010, PARASITE, V17, P257, DOI 10.1051/parasite/2010173257
   Shaw APM, 2013, PREV VET MED, V112, P447, DOI 10.1016/j.prevetmed.2013.08.001
   Shaw APM, 2013, PREV VET MED, V110, P290, DOI 10.1016/j.prevetmed.2012.12.014
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387
   Sinkins SP, 2000, INSECT TRANSGENESIS, P271
   Snyder AK, 2013, J BACTERIOL, V195, P4322, DOI 10.1128/JB.00487-13
   Solano P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000692
   Sow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037124
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Van den Abbeele J, 2013, J INVERTEBR PATHOL, V112, pS142, DOI 10.1016/j.jip.2012.07.020
   Vavre F, 2012, CURR OPIN MICROBIOL, V15, P263, DOI 10.1016/j.mib.2012.03.005
   Vreysen MJB, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P325, DOI 10.1007/1-4020-4051-2_12
   Vreysen M. J. B., 2007, P723, DOI 10.1007/978-1-4020-6059-5_66
   Vreysen MJB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002857
   Vreysen MJB, 2013, J INVERTEBR PATHOL, V112, pS15, DOI 10.1016/j.jip.2012.07.026
   Vreysen MJB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000907
   Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123
   WAKID AM, 1976, Z ANGEW ENTOMOL, V80, P311
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001
   Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109
   Ward CM, 2011, EVOLUTION, V65, P1149, DOI 10.1111/j.1558-5646.2010.01186.x
   Watanabe J, 2014, SCIENCE, V344, P380, DOI 10.1126/science.1249656
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101210
   WHO, 2015, TRYP HUM AFR SLEEP S
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Windbichler N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000291
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
   World Health Organisation, 2015, LYMPH FIL FACT SHEET
   World Health Organization, 2014, VECT BORN DIS
   Yahouedo GA, 2014, ACTA TROP, V132, pS96, DOI 10.1016/j.actatropica.2013.11.014
   Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223
   Yamada H, 2015, ACTA TROP, V142, P138, DOI 10.1016/j.actatropica.2014.11.013
   Yamada H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-318
   Yamada H, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-197
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2
   Zhou D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-42
   Zohdy S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0729-1
NR 208
TC 71
Z9 74
U1 1
U2 98
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2016
VL 157
BP 115
EP 130
DI 10.1016/j.actatropica.2016.01.009
PG 16
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH4MZ
UT WOS:000372761400014
PM 26774684
OA Other Gold
DA 2020-07-08
ER

PT J
AU Molloy, JC
   Sommer, U
   Viant, MR
   Sinkins, SP
AF Molloy, Jennifer C.
   Sommer, Ulf
   Viant, Mark R.
   Sinkins, Steven P.
TI Wolbachia Modulates Lipid Metabolism in Aedes albopictus Mosquito Cells
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID DENGUE VIRUS; MASS-SPECTROMETRY; AUTOPHAGY MACHINERY; CHIKUNGUNYA VIRUS;
   BLOCKS DENGUE; INFECTION; PATHWAY; CHOLESTEROL; POPULATIONS; ACTIVATION
AB Certain strains of the intracellular endosymbiont Wolbachia can strongly inhibit or block the transmission of viruses such as dengue virus (DENV) by Aedes mosquitoes, and the mechanisms responsible are still not well understood. Direct infusion and liquid chromatography-Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry-based lipidomics analyses were conducted using Aedes albopictus Aa23 cells that were infected with the wMel and wMelPop strains of Wolbachia in comparison to uninfected Aa23-T cells. Substantial shifts in the cellular lipid profile were apparent in the presence of Wolbachia. Most significantly, almost all sphingolipid classes were depleted, and some reductions in diacylglycerols and phosphatidylcholines were also observed. These lipid classes have previously been shown to be selectively enriched in DENV-infected mosquito cells, suggesting that Wolbachia may produce a cellular lipid environment that is antagonistic to viral replication. The data improve our understanding of the intracellular interactions between Wolbachia and mosquitoes.
   IMPORTANCE
   Mosquitoes transmit a variety of important viruses to humans, such as dengue virus and Zika virus. Certain strains of the intracellular bacterial genus called Wolbachia found in or introduced into mosquitoes can block the transmission of viruses, including dengue virus, but the mechanisms responsible are not well understood. We found substantial shifts in the cellular lipid profiles in the presence of these bacteria. Some lipid classes previously shown to be enriched in dengue virus-infected mosquito cells were depleted in the presence of Wolbachia, suggesting that Wolbachia may produce a cellular lipid environment that inhibits mosquito-borne viruses.
C1 [Molloy, Jennifer C.; Sinkins, Steven P.] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Molloy, Jennifer C.; Sinkins, Steven P.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.
   [Sommer, Ulf; Viant, Mark R.] Univ Birmingham, Sch Biosci, NERC Biomol Anal Facil Metab Node, Birmingham, W Midlands, England.
   [Sinkins, Steven P.] Univ Lancaster, Biomed & Life Sci, Lancaster, England.
RP Sinkins, SP (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Sinkins, SP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.; Sinkins, SP (corresponding author), Univ Lancaster, Biomed & Life Sci, Lancaster, England.
EM s.sinkins@lancaster.ac.uk
OI Molloy, Jenny/0000-0003-3477-8462
FU Wellcome TrustWellcome Trust [WT095121]; Biotechnology and Biological
   Sciences Research Council (BBSRC)Biotechnology and Biological Sciences
   Research Council (BBSRC) [BB/H016511/1]; Natural Environment Research
   Council (NERC)NERC Natural Environment Research Council [R8-H10-61];
   Natural Environment Research CouncilNERC Natural Environment Research
   Council [NBAF010004]
FX This work, including the efforts of Steven P. Sinkins, was funded by
   Wellcome Trust (WT095121). This work, including the efforts of Jennifer
   C. Molloy, was funded by Biotechnology and Biological Sciences Research
   Council (BBSRC) (BB/H016511/1). This work, including the efforts of Ulf
   Sommer and Mark Viant, was funded by Natural Environment Research
   Council (NERC) (R8-H10-61).
CR BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Carvalho M, 2010, DEVELOPMENT, V137, P3675, DOI 10.1242/dev.044560
   Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703
   Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185
   Dunn WB, 2008, J CHROMATOGR B, V871, P288, DOI 10.1016/j.jchromb.2008.03.021
   Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324
   Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gay B, 2012, INFECT GENET EVOL, V12, P1275, DOI 10.1016/j.meegid.2012.02.003
   Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009
   Glazov EA, 2005, GENOME RES, V15, P800, DOI 10.1101/gr.3545105
   Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006
   Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x
   HOBSON RALPH PERCIVAL, 1935, BIOCHEM JOUR, V29, P2023
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6
   Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005
   Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Khoo CCH, 2013, B ENTOMOL RES, V103, P251, DOI 10.1017/S0007485312000648
   Kirwan JA, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.12
   Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630
   Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Scheitz CJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072726
   Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059
   Shi JY, 2012, ACTA BIOCH BIOPH SIN, V44, P375, DOI 10.1093/abbs/gms010
   Sommer U, 2006, J LIPID RES, V47, P804, DOI 10.1194/jlr.M500506-JLR200
   Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p
   Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Viant MR, 2013, METABOLOMICS, V9, pS144, DOI 10.1007/s11306-012-0412-x
   Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weber RJM, 2011, ANAL CHEM, V83, P3737, DOI 10.1021/ac2001803
   Weber RJM, 2010, CHEMOMETR INTELL LAB, V104, P75, DOI 10.1016/j.chemolab.2010.04.010
   Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009
NR 69
TC 36
Z9 36
U1 3
U2 32
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD MAY
PY 2016
VL 82
IS 10
BP 3109
EP 3120
DI 10.1128/AEM.00275-16
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA DK9EU
UT WOS:000375234400024
PM 26994075
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Afebrile, asymptomatic and non thrombocytopenic Zika virus infection:
   don't miss it!
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
DE Afebrile; Asymptomatic; Thrombocytopenia; Zika virus; Infection
ID PREGNANT-WOMEN; GUIDELINES; DENGUE
AB Zika virus infection is the present problematic arboviral disease. Classically, this disease cause febrile illness and can result in low platelet count. However, there are some new obervations on atypical clinical presentations of Zika virus infection that can make the diagnosis more difficult. The afebrile, asymptomatic and non-thrombocytopenic Zika virus infection can be seen in clinical practice and can lead to missed or delayed diagnosis.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] DR DY Patil Med Univ, Delhi, India.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Chan JF, 2016, J INFECTION, V2
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2013, ANN TROP MED PUBLIC, V6, DOI 10.4103/1755-6783.140273
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 11
TC 71
Z9 74
U1 2
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAY
PY 2016
VL 9
IS 5
BP 499
EP 500
DI 10.1016/j.apjtm.2016.03.036
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DL0YS
UT WOS:000375359100019
PM 27261865
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Carvalho, MS
AF Carvalho, Marilia Sa
TI Zika in Cadernos de Saude Publica/Reports in Public Health: again?
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
RI CARVALHO, MARILIA S/C-3425-2013; CARVALHO, MARILIA/AAD-8283-2020
OI CARVALHO, MARILIA/0000-0002-9566-0284
CR Carvalho MS, 2016, ZIKA CADERNOS SAUDE, V32
   Departamento Intersindical de Assessoria Parlamentar, REAC CONS C BAN RUR
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Diniz D, 2010, CIENC SAUDE COLETIVA, V15, P959, DOI 10.1590/S1413-81232010000700002
   Haug CJ, 2016, N ENGL J MED
   Lowy I., ZIKA MICROCEPHALY CA
   Sala Nacional de Coordenacao e Controle para o Enfrentamento da Dengue do Virus Chikungunya e do Zika Virus, MON AT 1 CIC VIS IM
NR 7
TC 1
Z9 1
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR eED010516
DI 10.1590/0102-311XED010516
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900024
PM 27192031
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Perkasa, A
   Yudhaputri, F
   Haryanto, S
   Hayati, RF
   Ma'roef, CN
   Antonjaya, U
   Yohan, B
   Myint, KSA
   Ledermann, JP
   Rosenberg, R
   Powers, AM
   Sasmono, RT
AF Perkasa, Aditya
   Yudhaputri, Frilasita
   Haryanto, Sotianingsih
   Hayati, Rahma F.
   Ma'roef, Chairin Nisa
   Antonjaya, Ungke
   Yohan, Benediktus
   Myint, Khin Saw Aye
   Ledermann, Jeremy P.
   Rosenberg, Ronald
   Powers, Ann M.
   Sasmono, R. Tedjo
TI Isolation of Zika Virus from Febrile Patient, Indonesia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID INFECTION
C1 [Perkasa, Aditya; Yudhaputri, Frilasita; Hayati, Rahma F.; Ma'roef, Chairin Nisa; Yohan, Benediktus; Myint, Khin Saw Aye; Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
   [Haryanto, Sotianingsih] Siloam Hosp Jambi, Jambi, Indonesia.
   [Antonjaya, Ungke] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [Ledermann, Jeremy P.; Rosenberg, Ronald; Powers, Ann M.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Sasmono, RT (corresponding author), Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
EM sasmono@eijkman.go.id
RI Yohan, Benediktus/J-9039-2019; Sasmono, Tedjo/H-5680-2016
OI Yohan, Benediktus/0000-0003-2378-2386; Sasmono,
   Tedjo/0000-0003-0986-2590; Hayati, Rahma Fitri/0000-0002-1627-9187
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 48
Z9 51
U1 0
U2 16
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 924
EP 925
DI 10.3201/eid2205.151915
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100033
PM 27088970
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Arzuza-Ortega, L
   Polo, A
   Perez-Tatis, G
   Lopez-Garcia, H
   Parra, E
   Pardo-Herrera, LC
   Rico-Turca, AM
   Villamil-Gomez, W
   Rodriguez-Morales, AJ
AF Arzuza-Ortega, Laura
   Polo, Arnulfo
   Perez-Tatis, Giamina
   Lopez-Garcia, Humberto
   Parra, Edgar
   Pardo-Herrera, Lissethe C.
   Rico-Turca, Angelica M.
   Villamil-Gomez, Wilmer
   Rodriguez-Morales, Alfonso J.
TI Fatal Sickle Cell Disease and Zika Virus Infection in Girl from Colombia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID RISK-FACTORS; CHIKUNGUNYA; OUTBREAK; AMERICA; ANEMIA; DENGUE
C1 [Arzuza-Ortega, Laura] Entidades Promotoras Salud Barrios Unido Mutual, Quibdo, Colombia.
   [Polo, Arnulfo] Empresa Social Estado Hosp Malambo, Malambo, Colombia.
   [Perez-Tatis, Giamina; Lopez-Garcia, Humberto] Hosp Metropolitano, Barranquilla, Colombia.
   [Parra, Edgar; Pardo-Herrera, Lissethe C.; Rico-Turca, Angelica M.] Inst Nacl Salud, Bogota, Colombia.
   [Villamil-Gomez, Wilmer] Hosp Univ Sincelejo, Sincelejo, Colombia.
   [Villamil-Gomez, Wilmer] Univ Atlantico, Barranquilla, Colombia.
   [Villamil-Gomez, Wilmer] Univ Cartagena, Cartagena, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@ufp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; ARZUZA,
   LAURA/0000-0003-4986-8356
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Fong C, 2013, GENET MOL BIOL, V36, P494, DOI 10.1590/S1415-47572013000400005
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Moesker FM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002203
   Pan American Health Organisation, NEUR SYNDR CONG MALF
   Rankine-Mullings A, 2015, EBIOMEDICINE, V2, P937, DOI 10.1016/j.ebiom.2015.07.002
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
NR 10
TC 50
Z9 51
U1 1
U2 20
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 925
EP 927
DI 10.3201/eid2205.151934
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100034
PM 27089120
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Camacho, E
   Paternina-Gomez, M
   Blanco, PJ
   Osorio, JE
   Aliota, MT
AF Camacho, Erwin
   Paternina-Gomez, Margaret
   Blanco, Pedro J.
   Osorio, Jorge E.
   Aliota, Matthew T.
TI Detection of Autochthonous Zika Virus Transmission in Sincelejo,
   Colombia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID OUTBREAK; CHIKUNGUNYA; DENGUE; PCR
C1 [Camacho, Erwin; Osorio, Jorge E.; Aliota, Matthew T.] Univ Wisconsin, Madison, WI 53706 USA.
   [Paternina-Gomez, Margaret; Blanco, Pedro J.] Univ Sucre, Sincelejo, Colombia.
RP Aliota, MT (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM mtaliota@wisc.edu
OI Aliota, Matthew/0000-0002-6902-9149; Camacho Burgos,
   Erwin/0000-0003-2411-1875
CR Baronti C, 2014, GENOME ANNOUNC, V2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Harris E, 1998, J CLIN MICROBIOL, V36, P2634, DOI 10.1128/JCM.36.9.2634-2639.1998
   Instituto Nacional de Salud, 2016, ZIK SEM EP 01 DE 201
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
NR 10
TC 17
Z9 17
U1 0
U2 17
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 927
EP 929
DI 10.3201/eid2205.160023
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100035
PM 27089253
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lanciotti, RS
   Lambert, AJ
   Holodniy, M
   Saavedra, S
   Signor, LDC
AF Lanciotti, Robert S.
   Lambert, Amy J.
   Holodniy, Mark
   Saavedra, Sonia
   Castillo Signor, Leticia del Carmen
TI Phylogeny of Zika Virus in Western Hemisphere, 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID CHIKUNGUNYA
C1 [Lanciotti, Robert S.; Lambert, Amy J.] Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
   [Holodniy, Mark] Dept Vet Affairs, Palo Alto, CA USA.
   [Saavedra, Sonia] VA Caribbean Hlth Care Syst, San Juan, PR USA.
   [Castillo Signor, Leticia del Carmen] Lab Nacl Salud Guatemala, Villa Nueva, Guatemala.
RP Lanciotti, RS (corresponding author), Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
EM rsl2@cdc.gov
OI Holodniy, Mark/0000-0002-6655-7982
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, AM J TROP M IN PRESS
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 176
Z9 182
U1 0
U2 36
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 933
EP 935
DI 10.3201/eid2205.160065
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100038
PM 27088323
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diaz-Quinonez, JA
   Escobar-Escamilla, N
   Wong-Arambula, C
   Vazquez-Pichardo, M
   Torres-Longoria, B
   Lopez-Martinez, I
   Ruiz-Matus, C
   Kuri-Morales, P
   Ramirez-Gonzalez, JE
AF Alberto Diaz-Quinonez, Jose
   Escobar-Escamilla, Noe
   Wong-Arambula, Claudia
   Vazquez-Pichardo, Mauricio
   Torres-Longoria, Belem
   Lopez-Martinez, Irma
   Ruiz-Matus, Cuitlahuac
   Kuri-Morales, Pablo
   Ernesto Ramirez-Gonzalez, Jose
TI Asian Genotype Zika Virus Detected in Traveler Returning to Mexico from
   Colombia, October 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Alberto Diaz-Quinonez, Jose] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico.
   [Alberto Diaz-Quinonez, Jose; Escobar-Escamilla, Noe; Wong-Arambula, Claudia; Vazquez-Pichardo, Mauricio; Torres-Longoria, Belem; Lopez-Martinez, Irma; Ernesto Ramirez-Gonzalez, Jose] Inst Diagnost & Referencia Epidemiol Dr Manuel Ma, Francisco de P Miranda 177, Mexico City 01480, DF, Mexico.
   [Ruiz-Matus, Cuitlahuac] Direcc Gen Epidemiol, Mexico City, DF, Mexico.
   [Kuri-Morales, Pablo] Subsecretaria Prevenc & Promoc Salud, Mexico City, DF, Mexico.
RP Diaz-Quinonez, JA (corresponding author), Inst Diagnost & Referencia Epidemiol Dr Manuel Ma, Francisco de P Miranda 177, Mexico City 01480, DF, Mexico.
EM alberto.diaz@salud.gob.mx
OI Diaz-Quinonez, Jose Alberto/0000-0002-3503-7079; Escobar-Escamilla,
   Noe/0000-0001-8929-476X
CR Diaz-Quinonez JA, 2016, VIRUS GENES, V52, P127, DOI 10.1007/s11262-015-1275-9
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Centers for Disease Control and Prevention, ZIK VIR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306
NR 9
TC 9
Z9 9
U1 0
U2 16
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 937
EP 939
DI 10.3201/eid2205.160190
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100040
PM 27088574
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freitas, BD
   Dias, JRD
   Prazeres, J
   Sacramento, GA
   Ko, AI
   Maia, M
   Belfort, R
AF Freitas, Bruno de Paula
   de Oliveira Dias, Joao Rafael
   Prazeres, Juliana
   Sacramento, Gielson Almeida
   Ko, Albert Icksang
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Ocular Findings in Infants With Microcephaly Associated With Presumed
   Zika Virus Congenital Infection in Salvador, Brazil
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID FRENCH-POLYNESIA; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION;
   DECEMBER 2013; DENGUE; PREGNANCY; OUTBREAK; OUTCOMES; FEVER
AB IMPORTANCE The Zika virus (ZIKV) has rapidly reached epidemic proportions, especially in northeastern Brazil, and has rapidly spread to other parts of the Americas. A recent increase in the prevalence of microcephaly in newborn infants and vision-threatening findings in these infants is likely associated with the rapid spread of ZIKV.
   OBJECTIVE To evaluate the ocular findings in infants with microcephaly associated with presumed intrauterine ZIKV infection in Salvador, Bahia, Brazil.
   DESIGN, SETTING, AND PARTICIPANTS Case series at a tertiary hospital. Twenty-nine infants with microcephaly (defined by a cephalic circumference of <= 32 cm) with a presumed diagnosis of congenital ZIKV were recruited through an active search and referrals from other hospitals and health unities. The study was conducted between December 1 and December 21, 2015.
   INTERVENTIONS All infants and mothers underwent systemic and ophthalmic examinations from December 1 through December 21, 2015, in the Roberto Santos General Hospital, Salvador, Brazil. Anterior segment and retinal, choroidal, and optic nerve abnormalities were documented using a wide-field digital imaging system. The differential diagnosis included toxoplasmosis, rubella, cytomegalovirus, herpes simplex virus, syphilis, and human immunodeficiency virus, which were ruled out through serologic and clinical examinations.
   MAIN OUTCOMES AND MEASURES Ocular abnormalities associated with ZIKV.
   RESULTS Twenty-three of 29 mothers (79.3%) reported suspected ZIKV infection signs and symptoms during pregnancy, 18 in the first trimester, 4 in the second trimester, and 1 in the third trimester. Of the 29 infants (58 eyes) examined (18 [62.1%] female), ocular abnormalities were present in 17 eyes (29.3%) of 10 children (34.5%). Bilateral findings were found in 7 of 10 patients presenting with ocular lesions, the most common of which were focal pigment mottling of the retina and chorioretinal atrophy in 11 of the 17 eyes with abnormalities (64.7%), followed by optic nerve abnormalities in 8 eyes (47.1%), bilateral iris coloboma in 1 patient (2 eyes [11.8%]), and lens subluxation in 1 eye (5.9%).
   CONCLUSIONS AND RELEVANCE Congenital infection due to presumed ZIKV exposure is associated with vision-threatening findings, which include bilateral macular and perimacular lesions as well as optic nerve abnormalities in most cases.
C1 [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [de Oliveira Dias, Joao Rafael; Prazeres, Juliana; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
   [Sacramento, Gielson Almeida; Ko, Albert Icksang] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI Maia, Mauricio/I-5892-2015; Ko, Albert Icksang/P-2343-2015; de Oliveira
   Dias, Joao/J-6735-2016
OI Maia, Mauricio/0000-0002-7034-8091; Ko, Albert
   Icksang/0000-0001-9023-2339; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Federal University of Sao Paulo (Paulista Medical School);
   Vision Institute (IPEPO)
FX Hospital Geral Roberto Santos provided the site and materials for
   ophthalmologic examination. Federal University of Sao Paulo (Paulista
   Medical School), Vision Institute (IPEPO), and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) provided funds for
   travel expenses as well as the materials necessary for the ocular
   examinations.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelly JC, 2016, MEDSCAPE
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude, MICR 3174 CAS SAO IN
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude, NOT MED PER CEF DIAG
   Ministerio da Saude, MIN SAUD CONF REL EN
   Ministerio da Saude Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization (WHO), EP AL NEUR SYNDR CON
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 134
Z9 138
U1 1
U2 97
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAY
PY 2016
VL 134
IS 5
BP 529
EP 535
DI 10.1001/jamaophthalmol.2016.0267
PG 7
WC Ophthalmology
SC Ophthalmology
GA DL7CB
UT WOS:000375796100014
PM 26865554
OA Green Published, Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Chan, JFW
   Choi, GKY
   Yip, CCY
   Cheng, VCC
   Yuen, KY
AF Chan, Jasper F. W.
   Choi, Garnet K. Y.
   Yip, Cyril C. Y.
   Cheng, Vincent C. C.
   Yuen, Kwok-Yung
TI Zika fever and congenital Zika syndrome: An unexpected emerging
   arboviral disease
SO JOURNAL OF INFECTION
LA English
DT Review
DE Zika; Virus; Flavivirus; Arbovirus; Microcephaly; Aedes; Mosquito
ID WEST-NILE-VIRUS; RESPIRATORY SYNDROME CORONAVIRUS; BORNE
   VIRAL-INFECTIONS; INFLUENZA-A H5N1; RIO-DE-JANEIRO; YELLOW-FEVER;
   VERTICAL TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; DENGUE VIRUS
AB Unlike its mosquito-borne relatives, such as dengue, West Nile, and Japanese encephalitis viruses, which can cause severe human diseases, Zika virus (ZIKV) has emerged from obscurity by its association with a suspected "congenital Zika syndrome", while causing asymptomatic or mild exanthematous febrile infections which are dengue-or rubella-like in infected individuals. Despite having been discovered in Uganda for almost 60 years, <20 human cases were reported before 2007. The massive epidemics in the Pacific islands associated with the ZIKV Asian lineage in 2007 and 2013 were followed by explosive outbreaks in Latin America in 2015. Although increased mosquito breeding associated with the El Nino effect superimposed on global warming is suspected, genetic changes in its RNA virus genome may have led to better adaptation to mosquitoes, other animal reservoirs, and human. We reviewed the epidemiology, clinical manifestation, virology, pathogenesis, laboratory diagnosis, management, and prevention of this emerging infection. Laboratory diagnosis can be confounded by cross-reactivity with other circulating flaviviruses. Besides mosquito bite and transplacental transmission, the risk of other potential routes of transmission by transfusion, transplantation, sexual activity, breastfeeding, respiratory droplet, and animal bite is discussed. Epidemic control requires adequate clearance of mosquito breeding grounds, personal protection against mosquito bite, and hopefully a safe and effective vaccine. (C) 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Chan, Jasper F. W.; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper F. W.; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper F. W.; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper F. W.; Choi, Garnet K. Y.; Yip, Cyril C. Y.; Cheng, Vincent C. C.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
RP Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, State Key Lab Emerging Infect Dis, Carol Yu Ctr Infect,Dept Microbiol, 102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
EM kyyuen@hku.hk
RI Chan, Jasper F. W./D-8007-2013
OI Chan, Jasper F. W./0000-0001-6336-6657; Yuen,
   Kwok-yung/0000-0002-2083-1552
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Disease of the Department of Health, The Food and Health
   Bureau, Hong Kong Special Administrative Region, China
FX The study was partly supported by the Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Disease of the Department
   of Health, The Food and Health Bureau, Hong Kong Special Administrative
   Region, China; and by the donations of Hui Hoy and Chow Sin Lan Charity
   Fund Limited and Mr. Larry Chi-Kin Yung.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   [Anonymous], 2016, BRIT BROADCASTING CO
   Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Atkinson B, 2016, EMERG INFECT DIS
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LA, 2016, MICROBES INFECT
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P738
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1133
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002
   Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Melo Freire CC, 2015, BIORXIV
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2009, Med Trop (Mars), V69, P339
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Korhonen E., 2016, EURO SURVEILL, V21
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Roth A, 2014, EURO SURVEILL, V19
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007
   To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014
   To KKW, 2013, J THORAC DIS, V5, pS103, DOI 10.3978/j.issn.2072-1439.2013.06.02
   To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1
   To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   WHO, 2016, ZIK SIT REP NEUR SYN
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, 1 M INT HLTH REG 200
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 153
TC 121
Z9 126
U1 8
U2 119
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD MAY
PY 2016
VL 72
IS 5
BP 507
EP 524
DI 10.1016/j.jinf.2016.02.011
PG 18
WC Infectious Diseases
SC Infectious Diseases
GA DK6BD
UT WOS:000375004900001
PM 26940504
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Tambo, E
   Chuisseu, PD
   Ngogang, JY
   Khater, EIM
AF Tambo, Ernest
   Chuisseu, Pascal D.
   Ngogang, Jeanne Y.
   Khater, Emad I. M.
TI Deciphering emerging Zika and dengue viral epidemics: Implications for
   global maternal-child health burden
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article; Proceedings Paper
CT Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Research
   Initiative Workshop
CY SEP 09-10, 2015
CL Riyadh, SAUDI ARABIA
DE Zika virus; Epidemics; Health; Preparedness; Surveillance;
   Maternal-child
ID INTERIM GUIDELINES; VIRUS OUTBREAK; UNITED-STATES; INFECTION; TRAVELERS
AB Since its discovery in 1947 in Uganda and control and eradication efforts have aimed at its vectors (Aedes mosquitoes) in Latin America in the 1950s, an absolute neglect of Zika programs and interventions has been documented in Aedes endemic and epidemic-prone countries. The current unprecedented Zika viral epidemics and rapid spread in the Western hemisphere pose a substantial global threat, with associated anxiety and consequences. The lack of safe and effective drugs and vaccines against Zika or dengue epidemics further buttresses the realization from the West Africa Ebola outbreak that most emerging disease-prone countries are still poorly prepared for an emergency response. This paper examines knowledge gaps in both emerging and neglected arthropod-borne flavivirus infectious diseases associated with poverty and their implications for fostering local, national and regional emerging disease preparedness, effective and robust surveillance-response systems, sustained control and eventual elimination. Strengthening the regional and Global Health Flavivirus Surveillance-Response Network (GHFV-SRN) with other models of socio-economic, climatic, environmental and ecological mitigation and adaptation strategies will be necessary to improve evidence-based national and global maternal-child health agenda and action plans. (C) 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
C1 [Tambo, Ernest; Chuisseu, Pascal D.; Ngogang, Jeanne Y.] Univ Montagnes, Higher Inst Hlth Sci, Biochem & Pharmaceut Sci Dept, Bangangte, Cameroon.
   [Tambo, Ernest] Africa Intelligence & Surveillance Commun & Respo, Yaounde, Cameroon.
   [Ngogang, Jeanne Y.] CHU, Serv Biochim, Yaounde, Cameroon.
   [Khater, Emad I. M.] Jeddah Governate, Publ Hlth Pests Lab, Jeddah, Saudi Arabia.
RP Tambo, E (corresponding author), Univ Montagnes, Higher Inst Hlth Sci, Biochem & Pharmaceut Sci Dept, Bangangte, Cameroon.; Khater, EIM (corresponding author), Jeddah Governate, Publ Hlth Pests Lab, Jeddah, Saudi Arabia.
EM tambo0711@gmail.com
RI Khater, Emad I. M./D-4248-2009
OI Khater, Emad I. M./0000-0002-7510-6294; Tambo,
   Ernest/0000-0002-4799-3252
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Bogoch I, 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Fauci AS, 2016, N ENGL J MED
   Faye O, 2014, PLOS NEGLECT TROP D, V8
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Korhonen E., 2016, EURO SURVEILL, V21
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Roth A, 2014, EURO SURVEILLANCE, V19
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Tambo E, 2015, INT J VACCINES VACCI, V1, P00011
   Tambo E, 2015, J PREV INFECT CONTRO, V1, P2
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-42
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Tetro JA, 2016, MICROBES INFECT
   Ventura CV, 2016, LANCET
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 35
TC 10
Z9 10
U1 0
U2 26
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAY-JUN
PY 2016
VL 9
IS 3
BP 240
EP 250
DI 10.1016/j.jiph.2016.02.005
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DM6LM
UT WOS:000376463900009
PM 27052794
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lazear, HM
   Diamond, MS
AF Lazear, Helen M.
   Diamond, Michael S.
TI Zika Virus: New Clinical Syndromes and Its Emergence in the Western
   Hemisphere
SO JOURNAL OF VIROLOGY
LA English
DT Review
ID ENVELOPE PROTEIN GLYCOSYLATION; JAPANESE ENCEPHALITIS-VIRUS; NILE-VIRUS;
   DENGUE VIRUS; FRENCH-POLYNESIA; PREGNANT-WOMEN; UNITED-STATES; SEXUAL
   TRANSMISSION; INTERIM GUIDELINES; AEDES-AEGYPTI
AB Zika virus (ZIKV) had remained a relatively obscure flavivirus until a recent series of outbreaks accompanied by unexpectedly severe clinical complications brought this virus into the spotlight as causing an infection of global public health concern. In this review, we discuss the history and epidemiology of ZIKV infection, recent outbreaks in Oceania and the emergence of ZIKV in the Western Hemisphere, newly ascribed complications of ZIKV infection, including Guillain-Barre syndrome and microcephaly, potential interactions between ZIKV and dengue virus, and the prospects for the development of antiviral agents and vaccines.
C1 [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Dept Mol Microbiol,Dept Pathol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA.
RP Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, Dept Mol Microbiol,Dept Pathol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA.
EM helen.lazear@med.unc.edu; diamond@borcim.wustl.edu
RI amsalu, ribka/G-8780-2019; Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Lazear, Helen/0000-0002-8649-4579
FU HHS \ NIH \ National Institute of Allergy and Infectious Diseases
   (NIAID) [R01 AI073755]; Burroughs Wellcome Fund (BWF)Burroughs Wellcome
   Fund
FX This work, including the efforts of Michael S Diamond, was funded by HHS
   vertical bar NIH vertical bar National Institute of Allergy and
   Infectious Diseases (NIAID) (R01 AI073755). This work, including the
   efforts of Michael S Diamond, was funded by Burroughs Wellcome Fund
   (BWF).
CR Acosta EG, 2015, EXPERT REV VACCINES
   Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Atkinson B, 2016, EMERG INFECT DIS
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Baronti C, 2014, GENOME ANNOUNC  0605
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   CALISHER CH, 1995, EMERG INFECT DIS, V1, P147, DOI 10.3201/eid0104.950409
   Calvet G., 2016, LANCET INFECT DIS
   Camacho E, 2016, EMERG INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chiou SS, 2008, CLIN VACCINE IMMUNOL, V15, P825, DOI 10.1128/CVI.00004-08
   Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x
   Dallas County Health and Human Services, 2016, DCHHS PROV UPD ZIK V
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Paula Freitas B, 2016, JAMA OPHTHALMOL 0209
   Deen GF, 2015, N ENGL J MED
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   European Union Directorate-General for Health and Food Safety, 2012, W NIL VIR BLOOD SAF
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fleming-Dutra KE, 2016, MMWR MORB MORTAL WKL
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills S, 2016, MMWR MORB MORTAL WKL
   Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639
   JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931
   Karimi O, 2016, LANCET
   Kelly S, 2013, MMWR-MORBID MORTAL W, V62, P622
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maria AT, 2016, EURO SURVEILL
   Martin JN, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P960
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR MORB MORTAL WKL
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   O'Brien SF, 2010, TRANSFUSION, V50, P1118, DOI 10.1111/j.1537-2995.2009.02550.x
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Ortega LA, 2016, EMERG INFECT DIS
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Prow NA, 2011, J GEN VIROL, V92, P2286, DOI 10.1099/vir.0.034793-0
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Soares de Araujo JS, 2016, B WHO
   Stefanovic KB, 2009, AM FAM PHYSICIAN, V80, P1421
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Ubogu EE, 2015, ACTA NEUROPATHOL, V130, P445, DOI 10.1007/s00401-015-1466-4
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waggoner JJ, 2016, J CLIN MICROBIOL
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Yakob L, 2016, LANCET GLOB HLT 0201
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 144
TC 246
Z9 249
U1 3
U2 77
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2016
VL 90
IS 10
BP 4864
EP 4875
DI 10.1128/JVI.00252-16
PG 12
WC Virology
SC Virology
GA DK7SN
UT WOS:000375126100003
PM 26962217
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Sarmiento-Ospina, A
   Vasquez-Serna, H
   Jimenez-Canizales, CE
   Villamil-Gomez, WE
   Rodriguez-Morales, AJ
AF Sarmiento-Ospina, Andrea
   Vasquez-Serna, Heriberto
   Jimenez-Canizales, Carlos E.
   Villamil-Gomez, Wilmer E.
   Rodriguez-Morales, Alfonso J.
TI Zika virus associated deaths in Colombia
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID ARBOVIRUS THREAT; AMERICA
C1 [Sarmiento-Ospina, Andrea] Secretary Hlth Ibague, Ibague, Tolima, Colombia.
   [Vasquez-Serna, Heriberto; Jimenez-Canizales, Carlos E.] Secretary Hlth Tolima, Ibague, Tolima, Colombia.
   [Jimenez-Canizales, Carlos E.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Infect Dis Res Grp, Sucre, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Hosp Univ Sincelejo, Infect Dis Res Grp, Sucre, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016; Jimenez-Canizales, Carlos
   Eduardo/AAR-7264-2020
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Jimenez-Canizales, Carlos
   Eduardo/0000-0001-7728-1523
CR Arzusa-Ortega L, 2016, EMERG INFECT DIS, V22
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   PAHO, 2015, EP AL
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
NR 5
TC 46
Z9 49
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 523
EP 524
DI 10.1016/S1473-3099(16)30006-8
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DJ5TL
UT WOS:000374272900016
PM 27068488
OA Bronze
DA 2020-07-08
ER

PT J
AU de Noronha, L
   Zanluca, C
   Azevedo, MLV
   Luz, KG
   dos Santos, CND
AF de Noronha, Lucia
   Zanluca, Camila
   Viola Azevedo, Marina Luize
   Luz, Kleber Giovanni
   Duarte dos Santos, Claudia Nunes
TI Zika virus damages the human placental barrier and presents marked fetal
   neurotropism
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; transplacental transmission; Hofbauer cells; neurotropism
ID WEST-NILE VIRUS; INFECTIONS; TRANSMISSION; PATHOGENESIS; EMERGENCE
AB An unusually high incidence of microcephaly in newborns has recently been observed in Brazil. There is a temporal association between the increase in cases of microcephaly and the Zika virus (ZIKV) epidemic. Viral RNA has been detected in amniotic fluid samples, placental tissues and newborn and fetal brain tissues. However, much remains to be determined concerning the association between ZIKV infection and fetal malformations. In this study, we provide evidence of the transplacental transmission of ZIKV through the detection of viral proteins and viral RNA in placental tissue samples from expectant mothers infected at different stages of gestation. We observed chronic placentitis (TORCH type) with viral protein detection by immunohistochemistry in Hofbauer cells and some histiocytes in the intervillous spaces. We also demonstrated the neurotropism of the virus via the detection of viral proteins in glial cells and in some endothelial cells and the observation of scattered foci of microcalcifications in the brain tissues. Lesions were mainly located in the white matter. ZIKV RNA was also detected in these tissues by real-time-polymerase chain reaction. We believe that these findings will contribute to the body of knowledge of the mechanisms of ZIKV transmission, interactions between the virus and host cells and viral tropism.
C1 [de Noronha, Lucia; Viola Azevedo, Marina Luize] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
   [Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Luz, Kleber Giovanni] Univ Fed Rio Grande do Norte, Inst Med Trop, BR-59072970 Natal, RN, Brazil.
RP dos Santos, CND (corresponding author), Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
RI Santos, Claudia Duarte dos/P-4868-2019; noronha, lucia/F-6339-2015;
   Duarte dos Santos, Claudia/E-1857-2018
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; noronha,
   lucia/0000-0003-0310-7164; Duarte dos Santos,
   Claudia/0000-0001-8707-6638; Zanluca, Camila/0000-0001-7350-9105
FU FIOCRUZ; CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES; Fundacao AraucariaFundacao Araucaria
FX FIOCRUZ, CNPq, CAPES, Fundacao Araucaria. LN and CZ contributed equally
   to this work.
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Benirchke K, 2006, PATHOLOGY HUMAN PLAC, P502
   Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530
   Brasil P., 2016, N ENGL J ME IN PRESS
   Calvet G., 2016, LANCET INFECT DIS
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   EBC - Empresa Brasil de Comunicacao, 2016, CAS CONF MICR SOB PA
   GREENOUGH A, 1994, ARCH DIS CHILD-FETAL, V70, pF163, DOI 10.1136/fn.70.3.F163
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laszczyk Magdalena, 2007, Ginekol Pol, V78, P560
   Love S, 2002, GREENFIELDS NEUROPAT, P45
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 115
Z9 119
U1 1
U2 41
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2016
VL 111
IS 5
BP 287
EP +
DI 10.1590/0074-02760160085
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DN2EI
UT WOS:000376876500002
PM 27143490
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ellison, DW
   Ladner, JT
   Buathong, R
   Alera, MT
   Wiley, MR
   Hermann, L
   Rutvisuttinunt, W
   Klungthong, C
   Chinnawirotpisan, P
   Manasatienkij, W
   Melendrez, MC
   Berry, IM
   Thaisomboonsuk, B
   Ong-Ajchaowlerd, P
   Kaneechit, W
   Velasco, JM
   Tac-An, IA
   Villa, D
   Lago, CB
   Roque, VG
   Plipat, T
   Nisalak, A
   Srikiatkhachorn, A
   Fernandez, S
   Yoon, IK
   Haddow, AD
   Palacios, GF
   Jarman, RG
   Macareo, LR
AF Ellison, D. W.
   Ladner, J. T.
   Buathong, R.
   Alera, M. T.
   Wiley, M. R.
   Hermann, L.
   Rutvisuttinunt, W.
   Klungthong, C.
   Chinnawirotpisan, P.
   Manasatienkij, W.
   Melendrez, M. C.
   Berry, I. Maljkovic
   Thaisomboonsuk, B.
   Ong-Ajchaowlerd, P.
   Kaneechit, W.
   Velasco, J. M.
   Tac-An, I. A.
   Villa, D.
   Lago, C. B.
   Roque, V. G., Jr.
   Plipat, T.
   Nisalak, A.
   Srikiatkhachorn, A.
   Fernandez, S.
   Yoon, I. K.
   Haddow, A. D.
   Palacios, G. F.
   Jarman, R. G.
   Macareo, L. R.
TI Complete Genome Sequences of Zika Virus Strains Isolated from the Blood
   of Patients in Thailand in 2014 and the Philippines in 2012
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Here, we present the complete genome sequences of two Zika virus (ZIKV) strains, Zika virus/Homo sapiens-tc/THA/2014/SV0127-14 and Zika virus/H.sapiens-tc/PHL/2012/CPC-0740, isolated from the blood of patients collected in Thailand, 2014, and the Philippines, 2012, respectively. Sequencing and phylogenetic analysis showed that both strains belong to the Asian lineage.
C1 [Ellison, D. W.; Alera, M. T.; Hermann, L.; Rutvisuttinunt, W.; Klungthong, C.; Chinnawirotpisan, P.; Manasatienkij, W.; Thaisomboonsuk, B.; Ong-Ajchaowlerd, P.; Kaneechit, W.; Velasco, J. M.; Lago, C. B.; Nisalak, A.; Macareo, L. R.] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Ladner, J. T.; Wiley, M. R.; Haddow, A. D.; Palacios, G. F.] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD USA.
   [Buathong, R.; Plipat, T.] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Nonthaburi, Thailand.
   [Melendrez, M. C.; Berry, I. Maljkovic; Jarman, R. G.] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Tac-An, I. A.; Villa, D.] Cebu City Hlth Dept, Cebu, Philippines.
   [Roque, V. G., Jr.] Dept Hlth, Manila, Philippines.
   [Srikiatkhachorn, A.] Univ Massachusetts, Med Sch, Worcester, MA USA.
   [Fernandez, S.] US Army, Med Mat Dev Act, Frederick, MD USA.
   [Yoon, I. K.] Int Vaccine Inst, Seoul, South Korea.
RP Ellison, DW (corresponding author), Armed Forces Res Inst Med Sci, Bangkok, Thailand.
EM damon.ellison.mil@afrims.org
RI Haddow, Andrew D/C-5902-2008; Palacios, Gustavo/I-7773-2015
OI Haddow, Andrew D/0000-0002-8957-2608; Palacios,
   Gustavo/0000-0001-5062-1938; Wiley, Michael/0000-0001-6688-007X
FU Global Emerging Infections Surveillance and Response System -
   DOD/Defense Threat Reduction Agency (DTRA) [CB10246]
FX This work, including the efforts of Damon William Ellison, was funded by
   Global Emerging Infections Surveillance and Response System. This work,
   including the efforts of Jason T. Ladner, Michael R. Wiley, and Gustavo
   Palacios, was funded by DOD/Defense Threat Reduction Agency (DTRA)
   (CB10246).
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leguia M, 2015, PATHOGENS, V4, P816, DOI 10.3390/pathogens4040816
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
NR 15
TC 18
Z9 19
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAY-JUN
PY 2016
VL 4
IS 3
AR e00359-16
DI 10.1128/genomeA.00359-16
PG 2
WC Microbiology
SC Microbiology
GA VI1DQ
UT WOS:000460660100057
PM 27174274
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Ladner, JT
   Wiley, MR
   Prieto, K
   Yasuda, CY
   Nagle, E
   Kasper, MR
   Reyes, D
   Vasilakis, N
   Heang, V
   Weaver, SC
   Haddow, A
   Tesh, RB
   Sovann, L
   Palacios, G
AF Ladner, Jason T.
   Wiley, Michael R.
   Prieto, Karla
   Yasuda, Chadwick Y.
   Nagle, Elyse
   Kasper, Matthew R.
   Reyes, Daniel
   Vasilakis, Nikolaos
   Heang, Vireak
   Weaver, Scott C.
   Haddow, Andrew
   Tesh, Robert B.
   Sovann, Ly
   Palacios, Gustavo
TI Complete Genome Sequences of Five Zika Virus Isolates
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Zika virus is an emerging human pathogen of great concern due to putative links to microcephaly and Guillain-Barre syndrome. Here, we report the complete genomes, including the 5' and 3' untranslated regions, of five Zika virus isolates, one from the Asian lineage and four from the African lineage.
C1 [Ladner, Jason T.; Wiley, Michael R.; Prieto, Karla; Nagle, Elyse; Reyes, Daniel; Palacios, Gustavo] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21701 USA.
   [Yasuda, Chadwick Y.; Heang, Vireak] US Naval Med Res Unit 2, Phnom Penh NAMRU 2, Phnom Penh, Cambodia.
   [Kasper, Matthew R.] US Navy, Med Res Ctr, Silver Spring, MD USA.
   [Vasilakis, Nikolaos; Weaver, Scott C.; Tesh, Robert B.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos; Weaver, Scott C.; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos; Weaver, Scott C.; Tesh, Robert B.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Haddow, Andrew] US Army, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21701 USA.
   [Sovann, Ly] Cambodian Minist Hlth, Communicable Dis Ctr, Phnom Penh, Cambodia.
   [Yasuda, Chadwick Y.] US Navy, Res Lab, Washington, DC 20375 USA.
RP Palacios, G (corresponding author), US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21701 USA.
EM gustavo.f.palacios.ctr@mail.mil
RI Haddow, Andrew D/C-5902-2008; Palacios, Gustavo/I-7773-2015
OI Haddow, Andrew D/0000-0002-8957-2608; Palacios,
   Gustavo/0000-0001-5062-1938; Wiley, Michael/0000-0001-6688-007X
FU Department of Homeland Security Science and TechnologyUnited States
   Department of Homeland Security (DHS) [HSHQDC-13-C-B0009]; DOD \ Defense
   Threat Reduction Agency (DTRA)United States Department of DefenseDefense
   Threat Reduction Agency [CB10246]
FX This work, including the efforts of Nikolaos Vasilakis and Scott C.
   Weaver, was funded by Department of Homeland Security Science and
   Technology (HSHQDC-13-C-B0009). This work, including the efforts of
   Jason T. Ladner, Michael R. Wiley, Karla Prieto, Elyse Nagle, Daniel
   Reyes, and Gustavo Palacios, was funded by DOD vertical bar Defense
   Threat Reduction Agency (DTRA) (CB10246).
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   King AMQ, 2011, VIRUS TAXONOMY CLASS, V9
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leguia M, 2015, PATHOGENS, V4, P816, DOI 10.3390/pathogens4040816
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
NR 13
TC 17
Z9 17
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD MAY-JUN
PY 2016
VL 4
IS 3
AR e00377-16
DI 10.1128/genomeA.00377-16
PG 2
WC Microbiology
SC Microbiology
GA VI1DQ
UT WOS:000460660100073
PM 27174284
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Song, H
   Qi, JX
   Haywood, J
   Shi, Y
   Gao, GF
AF Song, Hao
   Qi, Jianxun
   Haywood, Joel
   Shi, Yi
   Gao, George F.
TI Zika virus NS1 structure reveals diversity of electrostatic surfaces
   among flaviviruses
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1
AB The association of Zika virus (ZIKV) infections with microcephaly has resulted in an ongoing public-health emergency. Here we report the crystal structure of a C-terminal fragment of ZIKV nonstructural protein 1 (NS1), a major host-interaction molecule that functions in flaviviral replication, pathogenesis and immune evasion. Comparison with West Nile and dengue virus NS1 structures reveals conserved features but diverse electrostatic characteristics at host-interaction interfaces, thus possibly implying different modes of flavivirus pathogenesis.
C1 [Song, Hao; Qi, Jianxun; Haywood, Joel; Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Song, Hao; Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
EM shiyi@im.ac.cn; gaof@im.ac.cn
RI Haywood, Joel/G-8311-2016
OI Haywood, Joel/0000-0003-1576-9704; Song, Hao/0000-0002-2811-0370
FU Emergency Task-Force Project of the National Natural Science Foundation
   of China (NSFC)National Natural Science Foundation of China [81641001];
   China Ministry of Science and Technology National 973 Project
   [2015CB910500]; Task Force of Zika Virus Research from the Chinese
   Academy of Sciences (CAS); Zika Special Project of the National
   Infectious Disease Control ST Grand Project; Strategic Priority Research
   Program of the CAS [XDB08020100]; Excellent Young Scientist Program of
   the CAS; Youth Innovation Promotion Association, CAS [2015078]; NSFC
   Innovative Research Group [81321063]
FX This work was supported by the Emergency Task-Force Project (grant no.
   81641001) of the National Natural Science Foundation of China (NSFC),
   the China Ministry of Science and Technology National 973 Project (grant
   no. 2015CB910500) and the Task Force of Zika Virus Research from the
   Chinese Academy of Sciences (CAS) and the Zika Special Project of the
   National Infectious Disease Control S&T Grand Project and Strategic
   Priority Research Program of the CAS (XDB08020100).; We thank the staff
   of the BL17U beamline at the Shanghai Synchrotron Radiation Facility for
   assistance during data collection. We thank X. Xu, H. Wang and Z. Su for
   assistance in protein preparation. Y.S. is supported by the Excellent
   Young Scientist Program of the CAS and the Youth Innovation Promotion
   Association, CAS (2015078). G.F.G. is supported partly as a leading
   principal investigator of the NSFC Innovative Research Group (grant no.
   81321063).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Mansuy JM, 2016, LANCET INFECT DIS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tang H, 2016, CELL STEM CELL
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 19
TC 92
Z9 102
U1 0
U2 49
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD MAY
PY 2016
VL 23
IS 5
BP 456
EP 458
DI 10.1038/nsmb.3213
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DL4UK
UT WOS:000375633100018
PM 27088990
OA Bronze
DA 2020-07-08
ER

PT J
AU Benelli, G
   Mehlhorn, H
AF Benelli, Giovanni
   Mehlhorn, Heinz
TI Declining malaria, rising of dengue and Zika virus: insights for
   mosquito vector control
SO PARASITOLOGY RESEARCH
LA English
DT Review
DE Arbovirus; Artemisinin; Biological control; Boosted SIT; Nanosynthesis;
   Sex pheromones; Sterile insect technique; Sound traps; Swarming
   behaviour; Vaccine
ID STERILE INSECT TECHNIQUE; AEDES-AEGYPTI DIPTERA; ASIAN TIGER MOSQUITO;
   MATING-BEHAVIOR; ESSENTIAL OILS; VETERINARY IMPORTANCE; POLYGYNOUS
   MOSQUITO; SEXUAL PERFORMANCE; ANOPHELES-GAMBIAE; CURRENT KNOWLEDGE
AB The fight against mosquito-borne diseases is a challenge of huge public health importance. To our mind, 2015 was an extraordinary year for malaria control, due to three hot news: the Nobel Prize to Youyou Tu for the discovery of artemisinin, the development of the first vaccine against Plasmodium falciparum malaria [i.e. RTS,S/AS01 (RTS,S)], and the fall of malaria infection rates worldwide, with special reference to sub-Saharan Africa. However, there are major challenges that still deserve attention, in order to boost malaria prevention and control. Indeed, parasite strains resistant to artemisinin have been detected, and RTS,S vaccine does not offer protection against Plasmodium vivax malaria, which predominates in many countries outside of Africa. Furthermore, the recent outbreaks of Zika virus infections, occurring in South America, Central America and the Caribbean, represent the most recent of four arrivals of important arboviruses in the Western Hemisphere, over the last 20 years. Zika virus follows dengue (which slyly arrived in the hemisphere over decades and became more aggressive in the 1990s), West Nile virus (emerged in 1999) and chikungunya (emerged in 2013). Notably, there are no specific treatments for these arboviruses. The emerging scenario highlights that the effective and eco-friendly control of mosquito vectors, with special reference to highly invasive species such as Aedes aegypti and Aedes albopictus, is crucial. The concrete potential of screening plant species as sources of metabolites for parasitological purposes is worthy of attention, as elucidated by the Y. Tu's example. Notably, plant-borne molecules are often effective at few parts per million against Aedes, Ochlerotatus, Anopheles and Culex young instars, can be used for the rapid synthesis of mosquitocidal nanoformulations and even employed to prepare cheap repellents with low human toxicity. In addition, behaviour-based control tools relying to the employ of sound traps and the manipulation of swarming behaviour (i.e. "lure and kill" approach) are discussed. The importance of further research on the chemical cues routing mosquito swarming and mating dynamics is highlighted. Besides radiation, transgenic and symbiont-based mosquito control approaches, an effective option may be the employ of biological control agents of mosquito young instars, in the presence of ultra-low quantities of nanoformulated botanicals, which boost their predation rates.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Mehlhorn, Heinz] Univ Dusseldorf, Dept Parasitol, Dusseldorf, Germany.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX We would like to thank A. Canale, M. Nicoletti and K. Murugan for
   helpful discussions on the topic. G. Benelli is supported by PROAPI
   (PRAF 2015) and University of Pisa, Department of Agriculture, Food and
   Environment (Grant ID: COFIN2015_22). Funders had no role in the study
   design, data collection and analysis, decision to publish or preparation
   of the manuscript.
CR Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   Becker Norbert, 2012, P31
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   Benelli G, 2014, J PEST SCI, V87, P385, DOI 10.1007/s10340-014-0577-3
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Callaway E, 2015, NATURE, V526, P174, DOI 10.1038/nature.2015.18507
   Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327
   Carlton JM, 2008, TRENDS PARASITOL, V24, P545, DOI 10.1016/j.pt.2008.09.003
   Cator LJ, 2011, ANIM BEHAV, V82, P627, DOI 10.1016/j.anbehav.2011.07.013
   Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x
   Cohen J, 2011, PARASITOL RES MG, V2, P121, DOI 10.1007/978-3-642-21396-0_7
   Dabire KR, 2014, ACTA TROP, V132, pS35, DOI 10.1016/j.actatropica.2013.12.012
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fawaz EY, 2014, J VECTOR ECOL, V39, P347, DOI 10.1111/jvec.12110
   Hamady D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-206
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   IKESHOJI T, 1981, Medical Entomology and Zoology, V32, P7
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   KAHN MC, 1949, AM J TROP MED, V29, P811
   KANDA T, 1988, Tropical Biomedicine, V5, P37
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mehlhorn H, 2005, PARASITOL RES, V95, P363, DOI 10.1007/s00436-004-1297-z
   Mehlhorn H., 2012, PARASITOL RES MONOGR, V3
   Mehlhorn H., 2016, PARASITOL RES MONOGR, V8
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Melaun C, 2015, PARASITOL RES, V114, P1051, DOI 10.1007/s00436-014-4274-1
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oehler E, 2014, EURO SURVEILL, V19
   Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021
   Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Philips TK, 1996, J INSECT BEHAV, V9, P739, DOI 10.1007/BF02213554
   Pitts RJ, 2014, ACTA TROP, V132, pS26, DOI 10.1016/j.actatropica.2013.09.005
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   South SH, 2008, J INSECT BEHAV, V21, P451, DOI 10.1007/s10905-008-9137-0
   South SH, 2011, ANIM BEHAV, V81, P645, DOI 10.1016/j.anbehav.2010.12.014
   South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   WHO, 2015, BACKGR BRIEF MAL VAC
   WHO, 2015, WHO UPD ART RES
   Wiwatanaratanabutr I, 2010, J AM MOSQUITO CONTR, V26, P265, DOI 10.2987/09-5937.1
   World Health Organization, 2015, FACT SHEET WORLD MAL
   Zsemlye JL, 2005, MED VET ENTOMOL, V19, P276, DOI 10.1111/j.1365-2915.2005.00570.x
NR 81
TC 36
Z9 37
U1 2
U2 227
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD MAY
PY 2016
VL 115
IS 5
BP 1747
EP 1754
DI 10.1007/s00436-016-4971-z
PG 8
WC Parasitology
SC Parasitology
GA DK5RG
UT WOS:000374976900001
PM 26932263
OA Bronze
DA 2020-07-08
ER

PT J
AU Karwowski, MP
   Nelson, JM
   Staples, JE
   Fischer, M
   Fleming-Dutra, KE
   Villanueva, J
   Powers, AM
   Mead, P
   Honein, MA
   Moore, CA
   Rasmussen, SA
AF Karwowski, Mateusz P.
   Nelson, Jennifer M.
   Staples, J. Erin
   Fischer, Marc
   Fleming-Dutra, Katherine E.
   Villanueva, Julie
   Powers, Ann M.
   Mead, Paul
   Honein, Margaret A.
   Moore, Cynthia A.
   Rasmussen, Sonja A.
TI Zika Virus Disease: A CDC Update for Pediatric Health Care Providers
SO PEDIATRICS
LA English
DT Article
ID INTERIM GUIDELINES; UNITED-STATES; FRENCH-POLYNESIA; INFECTION;
   TRANSMISSION; DENGUE; OUTBREAK; BRAZIL; OUTCOMES; CHILDREN
AB Zika virus is a mosquito-borne flavivirus discovered in Africa in 1947. Most persons with Zika virus infection are asymptomatic; symptoms when present are generally mild and include fever, maculopapular rash, arthralgia, and conjunctivitis. Since early 2015, Zika virus has spread rapidly through the Americas, with local transmission identified in 31 countries and territories as of February 29, 2016, including several US territories. All age groups are susceptible to Zika virus infection, including children. Maternal-fetal transmission of Zika virus has been documented; evidence suggests that congenital Zika virus infection is associated with microcephaly and other adverse pregnancy and infant outcomes. Perinatal transmission has been reported in 2 cases; 1 was asymptomatic, and the other had thrombocytopenia and a rash. Based on limited information, Zika virus infection in children is mild, similar to that in adults. The long-term sequelae of congenital, perinatal, and pediatric Zika virus infection are largely unknown. No vaccine to prevent Zika virus infection is available, and treatment is supportive. The primary means of preventing Zika virus infection is prevention of mosquito bites in areas with local Zika virus transmission. Given the possibility of limited local transmission of Zika virus in the continental United States and frequent travel from affected countries to the United States, US pediatric health care providers need to be familiar with Zika virus infection. This article reviews the Zika virus, its epidemiologic characteristics, clinical presentation, laboratory testing, treatment, and prevention to assist providers in the evaluation and management of children with possible Zika virus infection.
C1 [Karwowski, Mateusz P.; Nelson, Jennifer M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Karwowski, Mateusz P.] Ctr Dis Control & Prevent, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA USA.
   [Nelson, Jennifer M.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis & Hlth Promot, Atlanta, GA USA.
   [Staples, J. Erin; Fischer, Marc; Powers, Ann M.; Mead, Paul] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Fleming-Dutra, Katherine E.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Villanueva, Julie] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Honein, Margaret A.; Moore, Cynthia A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA USA.
RP Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-33, Atlanta, GA 30333 USA.
EM skr9@cdc.gov
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   American Academy of Pediatrics, 2015, RED BOOK ATL PED INF
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Arzuza-Ortega L, EMERG INFECT DIS
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brazil Ministry of Health, PROT SURV RESP OCC M
   Brazil Ministry of Health, PUBL HLTH EM OP CTR
   Brazil Ministry of Health, 2015, PUBL HLTH EM OP CTR, V47
   Brazil Ministry of Health, 2016, PUBL HLTH EM OP CTR
   Brunette GW, 2016, HLTH INFORM INT TRAV, V2016
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, MEM REV DIAGN TEST Z
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, RAP RISK ASS MICR BR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, MMWR MORB MORTAL WKL
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, N ENGL J MED
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   OLEARY DR, 2006, PEDIATRICS, V117
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852
   Ventura CV, ARQ BRAS OFTALMOL
   Ventura CV, LANCET
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   WESTAWAY EG, 1974, J IMMUNOL, V112, P656
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 63
TC 41
Z9 44
U1 1
U2 35
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD MAY
PY 2016
VL 137
IS 5
AR e20160621
DI 10.1542/peds.2016-0621
PG 13
WC Pediatrics
SC Pediatrics
GA DK8XZ
UT WOS:000375214300064
PM 27009036
OA Bronze
DA 2020-07-08
ER

PT J
AU Alfaro-Murillo, JA
   Parpia, AS
   Fitzpatrick, MC
   Tamagnan, JA
   Medlock, J
   Ndeffo-Mbah, ML
   Fish, D
   Avila-Aguero, ML
   Marin, R
   Ko, AI
   Galvani, AP
AF Alfaro-Murillo, Jorge A.
   Parpia, Alyssa S.
   Fitzpatrick, Meagan C.
   Tamagnan, Jules A.
   Medlock, Jan
   Ndeffo-Mbah, Martial L.
   Fish, Durland
   Avila-Aguero, Maria L.
   Marin, Rodrigo
   Ko, Albert I.
   Galvani, Alison P.
TI A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTBREAK
AB Background
   As Zika virus continues to spread, decisions regarding resource allocations to control the outbreak underscore the need for a tool to weigh policies according to their cost and the health burden they could avert. For example, to combat the current Zika outbreak the US President requested the allocation of $1.8 billion from Congress in February 2016.
   Methodology/Principal Findings
   Illustrated through an interactive tool, we evaluated how the number of Zika cases averted, the period during pregnancy in which Zika infection poses a risk of microcephaly, and probabilities of microcephaly and Guillain-Barre Syndrome (GBS) impact the cost at which an intervention is cost-effective. From Northeast Brazilian microcephaly incidence data, we estimated the probability of microcephaly in infants born to Zika-infected women (0.49% to 2.10%). We also estimated the probability of GBS arising from Zika infections in Brazil (0.02% to 0.06%) and Colombia (0.08%). We calculated that each microcephaly and GBS case incurs the loss of 29.95 DALYs and 1.25 DALYs per case, as well as direct medical costs for Latin America and the Caribbean of $91,102 and $28,818, respectively. We demonstrated the utility of our cost-effectiveness tool with examples evaluating funding commitments by Costa Rica and Brazil, the US presidential proposal, and the novel approach of genetically modified mosquitoes. Our analyses indicate that the commitments and the proposal are likely to be cost-effective, whereas the cost-effectiveness of genetically modified mosquitoes depends on the country of implementation.
   Conclusions/Significance
   Current estimates from our tool suggest that the health burden from microcephaly and GBS warrants substantial expenditures focused on Zika virus control. Our results justify the funding committed in Costa Rica and Brazil and many aspects of the budget outlined in the US president's proposal. As data continue to be collected, new parameter estimates can be customized in real-time within our user-friendly tool to provide updated estimates on cost-effectiveness of interventions and inform policy decisions in country-specific settings.
C1 [Alfaro-Murillo, Jorge A.; Parpia, Alyssa S.; Fitzpatrick, Meagan C.; Tamagnan, Jules A.; Ndeffo-Mbah, Martial L.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.
   [Alfaro-Murillo, Jorge A.; Parpia, Alyssa S.; Fitzpatrick, Meagan C.; Ndeffo-Mbah, Martial L.; Fish, Durland; Ko, Albert I.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Medlock, Jan] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.
   [Avila-Aguero, Maria L.] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Pediat Infect Dis Dept, San Jose, Costa Rica.
   [Marin, Rodrigo] Minist Salud, Programa Control Vectores, San Jose, Costa Rica.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Galvani, Alison P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
RP Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.; Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Galvani, AP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM alison.galvani@yale.edu
RI Avila-Aguero, Maria L./AAK-5086-2020; Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Fitzpatrick,
   Meagan/0000-0002-5248-2668
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH U01 GM087719, U01
   GM105627]
FX This research was supported by the National Institutes of Health (NIH
   U01 GM087719 and U01 GM105627). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2016, COUNTRIES TERRITORIE
   Boadle A., 2016, BRAZILS BNDES PROVID
   Brasil P, 2016, N ENGL J MED MASS ME
   Cao-Lormeau V. M., 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIKA VIRUS IN THE UN
   Centers for Disease Control and Prevention, 2016, TRANSCRIPT FOR CDC T
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P57
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, N ENGL J MED
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Instituto Brasileiro de Geografia e Estatistica, 2014, ESTIMATIVAS DA POPUL
   Instituto Nacional de Salud, 2016, CONTEO CASOS ZIKA MU
   Ministerio da Saude Brasil, 2016, PREVENCAO E COMBATE
   Ministerio de Salud, 2016, ANALISIS DE SITUACIO
   National Birth Defects Prevention Network, 2013, STATE BIRTH DEFECTS
   Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073
   Notimerica, 2015, MAS DE 10 MILLONES D
   Rasmussen SA, 2016, N ENGL J MED
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2015, REPORT NO VERSAO 1 2
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Stanaway JD, 2016, LANCET INFECT DIS
   Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09
   The White House Office of the Press Secretary, 2016, THE WHITE HOUSE OFFI
   The World Bank, 2014, PURCHASING POWER PAR
   UN Population Division, 2015, 2015 REVISION OF WOR
   United States Department of Labor: Bureau of Labor Statistics, 2016, DATABASES TABLES CAL
   WHO, 2016, MICROCEPHALY PANAMA
   World Development Indicators, 2013, BIRTH RATE CRUDE PER
   World Health Organization, 2010, CHOOSING INTERVENTIO
   World Health Organization, 2016, EMERGENCIES PREPARED
   World Health Organization, 2016, EMERGENCIES ZIKA VIR
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 39
TC 28
Z9 28
U1 0
U2 51
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004743
DI 10.1371/journal.pntd.0004743
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300070
PM 27205899
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aman, MJ
   Kashanchi, F
AF Aman, M. Javad
   Kashanchi, Fatah
TI Zika Virus: A New Animal Model for an Arbovirus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Editorial Material
C1 [Aman, M. Javad] Integrated BioTherapeut Inc, Gaithersburg, MD USA.
   [Kashanchi, Fatah] George Mason Univ, Mol Virol Lab, Manassas, VA USA.
RP Aman, MJ (corresponding author), Integrated BioTherapeut Inc, Gaithersburg, MD USA.
EM Jaman@integratedbiotherapeutics.com; fkashanc@gmu.edu
CR BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duvanel CB, 2001, J NEUROSCI RES, V65, P446, DOI 10.1002/jnr.1173
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Petersen L.R., 2016, N ENGL J MED
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   Rossi SL, 2016, AM J TROP MED HYG, P16
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Zanluca C, 2016, ZIKA VIRUS OVERVIEW
NR 12
TC 8
Z9 8
U1 0
U2 54
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004702
DI 10.1371/journal.pntd.0004702
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300044
PM 27149628
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dowall, SD
   Graham, VA
   Rayner, E
   Atkinson, B
   Hall, G
   Watson, RJ
   Bosworth, A
   Bonney, LC
   Kitchen, S
   Hewson, R
AF Dowall, Stuart D.
   Graham, Victoria A.
   Rayner, Emma
   Atkinson, Barry
   Hall, Graham
   Watson, Robert J.
   Bosworth, Andrew
   Bonney, Laura C.
   Kitchen, Samantha
   Hewson, Roger
TI A Susceptible Mouse Model for Zika Virus Infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; HEMORRHAGIC-FEVER VIRUS; RECEPTOR-KNOCKOUT
   MICE; WEST-NILE-VIRUS; BRAZIL; ADULT; TRANSMISSION; CHIKUNGUNYA;
   ISOLATIONS; OUTBREAK
AB Zika virus (ZIKV) is a mosquito-borne pathogen which has recently spread beyond Africa and into Pacific and South American regions. Despite first being detected in 1947, very little information is known about the virus, and its spread has been associated with increases in Guillain-Barre syndrome and microcephaly. There are currently no known vaccines or antivirals against ZIKV infection. Progress in assessing interventions will require the development of animal models to test efficacies; however, there are only limited reports on in vivo studies. The only susceptible murine models have involved intracerebral inoculations or juvenile animals, which do not replicate natural infection. Our report has studied the effect of ZIKV infection in type-I interferon receptor deficient (A129) mice and the parent strain (129Sv/Ev) after subcutaneous challenge in the lower leg to mimic a mosquito bite. A129 mice developed severe symptoms with widespread viral RNA detection in the blood, brain, spleen, liver and ovaries. Histological changes were also striking in these animals. 129Sv/Ev mice developed no clinical symptoms or histological changes, despite viral RNA being detectable in the blood, spleen and ovaries, albeit at lower levels than those seen in A129 mice. Our results identify A129 mice as being highly susceptible to ZIKV and thus A129 mice represent a suitable, and urgently required, small animal model for the testing of vaccines and antivirals.
C1 [Dowall, Stuart D.; Graham, Victoria A.; Rayner, Emma; Atkinson, Barry; Hall, Graham; Watson, Robert J.; Bosworth, Andrew; Bonney, Laura C.; Kitchen, Samantha; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
RP Dowall, SD (corresponding author), Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
EM stuart.dowall@phe.gov.uk
OI Atkinson, Barry/0000-0002-1348-7204; Bosworth,
   Andrew/0000-0003-0780-4362
FU Public Health England
FX This work was funded by a Public Health England Grant-In-Aid project.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aoki K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-105
   Atkinson B, 2016, EMERG INFECT DIS
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0
   Bogoch I, 2016, LANCET
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Buttigieg KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091516
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Christofferson RC, 2016, AM J TROP MED HYG
   Cohen S, 2016, NEUROLOGY, V86, P19, DOI 10.1212/WNL.0000000000002209
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2012, J GEN VIROL, V93, P560, DOI 10.1099/vir.0.038455-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   (ECDC) E.C.f.D.p.a.C, 2014, RAP RISK ZIK VIR INF
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Inomata K., 1980, BRAIN DEV, V2
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Jayasundara VK, 2008, B ENVIRON CONTAM TOX, V80, P374, DOI 10.1007/s00128-008-9392-y
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Milatovic D, 2002, J NEUROVIROL, V8, P295, DOI 10.1080/13550280290100743
   Mlakar J, 2016, N ENGL J MED
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nagel MA, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0614-5
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N
   REAGAN R L, 1955, Tex Rep Biol Med, V13, P934
   Salvador FS, 2015, TRAVEL MED INFECT DI
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Seymour RL, 2013, AM J TROP MED HYG, V88, P1170, DOI 10.4269/ajtmh.12-0674
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tetro JA, 2016, MICROBES INFECT
   Ventura CV, 2016, LANCET
   Waggoner JJ, 2016, J CLIN MICROBIOL
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, BRIEF ZIK VIR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 175
Z9 178
U1 2
U2 61
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004658
DI 10.1371/journal.pntd.0004658
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300025
PM 27149521
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kucharski, AJ
   Funk, S
   Eggo, RM
   Mallet, HP
   Edmunds, WJ
   Nilles, EJ
AF Kucharski, Adam J.
   Funk, Sebastian
   Eggo, Rosalind M.
   Mallet, Henri-Pierre
   Edmunds, W. John
   Nilles, Eric J.
TI Transmission Dynamics of Zika Virus in Island Populations: A Modelling
   Analysis of the 2013-14 French Polynesia Outbreak
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA OUTBREAK; COMMUNITY SIZE; DENGUE; AEGYPTI; VECTOR
AB Between October 2013 and April 2014, more than 30,000 cases of Zika virus (ZIKV) disease were estimated to have attended healthcare facilities in French Polynesia. ZIKV has also been reported in Africa and Asia, and in 2015 the virus spread to South America and the Caribbean. Infection with ZIKV has been associated with neurological complications including Guillain-Barre Syndrome (GBS) and microcephaly, which led the World Health Organization to declare a Public Health Emergency of International Concern in February 2015. To better understand the transmission dynamics of ZIKV, we used a mathematical model to examine the 2013-14 outbreak on the six major archipelagos of French Polynesia. Our median estimates for the basic reproduction number ranged from 2.6-4.8, with an estimated 11.5%(95% CI: 7.32-17.9%) of total infections reported. As a result, we estimated that 94% (95% CI: 91-97%) of the total population of the six archipelagos were infected during the outbreak. Based on the demography of French Polynesia, our results imply that if ZIKV infection provides complete protection against future infection, it would take 12-20 years before there are a sufficient number of susceptible individuals for ZIKV to re-emerge, which is on the same timescale as the circulation of dengue virus serotypes in the region. Our analysis suggests that ZIKV may exhibit similar dynamics to dengue virus in island populations, with transmission characterized by large, sporadic outbreaks with a high proportion of asymptomatic or unreported cases.
C1 [Kucharski, Adam J.; Funk, Sebastian; Eggo, Rosalind M.; Edmunds, W. John] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.
   [Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, Tahiti, France.
   [Nilles, Eric J.] World Hlth Org, Suva, Fiji.
RP Kucharski, AJ (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.
EM adam.kucharski@lshtm.ac.uk
OI Funk, Sebastian/0000-0002-2842-3406; Nilles, Eric/0000-0001-7044-5257;
   Eggo, Rosalind M/0000-0002-0362-6717
FU Medical Research CouncilMedical Research Council UK (MRC) [MR/K021524/1,
   MR/K021680/1]
FX AJK and SF are supported by the Medical Research Council ( fellowships
   MR/K021524/1 and MR/K021680/1). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   BLACK FL, 1966, J THEOR BIOL, V11, P207, DOI 10.1016/0022-5193(66)90161-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201
   Camacho A, 2011, P ROY SOC B-BIOL SCI, V278, P3635, DOI 10.1098/rspb.2011.0300
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centre d'hygiene et de salubrite publique, 2015, NOT INV AUT MALF CER
   Centre d'hygiene et de salubrite publique, 2014, SURV DENG ZIK POL FR
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   CIA-Central Intelligence Agency, 2016, WORLD FACTBOOK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Institut national de la statistique et des etudes economiques, 2012, POP SUBD ADM POL FRA
   Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65
   Lardeux F, 2001, MED VET ENTOMOL, V15, P167, DOI 10.1046/j.0269-283x.2001.00305.x
   Lessler J., 2016, BIORXIV
   Li DH, 2009, PAC ASIA J ASSOC INF, V1, P1
   Mallet H. P., 2015, B INFORM SANITAIRES
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   R Core Team, 2015, R LANG ENV STAT COMP
   Riviere F., 1988, THESIS
   Roth A, 2014, EURO SURVEILL, V19
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, P65, DOI 10.15585/mmwr.mm6503e2er
   Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09
   World Bank, 2016, CLIM CHANG KNOWL POR
NR 44
TC 105
Z9 107
U1 0
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004726
DI 10.1371/journal.pntd.0004726
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300064
PM 27186984
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Zmurko, J
   Marques, RE
   Schols, D
   Verbeken, E
   Kaptein, SJF
   Neyts, J
AF Zmurko, Joanna
   Marques, Rafael E.
   Schols, Dominique
   Verbeken, Erik
   Kaptein, Suzanne J. F.
   Neyts, Johan
TI The Viral Polymerase Inhibitor 7-Deaza-2 '-C-Methyladenosine Is a Potent
   Inhibitor of In Vitro Zika Virus Replication and Delays Disease
   Progression in a Robust Mouse Infection Model
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TRANSMISSION; ENCEPHALITIS
AB Zika virus (ZIKV) is an emerging flavivirus typically causing a dengue-like febrile illness, but neurological complications, such as microcephaly in newborns, have potentially been linked to this viral infection. We established a panel of in vitro assays to allow the identification of ZIKV inhibitors and demonstrate that the viral polymerase inhibitor 7-deaza-2'-C-methyladenosine (7DMA) efficiently inhibits replication. Infection of AG129 (IFN-alpha/beta and IFN-gamma receptor knock-out) mice with ZIKV resulted in acute neutrophilic encephalitis with viral antigens accumulating in neurons of the brain and spinal cord. Additionally, high levels of viral RNA were detected in the spleen, liver and kidney, and levels of IFN-gamma and IL-18 were systematically increased in serum of ZIKV-infected mice. Interestingly, the virus was also detected in testicles of infected mice. In line with its in vitro anti-ZIKV activity, 7DMA reduced viremia and delayed virus-induced morbidity and mortality in infected mice, which also validates this small animal model to assess the in vivo efficacy of novel ZIKV inhibitors. Since AG129 mice can generate an antibody response, and have been used in dengue vaccine studies, the model can also be used to assess the efficacy of ZIKV vaccines.
C1 [Zmurko, Joanna; Schols, Dominique; Kaptein, Suzanne J. F.; Neyts, Johan] KU Leuven Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Marques, Rafael E.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Verbeken, Erik] Univ Leuven, Dept Pathol, Leuven, Belgium.
   [Verbeken, Erik] Leuven Univ Hosp, Leuven, Belgium.
RP Neyts, J (corresponding author), KU Leuven Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium.
EM Johan.Neyts@rega.kuleuven.be
RI Kaptein, Suzanne JF/O-4714-2019; Marques, Rafael Elias/R-4890-2016;
   Schols, Dominique/S-9057-2017; Kaptein, Suzanne JF/O-8855-2018; Neyts,
   Johan/U-8267-2017
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Marques, Rafael
   Elias/0000-0002-6949-0947; Schols, Dominique/0000-0003-3256-5850;
   Kaptein, Suzanne JF/0000-0002-7935-0219; Neyts,
   Johan/0000-0002-0033-7514; Zmurko, Joanna/0000-0002-7617-5996
FU EU FP7European Union (EU) [264286]; Belgian Interuniversity Attraction
   Poles (IAP)Belgian Federal Science Policy Office [P7/45]; Fondation
   Dormeur, Vaduz; Hercules Foundation [ZW13-02]; Rega Foundation, KU
   Leuven
FX JZ's work was supported by: EU FP7 [FP7/2007-2013] project EUVIRNA under
   grant agreement no [264286]
   http://cordis.europa.eu/result/rcn/176954_de.html, a grant from the
   Belgian Interuniversity Attraction Poles (IAP) phase VII - P7/45
   (BELVIR) and the Fondation Dormeur, Vaduz. Part of this research work
   was performed using the 'Caps-It' research infrastructure (project
   ZW13-02) that was financially supported by the Hercules Foundation and
   Rega Foundation, KU Leuven. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bischoff K, 2012, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 2ND EDITION, P443, DOI 10.1016/B978-0-12-385926-6.00028-4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2015, ZIK VIR SYMPT TREATM
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Fauci AS, 2016, N ENGL J MED
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goorhuis A., 2015, PROMED
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Leyssen P, 2003, BRAIN PATHOL, V13, P279
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030
   Pan American Health Organization /World Health Organization, 2015, NEUR SYDNDR CONG MAL
   Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 38
TC 161
Z9 164
U1 1
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004695
DI 10.1371/journal.pntd.0004695
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300037
PM 27163257
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, LRC
   de Souza, AM
AF Cangussu da Silva, Lucia Regina
   de Souza, Adriano Miranda
TI Zika virus: what do we know about the viral structure, mechanisms of
   transmission, and neurological outcomes?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Zika virus; Transmission modes; Microcephaly; Guillain-Barre syndrome;
   Neurological disorders
ID FRENCH-POLYNESIA; DECEMBER 2013; INFECTION; BRAZIL; ENCEPHALITIS;
   FLAVIVIRUS; EPIDEMIC; OUTBREAK; TRAVEL; BRAIN
AB The Zika virus epidemic that started in Brazil in 2014 has spread to >30 countries and territories in Latin America, leading to a rapid rise in the incidence of microcephalic newborns and adults with neurological complications. At the beginning of the outbreak, little was known about Zika virus morphology, genome structure, modes of transmission, and its potential to cause neurological malformations and disorders. With the advancement of basic science, discoveries of the mechanisms of strain variability, viral transfer to the fetus, and neurovirulence were published. These will certainly lead to the development of strategies to block vertical viral transmission, neuronal invasion, and pathogenesis in the near future. This paper reviews the current literature on Zika virus infections, with the aim of gaining a holistic insight into their etiology and pathogenesis. We discuss Zika virus history and epidemiology in Brazil, viral structure and taxonomy, old and newly identified transmission modes, and neurological consequences of infection.
C1 [Cangussu da Silva, Lucia Regina] Univ Salgado de Oliveira, Dept Ciencias Biomed, Juiz De Fora, MG, Brazil.
   [de Souza, Adriano Miranda] Univ Fed Juiz de Fora, Dept Farmacol, Juiz De Fora, MG, Brazil.
RP da Silva, LRC (corresponding author), Univ Salgado de Oliveira, Dept Ciencias Biomed, Juiz De Fora, MG, Brazil.
EM Prof.luciacangussu@gmail.com
CR Adibi JJ, 2016, LANCET, V6736, P1
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bonaldo MC, 2016, BIORXIV
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOLOGICO
   Brito CAA, 2007, REV SOC BRAS MED TRO, V40, P236, DOI 10.1590/S0037-86822007000200019
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V6736, P1
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira DB, 2016, REV SOC BRAS MED TRO, V49, P125, DOI 10.1590/0037-8682-0208-2015
   de Sousa Adriano Miranda, 2014, Trop Med Health, V42, P115, DOI 10.2149/tmh.2014-06
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcez PP, 2016, COMBINED PROTEOME TR, DOI DOI 10.7287/PEERJ.PREPRINTS.2033V1
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Alves JAG, 2009, REV BRAS GINECOL OBS, V31, P89
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Henry R, 2014, EMERG INFECT DIS, V20, P1090, DOI DOI 10.3201/EID2006.131508
   Heymann DL, 2016, LANCET, V6736, P1
   Koga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124004
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude (BR), 2016, INF EP 25 SEM EP SE
   Ministerio da Saude. Brasil. Agencia Nacional de Vigilancia (ANVISA), 2015, 0012015 ANVISA CGSHG, P1
   Ministerio da Saude. Brasil. Instituto Evandro Chagas (IEC), 2015, COMPR REL VIR ZIK CO
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nyati KK, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/758639
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   PAHO/WHO, 2015, EP AL ZIK VIR INF
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Piorkowski G, 2016, GENOME ANNOUNC, V2
   Pyke AT, 2014, PLOS CURRENTS
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   Roth A, 2014, EUROSURVEILLANCE, V19, P20929
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stokic DS, 2012, FRONT NEUROL, V3, P1
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Vasconcelos P. F. C., 2015, REV PANAMAZ SAUDE, V2, P9
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   WHO, 2016, AMB AIR POLL GLOB AS, P1
   World Health Organization (WHO), 2016, 31 WHO, P1
   World Health Organization (WHO), 2016, ZIK VIR MICR GUILL B, V2016, P1
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeinad Audrey K., 2004, Rev. Bras. Hematol. Hemoter., V26, P114, DOI 10.1590/S1516-84842004000200009
NR 86
TC 10
Z9 11
U1 1
U2 91
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2016
VL 49
IS 3
BP 267
EP 273
DI 10.1590/0037-8682-0150-2016
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ6YW
UT WOS:000379354400002
PM 27384821
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Villamil-Gomez, WE
   Franco-Paredes, C
AF Rodriguez-Morales, Alfonso J.
   Villamil-Gomez, Wilmer E.
   Franco-Paredes, Carlos
TI The arboviral burden of disease caused by co-circulation and
   co-infection of dengue, chikungunya and Zika in the Americas
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
ID LATIN-AMERICA; THREAT
C1 [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Grp Res, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.; Villamil-Gomez, Wilmer E.; Franco-Paredes, Carlos] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, SUE Caribe, Programa Doctorado Med Trop, Barranquilla, Colombia.
   [Franco-Paredes, Carlos] Phoebe Putney Mem Hosp, Albany, GA USA.
   [Franco-Paredes, Carlos] Hosp Infantil Mexico Dr Federico Gomez, Federico Gomez, Mexico City, DF, Mexico.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Colombian Collaborat Network Zika RECOLZIKA, Pereira 660003, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016; Franco-Paredes, Carlos/R-4226-2019
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; 
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Bansal R, 2015, TROP DOCT, V45, P52, DOI 10.1177/0049475514552835
   Kumar K Jagadish, 2012, J Indian Med Assoc, V110, P752
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Parreira R, 2014, EUROSURVEILL B EUR M, V19
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
NR 10
TC 63
Z9 66
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 177
EP 179
DI 10.1016/j.tmaid.2016.05.004
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000002
PM 27224471
DA 2020-07-08
ER

PT J
AU Werner, H
   Fazecas, T
   Guedes, B
   Dos Santos, JL
   Daltro, P
   Tonni, G
   Campbell, S
   Araujo, E
AF Werner, H.
   Fazecas, T.
   Guedes, B.
   Lopes Dos Santos, J.
   Daltro, P.
   Tonni, G.
   Campbell, S.
   Araujo Junior, E.
TI Intrauterine Zika virus infection and microcephaly: correlation of
   perinatal imaging and three-dimensional virtual physical models
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
ID SCAN DATA; ULTRASOUND; BRAZIL; RECONSTRUCTION
C1 [Werner, H.; Fazecas, T.; Guedes, B.; Daltro, P.] Clin Diagnost Imagem CPDI, Dept Radiol, Rio De Janeiro, Brazil.
   [Lopes Dos Santos, J.] Pontificia Univ Catolica PUC Rio, Dept Arts & Design, Rio De Janeiro, Brazil.
   [Tonni, G.] AUSL Reggio Emilia, Guastalla Civil Hosp, Dept Obstet & Gynecol, Reggio Emilia, Italy.
   [Campbell, S.] Create Hlth Clin, London, England.
   [Araujo Junior, E.] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, Brazil.
RP Araujo, E (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, Brazil.
EM araujojred@terra.com.br
RI Werner, Heron/W-1578-2019; Tonni, Gabriele/AAM-9842-2020; Junior, Edward
   Araujo/E-1228-2012
OI Junior, Edward Araujo/0000-0002-6145-2532
CR Araujo E, 2014, J ULTRAS MED, V33, P1185, DOI 10.7863/ultra.33.7.1185
   Besnard M, 2014, EURO SURVEILL, V19
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E., 2013, EURO SURVEILL, V19
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Werner H, 2015, J MATERN-FETAL NEO M, P1
   Werner H, 2015, MED ULTRASON, V17, P252, DOI 10.11152/mu.2013.2066.172.tert
   Werner H, 2015, CHILD NERV SYST, V31, P511, DOI 10.1007/s00381-015-2641-6
   Werner H, 2014, ULTRASOUND Q, V30, P69, DOI 10.1097/RUQ.0000000000000048
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 21
TC 28
Z9 30
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD MAY
PY 2016
VL 47
IS 5
BP 657
EP 660
DI 10.1002/uog.15901
PG 4
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DL9KI
UT WOS:000375961100024
PM 26923098
OA Bronze
DA 2020-07-08
ER

PT J
AU Fernandes, LN
   de Paula, MB
   Araujo, AB
   Goncalves, EFB
   Romano, CM
   Natal, D
   Malafronte, RD
   Marrelli, MT
   Levi, JE
AF Fernandes, Licia Natal
   de Paula, Marcia Bicudo
   Araujo, Alessandra Bergamo
   Bertoletti Goncalves, Elisabeth Fernandes
   Romano, Camila Malta
   Natal, Delsio
   Malafronte, Rosely dos Santos
   Marrelli, Mauro Toledo
   Levi, Jose Eduardo
TI Detection of Culex flavivirus and Aedes flavivirus nucleotide sequences
   in mosquitoes from parks in the city of Sao Paulo, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Flavivirus; Mosquitoes; Parks; Polymerase chain reaction
ID WEST-NILE-VIRUS; INSECT-SPECIFIC FLAVIVIRUS; FUSING AGENT VIRUS;
   DIPTERA-CULICIDAE; ZIKA VIRUS; YUCATAN PENINSULA; YELLOW-FEVER;
   TRANSMISSION; IDENTIFICATION; POPULATION
AB The dengue viruses are widespread in Brazil and are a major public health concern. Other flaviviruses also cause diseases in humans, although on a smaller scale. The city of Sao Paulo is in a highly urbanized area with few green spaces apart from its parks, which are used for recreation and where potential vertebrate hosts and mosquito vectors of pathogenic Flavivirus species can be found. Although this scenario can contribute to the transmission of Flavivirus to humans, little is known about the circulation of members of this genus in these areas. In light of this, the present study sought to identify Flavivirus infection in mosquitoes (Diptera: Culicidae) collected in parks in the city of Sao Paulo. Seven parks in different sectors of the city were selected. Monthly mosquito collections were carried out in each park from March 2011 to February 2012 using aspiration and traps (Shannon and CD C-CO2). Nucleic acids were extracted from the mosquitoes collected and used for reverse-transcriptase and real-time polymerase chain reactions with genus-specific primers targeting a 200-nucleotide region in the Flavivirus NS5 gene. Positive samples were sequenced, and phylogenetic analyses were performed. Culex and Aedes were the most frequent genera of Culicidae collected. Culex flavivirus (CxFV)-related and Aedes flavivirus (AEFV)- related nucleotide sequences were detected in 17 pools of Culex and two pools of Aedes mosquitoes, respectively, among the 818 pools of non-engorged females analyzed. To the best of our knowledge, this is the first report of CxFV and AEFV in the city of Sao Paulo and Latin America, respectively. Both viruses are insect- specific flaviviruses, a group known to replicate only in mosquito cells and induce a cytopathic effect in some situations. Hence, our data suggests that CxFV and AEFV are present in Culex and Aedes mosquitoes, respectively, in parks in the city of Sao Paulo. Even though Flavivirus species of medical importance were not detected, surveillance is recommended in the study areas because of the presence of vertebrates and mosquitoes that could act as amplifying hosts and vectors of flaviviruses, providing the required conditions for circulation of these viruses. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Fernandes, Licia Natal; Malafronte, Rosely dos Santos] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Protozool, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
   [de Paula, Marcia Bicudo; Natal, Delsio; Marrelli, Mauro Toledo] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
   [Araujo, Alessandra Bergamo] Prefeitura Sao Paulo, Ctr Controle Zoonoses, Lab Fauna Sinantrop, Rua Santa Eulalia 86, BR-02031020 Sao Paulo, SP, Brazil.
   [Bertoletti Goncalves, Elisabeth Fernandes] Prefeitura Sao Paulo, Dept Parques & Areas Verdes, Ave 4 Centenario, BR-04030090 Sao Paulo, SP, Brazil.
   [Romano, Camila Malta; Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop Sao Paulo, Virol Lab, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
   [Levi, Jose Eduardo] Fundacao Prosangue, Hemoctr Sao Paulo, Dept Biol Mol, Av Dr Eneas de Carvalho Aguiar 155, BR-05403000 Sao Paulo, SP, Brazil.
RP Fernandes, LN (corresponding author), Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Protozool, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
EM licianatal@usp.br
RI Romano, Camila M/C-8185-2013; Marrelli, Mauro/H-2568-2013; Fernandes,
   Licia N/F-9619-2016
OI Marrelli, Mauro/0000-0002-0312-8777; Natal Fernandes,
   Licia/0000-0001-8008-1338
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: BIOTA
   Program)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2010/51230-8]
FX We would like to thank Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP: BIOTA Program: Project 2010/51230-8) for providing
   funding. Our thanks also to all the other members of the Department of
   Epidemiology in the Faculty of Public Health, University of Sao Paulo
   (especially Dr. Paulo Roberto Urbinatti and Aristides Fernandes), the
   staff at the Zoonosis Control Center/COVISA/SMS/PMSP (in particular
   Maria Helena Silva Homem de Mello and Renildo Souza Teixeira) and the
   staff at the Department of Parks and Green Spaces, SVMA-Sao Paulo, who
   helped with the field and laboratory work. Finally, we would like to
   thank Almir Robson Ferreira (Institute of Tropical Medicine, University
   of Sao Paulo) for providing the map.
CR Diaz LA, 2008, EMERG INFECT DIS, V14, P689, DOI 10.3201/eid1404.071257
   Almeida A. F., 2007, FAUN SILV QUEM OND V
   An Shu-yi, 2012, Chinese Journal of Virology, V28, P511
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Bosch I, 2007, EMERG INFECT DIS, V13, P651, DOI 10.3201/eid1304.061383
   Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324
   Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chen YY, 2013, COMP IMMUNOL MICROB, V36, P387, DOI 10.1016/j.cimid.2013.02.001
   Christophers S. R., 1960, BIONOMICS STRUCTURE
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   de BUSTAMANTE F M, 1951, Folha Med, V32, P53
   de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x
   de Paula MB, 2015, BIOTA NEOTROP, V15, DOI 10.1590/1676-0611-BN-2014-0026
   Espinoza-Gomez F, 2011, ARCH VIROL, V156, P1263, DOI 10.1007/s00705-011-0967-2
   Farfan-Ale JA, 2010, VECTOR-BORNE ZOONOT, V10, P777, DOI 10.1089/vbz.2009.0196
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85
   Figueiredo L. T., 1998, OVERVIEW ARBOVIROLOG, P154
   Figueiredo L. T. M., 2010, Dengue Bulletin, V34, P6
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   FORATTINI O.P., 2002, CULICIDOLOGIA MED, V2
   Goenaga S, 2014, J MED ENTOMOL, V51, P900, DOI 10.1603/ME13172
   GOMES AD, 1985, REV SAUDE PUBL, V19, P190, DOI 10.1590/S0034-89101985000200009
   Grisenti M, 2015, J GEN VIROL, V96, P420, DOI 10.1099/vir.0.069625-0
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025
   Johnson N, 2010, VECTOR-BORNE ZOONOT, V10, P665, DOI 10.1089/vbz.2009.0210
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kihara Y, 2007, J VIROL METHODS, V146, P372, DOI 10.1016/j.jviromet.2007.07.008
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006
   Komar N, 2000, REV SCI TECH OIE, V19, P166, DOI 10.20506/rst.19.1.1201
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Laporta GZ, 2006, REV BRAS ENTOMOL, V50, P125, DOI 10.1590/S0085-56262006000100019
   Luna E. J. A., 2003, EPIDEMIOL SERV SAUDE, V12, P7
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   Marin M. S., 1995, VIROLOGY, V213, P169
   Mattar S, 2005, EMERG INFECT DIS, V11, P1497, DOI 10.3201/eid1109.050426
   Medeiros-Sousa AR, 2015, ACTA TROP, V150, P200, DOI 10.1016/j.actatropica.2015.08.002
   Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1
   Melandri V, 2012, MEM I OSWALDO CRUZ, V107, P1073, DOI 10.1590/S0074-02762012000800020
   Montes J, 2005, REV SAUDE PUBL, V39, P578, DOI 10.1590/S0034-89102005000400010
   Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001
   Morais Sirlei Antunes de, 2006, Rev. Bras. entomol., V50, P413, DOI 10.1590/S0085-56262006000300012
   Morales-Betoulle ME, 2008, J MED ENTOMOL, V45, P1187, DOI 10.1603/0022-2585(2008)45[1187:CFIFMI]2.0.CO;2
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   NASCI RS, 1981, MOSQ NEWS, V41, P808
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   NATAL D, 1984, REV SAUDE PUBL, V18, P418, DOI 10.1590/S0034-89101984000500013
   Natal D., 2002, BIOLOGICO, V62, P205
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081
   Paiva BR, 2006, ACTA TROP, V99, P252, DOI 10.1016/j.actatropica.2006.08.009
   Pauvolid-Correa A, 2011, MEM I OSWALDO CRUZ, V106, P467, DOI 10.1590/S0074-02762011000400014
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Pereira LE, 2001, REV SAUDE PUBL, V35, P119, DOI 10.1590/S0034-89102001000200003
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Rizzo F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-395
   Roiz D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-223
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Saiyasombat R, 2010, ARCH VIROL, V155, P983, DOI 10.1007/s00705-010-0665-5
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Silverio ED, 2011, REV SOC BRAS MED TRO, V44, P504, DOI 10.1590/S0037-86822011000400020
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   SUNDIN DR, 1988, AM J TROP MED HYG, V38, P428, DOI 10.4269/ajtmh.1988.38.428
   Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Travassos da Rosa JFS, 1998, OVERVIEW ARBOVIROLOG, P19
   Urbinatti PR, 2001, REV SAUDE PUBL, V35, P461, DOI 10.1590/S0034-89102001000500009
   Vasconcelos P. F., 2005, TRATADO INFECTOLOGIA, P289
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2003, T ROY SOC TROP MED H, V97, P60, DOI 10.1016/S0035-9203(03)90023-X
   VASCONCELOS PFD, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Wang HY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-73
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 97
TC 7
Z9 7
U1 0
U2 96
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2016
VL 157
BP 73
EP 83
DI 10.1016/j.actatropica.2016.01.026
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH4MZ
UT WOS:000372761400009
PM 26829359
DA 2020-07-08
ER

PT J
AU Jaffe, S
AF Jaffe, Susan
TI US responds to increase in Zika cases
SO LANCET
LA English
DT Editorial Material
AB Health officials pursue Zika research and prepare to combat a formidable foe-the mosquito-despite uncertain funding. Susan Jaffe, The Lancet's Washington correspondent, reports.
NR 0
TC 1
Z9 1
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1801
EP 1802
DI 10.1016/S0140-6736(16)30360-9
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100011
PM 27203490
OA Bronze
DA 2020-07-08
ER

PT J
AU Grobusch, MP
   Karimi, O
   Schinkel, J
   Codrington, J
   Vreden, SGS
   Vermaat, JS
   Stijnis, C
   Goorhuis, A
AF Grobusch, Martin Peter
   Karimi, Ouafae
   Schinkel, Janke
   Codrington, John
   Vreden, Stephen Gerold S.
   Vermaat, Joost S.
   Stijnis, Cornelis
   Goorhuis, Abraham
TI Uncommon presentation of Zika fever or co-infection? Reply
SO LANCET
LA English
DT Letter
ID VIRUS
C1 [Grobusch, Martin Peter; Karimi, Ouafae; Stijnis, Cornelis; Goorhuis, Abraham] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
   [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Lab Clin Virol, Dept Med Microbiol, NL-1100 DD Amsterdam, Netherlands.
   [Vermaat, Joost S.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
   [Codrington, John] Acad Hosp Paramaribo, Dept Lab, Paramaribo, Suriname.
   [Vreden, Stephen Gerold S.] Acad Hosp Paramaribo, Internal Med & Infect Dis, Paramaribo, Suriname.
RP Grobusch, MP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
EM m.p.grobusch@amc.uva.nl
RI Schinkel, Janke/I-3099-2012
OI Schinkel, Janke/0000-0002-1112-0644; Vermaat, Joost/0000-0002-1628-6256
CR Breeveld FJV, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-95
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
NR 4
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1813
EP 1814
DI 10.1016/S0140-6736(16)30178-7
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100020
PM 27203499
OA Bronze
DA 2020-07-08
ER

PT J
AU Cordeiro, MT
   Pena, LJ
   Brito, CA
   Gil, LH
   Marques, ET
AF Cordeiro, Marli Tenorio
   Pena, Lindomar J.
   Brito, Carlos A.
   Gil, Laura H.
   Marques, Ernesto T.
TI Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates
   with microcephaly in Brazil
SO LANCET
LA English
DT Letter
C1 [Cordeiro, Marli Tenorio; Pena, Lindomar J.; Gil, Laura H.; Marques, Ernesto T.] Fiocruz MS, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, BR-50670420 Recife, PE, Brazil.
   [Brito, Carlos A.] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Marques, Ernesto T.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Cordeiro, MT (corresponding author), Fiocruz MS, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, BR-50670420 Recife, PE, Brazil.
EM marli@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
CR Carrolla ID, 2007, TRAVEL MED INFECT DI, V5, P3183
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 4
TC 77
Z9 77
U1 0
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1811
EP 1812
DI 10.1016/S0140-6736(16)30253-7
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100017
PM 27103126
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Musso, D
   de Pina, JJ
   Nhan, TX
   Deparis, X
AF Musso, Didier
   de Pina, Jean Jacques
   Tu-Xuan Nhan
   Deparis, Xavier
TI Uncommon presentation of Zika fever or co-infection?
SO LANCET
LA English
DT Letter
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Tahiti, France.
   [de Pina, Jean Jacques; Tu-Xuan Nhan] Inst Louis Malarde, Diag Lab, F-98713 Tahiti, France.
   [Deparis, Xavier] UMR SESSTIM, French Ctr Epidemiol & Publ Hlth, Marseille, France.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Tahiti, France.
EM dmusso@ilm.pf
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; DE
   PINA, Jean Jacques/0000-0002-2081-3936
CR Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
NR 5
TC 8
Z9 8
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1812
EP 1813
DI 10.1016/S0140-6736(16)30317-8
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100019
PM 27203498
OA Bronze
DA 2020-07-08
ER

PT J
AU Nielsen, KK
   Bygbjerg, IC
AF Nielsen, Karoline Kragelund
   Bygbjerg, Ib Christian
TI Zika virus and hyperglycaemia in pregnancy
SO LANCET
LA English
DT Letter
C1 [Nielsen, Karoline Kragelund; Bygbjerg, Ib Christian] Univ Copenhagen, Dept Publ Hlth, Global Hlth Sect, DK-1014 Copenhagen, Denmark.
RP Nielsen, KK (corresponding author), Univ Copenhagen, Dept Publ Hlth, Global Hlth Sect, DK-1014 Copenhagen, Denmark.
EM kani@sund.ku.dk
RI Nielsen, Karoline/E-2228-2016
OI Bygbjerg, Ib/0000-0001-9100-2754; Kragelund Nielsen,
   Karoline/0000-0002-4058-0615
CR [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Arteaga J, 2008, REV INVEST CLIN, V60, P107
   LOWY C, 1986, DIABETIC MED, V3, P458, DOI 10.1111/j.1464-5491.1986.tb00791.x
   Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Trujillo J, 2015, DIABETES RES CLIN PR, V108, P288, DOI 10.1016/j.diabres.2015.02.007
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 7
TC 3
Z9 3
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1812
EP 1812
DI 10.1016/S0140-6736(16)30254-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100018
PM 27103128
OA Bronze
DA 2020-07-08
ER

PT J
AU Palacios, R
   Poland, GA
   Kalil, J
AF Palacios, Ricardo
   Poland, Gregory A.
   Kalil, Jorge
TI Another emerging arbovirus, another emerging vaccine: Targeting Zika
   virus
SO VACCINE
LA English
DT Editorial Material
ID INFECTION; OUTBREAK; BRAZIL
C1 [Palacios, Ricardo; Kalil, Jorge] Inst Butantan, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
   [Poland, Gregory A.] Mayo Clin, Dept Internal Med, Mayo Vaccine Res Grp, Rochester, MN USA.
   [Kalil, Jorge] Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil.
RP Kalil, J (corresponding author), Inst Butantan, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM jorge.kalil@butantan.gov.br
RI KALIL, JORGE/C-8029-2012; Palacios, Ricardo/AAN-7606-2020; Palacios,
   Ricardo/B-7248-2018
OI KALIL, JORGE/0000-0001-8415-4274; Palacios, Ricardo/0000-0002-1410-8579;
   Palacios, Ricardo/0000-0002-1410-8579
CR [Anonymous], 2015, EV SAUD PUBL REL AOS
   [Anonymous], 2016, MON CAS MICR BRAS
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boseley S, 2014, WHO SEVERAL 100 1000
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V. M., 2016, LANCET
   da Saude Ministerio, 2015, B EP, V46, P1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Direction de la sante, 2015, B SURVEILL SANIT
   Dixit R., 2016, VACCINE
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kwong JC, 2013, LANCET INFECT DIS, V13, P769, DOI 10.1016/S1473-3099(13)70104-X
   Mallet HP, 2015, BISES B INFORM SANIT, P1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Sencer DJ, 2006, EMERG INFECT DIS, V12, P29
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 7
Z9 7
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 29
PY 2016
VL 34
IS 20
BP 2291
EP 2293
DI 10.1016/j.vaccine.2016.03.059
PG 3
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DL3AF
UT WOS:000375505900001
PM 27015734
DA 2020-07-08
ER

PT J
AU Guo, J
AF Guo, Jia
TI Studies using IPS cells support a possible link between ZIKA and
   microcephaly
SO CELL AND BIOSCIENCE
LA English
DT Editorial Material
DE Zika virus; Human neural progenitor cells; Microcephaly
ID VIRUS
AB There is a suspected link between Brazilian babies born with microcephaly and Zika virus (ZIKV) infection. However, little is know about the brain cell targets and the mechanisms that Zika virus may cause microcephaly. A recent report demonstrated that Zika virus infection increases cell death and dysregulates cell-cycle, resulting in attenuated human neural progenitor cells growth. This study fills a major gap and serves as an entry point to establish a mechanistic link between Zika infection and microcephaly.
C1 [Guo, Jia] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.
RP Guo, J (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.
EM jguo3@gmu.edu
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
NR 6
TC 5
Z9 6
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD APR 26
PY 2016
VL 6
AR 28
DI 10.1186/s13578-016-0096-4
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DK2EP
UT WOS:000374727700001
PM 27119012
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dasgupta, S
   Reagan-Steiner, S
   Goodenough, D
   Russell, K
   Tanner, M
   Lewis, L
   Petersen, EE
   Powers, AM
   Kniss, K
   Meaney-Delman, D
   Oduyebo, T
   O'Leary, D
   Chiu, S
   Talley, P
   Hennessey, M
   Hills, S
   Cohn, A
   Gregory, C
AF Dasgupta, Sharoda
   Reagan-Steiner, Sarah
   Goodenough, Dana
   Russell, Kate
   Tanner, Mary
   Lewis, Lillianne
   Petersen, Emily E.
   Powers, Ann M.
   Kniss, Krista
   Meaney-Delman, Dana
   Oduyebo, Titilope
   O'Leary, Dan
   Chiu, Sophia
   Talley, Pamela
   Hennessey, Morgan
   Hills, Susan
   Cohn, Amanda
   Gregory, Christopher
CA Zika Virus Response Epidemiology L
TI Patterns in Zika Virus Testing and Infection, by Report of Symptoms and
   Pregnancy Status - United States, January 3-March 5, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID REPRODUCTIVE AGE; EXPOSURE; WOMEN; BRAIN
C1 [Dasgupta, Sharoda; Russell, Kate; Tanner, Mary; Lewis, Lillianne; Oduyebo, Titilope; Chiu, Sophia; Talley, Pamela; Hennessey, Morgan] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Dasgupta, Sharoda; Tanner, Mary] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Reagan-Steiner, Sarah] CDC, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Goodenough, Dana] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Russell, Kate; Kniss, Krista] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Lewis, Lillianne] CDC, Natl Ctr Environm Hlth, Div Environm Hazards & Hlth Effects, Atlanta, GA 30333 USA.
   [Petersen, Emily E.; Oduyebo, Titilope] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Powers, Ann M.; Hennessey, Morgan; Hills, Susan] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [O'Leary, Dan] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Chiu, Sophia] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Washington, DC USA.
   [Talley, Pamela] Minnesota Dept Hlth, Minneapolis, MN 55414 USA.
   [Cohn, Amanda] CDC, Off Director, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Gregory, Christopher] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
RP Reagan-Steiner, S (corresponding author), CDC, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
EM sor1@cdc.gov
OI Russell, Kate/0000-0001-9343-3355; Lewis, Lillianne/0000-0002-0957-2190
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   CDC, 2016, AR WITH ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rasmussen SA, 2016, N ENGL J MED
NR 10
TC 19
Z9 19
U1 0
U2 13
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 22
PY 2016
VL 65
IS 15
BP 395
EP 399
DI 10.15585/mmwr.mm6515e1
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK0WT
UT WOS:000374633600003
PM 27101541
OA Bronze
DA 2020-07-08
ER

PT J
AU Sirohi, D
   Chen, ZG
   Sun, L
   Klose, T
   Pierson, TC
   Rossmann, MG
   Kuhn, RJ
AF Sirohi, Devika
   Chen, Zhenguo
   Sun, Lei
   Klose, Thomas
   Pierson, Theodore C.
   Rossmann, Michael G.
   Kuhn, Richard J.
TI The 3.8 angstrom resolution cryo-EM structure of Zika virus
SO SCIENCE
LA English
DT Article
ID DENGUE VIRUS; TRANSMISSION; INFECTION; COMPLEX
AB The recent rapid spread of Zika virus and its unexpected linkage to birth defects and an autoimmune neurological syndrome have generated worldwide concern. Zika virus is a flavivirus like the dengue, yellow fever, and West Nile viruses. We present the 3.8 angstrom resolution structure of mature Zika virus, determined by cryo-electron microscopy (cryo-EM). The structure of Zika virus is similar to other known flavivirus structures, except for the similar to 10 amino acids that surround the Asn(154) glycosylation site in each of the 180 envelope glycoproteins that make up the icosahedral shell. The carbohydrate moiety associated with this residue, which is recognizable in the cryo-EM electron density, may function as an attachment site of the virus to host cells. This region varies not only among Zika virus strains but also in other flaviviruses, which suggests that differences in this region may influence virus transmission and disease.
C1 [Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.
   [Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Rossmann, MG; Kuhn, RJ (corresponding author), Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.; Rossmann, MG; Kuhn, RJ (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
EM mr@purdue.edu; kuhnr@purdue.edu
RI Sirohi, Devika/I-7136-2019
OI Sirohi, Devika/0000-0001-8601-6211
FU National Institute of Allergy and Infectious Diseases of the NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI073755, R01AI076331]; National Institute of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID)
FX We thank X. de Lamballerie (Emergence des Pathologies Virales,
   Aix-Marseille Universite, Marseille, France) and the European Virus
   Archive Goes Global (EVAg) for consenting to the use of the H/PF/2013
   ZIKV strain for this study under a material transfer agreement with
   EVAg's partner, Aix-Marseille Universite, and we thank M. S. Diamond
   (Washington University, St. Louis, MO, USA) for sending the virus. We
   acknowledge E. Frye for help with sequence alignments. We also
   acknowledge the use of the Purdue cryo-EM facility. We are grateful to
   W. Jiang for his jspr program, which was used to perform the anisotropic
   magnification corrections, and Y. Liu for providing help in submitting
   the Protein Data Bank (PDB) coordinates. The work presented in this
   report was funded by the National Institute of Allergy and Infectious
   Diseases of the NIH through grants R01AI073755 and R01AI076331 to M.G.R.
   and R.J.K. T.C.P was supported by the intramural program of the National
   Institute of Allergy and Infectious Diseases. Supporting information for
   this research is provided in the supplementary materials. The atomic
   coordinates and cryo-EM density maps for the mature ZIKV are available
   at the PDB and Electron Microscopy Data Bank under accession codes 5IRE
   and EMD-8116, respectively.
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Guo F, 2014, METHODS MOL BIOL, V1117, P401, DOI 10.1007/978-1-62703-776-1_19
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 36
TC 358
Z9 379
U1 7
U2 127
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 22
PY 2016
VL 352
IS 6284
BP 467
EP 470
DI 10.1126/science.aaf5316
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ8RH
UT WOS:000374479700049
PM 27033547
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Huzly, D
   Hanselmann, I
   Schmidt-Chanasit, J
   Panning, M
AF Huzly, D.
   Hanselmann, I.
   Schmidt-Chanasit, J.
   Panning, M.
TI High specificity of a novel Zika virus ELISA in European patients after
   exposure to different flaviviruses
SO EUROSURVEILLANCE
LA English
DT Article
ID REACTIVITY; SEROLOGY
AB The current Zika virus (ZIKV) epidemic in the Americas caused an increase in diagnostic requests in European countries. Here we demonstrate high specificity of the Euroimmun anti-ZIKV IgG and IgM ELISA tests using putative cross-reacting sera of European patients with antibodies against tick-borne encephalitis virus, dengue virus, yellow fever virus and hepatitis C virus. This test may aid in counselling European travellers returning from regions where ZIKV is endemic.
C1 [Huzly, D.; Hanselmann, I.; Panning, M.] Univ Freiburg, Med Ctr, Inst Virol, Freiburg, Germany.
   [Schmidt-Chanasit, J.] Natl Reference Ctr Trop Infect Dis, Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Hamburg, Germany.
   [Schmidt-Chanasit, J.] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
RP Panning, M (corresponding author), Univ Freiburg, Med Ctr, Inst Virol, Freiburg, Germany.
EM marcus.panning@uniklinik-freiburg.de
RI Panning, Marcus/I-7889-2016
CR Alidjinou EK, 2016, J CLIN VIROL, V75, P60, DOI 10.1016/j.jcv.2015.11.025
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   [Anonymous], ZIK VIR INF SHORT FA
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   European Centre for Disease Prevention and Control (ECDC), ZIK VIR INF FACT SHE
   Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.14.20441
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Venturi G, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.10.30163
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
NR 13
TC 73
Z9 75
U1 0
U2 25
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 21
PY 2016
VL 21
IS 16
BP 9
EP 12
AR 30203
DI 10.2807/1560-7917.ES.2016.21.16.30203
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DK3QZ
UT WOS:000374833800003
PM 27126052
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mouchtouri, VA
   Hadjichristodoulou, C
AF Mouchtouri, V. A.
   Hadjichristodoulou, C.
TI European Union SHIPSAN ACT Joint Action publishes interim guidance on
   maritime transport and Zika virus disease
SO EUROSURVEILLANCE
LA English
DT News Item
C1 [Mouchtouri, V. A.; Hadjichristodoulou, C.] Univ Thessaly, European Union SHIPSAN ACT Joint Action, Larisa, Greece.
   [Mouchtouri, V. A.; Hadjichristodoulou, C.] Univ Thessaly, Dept Hyg & Epidemiol, Larisa, Greece.
RP Mouchtouri, VA (corresponding author), Univ Thessaly, European Union SHIPSAN ACT Joint Action, Larisa, Greece.; Mouchtouri, VA (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Larisa, Greece.
EM mouchtourib@med.uth.gr
CR European Centre for Disease Prevention and Control (ECDC), ZIK VIR INF
   WHO, 2008, INT HLTH REG
   World Health Organization (WHO), 2016, WHO 2 M IHR EM COMM
NR 3
TC 0
Z9 0
U1 0
U2 0
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 21
PY 2016
VL 21
IS 16
BP 61
EP 61
DI 10.2807/1560-7917.ES.2016.21.16.30207
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DK3QZ
UT WOS:000374833800009
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Velo, E
   Kadriaj, P
   Mersini, K
   Shukullari, A
   Manxhari, B
   Simaku, A
   Hoxha, A
   Caputo, B
   Bolzoni, L
   Rosa, R
   Bino, S
   Reiter, P
   della Torre, A
AF Velo, Enkelejda
   Kadriaj, Perparim
   Mersini, Kujtim
   Shukullari, Ada
   Manxhari, Blerta
   Simaku, Artan
   Hoxha, Adrian
   Caputo, Beniamino
   Bolzoni, Luca
   Rosa, Roberto
   Bino, Silvia
   Reiter, Paul
   della Torre, Alessandra
TI Enhancement of Aedes albopictus collections by ovitrap and sticky adult
   trap
SO PARASITES & VECTORS
LA English
DT Article
DE Mosquito monitoring; Mosquito surveillance; Aedes; Ovitrap; Sticky trap;
   Hay-infusion; Albania; Europe
ID CONTAINER-BREEDING MOSQUITOS; INVASIVE MOSQUITOS; ORGANIC INFUSIONS;
   OVIPOSITION ATTRACTANTS; CULICIDAE; DIPTERA; SURVEILLANCE; EUROPE; HAY;
   POPULATIONS
AB Background: In the last decades, Aedes albopictus has become an increasing public health threat in tropical as well as in more recently invaded temperate areas due to its capacity to transmit several human arboviruses, among which Dengue, Chikungunya and Zika. Enhancing the efficiency of currently used collection approaches, such as ovitraps and sticky traps, is desirable for optimal monitoring of the species abundance, for assessment of the risk of arbovirus transmission and for the optimisation of control activities.
   Findings: Two sets of 4 x 4 Latin-square experiments were carried out in Tirana (Albania) to test whether modifications in ovitrap shape and size and in oviposition substrate would increase collections of Ae. albopictus eggs and whether hay-infusion would increase adult catches by sticky trap. Generalized Linear Mixed Models with negative binomial error distribution were carried out to analyse the data. Cylindrical ovitraps lined with germination paper yielded significantly higher egg catches than those exploiting either the (commonly used) wooden paddles or floating polystyrene blocks as oviposition substrates. No difference was observed between cylindrical and conical shaped ovitraps. Ovitraps and sticky traps baited with hay infusion yielded significantly higher egg and adult catches than un-baited ones. A significant relationship between ovitrap and sticky trap catches was observed both in the absence and in the presence of attractants, with ovitrap catches increasing more than sticky trap catches at increasing adult female densities.
   Conclusions: This study provides grounds for optimisation of ovitraps and sticky traps as monitoring tools for Ae. albopictus by (i) supporting use of germination paper as most appropriate oviposition substrate; (ii) suggesting the possible use of stackable conical ovitraps for large scale monitoring; (iii) confirming the use of hay-infusion to increase egg catches in ovitraps, and showing that hay-infusion also significant increases adult catches by sticky traps.
C1 [Velo, Enkelejda; Kadriaj, Perparim; Simaku, Artan; Hoxha, Adrian; Bino, Silvia] Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania.
   [Mersini, Kujtim] Food Safety & Vet Inst, Natl Vet Epidemiol Unit, Tirana, Albania.
   [Shukullari, Ada; Manxhari, Blerta] Fac Nat Sci, Dept Biol, Tirana, Albania.
   [Caputo, Beniamino; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Bolzoni, Luca] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Parma, Italy.
   [Rosa, Roberto] Fdn Edmund Mach, Dipartimento Biodiversita & Ecol Mol, Ctr Ric & Innovaz, San Michele All Adige, Trento, Italy.
   [Reiter, Paul] Inst Pasteur, Insects & Infect Dis Unit, Paris, France.
RP Velo, E (corresponding author), Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania.
EM keladikolli@yahoo.com
RI Bolzoni, Luca/F-5061-2011; Rosa, Roberto/B-8562-2011
OI Bolzoni, Luca/0000-0001-8523-4460; Rosa, Roberto/0000-0002-8655-2230
FU Institute of Public Health, Tirana; EU grant EDENext [FP7-261504];
   Autonomous Province of Trento (Italy), Research funds for Grandi
   Progetti, Project LExEM (Laboratory of excellence for epidemiology and
   modelling)
FX This work has been funded by Institute of Public Health, Tirana and the
   EU grant FP7-261504 EDENext, and is catalogued by the EDENext Steering
   Committee as EDENext343. The contents of this publication are the sole
   responsibility of the authors and do not necessarily reflect the views
   of the European Commission. RR was partially funded by the Autonomous
   Province of Trento (Italy), Research funds for Grandi Progetti, Project
   LExEM (Laboratory of excellence for epidemiology and modelling;
   http://www.lexem.eu).
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Allan SA, 1995, J CHEM ECOL, V21, P1847, DOI 10.1007/BF02033681
   Burkett-Cadena ND, 2007, J AM MOSQUITO CONTR, V23, P117, DOI 10.2987/8756-971X(2007)23[117:FCOBIT]2.0.CO;2
   Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gopalakrishnan R, 2012, TROP BIOMED, V29, P598
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Obenauer PJ, 2010, J VECTOR ECOL, V35, P301, DOI 10.1111/j.1948-7134.2010.00086.x
   Obenauer PJ, 2009, J MED ENTOMOL, V46, P1507, DOI 10.1603/033.046.0639
   Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Ritchie SA, 2003, J AM MOSQUITO CONTR, V19, P235
   Sant'ana AL, 2006, J MED ENTOMOL, V43, P214, DOI 10.1603/0022-2585(2006)043[0214:COGIAO]2.0.CO;2
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schaffner F., 2001, MOUSTIQUES EUROPE
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   SOKAL RR, 1995, BIOMETRY, P686
   Zhang LY, 2008, ANN TROP MED PARASIT, V102, P399, DOI 10.1179/136485908X300878
NR 19
TC 7
Z9 7
U1 0
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 21
PY 2016
VL 9
AR 223
DI 10.1186/s13071-016-1501-x
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DK6MZ
UT WOS:000375039500001
PM 27102015
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kruger, RP
AF Kruger, Robert P.
TI Zika Research Shifts into High Gear
SO CELL
LA English
DT Editorial Material
CR Bayer A, 2016, CELL HOST MICROBE
   Faria NR, 2016, SCIENCE
   Kruger RP, 2016, CELL, V164, P585, DOI 10.1016/j.cell.2016.01.040
   Lazear HM, 2016, CELL HOST MICROBE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Rossi SL, 2016, AM J TROP MED HYG
   Sirohi D, 2016, SCIENCE
   Tang H, 2016, CELL STEM CELL
NR 9
TC 0
Z9 1
U1 0
U2 43
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD APR 21
PY 2016
VL 165
IS 3
BP 503
EP 505
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DK0XW
UT WOS:000374636800001
PM 27104968
OA Bronze
DA 2020-07-08
ER

PT J
AU Heymann, DL
   Liu, J
   Lillywhite, L
AF Heymann, David L.
   Liu, Joanne
   Lillywhite, Louis
TI Partnerships, Not Parachutists, for Zika Research
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
C1 [Heymann, David L.; Lillywhite, Louis] Ctr Global Hlth Secur, Chatham House, England.
   [Heymann, David L.] London Sch Hyg & Trop Med, Publ Hlth England, London WC1, England.
   [Liu, Joanne] Med Sans Frontieres, Geneva, Switzerland.
RP Heymann, DL (corresponding author), Ctr Global Hlth Secur, Chatham House, England.; Heymann, DL (corresponding author), London Sch Hyg & Trop Med, Publ Hlth England, London WC1, England.
CR Barchfield J, 2016, BRAZIL CONSIDERS REF
   Steenhuysen J., 2014, REUTERS
   WHO statement on the first meeting of the International Health Regulations, 2005, WHO STAT 1 M INT HLT
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
NR 4
TC 13
Z9 14
U1 0
U2 2
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 21
PY 2016
VL 374
IS 16
BP 1504
EP 1505
DI 10.1056/NEJMp1602278
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7IA
UT WOS:000374383900002
PM 26958936
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Roze, B
   Najioullah, F
   Signate, A
   Apetse, K
   Brouste, Y
   Gourgoudou, S
   Fagour, L
   Abel, S
   Hochedez, P
   Cesaire, R
   Cabie, A
AF Roze, B.
   Najioullah, F.
   Signate, A.
   Apetse, K.
   Brouste, Y.
   Gourgoudou, S.
   Fagour, L.
   Abel, S.
   Hochedez, P.
   Cesaire, R.
   Cabie, A.
CA Neuro-Zika Working Grp Martinique
TI Zika virus detection in cerebrospinal fluid from two patients with
   encephalopathy, Martinique, February 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID DENGUE
AB We report two cases of encephalopathy (one with seizures, one with electroencephalogram changes) in patients with Zika virus infection. The cases occurred on Martinique in February 2016, during the Zika virus outbreak. Awareness of the various neurological complications of Zika virus infection is needed for patients living in areas affected by Zika virus infections or for travellers to these areas.
C1 [Roze, B.; Abel, S.; Hochedez, P.; Cabie, A.] Univ Hosp Martinique, Infect & Trop Dis Dept, Fort De France, Martinique, France.
   [Najioullah, F.; Abel, S.; Hochedez, P.; Cabie, A.] Univ Hosp Martinique, Virol Lab, Fort De France, Martinique, France.
   [Signate, A.] Univ Antilles, EA4537, Fort De France, Martinique, France.
   [Apetse, K.] Univ Hosp Martinique, Dept Neurol, Fort De France, France.
   [Brouste, Y.; Gourgoudou, S.] Univ Hosp Martinique, Electrophysiol Dept, Fort De France, Martinique, France.
   [Cabie, A.] Univ Hosp Martinique, Emergency Dept, Fort De France, Martinique, France.
   INSERM CIC1424, Fort De France, Martinique, France.
RP Roze, B (corresponding author), Univ Hosp Martinique, Infect & Trop Dis Dept, Fort De France, Martinique, France.
EM benoit.roze@chu-fortdefrance.fr
OI Cabie, Andre/0000-0003-0117-3061; ABEL, Sylvie/0000-0002-3351-0547
FU University Hospital of Martinique; Clinical Research Hospital Program
   from the French Ministry of Health [PHRC 2009]
FX This work was sponsored by the University Hospital of Martinique for
   regulatory and ethic submission.r This work was supported by a grant
   from the Clinical Research Hospital Program from the French Ministry of
   Health (PHRC 2009).
CR Antilles Guyane CIRE, 2016, CIRE ANTILLES GUYANE, V12, P1
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Mathew S, 2010, J STROKE CEREBROVASC, V19, P253, DOI 10.1016/j.jstrokecerebrovasdis.2009.05.003
   Pan American Health Organization / World Health Organization, 2016, ZIK EP UPD 14 APR 20
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Wasay M, 2015, NEUROLOGY, V84, P421, DOI 10.1212/WNL.0000000000001177
NR 7
TC 22
Z9 22
U1 0
U2 59
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 21
PY 2016
VL 21
IS 16
BP 5
EP 8
AR 30205
DI 10.2807/1560-7917.ES.2016.21.16.30205
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DK3QZ
UT WOS:000374833800002
PM 27123558
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Broutet, N
   Krauer, F
   Riesen, M
   Khalakdina, A
   Almiron, M
   Aldighieri, S
   Espinal, M
   Low, N
   Dye, C
AF Broutet, Nathalie
   Krauer, Fabienne
   Riesen, Maurane
   Khalakdina, Asheena
   Almiron, Maria
   Aldighieri, Sylvain
   Espinal, Marcos
   Low, Nicola
   Dye, Christopher
TI Zika Virus as a Cause of Neurologic Disorders
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
C1 [Broutet, Nathalie; Khalakdina, Asheena; Dye, Christopher] WHO, CH-1211 Geneva, Switzerland.
   [Krauer, Fabienne; Riesen, Maurane; Dye, Christopher] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Almiron, Maria; Aldighieri, Sylvain; Espinal, Marcos] Pan Amer Hlth Org, Washington, DC USA.
RP Broutet, N (corresponding author), WHO, CH-1211 Geneva, Switzerland.
RI Low, Nicola/H-4718-2019
OI Low, Nicola/0000-0003-4817-8986; Krauer, Fabienne/0000-0001-8341-4011;
   Dye, Christopher/0000-0002-2957-1793
FU World Health OrganizationWorld Health Organization [001]
CR [Anonymous], 2016, ZIK VIR POT COMPL
   Cao-Lormeau V. M., 2016, LANCET
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204
   Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330, DOI 10.7326/0003-4819-134-4-200102200-00017
NR 5
TC 155
Z9 159
U1 1
U2 31
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 21
PY 2016
VL 374
IS 16
BP 1506
EP 1509
DI 10.1056/NEJMp1602708
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7IA
UT WOS:000374383900003
PM 26959308
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Petersen, LR
   Jamieson, DJ
   Powers, AM
   Honein, MA
AF Petersen, Lyle R.
   Jamieson, Denise J.
   Powers, Ann M.
   Honein, Margaret A.
TI Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; TREATED HOUSE SCREENS; WEST-NILE;
   DENGUE VIRUSES; AEDES-AEGYPTI; TRANSMISSION; INSECTICIDE; VECTOR;
   CHIKUNGUNYA; OUTBREAK
AB IN 1947, A STUDY OF YELLOW FEVER YIELDED THE FIRST ISOLATION OF A NEW virus, from the blood of a sentinel rhesus macaque that had been placed in the Zika Forest of Uganda.(1) Zika virus remained in relative obscurity for nearly 70 years; then, within the span of just 1 year, Zika virus was introduced into Brazil from the Pacific Islands and spread rapidly throughout the Americas.(2) It became the first major infectious disease linked to human birth defects to be discovered in more than half a century and created such global alarm that the World Health Organization (WHO) would declare a Public Health Emergency of International Concern.(3) This review describes the current understanding of the epidemiology, transmission, clinical characteristics, and diagnosis of Zika virus infection, as well as the future outlook with regard to this disease.
C1 [Petersen, Lyle R.; Powers, Ann M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Ft Collins, CO USA.
   [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA.
   [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA USA.
RP Petersen, LR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM lxp2@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Atkinson B, 2016, EMERG INFECT DIS
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EURO SURVEILL, V19
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   de Paula Freitas B, 2016, JAMA OPHTHALMOL 0209
   Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foulon I, 2012, INT J PEDIATR OTORHI, V76, P712, DOI 10.1016/j.ijporl.2012.02.026
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gabis L, 1997, J PERINAT MED, V25, P213
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4
   Jouannic JM, 2016, LANCET
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Korhonen E., 2016, EURO SURVEILL, V21
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciott RS, 2016, EMERG INFEC IN PRESS
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY, V116
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, BILAN EPIDEMIE VIRUS
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Mansuy JM, 2016, LANCET INFECT DIS
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines Roosecelis Brasil, 2016, MMWR Morb Mortal Wkly Rep, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Monaghan AJ, 2016, PLOS CURR
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Birth Defects Prevention Network, 2013, MAJ BIRTH DEF DAT PO
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   PECKHAM CS, 1972, ARCH DIS CHILD, V47, P571, DOI 10.1136/adc.47.254.571
   Perkasa A, 2016, EMERG INFEC IN PRESS
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rasmussen SA, 1990, DYSMORPHOL CLIN GENE, V4, P53
   Reddy UM, 2014, AM J OBSTET GYNECOL, V210, P387, DOI 10.1016/j.ajog.2014.02.028
   Reefhuis J, 2016, EMERG INFEC IN PRESS
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   RORKE LB, 1973, ARCH OTOLARYNGOL, V98, P249
   Roth A, 2014, EURO SURVEILL, V19
   Roze B, 2016, EURO SURVEILL, P21
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Webster WS, 1998, TERATOLOGY, V58, P13
   WELLER TH, 1962, NEW ENGL J MED, V266, P1233, DOI 10.1056/NEJM196206142662401
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 136
TC 586
Z9 599
U1 9
U2 283
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 21
PY 2016
VL 374
IS 16
BP 1552
EP 1563
DI 10.1056/NEJMra1602113
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7IA
UT WOS:000374383900008
PM 27028561
OA Bronze
DA 2020-07-08
ER

PT J
AU Carteaux, G
   Maquart, M
   Bedet, A
   Contou, D
   Brugieres, P
   Fourati, S
   de Langavant, LC
   de Broucker, T
   Brun-Buisson, C
   Leparc-Goffart, I
   Dessap, AM
AF Carteaux, Guillaume
   Maquart, Marianne
   Bedet, Alexandre
   Contou, Damien
   Brugieres, Pierre
   Fourati, Slim
   de Langavant, Laurent Cleret
   de Broucker, Thomas
   Brun-Buisson, Christian
   Leparc-Goffart, Isabelle
   Dessap, Armand Mekontso
TI Zika Virus Associated with Meningoencephalitis
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Carteaux, Guillaume; Bedet, Alexandre; Contou, Damien; Brugieres, Pierre; Fourati, Slim; de Langavant, Laurent Cleret; Brun-Buisson, Christian] AP HP, Creteil, France.
   [Maquart, Marianne; Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Marseille, France.
   [de Broucker, Thomas] Ctr Hosp St Denis, St Denis, France.
   [Dessap, Armand Mekontso] Univ Paris Est Creteil, Creteil, France.
RP Carteaux, G (corresponding author), AP HP, Creteil, France.
EM guillaume.carteaux@yahoo.fr
RI Fourati, Slim/B-2756-2016
OI carteaux, guillaume/0000-0003-1175-8821; Cleret de Langavant,
   Laurent/0000-0001-6551-4641; Bedet, Alexandre/0000-0001-7419-0650
CR [Anonymous], 2016, LAT ZIK VIR SIT REP
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E, 2014, EURO SURVEILL, V19
NR 5
TC 259
Z9 272
U1 1
U2 19
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 21
PY 2016
VL 374
IS 16
BP 1595
EP 1597
DI 10.1056/NEJMc1602964
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7IA
UT WOS:000374383900031
PM 26958738
OA Bronze
DA 2020-07-08
ER

PT J
AU Gyawali, N
   Bradbury, RS
   Taylor-Robinson, AW
AF Gyawali, Narayan
   Bradbury, Richard S.
   Taylor-Robinson, Andrew W.
TI The global spread of Zika virus: is public and media concern justified
   in regions currently unaffected?
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Article
DE Zika; Flavivirus; Arbovirus; Mosquito; Aedes; Transmission; Vector
   control; Diagnosis; Treatment; Epidemic
ID AEDES-AEGYPTI; TRANSMISSION; MICRONESIA; AUSTRALIA; INDONESIA;
   MOSQUITOS; SINGAPORE; EPIDEMIC; OUTBREAK; VECTOR
AB Background: Zika virus, an Aedes mosquito-borne flavivirus, is fast becoming a worldwide public health concern following its suspected association with over 4000 recent cases of microcephaly among newborn infants in Brazil.
   Discussion: Prior to its emergence in Latin America in 2015-2016, Zika was known to exist at a relatively low prevalence in parts of Africa, Asia and the Pacific islands. An extension of its apparent global dispersion may be enabled by climate conditions suitable to support the population growth of A. aegypti and A. albopictus mosquitoes over an expanding geographical range. In addition, increased globalisation continues to pose a risk for the spread of infection. Further, suspicions of alternative modes of virus transmission (sexual and vertical), if proven, provide a platform for outbreaks in mosquito non-endemic regions as well. Since a vaccine or anti-viral therapy is not yet available, current means of disease prevention involve protection from mosquito bites, excluding pregnant females from travelling to Zika-endemic territories, and practicing safe sex in those countries. Importantly, in countries where Zika is reported as endemic, caution is advised in planning to conceive a baby until such time as the apparent association between infection with the virus and microcephaly is either confirmed or refuted. The question arises as to what advice is appropriate to give in more economically developed countries distant to the current epidemic and in which Zika has not yet been reported.
   Summary: Despite understandable concern among the general public that has been fuelled by the media, in regions where Zika is not present, such as North America, Europe and Australia, at this time any outbreak (initiated by an infected traveler returning from an endemic area) would very probably be contained locally. Since Aedes spp. has very limited spatial dispersal, overlapping high population densities of mosquitoes and humans would be needed to sustain a focus of infection. However, as A. aegypti is distinctly anthropophilic, future control strategies for Zika should be considered in tandem with the continuing threat to human wellbeing that is presented by dengue, yellow fever and Japanese encephalitis, all of which are transmitted by the same vector species.
C1 [Gyawali, Narayan; Bradbury, Richard S.; Taylor-Robinson, Andrew W.] Cent Queensland Univ, Sch Med & Appl Sci, Infect Dis Res Grp, Rockhampton, Qld 4702, Australia.
RP Taylor-Robinson, AW (corresponding author), Cent Queensland Univ, Sch Med & Appl Sci, Infect Dis Res Grp, Rockhampton, Qld 4702, Australia.
EM a.taylor-robinson@cqu.edu.au
RI amsalu, ribka/G-8780-2019; Bradbury, Richard S/A-2094-2019
OI Bradbury, Richard S/0000-0002-5524-506X; Taylor-Robinson, Andrew
   W./0000-0001-7342-8348
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2016, TELEGRAPH
   [Anonymous], 2016, WHO DIRECTOR GEN SUM
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, 2016, ZIK VIR WHAT CDC IS
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahalingam S, 2016, CONVERSATION
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   PAHO/WHO, 2016, ZIK VIR INF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2013, FIELDS VIROLOGY, P746
   Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041
   Tappe D, 2013, EURO SURVEILL, V19
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Vogel G, 2016, ZIKA VIRUS YOUR QUES
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2012, HDB INT VECT MAN
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 36
Z9 37
U1 0
U2 40
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2095-5162
EI 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD APR 19
PY 2016
VL 5
AR 37
DI 10.1186/s40249-016-0132-y
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DS8MN
UT WOS:000381037600001
PM 27093860
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bullerdiek, J
   Dotzauer, A
   Bauer, I
AF Bullerdiek, Joern
   Dotzauer, Andreas
   Bauer, Ingrid
TI The mitotic spindle: linking teratogenic effects of Zika virus with
   human genetics?
SO MOLECULAR CYTOGENETICS
LA English
DT Article
DE Zika virus; Microcephaly; Chorioretinopathy; Mechanisms; Syndromes;
   Genetics; Phenocopy
ID NEURONAL DEVELOPMENT; MUTATIONS; INFECTION; EG5; CHORIORETINOPATHY;
   ASSOCIATION; LYMPHEDEMA; CHECKPOINT; BRAZIL; CELLS
AB Background: Recently, an association between Zika virus infection and microcephaly/ocular findings was found to be reasonable e.g. because of the demonstration that the virus was found in the brain of a fetus after presumed maternal infection. Although there is no proof yet for a causal relationship, for an appropriate risk calculation efforts are urgently needed to either establish or disprove this assumption.
   Presentation of the hypothesis: On the basis of inherited syndromes combining microcephaly with ocular findings similar to those associated with Zika infections, we have hypothesized that the impairment of the proper function of the mitotic apparatus is a possible mechanism by which Zika can exert teratogenic effects.
   Testing the hypothesis: A bundle of well-known cytogenetic and molecular-cytogenetic methods (e.g. formation of micronuclei, chromosomal lagging, immunofluorescence of centrosomes) to evaluate proper function, maintenance, and establishment of the mitotic spindle poles can be applied on infected cells. Also, the viral proteins can be tested for their possible interaction with proteins encoded by genes involved in inherited syndromes with microcephaly and ocular findings resembling those in presumed cases of intrauterine ZIKV infection.
   Implications of the hypothesis: Once proved, this hypothesis allows for a targeted approach into mechanisms of possible relevance as e.g. if different strains of the virus are implicated in the teratogenic effects to the same or a different extent.
C1 [Bullerdiek, Joern] Univ Bremen, Ctr Human Genet, Leobener Str ZHG, D-28359 Bremen, Germany.
   [Bullerdiek, Joern] Univ Rostock, Med Ctr, Inst Med Genet, Ernst Heydemann Str 8, D-18057 Rostock, Germany.
   [Dotzauer, Andreas; Bauer, Ingrid] Univ Bremen, Lab Virus Res, Leobener Str UFT 28359, D-28359 Bremen, Germany.
RP Bullerdiek, J (corresponding author), Univ Bremen, Ctr Human Genet, Leobener Str ZHG, D-28359 Bremen, Germany.; Bullerdiek, J (corresponding author), Univ Rostock, Med Ctr, Inst Med Genet, Ernst Heydemann Str 8, D-18057 Rostock, Germany.
EM bullerd@uni-bremen.de
CR BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Ferhat L, 1998, J NEUROSCI, V18, P7822
   Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003
   FRYNS JP, 1995, CLIN GENET, V48, P131
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503
   Lecland N, 2014, NAT CELL BIOL, V16, P770, DOI 10.1038/ncb2996
   Liu M, 2014, J PATHOL, V233, P138, DOI 10.1002/path.4333
   Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mirzaa GM, 2014, AM J MED GENET A, V164, P2879, DOI 10.1002/ajmg.a.36707
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018
   Scheidecker S, 2015, AM J HUM GENET, V96, P666, DOI 10.1016/j.ajhg.2015.02.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang H, 2016, CELL STEM CELL
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas JT, 1998, J VIROL, V72, P1131, DOI 10.1128/JVI.72.2.1131-1137.1998
   Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 23
TC 6
Z9 6
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1755-8166
J9 MOL CYTOGENET
JI Mol. Cytogenet.
PD APR 19
PY 2016
VL 9
AR 32
DI 10.1186/s13039-016-0240-1
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA DK2OG
UT WOS:000374753700003
PM 27099632
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barton, MA
   Salvadori, MI
AF Barton, Michelle A.
   Salvadori, Marina I.
TI Zika virus and microcephaly
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Editorial Material
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; PREGNANT-WOMEN; UNITED-STATES
C1 [Barton, Michelle A.; Salvadori, Marina I.] Univ Western Ontario, Dept Paediat, Div Paediat Infect Dis, London, ON, Canada.
RP Barton, MA (corresponding author), Univ Western Ontario, Dept Paediat, Div Paediat Infect Dis, London, ON, Canada.
EM mbartonf@uwo.ca
CR Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   [Anonymous], DISP RUM ZIK MICR
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Cauchemez S, 2016, LANCET
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 12
TC 4
Z9 4
U1 0
U2 69
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
EI 1488-2329
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD APR 19
PY 2016
VL 188
IS 7
BP E118
EP E119
DI 10.1503/cmaj.160179
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK3BQ
UT WOS:000374790500004
PM 27001741
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI Zika Can Cause Guillain-Barre Syndrome
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
NR 1
TC 1
Z9 1
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD APR 19
PY 2016
VL 315
IS 15
BP 1554
EP 1554
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ5ZK
UT WOS:000374289300004
DA 2020-07-08
ER

PT J
AU Chen, LH
AF Chen, Lin H.
TI Zika Virus Infection in a Massachusetts Resident After Travel to Costa
   Rica: A Case Report
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Letter
C1 [Chen, Lin H.] Harvard Univ, Sch Med, Mt Auburn Hosp, Cambridge, MA 02138 USA.
   [Chen, Lin H.] GeoSentinel Surveillance Network, Cambridge, MA USA.
RP Chen, LH (corresponding author), Harvard Univ, Sch Med, Mt Auburn Hosp, Cambridge, MA 02138 USA.; Chen, LH (corresponding author), GeoSentinel Surveillance Network, Cambridge, MA USA.
OI Chen, Lin/0000-0002-5684-8436
CR Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
NR 5
TC 16
Z9 16
U1 0
U2 12
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD APR 19
PY 2016
VL 164
IS 8
BP 574
EP 576
DI 10.7326/L16-0075
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ5OH
UT WOS:000374257900030
PM 26864175
DA 2020-07-08
ER

PT J
AU Messina, JP
   Kraemer, MUG
   Brady, OJ
   Pigott, DM
   Shearer, FM
   Weiss, DJ
   Golding, N
   Ruktanonchar, CW
   Gething, PW
   Cohn, E
   Brownstein, JS
   Khan, K
   Tatem, AJ
   Jaenisch, T
   Murray, CJL
   Marinho, F
   Scott, TW
   Hay, SI
AF Messina, Jane P.
   Kraemer, Moritz U. G.
   Brady, Oliver J.
   Pigott, David M.
   Shearer, Freya M.
   Weiss, Daniel J.
   Golding, Nick
   Ruktanonchar, Corrine W.
   Gething, Peter W.
   Cohn, Emily
   Brownstein, John S.
   Khan, Kamran
   Tatem, Andrew J.
   Jaenisch, Thomas
   Murray, Christopher J. L.
   Marinho, Fatima
   Scott, Thomas W.
   Hay, Simon I.
TI Mapping global environmental suitability for Zika virus
SO ELIFE
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; DENGUE-FEVER; HEMORRHAGIC-FEVER; ZOONOTIC NICHE;
   TRANSMISSION; CLIMATE; SURVIVAL; DISEASE; TEMPERATURE; MODELS
AB Zika virus was discovered in Uganda in 1947 and is transmitted by Aedes mosquitoes, which also act as vectors for dengue and chikungunya viruses throughout much of the tropical world. In 2007, an outbreak in the Federated States of Micronesia sparked public health concern. In 2013, the virus began to spread across other parts of Oceania and in 2015, a large outbreak in Latin America began in Brazil. Possible associations with microcephaly and Guillain-Barre syndrome observed in this outbreak have raised concerns about continued global spread of Zika virus, prompting its declaration as a Public Health Emergency of International Concern by the World Health Organization. We conducted species distribution modelling to map environmental suitability for Zika. We show a large portion of tropical and sub-tropical regions globally have suitable environmental conditions with over 2.17 billion people inhabiting these areas.
C1 [Messina, Jane P.; Kraemer, Moritz U. G.; Weiss, Daniel J.; Gething, Peter W.] Univ Oxford, Dept Zool, Oxford, England.
   [Brady, Oliver J.; Pigott, David M.; Shearer, Freya M.; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Pigott, David M.; Murray, Christopher J. L.; Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Golding, Nick] Univ Melbourne, Dept BioSci, Parkville, Vic, Australia.
   [Ruktanonchar, Corrine W.; Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, VorldPop Project, Southampton, Hants, England.
   [Cohn, Emily; Brownstein, John S.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA.
   [Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Res DZIF, Heidelberg Partner Site, Heidelberg, Germany.
   [Marinho, Fatima] Minist Hlth Brazil, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
RP Messina, JP (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Hay, SI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
EM jane.messina@zoo.ox.ac.uk; sihay@uw.edu
RI Jaenisch, Thomas/H-3473-2017; Hay, Simon I/F-8967-2015; Ruktanonchai,
   Corrine/M-3979-2016
OI Hay, Simon I/0000-0002-0611-7272; Golding, Nick/0000-0001-8916-5570;
   Ruktanonchai, Corrine/0000-0002-7889-3473; Gething,
   Peter/0000-0001-6759-5449
FU European CommissionEuropean Commission Joint Research Centre [21893];
   Bill and Melinda Gates FoundationGates Foundation [OPP1053338,
   OPP1119467, OPP1106023, OPP1093011, OPP1081737, OPP1068048]; Wellcome
   TrustWellcome Trust [095066]; University of Southampton; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P01AI098670];
   University of MelbourneUniversity of Melbourne; McKenzie fellowship;
   Economic and Social Research Council's Doctoral Training Centre
FX European Commission 21893 Jane P Messina Moritz UG Kraemer Thomas
   Jaenisch; Bill and Melinda Gates Foundation OPP1053338; OPP1119467;
   OPP1106023; OPP1093011; OPP1081737; OPP1068048 Oliver J Brady David M
   Pigott Daniel J Weiss Thomas W Scott Simon I Hay; Wellcome Trust 095066
   Simon I Hay; University of Southampton Economic and Social Research
   Council's Doctoral Training Centre Corrine W Ruktanonchai; National
   Institutes of Health P01AI098670 Thomas W Scott; University of Melbourne
   McKenzie fellowship Nick Golding
CR [Anonymous], 1999, WHO COLL CTR REF RES, P143
   Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010
   Arino O, 2008, ESA BULL-EUR SPACE, P24
   Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x
   Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290
   Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Lazcano JAB, 2006, REV PANAM SALUD PUBL, V19, P379, DOI 10.1590/S1020-49892006000600003
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Campbell KM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003957
   Chandy S, 2013, INDIAN J MED MICROBI, V31, P283, DOI 10.4103/0255-0857.115640
   Chowell G, 2006, J ENVIRON HEALTH, V68, P40
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Cox J, 2007, AM J TROP MED HYG, V76, P820, DOI 10.4269/ajtmh.2007.76.820
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, BRIT MED BULL, V9, P215, DOI 10.1093/oxfordjournals.bmb.a074360
   Dom NC, 2013, GEOCARTO INT, V28, P258, DOI 10.1080/10106049.2012.696726
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7
   Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   ICTV, 2014, VIR TAX 2014 REL
   Jones PG, 2000, AGRON J, V92, P445, DOI 10.2134/agronj2000.923445x
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lin QH, 2012, 2012 5TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P1043, DOI 10.1109/CISP.2012.6470008
   LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3
   Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009
   Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Luz C, 2008, MEM I OSWALDO CRUZ, V103, P214, DOI 10.1590/S0074-02762008000200016
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Messina JP, 2015, T ROY SOC TROP MED H, V109, P503, DOI 10.1093/trstmh/trv050
   Messina JP, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.16
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Nelson A, 2008, TRAVEL TIME MAJOR CI
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Pigott DM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003756
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]
   Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Sankari T, 2012, INDIAN J MED RES, V136, P649
   Schneider A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034002
   Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003
   Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Socio-economic Data andn Applications Center, 2015, GRIDD POP WORLD V4 G
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280
   Troyo A, 2009, SINGAPORE J TROP GEO, V30, P265, DOI 10.1111/j.1467-9493.2009.00367.x
   Trpis M., 1972, B WHO, V47
   UNFPA, 2014, STAT WORLDS MIDW 201
   United Nations, 2014, WORLD URB PROSP 2014
   Wan ZM, 2002, INT GEOSCI REMOTE SE, P3683, DOI 10.1109/IGARSS.2002.1027290
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weiss DJ, 2014, ISPRS J PHOTOGRAMM, V98, P106, DOI 10.1016/j.isprsjprs.2014.10.001
   Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
   World Health Organization, 2015, ZIK VIR INF BRAZ COL
   WorldPop, 2015, HIGH RES AG STRUCT P
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 114
TC 165
Z9 169
U1 3
U2 79
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD APR 19
PY 2016
VL 5
AR e15272
DI 10.7554/eLife.15272
PG 19
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DS0LQ
UT WOS:000380287500001
PM 27090089
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Saiz, JC
   Vazquez-Calvo, A
   Blazquez, AB
   Merino-Ramos, T
   Escribano-Romero, E
   Martin-Acebes, MA
AF Saiz, Juan-Carlos
   Vazquez-Calvo, Angela
   Blazquez, Ana B.
   Merino-Ramos, Teresa
   Escribano-Romero, Estela
   Martin-Acebes, Miguel A.
TI Zika Virus: the Latest Newcomer
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika; flavivirus; outbreak; microcephaly; zoonosis
ID WEST-NILE-VIRUS; YELLOW-FEVER EPIDEMIC; DENGUE VIRUS; FRENCH-POLYNESIA;
   3-DIMENSIONAL ARCHITECTURE; ANTIBODY PROPHYLAXIS; CHIKUNGUNYA VIRUS;
   ENVELOPE PROTEIN; AEDES-ALBOPICTUS; DECEMBER 2013
AB Since the beginning of this century, humanity has been facing a new emerging, or re-emerging, virus threat almost every year: West Nile, Influenza A, avian flu, dengue, Chikungunya, SARS, MERS, Ebola, and now Zika, the latest newcomer. Zika virus (ZIKV), a flavivirus transmitted by Aedes mosquitoes, was identified in 1947 in a sentinel monkey in Uganda, and later on in humans in Nigeria. The virus was mainly confined to the African continent until it was detected in south-east Asia the 1980's, then in the Micronesia in 2007 and, more recently in the Americas in 2014, where it has displayed an explosive spread, as advised by the World Health Organization, which resulted in the infection of hundreds of thousands of people. ZIKV infection was characterized by causing a mild disease presented with fever, headache, rash, arthralgia, and conjunctivitis, with exceptional reports of an association with Guillain Barre syndrome (GBS) and microcephaly. However, since the end of 2015, an increase in the number of GBS associated cases and an astonishing number of microcephaly in fetus and new-borns in Brazil have been related to ZIKV infection, raising serious worldwide public health concerns. Clarifying such worrisome relationships is, thus, a current unavoidable goal. Here, we extensively review what is currently known about ZIKV, from molecular biology, transmission routes, ecology, and epidemiology, to clinical manifestations, pathogenesis, diagnosis, prophylaxis, and public health.
C1 [Saiz, Juan-Carlos; Vazquez-Calvo, Angela; Blazquez, Ana B.; Merino-Ramos, Teresa; Escribano-Romero, Estela; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr Aiimentaria, Dept Biotechnol, Madrid, Spain.
RP Saiz, JC (corresponding author), Inst Nacl Invest & Tecnol Agr Aiimentaria, Dept Biotechnol, Madrid, Spain.
EM jcsaiz@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; Vazquez-Calvo, Angela/G-8795-2015;
   Blazquez, Ana/G-9791-2015; Escribano-Romero, Estela/H-1495-2015
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Vazquez-Calvo,
   Angela/0000-0003-3172-2762; Blazquez, Ana/0000-0002-0847-0977;
   Escribano-Romero, Estela/0000-0002-5036-7607; Saiz,
   Juan-Carlos/0000-0001-8269-5544
FU ZIKA-BIO from INIA; MINECO [AGL2014-56518-JIN]; "Formacion de Personal
   Investigador (FPI)" pre-doctoral fellowship from INIA
FX This work was supported by grant ZIKA-BIO from INIA to J-CS, and
   AGL2014-56518-JIN from MINECO to MM-A, AV-C is a recipient of a
   "Contrato de formacion postodoctoral" from MINECO. TM-R is a recipient
   of a "Formacion de Personal Investigador (FPI)" pre-doctoral fellowship
   from INIA.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blazquez AB, 2015, VIROLOGY, V482, P67, DOI 10.1016/j.virol.2015.03.020
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dominguez-Moreno R, 2014, REV NEUROLOGIA, V58, P4, DOI 10.33588/rn.5801.2013370
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i467
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   GOLLINS SW, 1986, J GEN VIROL, V67, P1941, DOI 10.1099/0022-1317-67-9-1941
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P271, DOI 10.1080/00034983.1948.11685376
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P113
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Puccioni-Sohler M, 2012, NEUROL INT, V4, P65, DOI 10.4081/ni.2012.e15
   Pupella S, 2013, BLOOD TRANSFUS-ITALY, V11, P563, DOI 10.2450/2013.0077-13
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ulbert S, 2014, FUTURE MICROBIOL, V9, P1221, DOI [10.2217/FMB.14.67, 10.2217/fmb.14.67]
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WINKLER G, 1987, VIROLOGY, V159, P237, DOI 10.1016/0042-6822(87)90460-0
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 156
TC 82
Z9 86
U1 2
U2 84
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 19
PY 2016
VL 7
AR 496
DI 10.3389/fmicb.2016.00496
PG 19
WC Microbiology
SC Microbiology
GA DJ5WJ
UT WOS:000374281200001
PM 27148186
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baggoley, C
   Knope, K
   Colwell, A
   Firman, J
AF Baggoley, Chris
   Knope, Katrina
   Colwell, Anna
   Firman, Jenny
TI Zika preparedness in Australia Our comprehensive national response
   encompasses prevention and surveillance, as well as monitoring and
   controlling Aedes aegypti in Australia
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Editorial Material
ID VIRUS-INFECTION; SEXUAL CONTACT; TRANSMISSION; OUTBREAK; STATES; BRAZIL
C1 [Baggoley, Chris; Knope, Katrina; Colwell, Anna; Firman, Jenny] Australian Govt, Dept Hlth, Canberra, ACT, Australia.
RP Baggoley, C (corresponding author), Australian Govt, Dept Hlth, Canberra, ACT, Australia.
EM chris.baggoley@health.gov.au
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Australian Government Department of Health, 2016, INT REC RED RISK SEX
   Australian Government Department of Health, 2016, INT REC ASS PREGN WO
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, CAR WOM CONF ZIK VIR
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 23
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD APR 18
PY 2016
VL 204
IS 7
BP 249
EP +
DI 10.5694/mja16.00186
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FG6YM
UT WOS:000410547500006
PM 27078587
DA 2020-07-08
ER

PT J
AU Swannell, C
AF Swannell, Cate
TI FDA clears experimental Zika blood test for use
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD APR 18
PY 2016
VL 204
IS 7
BP 256
EP 256
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FG6YM
UT WOS:000410547500004
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Baby Born in Hawaii With Brain Damage Confirmed to Have Zika Infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2016
VL 62
IS 8
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DK7EU
UT WOS:000375088500004
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Zika Virus May Infect up to 700 000 People in Colombia: Government
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 44
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2016
VL 62
IS 8
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DK7EU
UT WOS:000375088500001
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Interim Guidelines for Pregnant Women During a Zika Virus Outbreak
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2016
VL 62
IS 8
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DK7EU
UT WOS:000375088500005
DA 2020-07-08
ER

PT J
AU Traynor, K
AF Traynor, Kate
TI Public health officials alarmed at spread of Zika virus
SO AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 66
PU AMER SOC HEALTH-SYSTEM PHARMACISTS
PI BETHESDA
PA 7272 WISCONSIN AVE, BETHESDA, MD 20814 USA
SN 1079-2082
EI 1535-2900
J9 AM J HEALTH-SYST PH
JI Am. J. Health-Syst. Pharm.
PD APR 15
PY 2016
VL 73
IS 8
BP 508
EP 509
DI 10.2146/news160023
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DJ5VO
UT WOS:000374278400001
PM 27045056
DA 2020-07-08
ER

PT J
AU Baptista, T
   Quaghebeur, G
   Alarcon, A
AF Baptista, Tiago
   Quaghebeur, Gerardine
   Alarcon, Ana
TI Neuroimaging findings of babies with microcephaly and presumed
   congenital Zika virus infection
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Baptista, Tiago; Quaghebeur, Gerardine] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford OX3 9DU, England.
   [Alarcon, Ana] Oxford Univ Hosp NHS Fdn Trust, Neonatol Unit, Oxford OX3 9DU, England.
RP Baptista, T (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford OX3 9DU, England.
EM tiago.baptista@ouh.nhs.uk
CR de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Doshi P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1847
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Rasmussen SA, 2016, N ENGL J MED
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization-Regional Office for Europe, ZIK VIR VECT RISK SP
NR 8
TC 7
Z9 7
U1 0
U2 70
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 15
PY 2016
VL 353
AR i2194
DI 10.1136/bmj.i2194
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7EV
UT WOS:000374375600012
PM 27083981
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI US agency says Zika virus causes microcephaly
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Doshi P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1847
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 4
TC 10
Z9 10
U1 0
U2 60
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 15
PY 2016
VL 353
AR i2167
DI 10.1136/bmj.i2167
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7EV
UT WOS:000374375600008
PM 27083694
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Vasquez, AM
   Sapiano, MRP
   Basavaraju, SV
   Kuehnert, MJ
   Rivera-Garcia, B
AF Vasquez, Amber M.
   Sapiano, Mathew R. P.
   Basavaraju, Sridhar V.
   Kuehnert, Matthew J.
   Rivera-Garcia, Brenda
TI Survey of Blood Collection Centers and Implementation of Guidance for
   Prevention of Transfusion-Transmitted Zika Virus Infection - Puerto
   Rico, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
ID TRANSMISSION; OUTBREAK
C1 [Vasquez, Amber M.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Vasquez, Amber M.; Sapiano, Mathew R. P.; Basavaraju, Sridhar V.; Kuehnert, Matthew J.] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR 00936 USA.
RP Vasquez, AM (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Vasquez, AM (corresponding author), CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM avasquez@cdc.gov
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK VIR TRANSM RISKS
   Chung KW, 2016, TRANSFUSION IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Reuters, 2016, REUTERS         0204
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   US Department of Health and Human Services, 2016, HHS SHIPS BLOOD PROD
NR 9
TC 19
Z9 19
U1 0
U2 17
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 15
PY 2016
VL 65
IS 14
BP 375
EP 378
DI 10.15585/mmwr.mm6514e1
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK0WP
UT WOS:000374633200004
PM 27078190
OA Bronze
DA 2020-07-08
ER

PT J
AU Shakir, R
AF Shakir, Raad
TI Neurologists and Zika
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Editorial Material
ID GUILLAIN-BARRE-SYNDROME
C1 [Shakir, Raad] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, London W6 8RF, England.
   [Shakir, Raad] World Federat Neurol, London, England.
RP Shakir, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, London W6 8RF, England.; Shakir, R (corresponding author), World Federat Neurol, London, England.
EM r.shakir@imperial.ac.uk
CR [Anonymous], ZIKA VIR FACT SHEET
   Centers for Disease Control and Prevention, ZIK VIR SYMPT DIAGN
   Department of Health UK, 2011, CLIN GUID IMM US
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pritchard J., 2006, PRACT NEUROL, V6, P208
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
NR 10
TC 1
Z9 1
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2016
VL 363
BP 164
EP 164
DI 10.1016/j.jns.2016.02.045
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DJ3AW
UT WOS:000374078200034
PM 27000244
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI AROUND THE WORLD NIH seeks money for Zika, Ebola
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 6
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 274
EP 274
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100003
DA 2020-07-08
ER

PT J
AU Deckard, DT
   Chung, WM
   Brooks, JT
   Smith, JC
   Woldai, S
   Hennessey, M
   Kwit, N
   Mead, P
AF Deckard, D. Trew
   Chung, Wendy M.
   Brooks, John T.
   Smith, Jessica C.
   Woldai, Senait
   Hennessey, Morgan
   Kwit, Natalie
   Mead, Paul
TI Male-to-Male Sexual Transmission of Zika Virus - Texas, January 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
C1 [Deckard, D. Trew] Med Off Steven M Pounders, Dallas, TX USA.
   [Chung, Wendy M.; Smith, Jessica C.; Woldai, Senait] Dallas Cty Hlth & Human Serv, Acute Communicable Dis Epidemiol Div, Dallas, TX 75207 USA.
   [Brooks, John T.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis TB & STD Prevent, Atlanta, GA 30333 USA.
   [Hennessey, Morgan; Kwit, Natalie; Mead, Paul] CDC, Divis Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
   [Hennessey, Morgan; Kwit, Natalie] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
RP Brooks, JT (corresponding author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis TB & STD Prevent, Atlanta, GA 30333 USA.
EM zud4@cdc.gov
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 10
TC 196
Z9 199
U1 1
U2 20
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 15
PY 2016
VL 65
IS 14
BP 372
EP 374
DI 10.15585/mmwr.mm6514a3
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK0WP
UT WOS:000374633200003
PM 27078057
OA Bronze
DA 2020-07-08
ER

PT J
AU Faria, NR
   Azevedo, RDD
   Kraemer, MUG
   Souza, R
   Cunha, MS
   Hill, SC
   Theze, J
   Bonsall, MB
   Bowden, TA
   Rissanen, I
   Rocco, IM
   Nogueira, JS
   Maeda, AY
   Vasami, FGD
   Macedo, FLD
   Suzuki, A
   Rodrigues, SG
   Cruz, ACR
   Nunes, BT
   Medeiros, DBD
   Rodrigues, DSG
   Queiroz, ALN
   da Silva, EVP
   Henriques, DF
   da Rosa, EST
   de Oliveira, CS
   Martins, LC
   Vasconcelos, HB
   Casseb, LMN
   Simith, DD
   Messina, JP
   Abade, L
   Loureno, J
   Alcantara, LCJ
   de Lima, MM
   Giovanetti, M
   Hay, SI
   de Oliveira, RS
   Lemos, PD
   de Oliveira, LF
   de Lima, CPS
   da Silva, SP
   de Vasconcelos, JM
   Franco, L
   Cardoso, JF
   Vianez, JLDG
   Mir, D
   Bello, G
   Delatorre, E
   Khan, K
   Creatore, M
   Coelho, GE
   de Oliveira, WK
   Tesh, R
   Pybus, OG
   Nunes, MRT
   Vasconcelos, PFC
AF Faria, Nuno Rodrigues
   da Silva Azevedo, Raimunda do Socorro
   Kraemer, Moritz U. G.
   Souza, Renato
   Cunha, Mariana Sequetin
   Hill, Sarah C.
   Theze, Julien
   Bonsall, Michael B.
   Bowden, Thomas A.
   Rissanen, Ilona
   Rocco, Iray Maria
   Nogueira, Juliana Silva
   Maeda, Adriana Yurika
   da Silva Vasami, Fernanda Giseli
   de Lima Macedo, Fernando Luiz
   Suzuki, Akemi
   Rodrigues, Sueli Guerreiro
   Ribeiro Cruz, Ana Cecilia
   Nunes, Bruno Tardeli
   de Almeida Medeiros, Daniele Barbosa
   Guerreiro Rodrigues, Daniela Sueli
   Nunes Queiroz, Alice Louize
   Pinto da Silva, Eliana Vieira
   Henriques, Daniele Freitas
   Travassos da Rosa, Elisabeth Salbe
   de Oliveira, Consuelo Silva
   Martins, Livia Caricio
   Vasconcelos, Helena Baldez
   Neves Casseb, Livia Medeiros
   Simith, Darlene de Brito
   Messina, Jane P.
   Abade, Leandro
   Loureno, Jose
   Junior Alcantara, Luiz Carlos
   de Lima, Maricelia Maia
   Giovanetti, Marta
   Hay, Simon I.
   de Oliveira, Rodrigo Santos
   Lemos, Poliana da Silva
   de Oliveira, Layanna Freitas
   Silva de Lima, Clayton Pereira
   da Silva, Sandro Patroca
   de Vasconcelos, Janaina Mota
   Franco, Luciano
   Cardoso, Jedson Ferreira
   da Silva Gonalves Vianez-Junior, Joao Lidio
   Mir, Daiana
   Bello, Gonzalo
   Delatorre, Edson
   Khan, Kamran
   Creatore, Marisa
   Coelho, Giovanini Evelim
   de Oliveira, Wanderson Kleber
   Tesh, Robert
   Pybus, Oliver G.
   Nunes, Marcio R. T.
   Vasconcelos, Pedro F. C.
TI Zika virus in the Americas: Early epidemiological and genetic findings
SO SCIENCE
LA English
DT Article
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; BRAZIL; OUTBREAK; EVOLUTION;
   ISLAND; TRAVEL; CHILD
AB Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with similar to 30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.
C1 [Faria, Nuno Rodrigues; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; de Oliveira, Layanna Freitas; Silva de Lima, Clayton Pereira; da Silva, Sandro Patroca; de Vasconcelos, Janaina Mota; Franco, Luciano; Cardoso, Jedson Ferreira; da Silva Gonalves Vianez-Junior, Joao Lidio; Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Faria, Nuno Rodrigues; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Bonsall, Michael B.; Messina, Jane P.; Abade, Leandro; Loureno, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [da Silva Azevedo, Raimunda do Socorro; Rodrigues, Sueli Guerreiro; Ribeiro Cruz, Ana Cecilia; Nunes, Bruno Tardeli; de Almeida Medeiros, Daniele Barbosa; Guerreiro Rodrigues, Daniela Sueli; Nunes Queiroz, Alice Louize; Pinto da Silva, Eliana Vieira; Henriques, Daniele Freitas; Travassos da Rosa, Elisabeth Salbe; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Vasconcelos, Helena Baldez; Neves Casseb, Livia Medeiros; Simith, Darlene de Brito; Vasconcelos, Pedro F. C.] Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.
   [Souza, Renato; Cunha, Mariana Sequetin; Rocco, Iray Maria; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva Vasami, Fernanda Giseli; de Lima Macedo, Fernando Luiz; Suzuki, Akemi] Univ Sao Paulo, Inst Adolfo Lutz, Sao Paulo, Brazil.
   [Bowden, Thomas A.; Rissanen, Ilona; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Messina, Jane P.; Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA.
   [Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [de Lima, Maricelia Maia] Univ Estadual Feira de Santana, Ctr Post Grad Collect Hlth, Dept Hlth, Feira De Santana, BA, Brazil.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Mir, Daiana; Bello, Gonzalo; Delatorre, Edson] Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Creatore, Marisa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Coelho, Giovanini Evelim; de Oliveira, Wanderson Kleber] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Tesh, Robert; Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Nunes, MRT (corresponding author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.; Vasconcelos, PFC (corresponding author), Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.; Nunes, MRT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM oliver.pybus@zoo.ox.ac.uk; marcionunesbrasil@yahoo.com.br;
   pedrovasconcelos@iec.pa.gov.br
RI Azevedo, Raimunda/T-4656-2019; Vasconcelos, Pedro/AAH-3142-2019; Hay,
   Simon I/F-8967-2015; Giovanetti, Marta/AAK-7408-2020; Faria,
   Nuno/I-2975-2012; Oliveira, Wanderson/AAF-5182-2019; Delatorre,
   Edson/J-8330-2015; Pybus, Oliver g/B-2640-2012; Bentancor, Gonzalo Jose
   Bello/N-7377-2019; Cruz, Ana Cecilia Ribeiro/V-9276-2019; Bello,
   Gonzalo/E-6842-2013; , daiana/J-5515-2019; Vianez Junior, Joao
   Lidio/I-9547-2016
OI Azevedo, Raimunda/0000-0003-1932-9976; Hay, Simon I/0000-0002-0611-7272;
   Faria, Nuno/0000-0001-8839-2798; Oliveira,
   Wanderson/0000-0002-9662-1930; Delatorre, Edson/0000-0002-5746-0820;
   Pybus, Oliver g/0000-0002-8797-2667; Bentancor, Gonzalo Jose
   Bello/0000-0002-2724-2793; , daiana/0000-0002-3172-4867; Giovanetti,
   Marta/0000-0002-5849-7326; Rissanen, Ilona/0000-0003-4937-1825; Vianez
   Junior, Joao Lidio/0000-0001-6226-9441; Alcantara,
   Luiz/0000-0002-6769-9931; Lourenco, Jose/0000-0002-9318-2581; Bowden,
   Thomas/0000-0002-8066-8785; de Lima Macedo, Fernando
   Luiz/0000-0003-2097-0429; Pereira de Souza, Renato/0000-0003-1315-7085;
   Hill, Sarah/0000-0002-2995-2596
FU European Research Council (ERC) under the European UnionEuropean
   Research Council (ERC) [614725-PATHPHYLODYN]; ERC under the European
   Union [268904-DIVERSITY]; Metabiota; American people through the United
   States Agency for International Development (USAID) Emerging Pandemic
   Threats Program-PREDICTUnited States Agency for International
   Development (USAID); Wellcome TrustWellcome Trust [095066, 102427,
   090532/Z/09/Z]; Bill and Melinda Gates FoundationGates Foundation
   [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Evandro Chagas
   Institute; Brazilian Ministry of Health; CNPq (Brazilian National
   Council for Scientific and Technological Development)National Council
   for Scientific and Technological Development (CNPq) [302032/2011-8,
   200024/2015-9]; National Institute of Science and Technology for Viral
   Hemorrhagic Fevers; U.S. NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24 AT 120942]; UK
   Medical Research CouncilMedical Research Council UK (MRC)
   [MR/L009528/1]; CNPq-National Agency for Scientific and Technologic
   Development [573739/2008-0, 301641/2010-2, 457664/2013-4]; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L009528/1]
FX We thank X. de Lamballerie and J. Lednicky for permission to include
   their unpublished ZIKV genomes in our analysis. We thank the Death
   Verification Service (SVO); Central Laboratories of Public Health
   (LACEN); and health departments of the Ceara State and Maranhao State,
   Brazil, for collaboration. O.G.P. is supported by the European Research
   Council (ERC) under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 614725-PATHPHYLODYN. J.L. is supported by the
   ERC under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 268904-DIVERSITY. O.G.P. received consulting
   fees from Metabiota between 2015 and 2016. This study is made possible
   in part by the generous support of the American people through the
   United States Agency for International Development (USAID) Emerging
   Pandemic Threats Program-PREDICT. The contents are the responsibility of
   the authors and do not necessarily reflect the views of USAID or the
   U.S. government. S.I.H. is funded by a Senior Research Fellowship from
   the Wellcome Trust (095066) and grants from the Bill and Melinda Gates
   Foundation (OPP1119467, OPP1093011, OPP1106023, and OPP1132415).
   M.R.T.N. is funded as an associated researcher in public health by the
   Evandro Chagas Institute, Brazilian Ministry of Health, and as a
   researcher in scientific productivity by CNPq (Brazilian National
   Council for Scientific and Technological Development) grants
   302032/2011-8 and 200024/2015-9 and is also supported in part by the
   National Institute of Science and Technology for Viral Hemorrhagic
   Fevers. R.T. is funded by grant R24 AT 120942 from the U.S. NIH. S.C.H.
   is supported by a Wellcome Trust grant (102427). T.A.B. and I.R. are
   supported by grants from the UK Medical Research Council (MR/L009528/1)
   and the Wellcome Trust (090532/Z/09/Z). P.F.C.V. is supported by
   CNPq-National Agency for Scientific and Technologic Development (grants
   573739/2008-0, 301641/2010-2, and 457664/2013-4). All samples were
   obtained from persons visiting local clinics or hospitalized by the
   Brazilian Ministry of Health personnel as part of dengue, chikungunya,
   and Zika fever surveillance activities. In these cases, patient consent
   was oral and not recorded. The study was authorized by the Coordination
   of the National Program for Dengue, Chikungunya, and Zika Control
   coordinated by Brazil's Ministry of Health. The data are available at
   DRYAD (DOI: 10.5061/dryad.6kn23). The ZIKV genomes reported in this
   study are deposited in GenBank under accession numbers KU321639,
   KU365777 to KU365780, KU729217, and KU729218.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meyer AG, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 524
Z9 535
U1 7
U2 245
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 345
EP 349
DI 10.1126/science.aaf5036
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100041
PM 27013429
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Guzzetta, G
   Poletti, P
   Montarsi, F
   Baldacchino, F
   Capelli, G
   Rizzoli, A
   Rosa, R
   Merler, S
AF Guzzetta, G.
   Poletti, P.
   Montarsi, F.
   Baldacchino, F.
   Capelli, G.
   Rizzoli, A.
   Rosa, R.
   Merler, S.
TI Assessing the potential risk of Zika virus epidemics in temperate areas
   with established Aedes albopictus populations
SO EUROSURVEILLANCE
LA English
DT Article
ID VECTOR
AB Based on 2015 abundance of Aedes albopictus in nine northern Italian municipalities with temperate continental/oceanicclimate, we estimated the basic reproductive number R-o for Zika virus (ZIKV) to be systematically below the epidemic threshold in most scenarios. Results were sensitive to the value of the probability of mosquito infection after biting a viraemic host. Therefore, further studies are required to improve models and predictions, namely evaluating vector competence and potential non-vector transmissions.
C1 [Guzzetta, G.; Poletti, P.; Merler, S.] Fdn Bruno Kessler, Trento, Italy.
   [Poletti, P.] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy.
   [Montarsi, F.; Capelli, G.] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy.
   [Baldacchino, F.; Rizzoli, A.; Rosa, R.] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Trento, Italy.
RP Merler, S (corresponding author), Fdn Bruno Kessler, Trento, Italy.
EM merler@fbk.eu
RI Rosa, Roberto/B-8562-2011; Rizzoli, Annapaola/J-2439-2012; merler,
   stefano/I-3557-2017
OI Rosa, Roberto/0000-0002-8655-2230; Rizzoli,
   Annapaola/0000-0003-3997-6783; merler, stefano/0000-0002-5117-0611;
   Guzzetta, Giorgio/0000-0002-9296-9470; Poletti,
   Piero/0000-0001-5453-5199
FU Autonomous Province of Trento (Italy)Autonomous Province of Trento;
   Research funds for Grandi Progetti, Project LExEM (Laboratory of
   excellence for epidemiology and modelling)
FX We thank for mosquito collection Daniele Arnoldi, Francesca Bussola,
   Charlotte Lapere, Sara Carlin, Graziana Da Rold, Marco Dal Pont, Nicola
   Ferro Milone, Luca Tripepi. We thank Markus Metz and Markus Neteler for
   providing us with LST temperature data. This work was funded by the
   Autonomous Province of Trento (Italy), Research funds for Grandi
   Progetti, Project LExEM (Laboratory of excellence for epidemiology and
   modelling, http://www.lexem.eu).
CR Barnard DR, 2014, ACTA TROP, V136, P58, DOI 10.1016/j.actatropica.2014.04.019
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau V. M., 2016, LANCET
   Cauchemez S, 2016, LANCET
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Funk S, 2016, BIORXIV         0311
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064
   Mallet HP, 2015, B INFORM SANITAIRES, P13
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Metz M, 2014, REMOTE SENS-BASEL, V6, P3822, DOI 10.3390/rs6053822
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization Regional Office for Europe, ZIK VIR VECT RISK SP
NR 20
TC 22
Z9 22
U1 1
U2 34
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 14
PY 2016
VL 21
IS 15
BP 5
EP 10
AR 30199
DI 10.2807/1560-7917.ES.2016.21.15.30199
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DJ6LP
UT WOS:000374325000002
PM 27104366
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Aragao, MDV
   van der Linden, V
   Brainer-Lima, AM
   Coeli, RR
   Rocha, MA
   da Silva, PS
   de Carvalho, MDCG
   van der Linden, A
   de Holanda, AC
   Valenca, MM
AF Vasco Aragao, Maria de Fatima
   van der Linden, Vanessa
   Brainer-Lima, Alessandra Mertens
   Coeli, Regina Ramos
   Rocha, Maria Angela
   da Silva, Paula Sobral
   Costa Gomes de Carvalho, Maria Durce
   van der Linden, Ana
   de Holanda, Arthur Cesario
   Valenca, Marcelo Moraes
TI Clinical features and neuroimaging (CT and MRI) findings in presumed
   Zika virus related congenital infection and microcephaly: retrospective
   case series study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID ABNORMALITIES; OUTBREAK
AB OBJECTIVE
   To report radiological findings observed in computed tomography (CT) and magnetic resonance imaging (MRI) scans of the first cases of congenital infection and microcephaly presumably associated with the Zika virus in the current Brazilian epidemic.
   DESIGN
   Retrospective study with a case series.
   SETTING
   Association for Assistance of Disabled Children (AACD), Pernambuco state, Brazil.
   PARTICIPANTS
   23 children with a diagnosis of congenital infection presumably associated with the Zika virus during the Brazilian microcephaly epidemic.
   MAIN OUTCOME MEASURES
   Types of abnormalities and the radiological pattern of lesions identified on CT and MRI brain scans.
   RESULTS
   Six of the 23 children tested positive for IgM antibodies to Zika virus in cerebrospinal fluid. The other 17 children met the protocol criteria for congenital infection presumably associated with the Zika virus, even without being tested for IgM antibodies to the virus-the test was not yet available on a routine basis. Of the 23 children, 15 underwent CT, seven underwent both CT and MRI, and one underwent MRI. Of the 22 children who underwent CT, all had calcifications in the junction between cortical and subcortical white matter, 21 (95%) had malformations of cortical development, 20 (91%) had a decreased brain volume, 19 (86%) had ventriculomegaly, and 11 (50%) had hypoplasia of the cerebellum or brainstem. Of the eight children who underwent MRI, all had calcifications in the junction between cortical and subcortical white matter, malformations of cortical development occurring predominantly in the frontal lobes, and ventriculomegaly. Seven of the eight (88%) children had enlarged cisterna magna, seven (88%) delayed myelination, and six each (75%) a moderate to severe decrease in brain volume, simplified gyral pattern, and abnormalities of the corpus callosum (38% hypogenesis and 38% hypoplasia). Malformations were symmetrical in 75% of the cases.
   CONCLUSION
   Severe cerebral damage was found on imaging in most of the children in this case series with congenital infection presumably associated with the Zika virus. The features most commonly found were brain calcifications in the junction between cortical and subcortical white matter associated with malformations of cortical development, often with a simplified gyral pattern and predominance of pachygyria or polymicrogyria in the frontal lobes. Additional findings were enlarged cisterna magna, abnormalities of corpus callosum (hypoplasia or hypogenesis), ventriculomegaly, delayed myelination, and hypoplasia of the cerebellum and the brainstem.
C1 [Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Do Leite Recife, PE, Brazil.
   [Vasco Aragao, Maria de Fatima] Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
   [van der Linden, Vanessa] Associat Assistance Disabled Children, Recife, PE, Brazil.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Recife, PE, Brazil.
   [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, PROCAPE, Recife, PE, Brazil.
   [Coeli, Regina Ramos; Rocha, Maria Angela; da Silva, Paula Sobral; Costa Gomes de Carvalho, Maria Durce] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [van der Linden, Ana] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [de Holanda, Arthur Cesario] Univ Fed Pernambuco, Sch Med, Recife, PE, Brazil.
   [Valenca, Marcelo Moraes] Univ Fed Pernambuco, Neurol & Neurosurg, Recife, PE, Brazil.
RP Aragao, MDV (corresponding author), Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Do Leite Recife, PE, Brazil.; Aragao, MDV (corresponding author), Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
EM vascoaragao@gmail.com
RI Valenca, Marcelo/A-4302-2013; CESARIO, Alfredo/O-4215-2015
OI Valenca, Marcelo/0000-0003-0678-3782; Silva, Paula/0000-0001-9475-4732;
   CESARIO, Alfredo/0000-0003-4687-0709
CR Barkovich AJ, 2012, PEDIAT NEUROIMAGING
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bosemani T, 2015, RADIOGRAPHICS, V35, P200, DOI 10.1148/rg.351140038
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centre d'hygiene et de salubrite publique de la Direction de la sante, 2015, B TEL SIT SUIV RES O
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dogan Y, 2011, FETAL DIAGN THER, V30, P141, DOI 10.1159/000330636
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hess CP, 2013, IMAGING OF THE BRAIN, P45
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Malinger G, 2003, AJNR AM J NEURORADIO, V24, P28
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Ministerio da Saude (Brazil), 2016, CENTR OP EM SAUSD PU
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sze G, 1999, CRANIAL MRI CT, P453
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tavernise S, 2016, NY TIMES
NR 27
TC 175
Z9 180
U1 2
U2 30
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 13
PY 2016
VL 353
AR i1901
DI 10.1136/bmj.i1901
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7ET
UT WOS:000374375400003
PM 27075009
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI US health officials press Congress for $1.9bn to combat Zika
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1545
NR 1
TC 0
Z9 0
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 12
PY 2016
VL 353
AR i2106
DI 10.1136/bmj.i2106
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7ER
UT WOS:000374375200021
PM 27073228
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Smith, DW
   Mackenzie, J
AF Smith, David W.
   Mackenzie, John
TI Zika virus and Guillain-Barre syndrome: another viral cause to add to
   the list
SO LANCET
LA English
DT Editorial Material
C1 [Smith, David W.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.
   [Mackenzie, John] Curtin Univ, Fac Hlth Sci, Bentley, WA, Australia.
RP Smith, DW (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.
EM david.smith@health.wa.gov.au
RI /S-4986-2019
OI /0000-0002-5918-2190
CR [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Cao-Lormeau V. M., 2016, LANCET
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   WHO. WHO statement on the first meeting of the International Health Regulations, 2005, EM COMM ZIKA VIR OBS
   World Health Organization, GUILL BARR SYNDR COL
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 11
TC 45
Z9 47
U1 0
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 9
PY 2016
VL 387
IS 10027
BP 1486
EP 1488
DI 10.1016/S0140-6736(16)00564-X
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI8HH
UT WOS:000373741600005
PM 26948432
OA Bronze
DA 2020-07-08
ER

PT J
AU Cao-Lormeau, VM
   Blake, A
   Mons, S
   Lastere, S
   Roche, C
   Vanhomwegen, J
   Dub, T
   Baudouin, L
   Teissier, A
   Larre, P
   Vial, AL
   Decam, C
   Choumet, V
   Halstead, SK
   Willison, HJ
   Musset, L
   Manuguerra, JC
   Despres, P
   Fournier, E
   Mallet, HP
   Musso, D
   Fontanet, A
   Neil, J
   Ghawche, F
AF Cao-Lormeau, Van-Mai
   Blake, Alexandre
   Mons, Sandrine
   Lastere, Stephane
   Roche, Claudine
   Vanhomwegen, Jessica
   Dub, Timothee
   Baudouin, Laure
   Teissier, Anita
   Larre, Philippe
   Vial, Anne-Laure
   Decam, Christophe
   Choumet, Valerie
   Halstead, Susan K.
   Willison, Hugh J.
   Musset, Lucile
   Manuguerra, Jean-Claude
   Despres, Philippe
   Fournier, Emmanuel
   Mallet, Henri-Pierre
   Musso, Didier
   Fontanet, Arnaud
   Neil, Jean
   Ghawche, Frederic
TI Guillain-Barre Syndrome outbreak associated with Zika virus infection in
   French Polynesia: a case-control study
SO LANCET
LA English
DT Article
ID CAMPYLOBACTER; INFLUENZA; DENGUE; CHIKUNGUNYA; DIAGNOSIS; CRITERIA
AB Background Between October, 2013, and April, 2014, French Polynesia experienced the largest Zika virus outbreak ever described at that time. During the same period, an increase in Guillain-Barre syndrome was reported, suggesting a possible association between Zika virus and Guillain-Barre syndrome. We aimed to assess the role of Zika virus and dengue virus infection in developing Guillain-Barre syndrome.
   Methods In this case-control study, cases were patients with Guillain-Barre syndrome diagnosed at the Centre Hospitalier de Polynesie Francaise (Papeete, Tahiti, French Polynesia) during the outbreak period. Controls were age-matched, sex-matched, and residence-matched patients who presented at the hospital with a non-febrile illness (control group 1; n=98) and age-matched patients with acute Zika virus disease and no neurological symptoms (control group 2; n=70). Virological investigations included RT-PCR for Zika virus, and both microsphere immunofluorescent and seroneutralisation assays for Zika virus and dengue virus. Anti-glycolipid reactivity was studied in patients with Guillain-Barre syndrome using both ELISA and combinatorial microarrays.
   Findings 42 patients were diagnosed with Guillain-Barre syndrome during the study period. 41 (98%) patients with Guillain-Barre syndrome had anti-Zika virus IgM or IgG, and all (100%) had neutralising antibodies against Zika virus compared with 54 (56%) of 98 in control group 1 (p<0.0001). 39 (93%) patients with Guillain-Barre syndrome had Zika virus IgM and 37 (88%) had experienced a transient illness in a median of 6 days (IQR 4-10) before the onset of neurological symptoms, suggesting recent Zika virus infection. Patients with Guillain-Barre syndrome had electrophysiological findings compatible with acute motor axonal neuropathy (AMAN) type, and had rapid evolution of disease (median duration of the installation and plateau phases was 6 [IQR 4-9] and 4 days [3-10], respectively). 12 (29%) patients required respiratory assistance. No patients died. Anti-glycolipid antibody activity was found in 13 (31%) patients, and notably against GA1 in eight (19%) patients, by ELISA and 19 (46%) of 41 by glycoarray at admission. The typical AMAN-associated anti-ganglioside antibodies were rarely present. Past dengue virus history did not differ significantly between patients with Guillain-Barre syndrome and those in the two control groups (95%, 89%, and 83%, respectively).
   Interpretation This is the first study providing evidence for Zika virus infection causing Guillain-Barre syndrome. Because Zika virus is spreading rapidly across the Americas, at risk countries need to prepare for adequate intensive care beds capacity to manage patients with Guillain-Barre syndrome.
C1 [Cao-Lormeau, Van-Mai; Roche, Claudine; Teissier, Anita; Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, France.
   [Blake, Alexandre; Dub, Timothee; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, 25 Rue Docteur Roux, F-75015 Paris, France.
   [Mons, Sandrine; Baudouin, Laure] Ctr Hosp Polynesie Francaise, Serv Reanimat Polyvalente, Tahiti, France.
   [Lastere, Stephane] Ctr Hosp Polynesie Francaise, Clin Lab, Tahiti, France.
   [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France.
   [Vanhomwegen, Jessica; Choumet, Valerie; Manuguerra, Jean-Claude] Inst Pasteur, Unit Environm & Infect Risks, Paris, France.
   [Larre, Philippe; Ghawche, Frederic] Ctr Hosp Polynesie Francaise, Serv Neurol, Papeete, Tahiti, France.
   [Vial, Anne-Laure; Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, Papeete, France.
   [Decam, Christophe] Serv Sante Forces Armees, Papeete, France.
   [Halstead, Susan K.; Willison, Hugh J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Musset, Lucile; Neil, Jean] Grp Hosp Pitie Salpetriere, AP HP, Dept Immunol, Lab Immunochem & Autoimmun, F-75634 Paris, France.
   [Despres, Philippe] Univ Reunion Island, St Denis, Reunion, France.
   [Fournier, Emmanuel] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, F-75634 Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France.
   [Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth Res & Educ, Paris, France.
RP Fontanet, A (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, 25 Rue Docteur Roux, F-75015 Paris, France.
EM fontanet@pasteur.fr
RI Cao-Lormeau, Van-Mai/H-4879-2018; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Blake,
   Alexandre/0000-0002-1627-4992; Halstead, Susan/0000-0001-7396-8969
FU Labex Integrative Biology of Emerging Infectious Diseases; EUEuropean
   Union (EU); Wellcome TrustWellcome Trust
FX Labex Integrative Biology of Emerging Infectious Diseases, EU 7th
   framework programme PREDEMICS, and Wellcome Trust.
CR Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Beck C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/678084
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   Hiraga A, 2003, NEUROLOGY, V61, P471, DOI 10.1212/01.WNL.0000081231.08914.A1
   Ho TW, 1997, NEUROLOGY, V48, P717, DOI 10.1212/WNL.48.3.717
   Kokubun N, 2013, CLIN NEUROPHYSIOL, V124, P1671, DOI 10.1016/j.clinph.2013.02.010
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, B INFORM SANITAIRES
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Neil J, 2012, J NEUROIMMUNOL, V242, P72, DOI 10.1016/j.jneuroim.2011.11.007
   Oehler E., 2014, Eurosurveillance, V19, P20720
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Rinaldi S, 2008, CURR OPIN NEUROL, V21, P540, DOI 10.1097/WCO.0b013e32830b84b7
   Rinaldi S, 2012, METHODS MOL BIOL, V808, P413, DOI 10.1007/978-1-61779-373-8_28
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Willison HJ, 2007, J NEUROCHEM, V103, P143, DOI 10.1111/j.1471-4159.2007.04718.x
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 41
TC 1109
Z9 1152
U1 14
U2 133
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 9
PY 2016
VL 387
IS 10027
BP 1531
EP 1539
DI 10.1016/S0140-6736(16)00562-6
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI8HH
UT WOS:000373741600029
PM 26948433
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Adibi, JJ
   Marques, ETA
   Cartus, A
   Beigi, RH
AF Adibi, Jennifer J.
   Marques, Ernesto T. A., Jr.
   Cartus, Abigail
   Beigi, Richard H.
TI Teratogenic effects of the Zika virus and the role of the placenta
SO LANCET
LA English
DT Article
ID CEREBRAL-CORTEX; HUMAN FETUS; INFECTION; CELLS; PATHOGENESIS;
   ABNORMALITIES; EXOSOMES; STEM
AB The mechanism by which the Zika virus can cause fetal microcephaly is not known. Reports indicate that Zika is able to evade the normal immunoprotective responses of the placenta. Microcephaly has genetic causes, some associated with maternal exposures including radiation, tobacco smoke, alcohol, and viruses. Two hypotheses regarding the role of the placenta are possible: one is that the placenta directly conveys the Zika virus to the early embryo or fetus. Alternatively, the placenta itself might be mounting a response to the exposure; this response might be contributing to or causing the brain defect. This distinction is crucial to the diagnosis of fetuses at risk and the design of therapeutic strategies to prevent Zika-induced teratogenesis.
C1 [Adibi, Jennifer J.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA.
   [Adibi, Jennifer J.; Beigi, Richard H.] Univ Pittsburgh, Dept Obstet & Gynecol & Reprod Sci, Pittsburgh, PA USA.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Marques, Ernesto T. A., Jr.] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [Cartus, Abigail] Univ Texas Hlth Sci Ctr Houston, Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA.
RP Adibi, JJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA.
EM adibij@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013; Adibi, Jennifer/I-8077-2016
OI Marques, Ernesto T. A/0000-0003-3826-9358; Adibi,
   Jennifer/0000-0001-6562-8315
CR Adibi JJ, 2015, J CLIN ENDOCR METAB, V100, pE1216, DOI 10.1210/jc.2015-2370
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Burton GJ, 2001, PLACENTA, V22, pS70, DOI 10.1053/plac.2001.0639
   Calvet G., 2016, LANCET INFECT DIS
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   DEKABAN AS, 1968, J NUCL MED, V9, P471
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x
   Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026
   Garcez PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7474
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   HADEED AJ, 1989, PEDIATRICS, V84, P205
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   KENNEDY LA, 1984, TERATOLOGY, V29, P363, DOI 10.1002/tera.1420290306
   Leviton A, 2010, EARLY HUM DEV, V86, P515, DOI 10.1016/j.earlhumdev.2010.07.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montiel JF, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00022
   MOSTOUFIZADEH M, 1984, ARCH PATHOL LAB MED, V108, P403
   Nascimento EJM, 2014, CRIT REV IMMUNOL, V34, P227, DOI 10.1615/CritRevImmunol.2014010212
   Pulyers JN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00092
   Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/revreprod/4.2.81
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
NR 29
TC 93
Z9 99
U1 1
U2 46
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 9
PY 2016
VL 387
IS 10027
BP 1587
EP 1590
DI 10.1016/S0140-6736(16)00650-4
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI8HH
UT WOS:000373741600034
PM 26952548
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Daniel, KL
AF Daniel, Katherine Lyon
CA CDC Zika Response
TI Vital Signs: Preparing for Local Mosquito-Borne Transmission of Zika
   Virus - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Daniel, Katherine Lyon] CDC Zika Response, Atlanta, GA 30302 USA.
RP Daniel, KL (corresponding author), CDC Zika Response, Atlanta, GA 30302 USA.
EM eocjictriage2@cdc.gov
CR Brasil P, 2016, N ENGL J MED
   CDC, 2016, ZIK ACT PLAN ZAP SUM
   CDC, 2016, ZIK VIR
   CDC, 2016, ZIK VIR TRANSM RISKS
   Oster AM, 2016, MMWR MORB MORTAL WKL
   Petersen EE, 2015, MMWR MORB MORTAL WKL
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
NR 7
TC 4
Z9 4
U1 0
U2 65
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 8
PY 2016
VL 65
IS 13
BP 352
EP 352
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DJ3DJ
UT WOS:000374084700004
PM 27054688
OA Bronze
DA 2020-07-08
ER

PT J
AU Hayden, EC
AF Hayden, Erika Check
TI Zika highlights role of fetal-tissue research
SO NATURE
LA English
DT News Item
CR Brasil P, 2016, N ENG J MED
   Garcez P. P., 2016, PEERJ PREPRINTS, V4
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Tang H, 2016, CELL STEM CELL
NR 4
TC 9
Z9 9
U1 0
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD APR 7
PY 2016
VL 532
IS 7597
BP 16
EP 16
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI5RE
UT WOS:000373555500007
DA 2020-07-08
ER

PT J
AU Doshi, P
AF Doshi, Peter
TI INFECTIOUS DISEASES Convicting Zika
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Doshi, Peter] BMJ, London, England.
RP Doshi, P (corresponding author), BMJ, London, England.
EM pdoshi@bmj.com
CR [Anonymous], 2016, WHO DIRECTOR GEN ADD
   Boadle A, 2016, REUTERS
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Butler D., 2016, NATURE
   Cao-Lormeau V. M., 2016, LANCET
   Cauchemez S, 2016, LANCET
   CBC News, 2016, CBC NEWS
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   WHO, 2016, ZIK VIR GUILL BARR S
   WHO, 2016, MICR FACTSH
   World Health Organization, 2016, ZIK SIT REP
NR 14
TC 5
Z9 5
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 7
PY 2016
VL 353
AR i1847
DI 10.1136/bmj.i1847
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ0LT
UT WOS:000373895900003
PM 27056643
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Birbeck, GL
AF Birbeck, Gretchen L.
TI Zika virus What the neurologist wants to know
SO NEUROLOGY
LA English
DT Editorial Material
ID INTERIM GUIDELINES; FRENCH-POLYNESIA; UNITED-STATES; TRANSMISSION;
   INFECTION
AB Just as Neurology (R) Without Borders launched in late January, news coverage about the Zika virus epidemic in Latin America with Brazil at ground zero began to reach the popular press.(1-4) Photographs of devastated parents and microcephalic, dysmorphic infants have captured the public's attention. Recent articles in the New England Journal of Medicine(5) and Lancet(6-8) among others have outlined some of what is known about the epidemiology of this arbovirus and how we believe it made its way from Africa (identified in 1947) to Southeast Asia (mid-20th century) to Micronesia (2007) to French Polynesia (2014) and most recently to Latin America in 2015.(9</SUP)
C1 [Birbeck, Gretchen L.] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.
RP Birbeck, GL (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.
EM gretchen_birbeck@urmc.rochester.edu
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   CDC, 2016, ZIK VIR
   Crawford A, 2016, SKY NEWS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i467
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, N ENGL J MED
   Garcia-Navarro L., 2016, ZIKA VIRUS LIKELY AF
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EURO SURVEILL, V19
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   RSTMH, 2016, ZKA VIR 1 DESCR T
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tetro JA., MICROBES INFECT
   Triunfol M, 2015, LANCET INFECT DIS
NR 25
TC 1
Z9 2
U1 0
U2 42
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 5
PY 2016
VL 86
IS 14
BP 1272
EP 1274
DI 10.1212/WNL.0000000000002553
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA DI1YE
UT WOS:000373292100001
PM 26896047
OA Bronze
DA 2020-07-08
ER

PT J
AU Nah, K
   Mizumoto, K
   Miyamatsu, Y
   Yasuda, Y
   Kinoshita, R
   Nishiura, H
AF Nah, Kyeongah
   Mizumoto, Kenji
   Miyamatsu, Yuichiro
   Yasuda, Yohei
   Kinoshita, Ryo
   Nishiura, Hiroshi
TI Estimating risks of importation and local transmission of Zika virus
   infection
SO PEERJ
LA English
DT Article
DE Zika virus; Importation; Risk; Mathematical model; Transmission;
   Statistical estimation; Network; Epidemiology
ID AMERICA; BRAZIL
AB Background. An international spread of Zika virus (ZIKV) infection has attracted global attention. ZIKV is conveyed by a mosquito vector, Aedes species, which also acts as the vector species of dengue and chikungunya viruses.
   Methods. Arrival time of ZIKV importation (i.e., the time at which the first imported case was diagnosed) in each imported country was collected from publicly available data sources. Employing a survival analysis model in which the hazard is an inverse function of the effective distance as informed by the airline transportation network data, and using dengue and chikungunya virus transmission data, risks of importation and local transmission were estimated.
   Results. A total of 78 countries with imported case(s) have been identified, with the arrival time ranging from 1 to 44 weeks since the first ZIKV was identified in Brazil, 2015. Whereas the risk of importation was well explained by the airline transportation network data, the risk of local transmission appeared to be best captured by additionally accounting for the presence of dengue and chikungunya viruses.
   Discussion. The risk of importation may be high given continued global travel of mildly infected travelers but, considering that the public health concerns over ZIKV infection stems from microcephaly, it is more important to focus on the risk of local and widespread transmission that could involve pregnant women. The predicted risk of local transmission was frequently seen in tropical and subtropical countries with dengue or chikungunya epidemic experience.
C1 [Nah, Kyeongah; Mizumoto, Kenji; Miyamatsu, Yuichiro; Yasuda, Yohei; Kinoshita, Ryo; Nishiura, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan.
   [Nah, Kyeongah; Miyamatsu, Yuichiro; Kinoshita, Ryo; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Saitama, Japan.
   [Nah, Kyeongah; Mizumoto, Kenji; Miyamatsu, Yuichiro; Kinoshita, Ryo; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.
   [Mizumoto, Kenji] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.
RP Nishiura, H (corresponding author), Univ Tokyo, Grad Sch Med, Tokyo, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.; Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.
EM nishiurah@gmail.com
RI amsalu, ribka/G-8780-2019
OI Kinoshita, Ryo/0000-0002-0116-4598; Mizumoto, Kenji/0000-0002-2748-6560;
   Nah, Kyeongah/0000-0002-7708-1019
FU Japanese Society for the Promotion of Science (JSPS) KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [26670308, 26700028, 15K20936]; Japan Agency for
   Medical Research and DevelopmentJapan Agency for Medical Research and
   Development (AMED); Japan Science and Technology Agency (JST) CREST
   program; RISTEX program for Science of Science, Technology and
   Innovation Policy
FX HN received funding support from the Japanese Society for the Promotion
   of Science (JSPS) KAKENHI Grant Numbers 26670308 and 26700028, Japan
   Agency for Medical Research and Development, the Japan Science and
   Technology Agency (JST) CREST program and RISTEX program for Science of
   Science, Technology and Innovation Policy. KM received funding support
   from the Japanese Society for the Promotion of Science (JSPS) KAKENHI
   Grant Number 15K20936. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   [Anonymous], 2016, CONTROLLING DENGUE O
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGLAND IN PRESS, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOAL1602412]
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention (CDC) USA, 2016, CHIK VIR GEOGR DISTR
   Centers for Disease Control and Prevention (CDC) USA., 2016, DENG HOM
   Contentshare, 2016, OP DAT
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   European Centre for Disease Prevention and Control (ECDC), 2016, COUNTR TERR LOC ZIK
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korhonen EM, 2016, EUROSRUVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.2.30107, DOI 10.2807/1560-7915.ES.2016.21.2.30107]
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nah K, 2016, BMC INFECT IN PRESS
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Qin GS, 2008, STAT METHODS MED RES, V17, P207, DOI 10.1177/0962280207087173
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   The Walter Reed Biosystematics Unit USA, 2016, AED AFR
   World Health Organization Western Pacific Region (WPRO), 2016, PAC SYNDR SURV REP
NR 32
TC 31
Z9 31
U1 1
U2 38
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD APR 5
PY 2016
VL 4
AR e1904
DI 10.7717/peerj.1904
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ4FK
UT WOS:000374160600007
PM 27069825
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Vectors for Zika virus may spread further than was previously thought,
   CDC reports
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
NR 2
TC 1
Z9 1
U1 0
U2 75
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 4
PY 2016
VL 353
AR i1914
DI 10.1136/bmj.i1914
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ0LL
UT WOS:000373894800006
PM 27044278
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Everts, S
AF Everts, Sarah
TI New insights into Zika's biology
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
OI Everts, Sarah/0000-0001-8898-0581
NR 0
TC 0
Z9 0
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD APR 4
PY 2016
VL 94
IS 14
BP 5
EP 5
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DI3OX
UT WOS:000373409200004
DA 2020-07-08
ER

PT J
AU Mecharles, S
   Herrmann, C
   Poullain, P
   Tran, TH
   Deschamps, N
   Mathon, G
   Landais, A
   Breurec, S
   Lannuzel, A
AF Mecharles, Sylvie
   Herrmann, Cecile
   Poullain, Pascale
   Tran, Tuan-Huy
   Deschamps, Nathalie
   Mathon, Gregory
   Landais, Anne
   Breurec, Sebastien
   Lannuzel, Annie
TI Acute myelitis due to Zika virus infection
SO LANCET
LA English
DT Editorial Material
C1 [Mecharles, Sylvie; Tran, Tuan-Huy; Deschamps, Nathalie; Landais, Anne; Lannuzel, Annie] Ctr Hosp Univ Pointe A Pitre, Serv Neurol, Pointe A Pitre 97159, Guadeloupe, France.
   [Herrmann, Cecile; Breurec, Sebastien] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe A Pitre 97159, Guadeloupe, France.
   [Poullain, Pascale; Mathon, Gregory] Ctr Hosp Univ Pointe A Pitre, Serv Radiol, Pointe A Pitre 97159, Guadeloupe, France.
   [Breurec, Sebastien; Lannuzel, Annie] Univ Antilles, Fac Med, Antilles, Guadeloupe, France.
   [Breurec, Sebastien] Inst Pasteur Guadeloupe, Unite Sante & Environm, Pointe A Pitre, Guadeloupe, France.
   [Lannuzel, Annie] Univ Paris 04, INSERM, U1127, CNRS,UMR 7225,Inst Cerveau & Moelle Epiniere,ICM, Paris, France.
RP Lannuzel, A (corresponding author), Ctr Hosp Univ Pointe A Pitre, Serv Neurol, Pointe A Pitre 97159, Guadeloupe, France.
EM annie.lannuzel@chu-guadeloupe.fr
CR Ali M, 2005, AM J NEURORADIOL, V26, P289
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Larik A, 2012, BMJ CASE REP, DOI [10.1136/bcr.12.2011.53783, DOI 10.1136/BCR.12.2011.53783]
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Verma Rajesh, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007094
NR 5
TC 183
Z9 188
U1 0
U2 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 2
PY 2016
VL 387
IS 10026
BP 1481
EP 1481
DI 10.1016/S0140-6736(16)00644-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI0WH
UT WOS:000373217500036
PM 26946926
OA Bronze
DA 2020-07-08
ER

PT J
AU Brasil, P
   Sequeira, PC
   Freitas, AD
   Zogbi, HE
   Calvet, GA
   de Souza, RV
   Siqueira, AM
   de Mendonca, MCL
   Nogueira, RMR
   de Filippis, AMB
   Solomon, T
AF Brasil, Patricia
   Sequeira, Patricia Carvalho
   Freitas, Andrea D'Avila
   Zogbi, Heruza Einsfeld
   Calvet, Guilherme Amaral
   de Souza, Rogerio Valls
   Siqueira, Andre Machado
   Lima de Mendonca, Marcos Cesar
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   Solomon, Tom
TI Guillain-Barre syndrome associated with Zika virus infection
SO LANCET
LA English
DT Editorial Material
ID DENGUE
C1 [Brasil, Patricia; Freitas, Andrea D'Avila; Zogbi, Heruza Einsfeld; Calvet, Guilherme Amaral; de Souza, Rogerio Valls; Siqueira, Andre Machado] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Sequeira, Patricia Carvalho; Lima de Mendonca, Marcos Cesar; Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.
   [Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI Calvet, Guilherme/G-6959-2013; Siqueira, Andre M/G-1340-2010
OI Calvet, Guilherme/0000-0002-3545-5238; Siqueira, Andre
   M/0000-0003-2208-0294; Solomon, Tom/0000-0001-7266-6547
FU National Institute for Health ResearchNational Institute for Health
   Research (NIHR) [RP-PG-0108-10048, NF-SI-0514-10177]; Department of
   HealthDiabetes UK [RP-PG-0108-10048]; Medical Research CouncilMedical
   Research Council UK (MRC) [MC_PC_15096]
CR Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
NR 5
TC 157
Z9 164
U1 0
U2 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 2
PY 2016
VL 387
IS 10026
BP 1482
EP 1482
DI 10.1016/S0140-6736(16)30058-7
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI0WH
UT WOS:000373217500037
PM 27115821
OA Bronze
DA 2020-07-08
ER

PT J
AU Barreiro, P
AF Barreiro, Pablo
TI First Case of Zika Virus Infection in a HIV plus Patient
SO AIDS REVIEWS
LA English
DT News Item
C1 [Barreiro, Pablo] Hosp Carlos III La Paz, Trop & Travel Med Unit, Madrid, Spain.
RP Barreiro, P (corresponding author), Hosp Carlos III La Paz, Trop & Travel Med Unit, Madrid, Spain.
NR 0
TC 4
Z9 4
U1 0
U2 5
PU PERMANYER PUBL
PI BARCELONA
PA MALLORCA, 310, BARCELONA, 08037, SPAIN
SN 1139-6121
EI 1698-6997
J9 AIDS REV
JI Aids Rev.
PD APR-JUN
PY 2016
VL 18
IS 2
BP 112
EP 112
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EJ4KQ
UT WOS:000393186200006
PM 27232506
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, B.
   Wiwanitkit, V
TI In silico analysis to predict lack of carcinogenicity of Zika virus
SO INDIAN JOURNAL OF CANCER
LA English
DT Letter
C1 [Joob, B.] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, V] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Pogodin PV, 2015, SAR QSAR ENVIRON RES, V26, P783, DOI 10.1080/1062936X.2015.1078407
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0019-509X
EI 1998-4774
J9 INDIAN J CANCER
JI Indian J. Cancer
PD APR-JUN
PY 2016
VL 53
IS 2
DI 10.4103/0019-509X.197711
PG 1
WC Oncology
SC Oncology
GA EJ0XG
UT WOS:000392933700005
PM 28071614
DA 2020-07-08
ER

PT J
AU Soh, LT
   Squires, RC
   Tan, LK
   Pok, KY
   Yang, H
   Liew, C
   Shah, AS
   Aaskov, J
   Abubakar, S
   Hasabe, F
   Nga, LC
   Konings, F
AF Soh, Li Ting
   Squires, Raynal C.
   Tan, Li Kiang
   Pok, Kwoon Yong
   Yang, HuiTing
   Liew, Christina
   Shah, Aparna Singh
   Aaskov, John
   Abubakar, Sazaly
   Hasabe, Futoshi
   Nga, Lee Ching
   Konings, Frank
TI External quality assessment of dengue and chikungunya diagnostics in the
   Asia Pacific region, 2015
SO WESTERN PACIFIC SURVEILLANCE AND RESPONSE
LA English
DT Article
ID SEROLOGICAL DIAGNOSIS; PCR ASSAY; RT-PCR; VIRUS; INFECTIONS
AB Objective: To conduct an external quality assessment (EQA) of dengue and chikungunya diagnostics among national-level public health laboratories in the Asia Pacific region following the first round of EQA for dengue diagnostics in 2013.
   Methods: Twenty-four national-level public health laboratories performed routine diagnostic assays on a proficiency testing panel consisting of two modules. Module A contained serum samples spiked with cultured dengue virus (DENV) or chikungunya virus (CHIKV) for the detection of nucleic acid and DENV non-structural protein 1 (NS1) antigen. Module B contained human serum samples for the detection of anti-DENV antibodies.
   Results: Among 20 laboratories testing Module A, 17 (85%) correctly detected DENV RNA by reverse transcription polymerase chain reaction (RT-PCR), 18 (90%) correctly determined serotype and 19 (95%) correctly identified CHIKV by RT-PCR. Ten of 15 (66.7%) laboratories performing NS1 antigen assays obtained the correct results. In Module B, 18/23 (78.3%) and 20/20 (100%) of laboratories correctly detected anti-DENV IgM and IgG, respectively. Detection of acute/recent DENV infection by both molecular (RT-PCR) and serological methods (IgM) was available in 19/24 (79.2%) participating laboratories.
   Discussion: Accurate laboratory testing is a critical component of dengue and chikungunya surveillance and control. This second round of EQA reveals good proficiency in molecular and serological diagnostics of these diseases in the Asia Pacific region. Further comprehensive diagnostic testing, including testing for Zika virus, should comprise future iterations of the EQA.
C1 [Soh, Li Ting; Tan, Li Kiang; Pok, Kwoon Yong; Yang, HuiTing; Liew, Christina; Aaskov, John; Nga, Lee Ching] Natl Environm Agcy, WHO Collaborating Ctr Reference & Res Arbovirus &, Environm Hlth Inst, Singapore, Singapore.
   [Squires, Raynal C.; Konings, Frank] World Hlth Org, Reg Off Western Pacific, Div Hlth Secur & Emergencies, Emerging Dis Surveillance & Response, Manila, Philippines.
   [Shah, Aparna Singh] World Hlth Org, Reg Off South East Asia, Communicable Dis Dept, Blood Safety & Lab Technol, New Delhi, India.
   [Abubakar, Sazaly] Univ Malaya, WHO Collaborating Ctr Arbovirus Reference & Res D, Trop Infect Dis Res & Educ Ctr, Dept Med Microbiol,Fac Med, Kuala Lumpur, Malaysia.
   [Hasabe, Futoshi] Nagasaki Univ, WHO Collaborating Ctr Reference & Res Trop & Emer, Nagasaki, Japan.
RP Konings, F (corresponding author), World Hlth Org, Reg Off Western Pacific, Div Hlth Secur & Emergencies, Emerging Dis Surveillance & Response, Manila, Philippines.
EM koningsf@wpro.who.int
RI abubakar, sazaly/B-3957-2010
OI abubakar, sazaly/0000-0002-9267-1420
FU Global Partnership Program of Canada's Department of Foreign Affairs,
   Trade and Development
FX This 2015 round of proficiency testing was in part financially supported
   by the Global Partnership Program of Canada's Department of Foreign
   Affairs, Trade and Development.
CR [Anonymous], 2015, DENG SIT UPD
   [Anonymous], 2010, AS PAC STRAT EM DIS
   [Anonymous], 2014, DENG SIT UPD
   [Anonymous], 2012, WHO SPEC PROGR RES T
   Arima Y, 2014, WEST PAC SURVEILL RE, V5, P27, DOI [10.5365/WPSAR.2014.5.3.007, 10.5365/wpsar.2014.5.3.007]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833
   Hapuarachchi HC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22592
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.003, 10.5365/WPSAR.2013.4.2.003]
   Jacobsen S, 2016, J CLIN VIROL, V76, P55, DOI 10.1016/j.jcv.2016.01.008
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671
   Mantke OD, 2004, J CLIN VIROL, V29, P105, DOI 10.1016/S1386-6532(03)00110-0
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Pok KY, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.1.017, 10.5365/wpsar.2015.6.1.017]
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Squires RC, 2016, WEST PAC SURVEILL RE, V7, P44, DOI 10.5365/wpsar.2016.7.1.007
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2012, WHO EXT QUAL ASS PRO
   World Health Organization (WHO)/UNAIDS, 1996, GUID ORG NAT EXT QUA
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 27
TC 4
Z9 4
U1 0
U2 3
PU WORLD HEALTH ORGANIZATION, REGIONAL OFFICE WESTERN PACIFIC
PI MANILA
PA PO BOX 2932, MANILA, 1000, PHILIPPINES
SN 2094-7321
EI 2094-7313
J9 WEST PAC SURVEILL RE
JI West. Pa. Surveill. Response
PD APR-JUN
PY 2016
VL 7
IS 2
BP 26
EP 34
DI 10.5365/wpsar.2016.7.1.002
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EC7BS
UT WOS:000388291400004
PM 27508088
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mardani, M
AF Mardani, Masoud
TI Update on Zika Virus Infections
SO ARCHIVES OF CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika Virus; Infection; Microcephaly
ID TRANSMISSION
C1 [Mardani, Masoud] Shahid Beheshti Univ Med Sci, Infect Dis & Trop Med Res Ctr, Tehran, Iran.
RP Mardani, M (corresponding author), Shahid Beheshti Univ Med Sci, Infect Dis & Trop Med Res Ctr, Tehran, Iran.
EM drmasoudmardani@yahoo.com
OI Mardani, Masoud/0000-0001-6082-072X
CR Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Borchardt RA, 2016, JAAPA-J AM ACAD PHYS, V29, P48, DOI 10.1097/01.JAA.0000481413.11539.b1
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Centers for Disease Control and Prevention, ZIK VIR DIS US 2015
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guzzetta G, 2016, EJCB, V21
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korhonen EM, 2016, EJCB, V21
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li Jiandong, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P329, DOI 10.3760/cma.j.issn.0254-6450.2016.03.007
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Picone O, 2016, J GYNECOL OBST BIO R, V45, P415, DOI 10.1016/j.jgyn.2016.03.005
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
NR 25
TC 0
Z9 0
U1 0
U2 1
PU SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED
PI TEHRAN
PA SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN
SN 2345-2641
EI 2008-1081
J9 ARCH CLIN INFECT DIS
JI Arch. Clin. Infect. Dis.
PD APR
PY 2016
VL 11
IS 2
AR e38955
DI 10.5812/archcid.38955
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA EC1XZ
UT WOS:000387903800009
DA 2020-07-08
ER

PT J
AU Bueno, MAS
   Grunspun, H
AF Scarpinella Bueno, Marco Aurelio
   Grunspun, Henrique
TI Bioethical considerations at times of Zika virus
SO EINSTEIN-SAO PAULO
LA English
DT Editorial Material
C1 [Scarpinella Bueno, Marco Aurelio; Grunspun, Henrique] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.
RP Bueno, MAS (corresponding author), Ave Albert Einstein,627-701,Bldg A1,4th Floor, BR-05652900 Sao Paulo, SP, Brazil.
EM scarpinella@einstein.br
CR ACOG SMFM, 2016, PRACT ADV UPD INT GU
   Beauchamp TL, 1994, PRINCIPLES BIOMEDICA
   Brasil. Ministerio da Saude. Portal da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, 07 MIN SAUD PORT SAU
   Brasil. Ministerio da Saude. Portal da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, 22 MIN SAUD PORT SAU
   Brasil P, 2016, N ENGL J MED
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duarte G, 2016, ORIENTACOES RECOMEND, V[citado 2016 Maio 11]. Disponivel em
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Goldim JR, 2016, ALTERIDADE
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hossne WS, 2011, REV BIOETHIKOS CTR U, V5, P35
   Levinas E., 2004, ENTRE NOS ENSAIO ALT
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Segre M, 2005, REV BRAS BIOETICA, V1, P257
NR 19
TC 3
Z9 3
U1 0
U2 5
PU INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN
PI SAO PAULO SP
PA AVENIDA ALBERT EINSTEIN, 627 701, SAO PAULO SP, 05651-901, BRAZIL
SN 1679-4508
EI 2317-6385
J9 EINSTEIN-SAO PAULO
JI Einstein
PD APR-JUN
PY 2016
VL 14
IS 2
BP XIII
EP XVII
DI 10.1590/S1679-45082016ED3725
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ3BC
UT WOS:000385717300002
PM 27462882
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Turrini, F
   Ghezzi, S
   Pagani, I
   Poli, G
   Vicenzi, E
AF Turrini, Filippo
   Ghezzi, Silvia
   Pagani, Isabel
   Poli, Guido
   Vicenzi, Elisa
TI Zika Virus: a re-emerging pathogen with rapidly evolving public health
   implications
SO NEW MICROBIOLOGICA
LA English
DT Review
DE Zika Virus; epidemiology; pathology; virus genome and replication
ID FRENCH-POLYNESIA; SOUTH-PACIFIC; DENGUE VIRUS; TRANSMISSION;
   INACTIVATION; AMOTOSALEN; OUTBREAK; ULTRAVIOLET; INFECTION; EPIDEMIC
C1 [Turrini, Filippo; Ghezzi, Silvia; Pagani, Isabel; Vicenzi, Elisa] Osped San Raffaele, Viral Pathogens & Biosafety Unit, Milan, Italy.
   [Poli, Guido] Osped San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunopathogenesis Unit, Milan, Italy.
   [Poli, Guido] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy.
RP Vicenzi, E (corresponding author), Osped San Raffaele, Viral Pathogens & Biosafety Unit, Milan, Italy.
EM vicenzi.elisa@hsr.it
RI ghezzi, silvia/AAN-4092-2020; Vicenzi, Elisa/AAL-3980-2020; Turrini,
   Filippo/I-3677-2018; Pagani, Isabel/AAB-3301-2019
OI Turrini, Filippo/0000-0002-9121-9117; Pagani,
   Isabel/0000-0001-5396-0740; Vicenzi, Elisa/0000-0003-0051-3968; Poli,
   Guido/0000-0001-7241-4526; Ghezzi, Silvia/0000-0002-7586-663X
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET
   Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez P. P., 2016, SCIENCE
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazin A.N., 2016, N ENGL J MED
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J., 2016, CLIN INFECT DIS
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET INFECT DIS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Pinna D, 2005, TRANSFUSION MED, V15, P269, DOI 10.1111/j.0958-7578.2005.00588.x
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Sirohi D, 2016, SCIENCE
   Tang H., 2016, CELL STEM       0304
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Venturi G, 2016, EURO SURVEILL, V21
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 51
TC 5
Z9 5
U1 0
U2 12
PU EDIZIONI INT SRL
PI PAVIA
PA DIV EDIMES, EDIZIONI MEDICO SCIENTIFICHE PAVIA, VIA RIVIERA, PAVIA,
   39-27100, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD APR
PY 2016
VL 39
IS 2
BP 86
EP 90
PG 5
WC Microbiology
SC Microbiology
GA DY6XZ
UT WOS:000385274200002
PM 27196545
DA 2020-07-08
ER

PT J
AU Bobade, SS
   Gade, RM
AF Bobade, Sumedha S.
   Gade, Rajendra M.
TI Zika virus - A vector borne zoonotic disease: An international public
   health emergency
SO BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS
LA English
DT Article
DE AEDES; FLAVIVIRUS; MICROCEPHALY; ZIKA VIRUS
ID FEDERATED STATES; AEDES-ALBOPICTUS; POTENTIAL VECTOR; YAP ISLAND;
   INFECTION; TRANSMISSION; MOSQUITOS; DENGUE; CHIKUNGUNYA; MICRONESIA
AB The geographical distribution of Zika virus has expanded tremendously since 2007. The consequences of transmission of dengue and chikungunya, zika virus is the latest culprit in a long list of arbovirus epidemics that emerged as a global public health threat over the last decade. Zika virus (ZIKV) is a mosquito-borne flavivirus, first isolated in Uganda from a sentinel monkey in 1947, which is transmitted by Aedes genus mosquitoes, also transmits diseases such as chikungunya, dengue, and yellow fever. Mosquito and sentinel animal surveillance studies have demonstrated that ZIKV is endemic to Africa and Southeast Asia. It causes dengue-like syndromes but with milder symptoms. Among common clinical manifestations fever, arthralgia, conjunctivitis, myalgia, headache, and maculopapular rash. Newborn microcephaly, the most devastating and insidious complication associated. ZIKV, has been described in the offspring of women who became infected while pregnant. However, Zika virus infection in pregnant women has a suspected link with newborn microcephaly by mother to child transmission. In very few cases Guillain-Barre syndrome (GBS) is a rare condition in which immune system attacks the nerves, leading to muscle weakness and even paralysis. A number of countries have issued travel warnings and the outbreak is expected to have an impact on the tourism industry. This review is focused on zika virus transmitted by Aedes (Stegomyia) mosquitoes their symptoms, diagnosis, prevention, control strategy and treatment as an important challenge to public health emergency, monitoring environmental and climatic precursors of vector-borne diseases linked to integrated surveillance of human cases and vectors. Given the rapid geographic spread of ZIKV in recent years, a coordinated local, regional, and global effort is needed to generate sufficient resources and political traction to effectively halt and contain further expansion of the current outbreak. Certainly, raising awareness and increasing knowledge among the general public, public health practitioners, and policy makers about disease vectors and their relationship with infectious diseases. In addition, much more work needs to be done to produce an effective vaccine.
C1 [Bobade, Sumedha S.; Gade, Rajendra M.] Vasantrao Naik Coll Agr Biotechnol, Yawatmal, MS, India.
RP Bobade, SS (corresponding author), Vasantrao Naik Coll Agr Biotechnol, Yawatmal, MS, India.
EM afjalahmed24@yahoo.in
RI amsalu, ribka/G-8780-2019
CR Atkinson B, 2016, EMERG INFEC IN PRESS
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M., 2014, EURO SURVEILLANCE, V19
   Bhatt PN, 1960, P HAFFK I DIAM S, P57
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   CDC, 2016, CDC HLTH ADV REC MAN
   CDC, 2016, UPD DIAGN TEST ZIK C
   Centers for Disease Control and Prevention National Institutes of Health, 2009, BIOSAFETY MICROBIOLO
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2014, ZIK VIR INF OUTBR FR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gale Jason, 2016, BLOOMBERG NEWS
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kaur G., 2016, INT, V1, P31
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung G.H., 2015, SE ASIAN J TROP MED, V46
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1102
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Musso D, 2015, EMERG INFECT DIS, V21, P552
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization and World Health Organization, 2015, EP AL NEUR SYNDR CON
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Roth A, 2014, EURO SURVEILL, V19
   Rothan HA, 2014, ARCH VIROL, V159, P711, DOI 10.1007/s00705-013-1880-7
   Savage HM, 2015, AM J TROP MED HYG, V92, P429, DOI 10.4269/ajtmh.14-0374
   ScienceAlert, 2016, IND CO SAYS THEY HAV
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Tappe D, 2015, MED MICROBI IN PRESS
   Tappe D, 2013, EURO SURVEILL, V19
   Thome RCA, 2010, MATH BIOSCI, V223, P12, DOI 10.1016/j.mbs.2009.08.009
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WOLFE MS, 1982, LANCET, V2, P1306
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 75
TC 0
Z9 0
U1 1
U2 16
PU SOC SCIENCE & NATURE
PI BHOPAL
PA C-52 HOUSING BOARD COLONY, KOHE FIZA, BHOPAL, MADHYA PRADESH 462 001,
   INDIA
SN 0974-6455
J9 BIOSCI BIOTECHNO RES
JI Biosci. Biotechnol. Res. Commun.
PD APR-JUN
PY 2016
VL 9
IS 2
BP 201
EP 210
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DX1UW
UT WOS:000384153500006
DA 2020-07-08
ER

PT J
AU Bailey, SBC
AF Bailey, Stephanie B. C.
TI Zika: What Caused It? We Will Know When the Work is Done
SO INTERNATIONAL JOURNAL OF CHILDBIRTH EDUCATION
LA English
DT Editorial Material
C1 [Bailey, Stephanie B. C.] Tennessee State Univ, Coll Hlth Sci, Nashville, TN 37203 USA.
   [Bailey, Stephanie B. C.] CDC, Publ Hlth Practice, Atlanta, GA 30333 USA.
   [Bailey, Stephanie B. C.] Metropolitan Nashville Davidson Cty, Hlth, Nashville, TN USA.
RP Bailey, SBC (corresponding author), Tennessee State Univ, Coll Hlth Sci, Nashville, TN 37203 USA.
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Kinsman S, 2011, NELSON TXB PEDIAT
   Salerno A., 2015, PESTICIDE NOT ZIKA I
   Stein R., 2016, ZIKA VIRUS BIG ZIKA
   World Health Organization, 2016, ZIK VIR
NR 5
TC 0
Z9 0
U1 0
U2 0
PU INT CHILDBIRTH EDUCATION ASSOC
PI RALEIGH
PA 1500 SUNDAY DR, STE 102, RALEIGH, NC 27607 USA
SN 0887-8625
J9 INT J CHILDBIRTH EDU
JI Int. J. Childbirth Educ.
PD APR
PY 2016
VL 31
IS 2
BP 6
EP +
PG 2
WC Nursing
SC Nursing
GA DV3TC
UT WOS:000382845300003
DA 2020-07-08
ER

PT J
AU Kadri, MR
AF Kadri, Michele Rocha
TI Zika Virus in Brazil: A New Challenge for the National Health System and
   Nursing Care
SO INTERNATIONAL JOURNAL OF CHILDBIRTH EDUCATION
LA English
DT Article
DE Zika virus; Brazil
AB The appearance and rapid spread of the ZIKA virus in Brazil and elsewhere in the Americas has received increasing attention. The main vector for the Zika virus is the Aedes aegypti mosquito. There is mounting correlational evidence in support of this link between the Sika virus and microcephaly. The Zika virus epidemic has profound implications for mothers and their children in Brazil. Another issue affected by the ZIKA epidemic is pregnancy planning. Finally, there is the complex discussion of the effectiveness of control measures that are being taken to eliminate the Aedes aegypti mosquitoes. There are still many unanswered questions that will require long-term research efforts to resolve.
C1 [Kadri, Michele Rocha] Fundacao Oswaldo Cruz, Leonidas & Maria Deane Res Ctr, Manaus, Amazonas, Brazil.
RP Kadri, MR (corresponding author), Fundacao Oswaldo Cruz, Leonidas & Maria Deane Res Ctr, Manaus, Amazonas, Brazil.
CR Abrasco, NOT TECN MICR DOENC
   Agencia Fiocruz de Noticia, FIOCR DET PRES VIR Z
   Brasil, INF EP
   Brasil, 2010, PESQ NAC SAN BAS 200
   Ligia Formenti, 2015, DIRETOR MINISTERIO S
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
NR 6
TC 0
Z9 0
U1 0
U2 6
PU INT CHILDBIRTH EDUCATION ASSOC
PI RALEIGH
PA 1500 SUNDAY DR, STE 102, RALEIGH, NC 27607 USA
SN 0887-8625
J9 INT J CHILDBIRTH EDU
JI Int. J. Childbirth Educ.
PD APR
PY 2016
VL 31
IS 2
BP 26
EP 28
PG 3
WC Nursing
SC Nursing
GA DV3TC
UT WOS:000382845300007
DA 2020-07-08
ER

PT J
AU Yung, CF
   Chong, CY
   Yeo, KT
   Liew, C
   Ng, LC
   Tan, NWH
   Yeo, GSH
   Tee, NWS
   Lin, RTP
   Tan, TC
   Rajadurai, VS
   Chan, JKY
   Thoon, KC
AF Yung, Chee Fu
   Chong, Chia Yin
   Yeo, Kee Thai
   Liew, Christina
   Ng, Lee Ching
   Tan, Natalie W. H.
   Yeo, George S. H.
   Tee, Nancy W. S.
   Lin, Raymond T. P.
   Tan, Thiam Chye
   Rajadurai, Victor S.
   Chan, Jerry K. Y.
   Thoon, Koh Cheng
TI Zika Virus: An Evolving Public Health Threat
SO ANNALS ACADEMY OF MEDICINE SINGAPORE
LA English
DT Editorial Material
ID YELLOW-FEVER; INTERIM GUIDELINES; POTENTIAL VECTOR; UNITED-STATES;
   INFECTION; AEDES; OUTBREAK; UGANDA; MICRONESIA; INDONESIA
C1 [Yung, Chee Fu; Chong, Chia Yin; Tan, Natalie W. H.; Thoon, Koh Cheng] KK Womens & Childrens Hosp, Dept Paediat, Infect Dis Serv, 100 Bukit Timah Rd, Singapore 229899, Singapore.
   [Yeo, Kee Thai; Rajadurai, Victor S.] KK Womens & Childrens Hosp, Dept Neonatol, Singapore, Singapore.
   [Liew, Christina; Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
   [Ng, Lee Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Yeo, George S. H.] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore.
   [Tee, Nancy W. S.] KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore.
   [Lin, Raymond T. P.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.
   [Tan, Thiam Chye] KK Womens & Childrens Hosp, Dept Obstet & Gynaecol, Singapore, Singapore.
   [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore.
RP Yung, CF (corresponding author), KK Womens & Childrens Hosp, Dept Paediat, Infect Dis Serv, 100 Bukit Timah Rd, Singapore 229899, Singapore.
EM Yung.Chee.Fu@kkh.com.sg
OI Yeo, Kee Thai/0000-0003-4357-3610
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Surveillance of Congenital Abnormalies, 2005, INSTR REG SURV CONG
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health Singapore, 2016, 032016 MIN HLTH SING
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PanAmericanHealth Organization (PAHO), 2015, EP ZIK VIR INF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yap G, 2016, EPIDEMIOLOGICAL NEWS, V42, P3
NR 29
TC 1
Z9 1
U1 0
U2 3
PU ACAD MEDICINE SINGAPORE
PI REPUBLIC SINGAPORE
PA 142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE
SN 0304-4602
J9 ANN ACAD MED SINGAP
JI Ann. Acad. Med. Singap.
PD APR
PY 2016
VL 45
IS 4
BP 148
EP 151
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1MG
UT WOS:000381246200005
PM 27292005
DA 2020-07-08
ER

PT J
AU Yadav, S
   Rawal, G
   Baxi, M
AF Yadav, Sankalp
   Rawal, Gautam
   Baxi, Mudit
TI Zika virus: A pandemic in progress
SO JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE
LA English
DT Article
DE arboviruses; diagnosis; emerging disease; French Polynesia; serum;
   viruses; Zika virus
ID YELLOW-FEVER; TRANSMISSION; OUTBREAK; STATES
AB The world is facing a number of emerging infections. The latest outbreak of Zika virus infection has only added to the suffering. The WHO declared a state of emergency in the affected countries and has issued alarms worldwide. The paucity of literature leading to lack of clear guidelines is one of the most important factors resulting in a higher number of cases. The absence of clinical vaccine and an antiviral drug may prove to be a really grave situation. The present paper throws some light on this new emerging virus that has been known to man since 1947.
C1 [Yadav, Sankalp] North Delhi Municipal Corp, Dept Med & TB, Chest Clin Moti Nagar, New Delhi, India.
   [Rawal, Gautam] Max Super Specialty Hosp, Resp Intens Care, New Delhi, India.
   [Baxi, Mudit] Sri Aurobindo Med Coll & Postgrad Inst, Dept Orthoped, Indore, Madhya Pradesh, India.
RP Yadav, S (corresponding author), North Delhi Municipal Corp, Dept Med & TB, Chest Clin Moti Nagar, New Delhi, India.
EM drsankalpyadav@gmail.com
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, CDC HLTH ADV REC MAN
   CDC, 2016, ZIK VIR
   CDC, 2016, TRAV NOT
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2009, Med Trop (Mars), V69, P339
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasci RS, 2015, CDC HLTH INFORM INT, P94
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Reuters Staff, EL SALV URG PREGN 20
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yadav S, 2015, INT J PHARM CHEM ANA, V2, P139
   Yadav S, 2015, INT J HLTH SCI RES, V5, P368
   Yadav S, 2015, INT J SCI RES REV, V4, P101
   Yadav S, 2015, INT J PHARM CHEM ANA, V2, P46
   Yadav S, 2016, INT J HLTH SCI RES, V6, P364
   Yadav S, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.118.6455
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 47
TC 7
Z9 7
U1 0
U2 11
PU DE GRUYTER POLAND SP Z O O
PI WARSAW
PA BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND
SN 2450-131X
EI 2224-4018
J9 J TRANSL INTERN MED
JI J. TRANSL. INTERN. MED.
PD APR
PY 2016
VL 4
IS 1
SI SI
BP 42
EP 45
DI 10.1515/jtim-2016-0009
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT6XZ
UT WOS:000381629700009
PM 28191517
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Poland, GA
   Whitaker, JA
   Poland, CM
   Ovsyannikova, IG
   Kennedy, RB
AF Poland, Gregory A.
   Whitaker, Jennifer A.
   Poland, Caroline M.
   Ovsyannikova, Inna G.
   Kennedy, Richard B.
TI Vaccinology in the third millennium: scientific and social challenges
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; SUBUNIT CANDIDATE VACCINE; SYSTEMS BIOLOGY;
   INFLUENZA VACCINE; IMMUNE-RESPONSE; EMERGING FIELD; HERPES-ZOSTER;
   FAILURE; IMMUNOGENICITY; MEASLES
AB The epidemiology of deaths due to vaccine-preventable diseases has been significantly and positively altered through the use of vaccines. Despite this, significant challenges remain in vaccine development and use in the third millennium. Both new (Ebola, Chikungunya, Zika, and West Nile) and reemerging diseases (measles, mumps, and influenza) require the development of new or next-generation vaccines. The global aging of the population, and accumulating numbers of immunocompromised persons, will require new vaccine and adjuvant development to protect large segments of the population. After vaccine development, significant challenges remain globally in the cost and efficient use and acceptance of vaccines by the public. This article raises issues in these two areas and suggests a way forward that will benefit current and future generations.
C1 [Poland, Gregory A.; Whitaker, Jennifer A.; Ovsyannikova, Inna G.; Kennedy, Richard B.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.
   [Poland, Gregory A.; Whitaker, Jennifer A.; Ovsyannikova, Inna G.; Kennedy, Richard B.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA.
   [Whitaker, Jennifer A.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.
   [Poland, Caroline M.] Taylor Univ, Taylor Univ Counseling Ctr, Upland, IN 46989 USA.
RP Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.; Poland, GA (corresponding author), Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA.
EM poland.gregory@mayo.edu
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01AI089859, N01AI40065,
   R37AI048793, R01AI033144]
FX The authors were supported by the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health under award
   numbers U01AI089859, N01AI40065, R37AI048793, and R01AI033144. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR ALPER CA, 1989, NEW ENGL J MED, V321, P708, DOI 10.1056/NEJM198909143211103
   Anders JF, 1996, PEDIATR INFECT DIS J, V15, P62, DOI 10.1097/00006454-199601000-00014
   Ansaldi F, 2008, VACCINE, V26, P1525, DOI 10.1016/j.vaccine.2008.01.019
   Banchereau R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6283
   Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077
   Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bjornson ZB, 2013, CURR OPIN IMMUNOL, V25, P484, DOI 10.1016/j.coi.2013.07.004
   Boraschi D, 2014, IMMUNOL LETT, V162, P346, DOI 10.1016/j.imlet.2014.06.006
   Cardell K, 1999, SCAND J INFECT DIS, V31, P197, DOI 10.1080/003655499750006272
   Cardell K, 2008, J INFECT DIS, V198, P299, DOI 10.1086/589722
   Centers for Disease Control and Prevention, 2015, WHAT YOU NEED KNOW L
   Centers for Disease Control and Prevention, 2014, MARB HEM FEV
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P621
   Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002
   Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151
   Chlibek R, 2014, VACCINE, V32, P1745, DOI 10.1016/j.vaccine.2014.01.019
   Chlibek R, 2013, J INFECT DIS, V208, P1953, DOI 10.1093/infdis/jit365
   Clifford HD, 2012, VACCINE, V30, P6180, DOI 10.1016/j.vaccine.2012.07.063
   Davila S, 2010, GENES IMMUN, V11, P232, DOI 10.1038/gene.2010.1
   de Brevern AG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/904541
   DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727
   Duraisingham SS, 2013, CURR TOP MICROBIOL, V363, P117, DOI 10.1007/82_2012_250
   Durand M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00129
   Effros RB, 2003, IMMUNOL ALLERGY CLIN, V23, P41, DOI 10.1016/S0889-8561(02)00055-3
   Freitas DRC, 2013, VACCINE, V31, P950, DOI 10.1016/j.vaccine.2012.11.095
   Frey SE, 2014, VACCINE, V32, P5027, DOI 10.1016/j.vaccine.2014.07.013
   Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106
   Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630
   Gelder CM, 2002, J INFECT DIS, V185, P114, DOI 10.1086/338014
   Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317
   Gottschalk RA, 2013, SEMIN IMMUNOL, V25, P201, DOI 10.1016/j.smim.2012.11.002
   Grubeck-Loebenstein B, 2009, AGING CLIN EXP RES, V21, P201, DOI 10.1007/BF03324904
   Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025
   Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI 10.2217/FMB.10.146
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Higashigawa M, 2010, J INFECT CHEMOTHER, V16, P356, DOI 10.1007/s10156-010-0065-5
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Kennedy RB, 2011, OMICS, V15, P533, DOI 10.1089/omi.2011.0012
   Kibuuka H, 2015, LANCET, V385, P1545, DOI 10.1016/S0140-6736(14)62385-0
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Koff WC, 2014, NAT IMMUNOL, V15, P589, DOI 10.1038/ni.2871
   Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014
   Lawrence GL, 2005, COMMUN DIS INTELL, V29, P248
   Levy O, 2013, VACCINE, V31, P2500, DOI 10.1016/j.vaccine.2012.10.016
   Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751
   MARKS JS, 1980, JAMA-J AM MED ASSOC, V243, P2490, DOI 10.1001/jama.243.24.2490
   Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920
   McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6
   Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950
   Michalik DE, 2008, J INFECT DIS, V197, P944, DOI 10.1086/529043
   Montplaisir J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108489
   Mooney M, 2013, CURR OPIN IMMUNOL, V25, P551, DOI 10.1016/j.coi.2013.09.014
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536
   Oberg AL, 2015, VACCINE
   Oberg AL, 2011, CURR OPIN IMMUNOL, V23, P436, DOI 10.1016/j.coi.2011.04.005
   Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008
   Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002
   Ovsyannikova IG, 2006, EXPERT REV VACCINES, V5, P33, DOI 10.1586/14760584.5.1.33
   Ovsyannikova IG, 2011, AAPS J, V13, P438, DOI 10.1208/s12248-011-9281-x
   Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016
   Pappalardo F, 2015, PHARMACOL RES, V92, P40, DOI 10.1016/j.phrs.2014.08.006
   Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723
   Patel MK, 2012, J PHARMACOL PHARMACO, V3, P71, DOI 10.4103/0976-500X.92514
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Plotkin SA, 2014, CLIN INFECT DIS, V58, P830, DOI 10.1093/cid/cit934
   Poland CM, 2015, VACCINE, V33, P277, DOI 10.1016/j.vaccine.2014.11.022
   Poland CM, 2011, VACCINE, V29, P6145, DOI 10.1016/j.vaccine.2011.07.131
   Poland CM, 2014, WILEY BLACKWELL ENCY
   Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415
   Poland GA, 1997, JAMA-J AM MED ASSOC, V277, P1156, DOI 10.1001/jama.277.14.1156
   Poland GA, 2009, PEDIATR INFECT DIS J, V28, P431, DOI 10.1097/INF.0b013e3181a6a511
   Poland GA, 2008, EXPERT OPIN BIOL TH, V8, P1659, DOI [10.1517/14712598.8.11.1659, 10.1517/14712598.8.11.1659 ]
   Poland GA, 2014, CURR OPIN IMMUNOL, V29, P62, DOI 10.1016/j.coi.2014.04.005
   Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007
   Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344
   Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032
   Poland GA, 2010, VACCINE, V28, P3509, DOI 10.1016/j.vaccine.2010.03.031
   Poland GA, 2009, VACCINE, V27, P3240, DOI 10.1016/j.vaccine.2009.01.069
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004
   Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005
   Santillan Salas CF, 2013, J ASTHMA, V50, P1069
   Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511
   Schenkelberg T, 2015, EXPERT REV VACCINES, V14, P629, DOI 10.1586/14760584.2015.1013466
   Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Tsang JS, 2015, TRENDS IMMUNOL, V36, P479, DOI 10.1016/j.it.2015.06.005
   Valdezi Y, 2014, TRENDS IMMUNOL, V35, P526, DOI 10.1016/j.it.2014.07.003
   Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005
   Whitaker A, 2015, EXPERT REV VACCINES, P1
   Whiting CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133627
   WHO, 2016, EB SIT REP
   WHO, 2016, MIDDL E RESP SYNDR C
   World Health Organization, 2016, GLOB TUB REP 2015
   World Health Organization, 2016, MICR ZIK VIR
   World Health Organization (WHO), 2015, EB SIT REP
   Zak DE, 2014, ANNU REV IMMUNOL, V32, P547, DOI 10.1146/annurev-immunol-032713-120254
NR 105
TC 10
Z9 10
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2016
VL 17
BP 116
EP 125
DI 10.1016/j.coviro.2016.03.003
PG 10
WC Virology
SC Virology
GA DQ1LU
UT WOS:000378963300019
PM 27039875
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Solomon, T
AF Solomon, T.
TI Flavivirus encephalitis and other neurological syndromes (Japanese
   encephalitis, WNV, Tick borne encephalits, Dengue, Zika virus)
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Solomon, T.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
NR 0
TC 5
Z9 5
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
SU 1
MA 16.001
BP 24
EP 24
DI 10.1016/j.ijid.2016.02.086
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DK4GZ
UT WOS:000374876700046
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tambyah, PA
AF Tambyah, P. A.
TI Zika, MERS, Ebola, SARS and H1N1: Local and global responses to viral
   threats
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Tambyah, P. A.] Natl Univ Hlth Syst, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
SU 1
MA 36.001
BP 63
EP 63
DI 10.1016/j.ijid.2016.02.182
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DK4GZ
UT WOS:000374876700128
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tsankova, GS
   Kasimova, Z
   Todorova, TT
   Avdzhiyska, M
   Tsankova, D
AF Tsankova, Gabriela S.
   Kasimova, Zekie
   Todorova, Tatina T.
   Avdzhiyska, Milena
   Tsankova, Dajna
TI OUTBREAK OF ZIKA VIRUS DISEASE AND ITS COMPLICATIONS
SO JOURNAL OF IMAB
LA English
DT Article
DE Zika virus; Pregnancy; Microcephaly; Guillain-Barre syndrome
ID INTERIM GUIDELINES; UNITED-STATES; BRAZIL; TRANSMISSION; INFECTION
AB Zika virus (ZIKV) is an arbovirus from Flaviviridae family, genus Flavivirus. Like most of the viruses which belong to the Flavivirus genus, it replicates in and is transmitted by mosquitoes. Unlike other arbovirus infections including dengue and chikungunya, Zika virus causes a relatively mild disease. The most common symptoms of ZIKV are mild fever, arthralgia, myalgia, headache, asthenia, abdominal pain, oedema, lymphadenopathy, retro-orbital pain, conjunctivitis, and cutaneous maculopapular rash, which last for several days to a week. Although 80% of the cases with ZIKV are asymptomatic, severe complications such as microcephalia and GBS may be observed. This explains why ZIKV is more dangerous that it was thought to be and why it rapidly evolves in unexpected challenge for the international and national public health authorities.
C1 [Tsankova, Gabriela S.; Todorova, Tatina T.] Med Univ Varna, Fac Pharm, Dept Preclin & Clin Sci, 3 Bregalniza Str, Varna 9002, Bulgaria.
   [Kasimova, Zekie; Avdzhiyska, Milena; Tsankova, Dajna] Med Univ Varna, Varna, Bulgaria.
RP Tsankova, GS (corresponding author), Med Univ Varna, Fac Pharm, Dept Preclin & Clin Sci, 3 Bregalniza Str, Varna 9002, Bulgaria.
EM gabriela_sc@abv.bg
RI Todorova, Tatina/AAB-3224-2019
OI Todorova, Tatina/0000-0002-4668-9347
CR Besnard M, 2014, EURO SURVEILL, V19
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   WHO, 2016, PREGN MAN CONT ZIK V
NR 23
TC 0
Z9 0
U1 0
U2 20
PU GOSPODIN ILIEV PEYTCHINSKI, ED & PUB
PI PLEVEN
PA DROUJBA BL 116, PLEVEN, 5806, BULGARIA
SN 1312-773X
J9 J IMAB
JI J. IMAB
PD APR-JUN
PY 2016
VL 22
IS 2
BP 1136
EP 1138
DI 10.5272/jimab.2016222.1136
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP6EU
UT WOS:000378590500007
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Borchardt, RA
AF Borchardt, Roy A.
TI Zika virus: A rapidly emerging infectious disease
SO JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS
LA English
DT Article
DE Zika virus; arbovirus; flavivirus; microcephaly; pregnancy; infection
ID OUTBREAK; STATES
AB Zika virus is a flavivirus transmitted to humans via the bite of infected mosquitoes. A recent outbreak in Brazil has spread to several surrounding countries, and the virus also has been reported in the United States. The virus is associated with microcephaly among newborns whose mothers were infected. Because no vaccine or treatment is available, efforts have focused on preventing mosquito bites and advising pregnant women and women trying to get pregnant to avoid active areas of Zika virus transmission. Clinicians should understand the infection, its diagnosis and testing, and monitor pregnant women for travel history to outbreak regions and for the presence of clinical symptoms. Patient education on preventive measures offers the best option to avoid Zika virus infection.
C1 [Borchardt, Roy A.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Adv Practice Providers, Houston, TX 77030 USA.
RP Borchardt, RA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Adv Practice Providers, Houston, TX 77030 USA.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, N ENGL J MED
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oster AM, 2016, MMWR EARLY RELEASE, V65
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 12
TC 6
Z9 7
U1 0
U2 33
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1547-1896
EI 0893-7400
J9 JAAPA-J AM ACAD PHYS
JI JAAPA-J. Am. Acad. Physician Assist.
PD APR
PY 2016
VL 29
IS 4
BP 48
EP 50
DI 10.1097/01.JAA.0000481413.11539.b1
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO6FZ
UT WOS:000377880000017
PM 26953673
DA 2020-07-08
ER

PT J
AU Nunez, CA
   Gonzalez, CR
   Obreque, V
   Riquelme, B
   Reyes, C
   Rojas, M
AF Andrea Nunez, Claudia
   Raul Gonzalez, Christian
   Obreque, Victor
   Riquelme, Brenda
   Reyes, Carolina
   Rojas, Mabel
TI Molecular characterization of Aedes aegypti (L.) (Diptera: Culicidae) of
   Easter Island based on analysis of the mitochondrial ND4 gene
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE Dengue; Haplotypes; Rapa Nui
AB Aedes aegypti mosquitoes are the main vector of viruses Dengue, Zika and Chikungunya. Shortly after the first report of the dengue vector Ae. aegypti in Easter Island (Rapa Nui) in late 2000, the first disease outbreak dengue occurred. Viral serotyping during the 2002 outbreak revealed a close relationship withPacific DENV-1 genotype IV viruses, supporting the idea that the virus most likely originated in Tahiti. Mitochondrial NADH dehydrogenase subunit 4 (ND4) DNA sequences generated from 68 specimens of Ae. aegypti from Easter Island reporting a unique finding of a single maternal lineage of Ae. aegypti on Easter Island. (C) 2016 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.
C1 [Andrea Nunez, Claudia; Obreque, Victor; Rojas, Mabel] Univ Iberoamericana Ciencias & Tecnol, Ctr Biotechnol, Santiago, Chile.
   [Raul Gonzalez, Christian; Reyes, Carolina] Inst Salud Publ Chile, Sect Parasitol, Lab Med Entomol, Santiago, Chile.
   [Raul Gonzalez, Christian] Univ Metropolitana Ciencias Educ, Inst Entomol, Santiago, Chile.
   [Riquelme, Brenda] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.
RP Nunez, CA (corresponding author), Univ Iberoamericana Ciencias & Tecnol, Ctr Biotechnol, Santiago, Chile.
EM claudia.nunez@uibero.cl
CR Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   OLEA M. PILAR, 2003, Rev. chil. infectol., V20, P129, DOI 10.4067/S0716-10182003000200008
   Perret C, 2003, EMERG INFECT DIS, V9, P1465, DOI 10.3201/eid0911.020788
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Urdaneta-Marquez L, 2008, AM J TROP MED HYG, V78, P479, DOI 10.4269/ajtmh.2008.78.479
NR 13
TC 0
Z9 0
U1 0
U2 13
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PD APR-JUN
PY 2016
VL 60
IS 2
BP 186
EP 187
DI 10.1016/j.rbe.2016.03.001
PG 2
WC Entomology
SC Entomology
GA DO6II
UT WOS:000377886200011
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ladner, JT
   Kuhn, JH
   Palacios, G
AF Ladner, J. T.
   Kuhn, J. H.
   Palacios, G.
TI Standard finishing categories for high-throughput sequencing of viral
   genomes
SO REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
LA English
DT Article
DE Data curation; Genome assembly; High-throughput sequencing; Medical
   countermeasure development; Molecular epidemiology; Population genomics;
   Virus
ID EBOLA-VIRUS; DIVERSITY; EVOLUTION; DISCOVERY; VARIANTS; SURVEILLANCE;
   CORONAVIRUS; POPULATION; EMERGENCE; EPIDEMIC
AB Viral genome sequencing has become the cornerstone of almost all aspects of virology. In particular, high-throughput, next-generation viral genome sequencing has become an integral part of molecular epidemiological investigations into outbreaks of viral disease, such as the recent outbreaks of Middle Eastern respiratory syndrome, Ebola virus disease and Zika virus infection. Multiple institutes have acquired the expertise and necessary infrastructure to perform such investigations, as evidenced by the accumulation of thousands of novel viral sequences over progressively shorter time periods. The authors recently proposed a nomenclature comprised of five high-throughput sequencing standard categories to describe the quality of determined viral genome sequences. These five categories (standard draft, high quality, coding complete, complete and finished) cover all levels of viral genome finishing and can be applied to sequences determined by any technology platform or assembly technique.
C1 [Ladner, J. T.; Palacios, G.] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.
   [Kuhn, J. H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA.
RP Palacios, G (corresponding author), US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.
EM gustavo.f.palacios.ctr@mail.mil
RI Kuhn, Jens H./B-7615-2011; Palacios, Gustavo/I-7773-2015
OI Kuhn, Jens H./0000-0002-7800-6045; Palacios, Gustavo/0000-0001-5062-1938
FU Defense Threat Reduction AgencyUnited States Department of
   DefenseDefense Threat Reduction Agency [1881290]; Battelle Memorial
   Institute's prime contract; US National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272200700016I]
FX This work was partly funded by Defense Threat Reduction Agency Project
   No. 1881290 and by Battelle Memorial Institute's prime contract with the
   US National Institute of Allergy and Infectious Diseases under Contract
   No. HHSN272200700016I. A subcontractor who performed this work is JHK,
   an employee of Tunnell Government Services. The authors thank Laura
   Bollinger for editing this manuscript.
CR Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Brister JR, 2010, VIRUSES-BASEL, V2, P2258, DOI 10.3390/v2102258
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614
   Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010
   Chow CET, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00265
   Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404
   Domingo E, 2006, CURR TOP MICROBIOL, V299, P51
   Fancello L, 2012, VIROLOGY, V434, P162, DOI 10.1016/j.virol.2012.09.025
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   King A.M.Q., 2012, VIRUS TAXONOMY CLASS
   Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771
   Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038
   Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522
   Kuhn JH, 2014, VIRUSES-BASEL, V6, P3663, DOI 10.3390/v6093663
   Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0
   Labonte JM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00315
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93
   Lipkin WI, 2013, NAT REV MICROBIOL, V11, P133, DOI 10.1038/nrmicro2949
   Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417
   Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053
   Palacios G, 2011, J VIROL, V85, P3811, DOI 10.1128/JVI.02275-10
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Perez-Ruiz M, 2012, EMERG INFECT DIS, V18, P855, DOI 10.3201/eid1805.111646
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]
   Sanchez AB, 2006, VIROLOGY, V350, P370, DOI 10.1016/j.virol.2006.01.012
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Suttle C, 2005, ENVIRON MICROBIOL, V7, P481, DOI 10.1111/j.1462-2920.2005.803_11.x
   Suttle CA, 2013, GENOME, V56, P542, DOI 10.1139/gen-2013-0152
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478
   Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Webster JP, 2016, EVOL APPL, V9, P313, DOI 10.1111/eva.12341
   Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
NR 42
TC 4
Z9 4
U1 0
U2 50
PU OFFICE INT EPIZOOTIES
PI PARIS
PA 12 RUE DE PRONY, 75017 PARIS, FRANCE
SN 0253-1933
J9 REV SCI TECH OIE
JI Rev. Sci. Tech. Off. Int. Epizoot.
PD APR
PY 2016
VL 35
IS 1
BP 43
EP 52
DI 10.20506/rst.35.1.2416
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA DO8EA
UT WOS:000378014200004
PM 27217167
DA 2020-07-08
ER

PT J
AU Rodrigues, LC
AF Rodrigues, Laura C.
TI Zika: The Tragedy and the Opportunities
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London WC1, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, London WC1, England.
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
NR 0
TC 6
Z9 6
U1 0
U2 7
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 582
EP 582
DI 10.2105/AJPH.2016.303114
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000005
PM 26959248
OA Green Published
DA 2020-07-08
ER

PT J
AU Bell, BP
   Boyle, CA
   Petersen, LR
AF Bell, Beth P.
   Boyle, Coleen A.
   Petersen, Lyle R.
TI Preventing Zika Virus Infections in Pregnant Women: An Urgent Public
   Health Priority
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID BRAZIL
C1 [Bell, Beth P.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
   [Boyle, Coleen A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Petersen, Lyle R.] CDC, Div Vector Borne Dis, Ft Collins, CO USA.
RP Bell, BP (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd,Mailstop C12, Atlanta, GA 30329 USA.
EM bbell@cdc.gov
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EPID AM POT
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, N ENGL J MED
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Plotkin SA, 2008, VACCINES, P735
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
NR 14
TC 8
Z9 8
U1 0
U2 70
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 589
EP 590
DI 10.2105/AJPH.2016.303124
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000008
PM 26959253
OA Green Published
DA 2020-07-08
ER

PT J
AU Teixeira, MG
   Costa, MDN
   de Oliveira, WK
   Nunes, ML
   Rodrigues, LC
AF Teixeira, Maria G.
   Costa, Maria da Conceicao N.
   de Oliveira, Wanderson K.
   Nunes, Marilia Lavocat
   Rodrigues, Laura C.
TI The Epidemic of Zika Virus-Related Microcephaly in Brazil: Detection,
   Control, Etiology, and Future Scenarios
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID INFECTION; OUTBREAK
AB We describe the epidemic of microcephaly in Brazil, its detection and attempts to control it, the suspected causal link with Zika virus infection during pregnancy, and possible scenarios for the future. In October 2015, in Pernambuco, Brazil, an increase in the number of newborns with microcephaly was reported. Mothers of the affected newborns reported rashes during pregnancy and no exposure to other potentially teratogenic agents. Women delivering in October would have been in the first trimester of pregnancy during the peak of a Zika epidemic in March. By the end of 2015, 4180 cases of suspected microcephaly had been reported. Zika spread to other American countries and, in February 2016, the World Health Organization declared the Zika epidemic a public health emergency of international concern. This unprecedented situation underscores the urgent need to establish the evidence of congenital infection risk by gestational week and accrue knowledge. There is an urgent call for a Zika vaccine, better diagnostic tests, effective treatment, and improved mosquito-control methods.
C1 [Teixeira, Maria G.; Costa, Maria da Conceicao N.] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
   [de Oliveira, Wanderson K.; Nunes, Marilia Lavocat] Minist Hlth, Brasilia, DF, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM laura.rodrigues@lshtm.ac.uk
RI Teixeira, Maria Gloria/G-4808-2012; Oliveira, Wanderson/AAF-5182-2019
OI Teixeira, Maria Gloria/0000-0003-3318-3408; Oliveira,
   Wanderson/0000-0002-9662-1930
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
CR Brasil Ministerio da Saude, 2015, PREV COMB DENG CHIK
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOL, V46, P1
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOL
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, TRAV HLTH NOT AL LEV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Mlakar J, 2016, N ENGL J MED
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Pan American Health Organization, 2015, EP LOG AL NEUR SYNDR
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization World Health Organization, 2015, CONG AN 2 LEAD CAUS
   PARSONSON IM, 1977, INFECT IMMUN, V15, P254, DOI 10.1128/IAI.15.1.254-262.1977
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stein R, BIG ZIKA VIRUS OUTBR
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Ventura CV, 2016, LANCET, V387, P228
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, 2015, CONGENITAL ANOMALIES
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 28
TC 63
Z9 70
U1 2
U2 66
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 601
EP 605
DI 10.2105/AJPH.2016.303113
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000014
PM 26959259
OA Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika research
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD APR
PY 2016
VL 94
IS 4
BP 237
EP 238
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DJ8BB
UT WOS:000374436000007
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Psychosocial guidance and Zika
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD APR
PY 2016
VL 94
IS 4
BP 237
EP 237
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DJ8BB
UT WOS:000374436000006
DA 2020-07-08
ER

PT J
AU Lucey, DR
AF Lucey, Daniel R.
TI WILL ZIKA VIRUS AND MICROCEPHALY EPIDEMICS EMERGE AFTER EBOLA IN WEST
   AFRICA? THE NEED FOR PROSPECTIVE STUDIES NOW
SO HEALTH SECURITY
LA English
DT Editorial Material
C1 [Lucey, Daniel R.] Georgetown Univ, Sch Med, Med, Washington, DC USA.
   [Lucey, Daniel R.] Georgetown Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA.
RP Lucey, DR (corresponding author), Georgetown Univ Hosp, Med Ctr, Div Infect Dis, Dept Med, 3800 Reservoir Rd NW, Washington, DC 20057 USA.
EM DRL23@Georgetown.edu
CR Garcez PP, 2016, PEERJ PREPRINTS, V4
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   WHO, 2016, WHO STAT 2 M IHR EM
   World Health Organization, 2016, ZIK VIR RISK ASS WHO
NR 4
TC 1
Z9 1
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD APR
PY 2016
VL 14
IS 2
BP 53
EP 54
DI 10.1089/hs.2016.0033
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK1FJ
UT WOS:000374657600005
PM 26986702
DA 2020-07-08
ER

PT J
AU Higgs, S
   Vanlandingham, DL
AF Higgs, S.
   Vanlandingham, D. L.
TI Search and one will find: Zika virus everywhere
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Editorial Material
DE Aedes aegypti; Epidemic; Microcephaly; Transmission; Zika virus
C1 [Higgs, S.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
RP Higgs, S (corresponding author), Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
EM shiggs@ksu.edu
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Higgs S, 2015, T ROY SOC TROP MED H, V109, P543, DOI 10.1093/trstmh/trv061
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MacNamara FN., 1951, ANN REPORT VIRUS RES
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 11
TC 2
Z9 2
U1 0
U2 60
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD APR
PY 2016
VL 110
IS 4
BP 207
EP 208
DI 10.1093/trstmh/trw020
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DJ9ZV
UT WOS:000374573000001
PM 27076507
OA Bronze
DA 2020-07-08
ER

PT J
AU Liu, SQ
   Zhang, B
AF Liu, Si-Qing
   Zhang, Bo
TI Zika virus: a flavivirus caused pandemics in Latin America
SO VIROLOGICA SINICA
LA English
DT Editorial Material
ID MICRONESIA
C1 [Liu, Si-Qing; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
RP Zhang, B (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
EM zhangbo@wh.iov.cn
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MORB MORTAL WKLY REP, V65
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lamb RA, 2001, FIELDS VIROLOGY
   Lanciotti R.S., 2016, EMERG INFECT DIS, V22
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Schuler-Faccini L, 2016, MORB MORTAL WKLY REP, P65
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Van-Mai C-L, 2013, EMERG INFECT DIS, V20, P1084
   World Health Organization, 2016, ZIK SIT REP ZIK POT
NR 18
TC 0
Z9 0
U1 0
U2 63
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 101
EP 102
DI 10.1007/s12250-016-3738-0
PG 2
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800001
PM 26965108
OA Bronze
DA 2020-07-08
ER

PT J
AU Wang, ZY
   Wang, PG
   An, J
AF Wang, Zhaoyang
   Wang, Peigang
   An, Jing
TI Zika virus and Zika fever
SO VIROLOGICA SINICA
LA English
DT Review
DE Zika virus; Zika fever; Zika host interaction; microcephaly; neuronal
   disorder
ID ASIAN LINEAGE; AMERICA; INFECTION; OUTBREAK; MICRONESIA; SPREADS;
   STATES; CELLS
AB An emerging mosquito-borne arbovirus named Zika virus (ZIKV), of the family Flaviviridae and genus Flavivirus, is becoming a global health threat. ZIKV infection was long neglected due to its sporadic nature and mild symptoms. However, recently, with its rapid spread from Asia to the Americas, affecting more than 30 countries, accumulating evidences have demonstrated a close association between infant microcephaly and Zika infection in pregnant women. Here, we reviewed the virological, epidemiological, and clinical essentials of ZIKV infection.
C1 [Wang, Zhaoyang; Wang, Peigang; An, Jing] Chinese Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.
RP Wang, PG; An, J (corresponding author), Chinese Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.
EM pgwang@ccmu.edu.cn; anjing@ccmu.edu.cn
OI Wang, Peigang/0000-0001-6045-2007
FU National Natural Science Foundations of ChinaNational Natural Science
   Foundation of China [81471957, 81271839, 81372935, 81301435, 81401676]
FX This work was supported by the National Natural Science Foundations of
   China (81471957, 81271839, 81372935, 81301435, and 81401676).
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Franchini M, 2015, BLOOD TRANSFUS, V1
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 47
TC 12
Z9 14
U1 0
U2 47
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 103
EP 109
DI 10.1007/s12250-016-3780-y
PG 7
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800002
PM 27129450
OA Bronze
DA 2020-07-08
ER

PT J
AU Shen, S
   Shi, JM
   Wang, J
   Tang, S
   Wang, HL
   Hu, ZH
   Deng, F
AF Shen, Shu
   Shi, Junming
   Wang, Jun
   Tang, Shuang
   Wang, Hualin
   Hu, Zhihong
   Deng, Fei
TI Phylogenetic analysis revealed the central roles of two African
   countries in the evolution and worldwide spread of Zika virus
SO VIROLOGICA SINICA
LA English
DT Article
DE Flaviviridae; Zika virus (ZIKV); phylogenetic analysis; lineages;
   recombination; migration
ID MOSQUITO-BORNE DISEASE; INFECTION; ARBOVIRUSES; INDONESIA; CHIKUNGUNYA;
   MICRONESIA; PACIFIC; DENGUE; TRAVEL; GABON
AB Recent outbreaks of Zika virus (ZIKV) infections in Oceania's islands and the Americas were characterized by high numbers of cases and the spread of the virus to new areas. To better understand the origin of ZIKV, its epidemic history was reviewed. Although the available records and information are limited, two major genetic lineages of ZIKV were identified in previous studies. However, in this study, three lineages were identified based on a phylogenetic analysis of all virus sequences from GenBank, including those of the envelope protein (E) and non-structural protein 5 (NS5) coding regions. The spatial and temporal distributions of the three identified ZIKV lineages and the recombination events and mechanisms underlying their divergence and evolution were further elaborated. The potential migration pathway of ZIKV was also characterized. Our findings revealed the central roles of two African countries, Senegal and Cote d'Ivoire, in ZIKV evolution and genotypic divergence. Furthermore, our results suggested that the outbreaks in Asia and the Pacific islands originated from Africa. The results provide insights into the geographic origins of ZIKV outbreaks and the spread of the virus, and also contribute to a better understanding of ZIKV evolution, which is important for the prevention and control of ZIKV infections.
C1 [Shen, Shu; Shi, Junming; Wang, Jun; Tang, Shuang; Wang, Hualin; Hu, Zhihong; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
RP Deng, F (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
EM df@wh.iov.cn
RI Hu, Zhihong/AAS-2215-2020
OI Hu, Zhihong/0000-0002-1560-0928
FU Science and Technology Basic Work Program from the Ministry of Science
   and Technology of China [2013FY113500]
FX This work was supported by the Science and Technology Basic Work Program
   (2013FY113500) from the Ministry of Science and Technology of China.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   ASAHINA S, 1970, JPN J MED SCI BIOL, V23, P255, DOI 10.7883/yoken1952.23.255
   Baronti C, 2014, GENOME ANNOUNC, V2
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kindhauser MK, 2016, B WHO
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Roth A, 2014, EURO SURVEILL, V19
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 49
TC 31
Z9 32
U1 1
U2 41
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 118
EP 130
DI 10.1007/s12250-016-3774-9
PG 13
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800004
PM 27129451
DA 2020-07-08
ER

PT J
AU Mandell, BF
AF Mandell, Brian F.
TI Zika-a new continent and new complications?
SO CLEVELAND CLINIC JOURNAL OF MEDICINE
LA English
DT Editorial Material
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
NR 1
TC 0
Z9 0
U1 0
U2 0
PU CLEVELAND CLINIC
PI CLEVELAND
PA 9500 EUCLID AVE, CLEVELAND, OH 44106 USA
SN 0891-1150
EI 1939-2869
J9 CLEV CLIN J MED
JI Clevel. Clin. J. Med.
PD APR
PY 2016
VL 83
IS 4
BP 247
EP 248
DI 10.3949/ccjm.83b.04016
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK3TV
UT WOS:000374841200002
PM 27055196
OA Bronze
DA 2020-07-08
ER

PT J
AU Plotkin, SA
AF Plotkin, S. A.
TI Zika as still another argument for a new path to vaccine development
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Editorial Material
C1 [Plotkin, S. A.] Univ Penn, Philadelphia, PA 19104 USA.
RP Plotkin, SA (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.
EM Stanley.plotkin@vaxconsult.com
CR Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051
   Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755
NR 3
TC 5
Z9 5
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR
PY 2016
VL 22
IS 4
BP 294
EP 295
DI 10.1016/j.cmi.2016.03.001
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DL1NW
UT WOS:000375399900002
PM 27107300
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Huang, LM
AF Huang, Li-Min
TI How can we deal with Zika virus infection?
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID OUTBREAK
C1 [Huang, Li-Min] Natl Taiwan Univ, Dept Pediat, Childrens Hosp, 8 Chung Shan South Rd, Taipei, Taiwan.
RP Huang, LM (corresponding author), Natl Taiwan Univ, Dept Pediat, Childrens Hosp, 8 Chung Shan South Rd, Taipei, Taiwan.
EM lmhuang@ntu.edu.tw
OI HUANG, LI-MIN/0000-0002-9291-260X
CR Chang SC, 2015, J FORMOS MED ASSOC, V114, P1025, DOI 10.1016/j.jfma.2015.10.006
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WHO, 2016, ZIK SIT REP NEUR SYN
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wong SSY, 2015, J FORMOS MED ASSOC, V114, P384, DOI 10.1016/j.jfma.2015.01.012
NR 9
TC 0
Z9 0
U1 0
U2 56
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD APR
PY 2016
VL 115
IS 4
BP 221
EP 222
DI 10.1016/j.jfma.2016.03.001
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6MY
UT WOS:000375039400001
PM 27013108
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wong, SSY
   Poon, RWS
   Wong, SCY
AF Wong, Samson Sai-Yin
   Poon, Rosana Wing-Shan
   Wong, Sally Cheuk-Ying
TI Zika virus infection-the next wave after dengue?
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Review
DE Zika virus; Flavivirus; Aedes; travel medicine; congenital abnormalities
ID WEST-NILE-VIRUS; MOSQUITOS DIPTERA-CULICIDAE; YELLOW-FEVER; CHIKUNGUNYA
   VIRUS; INSECT REPELLENTS; AEDES-ALBOPICTUS; UNITED-STATES; FEDERATED
   STATES; FRENCH-POLYNESIA; PHYLOGENETIC-RELATIONSHIPS
AB Zika virus was initially discovered in east Africa about 70 years ago and remained a neglected arboviral disease in Africa and Southeast Asia. The virus first came into the limelight in 2007 when it caused an outbreak in Micronesia. In the ensuing decade, it spread widely in other Pacific islands, after which its incursion into Brazil in 2015 led to a widespread epidemic in Latin America. In most infected patients the disease is relatively benign. Serious complications include Guillain-Barre syndrome and congenital infection which may lead to microcephaly and maculopathy. Aedes mosquitoes are the main vectors, in particular, Ae. aegypti. Ae. albopictus is another potential vector. Since the competent mosquito vectors are highly prevalent in most tropical and subtropical countries, introduction of the virus to these areas could readily result in endemic transmission of the disease. The priorities of control include reinforcing education of travellers to and residents of endemic areas, preventing further local transmission by vectors, and an integrated vector management programme. The container habitats of Ae. aegypti and Ae. albopictus means engagement of the community and citizens is of utmost importance to the success of vector control. Copyright (C) 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Wong, Samson Sai-Yin] Univ Hong Kong, Dept Microbiol, Res Ctr Infect & Immunol, Fac Med, Hong Kong, Hong Kong, Peoples R China.
   [Poon, Rosana Wing-Shan; Wong, Sally Cheuk-Ying] Queen Mary Hosp, Dept Microbiol, LG-1 Block K,102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
RP Wong, SSY (corresponding author), Queen Mary Hosp, Dept Microbiol, LG-1 Block K,102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM samsonsy@hku.hk
RI Wong, Samson Sai Yin/C-4446-2009
OI Wong, Samson Sai Yin/0000-0003-0266-4401
CR Advisory Committee on Dangerous Pathogens UK, 2013, APPR LIST BIOL AG
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P69
   [Anonymous], 2012, GLOB STRAT DENG PREV
   [Anonymous], INDIA CO SAYS THEY H
   Antwi FB, 2008, REGUL TOXICOL PHARM, V51, P31, DOI 10.1016/j.yrtph.2008.03.002
   Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001
   Atkinson B, 2016, EMERG INFEC IN PRESS
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bordignon J, 2007, J MED VIROL, V79, P1506, DOI 10.1002/jmv.20958
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carroll I Dale, 2008, Travel Med Infect Dis, V6, P259, DOI 10.1016/j.tmaid.2008.04.005
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Centers for Disease Control and Prevention, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention National Institutes of Health, 2009, BIOSAFETY MICROBIOLO
   Chang SC, 2015, J FORMOS MED ASSOC, V114, P1025, DOI 10.1016/j.jfma.2015.10.006
   Chaves-Carballo E, 2005, MIL MED, V170, P881, DOI 10.7205/MILMED.170.10.881
   Chen TH, 2015, J FORMOS MED ASSOC, V114, P546, DOI 10.1016/j.jfma.2014.12.002
   Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Duvallet G, 2011, PARASITE, V18, P93
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Faull KJ, 2015, J VECTOR ECOL, V40, P292, DOI 10.1111/jvec.12167
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fibriansah G, 2016, ANTIVIRAL R IN PRESS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Goodyer LI, 2010, J TRAVEL MED, V17, P182, DOI 10.1111/j.1708-8305.2010.00402.x
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gubler DJ, 2007, FIELDS VIROLOGY, P1154
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Idrees Sobia, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P232, DOI 10.1016/S2221-1691(13)60057-X
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Kakumani PK, 2015, BIOCHEM J, V471, P89, DOI 10.1042/BJ20150445
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005
   KAWANO H, 1993, J VIROL, V67, P6567, DOI 10.1128/JVI.67.11.6567-6575.1993
   Kim Lien PT, 2015, ASIAN PAC J TROP MED, V8, P543
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Kumar JS, 2011, J MED VIROL, V83, P1063, DOI 10.1002/jmv.22097
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leiby DA, 2004, TRANSFUS MED REV, V18, P293, DOI 10.1016/j.tmrv.2004.07.001
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1102
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marcondes CB, 2015, REV SOC BRA IN PRESS
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Melian EB, 2013, J GEN VIROL, V94, P308, DOI 10.1099/vir.0.047076-0
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J ME IN PRESS
   Mogi M, 1996, J MED ENTOMOL, V33, P438, DOI 10.1093/jmedent/33.3.438
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   MUKWAYA L G, 1974, Acta Tropica, V31, P165
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasci RS, 2016, CDC HLTH INFORM INT
   Nordin JD, 2013, J TRAVEL MED, V20, P368, DOI 10.1111/jtm.12070
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onyett H, 2014, PAED CHILD HEALT-CAN, V19, P326, DOI 10.1093/pch/19.6.326
   Osimitz TG, 2010, REGUL TOXICOL PHARM, V56, P93, DOI 10.1016/j.yrtph.2009.09.004
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, CUM ZIK CONF SUSP CA
   Pan American Health Organization, ZIK EP AL UPD
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Public Health England, 2019, GUID MAL PREV TRAV U
   Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052
   Reed W, 1902, J HYG-CAMBRIDGE, V2, P101, DOI 10.1017/S0022172400001856
   Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rothan HA, 2013, TROP BIOMED, V30, P681
   Rothan HA, 2014, ARCH VIROL, V159, P711, DOI 10.1007/s00705-013-1880-7
   Royal College of Obstetricians and Gynaecologists, 2016, INT CLIN GUID ZIK VI
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Savage HM, 2015, AM J TROP MED HYG, V92, P429, DOI 10.4269/ajtmh.14-0374
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Saxena D, 2013, J CLIN VIROL, V58, P528, DOI 10.1016/j.jcv.2013.08.033
   SELIM S, 1995, FUND APPL TOXICOL, V25, P95, DOI 10.1006/faat.1995.1043
   Shi PY, 2014, CELL HOST MICROBE, V16, P269, DOI 10.1016/j.chom.2014.08.011
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Farias KJS, 2014, MICROBIOL IMMUNOL, V58, P318, DOI 10.1111/1348-0421.12154
   Farias KJS, 2013, SCI WORLD J, DOI 10.1155/2013/282734
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sissoko D, 2010, TROP MED INT HEALTH, V15, P600, DOI 10.1111/j.1365-3156.2010.02485.x
   Stanley E., 2009, Morbidity and Mortality Weekly Report, V58, P1263
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Sudakin DL, 2010, HAYES' HANDBOOK OF PESTICIDE TOXICOLOGY, VOLS 1 AND 2, 3RD EDITION, P2111, DOI 10.1016/B978-0-12-374367-1.00098-7
   Taiwan National Infectious Disease Statistics System, STAT DENG FEV NAT IN
   Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, MED MICROBI IN PRESS
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   TENENBEIN M, 1987, JAMA-J AM MED ASSOC, V258, P1509, DOI 10.1001/jama.258.11.1509
   Tognarelli J, 2015, ARCH VIROL IN PRESS
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   TravelHealthPro National Travel Health Network and Centre, ZIK VIR UPD ADV TRAV
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Vasani R, 2015, PEDIAT DERM IN PRESS
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   WHO, 2016, DIS OUTBREAK NE 0208
   Wiles D, 2014, J ANAL TOXICOL, V38, P696, DOI 10.1093/jat/bku082
   Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004
   Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2
   WOLFE MS, 1982, LANCET, V2, P1306
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wong SSY, 2015, J FORMOS MED ASSOC, V114, P384, DOI 10.1016/j.jfma.2015.01.012
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, YELL FEV VACC REQ RE
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang SL, 2006, VIROLOGY, V353, P35, DOI 10.1016/j.virol.2006.05.025
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 182
TC 33
Z9 35
U1 0
U2 23
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD APR
PY 2016
VL 115
IS 4
BP 226
EP 242
DI 10.1016/j.jfma.2016.02.002
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6MY
UT WOS:000375039400003
PM 26965962
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sadovsky, Y
   Clifton, VL
   Knofler, M
AF Sadovsky, Yoel
   Clifton, Vicki L.
   Knoefler, Martin
TI Editorial: ZIKA virus and placenta
SO PLACENTA
LA English
DT Editorial Material
RI Clifton, Vicki/A-1445-2012
OI Clifton, Vicki/0000-0002-4892-6748; Sadovsky, Yoel/0000-0003-2969-6737
NR 0
TC 6
Z9 6
U1 0
U2 9
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2016
VL 40
BP A1
EP A1
DI 10.1016/j.placenta.2016.03.008
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA DJ7WJ
UT WOS:000374423600001
PM 27016785
DA 2020-07-08
ER

PT J
AU Dickson, LB
   Sharakhova, MV
   Timoshevskiy, VA
   Fleming, KL
   Caspary, A
   Sylla, M
   Black, WC
AF Dickson, Laura B.
   Sharakhova, Maria V.
   Timoshevskiy, Vladimir A.
   Fleming, Karen L.
   Caspary, Alex
   Sylla, Massamba
   Black, William C.
TI Reproductive Incompatibility Involving Senegalese Aedes aegypti (L) Is
   Associated with Chromosome Rearrangements
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID QUANTITATIVE TRAIT LOCI; EASTERN TREEHOLE MOSQUITO; DENGUE VECTOR
   MOSQUITO; YELLOW-FEVER MOSQUITO; HALDANE RULE; L DIPTERA;
   GENETIC-VARIATION; GLAND PROTEINS; SSCP ANALYSIS; LINKAGE MAP
AB Aedes aegypti, the primary vector of dengue, yellow fever and Zika flaviviruses, consists of at least two subspecies. Aedes aegypti (Aaa) is light in color, has pale scales on the first abdominal tergite, oviposits in artificial containers, and preferentially feeds on humans. Aedes aegypti formosus (Aaf), has a dark cuticle, is restricted to sub-Saharan Africa, has no pale scales on the first abdominal tergite and frequently oviposits in natural containers. Scale patterns correlate with cuticle color in East Africa but not in Senegal, West Africa where black cuticle mosquitoes display a continuum of scaling patterns and breed domestically indoors. An earlier laboratory study did not indicate any pre- or postzygotic barriers to gene flow between Aaa and Aaf in East Africa. However, similar attempts to construct F-1 intercross families between Aaa laboratory strains and Senegal Ae. aegypti (SenAae) failed due to poor F-1 oviposition and low F-2 egg-to-adult survival. Insemination and assortative mating experiments failed to identify prezygotic mating barriers. Backcrosses were performed to test for postzygotic isolation patterns consistent with Haldane's rule modified for species, like Aedes, that have an autosomal sex determining locus (SDL). Egg-pupal survival was predicted to be low in females mated to hybrid F-1 males but average when a male mates with a hybrid F-1 female. Survival was in fact significantly reduced when females mated to hybrid males but egg-pupal survival was significantly increased when males were mated to hybrid F-1 females. These observations are therefore inconclusive with regards to Haldane's rule. Basic cytogenetic analyses and Fluorescent In Situ Hybridization (FISH) experiments were performed to compare SenAae strains with the IB12 strain of Aaa that was used for genome sequencing and physical mapping. Some SenAae strains had longer chromosomes than IB12 and significantly different centromeric indices on chromosomes 1 and 3. DAPI staining was used to identify AT-rich regions, chromomycin A3 following pretreatment with barium hydroxide stained for GC-rich regions and stained the ribosomal RNA locus and YOYO-1 was used to test for differential staining. Chromosome patterns in SenAae strains revealed by these three stains differed from those in IB12. For FISH, 40 BAC clones previously physically mapped on Aaa chromosomes were used to test for chromosome rearrangements in SenAae relative to IB12. Differences in the order of markers identified two chromosomal rearrangements between IB12 and SenAae strains. The first rearrangement involves two overlapping pericentric (containing the centromere) inversions in chromosome 3 or an insertion of a large fragment into the 3q arm. The second rearrangement is close to the centromere on the p arm of chromosome 2. Linkage analysis of the SDL and the white-eye locus identified a likely chromosomal rearrangement on chromosome 1. The reproductive incompatibility observed within SenAae and between SenAae and Aaa may be generally associated with chromosome rearrangements on all three chromosomes and specifically caused by pericentric inversions on chromosomes 2 and 3.
C1 [Dickson, Laura B.; Fleming, Karen L.; Caspary, Alex; Sylla, Massamba; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Sharakhova, Maria V.; Timoshevskiy, Vladimir A.] Virginia Tech, Fralin Life Sci Inst, Dept Entomol, Blacksburg, VA USA.
RP Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM william.black@colostate.edu
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI0833680, R21AI121853]
FX This work was supported by NIAID R01AI0833680 to WCB and by NIAID grant
   R21AI121853 to MVS. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alfonso-Parra C, 2014, J INSECT PHYSIOL, V70, P117, DOI 10.1016/j.jinsphys.2014.07.004
   Auguste AJ, 2010, J VIROL, V84, P9967, DOI 10.1128/JVI.00588-10
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634
   Bennett KE, 2005, J MED ENTOMOL, V42, P110, DOI 10.1603/0022-2585(2005)042[0110:SODAAA]2.0.CO;2
   Bernhardt SA, 2009, INSECT MOL BIOL, V18, P557, DOI 10.1111/j.1365-2583.2009.00895.x
   BHALLA SC, 1968, MOSQ NEWS, V28, P380
   BLACK WC, 1997, MOL BIOL INSECT DIS, P361
   Bosio CF, 2000, GENETICS, V156, P687
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Chen PS, 1996, EXPERIENTIA, V52, P503, DOI 10.1007/BF01969718
   COULTHART MB, 1988, MOL BIOL EVOL, V5, P182
   Coyne JA, 2004, SPECIATION, Vxiii, P545
   de Sousa RD, 1999, GENETICA, V105, P93
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   DOWNS WG, 1949, SCIENCE, V109, P200, DOI 10.1126/science.109.2826.200-a
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Fulton RE, 2001, GENETICS, V158, P715
   Gomez-Machorro C, 2004, INSECT MOL BIOL, V13, P637, DOI 10.1111/j.0962-1075.2004.00522.x
   Graham DH, 2004, J HERED, V95, P35, DOI 10.1093/jhered/esh014
   Graham DH, 2003, INSECT MOL BIOL, V12, P307, DOI 10.1046/j.1365-2583.2003.00412.x
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075
   Hamm RL, 2009, J MED ENTOMOL, V46, P169, DOI 10.1603/033.046.0121
   Harrington LC, 2010, AM J TROP MED HYG, V83, P225
   Harrison PW, 2015, P NATL ACAD SCI USA, V112, P4393, DOI 10.1073/pnas.1501339112
   Heiberger RM, 2009, R EXCEL SPREADSHEET, Vxxv
   Helinski ME, 2009, AM J TROP MED HYG, V81, P293
   Hollocher H, 1996, GENETICS, V143, P1243
   Huber K, 2008, AM J TROP MED HYG, V79, P218, DOI 10.4269/ajtmh.2008.79.218
   Kitzmiller JB, 1963, B WORLD HEALTH ORGAN, V29, P345
   Kubli E, 2012, CURR BIOL, V22, pR520, DOI 10.1016/j.cub.2012.04.058
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   LAVOIPIERRE MMJ, 1958, NATURE, V181, P1781, DOI 10.1038/1811781a0
   LEAHY MG, 1978, B ENTOMOL RES, V68, P455, DOI 10.1017/S0007485300009433
   Leahy Sister M. G., 1965, Mosquito News Albany NY, V25, P448
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACDONALD WW, 1965, ANN TROP MED PARASIT, V59, P74, DOI 10.1080/00034983.1965.11686285
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   MATTINGLY P. F., 1958, ANN TROP MED AND PARASITOL, V52, P5
   MATTINGLY PF, 1967, B WORLD HEALTH ORGAN, V36, P552
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x
   MCLAIN DK, 1986, EVOLUTION, V40, P1346, DOI 10.1111/j.1558-5646.1986.tb05759.x
   MCLAIN DK, 1985, EVOLUTION, V39, P998, DOI 10.1111/j.1558-5646.1985.tb00443.x
   MOORE DF, 1979, J MED ENTOMOL, V16, P223, DOI 10.1093/jmedent/16.3.223
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Mori A, 2008, HEREDITY, V101, P75, DOI 10.1038/hdy.2008.32
   Muller H. J., 1942, BIOL S, V6, P71
   MUNSTERMANN LE, 1979, J HERED, V70, P291, DOI 10.1093/oxfordjournals.jhered.a109261
   Mutebi JP, 1997, J HERED, V88, P489, DOI 10.1093/oxfordjournals.jhered.a023142
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   NEWTON ME, 1974, CHROMOSOMA, V49, P41, DOI 10.1007/BF00284986
   Orr HA, 1996, GENETICS, V143, P613
   ORR HA, 1989, GENETICS, V121, P527
   ORR HA, 1993, EVOLUTION, V47, P1606, DOI [10.1111/j.1558-5646.1993.tb02179.x, 10.2307/2410171]
   ORR HA, 1993, NATURE, V361, P532, DOI 10.1038/361532a0
   Paupy C, 2008, J MED ENTOMOL, V45, P391, DOI 10.1603/0022-2585(2008)45[391:GFBDAS]2.0.CO;2
   Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001
   POWELL JR, 1980, SCIENCE, V208, P1385
   Presgraves DC, 1998, SCIENCE, V282, P952, DOI 10.1126/science.282.5390.952
   RAI KS, 1963, CARYOLOGIA, V16, P595, DOI 10.1080/00087114.1963.10796099
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924
   Schneider MC, 2007, J ZOOL SYST EVOL RES, V45, P308, DOI 10.1111/j.1439-0469.2006.00398.x
   SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482
   Sharakhova MV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001335
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007
   Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989
   Sylla M, 2013, J VECTOR ECOL, V38, P237, DOI 10.1111/j.1948-7134.2013.12036.x
   Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408
   TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467
   TABACHNICK WJ, 1979, EVOLUTION, V33, P287, DOI 10.1111/j.1558-5646.1979.tb04682.x
   Team R.C, 2014, R LANG ENV STAT COMP
   Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27
   Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052
   Timoshevskiy VA, 2012, JOVE-J VIS EXP, DOI 10.3791/4215
   TRPIS M, 1970, CAN J ZOOLOG, V48, P892, DOI 10.1139/z70-158
   TRPIS M, 1975, B ENTOMOL RES, V65, P199, DOI 10.1017/S0007485300005903
   True JR, 1996, GENETICS, V142, P819
   Turelli M, 2000, GENETICS, V154, P1663
   Turelli M, 1997, GENETICS, V147, P1799
   van SOMEREN E. C. C., 1958, BULL ENT RES, V49, P643, DOI 10.1017/S0007485300053931
   Van Someren ECC, 1955, B ENTOMOL RES, V46
   Vazeille-Falcoz M, 1999, B SOC PATHOL EXOT, V92, P341
   WALLACE AJ, 1987, CHROMOSOMA, V95, P89, DOI 10.1007/BF00293847
   WALLIS GP, 1983, GENET RES, V41, P241, DOI 10.1017/S0016672300021315
   Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7
   Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1
   WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534
NR 94
TC 7
Z9 7
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004626
DI 10.1371/journal.pntd.0004626
PG 28
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700058
PM 27105225
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI Neglected Tropical Diseases in the Anthropocene: The Cases of Zika,
   Ebola, and Other Infections
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Editorial Material
ID CLIMATE-CHANGE; TRANSMISSION; SCHISTOSOMIASIS; LEISHMANIASIS; CONFLICT;
   DENGUE
C1 [Hotez, Peter J.] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Hotez, Peter J.] Sabin Vaccine Inst, Houston, TX USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Ctr Vaccine Dev, Houston, TX 77030 USA.
   [Hotez, Peter J.] Rice Univ, James Baker Inst Publ Policy 3, Houston, TX USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
RP Hotez, PJ (corresponding author), Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Baylor Coll Med, Natl Sch Trop Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Sabin Vaccine Inst, Houston, TX USA.; Hotez, PJ (corresponding author), Texas Childrens Hosp, Ctr Vaccine Dev, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Rice Univ, James Baker Inst Publ Policy 3, Houston, TX USA.; Hotez, PJ (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.
EM hotez@bcm.edu
OI Hotez, Peter/0000-0001-8770-1042
CR Agoramoorthy G, 2014, CAN MED ASSOC J, V186, P1170, DOI 10.1503/cmaj.114-0074
   Akullian A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004212
   Azhar EI, 2015, VIROL J, V11, DOI 10.1186/s12985-014-0235-7
   Aziz AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-258
   Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869
   Fallah MP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004260
   Faria NR, 2016, SCIENCE
   Chaves LF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003210
   Fischer D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001407
   Furst T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000513
   Garza M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002818
   Gautret P, 2009, EMERG INFECT DIS, V15, P1861, DOI 10.3201/eid1511.090201
   Gray DJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001588
   Habtamu E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004228
   Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008
   Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003852
   Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003575
   Hotez PJ, 2015, SCIENCE, V348, P296, DOI 10.1126/science.348.6232.296-b
   Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002570
   Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6
   Hotez PJ, 2016, PLOS NEGL T IN PRESS, V10
   Hotez PJ, 2014, PLOS SPEAKING M 0826
   Lingappa JR, 2003, EMERG INFECT DIS, V9, P665
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Mbabazi PS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001396
   Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Vaughan A., 2016, GUARDIAN
   Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622
   Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798
   Wilson EO, 2016, HALF EARTH OUR PLANE
   Ziegler AD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002166
NR 36
TC 26
Z9 27
U1 2
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004648
DI 10.1371/journal.pntd.0004648
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700070
PM 27058728
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Salazar, PM
   Suy, A
   Sanchez-Montalva, A
   Rodo, C
   Salvador, F
   Molina, I
AF Martinez de Salazar, Pablo
   Suy, Anna
   Sanchez-Montalva, Adrian
   Rodo, Carlota
   Salvador, Fernando
   Molina, Israel
TI Zika fever
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Review
DE Zika virus; Microencephaly; Flavivirus
ID BORNE VIRAL-INFECTIONS; VIRUS-INFECTION; INSECTICIDE RESISTANCE;
   FRENCH-POLYNESIA; TRANSMISSION; VECTOR; DENGUE; OUTBREAK; NIGERIA;
   BRAZIL
AB Zika fever is an arboviral systemic disease that has recently become a public health challenge of global concern after its spread through the Americas. This review highlights the current understanding on Zika virus epidemiology, its routes of transmission, clinical manifestations, diagnostic tests, and the current management, prevention and control strategies. It also delves the association between zika infection and complications, such as microencephaly or Guillem-Barre syndrome. (C) 2016 Elsevier Espafia, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Martinez de Salazar, Pablo] Vall dHebron Univ Hosp, Dept Microbiol, PROSICS Barcelona, Barcelona, Spain.
   [Martinez de Salazar, Pablo] IS Global, Barcelona, Spain.
   [Martinez de Salazar, Pablo] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Suy, Anna; Rodo, Carlota] Vall dHebron Univ Hosp, Dept Obstet & Gynaecol, Maternal Fetal Med Unit, Barcelona, Spain.
   [Sanchez-Montalva, Adrian; Salvador, Fernando; Molina, Israel] Vall dHebron Univ Hosp, PROSICS Barcelona, Dept Infect Dis, Barcelona, Spain.
RP de Salazar, PM (corresponding author), Vall dHebron Univ Hosp, Dept Microbiol, PROSICS Barcelona, Barcelona, Spain.; de Salazar, PM (corresponding author), IS Global, Barcelona, Spain.; de Salazar, PM (corresponding author), Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
EM pmartinezdesalazar@gmail.com
RI RODO, CARLOTA/K-9179-2017
OI RODO, CARLOTA/0000-0001-8801-5677; Salvador,
   Fernando/0000-0002-0546-1354; Suy Franch, Anna/0000-0003-2987-6105;
   Molina Romero, Israel/0000-0001-6642-7515
CR Baronti C, 2014, GENOME ANNOUNCE, V2
   Besnard M, 2014, EURO SURV B EUR MALA, V19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Institut de Veille Sanitaire (InVS), 2014, B HEBD INT 5 11 MARS
   Korhonen EM, 2016, EURO SURV B EUR MALA, V21
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EURO SURV B EUR MALA, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, ZIK VIR INF
   Ritchie SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105846
   Roth A, 2014, EURO SURV B EUR MALA, V19
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2014, EURO SURV B EUR MALA, V19
   The American Congress of Obstetricians and Gynecologists, PRACT ADV INT GUID C
   Tognarelli J, 2015, ARCH VIROL
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zammarchi L, 2015, EURO SURV B EUR MALA, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 66
TC 10
Z9 10
U1 0
U2 38
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD APR
PY 2016
VL 34
IS 4
BP 247
EP 252
DI 10.1016/j.eimc.2016.02.016
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DK2BM
UT WOS:000374719600008
PM 26993436
DA 2020-07-08
ER

PT J
AU Alvarado-Socarras, JL
   Rodriguez-Morales, AJ
AF Alvarado-Socarras, J. L.
   Rodriguez-Morales, A. J.
TI Etiological agents of microcephaly: implications for diagnosis during
   the current Zika virus epidemic
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Letter
ID INFECTION
C1 [Alvarado-Socarras, J. L.] Fdn Cardiovasc Colombia, Dept Pediat, Neonatal Unit, Floridablanca, Santander, Colombia.
   [Alvarado-Socarras, J. L.; Rodriguez-Morales, A. J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), OLFIS, Bucaramanga, Santander, Colombia.; Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Eyaid W, 2012, NEUROSCIENCES, V17, P248
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 5
TC 6
Z9 7
U1 0
U2 65
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD APR
PY 2016
VL 47
IS 4
BP 525
EP +
DI 10.1002/uog.15885
PG 2
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DJ0SY
UT WOS:000373915900024
PM 26947268
OA Bronze
DA 2020-07-08
ER

PT J
AU Hurlburt, A
   Brooks, J
   Money, D
   Patrick, D
AF Hurlburt, Andrew
   Brooks, James
   Money, Deborah
   Patrick, David
TI Zika virus: A summary
SO BRITISH COLUMBIA MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Hurlburt, Andrew] Univ British Columbia, Internal Med, Vancouver, BC, Canada.
   [Brooks, James; Money, Deborah] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.
   [Patrick, David] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
RP Hurlburt, A (corresponding author), Univ British Columbia, Internal Med, Vancouver, BC, Canada.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Brazil Ministry of Health, PUBL HLTH EM OP CTR
   Calvet G., 2016, LANCET INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, ZIK VIR INF FACT SHE
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EURO SURVEILL, V19
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization/World Health Organization, 2015, EP AL NEUR SYNDR CON
   Public Health Agency of Canada, INS BIT PREV
   Public Health Agency of Canada, 2016, RAP RISK ASS RISK ZI
   Public Health Agency of Canada, CAN REC PREV TREATM
   Public Health Agency of Canada, LAB TEST REC ZIK VIR
   Vancouver Coastal Health, COMM MED NEWSL ZIK V
NR 22
TC 0
Z9 0
U1 0
U2 0
PU BRITISH COLUMBIA MEDICAL ASSOCIATION
PI VANCOUVER
PA 115-1665 W BROADWAY, VANCOUVER, BC V6J 5A4, CANADA
SN 0007-0556
J9 B C MED J
JI B. C. Med. J.
PD APR
PY 2016
VL 58
IS 3
BP 158
EP 161
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI5ZC
UT WOS:000373578000023
DA 2020-07-08
ER

PT J
AU Burkle, FM
AF Burkle, Frederick M., Jr.
TI Zika: Defining the Public Health and Exposing its Vulnerabilities
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Editorial Material
ID PANDEMIC PREPAREDNESS
C1 [Burkle, Frederick M., Jr.] Woodrow Wilson Int Ctr Scholars, Washington, DC 20560 USA.
   [Burkle, Frederick M., Jr.] Harvard Humanitarian Initiat, 14 Story St,2nd Floor, Cambridge, MA 02138 USA.
RP Burkle, FM (corresponding author), Woodrow Wilson Int Ctr Scholars, Washington, DC 20560 USA.; Burkle, FM (corresponding author), Harvard Humanitarian Initiat, 14 Story St,2nd Floor, Cambridge, MA 02138 USA.
EM fburkle@hsph.harvard.edu
RI Burkle, Frederick/AAE-5423-2020
CR Burkle FM, 2015, DISASTER MED PUBLIC, V9, P568, DOI 10.1017/dmp.2015.26
   Burkle FM, 2014, DISASTER MED PUBLIC, V8, P377, DOI 10.1017/dmp.2014.121
   Burkle FM, 2010, DISASTER MED PUBLIC, V4, P24, DOI 10.1097/DMP.0b013e3181cb4193
   Burkle Jr FM, 1993, REDEFINING PUBLIC HL
   Checchi F, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i469
   Duchin JS, 2016, DISASTER MED PUBLIC, V10, P298, DOI 10.1017/dmp.2016.26
   Hanfling D, 2015, PLOS CURR, V7
   Johnson MM, 2005, CAN J PUBLIC HEALTH, V96, P412, DOI 10.1007/BF03405179
NR 8
TC 4
Z9 4
U1 0
U2 30
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD APR
PY 2016
VL 10
IS 2
BP 296
EP +
DI 10.1017/dmp.2016.27
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DI7ZC
UT WOS:000373719500021
PM 26952701
OA Bronze
DA 2020-07-08
ER

PT J
AU Duchin, JS
AF Duchin, Jeffrey S.
TI US Public Health Preparedness for Zika and Other Threats Remains
   Vulnerable
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Editorial Material
DE Zika; emergency preparedness; public health; foundational capacities;
   emerging infection
AB The unanticipated global outbreak of Zika virus infection is the most current but certainly not the last emerging infectious disease challenge to confront the US public heath system. Despite a number of such threats in recent years, significant gaps remain in core areas of public health system readiness. Stable, sustained investments are required to establish a solid foundation for achieving necessary national public health emergency preparedness and response capacity. (Disaster Med Public Health Preparedness. 2016;10:298-299)
C1 [Duchin, Jeffrey S.] Publ Hlth Seattle & King Cty, Communicable Dis Epidemiol & Immunizat Sect, Seattle, WA USA.
   [Duchin, Jeffrey S.] Univ Washington, Sch Med, Med, Seattle, WA USA.
   [Duchin, Jeffrey S.] Univ Washington, Sch Publ Hlth, Med, Seattle, WA 98195 USA.
   [Duchin, Jeffrey S.] Infect Dis Soc Amer, Publ Hlth Comm, Arlington, VA USA.
RP Duchin, JS (corresponding author), Publ Hlth Seattle & King Cty, Communicable Dis Epidemiol & Immunizat Sect, Seattle, WA USA.
EM jeff.duchin@kingcounty.gov
CR Centers for Disease Control and Prevention, 2013, 2013 2014 NAT SNAPSH
   Himmelstein DU, 2016, AM J PUBLIC HEALTH, V106, P56, DOI 10.2105/AJPH.2015.302908
   National Association of County and City Health Officials, 2015, CHANG PUBL HLTH LAND
   National Association of County and City Health Officials, 2015, IMP PUBL HLTH EM PRE
   Trust for Americas Health, 2016, PUBL HLTH EM PREP CO
NR 5
TC 7
Z9 7
U1 0
U2 20
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD APR
PY 2016
VL 10
IS 2
BP 298
EP 299
DI 10.1017/dmp.2016.26
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DI7ZC
UT WOS:000373719500022
PM 26952646
OA Bronze
DA 2020-07-08
ER

PT J
AU Frank, C
   Faber, M
   Stark, K
AF Frank, Christina
   Faber, Mirko
   Stark, Klaus
TI Causal or not: applying the Bradford Hill aspects of evidence to the
   association between Zika virus and microcephaly
SO EMBO MOLECULAR MEDICINE
LA English
DT Editorial Material
ID INFECTION; BRAZIL
C1 [Frank, Christina; Faber, Mirko; Stark, Klaus] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.
RP Frank, C (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.
EM frankc@rki.de
RI Faber, MIrko/O-1191-2018
OI Faber, MIrko/0000-0002-9196-570X; Frank, Christina/0000-0001-6776-8450
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   KATZ RG, 1968, CLIN PEDIATR, V7, P323, DOI 10.1177/000992286800700607
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 10
TC 12
Z9 12
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD APR
PY 2016
VL 8
IS 4
BP 305
EP 307
DI 10.15252/emmm.201506058
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DI7XK
UT WOS:000373715100001
PM 26976611
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kline, MW
   Schutze, GE
AF Kline, Mark W.
   Schutze, Gordon E.
TI What Pediatricians and Other Clinicians Should Know About Zika Virus
SO JAMA PEDIATRICS
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; INFECTION
C1 [Kline, Mark W.; Schutze, Gordon E.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, 6621 Fannin St,Ste A150,MC1150, Houston, TX 77030 USA.
RP Kline, MW (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, 6621 Fannin St,Ste A150,MC1150, Houston, TX 77030 USA.
EM mkline@bcm.edu
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines RB, 2015, MMWR MORB MORTAL WKL, DOI 10.15585/mmwr.mm6506e1er
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 7
TC 8
Z9 9
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD APR
PY 2016
VL 170
IS 4
BP 309
EP 310
DI 10.1001/jamapediatrics.2016.0429
PG 2
WC Pediatrics
SC Pediatrics
GA DI3EI
UT WOS:000373380800003
PM 26893150
OA Bronze
DA 2020-07-08
ER

PT J
AU Rowland, A
   Washington, CI
   Sheffield, JS
   Pardo-Villamizar, CA
   Segars, JH
AF Rowland, Ayresleigh
   Washington, Chantel I.
   Sheffield, Jeanne S.
   Pardo-Villamizar, Carlos A.
   Segars, James H.
TI Zika virus infection in semen: a call to action and research
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Rowland, Ayresleigh] Johns Hopkins Univ, Sch Med, 733 North Broadway, Baltimore, MD 21205 USA.
   [Washington, Chantel I.; Segars, James H.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624 Ross Bldg, Baltimore, MD 21205 USA.
   [Sheffield, Jeanne S.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, 600 North Wolfe St,Phipps Bldg,Room 203, Baltimore, MD 21287 USA.
   [Pardo-Villamizar, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, David H Koch Canc Res Bldg 2,1550 Orleans St, Baltimore, MD 21287 USA.
RP Segars, JH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624 Ross Bldg, Baltimore, MD 21205 USA.
EM jsegars2@jhmi.edu
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335
CR [Anonymous], 2015, SURV CONTR AED AEG A
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hynes NA, 2016, J HOPKINS POC IT ABX
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
NR 11
TC 19
Z9 19
U1 0
U2 19
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD APR
PY 2016
VL 33
IS 4
BP 435
EP 437
DI 10.1007/s10815-016-0684-6
PG 3
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA DI5XG
UT WOS:000373573200002
PM 26945753
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Burd, I
   Griffin, D
AF Burd, Irina
   Griffin, Diane
TI The chasm between public health and reproductive research: what history
   tells us about Zika virus
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article
DE Zika; Mother-to-child transmission; Sexual transmission virus in seminal
   fluid
ID DIARRHEA VIRUS; INFECTION; LESIONS; CALVES
AB Zika transmission from mother to fetus and its possible sexual transmission have become a media focus in the past months as a major public health concern. While mother-to-fetus transmission, fetal neurologic manifestations or sexual transmission have never been documented for this virus before, other viruses that belong to the same family are very well known to reproductive health workers, clinicians, and researchers. As a member of Flaviviridae family, including hepatitis C and bovine viral diarrhea virus (BVDV), Zika's pathogenesis may have some parallels with these infections which may pose future questions for public health and research. Vertical transmission of hepatitis C virus from mother to child is known to occur in up to 10 % of pregnancies. BVDV, a member of Pestivirus genus of Flaviviridae family is not known to be transmitted to humans but is known for its vertical transmission in cattle. BVDV infection at different stages of gestation may lead to a spectrum of adverse pregnancy outcomes, including pregnancy loss and neurologic manifestations (including deformations such as hydrocephalus and microcephaly) in the offspring. Similar to hepatitis C, which is a virus of Hepacivirus genus, BVDV is capable of persistent infection, meaning that virus may stay in mother and future generations of calves may be infected as well, which may, in turn, result in persistence of infection in offspring. Would this be a case with Zika virus? Along with mother-to-fetus transmission, sexual transmission is a concerning implication for Zika virus. Would woman become a persistent career or male be able to persistently carry virus with its sperm is yet unknown; yet, there is a concern for the reservoir of infection. Animal models of the disease are urgently needed not only to demonstrate the mother-to-fetus transmission and confirm the fetal neurologic manifestations but also to address the effects of virus on life-long host's immunity and reproductive health. Along those lines, women desiring pregnancies who are identified to travel, have a partner traveling to, or living in the areas of Zika infections should be encouraged to have a preconception consultation with maternal-fetal medicine.
C1 [Burd, Irina] Johns Hopkins Sch Med, Integrated Res Ctr Fetal Med, Dept Gynecol & Obstet, 600 N Wolfe St,Phipps 228, Baltimore, MD 21287 USA.
   [Burd, Irina] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21287 USA.
   [Griffin, Diane] Johns Hopkins Sch Publ Hlth, Mol Biol & Immunol, Baltimore, MD USA.
RP Burd, I (corresponding author), Johns Hopkins Sch Med, Integrated Res Ctr Fetal Med, Dept Gynecol & Obstet, 600 N Wolfe St,Phipps 228, Baltimore, MD 21287 USA.; Burd, I (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21287 USA.
EM iburd@jhmi.edu
CR Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   BADMAN RT, 1981, AUST VET J, V57, P306, DOI 10.1111/j.1751-0813.1981.tb05831.x
   HEWICKERTRAUTWEIN M, 1995, J VET MED B, V42, P65, DOI 10.1111/j.1439-0450.1995.tb00684.x
   Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024
   Peterhans E, 2013, BIOLOGICALS, V41, P39, DOI 10.1016/j.biologicals.2012.07.006
NR 5
TC 7
Z9 8
U1 0
U2 24
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD APR
PY 2016
VL 33
IS 4
BP 439
EP 440
DI 10.1007/s10815-016-0687-3
PG 2
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA DI5XG
UT WOS:000373573200003
PM 26943916
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Sampathkumar, P
   Sanchez, JL
AF Sampathkumar, Priya
   Sanchez, Joyce L.
TI Zika Virus in the Americas: A Review for Clinicians
SO MAYO CLINIC PROCEEDINGS
LA English
DT Review
ID WEST NILE VIRUS; UNITED-STATES; SEXUAL TRANSMISSION; INTERIM GUIDELINES;
   FRENCH-POLYNESIA; INFECTION; OUTBREAK; BRAZIL
AB Zika virus has recently emerged as a new public health threat. An arthropod-borne virus named after the Zika forest in Uganda, it was first discovered in 1947. The virus caused only sporadic cases of Zika infection in Africa and Southeast Asia until 2007, when the first large outbreak occurred in the Yap State in the Federated States of Micronesia. Another outbreak in French Polynesia in 2013 was notable for being associated temporally with an increase in cases of Guillain-Barre syndrome. In 2015, the virus was first reported in Brazil and since then has spread explosively through several additional countries in South and Central America and the Caribbean. Simultaneously, several of these countries have seen a dramatic increase in the incidence of infants born with microcephaly. The rapid spread of Zika virus through the Americas, together with the association of infection with microcephaly and Guillain-Barre syndrome, has resulted in the World Health Organization declaring a public health emergency. Zika virus has the potential to spread to new areas where the Aedes mosquito vector is present and therefore presents a risk to the United States. This concise review describes the clinical features of Zika virus infection and provides advice for clinicians on counseling travelers and others about the disease. (C) 2016 Mayo Foundation for Medical Education and Research
C1 [Sampathkumar, Priya; Sanchez, Joyce L.] Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USA.
RP Sampathkumar, P (corresponding author), Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USA.
EM sampathkumar.priya@mayo.edu
RI Sampathkumar, Priya/AAH-7033-2019
CR [Anonymous], 2016, REP PHYS CROP SPRAYE
   Besnard M, 2014, EURO SURVEILL, V19
   Boadle A, 2016, REUTERS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, TRAV NOT
   Centers for Disease Control and Prevention, ZIK VIR DIAGN TEST
   Centers for Disease Control and Prevention, INSTR SUBM DIAGN SPE
   Centers for Disease Control and Prevention, ZIK VIR AR ZIK
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Fleming-Dutra KE, MMWR MORB MORTAL WKL
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills S, 2016, MMWR MORB MORTAL WKL
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P552
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2013, EURO SURVEILL, V19
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization/World Health Organization, 2016, GEOGR DISTR CONF CAS
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Romero S, 2016, NY TIMES, pA10
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Sampathkumar P, 2003, MAYO CLIN PROC, V78, P1137, DOI 10.4065/78.9.1137
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wulifan JK, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-015-0281-3
NR 38
TC 26
Z9 27
U1 1
U2 48
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD APR
PY 2016
VL 91
IS 4
BP 514
EP 521
DI 10.1016/j.mayocp.2016.02.017
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI4TG
UT WOS:000373491600016
PM 27046524
OA Bronze
DA 2020-07-08
ER

PT J
AU Diniz, SG
AF Diniz, Simone Grilo
TI Zika virus and pregnancy: A perspective from Brazil
SO MIDWIFERY
LA English
DT Editorial Material
C1 [Diniz, Simone Grilo] Univ Sao Paulo, Dept Maternal & Child Hlth, Sch Publ Hlth, Ave Dr Arnaldo 715 Sala 203, BR-01246904 Sao Paulo, SP, Brazil.
RP Diniz, SG (corresponding author), Univ Sao Paulo, Dept Maternal & Child Hlth, Sch Publ Hlth, Ave Dr Arnaldo 715 Sala 203, BR-01246904 Sao Paulo, SP, Brazil.
EM sidiniz@usp.br
CR [Anonymous], GUID ZIK VIR
   Brazil Ministry of Health, 2016, PUBL HLTH EM OP CTR
   Brazilian Public Health Association (ABRASCO), TECHN NOT MICR VECT
   Centers for Disease Control and Prevention, EFF DIS PREGN WOM EN
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Public Health England, MOSQ BIT AV TRAV
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares de Araujo J. S., 2016, B WHO UNPUB
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 10
TC 2
Z9 2
U1 0
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-6138
EI 1532-3099
J9 MIDWIFERY
JI Midwifery
PD APR
PY 2016
VL 35
BP 22
EP 23
DI 10.1016/j.midw.2016.02.011
PG 2
WC Nursing
SC Nursing
GA DI4QO
UT WOS:000373484600005
PM 27060396
DA 2020-07-08
ER

PT J
AU Hoyt, K
   Hatchett, R
AF Hoyt, Kendall
   Hatchett, Richard
TI Preparing for the next Zika
SO NATURE BIOTECHNOLOGY
LA English
DT Article
C1 [Hoyt, Kendall] Geisel Sch Med Dartmouth, Hanover, NH USA.
   [Hatchett, Richard] Biomed Adv Res & Dev Author, HHS ASPR BARDA, Washington, DC USA.
RP Hoyt, K (corresponding author), Geisel Sch Med Dartmouth, Hanover, NH USA.
EM kendallhoyt@mac.com
CR Borio L, 2015, NEW ENGL J MED, V373, P993, DOI 10.1056/NEJMp1508708
   Commission on a Global Health Risk Framework for the Future, 2015, NEGL DIM GLOB SEC
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Hoyt K, 2012, LONG SHOT VACCINES N
   Lang T, 2015, NATURE, V524, P29, DOI 10.1038/524029a
   Lee J.-W., 2004, LEARNING SARS PREPAR
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051
   Thomas M. R., EC IMPACT EBOLA SUBS
   WHO, 2015, OUTC DOC FIN R D PRE
   Wright S., 2015, WAKE CALL LESSONS EB
NR 11
TC 9
Z9 10
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD APR
PY 2016
VL 34
IS 4
BP 384
EP 386
DI 10.1038/nbt.3532
PG 3
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DI6NL
UT WOS:000373616100015
PM 27054989
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Todd, B
AF Todd, Betsy
TI Zika Virus: An Unfolding Epidemic
SO AMERICAN JOURNAL OF NURSING
LA English
DT Editorial Material
AB What we know now about this emerging global threat.
CR Calvet G., 2016, LANCET INFECT DIS
   Centers for Disease Control and Prevention, 2015, ZIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, 2016, ZIK VIR QUEST ANSW
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIAGN TEST
   Centers for Disease Control and Prevention, 2015, ZIK VIR TRANSM
   Centers for Disease Control and Prevention, 2015, CHIK VIR SURV CONTR
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   WHO, 2016, EM MICR
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 12
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-936X
EI 1538-7488
J9 AM J NURS
JI Am. J. Nurs.
PD APR
PY 2016
VL 116
IS 4
BP 59
EP 60
DI 10.1097/01.NAJ.0000482140.35295.57
PG 2
WC Nursing
SC Nursing
GA DH5HS
UT WOS:000372817800004
PM 27011140
DA 2020-07-08
ER

PT J
AU Tepper, NK
   Goldberg, HI
   Bernal, MIV
   Rivera, B
   Frey, MT
   Malave, C
   Renquist, CM
   Bracero, NJ
   Dominguez, KL
   Sanchez, RE
   Shapiro-Mendoza, CK
   Rodriguez, BRC
   Simeone, RM
   Pesik, NT
   Barfield, WD
   Ko, JY
   Galang, RR
   Perez-Padilla, J
   Polen, KND
   Honein, MA
   Rasmussen, SA
   Jamieson, DJ
AF Tepper, Naomi K.
   Goldberg, Howard I.
   Bernal, Manuel I. Vargas
   Rivera, Brenda
   Frey, Meghan T.
   Malave, Claritsa
   Renquist, Christina M.
   Bracero, Nabal Jose
   Dominguez, Kenneth L.
   Sanchez, Ramon E.
   Shapiro-Mendoza, Carrie K.
   Rodriguez, Blanca R. Cuevas
   Simeone, Regina M.
   Pesik, Nicki T.
   Barfield, Wanda D.
   Ko, Jean Y.
   Galang, Romeo R.
   Perez-Padilla, Janice
   Polen, Kara N. D.
   Honein, Margaret A.
   Rasmussen, Sonja A.
   Jamieson, Denise J.
TI Estimating Contraceptive Needs and Increasing Access to Contraception in
   Response to the Zika Virus Disease Outbreak - Puerto Rico, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNINTENDED PREGNANCIES; NO-COST
C1 [Tepper, Naomi K.; Goldberg, Howard I.; Shapiro-Mendoza, Carrie K.; Barfield, Wanda D.; Ko, Jean Y.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Bernal, Manuel I. Vargas; Rivera, Brenda] Puerto Rico Dept Hlth, Mayaguez, PR USA.
   [Frey, Meghan T.; Renquist, Christina M.; Simeone, Regina M.; Polen, Kara N. D.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Malave, Claritsa] Off Reg Operat, Hlth Resources & Serv Adm, Rockville, MD 20857 USA.
   [Bracero, Nabal Jose] Univ Puerto Rico, Mayaguez, PR USA.
   [Bracero, Nabal Jose] Amer Coll Obstetricians & Gynecologists, Puerto Rico Sect, Washington, DC 20024 USA.
   [Dominguez, Kenneth L.; Galang, Romeo R.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Sanchez, Ramon E.] Univ Puerto Rico, Family Planning Program Title X Clin Preven, Mayaguez, PR USA.
   [Rodriguez, Blanca R. Cuevas] PROFAMILIAS, Santiago, Chile.
   [Pesik, Nicki T.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Galang, Romeo R.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Perez-Padilla, Janice] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Tepper, NK (corresponding author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Jamieson,
   Denise/0000-0003-2597-1201
CR Bensyl DM, 2005, MMWR SURVEILL SUMM, V54
   Brasil P, 2016, N ENGL J MED
   Daniels K, 2015, NATL HLTH STAT REPOR
   Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416
   Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x
   Hamilton Brady E Ph D, 2015, Natl Vital Stat Rep, V64, P1
   Meaney-Delman D, 2016, OBSTET GYNECOL
   Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]
   Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506
NR 9
TC 32
Z9 32
U1 0
U2 24
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 1
PY 2016
VL 65
IS 12
BP 311
EP 314
DI 10.15585/mmwr.mm6512e1
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH8IO
UT WOS:000373036900003
PM 27031817
DA 2020-07-08
ER

PT J
AU Oster, AM
   Russell, K
   Stryker, JE
   Friedman, A
   Kachur, RE
   Petersen, EE
   Jamieson, DJ
   Cohn, AC
   Brooks, JT
AF Oster, Alexandra M.
   Russell, Kate
   Stryker, Jo Ellen
   Friedman, Allison
   Kachur, Rachel E.
   Petersen, Emily E.
   Jamieson, Denise J.
   Cohn, Amanda C.
   Brooks, John T.
TI Update: Interim Guidance for Prevention of Sexual Transmission of Zika
   Virus - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Oster, Alexandra M.; Stryker, Jo Ellen; Brooks, John T.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Epidem Intelligence Serv, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Friedman, Allison; Kachur, Rachel E.] CDC, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Petersen, Emily E.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Cohn, Amanda C.] CDC, Off Director, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
RP Oster, AM (corresponding author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
EM AOster@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201; Russell, Kate/0000-0001-9343-3355
CR Atkinson B, 2016, EMERG INFECT DIS
   CDC, 2015, CONTRACEPTION
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen E. E., 2016, MMWR MORB MORTAL WKL, P65
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 10
TC 49
Z9 50
U1 0
U2 15
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 1
PY 2016
VL 65
IS 12
BP 323
EP 325
DI 10.15585/mmwr.mm6512e3
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH8IO
UT WOS:000373036900005
PM 27032078
OA Bronze
DA 2020-07-08
ER

PT J
AU Meaney-Delman, D
   Rasmussen, SA
   Staples, JE
   Oduyebo, T
   Ellington, SR
   Petersen, EE
   Fischer, M
   Jamieson, DJ
AF Meaney-Delman, Dana
   Rasmussen, Sonja A.
   Staples, J. Erin
   Oduyebo, Titilope
   Ellington, Sascha R.
   Petersen, Emily E.
   Fischer, Marc
   Jamieson, Denise J.
TI Zika Virus and Pregnancy What Obstetric Health Care Providers Need to
   Know
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID FRENCH-POLYNESIA; PERINATAL TRANSMISSION; UNITED-STATES; INFECTION;
   OUTBREAK; BRAZIL; OUTCOMES; SAFETY; DENGUE; WOMEN
AB Zika virus is a flavivirus transmitted by Aedes (Stegomyia) species of mosquitoes. In May 2015, the World Health Organization confirmed the first local transmission of Zika virus in the Americas in Brazil. The virus has spread rapidly to other countries in the Americas; as of January 29, 2016, local transmission has been detected in at least 22 countries or territories, including the Commonwealth of Puerto Rico and the U.S. Virgin Islands. Zika virus can infect pregnant women in all three trimesters. Although pregnant women do not appear to be more susceptible to or more severely affected by Zika virus infection, maternal-fetal transmission has been documented. Several pieces of evidence suggest that maternal Zika virus infection is associated with adverse neonatal outcomes, most notably microcephaly. Because of the number of countries and territories with local Zika virus transmission, it is likely that obstetric health care providers will care for pregnant women who live in or have traveled to an area of local Zika virus transmission. We review information on Zika virus, its clinical presentation, modes of transmission, laboratory testing, effects during pregnancy, and methods of prevention to assist obstetric health care providers in caring for pregnant women considering travel or with a history of travel to areas with ongoing Zika virus transmission and pregnant women residing in areas with ongoing Zika virus transmission.
C1 [Meaney-Delman, Dana; Rasmussen, Sonja A.; Staples, J. Erin; Oduyebo, Titilope; Ellington, Sascha R.; Petersen, Emily E.; Fischer, Marc; Jamieson, Denise J.] Ctr Dis Control & Prevent, Atlanta, GA 30345 USA.
RP Meaney-Delman, D (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd,Mailstop C12, Atlanta, GA 30345 USA.
EM Vmo0@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636
   [Anonymous], 2016, RAP RISK ASS ZIK VIR
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Centre for Disease Control and Prevention, FACTS MICR
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Environmental Protection Agency, REP TREAT CLOTH
   Fiorcruz-Parana Carlos Chagas Institute, 2016, INV FIORCR PAR INTR
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Getachew D, 2015, INTERDISCIP PERSPECT, V2015
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hashmi M, 2015, INDIAN J CRIT CARE M, V19, P678, DOI 10.4103/0972-5229.169353
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY
   Martines R. B., 2016, MMWR MORB MORTAL WKL
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR MORB MORTAL WKL
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oster AM, 2016, MMWR MORB MORTAL WKL
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV LA
   Pan American Health Organization World Health Organization, 2016, EP UPD NEU SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900
   Reddy UM, 2014, OBSTET GYNECOL, V123, P1070, DOI 10.1097/AOG.0000000000000245
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tocchio S, 2015, SEMIN PERINATOL, V39, P73, DOI 10.1053/j.semperi.2015.01.002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 45
TC 39
Z9 40
U1 0
U2 52
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2016
VL 127
IS 4
BP 642
EP 648
DI 10.1097/AOG.0000000000001378
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DH4YF
UT WOS:000372791000004
PM 26889662
DA 2020-07-08
ER

PT J
AU Rathore, MH
AF Rathore, Mobeen H.
TI Zika Virus-Pediatricians Be Aware
SO PEDIATRICS IN REVIEW
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES
C1 [Rathore, Mobeen H.] Univ Florida, Ctr HIV AIDS Res, Gainesville, FL 32611 USA.
RP Rathore, MH (corresponding author), Univ Florida, Ctr HIV AIDS Res, Gainesville, FL 32611 USA.
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, EP UPD OUTBR ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 6
TC 1
Z9 1
U1 0
U2 8
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0191-9601
EI 1526-3347
J9 PEDIATR REV
JI Pediatr. Rev.
PD APR
PY 2016
VL 37
IS 4
BP 133
EP 134
DI 10.1542/pir.2016-0003
PG 2
WC Pediatrics
SC Pediatrics
GA DI2RP
UT WOS:000373346100001
PM 27037098
DA 2020-07-08
ER

PT J
AU Mohammadi, D
AF Mohammadi, Dara
TI Zika-straight to the cortex
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2016
VL 16
IS 4
BP 416
EP 416
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DH0CH
UT WOS:000372449600028
DA 2020-07-08
ER

PT J
AU Stratton, SJ
AF Stratton, Samuel J.
TI Zika Virus Association with Microcephaly: The Power for Population
   Statistics to Identify Public Health Emergencies
SO PREHOSPITAL AND DISASTER MEDICINE
LA English
DT Editorial Material
OI Stratton, Samuel/0000-0002-2505-115X
CR Aschengrau A, 2008, ESSENTIALS EPIDEMIOL, P41
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 2
TC 2
Z9 2
U1 0
U2 20
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1049-023X
EI 1945-1938
J9 PREHOSP DISASTER MED
JI Prehospital Disaster Med.
PD APR
PY 2016
VL 31
IS 2
BP 119
EP +
DI 10.1017/S1049023X16000170
PG 2
WC Emergency Medicine
SC Emergency Medicine
GA DG8RX
UT WOS:000372352400005
PM 26940218
OA Bronze
DA 2020-07-08
ER

PT J
AU Maron, DF
AF Maron, Dina Fine
TI Travels with Zika The mosquito-borne virus migrates to the US from
   diverse nations
SO SCIENTIFIC AMERICAN
LA English
DT Editorial Material
NR 0
TC 1
Z9 1
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0036-8733
J9 SCI AM
JI Sci.Am.
PD APR
PY 2016
VL 314
IS 4
BP 84
EP 84
DI 10.1038/scientificamerican0416-84
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0NX
UT WOS:000372482000033
PM 27082204
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus: a little less speculation, a little more action
SO LANCET NEUROLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 58
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD APR
PY 2016
VL 15
IS 4
BP 343
EP 343
DI 10.1016/S1474-4422(16)00074-0
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA DG3MP
UT WOS:000371974000001
PM 26922439
OA Bronze
DA 2020-07-08
ER

PT J
AU Shakir, R
AF Shakir, Raad
TI Neurological expertise is essential for Zika virus infection
SO LANCET NEUROLOGY
LA English
DT Letter
ID GUILLAIN-BARRE-SYNDROME
C1 [Shakir, Raad] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, London W6 8RF, England.
RP Shakir, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, London W6 8RF, England.
EM r.shakir@imperial.ac.uk
CR [Anonymous], 2016, LANCET, V387, P96
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pritchard J, 2008, POSTGRAD MED J, V84, P532, DOI 10.1136/jnnp.2006.097709
   UK Department of Health, 2011, CLIN GUID IMM US
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
NR 7
TC 3
Z9 3
U1 0
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD APR
PY 2016
VL 15
IS 4
BP 353
EP 354
DI 10.1016/S1474-4422(16)00072-7
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA DG3MP
UT WOS:000371974000011
PM 26922438
OA Bronze
DA 2020-07-08
ER

PT J
AU Fry, DE
AF Fry, Donald E.
TI Zika Virus Infection and Surgery
SO SURGICAL INFECTIONS
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; TRANSMISSION
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Fry DE, 2010, J AM COLL SURGEONS, V211, P546, DOI 10.1016/j.jamcollsurg.2010.06.389
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EUROSURVEILLANCE, pii
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Waggoner JJ, 2016, J CLIN MICROBIOL, pii
NR 8
TC 1
Z9 1
U1 0
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-2964
EI 1557-8674
J9 SURG INFECT
JI Surg. Infect.
PD APR 1
PY 2016
VL 17
IS 2
BP 123
EP 123
DI 10.1089/sur.2016.29004.df
PG 1
WC Infectious Diseases; Surgery
SC Infectious Diseases; Surgery
GA DG6FL
UT WOS:000372178200001
PM 26978530
DA 2020-07-08
ER

PT J
AU Cohnstaedt, LW
   Ladner, J
   Campbell, LR
   Busch, N
   Barrera, R
AF Cohnstaedt, Lee W.
   Ladner, Jamie
   Campbell, Leslie Rickert
   Busch, Noah
   Barrera, Roberto
TI Determining Mosquito Distribution from Egg Data: The Role of the Citizen
   Scientist
SO AMERICAN BIOLOGY TEACHER
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; mosquito surveillance; citizen science;
   epidemiology; invasive species; public health
ID UNITED-STATES; AEGYPTI
AB Nationwide science classes, from elementary through secondary, are placing a larger emphasis on inquiry and authentic experiences. The opportunity for community members (students, teachers, or interested individuals) to collect real data and contribute to a research project is the definition of citizen science. Recent disease outbreaks of mosquito-transmitted pathogens (West Nile, eastern equine encephalitis, dengue, chikungunya, and Zika) demonstrate the need to educate children and adults about the public health risks posed by mosquitoes. This lesson plan has students determine mosquito species and subsequent disease risk around their house and in their community by collecting mosquito eggs and rearing a portion of them to adults. The students identify adult mosquitoes and associated health risks. Furthermore, students and teachers have the option to participate in a national mosquito-species-distribution study by submitting mosquito eggs and adults to the U.S. Department of Agriculture. The data generated by participant submissions will be available to all mosquito submitters, making each student and school part of a larger project. This lesson plan has three objectives beyond the citizen science experience: (1) clarify the individual's role in protecting individuals, communities, and pets from illness; (2) raise awareness of pathogens transmitted by mosquitoes; and (3) participate in a national program to gather mosquito distribution data. The lesson and the associated supplementary material (available at http://www.citizenscience.us) can be used for middle to high school classes, as well as Advanced Placement classes, because the materials and presentations can be easily modified to classroom needs.
C1 [Cohnstaedt, Lee W.] ARS, USDA, Arthropod Borne Anim Dis Res Unit, Manhattan, KS 66502 USA.
   [Campbell, Leslie Rickert; Busch, Noah] Manhattan High Sch, 2100 Poyntz Ave, Manhattan, KS 66502 USA.
   [Barrera, Roberto] Ctr Dis Control & Prevent CDC, Entomol & Ecol Act, Dengue Branch, San Juan, PR 00920 USA.
   [Ladner, Jamie] Kansas State Univ, Manhattan, KS 66502 USA.
RP Cohnstaedt, LW (corresponding author), ARS, USDA, Arthropod Borne Anim Dis Res Unit, Manhattan, KS 66502 USA.; Campbell, LR; Busch, N (corresponding author), Manhattan High Sch, 2100 Poyntz Ave, Manhattan, KS 66502 USA.; Barrera, R (corresponding author), Ctr Dis Control & Prevent CDC, Entomol & Ecol Act, Dengue Branch, San Juan, PR 00920 USA.; Ladner, J (corresponding author), Kansas State Univ, Manhattan, KS 66502 USA.
EM lee.cohnstaedt@ars.usda.gov; jlad011@ksu.edu; leslieca@usd383.org;
   noahb@usd383.org; rbarrera@cdc.gov
CR Centers for Disease Control and Prevention, 2015, CHIK VIR
   Centers for Disease Control and Prevention, 2015, INF VECT CONTR PROGR
   Centers for Disease Control and Prevention, 2010, EL MAL US 1947 1951
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   MORLAN HB, 1965, AM J TROP MED HYG, V14, P892, DOI 10.4269/ajtmh.1965.14.892
   U. S. Geological Survey, 2015, DIS MAPS
   Walter Reed Biosystematics Unit, 2015, MOSQ ID KEYS
NR 7
TC 6
Z9 6
U1 1
U2 28
PU NATL ASSOC BIOLOGY TEACHERS INC
PI RESTON
PA 12030 SUNRISE VALLEY DR, #110, RESTON, VA 20191 USA
SN 0002-7685
EI 1938-4211
J9 AM BIOL TEACH
JI Am. Biol. Teach.
PD APR
PY 2016
VL 78
IS 4
BP 317
EP 322
DI 10.1525/abt.2016.78.4.317
PG 6
WC Biology; Education, Scientific Disciplines
SC Life Sciences & Biomedicine - Other Topics; Education & Educational
   Research
GA DN0PT
UT WOS:000376766500007
DA 2020-07-08
ER

PT J
AU Miranda, DD
   Martelli, CMT
   Ximenes, RAD
   Araujo, TVB
   Rocha, MAW
   Ramos, RCF
   Dhalia, R
   Franca, RFD
   Marques, ETD
   Rodrigues, LC
AF Miranda-Filho, Democrito de Barros
   Turchi Martelli, Celina Maria
   de Alencar Ximenes, Ricardo Arraes
   Barreto Araujo, Thalia Velho
   Wanderley Rocha, Maria Angela
   Ferreira Ramos, Regina Coeli
   Dhalia, Rafael
   de Oliveira Franca, Rafael Freitas
   de Azevedo Marques Junior, Ernesto Torres
   Rodrigues, Laura Cunha
TI Initial Description of the Presumed Congenital Zika Syndrome
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID VIRUS; INFECTIONS; BRAZIL
AB Objectives. To provide an initial description of the congenital syndrome presumably associated with infection by Zika virus compared with other syndromes including congenital infections of established etiologies.
   Methods. We provide an overview of a published case series of 35 cases, a clinical series of 104 cases, and published and unpublished reports of clinical and laboratory findings describing cases diagnosed since the beginning of the epidemic of microcephaly in Brazil.
   Results. About 60% to 70% of mothers report rash during pregnancy; mainly in the first trimester. Principal features are microcephaly, facial disproportionality, cutis girata, hypertonia/spasticity, hyperreflexia, and irritability; abnormal neuroimages include calcifications, ventriculomegaly, and lissencephaly. Hearing and visual abnormalities may be present.
   Conclusions. Preliminary data suggest that severe congenital abnormalities are linked to Zika virus infection. Cases have severe abnormalities, and although sharing many characteristics with congenital abnormalities associated with other viral infections, abnormalities presumably linked to the Zika virus may have distinguishing characteristics. These severe neurologic abnormalities may result in marked mental retardation and motor disabilities for many surviving offspring.
   Policy Implications. Affected nations need to prepare to provide complex and costly multidisciplinary care that children diagnosed with this new congenital syndrome will require.
C1 [Miranda-Filho, Democrito de Barros; de Alencar Ximenes, Ricardo Arraes; Wanderley Rocha, Maria Angela; Ferreira Ramos, Regina Coeli] Univ Pernambuco, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria; Dhalia, Rafael; de Oliveira Franca, Rafael Freitas; de Azevedo Marques Junior, Ernesto Torres] Fiocruz MS, Oswaldo Cruz Fdn, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Barreto Araujo, Thalia Velho] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, London WC1, England.
RP Miranda, DD (corresponding author), Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM demofilho@gmail.com
RI Dhalia, Rafael/AAD-5432-2020; Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
FU Brazilian Ministry of Health, Pernambuco State Health Department
   (SES-PE); Pan American Health Organization; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPqNational Council for
   Scientific and Technological Development (CNPq) [306489/2010-4,
   308311/2009-4, 308590/2013-9]
FX We thank the support of the Brazilian Ministry of Health, Pernambuco
   State Health Department (SES-PE) and Pan American Health Organization.
   The authors received partial support from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (scholarship
   306489/2010-4 to C. M. T. M., 308311/2009-4 to R. A. A. X.,
   308590/2013-9 to D. B. M. F.).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brazilian Ministry of Health, 10 BRAZ MIN HLTH
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 8
TC 134
Z9 140
U1 0
U2 24
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 598
EP 600
DI 10.2105/AJPH.2016.303115
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000013
PM 26959258
OA Green Published
DA 2020-07-08
ER

PT J
AU Paixao, ES
   Barreto, F
   Teixeira, MD
   Costa, MDN
   Rodrigues, LC
AF Paixao, Enny S.
   Barreto, Florisneide
   Teixeira, Maria da Gloria
   Costa, Maria da Conceicao N.
   Rodrigues, Laura C.
TI History, Epidemiology, and Clinical Manifestations of Zika: A Systematic
   Review
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Review
ID VIRUS-INFECTION; FRENCH-POLYNESIA; DENGUE VIRUSES; TRANSMISSION;
   OUTBREAK; CHIKUNGUNYA; VECTOR; MOSQUITOS; TRAVEL
AB Objectives. To describe salient epidemiological characteristics of Zika virus outbreaks across the world and to examine the clinical presentations, complications, and atypical manifestations related to their occurrence in recent history.
   Methods. We conducted a systematic review of the literature by searching through MEDLINE, Embase, and Global Health Library, as well as the epidemiological bulletins and alerts from the World Health Organization, the Pan American Health Organization, and the European Centre for Disease Prevention and Control over the period 1954 to 2016.
   Results. The search yielded 547 records. We retained 333 for further analysis, to which we added 11 epidemiological bulletins from various sources. Of these, we systematically reviewed 52 articles and reports, revealing some epidemiological features and patterns of spread of the Zika virus worldwide, as well as pathological outcomes suspected to be linked to Zika outbreaks. Neurologic disorders among zika patients were similar in Brazil and French Polynesia but a causal link is not established. Incidence of zika infection in pregnant women is not known. In Brazil, during the zika outbreak the incidence of microcephaly increased more than 20 times. Among 35 infants with microcephaly, born from women suspected to have Zika infection during pregnancy in northeast Brazil, 74% of the mothers reported rash during the first and second trimester.
   Conclusions. On February 1, 2016, The World Health Organization declared the ongoing Zika crisis an emergency and that, although not yet scientifically proven, the link between the virus and growing numbers of microcephaly cases was "strongly suspected." However, the causal relationship between zika and microcephaly is not universally accepted.
   Public Health Implications. The current situation with regard to Zika is not encouraging, because there is no vaccine, no treatment, and no good serological test, and vector control remains a challenge.
C1 [Paixao, Enny S.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, London WC1, England.
   [Barreto, Florisneide; Teixeira, Maria da Gloria; Costa, Maria da Conceicao N.] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
RP Paixao, ES (corresponding author), 21 Woodside Pk Ave,Flat 25, London N12 8AQ, England.
EM enny.cruz@lshtm.ac.uk
RI Teixeira, Maria Gloria/G-4808-2012; amsalu, ribka/G-8780-2019
OI Teixeira, Maria Gloria/0000-0003-3318-3408; 
FU National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico)National Council
   for Scientific and Technological Development (CNPq) [205427/2014-6]
FX This study was supported by the National Council for Scientific and
   Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico; process 205427/2014-6).
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch I, 2016, LANCET
   Brust KB, 2014, IDCases, V1, P95, DOI 10.1016/j.idcr.2014.10.009
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Butler D, NATURE NEWS
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2015, SYMPT DIAGN TREATM
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2011, AM J TROP MED HYG S1, V85, P183
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hearn P, 2014, AM J TROP MED HYG S1, V91, P62
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malet H, EPIDEMIOLOGICAL STAT
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Ministry of Health of Brazil Secretary of Health of the State of Bahia, 2015, B EPIDEMIOL, P11
   Ministry of Health of Brazil Secretary of Surveillance in Health, 2015, EPIDEMIOLOGICAL B
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, 2016, EP AL NEUR SYNDR CON
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   PELLISSIER AIME, 1954, BULL SOC PATHOL EXOT, V47, P223
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas SM, 2014, INT J ENV RES PUB HE, V11, P3360, DOI 10.3390/ijerph110303360
   Tognarelli J, 2015, ARCH VIROL
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organization Regional Office for the Western Pacific Region, 2015, PAC SYNDR SURV REP M
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 74
TC 125
Z9 134
U1 5
U2 94
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 606
EP 612
DI 10.2105/AJPH.2016.303112
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000015
PM 26959260
OA Green Published
DA 2020-07-08
ER

PT J
AU Mor, G
AF Mor, Gil
TI Placental Inflammatory Response to Zika Virus may Affect Fetal Brain
   Development
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Editorial Material
ID EBOLA HEMORRHAGIC-FEVER; IMMUNE-SYSTEM; PREGNANCY; DISEASE
C1 [Mor, Gil] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.
RP Mor, G (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, 333 Cedar St,LSOG 305A, New Haven, CT 06520 USA.
EM gil.mor@yale.edu
CR Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050
   Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308
   Cardenas I, 2010, AM J REPROD IMMUNOL, V61, P397
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Cheslack-Postava K, 2013, NEUROTOXICOL TERATOL, V38, P1, DOI 10.1016/j.ntt.2013.04.001
   Fowden AL, 2015, PLACENTA, V36, pS50, DOI 10.1016/j.placenta.2014.11.018
   Gluckman PD, 2002, ENDOCRINE, V19, P81, DOI 10.1385/ENDO:19:1:81
   Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x
   Jackson P, 2012, MUTAT RES-GEN TOX EN, V745, P73, DOI 10.1016/j.mrgentox.2011.09.018
   Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902
   Jamieson DJ, 2014, OBSTET GYNECOL, V124, P1005, DOI 10.1097/AOG.0000000000000533
   Lee Jungun, 2015, Asian Pac J Cancer Prev, V16, P3029
   Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289
   Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x
   Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Sobrian SK, 1997, ENVIRON RES, V73, P227, DOI 10.1006/enrs.1997.3734
NR 18
TC 29
Z9 30
U1 1
U2 94
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD APR
PY 2016
VL 75
IS 4
BP 421
EP 422
DI 10.1111/aji.12505
PG 2
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA DF7IR
UT WOS:000371531900001
PM 26892436
DA 2020-07-08
ER

PT J
AU Flores, MS
   Burgess, TH
   Rajnik, M
AF Flores, Michelle S.
   Burgess, Timothy H.
   Rajnik, Michael
TI Zika virus: A primer for clinicians
SO CLEVELAND CLINIC JOURNAL OF MEDICINE
LA English
DT Review
ID INTERIM GUIDELINES; UNITED-STATES; SEXUAL TRANSMISSION; PREGNANT-WOMEN;
   INFECTION; OUTBREAK; BRAZIL; BRAIN; CHILD
AB The ongoing outbreak of Zika virus infection that began in South America and Central America in 2014 is worrisome because of associations with fetal microcephaly and with Guillain-Barre syndrome. Here we summarize what has happened and what is known so far. As the outbreak continues to evolve, we urge clinicians to watch for updates at cdc.gov.
C1 [Flores, Michelle S.; Rajnik, Michael] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA.
   [Burgess, Timothy H.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.
   [Burgess, Timothy H.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.
RP Rajnik, M (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pediat, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
EM michael.rajnik@usuhs.edu
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atkinson B, 2016, EMERG INFECT DIS
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, CLIN GUID DENG VIR
   Centers for Disease Control and Prevention, CHIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, UPD DIAGN TEST ZIK C
   Centers for Disease Control and Prevention, ZIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, EP UPD COMPL POT LIN
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fleming-Dutra K, 2016, MMWR-MORBID MORTAL W, V65, P1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR EARLY RELEASE
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MONATH TP, 1996, FIELDS VIROLOGY, P961
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization/World Health Organization, 2015, ZIK VIR INF
   Pan American Health Organization/World Health Organization, 2015, EP AL
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Regan DM, 2016, ASS B, V16
   Rubin E. J., 2016, N ENGL J MED
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith J, 2016, HLTH ADVISORY SEXUAL
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tognarelli J, 2014, REPORT OUTBREAK ZIKA
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, ZIK VIR FACT SHEET
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 60
TC 4
Z9 4
U1 0
U2 4
PU CLEVELAND CLINIC
PI CLEVELAND
PA 9500 EUCLID AVE, CLEVELAND, OH 44106 USA
SN 0891-1150
EI 1939-2869
J9 CLEV CLIN J MED
JI Clevel. Clin. J. Med.
PD APR
PY 2016
VL 83
IS 4
BP 1
EP 10
DI 10.3949/ccjm.83a.16027
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK3TV
UT WOS:000374841200001
PM 27055200
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus epidemics in Brazil: A broad view
SO CURRENT RESEARCH IN TRANSLATIONAL MEDICINE
LA English
DT Editorial Material
CR Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feuillet-Liger B., 2013, CORPS FEMME BIOMEDEC, P391
   Marques RM, 2015, PENSEE PARIS, V383, P117
   Morinet F., 2016, FEUILLETS BIOL, V330, P1
   Picone O, 2016, J GYNECOL OBSTET BIO
   Rocha S., 2014, ALLOCATIONS SOCIALES
NR 7
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 2452-3186
J9 CURR RES TRANSL MED
JI Curr. Res. Transl. Med.
PD APR-JUN
PY 2016
VL 64
IS 2
BP 53
EP 53
DI 10.1016/j.retram.2016.04.005
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FO4AB
UT WOS:000416779500001
PM 27316385
DA 2020-07-08
ER

PT J
AU Bachiller-Luque, P
   Gonzalez, MDG
   Alvarez-Manzanares, J
   Vazquez, A
   De Ory, F
   Farinas, MPSS
AF Bachiller-Luque, Pablo
   Dominguez-Gil Gonzalez, Marta
   Alvarez-Manzanares, Jesus
   Vazquez, Ana
   De Ory, Fernando
   Sanchez-Seco Farinas, M. Paz
TI First case of imported Zika virus infection in Spain
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Article
DE Zika virus; Flavivirus; Aedes mosquitoes; Arbovirus; Vector-borne
   diseases
AB We report a case of Zika virus (ZIKV) infection in a patient with diarrhea, fever, synovitis, non-purulent conjunctivitis, and with discreet retro-orbital pain, after returning from Colombia in January 2016. The patient referred several mosquito bites. Presence of ZIKV was detected by PCR (polymerase chain reaction) in plasma. Rapid microbiological diagnosis of ZIKV infection is needed in European countries with circulation of its vector, in order to avoid autochthonous circulation. The recent association of ZIKV infection with abortion and microcephaly, and a Guillain-Barre syndrome highlights the need for laboratory differentiation of ZIKV from other virus infection. Women with potential risk for Zika virus infection who are pregnant or planning to become pregnant must mention that fact during prenatal visits in order to be evaluated and properly monitored. (C) 2016 Elsevier Espafia, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Bachiller-Luque, Pablo] Univ Hosp Rio Hortega, Internal Med, Valladolid, Spain.
   [Dominguez-Gil Gonzalez, Marta] Univ Hosp Rio Hortega, Microbiol, Valladolid, Spain.
   [Alvarez-Manzanares, Jesus] Univ Hosp Rio Hortega, Emergency, Valladolid, Spain.
   [Vazquez, Ana; De Ory, Fernando; Sanchez-Seco Farinas, M. Paz] Inst Salud Carlos III, Natl Ctr Microbiol, Virol Area Arbovirus & Imported Viral Dis, Madrid, Spain.
RP Bachiller-Luque, P (corresponding author), Univ Hosp Rio Hortega, Internal Med, Valladolid, Spain.
EM pbachiller@gmail.com
RI Vazquez, Ana/H-4911-2013
OI Vazquez, Ana/0000-0002-9872-3316
CR [Anonymous], RAP RISK ASS ZIK VIR
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Centers for Disease Control and Prevention, EM PREP RESP REC MAN
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, N ENGL J MED
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude (Brazil), 2015, MON CAS DENG FEBR CH, V46
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2016, J INFECT PU IN PRESS
NR 12
TC 18
Z9 19
U1 1
U2 17
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD APR
PY 2016
VL 34
IS 4
BP 243
EP 246
DI 10.1016/j.eimc.2016.02.012
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DK2BM
UT WOS:000374719600007
PM 26994814
DA 2020-07-08
ER

PT J
AU Valle, D
   Pimenta, DN
   Aguiar, R
AF Valle, Denise
   Pimenta, Denise Nacif
   Aguiar, Raquel
TI Zika, dengue and chikungunya: challenges and issues
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Editorial Material
ID AEDES-AEGYPTI; VIRUS; TRANSMISSION; OUTBREAK
C1 [Valle, Denise] Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Pimenta, Denise Nacif] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Aguiar, Raquel] Inst Oswaldo Cruz, Serv Jornalismo Comunicacao, Rio De Janeiro, Brazil.
RP Valle, D (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM dvalle@ioc.fiocruz.br
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dennis B., 2016, WASHINGTON POST
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Globo O, 2016, FRANC CONTR ZIK AP R
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lourenco-de-Oliveira R, 2015, DENGUE TEORIAS PRATI, P76
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Organizacion Panamericana de la Saude, 2011, PREP RESP EV INTR VI
   Shapshak P., 2015, Global virology I - identifying and investigating viral diseases, P477
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Valle D, 2015, CIENC CULT, V67, P4
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 6
Z9 6
U1 0
U2 2
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PD APR-JUN
PY 2016
VL 25
IS 2
BP 419
EP 422
DI 10.5123/S1679-49742016000200020
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE2RB
UT WOS:000408062300020
PM 27869959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Graham, CA
AF Graham, Colin A.
TI Continuing challenges: migrants, terrorism, weather and Zika
SO EUROPEAN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Editorial Material
ID EMERGENCY-MEDICINE; EUROPE; PROGRESS; ETHICS
C1 [Graham, Colin A.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China.
RP Graham, CA (corresponding author), Chinese Univ Hong Kong, Dept Emergency Med, Shatin, Hong Kong, Peoples R China.
EM cagraham@cuhk.edu.hk
RI Graham, Colin A/B-4535-2013; Fitzgerald, Tanya/L-6222-2013
OI Graham, Colin A/0000-0002-4381-7470; Fitzgerald,
   Tanya/0000-0001-6275-0964
CR Graham CA, 2016, EUR J EMERG MED, V23, P1, DOI 10.1097/MEJ.0000000000000363
   Graham CA, 2015, EUR J EMERG MED, V22, P297, DOI 10.1097/MEJ.0000000000000329
   Graham CA, 2015, EUR J EMERG MED, V22, P149, DOI 10.1097/MEJ.0000000000000276
   Graham CA, 2014, EUR J EMERG MED, V21, P393, DOI 10.1097/MEJ.0000000000000222
   Graham CA, 2014, EUR J EMERG MED, V21, P1, DOI 10.1097/MEJ.0000000000000118
   Graham CA, 2013, EUR J EMERG MED, V20, P303, DOI 10.1097/01.mej.0000433925.83191.5e
   Graham CA, 2013, EUR J EMERG MED, V20, P71, DOI 10.1097/MEJ.0b013e32835f9834
   Graham CA, 2013, EUR J EMERG MED, V20, P1, DOI 10.1097/MEJ.0b013e32835dcaaa
   Graham CA, 2011, EUR J EMERG MED, V18, P313, DOI 10.1097/MEJ.0b013e32834e60ab
   Graham CA, 2011, EUR J EMERG MED, V18, P243, DOI 10.1097/MEJ.0b013e32834bf447
   Miro O, 2012, EUR J EMERG MED, V19, P63, DOI 10.1097/MEJ.0b013e32834749a0
   Sabbe MB, 2014, EUR J EMERG MED, V21, P323, DOI 10.1097/MEJ.0000000000000207
NR 12
TC 9
Z9 9
U1 0
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0969-9546
EI 1473-5695
J9 EUR J EMERG MED
JI Eur. J. Emerg. Med.
PD APR
PY 2016
VL 23
IS 2
BP 79
EP 79
DI 10.1097/MEJ.0000000000000384
PG 1
WC Emergency Medicine
SC Emergency Medicine
GA DI8TL
UT WOS:000373774700001
PM 26908259
DA 2020-07-08
ER

PT J
AU Hinojosa, T
   Saldivar, L
   Salas, L
   Giron, F
   Batista, C
   Caballero-Valdez, S
   del Angel, S
   Tyring, SK
AF Hinojosa, Tiffany
   Saldivar, Laura
   Salas, Lucia
   Giron, Fanny
   Batista, Caroline
   Caballero-Valdez, Selene
   del Angel, Sandra
   Tyring, Stephen K.
TI The Role of Skin-Pathology in Chikungunya and Zika Virus: clinical clues
   and histopathology insights
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Hinojosa, Tiffany; Saldivar, Laura; Salas, Lucia] Univ Monterrey, Garza Garcia, NL, Mexico.
   [Giron, Fanny] Univ Catolica Honduras, San Pedro Sula, Honduras.
   [Batista, Caroline] Fluminense Fed Univ, Dept Dermatol, Niteroi, RJ, Brazil.
   [Caballero-Valdez, Selene] Univ Autonoma Chihuahua, Chihuahua, Mexico.
   [del Angel, Sandra] Univ Autonoma Tamaulipas, Tampico, Mexico.
   [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA.
   [Tyring, Stephen K.] Ctr Clin Studies, Houston, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA lb463
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FJ
UT WOS:000406444700016
DA 2020-07-08
ER

PT J
AU Zumla, A
   Goodfellow, I
   Kasolo, F
   Ntoumi, F
   Buchy, P
   Bates, M
   Azhar, EI
   Cotten, M
   Petersen, E
AF Zumla, Alimuddin
   Goodfellow, Ian
   Kasolo, Francis
   Ntoumi, Francine
   Buchy, Philippe
   Bates, Matthew
   Azhar, Esam I.
   Cotten, Matthew
   Petersen, Eskild
TI Zika virus outbreak and the case for building effective and sustainable
   rapid diagnostics laboratory capacity globally
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika virus; Emerging pathogens; laboratory; diagnostics; surveillance;
   public health
ID SUB-SAHARAN AFRICA; RESPIRATORY SYNDROME; CORONAVIRUS; INFECTIONS; CARE
C1 [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCLHosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   [Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Hills Rd, Cambridge CB2 2QQ, England.
   [Goodfellow, Ian] Univ Makeni, Sch Publ Hlth, Makeni, Sierra Leone.
   [Kasolo, Francis] WHO AFRO, Country & Inter Country Support, Off Reg Director, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Fdn Congolaise Rech Med, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Marien Ngouabi, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Buchy, Philippe] GlaxoSmithKline Vaccines, R&D Asia Pacific, Gateway West, Singapore.
   [Bates, Matthew] Univ Teaching Hosp, UNZA UCLMS Res & Training Project, Lusaka, Zambia.
   [Azhar, Esam I.] King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah 21413, Saudi Arabia.
   [Cotten, Matthew] Wellcome Trust Sanger Inst, Cambridge, England.
   [Petersen, Eskild] Univ Aarhus, DK-8000 Aarhus C, Denmark.
   [Petersen, Eskild] Royal Hosp, Muscat, Oman.
RP Petersen, E (corresponding author), Univ Aarhus, DK-8000 Aarhus C, Denmark.; Petersen, E (corresponding author), Royal Hosp, Muscat, Oman.
EM a.i.zumla@gmail.com; ig299@cam.ac.uk; kasolof@who.int;
   fntoumi@fcrm-congo.com; philippe.x.buchy@gsk.com;
   matthew.bates@ucl.ac.uk; eazhar@kau.edu.sa; mc13@sanger.ac.uk;
   eskildp@dadlnet.dk
OI Cotten, Matthew/0000-0002-3361-3351; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735; Bates, Matthew/0000-0003-0464-1529;
   BUCHY, Philippe/0000-0003-1372-3008; Azhar, Esam/0000-0002-1736-181X;
   Goodfellow, Ian/0000-0002-9483-510X
FU Wellcome TrustWellcome Trust [100891]
CR Bates M, 2016, EXPERT REV MOL DIAGN, V17, P1
   *CDC, 1999, MMWR-MORBID MORTAL W, V48, P265
   Christofferson RC, 2016, AM J TROP MED HYG
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   European Centre for Disease Prevention and Control (ECDC) European Food Safety Authority (EFSA), MOSQ MAPS
   Goodfellow I, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.12.21074
   HEYMANN D.L., 2016, LANCET
   Mathis Margaux, 2015, Wkly Epidemiol Rec, V90, P238
   McNerney R, 2015, INT J INFECT DIS, V32, P81, DOI 10.1016/j.ijid.2015.01.012
   Mikanatha NM, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P1, DOI 10.1002/9781118543504
   Ndihokubwayo JB, 2015, STRENGTHENING PUBLIC
   PAHO, 2015, CUM ZIK SUSP CONF CA
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363
   TenoRes study group, 2016, LANCET INFECT DIS
   Tuite N, 2014, J ANTIMICROB CHEMOTH, V69, P1729, DOI 10.1093/jac/dku083
   Waggoner JJ, 2016, J CLIN MICROBIOL
   WHO, 2016, PROT HUM FUT HLTH CR
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Zaki AM, 2013, NEW ENGL J MED, V369, P394
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A., 2016, NAT REV DRUG DISCOV
   Zumla A, 2015, INT J INFECT DIS, V37, P77, DOI 10.1016/j.ijid.2015.06.020
   Zumla A, 2015, INT J INFECT DIS, V32, P46, DOI 10.1016/j.ijid.2014.12.039
   Zumla A, 2014, LANCET INFECT DIS, V14, P1123, DOI 10.1016/S1473-3099(14)70827-8
   Zumla A, 2013, LANCET RESP MED, V1, P284, DOI 10.1016/S2213-2600(13)70099-7
NR 26
TC 14
Z9 14
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
BP 92
EP 94
DI 10.1016/j.ijid.2016.02.1007
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DK4HE
UT WOS:000374877300017
PM 26952389
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Nishiura, H
   Kinoshita, R
   Mizumoto, K
   Yasuda, Y
   Nah, K
AF Nishiura, Hiroshi
   Kinoshita, Ryo
   Mizumoto, Kenji
   Yasuda, Yohei
   Nah, Kyeongah
TI Transmission potential of Zika virus infection in the South Pacific
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Epidemic; Basic reproduction number; Statistical estimation;
   Transmissibility
ID EPIDEMICS; DENGUE; STATES
AB Objectives: Zika virus has spread internationally through countries in the South Pacific and Americas. The present study aimed to estimate the basic reproduction number, R-0, of Zika virus infection as a measurement of the transmission potential, reanalyzing past epidemic data from the South Pacific.
   Methods: Incidence data from two epidemics, one on Yap Island, Federal State of Micronesia in 2007 and the other in French Polynesia in 2013-2014, were reanalyzed. R-0 of Zika virus infection was estimated from the early exponential growth rate of these two epidemics.
   Results: The maximum likelihood estimate (MLE) of R-0 for the Yap Island epidemic was in the order of 4.3-5.8 with broad uncertainty bounds due to the small sample size of confirmed and probable cases. The MLE of R-0 for French Polynesia based on syndromic data ranged from 1.8 to 2.0 with narrow uncertainty bounds.
   Conclusions: The transmissibility of Zika virus infection appears to be comparable to those of dengue and chikungunya viruses. Considering that Aedes species are a shared vector, this finding indicates that Zika virus replication within the vector is perhaps comparable to dengue and chikungunya. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Nishiura, Hiroshi; Kinoshita, Ryo; Mizumoto, Kenji; Yasuda, Yohei; Nah, Kyeongah] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7, Sapporo, Hokkaido 0608638, Japan.
   [Nishiura, Hiroshi; Kinoshita, Ryo; Nah, Kyeongah] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.
   [Nishiura, Hiroshi; Kinoshita, Ryo; Mizumoto, Kenji; Nah, Kyeongah] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.
   [Mizumoto, Kenji] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1130033, Japan.
RP Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7, Sapporo, Hokkaido 0608638, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.; Nishiura, H (corresponding author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.
EM nishiurah@gmail.com
OI Kinoshita, Ryo/0000-0002-0116-4598; Mizumoto, Kenji/0000-0002-2748-6560;
   Nah, Kyeongah/0000-0002-7708-1019
FU Japanese Society for the Promotion of Science (JSPS) KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [26670308, 26700028]; Japan Agency for Medical
   Research and DevelopmentJapan Agency for Medical Research and
   Development (AMED); Japan Science and Technology Agency (JST) CREST
   program; RISTEX program for Science of Science, Technology and
   Innovation Policy
FX HN received funding support from the Japanese Society for the Promotion
   of Science (JSPS) KAKENHI (grant numbers 26670308 and 26700028), Japan
   Agency for Medical Research and Development, the Japan Science and
   Technology Agency (JST) CREST program, and RISTEX program for Science of
   Science, Technology and Innovation Policy. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Keyfitz N., 1968, INTRO MATH POPULATIO
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Majumder MS, 2016, B WHO IN PRESS
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishiura H, 2010, J R SOC INTERFACE, V7, P297, DOI 10.1098/rsif.2009.0153
   Perkins TA, 2015, PLOS CURR, P7
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
NR 20
TC 49
Z9 51
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
BP 95
EP 97
DI 10.1016/j.ijid.2016.02.017
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DK4HE
UT WOS:000374877300018
PM 26923081
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chang, C
   Ortiz, K
   Ansari, A
   Gershwin, ME
AF Chang, Christopher
   Ortiz, Kristina
   Ansari, Aftab
   Gershwin, M. Eric
TI The Zika outbreak of the 21st century
SO JOURNAL OF AUTOIMMUNITY
LA English
DT Article
DE Guillain-Barre; Mosquitoes; Zika fever; Pandemic; Arborvirus; Sexual
   transmission; Aedes aegypti; Autophagy; Centrosome; Dengue;
   Glycosylation
ID WEST NILE VIRUS; YELLOW-FEVER; FRENCH-POLYNESIA; TRANSMISSION;
   ARBOVIRUS; INFECTION; MOSQUITOS; VECTOR; FOREST; DENGUE
AB The Zika virus outbreak has captivated the attention of the global audience and information has spread rapidly and wildly through the internet and other media channels. This virus was first identified in 1947, when it was isolated from a sentinel rhesus monkey placed by British scientists working at the Yellow Fever Research Laboratory located in the Zika forest area of Uganda, hence its name, and is transmitted primarily by the mosquito vector, Aedes aegypti. The fact that the rhesus macaque is an Asian species being placed in an African forest brings to mind the possibility of rapid adaptation of the virus from an African to Asian species, an issue that has not been considered. Whether such adaptation has played any role in acquiring pathogenicity due to cross species transmission remains to be identified. The first human infection was described in Nigeria in 1954, with only scattered reports of about a dozen human infections identified over a 50-year period. It was not until 2007 that Zika virus raised its ugly head with infections noted in three-quarters of the population on the tiny island of Yap located between the Philippines and Papua New Guinea in the western Pacific Ocean, followed by a major outbreak in French Polynesia in 2013. The virus remained confined to a narrow equatorial band in Africa and Asia until 2014 when it began to spread eastward, first toward Oceania and then to South America. Since then, millions of infected individuals have been identified in Brazil, Colombia, Venezuela, including 25 additional countries in the Americas. While the symptoms associated with Zika virus infection are generally mild, consisting of fever, maculopapular rash, arthralgia and conjunctivitis, there have been reports of more severe reactions that are associated with neurological complications. In pregnant women, fetal neurological complications include brain damage and microcephaly, while in adults there have been several cases of virus-associated Guillain-Barre syndrome. The virus was until recently believed to only be transmitted via mosquitoes. But when the Zika virus was isolated from the semen specimens from a patient in Texas, this provided the basis for the recent report of possible sexual transmission of the Zika virus. Due to the neurological complications, various vectors for infection as well as the rapid spread throughout the globe, it has prompted the World Health Organization to issue a global health emergency. Various governmental organizations have recommended that pregnant women do not travel to countries where the virus is epidemic, and within the countries affected by the virus, recommendations were provided for women of childbearing age to delay pregnancy. The overall public health impact of these above findings highlights the need for a rapid but specific diagnostic test for blood banks worldwide to identify those infected and for the counseling of women who are pregnant or contemplating pregnancy. As of this date, there are neither commercially licensed diagnostic tests nor a vaccine. Because cross reactivity of the Zika virus with dengue and Chikungunya virus is common, it may pose difficulty in being able to quickly develop such tests and vaccines. So far the most effective public health measures include controlling the mosquito populations via insecticides and preventing humans from direct exposure to mosquitoes. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chang, Christopher; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.
   [Ortiz, Kristina; Ansari, Aftab] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA USA.
RP Gershwin, ME (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.
EM megershwin@ucdavis.edu
RI amsalu, ribka/G-8780-2019
CR Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barboza P, 2008, MED MALADIES INFECT, V38, P513, DOI 10.1016/j.medmal.2008.06.011
   Baronti C., 2014, GENOME ANNOUNC, P2
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   Choumet V., 2015, REV SCI TECH, V34, P67
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i467
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M., 2015, BLOOD TRANSFUS, P1, DOI DOI 10.1136/BJSPORTS-2014-094015
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x
   Gatherer D, 2015, J GEN VIROL
   Gautret P, 2014, TRAVEL MED INFECT DI
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i753
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Heang V, 2010, EMERG INFECT DIS, V2012, P349
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Kelser E.A., 2015, MICROBES INFECT
   Kerkar N, 2016, J AUTOIMMUN, V66, P17, DOI 10.1016/j.jaut.2015.08.017
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Korhonen E.M., 2015, EUROSURVEILLANCE, P21
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, P19
   Kwang-Seob Shin, 2016, J TRAVEL MED, P23
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lucey DR, 2016, JAMA
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Martinez-Pulgarin D.F., 2015, TRAVEL MED INFECT DI
   Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MILLER BR, 1991, AM J TROP MED HYG, V45, P399, DOI 10.4269/ajtmh.1991.45.399
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2013, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Dowd A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i692
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onken J., 2016, ONCOTARGET
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Paz S., 2016, LANCET
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, P19
   Sabogal-Roman J.A., 2015, TRAVEL MED INFECT DI
   Salvador FS, 2015, TRAVEL MED INFECT DI
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D., 2014, EUROSURVEILLANCE, P19
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT
   THIEL HJ, 2005, VIRUS TAXONOMY, P981
   Tognarelli J., 2014, ARCH VIROL      1126
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Valero N, 2015, INVEST CLIN, V56, P241
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wang LF, 2015, J INTERN MED, V278, P369, DOI 10.1111/joim.12395
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L., 2016, LANCET GLOB HLTH
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 136
TC 102
Z9 109
U1 4
U2 161
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0896-8411
EI 1095-9157
J9 J AUTOIMMUN
JI J. Autoimmun.
PD APR
PY 2016
VL 68
BP 1
EP 13
DI 10.1016/j.jaut.2016.02.006
PG 13
WC Immunology
SC Immunology
GA DI5NP
UT WOS:000373546200001
PM 26925496
OA Green Published
DA 2020-07-08
ER

PT J
AU Waggoner, JJ
   Pinsky, BA
AF Waggoner, Jesse J.
   Pinsky, Benjamin A.
TI Zika Virus: Diagnostics for an Emerging Pandemic Threat
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Review
ID INTERIM GUIDELINES; FRENCH-POLYNESIA; DENGUE VIRUSES; UNITED-STATES;
   TRANSMISSION; INFECTIONS; OUTBREAK; NIGERIA; PCR; ANTIBODIES
AB Zika virus (ZIKV) is an Aedes mosquito-borne flavivirus that emerged in Brazil in 2015 and then rapidly spread throughout the tropical and subtropical Americas. Based on clinical criteria alone, ZIKV cannot be reliably distinguished from infections with other pathogens that cause an undifferentiated systemic febrile illness, including infections with two common arboviruses, dengue virus and chikungunya virus. This minireview details the methods that are available to diagnose ZIKV infection.
C1 [Waggoner, Jesse J.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.
RP Pinsky, BA (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
EM bpinsky@stanford.edu
OI Pinsky, Benjamin/0000-0001-8751-4810
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [K08 AI110528]
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EURO SURVEILL, V19
   BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Enfissi A., 2016, LANCET
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, N ENGL J MED
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korhonen E., 2016, EURO SURVEILL, V21
   Kucharski AJ, 2016, TRANSMISSION DYNAMIC
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EURO SURVEILL, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OEHLER E, 2013, ZIKA VIRUS INFECTION
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ritchie SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105846
   ROTH A, 2014, EUR SUVEILL, V19
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT
   Tognarelli J, 2014, REPORT OUTBREAK ZIKA
   Ventura CV, 2016, LANCET
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waggoner JJ, 2014, J CLIN MICROBIOL, V52, P1801, DOI 10.1128/JCM.00013-14
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 85
TC 123
Z9 128
U1 2
U2 26
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD APR
PY 2016
VL 54
IS 4
BP 860
EP 867
DI 10.1128/JCM.00279-16
PG 8
WC Microbiology
SC Microbiology
GA DI2OX
UT WOS:000373337100058
PM 26888897
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Chen, HL
   Tang, RB
AF Chen, Hui-Lan
   Tang, Ren-Bin
TI Why Zika virus infection has become a public health concern?
SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION
LA English
DT Review
DE microcephaly; transmission; Zika virus
ID INTERIM GUIDELINES; UNITED-STATES; PREGNANT-WOMEN; OUTBREAK
AB Prior to 2015, Zika Virus (ZIKV) outbreaks had occurred in areas of Africa, Southeast Asia, and the Pacific Islands. Although a causal relationship between Zika infection during pregnancy and microcephaly is strongly suspected, such a connection has not yet been scientifically proven. In May 2015, the outbreak of ZIKV infection in Brazil led to reports of syndrome and pregnant women giving birth to babies with birth defects and poor pregnancy outcomes; the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed ZIKV infection in Brazil. Currently, ZIKV outbreaks are ongoing and it will be difficult to predict how the virus will spread over time. ZIKV is transmitted to humans primarily through the bite of infected mosquitos, Aedes aegypti and Aedes albopictus. These mosquitoes are the principle vectors of dengue, and ZIKV disease generally is reported to include symptoms associated with acute febrile illnesses that clinically resembles dengue fever. The laboratory diagnosis can be performed by using reverse-transcriptase polymerase chain reaction (RT-PCR) on serum, viral nucleic acid and virus-specific immunoglobulin M. There is currently no vaccine and antiviral treatment available for ZIKV infection, and the only way to prevent congenital ZIKV infection is to prevent maternal infection. In February 2016, the Taiwan Centers for Disease Control (Taiwan CDC) activated ZIKV as a Category V Notifiable Infectious Disease similar to Ebola virus disease and MERS. Copyright (C) 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC.
C1 [Chen, Hui-Lan] Keelung Hosp, Dept Pediat, Minist Hlth & Welf, Keelung, Taiwan.
   [Tang, Ren-Bin] Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
RP Tang, RB (corresponding author), Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
EM ch9406@chgh.org.com.tw
RI amsalu, ribka/G-8780-2019
CR [Anonymous], EP UPD OUTBR ZIK VIR
   Bagla P, HUFFINGTON POST
   Center for Disease Control and Prevention (CDC) Centers for Disease Control ROC (Taiwan), 2016, PEOPL RET ZIK AFF CO
   Centers for Disease Control and Prevention, ZIK VIR HLTH CAR PRO
   Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, CDC NEWS ROOM ZIKA V
   Centers for Disease Control and Prevention, 2016, TRANSMISSION
   Centers for Disease Control and Prevention, BIRTH DEF FACTS MICR
   Centers for Disease Control and Prevention, ZIK VIR FACT SHEETS
   Centers for Disease Control R.O.C (Taiwan), 2016, ZIK OUTBR PERS LAT A
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Maron DF, 2015, SCI AM HLTH     1230
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health New Zealand, 2016, ZIK VIR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   World Health Organization, ZIK SIT REP ZIK POT
   World Health Organization, WHODENGUE SEV DENG
   World Health Organization, WHO IMM VACC BIOL DE
NR 32
TC 19
Z9 19
U1 0
U2 43
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1726-4901
EI 1728-7731
J9 J CHIN MED ASSOC
JI J. Chin. Med. Assoc.
PD APR
PY 2016
VL 79
IS 4
BP 174
EP 178
DI 10.1016/j.jcma.2016.03.001
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK3GA
UT WOS:000374803900003
PM 27052792
OA Other Gold
DA 2020-07-08
ER

PT J
AU Huang, ASE
   Shu, PY
   Yang, CH
AF Huang, Angela Song-En
   Shu, Pei-Yun
   Yang, Chin-Hui
TI A new reportable disease is born: Taiwan Centers for Disease Control's
   response to emerging Zika virus infection
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
ID OUTBREAK; TRANSMISSION; STATES
AB Zika virus infection, usually a mild disease transmitted through the bite of Aedes mosquitos, has been reported to be possibly associated with microcephaly and neurologic complications. Taiwan's first imported case of Zika virus infection was found through fever screening at airport entry in January 2016. No virus was isolated from patient's blood taken during acute illness; however, PCR products showed that the virus was of Asian lineage closely related to virus from Cambodia. To prevent Zika virus from spreading in Taiwan, the Taiwan Centers for Disease Control has strengthened efforts in quarantine and surveillance, increased Zika virus infection diagnostic capacity, implemented healthcare system preparedness plans, and enhanced vector control program through community mobilization and education. Besides the first imported case, no additional cases of Zika virus infection have been identified. Furthermore, no significant increase in the number of microcephaly or Guillain-Barre Syndrome has been observed in Taiwan. To date, there have been no autochthonous transmissions of Zika virus infection. Copyright (C) 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Huang, Angela Song-En; Yang, Chin-Hui] Taiwan Ctr Dis Control, Div Acute Infect Dis, Taipei, Taiwan.
   [Shu, Pei-Yun] Taiwan Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan.
RP Yang, CH (corresponding author), 6 Linsen South Rd, Taipei 10050, Taiwan.
EM inf@cdc.gov.tw
CR Brazil Ministry of Health, 2015, MIN DIV B EP MICR
   Calvet G., 2016, LANCET INFE IN PRESS
   Centre D'Hygiene et de Salubrite Publique, 2014, SURV DENG ZIK POL FR
   Chang SC, 2015, J FORMOS MED ASSOC, V114, P1025, DOI 10.1016/j.jfma.2015.10.006
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Shinohara K, ZIKA FEVER IMPORTED
   Worl Health Organization (WHO), 2016, GUILL BARR SYNDR
NR 12
TC 14
Z9 14
U1 0
U2 9
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD APR
PY 2016
VL 115
IS 4
BP 223
EP 225
DI 10.1016/j.jfma.2016.03.002
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6MY
UT WOS:000375039400002
PM 27013110
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Solomon, T
   Baylis, M
   Brown, D
AF Solomon, Tom
   Baylis, Matthew
   Brown, David
TI Zika virus and neurological disease-approaches to the unknown
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID BRAZIL; INFECTION; ENCEPHALITIS
C1 [Solomon, Tom; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
   [Solomon, Tom; Baylis, Matthew; Brown, David] Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Brown, David] Oswaldo Cruz Inst Fiocruz, Influenza Lab, Rio De Janeiro, Brazil.
   [Brown, David] Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London, England.
RP Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.; Solomon, T (corresponding author), Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.; Solomon, T (corresponding author), Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
EM tsolomon@liv.ac.uk
OI Solomon, Tom/0000-0001-7266-6547; Baylis, Matthew/0000-0003-0335-187X
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/K018507/1]; Medical
   Research CouncilMedical Research Council UK (MRC) [MC_PC_15090];
   National Institute for Health ResearchNational Institute for Health
   Research (NIHR) [RP-PG-0108-10048, NF-SI-0514-10177]; Department of
   HealthDiabetes UK [RP-PG-0108-10048]; Medical Research CouncilMedical
   Research Council UK (MRC) [MC_PC_15096]
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 11
TC 21
Z9 21
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2016
VL 16
IS 4
BP 402
EP 404
DI 10.1016/S1473-3099(16)00125-0
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DH0CH
UT WOS:000372449600015
PM 26923117
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Mansuy, JM
   Dutertre, M
   Mengelle, C
   Fourcade, C
   Marchou, B
   Delobel, P
   Izopet, J
   Martin-Blondel, G
AF Mansuy, Jean Michel
   Dutertre, Marine
   Mengelle, Catherine
   Fourcade, Camille
   Marchou, Bruno
   Delobel, Pierre
   Izopet, Jacques
   Martin-Blondel, Guillaume
TI Zika virus: high infectious viral load in semen, a new sexually
   transmitted pathogen?
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
C1 [Mansuy, Jean Michel; Mengelle, Catherine; Izopet, Jacques] Ctr Hosp & Univ, Virol Lab, Inst Federatif Biol, F-31059 Toulouse, France.
   [Dutertre, Marine; Fourcade, Camille; Marchou, Bruno; Delobel, Pierre; Martin-Blondel, Guillaume] Ctr Hosp & Univ, Serv Malad Infect & Trop, F-31059 Toulouse, France.
   [Dutertre, Marine; Marchou, Bruno; Delobel, Pierre; Izopet, Jacques; Martin-Blondel, Guillaume] Ctr Physiopathol Toulouse Purpan, CNRS, UMR 5282, INSERM,U1043, Toulouse, France.
RP Mansuy, JM (corresponding author), Ctr Hosp & Univ, Virol Lab, Inst Federatif Biol, F-31059 Toulouse, France.
EM mansuy.jm@chu-toulouse.fr
RI Delobel, Pierre/K-3166-2014; Martin-Blondel, Guillaume/K-6762-2014;
   Delobel, Pierre/Q-6028-2019
OI Delobel, Pierre/0000-0002-2874-3581; Martin-Blondel,
   Guillaume/0000-0002-8363-7028; Delobel, Pierre/0000-0002-2874-3581;
   MARCHOU, Bruno/0000-0002-0673-2945; IZOPET, JACQUES/0000-0002-8462-3234
CR Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Roa M, 2016, LANCET
NR 5
TC 220
Z9 227
U1 2
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2016
VL 16
IS 4
BP 405
EP 405
DI 10.1016/S1473-3099(16)00138-9
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DH0CH
UT WOS:000372449600016
PM 26949027
OA Bronze
DA 2020-07-08
ER

PT J
AU Watrin, L
   Ghawche, F
   Larre, P
   Neau, JP
   Mathis, S
   Fournier, E
AF Watrin, Louise
   Ghawche, Frederic
   Larre, Philippe
   Neau, Jean-Philippe
   Mathis, Stephane
   Fournier, Emmanuel
TI Guillain-Barre Syndrome (42 Cases) Occurring During a Zika Virus
   Outbreak in French Polynesia
SO MEDICINE
LA English
DT Article
ID INFECTION; DIAGNOSIS; PATTERNS; DENGUE
AB Zika virus (transmitted by mosquitoes) reached French Polynesia for the first time in 2013, leading to an epidemic affecting 10% of the total population. So far, it has not been known to induce any neurological complications, but, a few weeks after the outbreak, an unexpectedly high number of 42 patients presented with Guillain-Barre syndrome.We report the clinical and electrophysiological characteristics of this series. Males predominated with a sex ratio of 2.82 (mean age: 46). All patients (except 2) were native Polynesian. At admission, 55% were able to walk unaided against 38% at nadir, 24% had swallowing troubles (nadir: 45%), 74% had motor weakness of the limbs (nadir: 86%) and deep tendon reflexes were diminished or not found in the vast majority of patients. Mean duration of the progressive phase and of the plateau phase was respectively 7 and 9 days. Thirty-eight percent of the patients were admitted in intensive care unit and 10 patients underwent tracheotomy. Nerve electrophysiological studies at admission showed marked distal motor conduction alterations, which had almost completely disappeared at the 4th month; this pattern was more suggestive of acute motor axonal neuropathy (AMAN) than of acute inflammatory demyelinating polyneuropathy (AIDP). Lumbar puncture showed elevated proteins in 90% of the cases, with cell count always inferior to 50/L.This epidemic raises several questions, such as the potential existence of interactions between Zika virus and Polynesian HLA system and/or the consequences of several recombination events of this virus. This situation should call for increased vigilance, especially in countries where Aedes mosquitoes are present.
C1 [Watrin, Louise; Neau, Jean-Philippe; Mathis, Stephane] Ctr Hosp Univ Poitiers, Dept Neurol, Rue Mil, Poitiers, France.
   [Ghawche, Frederic; Larre, Philippe] French Polynesia Hosp Ctr, Dept Neurol, Papeete, Tahiti, France.
   [Fournier, Emmanuel] La Pitie Salpetriere Univ Hop Ctr, Grp Hosp Pitie Salpetriere, AP HP, Dept Clin Neurophysiol, Bd Hop, Paris, France.
RP Mathis, S (corresponding author), Ctr Hosp Univ Poitiers, Dept Neurol, Rue Mil, Poitiers, France.
EM stephane.mathis@chu-poitiers.fr
CR Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737
   Baronti C, 2014, GENOME ANNOUNC
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2014, RAP ASS ZIK INF OUTB, DOI http://ecdc.europa.eu/en/publications/Publications/zika-virus-rapid-risk-assessment-23-february-2016.pdf
   Edinur HA, 2013, HUM IMMUNOL, V74, P1119, DOI 10.1016/j.humimm.2013.06.011
   Enfissi A, 2016, LANCET
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR DIS EP POT A
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Fournier E., 2008, EXAMEN ELECTROMYOGRA, P858
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P984, DOI 10.4269/ajtmh.1969.18.984
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Isose S, 2009, J PERIPHER NERV SYST, V14, P151, DOI 10.1111/j.1529-8027.2009.00226.x
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jin PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131374
   Kimura J, 2005, PERIPHERAL NEUROPATH, V1, P899
   Kokubun N, 2013, J NEUROL SCI, V326, P111, DOI 10.1016/j.jns.2013.01.015
   Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler Erwan, 2012, Presse Med, V41, pe547, DOI 10.1016/j.lpm.2012.03.010
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Schmidt-Chanasit J, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.3.20681
   Sejvar James J, 2011, Curr Infect Dis Rep, V13, P387, DOI 10.1007/s11908-011-0194-8
   SHAHANI BT, 1979, ACTA NEUROL SCAND, V60, P118
   Thorsby E, 2012, PHILOS T R SOC B, V367, P812, DOI 10.1098/rstb.2011.0319
   Uncini A, 2013, CLIN NEUROPHYSIOL, V124, P212, DOI 10.1016/j.clinph.2012.05.024
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   Verity C, 2014, ARCH DIS CHILD, V99, P532, DOI 10.1136/archdischild-2013-304475
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yap State Department of Health Services, 2007, PLAQ ZIK VIR, DOI https://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&vedOahUKEwjzpuD5jNnLAhVI1BoKHWmkBowQFggcMAA&url=http%3A%2F%2Fwww.invs.sante.fr%2Fcontent%2Fdownload%2F83617%2F305876%2Fversion%2F10%2Ffile%2FZika%2B2014%2Bnote%2B-%2Bpolynesie%2Bet%2Bmicronesie-revue%2BSI%2BVf2.pdf&usg=AFQjCNEQs7PF9YuwE1aXvHAPH6yFGSHsA&bvm=bv.117604692,d.ZWU&cad=rja.
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 41
TC 56
Z9 58
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD APR
PY 2016
VL 95
IS 14
AR UNSP e3257
DI 10.1097/MD.0000000000003257
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK9NI
UT WOS:000375257000050
PM 27057874
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petersen, EE
   Polen, KND
   Meaney-Delman, D
   Ellington, SR
   Oduyebo, T
   Cohn, A
   Oster, AM
   Russell, K
   Kawwass, JF
   Karwowski, MP
   Powers, AM
   Bertolli, J
   Brooks, JT
   Kissin, D
   Villanueva, J
   Munoz-Jordan, J
   Kuehnert, M
   Olson, CK
   Honein, MA
   Rivera, M
   Jamieson, DJ
   Rasmussen, SA
AF Petersen, Emily E.
   Polen, Kara N. D.
   Meaney-Delman, Dana
   Ellington, Sascha R.
   Oduyebo, Titilope
   Cohn, Amanda
   Oster, Alexandra M.
   Russell, Kate
   Kawwass, Jennifer F.
   Karwowski, Mateusz P.
   Powers, Ann M.
   Bertolli, Jeanne
   Brooks, John T.
   Kissin, Dmitry
   Villanueva, Julie
   Munoz-Jordan, Jorge
   Kuehnert, Matthew
   Olson, Christine K.
   Honein, Margaret A.
   Rivera, Maria
   Jamieson, Denise J.
   Rasmussen, Sonja A.
TI Update: Interim Guidance for Health Care Providers Caring for Women of
   Reproductive Age with Possible Zika Virus Exposure - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID SEXUAL TRANSMISSION; INFECTION; SEMEN; GUIDELINES; TRAVELERS; HIV-1
C1 [Petersen, Emily E.; Ellington, Sascha R.; Oduyebo, Titilope; Kawwass, Jennifer F.; Kissin, Dmitry; Olson, Christine K.; Rivera, Maria; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Polen, Kara N. D.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Off Director, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope; Russell, Kate; Karwowski, Mateusz P.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Cohn, Amanda] CDC, Off Director, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Oster, Alexandra M.; Bertolli, Jeanne; Brooks, John T.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, NCIRD, Atlanta, GA 30333 USA.
   [Kawwass, Jennifer F.] Emory Univ, Div Reprod Endocrinol & Infertil, Dept Gynecol & Obstet, Sch Med, Atlanta, GA 30322 USA.
   [Karwowski, Mateusz P.] CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.
   [Powers, Ann M.; Munoz-Jordan, Jorge] CDC, Div Vector Borne Dis, NCEZID, Atlanta, GA 30333 USA.
   [Villanueva, Julie] CDC, Div Preparedness & Emerging Infect, NCEZID, Atlanta, GA 30333 USA.
   [Kuehnert, Matthew] CDC, Div Healthcare Qual Promot, NCEZID, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Petersen, EE (corresponding author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM ZikaMCH@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201; Kawwass,
   Jennifer/0000-0001-7345-735X; Russell, Kate/0000-0001-9343-3355
CR Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P47, DOI 10.1016/j.fertnstert.2012.09.037
   Atkinson B, DETECTION ZIKA VIRUS
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438
   Brasil P, 2016, N ENGL J MED
   Bujan L, 2002, FERTIL STERIL, V78, P1321, DOI 10.1016/S0015-0282(02)04344-3
   Calvet G, LANCET INFECT DIS
   Cauchemez M, LANCET
   CDC, 2015, CONTRACEPTION
   CDC, 2016, ALL COUNTR TERR ACT
   CDC, 2015, ZIK VIR DIS US 2015
   CDC, 2016, UPD DIAGN TEST ZIK C
   Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ENDERS G, 1988, LANCET, V1, P1445
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasci RS, 2016, CDC HLTH INF INT 201
   Nunoue T, 2002, PEDIATR INFECT DIS J, V21, P1133, DOI 10.1097/00006454-200212000-00009
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pasquier C, 2003, J MED VIROL, V69, P344, DOI 10.1002/jmv.10295
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Revello MG, 2002, J INFECT DIS, V186, P553, DOI 10.1086/341831
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 35
TC 74
Z9 76
U1 0
U2 20
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 1
PY 2016
VL 65
IS 12
BP 315
EP 322
DI 10.15585/mmwr.mm6512e2
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH8IO
UT WOS:000373036900004
PM 27031943
OA Bronze
DA 2020-07-08
ER

PT J
AU Liuzzi, G
   Puro, V
   Lanini, S
   Vairo, F
   Nicastri, E
   Capobianchi, MR
   Di Caro, A
   Piacentini, M
   Zumla, A
   Ippolito, G
AF Liuzzi, Giuseppina
   Puro, Vincenzo
   Lanini, Simone
   Vairo, Francesco
   Nicastri, Emanuele
   Capobianchi, Maria Rosaria
   Di Caro, Antonino
   Piacentini, Mauro
   Zumla, Alimuddin
   Ippolito, Giuseppe
TI Zika virus and microcephaly: is the correlation causal or coincidental?
SO NEW MICROBIOLOGICA
LA English
DT Review
DE ZIKA Virus; Microcephaly
ID NERVOUS-SYSTEM; INFECTION; BRAZIL
C1 [Liuzzi, Giuseppina; Puro, Vincenzo; Lanini, Simone; Vairo, Francesco; Nicastri, Emanuele; Capobianchi, Maria Rosaria; Di Caro, Antonino; Piacentini, Mauro; Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
   [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
RP Ippolito, G (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
EM giuseppe.ippolito@inmi.it
RI Di Caro, Antonino/K-6854-2016; Piacentini, Mauro/I-2411-2016; Ippolito,
   Giuseppe/J-7207-2017; Lanini, Simone/C-7523-2012; nicastri,
   emanuele/K-7780-2016; Vairo, Francesco/M-5676-2013
OI Di Caro, Antonino/0000-0001-6027-3009; Piacentini,
   Mauro/0000-0003-2919-1296; Lanini, Simone/0000-0002-6743-4001; nicastri,
   emanuele/0000-0002-5606-8712; Vairo, Francesco/0000-0002-8375-7468;
   Zumla, Professor Sir Alimuddin/0000-0002-5111-5735; Capobianchi, Maria
   Rosaria/0000-0003-3465-0071; Ippolito, Giuseppe/0000-0002-1076-2979
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   CIDRAP, 2016, WHO GIV OV ZIK IMP B
   Degani S, 2006, OBSTET GYNECOL SURV, V61, P329, DOI 10.1097/01.ogx.0000216518.85796.88
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, 2016, EM MICR
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 22
TC 6
Z9 7
U1 0
U2 7
PU EDIZIONI INT SRL
PI PAVIA
PA DIV EDIMES, EDIZIONI MEDICO SCIENTIFICHE PAVIA, VIA RIVIERA, PAVIA,
   39-27100, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD APR
PY 2016
VL 39
IS 2
BP 83
EP 85
PG 3
WC Microbiology
SC Microbiology
GA DY6XZ
UT WOS:000385274200001
DA 2020-07-08
ER

PT J
AU Jennings, LC
   Mackenzie, JS
AF Jennings, Lance C.
   Mackenzie, John S.
TI Zika virus threat
SO NEW ZEALAND MEDICAL JOURNAL
LA English
DT Editorial Material
ID TRANSMISSION; STATES
C1 [Jennings, Lance C.] Univ Otago, Christchurch, New Zealand.
   [Jennings, Lance C.] Canterbury Hlth Labs, POB 151, Christchurch 8011, New Zealand.
   [Mackenzie, John S.] Curtin Univ, Trop Infect Dis, Perth, WA, Australia.
   [Mackenzie, John S.] PathWest, Div Microbiol & Infect Dis, Nedlands, WA, Australia.
RP Jennings, LC (corresponding author), Canterbury Hlth Labs, POB 151, Christchurch 8011, New Zealand.
EM lance.jennings@cdhb.health.nz
RI /S-4986-2019
OI /0000-0002-5918-2190
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau V M, 2016, LANCET
   CDC, 2016, ZIK VIR AR ZIK
   Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, 2016, MEM REV DIAGN TEST Z
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Craig AT, 2016, B WHO
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Ministry of Health, 2016, ZIK VIR
   Ministry of Health, 2016, ZIK VIR INT GUID INF
   Mlakar J, 2016, N ENGL J MED
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nogueira RM, 2016, N ENGL J MED
   PAHO, ZIK EP UPD 3 MRCH 20
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shaun Y., 2015, SURVEILLANCE, V42, P29
   Smith DW, 2016, LANCET, V2016
NR 31
TC 0
Z9 0
U1 0
U2 1
PU NEW ZEALAND MEDICAL ASSOC
PI CHRISTCHURCH
PA C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345,
   CHRISTCHURCH, 00000, NEW ZEALAND
SN 0028-8446
EI 1175-8716
J9 NEW ZEAL MED J
JI N. Z. Med. J.
PD APR 1
PY 2016
VL 129
IS 1432
BP 10
EP 15
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FE3MR
UT WOS:000408120500002
PM 27356247
DA 2020-07-08
ER

PT J
AU Akiner, MM
   Demirci, B
   Babuadze, G
   Robert, V
   Schaffner, F
AF Akiner, Muhammet M.
   Demirci, Berna
   Babuadze, Giorgi
   Robert, Vincent
   Schaffner, Francis
TI Spread of the Invasive Mosquitoes Aedes aegypti and Aedes albopictus in
   the Black Sea Region Increases Risk of Chikungunya, Dengue, and Zika
   Outbreaks in Europe
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
C1 [Akiner, Muhammet M.] Recep Tayyip Erdogan Univ, Fac Arts & Sci, Dept Biol, Fener, Rize, Turkey.
   [Demirci, Berna] Kafkas Univ, Dept Mol Biol & Genet, Kars, Turkey.
   [Babuadze, Giorgi] Natl Ctr Dis Control & Publ Hlth NCDC, Div Virol & Mol Biol, Tbilisi, Georgia.
   [Robert, Vincent] Inst Rech Dev, Res Unit MIVEGEC, Montpellier, France.
   [Schaffner, Francis] Avia GIS, Zoersel, Belgium.
RP Schaffner, F (corresponding author), Avia GIS, Zoersel, Belgium.
EM fschaffner@avia-gis.com
OI Schaffner, Francis/0000-0001-9166-7617
FU European Food Safety Authority (EFSA) [OC/EFSA/AHAW/2013/02-FWC1];
   European Centre for Disease prevention and Control (ECDC)
FX This work was carried out under the VectorNet framework contract
   OC/EFSA/AHAW/2013/02-FWC1 funded by the European Food Safety Authority
   (EFSA) and the European Centre for Disease prevention and Control
   (ECDC). The funders contributed to the study design, but had no role in
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2012, GLOB STRAT DENG PREV
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Cauchemez S, 2014, EURO SURVEILL, V19
   ECDC, 2014, GUID SURV NAT MOSQ E
   European Environment Agency, BIOG REG EUR
   Ganushkina LA, 2016, VECTOR-BORNE ZOONOT, V16, P58, DOI 10.1089/vbz.2014.1761
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Roth A, 2014, EURO SURVEILL, V19
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Scholte E, 2010, EURO SURVEILL, V15
   Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386
   Septfons A., 2015, Bulletin Epidemiologique Hebdomadaire, P204
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Van den Berg W, 2013, REGIONAL FRAMEWORK S
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 55
Z9 56
U1 1
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004664
DI 10.1371/journal.pntd.0004664
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700076
PM 27115737
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Caine, EA
   Walker, EC
   Larkin, KE
   Camacho, E
   Osorio, JE
AF Aliota, Matthew T.
   Caine, Elizabeth A.
   Walker, Emma C.
   Larkin, Katrina E.
   Camacho, Erwin
   Osorio, Jorge E.
TI Characterization of Lethal Zika Virus Infection in AG129 Mice
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS; MOUSE MODEL; T-CELLS; INTERFERON; PROTECTION; AEDES;
   RESPONSES; REPLICATION; MICRONESIA; ISOLATIONS
AB Background
   Mosquito-borne Zika virus (ZIKV) typically causes a mild and self-limiting illness known as Zika fever, which often is accompanied by maculopapular rash, headache, and myalgia. During the current outbreak in South America, ZIKV infection during pregnancy has been hypothesized to cause microcephaly and other diseases. The detection of ZIKV in fetal brain tissue supports this hypothesis. Because human infections with ZIKV historically have remained sporadic and, until recently, have been limited to small-scale epidemics, neither the disease caused by ZIKV nor the molecular determinants of virulence and/or pathogenicity have been well characterized. Here, we describe a small animal model for wild-type ZIKV of the Asian lineage.
   Methodology/Principal Findings
   Using mice deficient in interferon alpha/beta and (sic) receptors (AG129 mice), we report that these animals were highly susceptible to ZIKV infection and disease, succumbing within seven to eight days. Rapid viremic dissemination was observed in visceral organs and brain; but only was associated with severe pathologies in the brain and muscle. Finally, these results were consistent across challenge routes, age of mice, and inoculum doses. These data represent a mouse model for ZIKV that is not dependent on adapting ZIKV to intracerebral passage in mice.
   Conclusions/Significance
   Foot pad injection of AG129 mice with ZIKV represents a biologically relevant model for studying ZIKV infection and disease development following wild-type virus inoculation without the requirement for adaptation of the virus or intracerebral delivery of the virus. This newly developed Zika disease model can be exploited to identify determinants of ZIKV virulence and reveal molecular mechanisms that control the virus-host interaction, providing a framework for rational design of acute phase therapeutics and for vaccine efficacy testing.
C1 [Aliota, Matthew T.; Caine, Elizabeth A.; Walker, Emma C.; Larkin, Katrina E.; Camacho, Erwin; Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP Osorio, JE (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM jorge.osorio@wisc.edu
OI Camacho Burgos, Erwin/0000-0003-2411-1875; Aliota,
   Matthew/0000-0002-6902-9149
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI117413-01];
   University of Wisconsin-Madison Microbes in Health and Disease
   predoctoral fellowship NIH [T32AI055397]
FX This project was partially funded by National Institutes of Health (NIH)
   Grant #AI117413-01 (to JEO and MTA). EAC is supported by the University
   of Wisconsin-Madison Microbes in Health and Disease predoctoral
   fellowship NIH T32AI055397. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   [Anonymous], 2015, RAPID RISK ASSESSMEN
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bourne N, 2007, J VIROL, V81, P9100, DOI 10.1128/JVI.00316-07
   Caine EA, 2015, VIRUSES-BASEL, V7, P5919, DOI 10.3390/v7112916
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lobigs M, 2003, J GEN VIROL, V84, P567, DOI 10.1099/vir.0.18654-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Partidos CD, 2011, VACCINE, V29, P3067, DOI 10.1016/j.vaccine.2011.01.076
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 41
TC 73
Z9 76
U1 1
U2 48
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004682
DI 10.1371/journal.pntd.0004682
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700087
PM 27093158
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brasil, P
   Calvet, GA
   Siqueira, AM
   Wakimoto, M
   de Sequeira, PC
   Nobre, A
   Quintana, MDB
   de Mendonca, MCL
   Lupi, O
   de Souza, RV
   Romero, C
   Zogbi, H
   Bressan, CD
   Alves, SS
   Lourenco-de-Oliveira, R
   Nogueira, RMR
   Carvalho, MS
   de Filippis, AMB
   Jaenisch, T
AF Brasil, Patricia
   Calvet, Guilherme Amaral
   Siqueira, Andre Machado
   Wakimoto, Mayumi
   de Sequeira, Patricia Carvalho
   Nobre, Aline
   Borges Quintana, Marcel de Souza
   Lima de Mendonca, Marco Cesar
   Lupi, Otilia
   de Souza, Rogerio Valls
   Romero, Carolina
   Zogbi, Heruza
   Bressan, Clarisse da Silveira
   Alves, Simone Sampaio
   Lourenco-de-Oliveira, Ricardo
   Ribeiro Nogueira, Rita Maria
   Carvalho, Marilia Sa
   Bispo de Filippis, Ana Maria
   Jaenisch, Thomas
TI Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical
   Characterization, Epidemiological and Virological Aspects
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUSES; TRANSMISSION; CHIKUNGUNYA; STATE
AB Background
   In 2015, Brazil was faced with the cocirculation of three arboviruses of major public health importance. The emergence of Zika virus (ZIKV) presents new challenges to both clinicians and public health authorities. Overlapping clinical features between diseases caused by ZIKV, Dengue (DENV) and Chikungunya (CHIKV) and the lack of validated serological assays for ZIKV make accurate diagnosis difficult.
   Methodology/Principal Findings
   The outpatient service for acute febrile illnesses in Fiocruz initiated a syndromic clinical observational study in 2007 to capture unusual presentations of DENV infections. In January 2015, an increase of cases with exanthematic disease was observed. Trained physicians evaluated the patients using a detailed case report form that included clinical assessment and laboratory investigations. The laboratory diagnostic algorithm included assays for detection of ZIKV, CHIKV and DENV. 364 suspected cases of Zika virus disease were identified based on clinical criteria between January and July 2015. Of these, 262 (71.9%) were tested and 119 (45.4%) were confirmed by the detection of ZIKV RNA. All of the samples with sequence information available clustered within the Asian genotype.
   Conclusions / Significance
   This is the first report of a ZIKV outbreak in the state of Rio de Janeiro, based on a large number of suspected (n = 364) and laboratory confirmed cases (n = 119). We were able to demonstrate that ZIKV was circulating in Rio de Janeiro as early as January 2015. The peak of the outbreak was documented in May/June 2015. More than half of the patients reported headache, arthralgia, myalgia, non-purulent conjunctivitis, and lower back pain, consistent with the case definition of suspected ZIKV disease issued by the Pan American Health Organization (PAHO). However, fever, when present, was low-intensity and short-termed. In our opinion, pruritus, the second most common clinical sign presented by the confirmed cases, should be added to the PAHO case definition, while fever could be given less emphasis. The emergence of ZIKV as a new pathogen for Brazil in 2015 underscores the need for clinical vigilance and strong epidemiological and laboratory surveillance.
C1 [Brasil, Patricia; Calvet, Guilherme Amaral; Siqueira, Andre Machado; Wakimoto, Mayumi; Lupi, Otilia; de Souza, Rogerio Valls; Romero, Carolina; Zogbi, Heruza; Bressan, Clarisse da Silveira] Oswaldo Cruz Fdn Fiocruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [de Sequeira, Patricia Carvalho; Lima de Mendonca, Marco Cesar; Alves, Simone Sampaio; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Oswaldo Cruz Fdn Fiocruz, Flavivirus Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Nobre, Aline; Carvalho, Marilia Sa] Oswaldo Cruz Fdn Fiocruz, Sci Computat Program, Rio De Janeiro, Brazil.
   [Borges Quintana, Marcel de Souza] Oswaldo Cruz Fdn Fiocruz, Clin Res Platform, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Lourenco-de-Oliveira, Ricardo] Oswaldo Cruz Fdn Fiocruz, Mosquito Transmitters Hematozoans Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Dis Res, Heidelberg, Germany.
RP Brasil, P (corresponding author), Oswaldo Cruz Fdn Fiocruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI CARVALHO, MARILIA/AAD-8283-2020; CARVALHO, MARILIA S/C-3425-2013;
   Jaenisch, Thomas/H-3473-2017; Siqueira, Andre M/G-1340-2010; Calvet,
   Guilherme/G-6959-2013
OI CARVALHO, MARILIA/0000-0002-9566-0284; Siqueira, Andre
   M/0000-0003-2208-0294; Calvet, Guilherme/0000-0002-3545-5238
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [484735/2013-6, 402135/2011-3]; Fundacao de Amparo a Pesquisa no Estado
   do Rio de Janeiro-FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E- 26/010.001558/2014];
   European CommissionEuropean Commission Joint Research Centre [FP7-21803
   IDAMS]
FX We thank the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq (grant no. 484735/2013-6 and 402135/2011-3), the
   Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro-FAPERJ (grant
   no. E- 26/010.001558/2014) and the European Commission, grant FP7-21803
   IDAMS (http://www.idams.eu), for having funded the study. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Besnard M, 2014, INCREASE CEREBRAL CO
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favaro EA, 2013, REV SAUDE PUBL, V47, P588, DOI 10.1590/S0034-8910.2013047004506
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, EURO SURVEILLANCE B, V19
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   R Core Team, 2015, R LANG ENV STAT COMP
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 144
Z9 145
U1 1
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004636
DI 10.1371/journal.pntd.0004636
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700064
PM 27070912
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lednicky, J
   De Rochars, VMB
   El Badry, M
   Loeb, J
   Telisma, T
   Chavannes, S
   Anilis, G
   Cella, E
   Ciccozzi, M
   Rashid, M
   Okech, B
   Salemi, M
   Morris, JG
AF Lednicky, John
   De Rochars, Valery Madsen Beau
   El Badry, Maha
   Loeb, Julia
   Telisma, Taina
   Chavannes, Sonese
   Anilis, Gina
   Cella, Eleonora
   Ciccozzi, Massimo
   Rashid, Mohammed
   Okech, Bernard
   Salemi, Marco
   Morris, J. Glenn, Jr.
TI Zika Virus Outbreak in Haiti in 2014: Molecular and Clinical Data
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE; ASSAY
AB Background
   Zika virus (ZIKV), first isolated in Uganda in 1947, is currently spreading rapidly through South America and the Caribbean. In Brazil, infection has been linked with microcephaly and other serious complications, leading to declaration of a public health emergency of international concern; however, there currently are only limited data on the virus (and its possible sources and manifestations) in the Caribbean.
   Methods
   From May, 2014-February, 2015, in conjunction with studies of chikungunya (CHIKV) and dengue (DENV) virus infections, blood samples were collected from children in the Gressier/Leogane region of Haiti who presented to a school clinic with undifferentiated febrile illness. Samples were initially screened by RT-PCR for CHIKV and DENV, with samples negative in these assays further screened by viral culture.
   Findings
   Of 177 samples screened, three were positive for ZIKV, confirmed by viral sequencing; DENV-1 was also identified in culture from one of the three positive case patients. Patients were from two different schools and 3 different towns, with all three cases occurring within a single week, consistent with the occurrence of an outbreak in the region. Phylogenetic analysis of known full genome viral sequences demonstrated a close relationship with ZIKV from Brazil; additional analysis of the NS5 gene, for which more sequences are currently available, showed the Haitian strains clustering within a monophyletic clade distinct from Brazilian, Puerto Rican and Guatemalan sequences, with all part of a larger clade including isolates from Easter Island. Phylogeography also clarified that at least three major African sub-lineages exist, and confirmed that the South American epidemic is most likely to have originated from an initial ZIKV introduction from French Polynesia into Easter Island, and then to the remainder of the Americas.
   Conclusions
   ZIKV epidemics in South America, as well as in Africa, show complex dissemination patterns. The virus appears to have been circulating in Haiti prior to the first reported cases in Brazil. Factors contributing to transmission and the possible linkage of this early Haitian outbreak with microcephaly remain to be determined.
C1 [Lednicky, John; De Rochars, Valery Madsen Beau; El Badry, Maha; Loeb, Julia; Telisma, Taina; Chavannes, Sonese; Anilis, Gina; Cella, Eleonora; Rashid, Mohammed; Okech, Bernard; Salemi, Marco; Morris, J. Glenn, Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Lednicky, John; El Badry, Maha; Loeb, Julia; Okech, Bernard] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [De Rochars, Valery Madsen Beau] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA.
   [Telisma, Taina; Chavannes, Sonese; Anilis, Gina] Christianville Fdn Sch Clin, Gressier, Haiti.
   [Cella, Eleonora; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Sci, Gainesville, FL USA.
   [Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Reference Ctr Phylogeny, Mol Epidemiol & Microbial Evolut FEMEM Epidemiol, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA.
RP Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.; Morris, JG (corresponding author), Univ Florida, Coll Med, Dept Med, Gainesville, FL USA.
EM jgmorris@epi.ufl.edu
RI Lednicky, John A/C-5678-2012; Elbadry, Maha Adel/AAH-4444-2020;
   CICCOZZI, MASSIMO/C-6484-2016; Cella, Eleonora/J-9961-2016
OI Elbadry, Maha Adel/0000-0002-6089-4523; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; Cella, Eleonora/0000-0002-7870-9744
FU University of FloridaUniversity of Florida
FX The authors received no funding outside of the University of Florida for
   the work described. Funding was from an internal University of Florida
   pilot grant fund. Funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   De Rochars VEMB, 2015, AM J TROP MED HYG, V92, P752, DOI 10.4269/ajtmh.14-0059
   Driggers RW, 2016, N ENGL J MED
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciotti RS, 2016, EMERG INFECT DIS
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
NR 28
TC 67
Z9 69
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004687
DI 10.1371/journal.pntd.0004687
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700089
PM 27111294
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bicheru, S
   Stefan, I
   Necsulescu, M
   Popescu, D
   Ionescu, L
   Dumitrescu, G
   Ordeanu, V
AF Bicheru, Simona
   Stefan, Ion
   Necsulescu, Marius
   Popescu, Diana
   Ionescu, Lucia
   Dumitrescu, Gabriela
   Ordeanu, Viorel
TI A new global threat for the public safety: Zika virus
SO ROMANIAN JOURNAL OF MILITARY MEDICINE
LA English
DT Review
DE Zika virus; Flaviviruses; microcephaly; Aedes aegypti; mosquitoes
AB Zika virus, the etiological agent of Zika fever, is transmitted by mosquitoes and has been affecting the South American continent starting with 2015. It was reported in several European countries, carried by the people who returned from Latin America, as reported by the health authorities in those countries. Today, according to the World Health Organization (WHO), the virus suspected to cause serious birth defects in the fetus has also been confirmed in 21 of the 55 countries of South America, but also in other states from Europe and North America. Zika virus is a single stranded positive sense RNA virus belonging to Flavivirus genus (family Flaviviridae) and was first identified in 1947 in Uganda rainforest Zika. The increased number of cases of microcephaly, in children from northern Brazil, suggested a connection with Zika virus, but it has not yet been proven. Also, the virus can be transmitted sexually and through blood or blood products. Diagnosis of the infection is made using Polymerase Chain Reaction (PCR). So far, there is no specific antiviral treatment or vaccine against the infection with Zika virus. The best form of prevention is to avoid mosquito bites. WHO has estimated that the spread of Zika virus, transmitted through mosquito bite, is "a global public health emergency". The priority is to protect pregnant women and to control the mosquitoes.
C1 [Bicheru, Simona; Necsulescu, Marius; Popescu, Diana; Ionescu, Lucia; Dumitrescu, Gabriela; Ordeanu, Viorel] Mil Med Res Ctr, Bucharest, Romania.
   [Stefan, Ion] Carol Davila Cent Univ, Emergency Mil Hosp, Bucharest, Romania.
   [Ordeanu, Viorel] Carol Davila Univ Med & Pharm, Bucharest, Romania.
RP Bicheru, S (corresponding author), Mil Med Res Ctr, Bucharest, Romania.
RI Bicheru, Nicoleta Simona/AAA-3527-2019; Ordeanu, Viorel V/F-1056-2011;
   Ionescu, Lucia Elena/AAA-2818-2019; Popescu, Diana
   Mihaela/AAA-1405-2019; Necsulescu, Marius/AAA-2848-2019; Dumitrescu,
   Gabriela Victoria/AAA-1398-2019
OI Dumitrescu, Gabriela Victoria/0000-0002-7823-4275
CR Aguiar Leonardo, MINISTERIO SAUDE CON
   Altman L. K., 2007, NY TIMES
   [Anonymous], 2016, PREGN IR WOM WARN ZI
   [Anonymous], EP UPD OUTBR ZIK VIR
   [Anonymous], 2016, MOSQ CAP CARR ZIK VI
   [Anonymous], QUEST ANSW OBST HEAL
   [Anonymous], 2015, RAP RISK ASS ZIK VIR, P14
   [Anonymous], 2016, ITV NEWS        0122
   [Anonymous], 2016, HLTH CAR PROV CLIN E
   [Anonymous], WHO DENG VACC RES
   [Anonymous], 2016, TRAV HLTH TRAV NOT
   [Anonymous], SYMPT DIAGN TREATM
   BBC, 2016, BBC
   Bennett John E., 2014, PRINCIPLES PRACTICE, P1881
   Cook J., 2016, BBC NEWS
   Darlington S, 2015, CNN
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Enserink M, 2011, SCI NEWS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foundation Thomson Reuters, FACTBOX ZIK VIR SPRE
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henry R, 2014, EMERG INFECT DIS, V20, P1090, DOI DOI 10.3201/EID2006.131508
   Knipe David M., 2007, FIELDS VIROLOGY, p[1156, 1199]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lowes R, 2016, CDC
   Maron Dina Fine, 1 DENGUE FEVER VACCI
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mitchell C., PAHO STATEMENT ZIKA
   Mitchell Cristina, ZIKA VIRUS SPREADS P
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rowlatt Justin, 2016, BBC NEWS
   Sternberg S., 2016, US NEWS WORLD REPORT
   Vogel Gretchen, 2015, SCI NEWS, DOI [10.1126/science.aad7527, DOI 10.1126/SCIENCE.AAD7527]
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 40
TC 0
Z9 0
U1 0
U2 1
PU CAROL DAVILA UNIV MEDICINE & PHARMACY PUBL
PI BUCHAREST
PA STR INST MEDICO-MILITAR, NR 3-5, SECTOR 1, BUCHAREST, 010919, ROMANIA
SN 1222-5126
EI 2501-2312
J9 ROM J MIL MED
JI Rom. J. Milit. Med.
PD APR
PY 2016
VL 119
IS 1
BP 18
EP 25
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA VF7LR
UT WOS:000443506800004
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Deng, YQ
   Zhao, H
   Li, XF
   Zhang, NN
   Liu, ZY
   Jiang, T
   Gu, DY
   Shi, L
   He, JA
   Wang, HJ
   Sun, ZZ
   Ye, Q
   Xie, DY
   Cao, WC
   Qin, CF
AF Deng, Yong-Qiang
   Zhao, Hui
   Li, Xiao-Feng
   Zhang, Na-Na
   Liu, Zhong-Yu
   Jiang, Tao
   Gu, Da-Yong
   Shi, Lei
   He, Jian-An
   Wang, Hong-Jiang
   Sun, Zhao-Zeng
   Ye, Qing
   Xie, Dong-Yang
   Cao, Wu-Chun
   Qin, Cheng-Feng
TI Isolation, identification and genomic characterization of the Asian
   lineage Zika virus imported to China
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Letter
ID AMERICA
C1 [Deng, Yong-Qiang; Zhao, Hui; Li, Xiao-Feng; Liu, Zhong-Yu; Jiang, Tao; Wang, Hong-Jiang; Ye, Qing; Cao, Wu-Chun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhang, Na-Na; Qin, Cheng-Feng] Guangxi Med Univ, Grad Sch, Xining 530021, Peoples R China.
   [Gu, Da-Yong; Shi, Lei; He, Jian-An] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen Travel Healthcare Ctr, Cent Lab Hlth Quarantine, Shenzhen 518033, Peoples R China.
   [Sun, Zhao-Zeng] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China.
   [Xie, Dong-Yang; Qin, Cheng-Feng] Anhui Med Univ, Grad Sch, Hefei 230032, Peoples R China.
RP Cao, WC; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), Guangxi Med Univ, Grad Sch, Xining 530021, Peoples R China.; Qin, CF (corresponding author), Anhui Med Univ, Grad Sch, Hefei 230032, Peoples R China.
EM caowc@bmi.ac.cn; qincf@bmi.ac.cn
RI Tao, Jiang/AAE-6623-2019; Qin, Cheng-Feng/I-6839-2019
OI Tao, Jiang/0000-0003-1908-2926; Qin, Cheng-Feng/0000-0002-0632-2807;
   Liu, Zhong-Yu/0000-0001-7385-5681
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Li X.F., 2016, SCI CHINA L IN PRESS, V59
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
NR 9
TC 67
Z9 70
U1 0
U2 14
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD APR
PY 2016
VL 59
IS 4
BP 428
EP 430
DI 10.1007/s11427-016-5043-4
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DJ3JQ
UT WOS:000374101500015
PM 26993654
OA Other Gold
DA 2020-07-08
ER

PT J
AU Li, XF
   Han, JF
   Shi, PY
   Qin, CF
AF Li, Xiao-Feng
   Han, Jian-Feng
   Shi, Pei-Yong
   Qin, Cheng-Feng
TI Zika virus: a new threat from mosquitoes
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Editorial Material
ID OUTBREAK; DENGUE; BRAZIL; CHINA
C1 [Li, Xiao-Feng; Han, Jian-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
   [Li, Xiao-Feng; Han, Jian-Feng; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Phamarcol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Phamarcol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.gov; qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, N ENGL J MED
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Pan American Health Organization, 2016, UPD NEUR SYNDR CONG
   Qin CF, 2014, SCI CHINA LIFE SCI, V57, P1230, DOI 10.1007/s11427-014-4783-2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Zhao H, 2014, SCI CHINA LIFE SCI, V57, P1149, DOI 10.1007/s11427-014-4782-3
NR 12
TC 13
Z9 13
U1 0
U2 19
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD APR
PY 2016
VL 59
IS 4
BP 440
EP 442
DI 10.1007/s11427-016-5020-y
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DJ3JQ
UT WOS:000374101500020
PM 26944581
OA Other Gold
DA 2020-07-08
ER

PT J
AU Papageorghiou, AT
   Thilaganathan, B
   Bilardo, CM
   Ngu, A
   Malinger, G
   Herrera, M
   Salomon, LJ
   Riley, LE
   Copel, JA
AF Papageorghiou, A. T.
   Thilaganathan, B.
   Bilardo, C. M.
   Ngu, A.
   Malinger, G.
   Herrera, M.
   Salomon, L. J.
   Riley, L. E.
   Copel, J. A.
TI ISUOG Interim Guidance on ultrasound for Zika virus infection in
   pregnancy: information for healthcare professionals
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Editorial Material
ID HEAD CIRCUMFERENCE; GUIDELINES; BRAZIL; BRAIN
C1 [Papageorghiou, A. T.; Thilaganathan, B.] St Georges Univ Fdn Hosp NHS Trust, Fetal Med Unit, London, England.
   [Papageorghiou, A. T.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Bilardo, C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet, Groningen, Netherlands.
   [Ngu, A.] East Melbourne Ultrasound, East Melbourne, Vic, Australia.
   [Malinger, G.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lis Matern Hosp,Div Ultrasound Obstet & Gynecol, IL-69978 Tel Aviv, Israel.
   [Herrera, M.] Colombian Univ Clin, Colsanitas Clin, Maternal Fetal Med Dept, Bogota, Colombia.
   [Salomon, L. J.] Univ Paris 05, Necker Enfants Malades Hosp, AP HP, Dept Obstet & Maternal Fetal Med, Paris, France.
   [Riley, L. E.] Massachusetts Gen Hosp, Obstet & Gynecol, Boston, MA 02114 USA.
   [Copel, J. A.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
RP Papageorghiou, AT (corresponding author), St Georges Univ Fdn Hosp NHS Trust, Fetal Med Unit, London, England.; Papageorghiou, AT (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Deloison B, 2012, PRENATAL DIAG, V32, P869, DOI 10.1002/pd.3923
   Interim guidance. World Health Organization, ASS INF MICR CONT ZI
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Royal College of Obstetricians & Gynaecologists, INT RCOG RCM PHE HPS
   Salomon LJ, 2013, ULTRASOUND OBST GYN, V41, P233, DOI 10.1002/uog.12407
   Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, WHO CHILD GROWTH STA
   World Health Organization, PREGN MAN CONT ZIK V
NR 17
TC 38
Z9 39
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD APR
PY 2016
VL 47
IS 4
BP 530
EP 532
DI 10.1002/uog.15896
PG 3
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DJ0SY
UT WOS:000373915900027
PM 26969966
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Deng, CL
   Liu, SQ
   Zhang, QY
   Xu, MY
   Zhang, HL
   Gu, DY
   Shi, L
   He, JA
   Xiao, GF
   Zhang, B
AF Deng, Chenglin
   Liu, Siqing
   Zhang, Qiuyan
   Xu, Mingyue
   Zhang, Honglei
   Gu, Dayong
   Shi, Lei
   He, Jian'an
   Xiao, Gengfu
   Zhang, Bo
TI Isolation and characterization of Zika virus imported to China using
   C6/36 mosquito cells
SO VIROLOGICA SINICA
LA English
DT Letter
C1 [Deng, Chenglin; Liu, Siqing; Zhang, Qiuyan; Xu, Mingyue; Zhang, Honglei; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
   [Zhang, Qiuyan; Xu, Mingyue; Zhang, Honglei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Gu, Dayong; Shi, Lei; He, Jian'an] Shenzhen Entry Exit Inspect & Quarantine Bur, Cent Lab Hlth Quarantine, Shenzhen Travel Healthcare Ctr, Shenzhen 518033, Peoples R China.
   [Xiao, Gengfu] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
RP Zhang, B (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
EM zhangbo@wh.iov.cn
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Gubler DJ, 2007, FIELDS VIROLOGY, P1154
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Li J, 2016, EMERG INFECT DIS, DOI [10.3201/eld2206.160273, DOI 10.3201/ELD2206.160273]
   Liu S-Q, 2016, VIROL SIN, V31, P1
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
NR 9
TC 30
Z9 31
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 176
EP 179
DI 10.1007/s12250-016-3778-5
PG 4
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800010
PM 27105638
OA Bronze
DA 2020-07-08
ER

PT J
AU Campos, RD
   Cirne-Santos, C
   Meira, GLS
   Santos, LLR
   de Meneses, MD
   Friedrich, J
   Jansen, S
   Ribeiro, MS
   Cruz, IC
   Schmidt-Chanasit, J
   Ferreira, DF
AF Campos, Renata de M.
   Cirne-Santos, Claudio
   Meira, Guilherme L. S.
   Santos, Luana L. R.
   de Meneses, Marcelo D.
   Friedrich, Johannes
   Jansen, Stephanie
   Ribeiro, Mario S.
   da Cruz, Igor C.
   Schmidt-Chanasit, Jonas
   Ferreira, Davis F.
TI Prolonged detection of Zika virus RNA in urine samples during the
   ongoing Zika virus epidemic in Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
ID INFECTION; TRAVEL
C1 [Campos, Renata de M.; Cirne-Santos, Claudio; Meira, Guilherme L. S.; Santos, Luana L. R.; de Meneses, Marcelo D.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [de Meneses, Marcelo D.; Ribeiro, Mario S.; da Cruz, Igor C.] Noel Nutels Cent Lab LACEN, Rio De Janeiro, Brazil.
   [Friedrich, Johannes; Jansen, Stephanie] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Ribeiro, Mario S.] Univ Fed Rio de Janeiro, Inst Publ Hlth, BR-21941 Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, Bochum, Germany.
RP Ferreira, DF (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Bloco 1,Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM davisf@micro.ufrj.br
RI Cirne-Santos, Claudio/T-4009-2019; Ferreira, Davis/D-9356-2014; Azevedo,
   Renata/V-3130-2019
OI Cirne-Santos, Claudio/0000-0001-8376-1830; 
CR Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 8
TC 73
Z9 74
U1 0
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2016
VL 77
BP 69
EP 70
DI 10.1016/j.jcv.2016.02.009
PG 2
WC Virology
SC Virology
GA DG0WR
UT WOS:000371787100014
PM 26921737
OA Bronze
DA 2020-07-08
ER

PT J
AU Drosten, C
AF Drosten, C.
TI Zika virus and congenital malformations in perspective
SO EUROSURVEILLANCE
LA English
DT Editorial Material
C1 [Drosten, C.] Univ Bonn, Inst Virol, Bonn, Germany.
   [Drosten, C.] Deutsch Zentrum Infekt Forsch, Bonn, Germany.
RP Drosten, C (corresponding author), Univ Bonn, Inst Virol, Bonn, Germany.; Drosten, C (corresponding author), Deutsch Zentrum Infekt Forsch, Bonn, Germany.
EM drosten@virology-bonn.de
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, N ENGL J MED
   Cauchemez S, 2016, LANCET
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Kindhauser MK, 2016, B WHO UNPUB
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Pan American Health Organization (PAHO) / World Health Organization Regional Office for the Americas (WHO), 2016, EP AL INCR MICR NE B
   Pan American Health Organization / World Health Organization, 2016, ZIK EP UPD 09 MARCH
   Rocha HAL, 2016, B WORLD HLTH O UNPUB, DOI [10.2471/BLT.16.171215, DOI 10.2471/BLT.16.171215]
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   WHO, 2016, B WHO
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 12
TC 0
Z9 0
U1 0
U2 35
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 31
PY 2016
VL 21
IS 13
BP 2
EP 4
AR 30182
DI 10.2807/1560-7917.ES.2016.21.13.30182
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DI1PS
UT WOS:000373268600001
PM 27055385
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Besnard, M
   Eyrolle-Guignot, D
   Guillemette-Artur, P
   Lastere, S
   Bost-Bezeaud, F
   Marcelis, L
   Abadie, V
   Garel, C
   Moutard, M
   Jouannic, J
   Rozenberg, F
   Leparc-Goffart, I
   Mallet, H
AF Besnard, M.
   Eyrolle-Guignot, D.
   Guillemette-Artur, P.
   Lastere, S.
   Bost-Bezeaud, F.
   Marcelis, L.
   Abadie, V.
   Garel, C.
   Moutard, M.
   Jouannic, J.
   Rozenberg, F.
   Leparc-Goffart, I.
   Mallet, H.
TI Congenital cerebral malformations and dysfunction in fetuses and
   newborns following the 2013 to 2014 Zika virus epidemic in French
   Polynesia
SO EUROSURVEILLANCE
LA English
DT Article
ID INFECTION; BRAIN; BRAZIL
AB We detected an unusual increase in congenital cerebral malformations and dysfunction in fetuses and newborns in French Polynesia, following an epidemic of Zika virus (ZIKV), from October 2013 to March 2014. A retrospective review identified 19 cases, including eight with major brain lesions and severe microcephaly, six with severe cerebral lesions without microcephaly and five with brainstem dysfunction without visible malformations. Imaging revealed profound neurological lesions (septal and callosal disruption, ventriculomegaly, abnormal neuronal migration, cerebellar hypoplasia, occipital pseudocysts, brain calcifications). Amniotic fluid was drawn from seven cases at gestation weeks 20 to 29. ZIKV RNA was detected by RT-PCR and infectious ZIKV isolates were obtained in four of five microcephalic, but not in two non-microcephalic cases with severe brain lesions. Medical termination of pregnancy was performed in eleven cases; two cases with brainstem dysfunction died in the first months of life; six cases are alive, with severe neurological impairment. The results show that four of seven tested fetuses with major neurological injuries were infected with ZIKV in utero. For other non-microcephalic, congenital abnormalities we were not able to prove or exclude ZIKV infection retrospectively. The unusual occurrence of brain malformations or dysfunction without microcephaly following a ZIKV outbreak needs further studies.
C1 [Besnard, M.] CHPF, Serv Reanimat Neonatale, Pirae, France.
   [Eyrolle-Guignot, D.] CHPF, Serv Obstet, Pirae, France.
   [Guillemette-Artur, P.] CHPF, Serv Radiol, Pirae, France.
   [Lastere, S.] CHPF, Med Biol Lab, Pirae, France.
   [Bost-Bezeaud, F.] CHPF, Lab Anat Pathol, Pirae, France.
   [Marcelis, L.; Mallet, H.] Direct Sante, Bur Veille Sanit, Papeete, France.
   [Abadie, V.] Hop Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France.
   [Garel, C.] Hop Armand Trousseau, AP HP, Serv Radiol, Paris, France.
   [Moutard, M.] Hop Armand Trousseau, AP HP, Serv Neuropediat, Paris, France.
   [Jouannic, J.] Hop Armand Trousseau, AP HP, Serv Med Foetale, Paris, France.
   [Rozenberg, F.] Hop Cochin, AP HP, Serv Virol, 27 Rue Faubourg St Jacques, F-75674 Paris, France.
   [Leparc-Goffart, I.] IRBA, Ctr Natl Reference Arbovirus, Marseille, France.
RP Besnard, M (corresponding author), CHPF, Serv Reanimat Neonatale, Pirae, France.
EM mbesnard@nohao.net
RI Rozenberg, Flore/O-8854-2017; Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480
CR Abadie V, 2002, EUR J PEDIATR, V161, P275, DOI 10.1007/s00431-002-0936-6
   Abadie V, 2013, HAND CLINIC, V113, P1539, DOI 10.1016/B978-0-444-59565-2.00024-1
   Association des Utilisateurs de Dossiers Informatises en Pediatrie, HEAD CIRC CHARTS
   Besnard M, INCREASE CEREBRAL CO
   Esteban H, 2015, ULTRASOUND OBST GYN, V46, P678, DOI 10.1002/uog.14820
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Haute Autorite de Sante (HAS), 2007, SUIV OR FEMM ENC FON
   Holder-Espinasse M, 2001, J PEDIATR-US, V139, P588, DOI 10.1067/mpd.2001.117784
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kucharski AJ, 2016, BIORXIV, P7, DOI [10. 1101/ 038588, DOI 10.1101/038588]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL INCR MICR NE B
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   World Health Organization, 2016, INT STAT CLASS DIS R
NR 19
TC 79
Z9 80
U1 0
U2 0
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 31
PY 2016
VL 21
IS 13
BP 22
EP 30
AR 30181
DI 10.2807/1560-7917.ES.2016.21.13.30181
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DI1PS
UT WOS:000373268600004
PM 27063794
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Couples at risk from exposure to Zika virus should consider delaying
   pregnancy, says CDC
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Oster AM, 2016, MMWR MORB MORTAL WKL
   Petersen E. E., 2016, MMWR MORB MORTAL WKL, P65
NR 2
TC 1
Z9 1
U1 0
U2 39
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 30
PY 2016
VL 352
AR i1813
DI 10.1136/bmj.i1813
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI4TO
UT WOS:000373492400019
PM 27029872
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Vogel, G
AF Vogel, Gretchen
TI INFECTIOUS DISEASE Don't blame sports for Zika's spread
SO SCIENCE
LA English
DT News Item
NR 0
TC 4
Z9 4
U1 0
U2 9
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAR 25
PY 2016
VL 351
IS 6280
BP 1377
EP 1378
DI 10.1126/science.351.6280.1377
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH4KZ
UT WOS:000372756200012
PM 27013706
DA 2020-07-08
ER

PT J
AU Armstrong, P
   Hennessey, M
   Adams, M
   Cherry, C
   Chiu, S
   Harrist, A
   Kwit, N
   Lewis, L
   McGuire, DO
   Oduyebo, T
   Russell, K
   Talley, P
   Tanner, M
   Williams, C
AF Armstrong, Paige
   Hennessey, Morgan
   Adams, Monica
   Cherry, Cara
   Chiu, Sophia
   Harrist, Alexia
   Kwit, Natalie
   Lewis, Lillianne
   McGuire, Dana Olzenak
   Oduyebo, Titilope
   Russell, Kate
   Talley, Pamela
   Tanner, Mary
   Williams, Charnetta
CA Zika Virus Response Epidemiology
TI Travel-Associated Zika Virus Disease Cases Among US Residents - United
   States, January 2015-February 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDELINES; INFECTION
C1 [Armstrong, Paige; Hennessey, Morgan; Adams, Monica; Cherry, Cara; Chiu, Sophia; Harrist, Alexia; Kwit, Natalie; Lewis, Lillianne; McGuire, Dana Olzenak; Oduyebo, Titilope; Russell, Kate; Talley, Pamela; Tanner, Mary; Williams, Charnetta] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
RP Armstrong, P (corresponding author), Care of Fischer M, Zika Virus Response Epidemiol & Lab Team, New York, NY USA.
EM mfischer@cdc.gov
OI Russell, Kate/0000-0001-9343-3355; Lewis, Lillianne/0000-0002-0957-2190
CR Cao-Lormeau V. M., 2016, LANCET
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
NR 10
TC 43
Z9 43
U1 0
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 25
PY 2016
VL 65
IS 11
BP 286
EP 289
DI 10.15585/mmwr.mm6511e1
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH4CS
UT WOS:000372733700005
PM 27023833
OA Bronze
DA 2020-07-08
ER

PT J
AU Olson, CK
   Iwamoto, M
   Perkins, KM
   Polen, KND
   Hageman, J
   Meaney-Delman, D
   Igbinosa, II
   Khan, S
   Honein, MA
   Bell, M
   Rasmussen, SA
   Jamieson, DJ
AF Olson, Christine K.
   Iwamoto, Martha
   Perkins, Kiran M.
   Polen, Kara N. D.
   Hageman, Jeffrey
   Meaney-Delman, Dana
   Igbinosa, Irogue I.
   Khan, Sumaiya
   Honein, Margaret A.
   Bell, Michael
   Rasmussen, Sonja A.
   Jamieson, Denise J.
TI Preventing Transmission of Zika Virus in Labor and Delivery Settings
   Through Implementation of Standard Precautions - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Olson, Christine K.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Iwamoto, Martha] CDC, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Perkins, Kiran M.; Hageman, Jeffrey; Bell, Michael] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Polen, Kara N. D.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Off Director, Atlanta, GA 30333 USA.
   [Igbinosa, Irogue I.] CDC, Ctr Surveillance Epidemiol & Lab Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Khan, Sumaiya] CDC, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Ctr Surveillance Epidemiol & Lab Serv, Div Publ Hlth Informat Disseminat, Atlanta, GA 30333 USA.
RP Olson, CK (corresponding author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, NEW ENGL J MED
   Cao-Lormeau V M, 2016, LANCET
   Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   KOURI DL, 1993, AM J OBSTET GYNECOL, V169, P312, DOI 10.1016/0002-9378(93)90081-S
   Likis FE, 2015, MANAGEMENT POSTPARTU
   Mischke C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009573.pub2
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Sandlin AT, 2014, ARCH GYNECOL OBSTET, V289, P967, DOI 10.1007/s00404-013-3087-2
   Siegel JD, 2007, 2007 GUIDELINE ISOLA
NR 11
TC 22
Z9 24
U1 0
U2 12
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 25
PY 2016
VL 65
IS 11
BP 290
EP 292
DI 10.15585/mmwr.mm6511e3
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH4CS
UT WOS:000372733700006
PM 27010422
OA Bronze
DA 2020-07-08
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI WHO's Chan warns over spread of Zika virus beyond Latin America
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 6
Z9 6
U1 0
U2 13
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 24
PY 2016
VL 352
AR i1739
DI 10.1136/bmj.i1739
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH8LN
UT WOS:000373044800017
PM 27012725
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Omer, SB
   Beigi, RH
AF Omer, Saad B.
   Beigi, Richard H.
TI Pregnancy in the Time of Zika Addressing Barriers for Developing
   Vaccines and Other Measures for Pregnant Women
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID MATERNAL IMMUNIZATION; PEDIATRIC RESEARCH; LIABILITY ISSUES
C1 [Omer, Saad B.] Emory Univ, Dept Global Hlth, Atlanta, GA 30322 USA.
   [Omer, Saad B.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Omer, Saad B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.
   [Beigi, Richard H.] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA.
   [Omer, Saad B.] 1518 Clifton Rd NE,Room 7017 CNR Bldg, Atlanta, GA 30322 USA.
RP Omer, SB (corresponding author), 1518 Clifton Rd NE,Room 7017 CNR Bldg, Atlanta, GA 30322 USA.
EM somer@emory.edu
CR Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8
   Fulton TR, 2015, VACCINE, V33, P6453, DOI 10.1016/j.vaccine.2015.08.043
   Gruber MF, 2015, VACCINE, V33, P6499, DOI 10.1016/j.vaccine.2015.05.107
   Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Paradiso PR, 2001, VACCINE, V20, pS73, DOI 10.1016/S0264-410X(01)00302-4
   Ren ZX, 2015, SEMIN PERINATOL, V39, P530, DOI 10.1053/j.semperi.2015.08.006
   Shah S, 2004, JAMA-J AM MED ASSOC, V291, P476, DOI 10.1001/jama.291.4.476
   Trannoy E, 1998, VACCINE, V16, P1482, DOI 10.1016/S0264-410X(98)80005-4
NR 9
TC 20
Z9 20
U1 0
U2 9
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAR 22
PY 2016
VL 315
IS 12
BP 1227
EP 1228
DI 10.1001/jama.2016.2237
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH0YQ
UT WOS:000372511100003
PM 26914692
OA Bronze
DA 2020-07-08
ER

PT J
AU Anaya, JM
   Ramirez-Santana, C
   Salgado-Castaneda, I
   Chang, C
   Ansari, A
   Gershwin, ME
AF Anaya, Juan-Manuel
   Ramirez-Santana, Carolina
   Salgado-Castaneda, Ignacio
   Chang, Christopher
   Ansari, Aftab
   Gershwin, M. Eric
TI Zika virus and neurologic autoimmunity: the putative role of
   gangliosides
SO BMC MEDICINE
LA English
DT Editorial Material
DE Autoimmunity; Gangliosides; Guillain-Barre syndrome; Microcephaly; Zika
   virus
ID GUILLAIN-BARRE-SYNDROME; NERVOUS-SYSTEM; ANTIBODIES; INFECTION
AB An increasing number of severe neurological complications associated with Zika virus (ZIKV), chiefly Guillain-Barre syndrome (GBS) and primary microcephaly, have led the World Health Organization to declare a global health emergency. Molecular mimicry between glycolipids and surface molecules of infectious agents explain most of the cases of GBS preceded by infection, while a direct toxicity of ZIKV on neural cells has been raised as the main mechanism by which ZIKV induces microcephaly. Gangliosides are crucial in brain development, and their expression correlates with neurogenesis, synaptogenesis, synaptic transmission, and cell proliferation. Targeting the autoimmune response to gangliosides may represent an underexploited opportunity to examine the increased incidence of neurological complications related to ZIKV infection.
C1 [Anaya, Juan-Manuel; Ramirez-Santana, Carolina] Univ Rosario, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
   [Salgado-Castaneda, Ignacio] Hosp Cent Policia, Serv Neurol, Bogota, Colombia.
   [Chang, Christopher; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
   [Ansari, Aftab] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Anaya, JM (corresponding author), Univ Rosario, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
EM anayajm@gmail.com
RI Anaya, Juan-Manuel/J-1960-2016; Ramirez-Santana, Carolina/J-2363-2016
OI Anaya, Juan-Manuel/0000-0002-6444-1249; Ramirez-Santana,
   Carolina/0000-0003-2137-4899
CR Anaya J.-M., 2013, AUTOIMMUNITY
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau V. M., 2016, LANCET
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Christofferson RC, 2016, AM J TROP MED HYG
   Dalakas MC, 2015, BBA-MOL BASIS DIS, V1852, P658, DOI 10.1016/j.bbadis.2014.06.013
   Denman AM, 2004, AUTOIMMUN REV, V3, P355, DOI 10.1016/j.autrev.2004.03.001
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ghiulai RM, 2014, GLYCOCONJUGATE J, V31, P231, DOI 10.1007/s10719-014-9517-y
   Kivity S, 2014, J AUTOIMMUN, V51, P17, DOI 10.1016/j.jaut.2014.02.008
   Kolter T., 2012, ISRN BIOCH, V2012, DOI DOI 10.5402/2012/506160
   Kostovic I, 2003, GUIDANCE CUES DEV BR
   Lardone RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19901
   Lazear H. M., 2016, J VIROL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2016, LANCET INFECT DIS
   Nahmias AJ, 2006, CLIN DEV IMMUNOL, V13, P167, DOI 10.1080/17402520600801745
   Tang H, 2016, CELL STEM CELL
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 24
TC 39
Z9 41
U1 0
U2 33
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD MAR 21
PY 2016
VL 14
AR 49
DI 10.1186/s12916-016-0601-y
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI0GI
UT WOS:000373173200001
PM 27001187
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rafiei, N
   Hajkowicz, K
   Redmond, A
   Taylor, C
AF Rafiei, Nastaran
   Hajkowicz, Krispin
   Redmond, Andrew
   Taylor, Carmel
TI First report of Zika virus infection in a returned traveller from the
   Solomon Islands
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Editorial Material
C1 [Rafiei, Nastaran; Hajkowicz, Krispin; Redmond, Andrew] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia.
   [Taylor, Carmel] Queensland Hlth Forens & Sci Serv, Brisbane, Qld, Australia.
RP Rafiei, N (corresponding author), Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia.
EM nastaran.rafiei@uqconnect.edu.au
RI Redmond, Andrew/S-4559-2016
OI Redmond, Andrew/0000-0002-1125-5362; Taylor, Carmel/0000-0001-6283-2695
CR Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 7
TC 5
Z9 5
U1 0
U2 3
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD MAR 21
PY 2016
VL 204
IS 5
BP 186
EP +
DI 10.5694/mja15.01275
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FG6XU
UT WOS:000410543600016
PM 26985845
DA 2020-07-08
ER

PT J
AU Maurice, J
AF Maurice, John
TI WHO meeting thrashes out R&D strategy against Zika
SO LANCET
LA English
DT Editorial Material
NR 0
TC 4
Z9 5
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 19
PY 2016
VL 387
IS 10024
BP 1147
EP 1147
DI 10.1016/S0140-6736(16)30012-5
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG9OB
UT WOS:000372412000010
PM 27025322
OA Bronze
DA 2020-07-08
ER

PT J
AU Tickell, O
AF Tickell, Oliver
TI Feedback on The Ecologist and Zika
SO NEW SCIENTIST
LA English
DT Letter
NR 0
TC 0
Z9 0
U1 0
U2 0
PU REED BUSINESS INFORMATION LTD
PI SUTTON
PA QUADRANT HOUSE THE QUADRANT, SUTTON SM2 5AS, SURREY, ENGLAND
SN 0262-4079
J9 NEW SCI
JI New Sci.
PD MAR 19
PY 2016
VL 229
IS 3065
BP 52
EP 53
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG9IA
UT WOS:000372394800034
DA 2020-07-08
ER

PT J
AU Cetron, M
AF Cetron, Martin
TI Revision to CDC's Zika Travel Notices: Minimal Likelihood for
   Mosquito-Borne Zika Virus Transmission at Elevations Above 2,000 Meters
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
C1 [Cetron, Martin] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Cetron, M (corresponding author), CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM MCetron@cdc.gov
CR Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Danielson J. J., 2011, GLOBAL MULTIRESOLUTI
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   GARNHAM PCC, 1945, BRIT MED J, V2, P45, DOI 10.1136/bmj.2.4410.45
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Pan American Health Organization-World Health Organization-Regional Office for the Americas, 2015, EP AL ZIK VIR INF 20
NR 9
TC 12
Z9 13
U1 0
U2 13
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 18
PY 2016
VL 65
IS 10
BP 267
EP 268
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DG5SX
UT WOS:000372140000004
PM 26985965
OA Bronze
DA 2020-07-08
ER

PT J
AU Logan, IS
AF Logan, Ian S.
TI ZIKA-How fast does this virus mutate?
SO ZOOLOGICAL RESEARCH
LA English
DT Article
AB The World Health Organization has declared the present Zika virus epidemic to be a 'Public Health Emergency of International Concern'. The virus appears to have spread from Thailand to French Polynesia in 2013, and has since infected over a million people in the countries of South and Central America. In most cases the infection is mild and transient, but the virus does appear to be strongly neurotropic and the presumptive cause of both birth defects in fetuses and Guillain-Barre syndrome in some adults. In this paper, the techniques and utilities developed in the study of mitochondrial DNA were applied to the Zika virus. As a result, it is possible to show in a simple manner how a phylogenetic tree may be constructed and how the mutation rate of the virus can be measured. The study showed the mutation rate to vary between 12 and 25 bases a year, in a viral genome of 10 272 bases. This rapid mutation rate will enable the geographic spread of the epidemic to be monitored easily and may also prove useful in assisting the identification of preventative measures that are working, and those that are not.
C1 [Logan, Ian S.] 22 Parkside Dr, Exmouth EX8 4LB, Devon, England.
RP Logan, IS (corresponding author), 22 Parkside Dr, Exmouth EX8 4LB, Devon, England.
EM ianlogan22@btinternet.com
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Khan NA, 2011, N AM J MED SCI, V3, P428, DOI 10.4297/najms.2011.3428
   Korff C., 2013, GUILLAIN BARRE SYNDR
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Logan I., 2015, CALCULATING HUMAN MU
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   OXFORD JS, 1970, NATURE, V226, P82, DOI 10.1038/226082a0
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Willison HJ, 2016, LANCET
   Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Yang M, 2015, JAPANESE J INFECT DI, DOI [10.7883/yoken.JJID.2015.104, DOI 10.7883/Y0KEN.JJID.2015.104]
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zhou ZH, 2014, CURR OPIN VIROL, V5, P111, DOI 10.1016/j.coviro.2014.04.001
NR 26
TC 14
Z9 16
U1 1
U2 14
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 2095-8137
J9 ZOOL RES
JI Zool. Res.
PD MAR 18
PY 2016
VL 37
IS 2
BP 110
EP 115
PG 6
WC Zoology
SC Zoology
GA DH0YT
UT WOS:000372511500008
PM 27029869
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Nabel, GJ
   Zerhouni, EA
AF Nabel, Gary J.
   Zerhouni, Elias A.
TI Once and future epidemics: Zika virus emerging
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Editorial Material
ID AMERICA
C1 [Nabel, Gary J.] Sanofi, Global Res & Dev R&D, 640 Mem Dr, Cambridge, MA 02139 USA.
   [Zerhouni, Elias A.] Sanofi, Global R&D, F-75008 Paris, France.
RP Nabel, GJ (corresponding author), Sanofi, Global Res & Dev R&D, 640 Mem Dr, Cambridge, MA 02139 USA.
EM gary.nabel@sanofi.com
CR Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Marcondes C. B., 2015, REV SOC BRAS MED TRO, V22
   Rubin E. J., 2016, N ENGL J MED, V10
   The World Bank, 2013, PAND RISK ON HLTH
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
NR 7
TC 3
Z9 3
U1 0
U2 68
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD MAR 16
PY 2016
VL 8
IS 330
AR 330ed2
DI 10.1126/scitranslmed.aaf4548
PG 3
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA DG4YS
UT WOS:000372079700001
PM 27089202
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhu, Z
   Chan, JFW
   Tee, KM
   Choi, GKY
   Lau, SKP
   Woo, PCY
   Tse, H
   Yuen, KY
AF Zhu, Zheng
   Chan, Jasper Fuk-Woo
   Tee, Kah-Meng
   Choi, Garnet Kwan-Yue
   Lau, Susanna Kar-Pui
   Woo, Patrick Chiu-Yat
   Tse, Herman
   Yuen, Kwok-Yung
TI Comparative genomic analysis of pre-epidemic and epidemic Zika virus
   strains for virological factors potentially associated with the rapidly
   expanding epidemic
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE arbovirus; flavivirus; genome; microcephaly; mosquito; mutation; virus;
   Zika
ID WEST-NILE-VIRUS; NONSTRUCTURAL PROTEIN NS1; AMINO-ACID SUBSTITUTION;
   DENGUE VIRUS; SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION; CORE
   PROTEIN; REGION; MUTATION; NS4B
AB Less than 20 sporadic cases of human Zika virus (ZIKV) infection were reported in Africa and Asia before 2007, but large outbreaks involving up to 73% of the populations on the Pacific islands have started since 2007, and spread to the Americas in 2014. Moreover, the clinical manifestation of ZIKV infection has apparently changed, as evident by increasing reports of neurological complications, such as Guillain-Barre syndrome in adults and congenital anomalies in neonates. We comprehensively compared the genome sequences of pre-epidemic and epidemic ZIKV strains with complete genome or complete polyprotein sequences available in GenBank. Besides the reported phylogenetic clustering of the epidemic strains with the Asian lineage, we found that the topology of phylogenetic tree of all coding regions is the same except that of the non-structural 2B (NS2B) coding region. This finding was confirmed by bootscan analysis and multiple sequence alignment, which suggested the presence of a fragment of genetic recombination at NS2B with that of Spondweni virus. Moreover, the representative epidemic strain possesses one large bulge of nine bases instead of an external loop on the first stem-loop structure at the 3'-untranslated region just distal to the stop codon of the NS5 in the 1947 pre-epidemic prototype strain. Fifteen amino acid substitutions are found in the epidemic strains when compared with the pre-epidemic strains. As mutations in other flaviviruses can be associated with changes in virulence, replication efficiency, antigenic epitopes and host tropism, further studies would be important to ascertain the biological significance of these genomic changes.
C1 [Zhu, Zheng; Chan, Jasper Fuk-Woo; Tee, Kah-Meng; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Choi, Garnet Kwan-Yue; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JFW (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW (corresponding author), Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
RI Chan, Jasper F. W./D-8007-2013; Lau, Susanna Kar Pui/AAJ-6848-2020; ZHU,
   ZHENG/P-2173-2016; Woo, Patrick Chiu Yat/AAJ-6112-2020
OI Chan, Jasper F. W./0000-0001-6336-6657; Lau, Susanna Kar
   Pui/0000-0002-1383-7374; ZHU, ZHENG/0000-0002-2035-0804; Woo, Patrick
   Chiu Yat/0000-0001-9401-1832; Yuen, Kwok-yung/0000-0002-2083-1552
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Disease of the Department of Health, the Food and Health
   Bureau, Hong Kong Special Administrative Region, China; Key Laboratory
   of Medical Molecular Virology, Fudan University; Croucher Senior Medical
   Research Fellowship; Strategic Research Theme Fund, The University of
   Hong Kong; Mr Larry Chi-Kin Yung and Hui Hoy & Chow Sin Lan Charity Fund
   Limited
FX We thank James Cai (Department of Veterinary Integrative Biosciences,
   Texas A&M University) and Yu-Mei Wen (Key Laboratory of Medical
   Molecular Virology, Fudan University) for facilitation of the study. The
   study was partly supported by the Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Disease of the Department
   of Health, the Food and Health Bureau, Hong Kong Special Administrative
   Region, China; the Key Laboratory of Medical Molecular Virology, Fudan
   University; the Croucher Senior Medical Research Fellowship; and the
   Strategic Research Theme Fund, The University of Hong Kong; and by the
   donations of Mr Larry Chi-Kin Yung and Hui Hoy & Chow Sin Lan Charity
   Fund Limited. The funding sources had no role in study design; data
   collection, analysis or interpretation; or writing of the report. Jasper
   Fuk-Woo Chan and Kwok-Yung Yuen had full access to all the data in the
   study and had final responsibility for the decision to submit for
   publication.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Freire CCM, 2015, BIORXIV
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jia F, 2016, VIROLOGY, V490, P109, DOI 10.1016/j.virol.2016.01.001
   Lau SKP, 2011, J VIROL, V85, P11325, DOI 10.1128/JVI.05512-11
   Lin HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100130
   Lin YJ, 2005, J VIROL, V79, P8535, DOI 10.1128/JVI.79.13.8535-8544.2005
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0
   Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Wicker JA, 2012, VIROLOGY, V426, P22, DOI 10.1016/j.virol.2011.11.022
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-138
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 59
TC 113
Z9 115
U1 3
U2 56
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 16
PY 2016
VL 5
AR e22
DI 10.1038/emi.2016.48
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DJ0IO
UT WOS:000373885900001
PM 26980239
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jacob, JA
AF Jacob, Julie A.
TI Researchers Focus on Solving the Zika Riddles
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
CR Alout H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-417
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 5
TC 3
Z9 3
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAR 15
PY 2016
VL 315
IS 11
BP 1097
EP 1099
DI 10.1001/jama.2016.1219
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG5ZB
UT WOS:000372159800002
PM 26914596
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI US health officials press Congress for Zika funds
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 2
Z9 2
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 15
PY 2016
VL 352
AR i1545
DI 10.1136/bmj.i1545
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH1ZT
UT WOS:000372584400025
PM 26979935
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU MacFadden, DR
   Bogoch, II
AF MacFadden, Derek R.
   Bogoch, Isaac I.
TI Zika virus infection
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Editorial Material
C1 [MacFadden, Derek R.; Bogoch, Isaac I.] Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   [MacFadden, Derek R.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
RP MacFadden, DR (corresponding author), Univ Toronto, Div Infect Dis, Toronto, ON, Canada.; MacFadden, DR (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
EM derek.macfadden@mail.utoronto.ca
CR Bogoch I, 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
NR 3
TC 2
Z9 3
U1 0
U2 74
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
EI 1488-2329
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD MAR 15
PY 2016
VL 188
IS 5
BP 367
EP 367
DI 10.1503/cmaj.151486
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG1NS
UT WOS:000371835400003
PM 26858352
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Barnosky, AD
   Ehrlich, PR
   Hadly, EA
AF Barnosky, Anthony D.
   Ehrlich, Paul R.
   Hadly, Elizabeth A.
TI Avoiding collapse: Grand challenges for science and society to solve by
   2050
SO ELEMENTA-SCIENCE OF THE ANTHROPOCENE
LA English
DT Article
ID CLIMATE-CHANGE; HUMAN APPROPRIATION; PLASTIC DEBRIS; FOOD SECURITY;
   MICROPLASTICS; EXTINCTION; FUTURE; ACIDIFICATION; ANTHROPOCENE;
   CONSEQUENCES
AB We maintain that humanity's grand challenge is solving the intertwined problems of human population growth and overconsumption, climate change, pollution, ecosystem destruction, disease spillovers, and extinction, in order to avoid environmental tipping points that would make human life more difficult and would irrevocably damage planetary life support systems. These are not future issues: for example, detrimental impacts of climate change (increased wildfires and extreme weather, sea-level rise, ocean acidification), pollution (contaminated drinking water in many parts of the world), rapid population growth in some areas (contributing to poverty, war, and increasingly frequent migration) and overconsumption in others (a main driver of overexploitation of resources and greenhouse gas emissions), and new disease outbreaks (Ebola, Zika virus) already are apparent today, and if trends of the past half century continue, even more damaging, long-lasting impacts would be locked in within three decades. Solving these problems will require some scientific and technological breakthroughs, but that will not be enough. Even more critical will be effective collaboration of environmental and physical scientists with social scientists and those in the humanities, active exchange of information among practitioners in academics, politics, religion, and business and other stakeholders, and clear communication of relevant issues and solutions to the general public. This special feature offers examples of how researchers are addressing this grand challenge through the process of discovering new knowledge and relevant tools, transferring insights across disciplinary boundaries, and establishing critical dialogues with those outside academia to help effect positive global change.
C1 [Barnosky, Anthony D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.
   [Barnosky, Anthony D.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.
   [Barnosky, Anthony D.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.
   [Ehrlich, Paul R.; Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA.
RP Barnosky, AD (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.; Barnosky, AD (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.; Barnosky, AD (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.
EM barnosky@berkeley.edu
CR Abdi AM, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/094003
   Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030
   Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206
   Barnes DKA, 2010, MAR ENVIRON RES, V70, P250, DOI 10.1016/j.marenvres.2010.05.006
   Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205
   Barnosky AD, 2015, END GAME TIPPING POI
   Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105
   Barnosky AD, 2014, ANTHROPOCENE REV, V1, P78, DOI 10.1177/2053019613516290
   Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018
   Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678
   Barnosky Anthony D., 2014, DODGING EXTINCTION P
   Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698
   Berner RA, 2003, NATURE, V426, P323, DOI 10.1038/nature02131
   Blois JL, 2009, ANN REV EARTH PLANET, V37, P81
   Brown JH, 2011, BIOSCIENCE, V61, P19, DOI 10.1525/bio.2011.61.1.7
   Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148
   Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100
   Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253
   Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]
   CNA, 2014, NAT SEC ACC RISKS CL
   CNA Corporation, 2007, NAT SEC THREAT CLIM
   Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025
   Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395
   David Quammen, 2012, SPILLOVER ANIMAL INF
   Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1
   DePaolo D. J., 2008, ORIGIN EVOLUTION EAR
   Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401
   Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123
   Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532
   Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845
   Ehrlich PR, 2012, NATURE, V486, P68, DOI 10.1038/nature11157
   Fendall LS, 2009, MAR POLLUT BULL, V58, P1225, DOI 10.1016/j.marpolbul.2009.04.025
   Field C. B., 2012, MANAGING RISKS EXTRE, P1, DOI DOI 10.1017/CB09781139177245
   Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772
   Foley JA, 2011, SCI AM, V305, P60, DOI 10.1038/scientificamerican1111-60
   Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452
   Food and Agriculture Organization of the United Nations, 2012, STAT FOOD INS WORLD
   Food and Agriculture Organization of the United Nations, 2015, M 2015 INT HUNG TARG
   Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010
   GFN, 2013, GLOB FOOTPR NETW ADV
   Gibbons M, 1999, NATURE, V402, pC81, DOI 10.1038/35011576
   Gower R, 2012, OXFAM BRIEFING PAPER, V157, P1
   Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104
   Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932
   Hoekstra JM, 2010, ATLAS GLOBAL CONSERV
   Hooke R. LeB, 2012, GSA TODAY, V22, P4, DOI DOI 10.1130/GSAT151A.1
   Husbands J. L., 2012, CLIMATE SOCIAL STRES
   IPCC, 2014, SUMM POL
   IPCC, 2013, SUMM POL
   IPCC, 2007, INT PAN CLIM CHANG 4
   Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199
   Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105
   Kienk NL, 2015, SCIENCE, V350, P743, DOI 10.1126/science.aab1495
   LEACH M, 2013, SOCIAL PLANETARY BOU, V2013, P84, DOI DOI 10.1787/9789264203419-10-EN
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679
   Living Planet Rport, 2012, LIV PLAN REP 2012 BI
   Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339
   McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641
   Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661
   Moore FC, 2014, NAT CLIM CHANGE, V4, P610, DOI [10.1038/nclimate2228, 10.1038/NCLIMATE2228]
   Mychajliw AM, 2015, ANTHROPOCENE REV, V2, P267, DOI 10.1177/2053019615601444
   Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024
   Ng KL, 2006, MAR POLLUT BULL, V52, P761, DOI 10.1016/j.marpolbul.2005.11.017
   PAS and PASS, 2014, P JOINT WORKSH EXTR, V41
   Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752
   Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103
   PRB, 2015, WORLD POP DAT SHEET
   Qiu J, 2013, NATURE, V493, P144, DOI 10.1038/493144a
   Ramanathan V, 2015, EXECUTIVE SUMMARY RE
   Raworth K., 2012, OXFAM DISCUSSION PAP, V2012, P1, DOI DOI 10.1080/00420980120087081
   Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428
   Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a
   Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620
   Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207
   Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL 3
   Shah A, 2013, POVERTY FACTS SATS
   Shah A, 2011, HLTH ISSUES
   Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107
   Smil V, 2011, POPUL DEV REV, V37, P613, DOI 10.1111/j.1728-4457.2011.00450.x
   Smith WK, 2012, BIOSCIENCE, V62, P911, DOI 10.1525/bio.2012.62.10.11
   Staff BI, 2012, WORLDS WORST POLLUTI
   Steffen W, 2011, AMBIO, V40, P739, DOI 10.1007/s13280-011-0185-x
   TERCEK MARK R., 2013, NATURES FORTUNE BUSI
   Trnka M, 2014, NAT CLIM CHANGE, V4, P637, DOI [10.1038/nclimate2242, 10.1038/NCLIMATE2242]
   Tyrrell T, 2011, PHILOS T R SOC A, V369, P887, DOI [10.1098/rsta.2010.0334, 10.1098/rsta.2010.0331]
   UNDESA, 2013, WORLD POP PROSP 2012, VII
   UNDESA, 2013, WORLD POP PROSP 2012, VI
   Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984
   Vatican, 2015, ENC LETT LAUD SI HOL
   VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258
   Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494
   WBSCD, 2013, VIS 2050
   WBSCD, 2013, VIS 2050 ACT 2020
   West PC, 2014, SCIENCE, V345, P325, DOI 10.1126/science.1246067
   White J.W.C, 2013, ABRUPT IMPACTS CLIMA
   World Health Organization, 2013, MILL DEV GOALS MDGS
   WWF, 2014, LIV PLAN REP 2014 SP
   Young HS, 2014, P NATL ACAD SCI USA, V111, P7036, DOI 10.1073/pnas.1404958111
   Zarfl C, 2011, MAR POLLUT BULL, V62, P1589, DOI 10.1016/j.marpolbul.2011.02.040
   Zarfl C, 2010, MAR POLLUT BULL, V60, P1810, DOI 10.1016/j.marpolbul.2010.05.026
NR 101
TC 15
Z9 15
U1 3
U2 143
PU UNIV CALIFORNIA PRESS
PI OAKLAND
PA 155 GRAND AVE, SUITE 400, OAKLAND, CA 94612-3758 USA
SN 2325-1026
J9 ELEMENTA-SCI ANTHROP
JI Elementa-Sci. Anthrop.
PD MAR 15
PY 2016
VL 4
BP 1
EP 9
AR UNSP 000094
DI 10.12952/journal.elementa.000094
PG 9
WC Environmental Sciences; Meteorology & Atmospheric Sciences
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences
GA DO0GZ
UT WOS:000377458700001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dupont-Rouzeyrol, M
   Biron, A
   O'Connor, O
   Huguon, E
   Descloux, E
AF Dupont-Rouzeyrol, Myrielle
   Biron, Antoine
   O'Connor, Olivia
   Huguon, Emilie
   Descloux, Elodie
TI Infectious Zika viral particles in breastmilk
SO LANCET
LA English
DT Letter
ID VIRUS; TRANSMISSION
C1 [Dupont-Rouzeyrol, Myrielle; Biron, Antoine; O'Connor, Olivia] Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caledonie, Noumea, New Caledonia.
   [Huguon, Emilie; Descloux, Elodie] Ctr Hosp Terr, Noumea, New Caledonia.
RP Dupont-Rouzeyrol, M (corresponding author), Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caledonie, Noumea, New Caledonia.
EM mdupont@pasteur.nc
OI O'CONNOR, Olivia/0000-0002-8108-8408
CR Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ognjan A, 2002, JAMA-J AM MED ASSOC, V288, P1976
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 6
TC 129
Z9 132
U1 1
U2 59
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 12
PY 2016
VL 387
IS 10023
BP 1051
EP 1051
DI 10.1016/S0140-6736(16)00624-3
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG0SD
UT WOS:000371775000017
PM 26944028
OA Bronze
DA 2020-07-08
ER

PT J
AU Jouannic, JM
   Friszer, S
   Leparc-Goffart, I
   Garel, C
   Eyrolle-Guignot, D
AF Jouannic, Jean-Marie
   Friszer, Stephanie
   Leparc-Goffart, Isabelle
   Garel, Catherine
   Eyrolle-Guignot, Dominique
TI Zika virus infection in French Polynesia
SO LANCET
LA English
DT Letter
C1 [Jouannic, Jean-Marie; Friszer, Stephanie] Univ Paris 06, Hop Armand Trousseau, AP HP, Serv Med Foetale, Paris, France.
   [Garel, Catherine] Univ Paris 06, Hop Armand Trousseau, AP HP, Serv Radiol Pediat, Paris, France.
   [Leparc-Goffart, Isabelle] Hop Instruct Armees Laveran, Ctr Natl Reference Arbovirus, Inst Rech Biomed Armees, Serv Biol, Marseille, France.
   [Eyrolle-Guignot, Dominique] Ctr Hosp Terr, Serv Gynecol Obstetr, Mamao, Papeete, France.
RP Jouannic, JM (corresponding author), Univ Paris 06, Hop Armand Trousseau, AP HP, Serv Med Foetale, Paris, France.
EM jean-marie.jouannic@aphp.fr
CR European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
NR 5
TC 69
Z9 71
U1 0
U2 42
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 12
PY 2016
VL 387
IS 10023
BP 1051
EP 1052
DI 10.1016/S0140-6736(16)00625-5
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG0SD
UT WOS:000371775000018
PM 26944027
DA 2020-07-08
ER

PT J
AU Vogel, G
AF Vogel, Gretchen
TI INFECTIOUS DISEASE Evidence grows for Zika virus as pregnancy danger
SO SCIENCE
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 7
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAR 11
PY 2016
VL 351
IS 6278
BP 1123
EP 1124
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ8YI
UT WOS:000386158400010
PM 26965596
DA 2020-07-08
ER

PT J
AU de Oliveira, WK
   Cortez-Escalante, J
   De Oliveira, WTGH
   do Carmo, GMI
   Henriques, CMP
   Coelho, GE
   de Franca, GVA
AF de Oliveira, Wanderson Kleber
   Cortez-Escalante, Juan
   Goncalves Holanda De Oliveira, Wanessa Tenorio
   Ikeda do Carmo, Greice Madeleine
   Pessanha Henriques, Claudio Maierovitch
   Coelho, Giovanini Evelim
   Araujo de Franca, Giovanny Vinicius
TI Increase in Reported Prevalence of Microcephaly in Infants Born to Women
   Living in Areas with Confirmed Zika Virus Transmission During the First
   Trimester of Pregnancy - Brazil, 2015
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [de Oliveira, Wanderson Kleber; Goncalves Holanda De Oliveira, Wanessa Tenorio; Ikeda do Carmo, Greice Madeleine; Pessanha Henriques, Claudio Maierovitch; Coelho, Giovanini Evelim; Araujo de Franca, Giovanny Vinicius] Minist Hlth, Brasilia, DF, Brazil.
   [Cortez-Escalante, Juan] Pan Amer Hlth Org, Sao Paulo, Brazil.
RP de Franca, GVA (corresponding author), Minist Hlth, Brasilia, DF, Brazil.
EM giovanny.franca@saude.gov.br
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nazer J, 2011, REV MED CHILE, V139, P72, DOI /S0034-98872011000100010
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 90
Z9 90
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 11
PY 2016
VL 65
IS 9
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF9QR
UT WOS:000371696600005
DA 2020-07-08
ER

PT J
AU Vorou, R
AF Vorou, R.
TI Letter to the editor: diagnostic challenges to be considered regarding
   Zika virus in the context of the presence of the vector Aedes albopictus
   in Europe
SO EUROSURVEILLANCE
LA English
DT Letter
C1 [Vorou, R.] Hellen Ctr Dis Control & Prevent, Unit Strateg Dev & Policy, Athens, Greece.
RP Vorou, R (corresponding author), Hellen Ctr Dis Control & Prevent, Unit Strateg Dev & Policy, Athens, Greece.
EM vorou@keelpno.gr
OI Vorou, Rengina/0000-0003-4176-8086
CR Boukraa S, 2015, J VECTOR ECOL, V40, P398, DOI 10.1111/jvec.12180
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calzolari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140915
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rubin E. J., 2016, N ENGL J MED
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 11
TC 12
Z9 12
U1 0
U2 60
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 10
PY 2016
VL 21
IS 10
BP 27
EP 28
AR 30161
DI 10.2807/1560-7917.ES.2016.21.10.30161
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DG6LL
UT WOS:000372195800005
PM 26988027
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Venturi, G
   Zammarchi, L
   Fortuna, C
   Remoli, ME
   Benedetti, E
   Fiorentini, C
   Trotta, M
   Rizzo, C
   Mantella, A
   Rezza, G
   Bartoloni, A
AF Venturi, G.
   Zammarchi, L.
   Fortuna, C.
   Remoli, M. E.
   Benedetti, E.
   Fiorentini, C.
   Trotta, M.
   Rizzo, C.
   Mantella, A.
   Rezza, G.
   Bartoloni, A.
TI Authors' reply: diagnostic challenges to be considered regarding Zika
   virus in the context of the presence of the vector Aedes albopictus in
   Europe
SO EUROSURVEILLANCE
LA English
DT Letter
C1 [Venturi, G.; Fortuna, C.; Remoli, M. E.; Benedetti, E.; Fiorentini, C.; Rezza, G.] Ist Super Sanita, Dept Infect Parasit & Immune Mediate Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Zammarchi, L.; Mantella, A.; Bartoloni, A.] Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
   [Zammarchi, L.; Trotta, M.; Bartoloni, A.] Azienda Osped Univ Caeggi, SOD Malattie Infett & Trop, Florence, Italy.
   [Rizzo, C.] Ist Super Sanita, Natl Ctr Epidemiol & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.
RP Bartoloni, A (corresponding author), Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.; Bartoloni, A (corresponding author), Azienda Osped Univ Caeggi, SOD Malattie Infett & Trop, Florence, Italy.
EM alessandro.bartoloni@unifi.it
RI VENTURI, GIULIETTA/O-8123-2015; BARTOLONI, ALESSANDRO/K-3403-2018;
   Rizzo, Caterina/H-4092-2012; rezza, giovanni/D-4393-2016; FORTUNA,
   CLAUDIA/O-9446-2015; Remoli, Maria Elena ME/O-9447-2015
OI VENTURI, GIULIETTA/0000-0002-9078-8350; BARTOLONI,
   ALESSANDRO/0000-0001-9758-1523; Rizzo, Caterina/0000-0002-5583-7508;
   rezza, giovanni/0000-0003-0268-6790; FORTUNA,
   CLAUDIA/0000-0001-8878-4505; Remoli, Maria Elena ME/0000-0003-3565-383X;
   ZAMMARCHI, Lorenzo/0000-0003-0892-8404
CR Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   European Centre for Disease Prevention Control (ECDC), 2016, FACTSH HLTH PROF
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Ministero della salute, 2015, DIR GEN PREV SAN UFF
   Olsen SJ, 2015, EMERG INFECT DIS, V21, P280, DOI 10.3201/eid2102.140291
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
NR 7
TC 8
Z9 8
U1 0
U2 5
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 10
PY 2016
VL 21
IS 10
BP 29
EP 30
DI 10.2807/1560-7917.ES.2016.21.10.30163
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DG6LL
UT WOS:000372195800006
PM 26988337
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI WHO strengthens Zika travel advice to pregnant women
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1042
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
NR 2
TC 1
Z9 3
U1 1
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 10
PY 2016
VL 352
AR i1460
DI 10.1136/bmj.i1460
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG4NP
UT WOS:000372049200009
PM 26965035
OA Green Published
DA 2020-07-08
ER

PT J
AU Kirk, EP
AF Kirk, Edwin P.
TI Zika virus: accurate terminology matters
SO NATURE
LA English
DT Letter
C1 [Kirk, Edwin P.] Sydney Childrens Hosp, Randwick, NSW, Australia.
   [Kirk, Edwin P.] Univ New S Wales, Randwick, NSW, Australia.
   [Kirk, Edwin P.] SEALS Labs, Randwick, NSW, Australia.
RP Kirk, EP (corresponding author), Sydney Childrens Hosp, Randwick, NSW, Australia.; Kirk, EP (corresponding author), Univ New S Wales, Randwick, NSW, Australia.; Kirk, EP (corresponding author), SEALS Labs, Randwick, NSW, Australia.
EM edwin.kirk@health.nsw.gov.au
OI Kirk, Edwin/0000-0002-4662-0024
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   MERLOB P, 1988, J MED GENET, V25, P750, DOI 10.1136/jmg.25.11.750
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 3
TC 0
Z9 0
U1 0
U2 76
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 10
PY 2016
VL 531
IS 7593
BP 173
EP 173
DI 10.1038/531173b
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF9EZ
UT WOS:000371665100021
PM 26961646
OA Bronze
DA 2020-07-08
ER

PT J
AU Scheuermann, RH
AF Scheuermann, Richard H.
CA Viral Genome Annotation Stand Work
TI Zika virus: designate standardized names
SO NATURE
LA English
DT Letter
C1 [Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA USA.
RP Scheuermann, RH (corresponding author), J Craig Venter Inst, La Jolla, CA USA.
EM rscheuermann@jcvi.org
NR 0
TC 2
Z9 2
U1 0
U2 65
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 10
PY 2016
VL 531
IS 7593
BP 173
EP 173
DI 10.1038/531173a
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF9EZ
UT WOS:000371665100020
PM 26961650
DA 2020-07-08
ER

PT J
AU Butler, D
AF Butler, Declan
TI Zika-linked birth defects seen in Colombia
SO NATURE
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 10
PY 2016
VL 531
IS 7593
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF9EZ
UT WOS:000371665100012
DA 2020-07-08
ER

PT J
AU Barzon, L
   Pacenti, M
   Berto, A
   Sinigaglia, A
   Franchin, E
   Lavezzo, E
   Brugnaro, P
   Palu, G
AF Barzon, L.
   Pacenti, M.
   Berto, A.
   Sinigaglia, A.
   Franchin, E.
   Lavezzo, E.
   Brugnaro, P.
   Palu, G.
TI Isolation of infectious Zika virus from saliva and prolonged viral RNA
   shedding in a traveller returning from the Dominican Republic to Italy,
   January 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID WEST NILE VIRUS; RT-PCR ASSAY; FRENCH-POLYNESIA; TRANSMISSION;
   CHIKUNGUNYA; DENGUE; OUTBREAK; URINE; EPIDEMIC; REGION
AB We report the isolation of infectious Zika virus (ZIKV) in cell culture from the saliva of a patient who developed a febrile illness after returning from the Dominican Republic to Italy, in January 2016. The patient had prolonged shedding of viral RNA in saliva and urine, at higher load than in blood, for up to 29 days after symptom onset. Sequencing of ZIKV genome showed relatedness with strains from Latin America.
C1 [Barzon, L.; Berto, A.; Franchin, E.; Lavezzo, E.; Palu, G.] Univ Padua, Dept Mol Med, Padua, Italy.
   [Barzon, L.; Pacenti, M.; Franchin, E.; Palu, G.] Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
   [Sinigaglia, A.] Veneto Inst Oncol IOV IRCCS, Padua, Italy.
   [Brugnaro, P.] Venice City Hosp SS Giovanni & Paolo, Dept Infect Dis, Venice, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.; Barzon, L (corresponding author), Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
EM luisa.barzon@unipd.it
RI Lavezzo, Enrico/K-7962-2016; Barzon, Luisa/K-7961-2016
OI Lavezzo, Enrico/0000-0002-3902-8356; Barzon, Luisa/0000-0003-0720-8456;
   sinigaglia, alessandro/0000-0002-2386-1757
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Barzon L, 2012, CLIN MICROBIOL INFEC, V18, pE541, DOI 10.1111/1469-0691.12001
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G., 2016, LANCET INFECT DIS
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET
   Centers for Disease Control and Prevention (CDC), 2016, HAN PRIOR PROF MED P
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupount-Rouzeyrol M, 2016, LANCET
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gobbi F, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-60
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 37
TC 90
Z9 90
U1 0
U2 41
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 10
PY 2016
VL 21
IS 10
BP 2
EP 6
AR 30159
DI 10.2807/1560-7917.ES.2016.21.10.30159
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DG6LL
UT WOS:000372195800001
PM 26987769
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mlakar, J
   Korva, M
   Tul, N
   Popovic, M
   Poljsak-Prijatelj, M
   Mraz, J
   Kolenc, M
   Rus, KR
   Vipotnik, TV
   Vodusek, VF
   Vizjak, A
   Pizem, J
   Petrovec, M
   Zupanc, TA
AF Mlakar, Jernej
   Korva, Misa
   Tul, Natasa
   Popovic, Mara
   Poljsak-Prijatelj, Mateja
   Mraz, Jerica
   Kolenc, Marko
   Rus, Katarina Resman
   Vipotnik, Tina Vesnaver
   Vodusek, Vesna Fabjan
   Vizjak, Alenka
   Pizem, Joze
   Petrovec, Miroslav
   Zupanc, Tatjana Avsic
TI Zika Virus Associated with Microcephaly
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
AB A widespread epidemic of Zika virus (ZIKV) infection was reported in 2015 in South and Central America and the Caribbean. A major concern associated with this infection is the apparent increased incidence of microcephaly in fetuses born to mothers infected with ZIKV. In this report, we describe the case of an expectant mother who had a febrile illness with rash at the end of the first trimester of pregnancy while she was living in Brazil. Ultrasonography performed at 29 weeks of gestation revealed microcephaly with calcifications in the fetal brain and placenta. After the mother requested termination of the pregnancy, a fetal autopsy was performed. Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation. ZIKV was found in the fetal brain tissue on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, with consistent findings on electron microscopy. The complete genome of ZIKV was recovered from the fetal brain.
C1 [Mlakar, Jernej; Popovic, Mara; Mraz, Jerica; Vizjak, Alenka; Pizem, Joze] Univ Ljubljana, Inst Pathol, Fac Med, Ljubljana, Slovenia.
   [Korva, Misa; Poljsak-Prijatelj, Mateja; Kolenc, Marko; Rus, Katarina Resman; Petrovec, Miroslav; Zupanc, Tatjana Avsic] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia.
   [Tul, Natasa; Vodusek, Vesna Fabjan] Univ Med Ctr Ljubljana, Dept Perinatol, Div Gynecol & Obstet, Ljubljana, Slovenia.
   [Vipotnik, Tina Vesnaver] Univ Med Ctr Ljubljana, Inst Radiol, Ljubljana, Slovenia.
RP Zupanc, TA (corresponding author), Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia.
EM tatjana.avsic@mf.uni-ij.si
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goldsmith CS, 2013, EMERG INFECT DIS, V19, P886, DOI 10.3201/eid1906.130173
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Macdonald EM, 2014, INT J PEDIAT, DOI 10.1155/2014/291846
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
NR 19
TC 1238
Z9 1309
U1 38
U2 768
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 10
PY 2016
VL 374
IS 10
BP 951
EP 958
DI 10.1056/NEJMoa1600651
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF9DH
UT WOS:000371660000008
PM 26862926
DA 2020-07-08
ER

PT J
AU Rubin, EJ
   Greene, MF
   Baden, LR
AF Rubin, Eric J.
   Greene, Michael F.
   Baden, Lindsey R.
TI Zika Virus and Microcephaly
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID INFECTION
C1 [Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.
   [Greene, Michael F.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.
RP Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Koch R, 1891, 10 VERH INT MED C BE, VI, P35
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 7
TC 78
Z9 86
U1 0
U2 52
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 10
PY 2016
VL 374
IS 10
BP 984
EP 985
DI 10.1056/NEJMe1601862
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF9DH
UT WOS:000371660000015
PM 26862812
OA Bronze
DA 2020-07-08
ER

PT J
AU Ai, JW
   Zhang, Y
   Zhang, WH
AF Ai, Jing-Wen
   Zhang, Ying
   Zhang, Wenhong
TI Zika virus outbreak: 'a perfect storm'
SO EMERGING MICROBES & INFECTIONS
LA English
DT News Item
C1 [Ai, Jing-Wen; Zhang, Ying; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China.
   [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
   [Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOH, Shanghai 200032, Peoples R China.
   [Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOE Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
RP Zhang, WH (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China.; Zhang, WH (corresponding author), Fudan Univ, Shanghai Med Coll, MOH, Shanghai 200032, Peoples R China.; Zhang, WH (corresponding author), Fudan Univ, Shanghai Med Coll, MOE Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
EM zhangwenhong@fudan.edu.cn
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, EPIDEMIOLOGICAL ALER
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, 2015 NUM REP CAS DEN
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, 2014 NUMB REP CAS DE
   Ritchie SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105846
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 18
TC 14
Z9 14
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 9
PY 2016
VL 5
AR e21
DI 10.1038/emi.2016.42
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DJ0IV
UT WOS:000373886600002
PM 26956448
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mayor, S
AF Mayor, Susan
TI Zika infection in pregnancy is linked to range of fetal abnormalities,
   data indicate
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412..26943629, DOI 10.1056/NEJM0A1602412..26943629]
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1322
NR 2
TC 4
Z9 4
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 7
PY 2016
VL 352
AR i1362
DI 10.1136/bmj.i1362
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG4NH
UT WOS:000372048400009
PM 26951804
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Barreto, ML
   Barral-Netto, M
   Stabeli, R
   Almeida, N
   Vasconcelos, PFC
   Teixeira, M
   Buss, P
   Gadelha, PE
AF Barreto, Mauricio L.
   Barral-Netto, Manoel
   Stabeli, Rodrigo
   Almeida-Filho, Naomar
   Vasconcelos, Pedro F. C.
   Teixeira, Mauro
   Buss, Paulo
   Gadelha, Paulo E.
TI Zika virus and microcephaly in Brazil: a scientific agenda
SO LANCET
LA English
DT Editorial Material
C1 [Barreto, Mauricio L.; Barral-Netto, Manoel] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Buss, Paulo] Fundacao Oswaldo Cruz, Ctr Int Relat Hlth, Rio De Janeiro, Brazil.
   [Stabeli, Rodrigo; Gadelha, Paulo E.] Fundacao Oswaldo Cruz, Off Presidency, Rio De Janeiro, Brazil.
   [Almeida-Filho, Naomar] Univ Fed Sul Bahia, Itabuna, Brazil.
   [Vasconcelos, Pedro F. C.] Inst Evandro Chagas, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil.
   [Teixeira, Mauro] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
RP Barreto, ML (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
EM mauricio.barreto@bahia.fiocruz.br
RI Teixeira, Mauro M/A-4587-2008; Barral-Netto, Manoel/B-3904-2009;
   Barreto, Mauricio L/B-1752-2008; Vasconcelos, Pedro/AAH-3142-2019;
   Stabeli, Rodrigo Guerino/G-1721-2017
OI Teixeira, Mauro M/0000-0002-6944-3008; Barral-Netto,
   Manoel/0000-0002-5823-7903; Barreto, Mauricio L/0000-0002-0215-4930;
   Stabeli, Rodrigo Guerino/0000-0002-0476-920X
CR Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   Horton R, 2016, LANCET, V387, P520, DOI 10.1016/S0140-6736(16)00229-4
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lederberg J, 1992, EMERGING INFECT MICR
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude Brazil, 2016, 11 MIN SAUD
   Ministerio da Saude Brazil, 2015, 1813 MIN SAUD
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 12
TC 28
Z9 32
U1 0
U2 52
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 5
PY 2016
VL 387
IS 10022
BP 919
EP 921
DI 10.1016/S0140-6736(16)00545-6
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF8XP
UT WOS:000371644200005
PM 26921913
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Karimi, O
   Goorhuis, A
   Schinkel, J
   Codrington, J
   Vreden, SGS
   Vermaat, JS
   Stijnis, C
   Grobusch, MP
AF Karimi, Ouafae
   Goorhuis, Abraham
   Schinkel, Janke
   Codrington, John
   Vreden, Stephen Gerold S.
   Vermaat, Joost S.
   Stijnis, Cornelis
   Grobusch, Martin Peter
TI Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus
   infection
SO LANCET
LA English
DT Letter
C1 [Karimi, Ouafae; Goorhuis, Abraham; Stijnis, Cornelis; Grobusch, Martin Peter] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis, NL-1100 DD Amsterdam, Netherlands.
   [Vermaat, Joost S.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1100 DD Amsterdam, Netherlands.
   [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
   [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1100 DD Amsterdam, Netherlands.
   [Codrington, John] Acad Hosp Paramaribo, Dept Lab, Paramaribo, Suriname.
   [Vreden, Stephen Gerold S.] Acad Hosp Paramaribo, Internal Med & Infect Dis, Paramaribo, Suriname.
RP Grobusch, MP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis, NL-1100 DD Amsterdam, Netherlands.
EM m.p.grobusch@amc.uva.nl
RI Schinkel, Janke/I-3099-2012
OI Schinkel, Janke/0000-0002-1112-0644; Vermaat, Joost/0000-0002-1628-6256
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Overbosch FW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-493
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 5
TC 56
Z9 56
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 5
PY 2016
VL 387
IS 10022
BP 939
EP 940
DI 10.1016/s0140-6736(16)00502-X
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF8XP
UT WOS:000371644200017
PM 26906627
DA 2020-07-08
ER

PT J
AU Meaney-Delman, D
   Hills, SL
   Williams, C
   Galang, RR
   Iyengar, P
   Hennenfent, AK
   Rabe, IB
   Panella, A
   Oduyebo, T
   Honein, MA
   Zaki, S
   Lindsey, N
   Lehman, JA
   Kwit, N
   Bertolli, J
   Ellington, S
   Igbinosa, I
   Minta, AA
   Petersen, EE
   Mead, P
   Rasmussen, SA
   Jamieson, DJ
AF Meaney-Delman, Dana
   Hills, Susan L.
   Williams, Charnetta
   Galang, Romeo R.
   Iyengar, Preetha
   Hennenfent, Andrew K.
   Rabe, Ingrid B.
   Panella, Amanda
   Oduyebo, Titilope
   Honein, Margaret A.
   Zaki, Sherif
   Lindsey, Nicole
   Lehman, Jennifer A.
   Kwit, Natalie
   Bertolli, Jeanne
   Ellington, Sascha
   Igbinosa, Irogue
   Minta, Anna A.
   Petersen, Emily E.
   Mead, Paul
   Rasmussen, Sonja A.
   Jamieson, Denise J.
TI Zika Virus Infection Among US Pregnant Travelers - August 2015-February
   2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES; INTERIM GUIDELINES; WOMEN; OUTBREAK
C1 [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Hills, Susan L.; Rabe, Ingrid B.; Panella, Amanda; Lindsey, Nicole; Lehman, Jennifer A.; Mead, Paul] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Williams, Charnetta; Galang, Romeo R.; Oduyebo, Titilope; Kwit, Natalie; Minta, Anna A.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Williams, Charnetta; Galang, Romeo R.; Bertolli, Jeanne] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Iyengar, Preetha] District Columbia Dept Hlth, Washington, DC USA.
   [Hennenfent, Andrew K.] CDC, CSTE Appl Epidemiol Fellowship, Dist Columbia Dept Hlth, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope; Ellington, Sascha; Petersen, Emily E.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Zaki, Sherif] CDC, Div High Consequence Pathogens, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Igbinosa, Irogue] CDC, Div Sci Educ & Dev, Atlanta, GA 30333 USA.
   [Minta, Anna A.] CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Meaney-Delman, D (corresponding author), CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM ZikaMCH@cdc.gov
RI Hennenfent, Andrew/K-6548-2019
OI Jamieson, Denise/0000-0003-2597-1201
CR CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401
NR 13
TC 83
Z9 89
U1 0
U2 27
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 4
PY 2016
VL 65
IS 8
BP 211
EP 214
DI 10.15585/mmwr.mm6508e1
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4UC
UT WOS:000371345500004
PM 26938703
OA Bronze
DA 2020-07-08
ER

PT J
AU Hills, SL
   Russell, K
   Hennessey, M
   Williams, C
   Oster, AM
   Fischer, M
   Mead, P
AF Hills, Susan L.
   Russell, Kate
   Hennessey, Morgan
   Williams, Charnetta
   Oster, Alexandra M.
   Fischer, Marc
   Mead, Paul
TI Transmission of Zika Virus Through Sexual Contact with Travelers to
   Areas of Ongoing Transmission - Continental United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID INTERIM GUIDELINES
C1 [Hills, Susan L.; Hennessey, Morgan; Fischer, Marc; Mead, Paul] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Russell, Kate; Hennessey, Morgan; Williams, Charnetta] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Williams, Charnetta] CDC, Div Sexually Transmitted Dis Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Oster, Alexandra M.] CDC, Div HIV AIDS Prevent, NCHHSTP, Atlanta, GA 30333 USA.
RP Mead, P (corresponding author), CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM pmead@cdc.gov
OI Russell, Kate/0000-0001-9343-3355
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Council of State and Territorial Epidemiologists, 2015, 2015 NAT SURV CAS DE
   Dallas County Health and Human Services, 2016, DCHHS REP 1 ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Meaney-Delman D, 2016, MMWR MORB MORTAL WKL, V65
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, COUNTR TERR AUT ZIK
NR 9
TC 259
Z9 264
U1 0
U2 50
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 4
PY 2016
VL 65
IS 8
BP 215
EP 216
DI 10.15585/mmwr.mm6508e2
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4UC
UT WOS:000371345500005
PM 26937739
OA Bronze
DA 2020-07-08
ER

EF